Citrus Sinensis ID: 003555

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-
Protein Sequence
MASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSSNSQTLSSAFTNTD
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEccccEEEEEEEEccccEEEEEEccccccccEEEEccccccccccccEEEEEEccEEEEEcccccEEEEcccccccccEEEEEccccEEEEEccccEEEEEccccccccccccEEccccEEEEccccccccccEEEEEEEcccEEEEEEccccEEEEEcccccccccEEEEEEEccccEEEEEEcccccEEEEEEEEEEEccccEEEEEEEcccccEEEEEEcccccccccEEEEEEEcccccccccccccccccccccccccccccccccccEEccccccccccEEcccccccccccccccEEEEEccccccccccccccccccHHHHHHHHHccccEEEEEEccccEEEcccccccEEEEcccccEEEEEEccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHcccccccccccccEEEEEEEccccEEEEEEEcccccHHHHHHHHHHHHHHHHHcccccccEEEcccccccEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccHHHHEHHcccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccEccccccEEEccccEEEEEEEcccccEEEEEEEEcccccEEEEEEccccccccccEEEEEccccEEEEEccccEEEEEcccccccccEEEEEccccEEEEcccccEEEEcccccccccccccccccccEEEEcccccccccccEEEEEccccccEEEEEcccEEEEEcccccccEEEEcccccccccEEEEEEEEccHHHccEEEEEEEEcccEEEEEEEccccEEEEEEEEccccccccEEEEEEccccccccccccccccEEEcccccccccccccccccccccHHHHHcccccccccccccEEcccccEEEEccccccccccEEEEEccccHHHHHHHHHHcccEEEEEEcccccEEccccEEEEEEcccccccEEEEEccccccEEEEEcHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEcHHHHHHHHHcccHcccccccccEEccEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccHcEEEEcccccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHccccEEEEcccccccHHHHHHHHHHHHHHHcccccccccHHHHEEEccccccccccccccEEEEccccccccccccccc
Coil and Loop (DISEMBL)
MASSACVSLILFFTIFEIINAAQlknqqskpislgsslspssepsswtspsglfqfgfykegtgfsvgtwlvtspniTVIWTafrdeppvssnakLILTMDGLVLQTEESKHKLIAnttsdepasfasildsgnfvlcndRFDFIwesfnfpthtivggqslvngsklfssasetnsstgrfcleqrdgilvlypvrdsrqiYWVSKLYWasdrvhgmvnltpggilqagsadATQILARSSysvkssneTVIYRATLDFDGILRLYShhftsdsnyraDIEWYVLQNQClvkgfcgfnsfcsnptnsstkgecfcfrgfnfinpemkflgcyrnftdeegckrkmpaefyKITSLEISQLGGMAYAKLSvnekdcsksclndcycgaAIYAnascskhklPLIFAMKYQNVPATLFIKWssgqanlstnlsalpivskkhgdnkKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLrinsslgpsqeFIIQSFstgeleratngfeeelgrgcfgavykgsicegNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLsnvesgpiwRDRVRIALDVARGITYLHEECEVQIIhcninprnillddsltaKISNFSLAkilmpnqtgivtgvkgtrgymspewqnsglitvksdvySFGVVVLEIVCCrsnfevnvSTADVVLLSTWVYNCFIAKElsklvgedeevdLRTLETMVRVGLLciqdepnlrpsMKNVILMLEgtmeipvvpfpilsnfssnsqtlssaftntd
Flexible Loop (DISEMBL)
MASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASEtnsstgrfcleqrdgilvlypvrdsrqIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSsysvkssnetVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRinsslgpsqEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLsnvesgpiwrDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFslakilmpnqtGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKElsklvgedeeVDLRTLETMVRVGLlciqdepnlrpSMKNVILMLEGTMEIPVVPFPILsnfssnsqtlssaftntd
Low Complexity Region (SEG)
MASSACVSLILFFTIFEIINAAQLKNQQskpislgsslspssepsswtspsGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPIlsnfssnsqtlssaftNTD
Disordered region (IsUnstruct)
****ACVSLILFFTIFEIINAAQ****************************GLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQT*******I*********SFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKL***********GRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN********FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSN****************
Disordered Region (DISOPRED)
****ACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSE**SWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCY****************FYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQA**********************LVSVLAACLGSITFLCFLIAISSLLAYKQ********************IIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF*****TADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP********************
Disordered Region (DISEMBL)
MASSACVSLILFFTIFEIINAAQLK***********************SPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLF*********TGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSSNS***********
Disordered Region (DISPRO)
*ASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQ**************EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFS**************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSSNSQTLSSAFTNTD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	811	2.2.26 [Sep-21-2011]
Q39202	832	G-type lectin S-receptor-	yes	no	0.948	0.924	0.325	1e-102
Q9XID3	829	G-type lectin S-receptor-	no	no	0.871	0.852	0.322	1e-88
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.928	0.863	0.300	3e-84
Q39203	797	G-type lectin S-receptor-	no	no	0.833	0.848	0.303	6e-77
O64477	828	G-type lectin S-receptor-	no	no	0.865	0.847	0.294	8e-75
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.865	0.855	0.293	3e-74
P17801	817	Putative receptor protein	N/A	no	0.905	0.898	0.296	1e-72
O65238	872	G-type lectin S-receptor-	no	no	0.848	0.788	0.289	5e-69
O81905	850	Receptor-like serine/thre	no	no	0.898	0.857	0.291	5e-67
O64782	805	G-type lectin S-receptor-	no	no	0.916	0.922	0.284	3e-66

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  374 bits (960), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 281/862 (32%), Positives = 426/862 (49%), Gaps = 93/862 (10%)

Query: 1   MASSAC--VSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSE---PSSWTSPSGLFQ 55
           M S +C  + L+L   +      +Q  N ++  + +G SL+ S      SSW SPSG F 
Sbjct: 1   MGSLSCSIIHLVLILQLQTFFVFSQ--NIRNGSVPVGESLTASESQQISSSWRSPSGDFA 58

Query: 56  FGFYK--EGTGFSVGTWLVTSPNITVIWTAFRDEPP---VSSNAKLILTMDGLVLQTEES 110
           FGF K     GF++  W     + T++W A         V + +K+ LT DG ++  +  
Sbjct: 59  FGFRKIQPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPR 118

Query: 111 KHKLIANTTSDEPASFASILDSGNFVL----CNDRFDFIWESFNFPTHTIVGGQSLVNGS 166
             +L     S    S     D GNFVL      D  + +W SF  PT T++  Q++  G 
Sbjct: 119 GQELW-RALSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGR 177

Query: 167 KLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGG 225
            L S  +ET+   GRF L  + DG L L+ +  + +    S +Y      +      PG 
Sbjct: 178 NLSSRRTETSFKKGRFSLRLEDDGNLQLHSL--NAETASESDIYSQYYESNTNDPNNPGI 235

Query: 226 ILQAGSADATQILAR--SSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADI-- 281
            L    +    +L R  S + VK            D D    + +  + S     + I  
Sbjct: 236 QLVFNQSGEIYVLQRNNSRFVVK------------DRDPDFSIAAPFYISTGFLLSTIIP 283

Query: 282 -EWYVLQNQCLVKGFC----------------GFNSFCSNPTNSSTKGECFCFRGFNFIN 324
            E   +   CL+ G C                G+N+ CS   N   K  C C   F   +
Sbjct: 284 KEARRIVGGCLL-GLCRDNMCSPDDALGNMACGYNNICSLGNNKRPK--CECPERFVLKD 340

Query: 325 PEMKFLGCYRNFTDE----EGCKRKMPAEFYKITSLEISQLGGMAYAKLS-VNEKDCSKS 379
           P  ++  C  +F  +    E          Y+  +LE +      Y   +  +E+ C  S
Sbjct: 341 PSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKAS 400

Query: 380 CLNDCYCGAAIYA---NASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPI 436
           CL+DC C A I+    +  C K K PL    +     +  FIK        + +++ +P+
Sbjct: 401 CLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVR------NRSIADVPV 454

Query: 437 VSKKHGDNKKKLVSVLAAC---LGSITFLCFLIAISSLLAYKQR---VNQYQKLRINSSL 490
                G+  KKL  ++ AC   LG+  F+ F  + S     K +    NQ + +   ++ 
Sbjct: 455 T----GNRAKKLDWLIIACSVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTAT 510

Query: 491 GPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG--SICEGNKI-VAVKRLENPVE 547
             + E  ++ F+ GEL  AT  F EELGRG FG VYKG   +  G+++ VAVK+L+    
Sbjct: 511 TTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDL 570

Query: 548 EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR 607
           + E++F+ E+  + + HHKNLVRL+GFC +   +++VYEF+ +G+L N L      P W 
Sbjct: 571 DNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR-RPRPSWE 629

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           DR  IA+ +ARGI YLHEEC  QIIHC+I P+NILLD+  T +IS+F LAK+L+ NQT  
Sbjct: 630 DRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYT 689

Query: 668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV 727
           +T ++GT+GY++PEW  +  IT K DVYS+GV++LEIVCC+      V   D V+L  W 
Sbjct: 690 LTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKK----AVDLEDNVILINWA 745

Query: 728 YNCFIAKELSKLVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI 785
           Y+CF    L  L  +D E   D+ T+E  V++ + CIQ+E  +RP+M+NV  MLEG +++
Sbjct: 746 YDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQV 805

Query: 786 --PVVPFPILSNFSSNSQTLSS 805
             P  P P  S F+ + ++LSS
Sbjct: 806 FDPPNPSP-YSTFTWSDESLSS 826

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  328 bits (840), Expect = 1e-88,   Method: Compositional matrix adjust.
 Identities = 267/828 (32%), Positives = 393/828 (47%), Gaps = 121/828 (14%)

Query: 32  ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPP-- 89
           I LGS +  S    +W SP+  F   F               SPN  +   +F    P  
Sbjct: 27  IPLGSVIYASGSNQNWPSPNSTFSVSFVPS-----------PSPNSFLAAVSFAGSVPIW 75

Query: 90  ----VSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFI 145
               V S   L L   G +  T  S   +  + T     +  SI D+G F+L N+R   +
Sbjct: 76  SAGTVDSRGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPV 135

Query: 146 WESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYW 204
           W SF+ PT TIV  Q+   G  L S         G +  + +R G L L    ++  IYW
Sbjct: 136 WSSFDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLR--WNTSAIYW 184

Query: 205 VSKLYWA----------SDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIY 254
              L  +          S + +G+V++    +L  G A+         YS    +     
Sbjct: 185 NHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLL--GGAEIV-------YSGDYGDSNTFR 235

Query: 255 RATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCS-NPTNSSTKGE 313
              LD DG LR+YS    S ++   +  W  + +QCLV G+CG    CS N TN      
Sbjct: 236 FLKLDDDGNLRIYSS--ASRNSGPVNAHWSAV-DQCLVYGYCGNFGICSYNDTNPI---- 288

Query: 314 CFC-FRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGG------MAY 366
           C C  R F+F++   +           +GCKRK          +E+S   G      + +
Sbjct: 289 CSCPSRNFDFVDVNDR----------RKGCKRK----------VELSDCSGNTTMLDLVH 328

Query: 367 AKLSVNEKD------------CSKSCLNDCYCGAAIY---ANASC-SKHKLPLIFAMKYQ 410
            +L   E D            C  +CL+   C A++     + +C  KH        ++ 
Sbjct: 329 TRLFTYEDDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWP 388

Query: 411 NVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISS 470
           +VP+T ++K       +   + A  +     GD+    V +    +  I  L  L+A+  
Sbjct: 389 SVPSTSYVK-------VCGPVVANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEI 441

Query: 471 LLAYK--QRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG 528
            L +   ++  ++  L  + +L          F+  EL+R T  F+E+LG G FG VY+G
Sbjct: 442 GLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRG 501

Query: 529 SICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM 588
            +     +VAVK+LE  +E+GE++F+ E+A +  THH NLVRL+GFC Q   +LLVYEFM
Sbjct: 502 -VLTNRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFM 559

Query: 589 SKGSLENLLSNVESGPI--WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS 646
             GSL+N L   +S     W  R  IAL  A+GITYLHEEC   I+HC+I P NIL+DD+
Sbjct: 560 RNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDN 619

Query: 647 LTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             AK+S+F LAK+L P      ++ V+GTRGY++PEW  +  IT KSDVYS+G+V+LE+V
Sbjct: 620 FAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELV 679

Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCF----IAKELSKLVGEDEEVDLRTLETMVRVGLLC 761
             + NF+V+  T +    S W Y  F        L   + ED+ VD+  +  MV+    C
Sbjct: 680 SGKRNFDVSEKT-NHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWC 738

Query: 762 IQDEPNLRPSMKNVILMLEGTMEI--PVVPFPILS-NFSSNSQTLSSA 806
           IQ++P  RP+M  V+ MLEG  EI  P+ P  I   +FS NS + S A
Sbjct: 739 IQEQPLQRPTMGKVVQMLEGITEIKNPLCPKTISEVSFSGNSMSTSHA 786

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  313 bits (803), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 251/836 (30%), Positives = 397/836 (47%), Gaps = 83/836 (9%)

Query: 7   VSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGF--YKEGTG 64
           V L  FF  F +  A +        I LGS L  S    +W S +G F  GF  +K    
Sbjct: 11  VGLFSFFCFFLVSLATE------PHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDR 64

Query: 65  FSVGTWLVTSP-NITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEP 123
           F +  W    P + T++W+  R+ P V+  A L L   G ++ ++++     +NT S+  
Sbjct: 65  FLLSIWFAQLPGDPTIVWSPNRNSP-VTKEAVLELEATGNLVLSDQNTVVWTSNT-SNHG 122

Query: 124 ASFASILDSGNFVLCNDRFDF---IWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTG 180
              A + +SGNF+L          IW+SF+ P+ T++  Q L    +L S+ S +     
Sbjct: 123 VESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHY 182

Query: 181 RFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGS--------- 231
              + Q+   L L    +       +  YW+   +  +       +   GS         
Sbjct: 183 SLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIVYGESS 242

Query: 232 ----------ADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADI 281
                      D  +    SS ++  +   V+ R  L+ +G LRLY      + + +   
Sbjct: 243 IGAVYVYKNPVDDNRNYNNSS-NLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSSQWVP 301

Query: 282 EWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEG 341
           EW  + N C + G CG N  C N   +    +C C  G   +  +     C  N +  + 
Sbjct: 302 EWAAVSNPCDIAGICG-NGVC-NLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQE 359

Query: 342 CKRKMPAE-FYKITSLEISQLGGMAYAKLSV--------NEKDCSKSCLNDCYCGAAIYA 392
           C+  +     +KI+++   Q     +++ SV        N + C + CL+DC C A++Y 
Sbjct: 360 CESNINRNGSFKISTV---QETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVYG 416

Query: 393 NASCSKHKLPLIFAMK------YQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKK 446
                  + P  + +K      +++  +TLF+K  + ++  S + +      K HG  +K
Sbjct: 417 ----LDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQK 472

Query: 447 KLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGEL 506
            LV  +      +  L  +  +  LL Y     +  K    +SL      +  SF+  +L
Sbjct: 473 VLVIPIV-----VGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPV--SFTYRDL 525

Query: 507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK 566
           +  TN F + LG G FG VYKG++  G  +VAVKRL+  +  GER+F  E+  +   HH 
Sbjct: 526 QNCTNNFSQLLGSGGFGTVYKGTVA-GETLVAVKRLDRALSHGEREFITEVNTIGSMHHM 584

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP---IWRDRVRIALDVARGITYL 623
           NLVRL G+C + S +LLVYE+M  GSL+  + + E       WR R  IA+  A+GI Y 
Sbjct: 585 NLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYF 644

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           HE+C  +IIHC+I P NILLDD+   K+S+F LAK++    + +VT ++GTRGY++PEW 
Sbjct: 645 HEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWV 704

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY----NCFIAKELSKL 739
           ++  ITVK+DVYS+G+++LEIV  R N +++    D      W Y    N    K + K 
Sbjct: 705 SNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAED-FFYPGWAYKELTNGTSLKAVDKR 763

Query: 740 ---VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM-EIPVVPFP 791
              V E+EEV        ++V   CIQDE ++RPSM  V+ +LEGT  EI + P P
Sbjct: 764 LQGVAEEEEV-----VKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  289 bits (739), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 229/755 (30%), Positives = 352/755 (46%), Gaps = 79/755 (10%)

Query: 53  LFQFGFYKEGTGFS---VGTWLVTSPNITVIWTAFRDEP---PVSSNAKLILTMDGLVLQ 106
           +F+ GF+    G S   +G    + P  T +W A R  P   P SS   L LT  G ++ 
Sbjct: 39  IFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSST--LELTSTGYLI- 95

Query: 107 TEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGS 166
               +  ++  T + +P +     ++GN +L ND    +W+SF+ PT T + G ++   +
Sbjct: 96  VSNLRDGVVWQTDNKQPGTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLT 155

Query: 167 KLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGI 226
            + S  S  + S G + L           V      YW S   W  +   G+  +T   I
Sbjct: 156 AMTSWRSLFDPSPGFYSLRLSPSFNEFQLVYKGTTPYW-STGNWTGEAFVGVPEMTIPYI 214

Query: 227 LQAGSADATQILARSSYSV---KSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEW 283
            +    +     A   Y V    S +E  + R  +  +G L+ Y+    + S    ++ W
Sbjct: 215 YRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDPQTQS---WNMFW 271

Query: 284 YVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCK 343
              ++ C V   CG   FCS    S     C C RGF   N        +R+    +GC+
Sbjct: 272 LQPEDPCRVYNLCGQLGFCS----SELLKPCACIRGFRPRND-----AAWRSDDYSDGCR 322

Query: 344 RKMPAEFYKITSLE----ISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKH 399
           R+      K  + E    +   G +  ++L V++  C+K+CL +  C    Y       H
Sbjct: 323 RENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSC-VGFY-------H 374

Query: 400 KLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSI 459
           K                       ++NL   L   P   K    N  K + +L + +GSI
Sbjct: 375 K----------------------EKSNLCKILLESPNNLKNSKGNISKSIIILCSVVGSI 412

Query: 460 TFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGR 519
           + L F + +  +L  + R  +  + +            ++ FS  EL+ ATNGF +++G 
Sbjct: 413 SVLGFTLLVPLILLKRSRKRKKTRKQDEDGFA---VLNLKVFSFKELQSATNGFSDKVGH 469

Query: 520 GCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS 579
           G FGAV+KG++   +  VAVKRLE P   GE +F+AE+  +    H NLVRL GFC +  
Sbjct: 470 GGFGAVFKGTLPGSSTFVAVKRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENL 528

Query: 580 KKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINP 638
            +LLVY++M +GSL + LS      + W  R RIAL  A+GI YLHE C   IIHC+I P
Sbjct: 529 HRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKP 588

Query: 639 RNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFG 698
            NILLD    AK+S+F LAK+L  + + ++  ++GT GY++PEW +   IT K+DVYSFG
Sbjct: 589 ENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFG 648

Query: 699 VVVLEIVCCRSNFEVNVST--ADVVLLSTWVYNCFIAKEL----------SKLVGEDEEV 746
           + +LE++  R N  VN  T          W +  + A+E+          S+L G   E 
Sbjct: 649 MTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNG---EY 705

Query: 747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
           +   +  M  V + CIQD   +RP+M  V+ MLEG
Sbjct: 706 NTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  282 bits (721), Expect = 8e-75,   Method: Compositional matrix adjust.
 Identities = 230/780 (29%), Positives = 371/780 (47%), Gaps = 78/780 (10%)

Query: 49  SPSGLFQFGFYKEGT--GFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQ 106
           S  G ++ GF+K G+   F +G W     + T++W A RD+     N+ +    +G ++ 
Sbjct: 40  SSDGTYEMGFFKPGSSSNFYIGMWY-KQLSQTILWVANRDKAVSDKNSSVFKISNGNLIL 98

Query: 107 TEESKHKLI----ANTTSDEPASFASILDSGNFVLCND----RFDFIWESFNFPTHTIVG 158
            + +    +     N+TS   A  A + D GN VL         + +W+SF+ P  T + 
Sbjct: 99  LDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLP 158

Query: 159 GQSLV------NGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWAS 212
           G  +          +L S  S  + S G F LE  +          S + YW S  +   
Sbjct: 159 GVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSNE-YWSSGPWNPQ 217

Query: 213 DRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFT 272
            R+   V       +   S  +    +  +YS+   N+  + R  +D  G ++ ++    
Sbjct: 218 SRIFDSVPEMRLNYIYNFSFFSNTTDSYFTYSIY--NQLNVSRFVMDVSGQIKQFTWL-- 273

Query: 273 SDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFC-----FRGFNFINPEM 327
            + N   ++ W   + QC V  +CG    CS+      K E FC     FR  +  + ++
Sbjct: 274 -EGNKAWNLFWSQPRQQCQVYRYCGSFGICSD------KSEPFCRCPQGFRPMSQKDWDL 326

Query: 328 KFL--GCYRNFTDEEGCKRKMPAEFYKITSLEISQLGG-MAYAKLSVNEKDCSKSCLNDC 384
           K    GC R    E  C R    +F+++ +++++     +    LS+    C+ +C  DC
Sbjct: 327 KDYSAGCVRK--TELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSI----CASACQGDC 380

Query: 385 YCGAAIYANASC-----SKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSK 439
            C A  Y   S      SK  L L   ++ +N    +F         L    S +P V  
Sbjct: 381 SCKAYAYDEGSSKCLVWSKDVLNLQ-QLEDENSEGNIFY--------LRLAASDVPNVGA 431

Query: 440 KHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQ 499
               N K L+    A LGS+           +L     +   +  R     G   +  + 
Sbjct: 432 SGKSNNKGLI--FGAVLGSLG--------VIVLVLLVVILILRYRRRKRMRGEKGDGTLS 481

Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           +FS  EL+ AT  F ++LG G FG+V+KG++ + + I AVKRLE  + +GE++F+ E+  
Sbjct: 482 AFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDI-AVKRLEG-ISQGEKQFRTEVVT 539

Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN--LLSNVESGPI--WRDRVRIALD 615
           +    H NLVRL GFC + SKKLLVY++M  GSL++   L+ VE   +  W+ R +IAL 
Sbjct: 540 IGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALG 599

Query: 616 VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR 675
            ARG+ YLH+EC   IIHC+I P NILLD     K+++F LAK++  + + ++T ++GTR
Sbjct: 600 TARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTR 659

Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK- 734
           GY++PEW +   IT K+DVYS+G+++ E+V  R N E +     V    +W         
Sbjct: 660 GYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSWAATILTKDG 718

Query: 735 ELSKLVG---EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           ++  LV    E + VD+  +    +V   CIQDE + RP+M  V+ +LEG +E+   PFP
Sbjct: 719 DIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  280 bits (717), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 226/770 (29%), Positives = 380/770 (49%), Gaps = 68/770 (8%)

Query: 54  FQFGFYKEGTGFSVGTW-LVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKH 112
           F FGF       ++ T  ++   +  +IW+A R   PVS++ K +   +G V+       
Sbjct: 55  FGFGFVTTQDSVTLFTLSIIHKSSTKLIWSANR-ASPVSNSDKFVFDDNGNVVMEGTEVW 113

Query: 113 KLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSA 172
           +L     S + AS   + DSGN V+ +     IWESF+ PT T++  Q+   G KL SS 
Sbjct: 114 RL---DNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSP 170

Query: 173 SETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSA 232
           S +N +   + LE + G +VL     + Q+YW   +  A +R+   +N   GG++ + S 
Sbjct: 171 SSSNMT---YALEIKSGDMVLSVNSLTPQVYW--SMANARERI---IN-KDGGVVTSSSL 221

Query: 233 --------DATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWY 284
                   D  Q+L        + ++   + A L  +G++  +S+  +  S   AD    
Sbjct: 222 LGNSWRFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVIS-FSNLGSGAS--AADSSTK 278

Query: 285 VLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKR 344
           +  + C     CG    CS          C C  G +    +     C    T    CK+
Sbjct: 279 IPSDLCGTPEPCGPYYVCSGSK------VCGCVSGLSRARSD-----CKTGITSP--CKK 325

Query: 345 K-----MPAEFYKITSLEISQLGGMAYAKLSVNEKD---CSKSCLNDCYCGAAIYANASC 396
                 +P +   +++ +      + YA     + D   C + C N+C C    + N+S 
Sbjct: 326 TKDNATLPLQL--VSAGDGVDYFALGYAPPFSKKTDLDSCKEFCHNNCSCLGLFFQNSSG 383

Query: 397 SKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACL 456
           +      I + K      + F+ +    A+  +          KH      +V V    +
Sbjct: 384 NCFLFDYIGSFKTSGNGGSGFVSYIK-IASTGSGGGDNGEDDGKHFPYVVIIVVVTVFII 442

Query: 457 GSITFLCFLIAISS--LLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFE 514
             + F+ F I      +L   Q  ++      N S  P +      F+  +L+ ATN F 
Sbjct: 443 AVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIR------FAYKDLQSATNNFS 496

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
            +LG+G FG+VY+G++ +G+++ AVK+LE  + +G+++F+AE++ +   HH +LVRL GF
Sbjct: 497 VKLGQGGFGSVYEGTLPDGSRL-AVKKLEG-IGQGKKEFRAEVSIIGSIHHLHLVRLRGF 554

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPI---WRDRVRIALDVARGITYLHEECEVQI 631
           C + + +LL YEF+SKGSLE  +   + G +   W  R  IAL  A+G+ YLHE+C+ +I
Sbjct: 555 CAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARI 614

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           +HC+I P NILLDD+  AK+S+F LAK++   Q+ + T ++GTRGY++PEW  +  I+ K
Sbjct: 615 VHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEK 674

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV-GEDEEVDL-- 748
           SDVYS+G+V+LE++  R N++ +  T++     ++ +      +L  +V G+ + VD+  
Sbjct: 675 SDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTD 733

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSS 798
             ++  ++  L CIQ++   RPSM  V+ MLEG    PVV  P  S   S
Sbjct: 734 ERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVF--PVVQPPSSSTMGS 781

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2

 Score =  275 bits (702), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 252/850 (29%), Positives = 391/850 (46%), Gaps = 116/850 (13%)

Query: 1   MASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSS-EPSSWTSPSGLFQFGFY 59
           + S+AC+ L  F  +F    AA  ++     + LGSSL   S E S+  S  G F  GFY
Sbjct: 8   LLSTACI-LSFFIALFP--RAASSRDI----LPLGSSLVVESYESSTLQSSDGTFSSGFY 60

Query: 60  KEGT-GFSVGTWL-----VTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKH 112
           +  T  F+   W        + N T++W+A  D P  +  + L L  DG +VL   +   
Sbjct: 61  EVYTHAFTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAA 120

Query: 113 KLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSA 172
              A+  +      A +LD+GN V+ +   + +W+SF+ PT T +  Q +   ++L  + 
Sbjct: 121 VWRADGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTT 180

Query: 173 SETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVS---KLY------WASDRVHGMVNLTP 223
              +     F       + ++Y V     IYW      LY      + S R+ GM  LT 
Sbjct: 181 QSRSPGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRL-GM--LTD 237

Query: 224 GGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEW 283
            G+L +      Q L  S          V  R TLD DG LRLYS    +DS+    +  
Sbjct: 238 SGVLASSDFADGQALVASDV-----GPGVKRRLTLDPDGNLRLYS---MNDSDGSWSVSM 289

Query: 284 YVLQNQCLVKGFCGFNSFCS-NPTNSSTKGECFCFRGFNFINPEMKFLGCYR--NFTDEE 340
             +   C + G CG N  C  +PT +     C C  G+   NP     GC    N T + 
Sbjct: 290 VAMTQPCNIHGLCGPNGICHYSPTPT-----CSCPPGYATRNPGNWTEGCMAIVNTTCDR 344

Query: 341 GCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHK 400
             KR M   F ++ + +    G      LSV+ + C   C++DC C    Y   + S + 
Sbjct: 345 YDKRSM--RFVRLPNTDF--WGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYP 400

Query: 401 LPLIFAMKYQNVP--ATLFIKWSSGQANLSTNL------------------------SAL 434
              +F+ +        T+++K  +G  ++S  L                           
Sbjct: 401 KAYLFSGRTYPTSDVRTIYLKLPTG-VSVSNALIPRSDVFDSVPRRLDCDRMNKSIREPF 459

Query: 435 PIVSKKHGDNKKK------LVSVLAACLGSITFLCFLIAISSLLAYKQRVNQ--YQKLRI 486
           P V K  G   K       + +     +  I+F  F +    L   +   ++  Y+ +  
Sbjct: 460 PDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKGYKAMTS 519

Query: 487 NSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV 546
           N           + +S  EL +AT  F+ ELGRG  G VYKG + E ++ VAVK+LEN V
Sbjct: 520 N----------FRRYSYRELVKATRKFKVELGRGESGTVYKG-VLEDDRHVAVKKLEN-V 567

Query: 547 EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI- 605
            +G+  FQAE++ + R +H NLVR+ GFC + S +LLV E++  GSL N+L + E G I 
Sbjct: 568 RQGKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFS-EGGNIL 626

Query: 606 --WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-MP 662
             W  R  IAL VA+G+ YLH EC   +IHC++ P NILLD +   KI++F L K+L   
Sbjct: 627 LDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRG 686

Query: 663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
             T  V+ V+GT GY++PEW +S  IT K DVYS+GVV+LE++      E+   T +V  
Sbjct: 687 GSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHS 746

Query: 723 LSTWVYNCFIAKELSKLVGEDEE-------------VDLRTLETMVRVGLLCIQDEPNLR 769
           +   +     A    KL GE++              V+     T++++ + C++++ + R
Sbjct: 747 MLRKLVRMLSA----KLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKR 802

Query: 770 PSMKNVILML 779
           P+M++ +  L
Sbjct: 803 PTMEHAVQTL 812

Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  263 bits (671), Expect = 5e-69,   Method: Compositional matrix adjust.
 Identities = 231/798 (28%), Positives = 359/798 (44%), Gaps = 110/798 (13%)

Query: 51  SGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGL-VLQTEE 109
           +GLF  G     TGF      V S   + IW++ RD P VSS+  + LT  G+ V++  +
Sbjct: 59  AGLFSPGGDDSSTGFYFSVVHVDSG--STIWSSNRDSP-VSSSGTMNLTPQGISVIEDGK 115

Query: 110 SKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLF 169
           S+  + +      P     + D+GN +L +     +WESF+FPT +IV GQ L  G  L 
Sbjct: 116 SQIPVWSTPVLASPVKSLRLTDAGNLLLLDHLNVSLWESFDFPTDSIVLGQRLKLGMFLS 175

Query: 170 SSASETNSSTG--RFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLT---PG 224
            S S ++ STG  +F + + DG++            W  + YW   R+H   N+    P 
Sbjct: 176 GSVSRSDFSTGDYKFLVGESDGLM-----------QWRGQNYWKL-RMHIRANVDSNFPV 223

Query: 225 GILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSD------SNYR 278
             L   +     ++AR+          V+ R  L      R+     +        S   
Sbjct: 224 EYLTV-TTSGLALMARN-------GTVVVVRVALPPSSDFRVAKMDSSGKFIVSRFSGKN 275

Query: 279 ADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTD 338
              E+    + C +   CG    C N  N+S    C C        P+   +   +    
Sbjct: 276 LVTEFSGPMDSCQIPFVCGKLGLC-NLDNASENQSCSC--------PDEMRMDAGKGVCV 326

Query: 339 EEGCKRKMPA--EFYKITSLEISQLGGMAYAKLSVNEKD----------CSKSCLNDCYC 386
                  +P   E   I+ LE+    G+  +  S +  D          C   C  +C C
Sbjct: 327 PVSQSLSLPVSCEARNISYLEL----GLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSC 382

Query: 387 GAAIYANASCSKHKLPLIFAMK--YQNVPATL----FIKWSSGQANLSTNLSALPIVSKK 440
               Y N S S + +   F      +N P       ++K S  + N     +  P  + +
Sbjct: 383 LGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDLIGYVKLSIRKTN-----AQPPGNNNR 437

Query: 441 HGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQ------ 494
            G +   +  VL  C G       LIA+  L   +  V +Y  +R      P        
Sbjct: 438 GGSSFPVIALVLLPCSG----FFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDL 493

Query: 495 -EFII----QSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG 549
             F I    Q F   ELE+AT  F+ ++G G FG+VYKG++ +   ++AVK++ N    G
Sbjct: 494 GSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPD-ETLIAVKKITNHGLHG 552

Query: 550 ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI--WR 607
            ++F  E+A +    H NLV+L GFC +  + LLVYE+M+ GSLE  L +  +GP+  W+
Sbjct: 553 RQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS-GNGPVLEWQ 611

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           +R  IAL  ARG+ YLH  C+ +IIHC++ P NILL D    KIS+F L+K+L   ++ +
Sbjct: 612 ERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL 671

Query: 668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV------ 721
            T ++GTRGY++PEW  +  I+ K+DVYS+G+V+LE+V  R N      +  V       
Sbjct: 672 FTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQN 731

Query: 722 ------LLSTWVYNCFIAKELSKLVGEDEEVDLR--------TLETMVRVGLLCIQDEPN 767
                   +  VY    A ++ +     E  D R          E +VR+ L C+ +EP 
Sbjct: 732 HSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPA 791

Query: 768 LRPSMKNVILMLEGTMEI 785
           LRP+M  V+ M EG++ +
Sbjct: 792 LRPTMAAVVGMFEGSIPL 809

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  256 bits (654), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 236/810 (29%), Positives = 377/810 (46%), Gaps = 81/810 (10%)

Query: 32  ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEG--TGFSVGTWLVTSPNITVIWTAFRDEPP 89
           +S   SL+ SS  ++  SP  +F+ GF+K G  + + +G W       T +W A RD P 
Sbjct: 32  LSASESLTISSN-NTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTPL 90

Query: 90  VSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPAS--FASILDSGNFVLCNDRFD---- 143
            SS   L ++   LV+  +        N T  +  S   A +LD+GNFVL + +      
Sbjct: 91  SSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDG 150

Query: 144 FIWESFNFPTHTIVGGQSLVNGSK------LFSSASETNSSTGRFCLE-QRDGILVLYPV 196
            +W+SF+FPT T++    L   +K      + S  S  + S+G F  + + +G   ++  
Sbjct: 151 VLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEIFLW 210

Query: 197 RDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRA 256
               ++Y      W   R  G+  + P    +    + T      +YS + +   V  R 
Sbjct: 211 NRESRMYRSGP--WNGIRFSGVPEMQP---FEYMVFNFTTSKEEVTYSFRITKSDVYSRL 265

Query: 257 TLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFC 316
           ++   G+L+ ++   T+ +  +    WY  ++QC     CG   +C    +S+T   C C
Sbjct: 266 SISSSGLLQRFTWIETAQNWNQF---WYAPKDQCDEYKECGVYGYC----DSNTSPVCNC 318

Query: 317 FRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAE------FYKITSLEISQLGGMAYAKLS 370
            +GF   NP++  L   R+ +D  GC RK          F ++  +++      A     
Sbjct: 319 IKGFKPRNPQVWGL---RDGSD--GCVRKTLLSCGGGDGFVRLKKMKLPDTT-TASVDRG 372

Query: 371 VNEKDCSKSCLNDCYCGAAIYAN-------ASCSKHKLPLIFAMKYQNVPATLFIKWSSG 423
           +  K+C + CL DC C A  +AN       + C      L     Y      L+++ ++ 
Sbjct: 373 IGVKECEQKCLRDCNCTA--FANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAAT 430

Query: 424 QANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQK 483
                 N SA  I+    G      VSVL      I FL       S+L     V+   +
Sbjct: 431 DLEDKRNRSA-KIIGSSIG------VSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLR 483

Query: 484 LR---INSSLGPSQEFIIQSFSTGELERATNGFEE------------ELGRGCFGAVYKG 528
            R   +N  +  S+  I +  +T +LE     FEE            +LG+G FG VYKG
Sbjct: 484 SRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKG 543

Query: 529 SICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM 588
            + +G ++ AVKRL     +G  +F+ E+  + R  H NLVRLL  C+   +K+L+YE++
Sbjct: 544 KLLDGQEM-AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYL 602

Query: 589 SKGSLENLL--SNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS 646
              SL++ L   +  S   W+ R  I   +ARG+ YLH++   +IIH ++   NILLD  
Sbjct: 603 ENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKY 662

Query: 647 LTAKISNFSLAKILMPNQTGIVT-GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           +T KIS+F +A+I   ++T   T  V GT GYMSPE+   G+ ++KSDV+SFGV++LEI+
Sbjct: 663 MTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 722

Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAK--ELSKLVGEDEEVDLRTLETM--VRVGLLC 761
             + N     S  D+ LL     N    K  E+   +  D     R  E +  +++GLLC
Sbjct: 723 SSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLC 782

Query: 762 IQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           +Q+    RP+M  VILML    E   +P P
Sbjct: 783 VQERAEDRPTMSLVILMLGS--ESTTIPQP 810

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1

 Score =  253 bits (647), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 241/847 (28%), Positives = 384/847 (45%), Gaps = 104/847 (12%)

Query: 1   MASSACVSLILFFTI--FEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGF 58
           M   AC+ L++ F    +  IN        S P+S+  +LS         SP G ++ GF
Sbjct: 3   MVLFACLLLLIIFPTCGYAAINT-------SSPLSIRQTLS---------SPGGFYELGF 46

Query: 59  YKEGTGFS--VGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIA 116
           +      +  VG W        V+W A RD P  SS A L ++ +G ++  +  K  +I 
Sbjct: 47  FSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLD-GKQDVIW 105

Query: 117 NT----TSDEPASFASILDSGNFVLCND-RFDFIWESFNFPTHTIVGGQSLV----NGSK 167
           +T    TS++    A +LD+GNFV+ +D   + +W+SF    +T++   SL+    NG K
Sbjct: 106 STGKAFTSNK--CHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKK 163

Query: 168 --LFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNL---- 221
             L +  S ++ S G F LE    I     +R     YW     WA  R  G+  +    
Sbjct: 164 RVLTTWKSNSDPSPGEFSLEITPQIPTQGLIRRGSVPYWRCGP-WAKTRFSGISGIDASY 222

Query: 222 -TPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRAD 280
            +P  ++Q  +A         S+S  +     +   TL  +G +++    +   +N++  
Sbjct: 223 VSPFSVVQDTAA------GTGSFSYSTLRNYNLSYVTLTPEGKMKIL---WDDGNNWKLH 273

Query: 281 IEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMK-----FLGCYRN 335
           +   + +N C + G CG    C      S   +C C +GF   + E         GC R 
Sbjct: 274 LS--LPENPCDLYGRCGPYGLCVR----SDPPKCECLKGFVPKSDEEWGKGNWTSGCVRR 327

Query: 336 FTDEEGCKRKMPAE------FYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAA 389
                  K  M  +      FY++T ++   L   A     +N + C + CL +C C A 
Sbjct: 328 TKLSCQAKSSMKTQGKDTDIFYRMTDVKTPDLHQFASF---LNAEQCYQGCLGNCSCTAF 384

Query: 390 IYANA-SCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKL 448
            Y +   C      L   +++ +    LFI+ +S               S+  G +++K+
Sbjct: 385 AYISGIGCLVWNGELADTVQFLSSGEFLFIRLAS---------------SELAGSSRRKI 429

Query: 449 VSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELER 508
           +      L    FL  + A   L  Y+ + N   K            F    F    +  
Sbjct: 430 IVGTTVSLS--IFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNF----FEMHTIRT 483

Query: 509 ATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK 566
           ATN F    +LG+G FG VYKG + +G +I  VKRL +   +G  +F  E+  + +  H+
Sbjct: 484 ATNNFSPSNKLGQGGFGPVYKGKLVDGKEI-GVKRLASSSGQGTEEFMNEITLISKLQHR 542

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARGITYLH 624
           NLVRLLG+C+   +KLL+YEFM   SL+  + +  ++    W  R  I   +ARG+ YLH
Sbjct: 543 NLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLH 602

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT-GVKGTRGYMSPEWQ 683
            +  +++IH ++   NILLDD +  KIS+F LA++    Q    T  V GT GYMSPE+ 
Sbjct: 603 RDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYA 662

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCR--SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG 741
            +GL + KSD+YSFGV++LEI+  +  S F +    +  +L  TW   C      S L+ 
Sbjct: 663 WAGLFSEKSDIYSFGVLMLEIISGKRISRF-IYGDESKGLLAYTWDSWCETGG--SNLLD 719

Query: 742 EDEEVDLRTLETM--VRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSSN 799
            D     +  E    V++GLLC+Q E   RP+   V+ ML    ++PV   PI +  + N
Sbjct: 720 RDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQPIFAVHTLN 779

Query: 800 SQTLSSA 806
              +  A
Sbjct: 780 DMPMLQA 786

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	811
359477048	792	PREDICTED: G-type lectin S-receptor-like	0.959	0.982	0.528	0.0
225431571	762	PREDICTED: G-type lectin S-receptor-like	0.926	0.985	0.528	0.0
225431567	762	PREDICTED: G-type lectin S-receptor-like	0.918	0.977	0.532	0.0
147782422	762	hypothetical protein VITISV_038481 [Viti	0.918	0.977	0.532	0.0
359477046	798	PREDICTED: G-type lectin S-receptor-like	0.956	0.972	0.511	0.0
225431565	791	PREDICTED: G-type lectin S-receptor-like	0.942	0.965	0.470	0.0
224116040	781	predicted protein [Populus trichocarpa]	0.923	0.959	0.473	0.0
359477052	767	PREDICTED: G-type lectin S-receptor-like	0.918	0.971	0.465	0.0
224116056	776	predicted protein [Populus trichocarpa]	0.939	0.981	0.459	0.0
224093336	755	predicted protein [Populus trichocarpa]	0.900	0.966	0.469	0.0

>gi|359477048|ref|XP_002275811.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  783 bits (2023), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/797 (52%), Positives = 539/797 (67%), Gaps = 19/797 (2%)

Query: 5   ACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPS-SEPSSWTSPSGLFQFGFYKEGT 63
           A V  + F  +  +   AQ   +++K ISL SSLSP    P  W SPSGLF FGFY +G+
Sbjct: 2   ASVWFVFFLPLLCVGVRAQ--PEKAKLISLNSSLSPKYGSPMGWASPSGLFAFGFYPQGS 59

Query: 64  GFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDE 122
           GFSVG WLV +   TV+WTA RD+PP S+NAKL  T DG L+LQTEE     I+ T    
Sbjct: 60  GFSVGIWLVGTDENTVVWTANRDDPPASANAKLYFTEDGKLLLQTEEGSE--ISITDGSG 117

Query: 123 PASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRF 182
           PA  AS+LDSG+FVL +     IW SF++PT T++GGQ+L +  K+ SS S +N S+G F
Sbjct: 118 PAVAASMLDSGSFVLYDQNLSVIWNSFSYPTDTLLGGQNLDSNKKMVSSESRSNHSSGWF 177

Query: 183 CLE-QRDGILVLYPVR---DSRQIYWVSKLYWAS--DRVHGMVNLTPGGILQAGSADATQ 236
            L  Q DG LV YPV    +S   YW S    AS  +     ++L   G L   S  ++ 
Sbjct: 178 FLAMQGDGNLVSYPVNSSGESDDSYWSSGTSSASRLNFYSTQLSLNTEGALYLSSGMSSL 237

Query: 237 ILA--RSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKG 294
           I+   R+S S  S N+T IYRAT D DGI RLYSH F ++ +    I W  L +QC VKG
Sbjct: 238 IIQTFRNS-SNPSKNKTTIYRATFDPDGIFRLYSHRFENNGSSNESIVWSSLSDQCDVKG 296

Query: 295 FCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKIT 354
           FCGFNS+CSNP     K EC C  GF F NP  K  GC R F  ++  K       Y IT
Sbjct: 297 FCGFNSYCSNP---GAKAECHCLPGFAFNNPSEKIRGCSRIFNGDDCSKMNNQLISYNIT 353

Query: 355 SLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPA 414
           +LE +  G   Y K S+  ++CSK CL+DC CGAA+Y N SC K+KLP+ +    +N  A
Sbjct: 354 TLENTGWGDYPYYKKSMKMEECSKFCLDDCNCGAALYRNGSCYKYKLPVRYGRINRNETA 413

Query: 415 TLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAY 474
           T  +K    +   +      P+ ++   D KK L+ VL+  LGSI FLC +IAISS   Y
Sbjct: 414 TALLKGHLQRVKSAYRPPPAPMNTEVKIDGKKTLILVLSLSLGSIAFLCLVIAISSFWVY 473

Query: 475 KQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGN 534
           + +V  Y++L    +LG ++EF +QSFS  ELE+AT+GF EELGRGC+GAVYKG+I   N
Sbjct: 474 RHQVWSYRQLSEEVNLGSTEEFTLQSFSYDELEKATDGFREELGRGCYGAVYKGTIERDN 533

Query: 535 KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLE 594
           K+VAVKRLE  VE+GE++FQAEM A+ +THH+NLVRLLGFC++ SKKLLVYEFM  GSL 
Sbjct: 534 KVVAVKRLEKVVEQGEKEFQAEMTAIGQTHHRNLVRLLGFCIEGSKKLLVYEFMRNGSLA 593

Query: 595 NLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF 654
           +LL N E   IW+ RVRIAL++ARGI YLHEECE QI+HC+I P+NIL+DD+ TAKIS+F
Sbjct: 594 DLLFNAEKRSIWKVRVRIALELARGILYLHEECESQIVHCDIKPQNILMDDAWTAKISDF 653

Query: 655 SLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
             +K+LMPNQ GIVTG++GT GY +PEW  + LI+VK+D+YSFGVV+LEIVCCR + EV 
Sbjct: 654 GFSKLLMPNQEGIVTGIRGTAGYSAPEWHKNTLISVKADIYSFGVVLLEIVCCRRSIEVK 713

Query: 715 VSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKN 774
           VSTAD ++LS+WVY C +A+EL KLVG DE+V+ ++LE MV+VGL C+QD+P LRPSMKN
Sbjct: 714 VSTADEIILSSWVYGCLVARELDKLVG-DEQVEFKSLERMVKVGLWCVQDDPALRPSMKN 772

Query: 775 VILMLEGTMEIPVVPFP 791
           VILMLEGT++IP  P P
Sbjct: 773 VILMLEGTVDIPFPPSP 789

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431571|ref|XP_002276322.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 410/776 (52%), Positives = 529/776 (68%), Gaps = 25/776 (3%)

Query: 21  AAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVI 80
             + +  + K I LGSSL P +  SSW SPSG F FGFY +GTGF+VG WLV+    TV+
Sbjct: 2   GVRAETAEPKLIKLGSSLFPHNGSSSWVSPSGHFAFGFYPQGTGFAVGVWLVSQSGNTVV 61

Query: 81  WTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCN 139
           WTA RD+P VS N  L  T +G L+L+T   +   IA+    E A+ AS+LDSGNFVL  
Sbjct: 62  WTANRDKPLVSFNTTLEFTTNGKLLLRTGPGEQITIADVA--ESAASASMLDSGNFVLFG 119

Query: 140 DRFD-FIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRD 198
           D     IW+SF +PT T++GGQ+   G  L S  +E+  + G F L   DG +V YP   
Sbjct: 120 DNSSSIIWQSFQYPTDTLLGGQNFSTGDILSSRKTES-PAIGDFYLSTSDGQIVSYPY-- 176

Query: 199 SRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATL 258
              +      YW  D      +L   G+L +  A    + + +  S  + NET+IYRATL
Sbjct: 177 --NLAVSEDPYWTVD----ARDLNDMGLLSSYDAFTLTLASNNISSDDAKNETIIYRATL 230

Query: 259 DFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFR 318
           D DGI RLYSH F + +     I W  ++N C VKG CG N+ CS+   + T   C C  
Sbjct: 231 DVDGIFRLYSHSFGNSNISTVSIMWSAIKNPCDVKGLCGVNALCSS---NGTNANCSCVP 287

Query: 319 GFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLE-ISQLGGMAYAKL-SVNEKDC 376
           GF  IN E K+ GCYR+F +EEGC+ + P   Y IT+L  +S      Y+ + S+NEKDC
Sbjct: 288 GFVSINRE-KYSGCYRSFNNEEGCRGQEPESIYNITTLRNVSWKDANPYSGIKSLNEKDC 346

Query: 377 SKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPI 436
           S+SCL DC C AA Y N +C ++KLPL++ +  QN     F+K S G A +  N+ A   
Sbjct: 347 SRSCLQDCNCWAAYYFNGTCRRYKLPLVYGIANQNESGITFLKMSLGTAYVGDNIPAPRN 406

Query: 437 VSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEF 496
            +K    NKK+L+ +LA+ LGSI FLC L+A+SS   Y+ +V++Y+KL    S    +EF
Sbjct: 407 QTKVIESNKKELILILASSLGSIAFLCALVAMSSFFIYRSQVHRYRKL----SETAMEEF 462

Query: 497 IIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAE 556
            ++SFS  +LE+AT+GF EELGRG FGAVYKG+I +GN+ +AVKRLE  VEEGER+FQAE
Sbjct: 463 TLRSFSYNDLEKATDGFREELGRGPFGAVYKGTIAQGNQTIAVKRLEKAVEEGEREFQAE 522

Query: 557 MAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDV 616
           MA + RTHH+NLVRLLGFCMQ S+KLLVYE+MS GSL +LL N E  PIWR+RVRIALDV
Sbjct: 523 MAIIGRTHHRNLVRLLGFCMQGSRKLLVYEYMSNGSLADLLFNGEKRPIWRERVRIALDV 582

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG-TR 675
           ARGI YLHEECEV IIH NI P+NILLDDS TAK+S+F LA++L PNQTG ++ + G +R
Sbjct: 583 ARGIFYLHEECEVHIIHGNIKPKNILLDDSWTAKLSDFRLARLLRPNQTGTISRLGGSSR 642

Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE 735
           GY +PE Q   LI+V++DVYSFGVV+LEIVCCRSN ++NVST D +LL +WVY+CF+A+E
Sbjct: 643 GYSAPERQKRMLISVEADVYSFGVVLLEIVCCRSNLDINVSTGDEILLCSWVYSCFVARE 702

Query: 736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           L KLV E EEV+++TLE MV+VGLLCIQD+P+LRP+MKNVILMLEGTM +PV P P
Sbjct: 703 LEKLV-EGEEVNMKTLERMVKVGLLCIQDDPSLRPTMKNVILMLEGTMNVPVPPSP 757

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431567|ref|XP_002276274.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  767 bits (1981), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/778 (53%), Positives = 532/778 (68%), Gaps = 33/778 (4%)

Query: 24  LKNQQSKP--ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIW 81
           ++ Q +KP  I LGSSLSP++  SSW SPSG F FGFY + TGF+VG WLV     TV+W
Sbjct: 3   VRAQTAKPKLIELGSSLSPTNGSSSWVSPSGHFAFGFYPQDTGFAVGVWLVGQSGKTVVW 62

Query: 82  TAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCND 140
           TA RD+PPVSSN  L  T +G L+L+T   +   IA+    E ++ AS+LDSGNFVL  D
Sbjct: 63  TANRDDPPVSSNTALEFTRNGKLLLRTGPGEEVSIADVA--ESSASASMLDSGNFVLFGD 120

Query: 141 RFDFI-WESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDS 199
              FI W+SF  PT T++GGQ+L N   L SS +E+++  G F   Q  G +V YP    
Sbjct: 121 NSSFIIWQSFQHPTDTLLGGQNLSN--ILSSSKTESSAIGGFFLSLQSGGRIVSYPY--- 175

Query: 200 RQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQ---ILARSSYSVKSSNETVIYRA 256
             +      YW  D      +L   G+L   S DAT     LA +  S  + NET+IYRA
Sbjct: 176 -NMGVSEDPYWTVD----ARDLNDKGLLS--SYDATSNVLTLASNISSDDAKNETIIYRA 228

Query: 257 TLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFC 316
           TLD DG+ RLYSH F + +     I W   +N C VKG CG N  CS+   + T   C C
Sbjct: 229 TLDVDGVFRLYSHSFGNSNISSVSIMWSAFKNPCDVKGLCGVNGLCSS---NGTNANCSC 285

Query: 317 FRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLE-ISQLGGMAYAKL-SVNEK 374
             GF  IN E K+ GCYR+F +EEGC+ + P   Y IT+L  +S  G   Y+ L S+NE+
Sbjct: 286 VPGFVSINRE-KYSGCYRSFNNEEGCRGQEPESLYNITTLRNVSWEGANPYSALTSLNEQ 344

Query: 375 DCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSAL 434
            CS+SCL DC C AA Y N +C ++KLPL+  +  QN     F+K S G A +  ++ A 
Sbjct: 345 GCSRSCLQDCNCWAAYYFNGTCRRYKLPLVHGIANQNESGITFLKMSLGTAYVGDDIPAP 404

Query: 435 PIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQ 494
              +K    NKK+L+ +LA+ LGSI FLC L+A+SS   Y+ +V++Y+ L  N+     +
Sbjct: 405 RNQTKVIESNKKELILILASSLGSIAFLCALVAVSSFFIYRSQVHRYRTLSENAM----E 460

Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ 554
           EF ++SFS  +LE+AT+GF EELGRG FGAVYKG+I +GN+ +AVKRLE  VEEGER+FQ
Sbjct: 461 EFTLRSFSYNDLEKATDGFREELGRGPFGAVYKGTIAQGNQTIAVKRLEKVVEEGEREFQ 520

Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL 614
           AEM  + RTHH+NLVRLLGFCMQ SKKLLVYE+MS GSL +LL N E  PIWR+RVRIAL
Sbjct: 521 AEMTIIGRTHHRNLVRLLGFCMQGSKKLLVYEYMSNGSLADLLFNGEKRPIWRERVRIAL 580

Query: 615 DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG- 673
           DVARGI YLHEECEV IIH +I P+NILLDDS TAK+S+F LA++L PNQTG ++   G 
Sbjct: 581 DVARGIFYLHEECEVHIIHGDIKPKNILLDDSWTAKLSDFRLARLLRPNQTGTISRFGGS 640

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA 733
           +RGY +PE Q   LI+V++DVYSFGVV+LEIVCCRSN ++NVST D +LL +WVY+CF+A
Sbjct: 641 SRGYSAPERQKRMLISVEADVYSFGVVLLEIVCCRSNLDINVSTGDEILLCSWVYSCFVA 700

Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           +EL KLV E  EV+++TLE MV+VGLLCIQD+P+LRP+MKNVILMLEGT+++PV P P
Sbjct: 701 RELEKLV-EGAEVNMKTLERMVKVGLLCIQDDPSLRPTMKNVILMLEGTVDVPVPPSP 757

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147782422|emb|CAN72833.1| hypothetical protein VITISV_038481 [Vitis vinifera]

 Score =  767 bits (1980), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/778 (53%), Positives = 530/778 (68%), Gaps = 33/778 (4%)

Query: 24  LKNQQSKP--ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIW 81
           ++ Q +KP  I LGSSLSP++  SSW SPSG F FGFY + TGF+VG WLV     TV+W
Sbjct: 3   VRAQTAKPKLIELGSSLSPTNGSSSWVSPSGHFAFGFYPQDTGFAVGVWLVGQSGKTVVW 62

Query: 82  TAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCND 140
           TA RD+PPVSSN  L  T +G L+L+T   +   IA+    E  + AS+LDSGNFVL  D
Sbjct: 63  TANRDDPPVSSNTALEFTRNGKLLLRTGPGEEVSIADVA--ESXASASMLDSGNFVLFGD 120

Query: 141 RFDFI-WESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDS 199
              FI W+SF  PT T++GGQ+L N   L SS +E+ +  G F   Q  G +V YP    
Sbjct: 121 NSSFIIWQSFQHPTBTLLGGQNLSN--ILSSSKTESXAIGGFFLSLQSGGRIVSYPY--- 175

Query: 200 RQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQ---ILARSSYSVKSSNETVIYRA 256
             +      YW  D      +L   G+L   S DAT     LA +  S  + NET+IYRA
Sbjct: 176 -NMGVSEDPYWTVD----ARDLNDKGLLS--SYDATSNVLTLASNISSDDAKNETIIYRA 228

Query: 257 TLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFC 316
           TLD DG+ RLYSH F + +     I W   +N C VKG CG N  CS+   + T   C C
Sbjct: 229 TLDVDGVFRLYSHSFGNSNISSVSIMWSAFKNPCDVKGLCGVNGLCSS---NGTNANCSC 285

Query: 317 FRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLE-ISQLGGMAYAKL-SVNEK 374
             GF  IN E K+ GCYR+F +EEGC+ + P   Y IT+L  +S  G   Y+ L S+NE+
Sbjct: 286 VPGFVSINRE-KYSGCYRSFNNEEGCRGQEPESLYNITTLRNVSWEGANPYSALTSLNEQ 344

Query: 375 DCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSAL 434
            CS+SCL DC C AA Y N +C ++KLPL+  +  QN     F+K S G A +  ++ A 
Sbjct: 345 GCSRSCLQDCNCWAAYYFNGTCRRYKLPLVHGIANQNESGITFLKMSLGTAYVGDDIPAP 404

Query: 435 PIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQ 494
              +K    NKK+L+ +LA+ LGSI FLC L+A+SS   Y+ +V++Y+ L  N+     +
Sbjct: 405 RNQTKVIESNKKELILILASSLGSIAFLCALVAVSSFFIYRSQVHRYRTLSENAM----E 460

Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ 554
           EF ++SFS  +LE+AT+GF EELGRG FGAVYKG+I +GN+ +AVKRLE  VEEGER+FQ
Sbjct: 461 EFTLRSFSYNDLEKATDGFREELGRGPFGAVYKGTIAQGNQTIAVKRLEKVVEEGEREFQ 520

Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL 614
           AEM  + RTHH+NLVRLLGFCMQ SKKLLVYE+MS GSL +LL N E  PIWR+RVRIAL
Sbjct: 521 AEMTIIGRTHHRNLVRLLGFCMQGSKKLLVYEYMSNGSLADLLFNGEKRPIWRERVRIAL 580

Query: 615 DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG- 673
           DVARGI YLHEECEV IIH +I P+NILLDDS TAK+S+F LA++L PNQTG ++   G 
Sbjct: 581 DVARGIFYLHEECEVHIIHGDIKPKNILLDDSWTAKLSDFRLARLLRPNQTGTISRFGGS 640

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA 733
           +RGY +PE Q   LI+V++DVYSFGVV+LEIVCCRSN ++NVST D +LL +WVY+CF+A
Sbjct: 641 SRGYSAPERQKRMLISVEADVYSFGVVLLEIVCCRSNLDINVSTGDEILLCSWVYSCFVA 700

Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           +EL KLV E  EV+++TLE MV+VGLLCIQD+P+LRP+MKNVILMLEGT+++PV P P
Sbjct: 701 RELEKLV-EGXEVNMKTLERMVKVGLLCIQDDPSLRPTMKNVILMLEGTVDVPVPPSP 757

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477046|ref|XP_002275786.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 [Vitis vinifera]

 Score =  728 bits (1878), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/803 (51%), Positives = 535/803 (66%), Gaps = 27/803 (3%)

Query: 1   MASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYK 60
           MAS + V  IL   +F     AQ K   S  ISLGSSLSP SEP+SW S SG F FGFY+
Sbjct: 6   MASVSVVYFILL--VFSAAEGAQPK--PSNQISLGSSLSPESEPTSWPSRSGQFAFGFYQ 61

Query: 61  EGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTT 119
           +G  F+VG WLV +PN TV+WTA RD+PPV+SNA L LT DG L+L+T++ + KLIAN T
Sbjct: 62  QGLNFAVGIWLVGNPNNTVVWTANRDDPPVNSNATLDLTKDGKLLLRTDQGEEKLIANAT 121

Query: 120 SDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFS--SASETNS 177
           +   A+FAS+LDSGNFVL N+  D IWESF+FPT TI+GGQSL  G +L S  S SE++ 
Sbjct: 122 TA--AAFASMLDSGNFVLYNEDSDPIWESFSFPTDTILGGQSLRTGGELVSISSLSESDH 179

Query: 178 STGRFCLE-QRDGILVLYPVRDSR---QIYWVSKLYWASDRVHGMVNLTPGGILQAGSAD 233
           S+GRF L  Q DG LVLYP   +      YW +  + +    H  +N + G +L   + D
Sbjct: 180 SSGRFDLNMQLDGNLVLYPADTAHTPGDAYWSTGTFTSGS--HLYLNDSRGDLLLRRNDD 237

Query: 234 --ATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCL 291
             +   +  SS S+      VIYRATLD DG+ RLYSH   ++S  +  +E  VL + C 
Sbjct: 238 LGSLTSVLTSSSSINKDANKVIYRATLDVDGVFRLYSHANYNNSEPKITMEESVLNSACD 297

Query: 292 VKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKR-KMPAEF 350
           VK FCGFNSFC   T +  K  C C  G +FI+P  + LGC RNF+ EEGC+  +  A F
Sbjct: 298 VKSFCGFNSFC---TFADDKPYCDCLPGSDFIDPNRRSLGCGRNFS-EEGCRDGEEKAPF 353

Query: 351 YKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQ 410
           Y I ++E    G  AY    +++ DCS SCL DC CGAA+Y N  C K   PL + ++ +
Sbjct: 354 YGIKTMENLNWGDHAYFDAPMSKDDCSNSCLEDCDCGAALYLNGLCKKQNFPLRYVVRDR 413

Query: 411 NVPATLFIKWSSGQANLSTNLSALPIVSKKHG--DNKKKLVSVLAACLGSITFLCFLIAI 468
            V +T F+K   G  ++ T     P   K      +KK +V ++   L  +T     ++ 
Sbjct: 414 KVSSTAFLK--VGMRSIETKNGTFPSPKKPPVIVTSKKAVVLIIVLSLSFVTCSFVALSF 471

Query: 469 SSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG 528
           S    +K RV +Y++L    +LGP++E  +Q FS  EL RAT+GF+EELG+G FGAVYKG
Sbjct: 472 SGFFIFKYRVLRYRRLLETGNLGPAKELTLQLFSYKELIRATSGFKEELGKGSFGAVYKG 531

Query: 529 SICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM 588
            + +  K+VAVKRLE  VEEGER+FQAEM A+ RTHH+NLVRL+G+C + S++LLVYE+M
Sbjct: 532 FLYKSKKLVAVKRLEKIVEEGEREFQAEMRAIGRTHHRNLVRLMGYCAENSRRLLVYEYM 591

Query: 589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT 648
           S GSL NLL N  + P W +RVRIALDVARGI YLHEECE  IIHC+I P+NIL+D+ L 
Sbjct: 592 SNGSLANLLFNAGTRPHWNERVRIALDVARGILYLHEECETPIIHCDIKPQNILMDEFLN 651

Query: 649 AKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
           AKIS+F LAK+LMP+QT   TGV+GTRGY++PEWQ +  I+VK+D+YS+G+V+LEIVCCR
Sbjct: 652 AKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQRNTPISVKADIYSYGIVLLEIVCCR 711

Query: 709 SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNL 768
            N EV V   + ++LS WVY C +++EL KLV  DE  D +TLE MV+VGL CIQDEP L
Sbjct: 712 KNMEVQVKNPEEIILSNWVYQCMVSRELDKLVA-DEVADKKTLERMVKVGLWCIQDEPAL 770

Query: 769 RPSMKNVILMLEGTMEIPVVPFP 791
           RPSMK+V+L+LEG  +I V P P
Sbjct: 771 RPSMKSVVLILEGITDIVVPPCP 793

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225431565|ref|XP_002276127.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  692 bits (1785), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/808 (47%), Positives = 519/808 (64%), Gaps = 44/808 (5%)

Query: 5   ACVSLI--LFFTIFEIINAAQLKNQQSKP---ISLGS-SLSPSSEPSSWTSPSGLFQFGF 58
           ACV ++  LFF  FE + A     Q+  P   I+L S +LSP+ +P+SWTSPSG+F FGF
Sbjct: 2   ACVYVVFLLFFVSFEAVGA-----QEEPPAGFITLESATLSPTIQPTSWTSPSGIFAFGF 56

Query: 59  YKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANT 118
           Y +G+ F +G WL+     T++WTA RD+PPV  +AKL+     L+L+T +S+ K+I   
Sbjct: 57  YPQGSDFLLGIWLMDEEK-TLVWTAHRDDPPVPLDAKLLTINGKLLLRTGQSEEKVIV-- 113

Query: 119 TSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSS 178
              E ASFA + DSGNF++ N  F  IWESF FPT TI+GGQ+L  G +LFSS SETN S
Sbjct: 114 ---ESASFAFMRDSGNFMVYNQSFHVIWESFKFPTDTILGGQNLTTGDQLFSSLSETNHS 170

Query: 179 TGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADAT-Q 236
           TGRF L+ Q DG LV Y V     +  V   YWAS    G V++      Q    DAT Q
Sbjct: 171 TGRFRLQMQTDGNLVSYFVD---ALPMVLDAYWASGTRDGDVSMN-----QMYLNDATGQ 222

Query: 237 ILARSS---------YSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVL- 286
           ++ R+S         Y+   S +  IY A L +DG+ R+YSH F S+SN    + W  + 
Sbjct: 223 LVIRNSTNLVTRAVLYTSSRSAKNTIYSARLSYDGMFRMYSHSFDSNSNGDKSVLWSAVA 282

Query: 287 -QNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRK 345
              +C VKGFCG NS+C   T ++++  C C  G +F++   K LGC +NFT+       
Sbjct: 283 EDEKCQVKGFCGLNSYC---TRNNSEPYCVCLPGTDFVDSNQKLLGCLKNFTEYSCNNIS 339

Query: 346 MPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIY-ANASCSKHKLPLI 404
             A ++ + + +  Q   + Y K +++ ++C   CL DC C  A+Y  +  CSK  LPL 
Sbjct: 340 YSASYHIVRAEQNLQWDDLPYFKGTMSMEECINGCLEDCNCEVALYDKDGYCSKRALPLK 399

Query: 405 FAMKYQNVPATLFIKWSSGQANLSTNLSALPI-VSKKHGDNKKKLVSVLAACLGSITFLC 463
           +A   +NV +  F K S     +  + S +P   ++    + K LV +L   +G IT   
Sbjct: 400 YARSDENVLSAAFFKVSKKSIEIKNDTSFIPDHTTEVTTTSTKDLVLILVITVGFITCSF 459

Query: 464 FLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFG 523
             +AIS    +K RV +Y++L  +   G  +E  +QSFS  EL++A+  F+EELG+G FG
Sbjct: 460 VSLAISGFFIFKFRVAKYRRLLEDGKRGLMEELKMQSFSYKELQKASRNFKEELGKGAFG 519

Query: 524 AVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL 583
            VY G + +G K+VA+KRLE  VEEGER+F+AEM A+ RTHHKNLVRLLG+C + SK+LL
Sbjct: 520 TVYLGVLHKGKKLVAIKRLEKMVEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSKRLL 579

Query: 584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL 643
           VYE+MS  SL ++L   ++ P W +RVRIALDVARGI YLHEECE  IIHC+I P+NIL+
Sbjct: 580 VYEYMSNRSLADILFKSKTRPPWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILM 639

Query: 644 DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLE 703
           DD  TAKIS+F LAK+LMP+QT   TGV+GTRGY++PEWQ +  I+VK+DVYS+G+V+LE
Sbjct: 640 DDFWTAKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLE 699

Query: 704 IVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQ 763
           +VCCR N EVNVS  + ++LS W Y CF+A EL KL+G  EEV+ ++LE MV++GL CIQ
Sbjct: 700 LVCCRRNLEVNVSKPEEIVLSNWAYKCFVAGELYKLLG-GEEVERKSLEEMVKLGLWCIQ 758

Query: 764 DEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           DEP LRPS+K+++LMLEG  EI V P P
Sbjct: 759 DEPALRPSIKSIVLMLEGITEIAVPPCP 786

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116040|ref|XP_002332033.1| predicted protein [Populus trichocarpa] gi|222875258|gb|EEF12389.1| predicted protein [Populus trichocarpa]

 Score =  684 bits (1766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/773 (47%), Positives = 500/773 (64%), Gaps = 24/773 (3%)

Query: 22  AQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIW 81
           A+ +  Q   I LGS LSP S  +SW SPSG F FGFY +G GF+VG W++  PN TV+W
Sbjct: 19  ARTQPNQFGEIHLGSQLSPISNLNSWQSPSGNFAFGFYSQGNGFAVGIWMMGQPNNTVVW 78

Query: 82  TAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCND 140
           TA RD+ PVS NA + L+ +G L+L+TE+    LIAN +  E A+ AS+LDSGNFVL N 
Sbjct: 79  TANRDDEPVSFNATIHLSEEGKLLLRTEQGNENLIANVS--EIAASASMLDSGNFVLYNG 136

Query: 141 RFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRD- 198
               IW+SF++PT TI+ GQ+L    KL SS S +N S+GRF L  Q DG LV YP    
Sbjct: 137 S-SVIWQSFDYPTDTILVGQNLTYSDKLVSSVSSSNHSSGRFFLAMQADGNLVAYPTNSA 195

Query: 199 --SRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRA 256
             S   YW S  Y  S +   +     G +     +    +LARSSY    +N+T I+RA
Sbjct: 196 GLSVDAYWASNTYKDSKKGLSLYFNHQGFLFMDTVSKKPVLLARSSYPC--NNKTTIFRA 253

Query: 257 TLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFC 316
           TLD DGI RLYSH   + ++    IEW  L N C V+GFC FNS+CS      T  +C C
Sbjct: 254 TLDADGIFRLYSHCLENKTSRSVHIEWSALNNTCNVRGFCDFNSYCSG---MGTNADCSC 310

Query: 317 FRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDC 376
           + GF F +P  KF GCY+N   E  C      +   + ++E        Y+ L   +++C
Sbjct: 311 YPGFAFNDPSEKFSGCYKN-VPESFCTDTKDGQMNDVITVENILFERYPYSVLDEKKENC 369

Query: 377 SKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPI 436
             SCL DC C  A+Y N  C K+  P+ + +K  N  +  F K     A    +L+ +  
Sbjct: 370 GLSCLEDCLCDVALYMNERCEKYTAPIRYGIKDINASSIAFFKVKPTPAAPPMSLTIII- 428

Query: 437 VSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEF 496
                 ++KK L+  LA   GS+TFLCF+IAIS+   Y+ R   Y+KL    SL  + EF
Sbjct: 429 ------ESKKSLLVFLAIAFGSVTFLCFVIAISTFCVYRDRAYLYEKLSGIISL--AGEF 480

Query: 497 IIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAE 556
            ++SFS  ELE+AT+GF EELGRG  GAVY+G+I  G++ VAVKRLE  ++EGE+KF+AE
Sbjct: 481 TLRSFSYSELEKATSGFREELGRGSIGAVYRGTIPGGDRTVAVKRLEKVLDEGEKKFRAE 540

Query: 557 MAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDV 616
           +  + +T+H+NLVRLLGFC++ S+++LVYE++  G+L +LL   E  PIW++RVRIALD+
Sbjct: 541 ITVIGQTYHRNLVRLLGFCVEGSRRVLVYEYLRNGTLADLLFQSERRPIWKERVRIALDI 600

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
           ARGI YLHEEC+  IIHCNI P+NIL+DDS  AKIS+F L+K+L P++      +  +RG
Sbjct: 601 ARGILYLHEECQACIIHCNITPQNILMDDSWMAKISDFGLSKLLYPDEIRSSMALSQSRG 660

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL 736
           +M+PEWQN+ L++VK+D+YSFGVV+LEI+CCRS+ +V+VST D + L +W Y CF A +L
Sbjct: 661 HMAPEWQNNALMSVKADIYSFGVVLLEIICCRSSIKVDVSTPDEMNLPSWAYQCFAAGQL 720

Query: 737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
            KLV +DE+++  +LE MV++GLLC+Q +P LRP +KNVILMLEG+ +IP  P
Sbjct: 721 DKLV-KDEDIEFESLERMVKIGLLCVQHDPALRPCIKNVILMLEGSDDIPAPP 772

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477052|ref|XP_002276297.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/803 (46%), Positives = 508/803 (63%), Gaps = 58/803 (7%)

Query: 5   ACVSLI--LFFTIFEIINAAQLKNQQSKP---ISLGS-SLSPSSEPSSWTSPSGLFQFGF 58
           AC+ ++  LFF  FE + A     Q+  P   I+L S +LSP+ +P+SW SPSGLF FGF
Sbjct: 2   ACIYVVFLLFFVSFEDVGA-----QEEPPAEFITLESATLSPTIQPTSWLSPSGLFAFGF 56

Query: 59  YKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANT 118
           Y +G+ F +G WL+     T+ WTA RD+PPV  +AKL+     L+L+T +S+ K+I   
Sbjct: 57  YPQGSDFLLGIWLMDKER-TLSWTAHRDDPPVPLDAKLLTINGKLLLRTRQSEEKVIV-- 113

Query: 119 TSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSS 178
              E ASFA + DSGNFV+ N  +  IWESF FPT TI+GGQ+L  G  LFSS SETN S
Sbjct: 114 ---ESASFALMRDSGNFVVYNKSYHVIWESFKFPTDTILGGQNLTTGVPLFSSLSETNHS 170

Query: 179 TGRFCLE-QRDGILVLY---PVRDSRQIYWVSKLYWASDRV-HGM-VNLTPGGILQAGSA 232
           TGRF L+ Q DG LVLY    +  S   YW S  + A + + H + +N T GG++   S 
Sbjct: 171 TGRFRLDMQADGNLVLYFADSMLSSVDAYWASNTWKAGNSMDHQLYLNDTTGGLVVRNS- 229

Query: 233 DATQILARSS-YSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQ--NQ 289
             T +  R   Y   SS    IY A L ++G+ ++YSH F S+ N    + W  +   NQ
Sbjct: 230 --TNLETRGIIYKGSSSASKTIYSARLSYNGMFQVYSHSFDSNGNDNKTLAWSAVATVNQ 287

Query: 290 CLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAE 349
           C VKGFCG NS+C   T +  +  C+C  G +F++ +   LGC +NFT E  C     + 
Sbjct: 288 CQVKGFCGLNSYC---TQNDIEPYCYCLPGTDFVDSKQMLLGCLKNFT-ESSCNNISYSA 343

Query: 350 FYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIY-ANASCSKHKLPLIFAMK 408
            Y +   +      + Y K ++   +CS  CL DC C  A+Y  +  CSK  LPL +A +
Sbjct: 344 SYHMVREDNLVWDDLPYFKETMTIDECSNGCLEDCNCDVALYDQDGHCSKRALPLKYAKR 403

Query: 409 YQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAI 468
            ++V ++ F K  +                         LV +L   +G IT     +AI
Sbjct: 404 SRDVQSSAFFKVRT-----------------------TDLVLILVITIGFITCSFVSLAI 440

Query: 469 SSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG 528
           S    +K RV +Y++L  +  LG ++E  +QSFS  EL++A+  F+EELG+G FG VY G
Sbjct: 441 SGFFIFKFRVVKYRRLLEDGKLGLTEELKMQSFSYKELQKASRNFKEELGKGAFGTVYLG 500

Query: 529 SICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM 588
            + +G K+VA+KRLE  VEEGER+F+AEM A+ RTHHKNLVRLLG+C + S++LLVYE+M
Sbjct: 501 VLQQGKKLVAIKRLEKMVEEGEREFRAEMRAIGRTHHKNLVRLLGYCTEGSRRLLVYEYM 560

Query: 589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT 648
           S  SL ++L   ++ P W +RVRIALDVARGI YLHEECE  IIHC+I P+NIL+DD  T
Sbjct: 561 SNRSLADILFKSKTRPPWDERVRIALDVARGILYLHEECEAPIIHCDIKPQNILMDDFWT 620

Query: 649 AKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
           AKIS+F LAK+LMP+QT   TGV+GTRGY++PEWQ +  I+VK+DVYS+G+V+LE+VCCR
Sbjct: 621 AKISDFGLAKLLMPDQTRTFTGVRGTRGYLAPEWQQNIPISVKADVYSYGIVLLELVCCR 680

Query: 709 SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNL 768
            N EVNVS  + ++LS W Y CF+A EL KL+G  EEV+ ++LE MV++GL CIQDEP L
Sbjct: 681 RNLEVNVSEPEEIVLSNWAYKCFVAGELHKLLG-GEEVERKSLEQMVKLGLWCIQDEPAL 739

Query: 769 RPSMKNVILMLEGTMEIPVVPFP 791
           RPS+K+++LMLEG  EI V P P
Sbjct: 740 RPSIKSIVLMLEGITEIAVPPCP 762

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116056|ref|XP_002332037.1| predicted protein [Populus trichocarpa] gi|222875262|gb|EEF12393.1| predicted protein [Populus trichocarpa]

 Score =  676 bits (1743), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/794 (45%), Positives = 507/794 (63%), Gaps = 32/794 (4%)

Query: 1   MASSACVSLILFFTIFEIINAAQLKNQQSKPISLGSSLSPSSEPSSWTSPSGLFQFGFYK 60
           MA +     +L   I++ +++ Q     S  ISLGSS+S + +P+SW SPSG F FGFY 
Sbjct: 1   MAFAYAAFFLLVICIYKPVSSQQ---NHSNLISLGSSISTNVQPTSWRSPSGTFAFGFYP 57

Query: 61  EGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTT 119
           +G+GF VG WLV  P   + WTA+RD+PPV SNA L LT++G L+L+T  + ++      
Sbjct: 58  QGSGFIVGIWLVCKPADIITWTAYRDDPPVPSNATLELTINGKLLLRTYSANNEA----- 112

Query: 120 SDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSST 179
             E A+ AS+LDSGNFVL +     IW+SF++PT TI+ GQ+L +  KL SS S +N S+
Sbjct: 113 --EIAASASMLDSGNFVLYSGS-SVIWQSFDYPTDTILVGQNLTDFDKLVSSVSSSNHSS 169

Query: 180 GRFCLE-QRDGILVLYPVR---DSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADAT 235
           GRF L  Q DG LV YP     +S   YW S      D     + L   G L   +    
Sbjct: 170 GRFFLAMQEDGNLVAYPTNSAGESVDAYWASST--TGDNKGLSLYLNQQGFLSMDTVSKK 227

Query: 236 QILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGF 295
            +L  SS S   +N+T I+RATLD DGI RLYSH   + ++    IEW  L NQC V GF
Sbjct: 228 PVLLASS-SYPCNNKTTIFRATLDADGIFRLYSHCLENKTSRSVHIEWSALNNQCNVHGF 286

Query: 296 CGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFYKITS 355
           C FNS+CS      T  +C C+ GF F +P  KF GCY+N T E  C+     E Y + +
Sbjct: 287 CDFNSYCSG---MGTNFDCSCYPGFAFNDPSEKFSGCYKNVT-ESFCRGTKEGEMYDVKA 342

Query: 356 LEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPAT 415
           +E        Y+ L V +++C  SCL DC C  A+Y N  C K+  P+ + +K  N+ + 
Sbjct: 343 VENILFERFPYSVLHVKKENCGLSCLEDCLCDVALYMNEKCEKYAAPIRYGLKDINISSI 402

Query: 416 LFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYK 475
            F K  +         +A P+      ++KK L+  LA   GS+T LCF+IAIS+   Y+
Sbjct: 403 AFFKVKAASP------AAPPMSPTIIIESKKSLLVFLAIAFGSVTLLCFVIAISTFCVYR 456

Query: 476 QRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK 535
            R   Y+KL    SL  + EF ++SFS  ELE+AT+GF EELGRG  GAVY+G+I  G++
Sbjct: 457 DRAFLYEKLSGIISL--AGEFTLRSFSYSELEKATSGFMEELGRGSIGAVYRGTIPGGDR 514

Query: 536 IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN 595
            VAVKRLE  ++E E+KF+AE+  + +T+H+NLVRLLGFC++ S+++LVYE++  G+L +
Sbjct: 515 TVAVKRLEKVLDEAEKKFRAEITVIGQTYHRNLVRLLGFCVEGSRRVLVYEYLRNGTLAD 574

Query: 596 LLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
           LL   E  PIW++RVRIALD+ARGI YLHEEC+  IIHCNI P+NIL+DDS  AKIS+F 
Sbjct: 575 LLFQSERRPIWKERVRIALDIARGILYLHEECQACIIHCNITPQNILMDDSWIAKISDFG 634

Query: 656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
           L+K+L P++      +  +RG+++PEWQN+ L++VK+D+YSFGVV+LE++CCRS+ +V+V
Sbjct: 635 LSKLLYPDEIRSSMALSQSRGHLAPEWQNNALMSVKADIYSFGVVLLEVICCRSSIKVDV 694

Query: 716 STADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
           ST D + L +W Y CF A +L KLV E E ++  +LE MV++GLLC+Q +P  RP +KNV
Sbjct: 695 STPDEMNLPSWAYQCFAAGQLDKLVKE-EVIEFESLERMVKIGLLCVQHDPASRPCIKNV 753

Query: 776 ILMLEGTMEIPVVP 789
           ILMLEG+ +IP  P
Sbjct: 754 ILMLEGSDDIPAPP 767

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224093336|ref|XP_002309887.1| predicted protein [Populus trichocarpa] gi|222852790|gb|EEE90337.1| predicted protein [Populus trichocarpa]

 Score =  663 bits (1710), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/777 (46%), Positives = 495/777 (63%), Gaps = 47/777 (6%)

Query: 32  ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVS 91
           + LGSSLS +  P+SW SPS  F FGFY++G+GF VG WL + P+ T  WT  RD P VS
Sbjct: 4   LELGSSLSTNIPPTSWRSPSRHFAFGFYRQGSGFIVGIWLASKPDATFTWTINRDVPHVS 63

Query: 92  SNAKLILTMDGLVLQTEESKHKLIANTTSDEP---------ASFASILDSGNFVLCNDRF 142
           SNA L LT  G +L     +H+   N  +DE          AS+A +LDSGNFVL N+  
Sbjct: 64  SNATLELTKKGKLLL---RRHR---NNATDEEIFIANFKGSASYAQMLDSGNFVLYNEHS 117

Query: 143 DFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQ 201
           + IWESF+FPT TI+GGQ+L  G +LFS AS  + STGRF L+ Q DG LVLYPV D+  
Sbjct: 118 EAIWESFSFPTDTILGGQNLYKGGELFSRASAIDLSTGRFHLKMQDDGNLVLYPV-DTLD 176

Query: 202 I----YWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRAT 257
           +    YW S  Y  +  +H  + LT  G L   +    +I   +S   +S++ ++IYRAT
Sbjct: 177 LPLDAYWSSDTY-GNPGIH--LILTGTGDLLLVNQTLHKIKTVTSSGSESNSTSIIYRAT 233

Query: 258 LDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCF 317
           LD+DGI RLYSH+F   + Y   + WYV   QC V+GFCGFNS+C+   N   + +C C 
Sbjct: 234 LDYDGIFRLYSHNFDGVAKYIISLMWYVPWIQCEVRGFCGFNSYCT--MNDDDQPDCLCL 291

Query: 318 RGFNFINPEMKFLGCYRNFTDEEGCKRKMP-AEFYKITSLEISQLGGMAYAKLSVNEKDC 376
            G  +++P  +F GC R++ +E  CK     +  Y IT ++       AY + S++E+ C
Sbjct: 292 PGTAYVDPNQRFRGCERDY-NEGSCKHTNEMSSLYNITVMDQIAWDDNAYFQASMSEEGC 350

Query: 377 SKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPI 436
            KSCL DC C  A+Y + +C K K P+ +A K ++  +  F K             AL I
Sbjct: 351 RKSCLEDCNCAGALYESGNCKKQKYPVKYAWKTEDQLSKSFFK------------VALEI 398

Query: 437 VSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEF 496
           + +    +KK +V +L   L  IT+    +AIS L  +K RV + +    + + G ++E 
Sbjct: 399 IQRT---SKKAVVLILVMSLAFITWCLVALAISGLFIFKSRVIKGRMQTESGNFGLAREL 455

Query: 497 IIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAE 556
            +++FS  EL++AT GF+EELG+G  GAVYKG++ +G K +AVKRLE  V E ER+F AE
Sbjct: 456 TLRAFSYRELKKATKGFKEELGKGSSGAVYKGTLYKGKKAIAVKRLEKVVSESEREFLAE 515

Query: 557 MAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDV 616
           M ++ +THHKNLVRLLG+C + S +LLVYE+MS GSL NLL   E  P W DRV+IALD+
Sbjct: 516 MRSIGKTHHKNLVRLLGYCTEGSHRLLVYEYMSNGSLANLLFRNERIPDWSDRVKIALDI 575

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
           A+GI YLHEECE  I+HC+I P+NIL+DD  TAKIS+F LAK+L+P+QT  +T  +GT G
Sbjct: 576 AKGILYLHEECEAPIMHCDIKPQNILMDDFWTAKISDFGLAKLLVPDQTRTLTIARGTPG 635

Query: 677 YMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE 735
           YM+PEW   S   +VK DVYS+GVV+LEIV CR N ++NVS  + VLLS W Y   +A+E
Sbjct: 636 YMAPEWTKISTPTSVKVDVYSYGVVLLEIVFCRRNMKINVSKPEEVLLSKWAYELLVARE 695

Query: 736 LSKL-VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
           L +L +GED  VD + LE MV +G+ CIQDEP LRPSMK V++MLEG  ++ V P P
Sbjct: 696 LDRLDLGED--VDRQKLEKMVMIGIWCIQDEPGLRPSMKTVVMMLEGITDVSVPPHP 750

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	811
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.868	0.850	0.299	3.4e-77
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.736	0.720	0.346	1.5e-76
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.770	0.761	0.309	7.7e-71
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.401	0.373	0.366	4.7e-66
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.372	0.385	0.362	5.6e-64
TAIR|locus:2137010	849	AT4G11900 [Arabidopsis thalian	0.778	0.743	0.308	7.7e-64
TAIR|locus:2197729	805	SD1-29 "S-domain-1 29" [Arabid	0.860	0.867	0.296	1.2e-63
TAIR|locus:2197734	814	AT1G61370 [Arabidopsis thalian	0.870	0.867	0.284	2.6e-63
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	0.855	0.836	0.299	4.2e-63
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.875	0.843	0.292	5.4e-63

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
 Identities = 231/772 (29%), Positives = 380/772 (49%)

Query:    52 GLFQFGFYKEGTG--FSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEE 109
             G ++ GF+K G+   F +G W       T++W A RD+     N+ +    +G ++  + 
Sbjct:    43 GTYEMGFFKPGSSSNFYIGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLILLDG 101

Query:   110 SKHKLI----ANTTSDEPASFASILDSGNFVLCND----RFDFIWESFNFPTHTIVGGQS 161
             +    +     N+TS   A  A + D GN VL         + +W+SF+ P  T + G  
Sbjct:   102 NYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVK 161

Query:   162 LV------NGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRV 215
             +          +L S  S  + S G F LE  +          S + YW S  +    R+
Sbjct:   162 IRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSNE-YWSSGPWNPQSRI 220

Query:   216 HGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDS 275
                V       +   S  +    +  +YS+   N+  + R  +D  G ++ ++     + 
Sbjct:   221 FDSVPEMRLNYIYNFSFFSNTTDSYFTYSIY--NQLNVSRFVMDVSGQIKQFTW---LEG 275

Query:   276 NYRADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINP---EMK--FL 330
             N   ++ W   + QC V  +CG    CS+ +       C C +GF  ++    ++K    
Sbjct:   276 NKAWNLFWSQPRQQCQVYRYCGSFGICSDKSEPF----CRCPQGFRPMSQKDWDLKDYSA 331

Query:   331 GCYRNFTDEEGCKRKMPAEFYKITSLEISQLGG-MAYAKLSVNEKDCSKSCLNDCYCGAA 389
             GC R    E  C R    +F+++ +++++     +    LS+    C+ +C  DC C A 
Sbjct:   332 GCVRK--TELQCSRGDINQFFRLPNMKLADNSEVLTRTSLSI----CASACQGDCSCKAY 385

Query:   390 IYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQA-NLSTNLSALPIVSKKHGDNKKKL 448
              Y   S SK    L+++    N+   L  + S G    L    S +P V      N K L
Sbjct:   386 AYDEGS-SKC---LVWSKDVLNLQQ-LEDENSEGNIFYLRLAASDVPNVGASGKSNNKGL 440

Query:   449 VSVLAACLGSI-TFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELE 507
             +    A LGS+   +  L+ +  +L Y++R    +++R     G   +  + +FS  EL+
Sbjct:   441 I--FGAVLGSLGVIVLVLLVVILILRYRRR----KRMR-----GEKGDGTLSAFSYRELQ 489

Query:   508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
              AT  F ++LG G FG+V+KG++ + + I AVKRLE  + +GE++F+ E+  +    H N
Sbjct:   490 NATKNFSDKLGGGGFGSVFKGALPDSSDI-AVKRLEG-ISQGEKQFRTEVVTIGTIQHVN 547

Query:   568 LVRLLGFCMQTSKKLLVYEFMSKGSLEN--LLSNVESGPI--WRDRVRIALDVARGITYL 623
             LVRL GFC + SKKLLVY++M  GSL++   L+ VE   +  W+ R +IAL  ARG+ YL
Sbjct:   548 LVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYL 607

Query:   624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             H+EC   IIHC+I P NILLD     K+++F LAK++  + + ++T ++GTRGY++PEW 
Sbjct:   608 HDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWI 667

Query:   684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK-ELSKLVG- 741
             +   IT K+DVYS+G+++ E+V  R N E +     V    +W         ++  LV  
Sbjct:   668 SGVAITAKADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSWAATILTKDGDIRSLVDP 726

Query:   742 --EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
               E + VD+  +    +V   CIQDE + RP+M  V+ +LEG +E+   PFP
Sbjct:   727 RLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
 Identities = 224/647 (34%), Positives = 331/647 (51%)

Query:   166 SKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLY--WASDRVHGMVNLTP 223
             S+ F++     S    F LE R G L L    ++  IYW   L   ++S+     ++L  
Sbjct:   149 SQNFTAGKILRSGLYSFQLE-RSGNLTLR--WNTSAIYWNHGLNSSFSSNLSSPRLSLQT 205

Query:   224 GGILQAGSADATQIL--ARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADI 281
              G++   S   + +L  A   YS    +        LD DG LR+YS    S ++   + 
Sbjct:   206 NGVV---SIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYSS--ASRNSGPVNA 260

Query:   282 EWYVLQNQCLVKGFCGFNSFCS-NPTNSSTKGECFC-FRGFNFINPEMKFLGCYRN--FT 337
              W  + +QCLV G+CG    CS N TN      C C  R F+F++   +  GC R    +
Sbjct:   261 HWSAV-DQCLVYGYCGNFGICSYNDTNPI----CSCPSRNFDFVDVNDRRKGCKRKVELS 315

Query:   338 DEEGCKRKMPAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIY---ANA 394
             D  G    +     ++ + E        +A  S     C  +CL+   C A++     + 
Sbjct:   316 DCSGNTTMLDLVHTRLFTYEDDPNSESFFAGSS----PCRANCLSSVLCLASVSMSDGSG 371

Query:   395 SC-SKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLA 453
             +C  KH        ++ +VP+T ++K   G    +T    L   +K  GD+    V +  
Sbjct:   372 NCWQKHPGSFFTGYQWPSVPSTSYVK-VCGPVVANT----LERATK--GDDNNSKVHLWI 424

Query:   454 ACLGSITFLCFLIAISSLLAYKQ-RVN-QYQKLRINSSLGPSQEFIIQSFSTGELERATN 511
               +  I  L  L+A+   L +   R N ++  L  + +L          F+  EL+R T 
Sbjct:   425 VAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTK 484

Query:   512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
              F+E+LG G FG VY+G +     +VAVK+LE  +E+GE++F+ E+A +  THH NLVRL
Sbjct:   485 SFKEKLGAGGFGTVYRG-VLTNRTVVAVKQLEG-IEQGEKQFRMEVATISSTHHLNLVRL 542

Query:   572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI--WRDRVRIALDVARGITYLHEECEV 629
             +GFC Q   +LLVYEFM  GSL+N L   +S     W  R  IAL  A+GITYLHEEC  
Sbjct:   543 IGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRD 602

Query:   630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLI 688
              I+HC+I P NIL+DD+  AK+S+F LAK+L P      ++ V+GTRGY++PEW  +  I
Sbjct:   603 CIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPI 662

Query:   689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE----LSKLVGEDE 744
             T KSDVYS+G+V+LE+V  + NF+V+  T +    S W Y  F        L   + ED+
Sbjct:   663 TSKSDVYSYGMVLLELVSGKRNFDVSEKT-NHKKFSIWAYEEFEKGNTKAILDTRLSEDQ 721

Query:   745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI--PVVP 789
              VD+  +  MV+    CIQ++P  RP+M  V+ MLEG  EI  P+ P
Sbjct:   722 TVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 717 (257.5 bits), Expect = 7.7e-71, P = 7.7e-71
 Identities = 218/704 (30%), Positives = 360/704 (51%)

Query:   120 SDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSST 179
             S + AS   + DSGN V+ +     IWESF+ PT T++  Q+   G KL SS S +N + 
Sbjct:   118 SGKNASRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSPSSSNMT- 176

Query:   180 GRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSA------- 232
               + LE + G +VL     + Q+YW   +  A +R+   +N   GG++ + S        
Sbjct:   177 --YALEIKSGDMVLSVNSLTPQVYW--SMANARERI---IN-KDGGVVTSSSLLGNSWRF 228

Query:   233 -DATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCL 291
              D  Q+L        + ++   + A L  +G++  +S+  +  S   AD    +  + C 
Sbjct:   229 FDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVIS-FSNLGSGAS--AADSSTKIPSDLCG 285

Query:   292 VKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEGCKRKMPAEFY 351
                 CG    CS      +K  C C  G +    +     C    T    CK+    +  
Sbjct:   286 TPEPCGPYYVCSG-----SK-VCGCVSGLSRARSD-----CKTGITSP--CKK---TKDN 329

Query:   352 KITSLEISQLG-GMAYAKLSVNEKDCSKSCLNDC--YCGAAIYANASCSKHKLPLIFAMK 408
                 L++   G G+ Y  L        K+ L+ C  +C    + N SC    L L F   
Sbjct:   330 ATLPLQLVSAGDGVDYFALGYAPPFSKKTDLDSCKEFC----HNNCSC----LGLFF--- 378

Query:   409 YQNVPATLFIKWSSGQANLSTN-----LSALPIVSKKHG--DNKKKLVSVLAACLGSITF 461
              QN     F+    G    S N     +S + I S   G  DN +         +  +  
Sbjct:   379 -QNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVV 437

Query:   462 LCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQE--FIIQ------SFSTGELERATNGF 513
               F+IA+   +A+  R+++ +K+ + +    S+E  F+         F+  +L+ ATN F
Sbjct:   438 TVFIIAVLIFVAF--RIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNF 495

Query:   514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
               +LG+G FG+VY+G++ +G+++ AVK+LE  + +G+++F+AE++ +   HH +LVRL G
Sbjct:   496 SVKLGQGGFGSVYEGTLPDGSRL-AVKKLEG-IGQGKKEFRAEVSIIGSIHHLHLVRLRG 553

Query:   574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPI---WRDRVRIALDVARGITYLHEECEVQ 630
             FC + + +LL YEF+SKGSLE  +   + G +   W  R  IAL  A+G+ YLHE+C+ +
Sbjct:   554 FCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDAR 613

Query:   631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
             I+HC+I P NILLDD+  AK+S+F LAK++   Q+ + T ++GTRGY++PEW  +  I+ 
Sbjct:   614 IVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISE 673

Query:   691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV-GEDEEVDL- 748
             KSDVYS+G+V+LE++  R N++ +  T++     ++ +      +L  +V G+ + VD+ 
Sbjct:   674 KSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVT 732

Query:   749 -RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP 791
                ++  ++  L CIQ++   RPSM  V+ MLEG    PVV  P
Sbjct:   733 DERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVF--PVVQPP 774

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 513 (185.6 bits), Expect = 4.7e-66, Sum P(3) = 4.7e-66
 Identities = 129/352 (36%), Positives = 192/352 (54%)

Query:   376 CSKSCLNDCYCGAAIYANASCSKHKLPLIFAMK--YQNVPATLFIKWSSGQANLSTN-LS 432
             C   C  +C C    Y N S S + +   F      +N P    +    G   LS    +
Sbjct:   372 CHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLSLVKNSPENHDL---IGYVKLSIRKTN 428

Query:   433 ALPIVSKKHGDNKKKLVS-VLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLG 491
             A P  +   G +   +++ VL  C G   FL  LIA+  L   +  V +Y  +R      
Sbjct:   429 AQPPGNNNRGGSSFPVIALVLLPCSGF--FL--LIALGLLWWRRCAVMRYSSIREKQVTR 484

Query:   492 PSQ-------EFII----QSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVK 540
             P          F I    Q F   ELE+AT  F+ ++G G FG+VYKG++ +   ++AVK
Sbjct:   485 PGSFESGDLGSFHIPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPD-ETLIAVK 543

Query:   541 RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV 600
             ++ N    G ++F  E+A +    H NLV+L GFC +  + LLVYE+M+ GSLE  L + 
Sbjct:   544 KITNHGLHGRQEFCTEIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFS- 602

Query:   601 ESGPI--WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +GP+  W++R  IAL  ARG+ YLH  C+ +IIHC++ P NILL D    KIS+F L+K
Sbjct:   603 GNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSK 662

Query:   659 ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSN 710
             +L   ++ + T ++GTRGY++PEW  +  I+ K+DVYS+G+V+LE+V  R N
Sbjct:   663 LLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 500 (181.1 bits), Expect = 5.6e-64, Sum P(2) = 5.6e-64
 Identities = 113/312 (36%), Positives = 181/312 (58%)

Query:   480 QYQKLRINSSLGPSQEFIIQSFSTGELERATNGFE--EELGRGCFGAVYKGSICEGNKIV 537
             Q +  R++S     ++  +       +  AT+GF    +LG+G FG VYKG++  G + V
Sbjct:   432 QRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQE-V 490

Query:   538 AVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL 597
             AVKRL     +G  +F+ E+  + +  H+NLV++LG+C+   +++L+YE+    SL++ +
Sbjct:   491 AVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFI 550

Query:   598 SNVESGPI--WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
              + E      W  RV I   +ARG+ YLHE+  ++IIH ++   N+LLD  + AKIS+F 
Sbjct:   551 FDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFG 610

Query:   656 LAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
             LA+ L  ++T    T V GT GYMSPE+Q  G  ++KSDV+SFGV+VLEIV  R N    
Sbjct:   611 LARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFR 670

Query:   715 VSTADVVLLSTWVYNCFIAKELSKLVGE--DEE-VDLRTLETMVRVGLLCIQDEPNLRPS 771
                  + LL    +  F+  +  +++ E  +E   D+  +  ++ +GLLC+Q +P  RP+
Sbjct:   671 NEEHKLNLLGH-AWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPN 729

Query:   772 MKNVILMLEGTM 783
             M  V+LML   M
Sbjct:   730 MSVVVLMLSSEM 741

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2137010 AT4G11900 [Arabidopsis thaliana (taxid:3702)]

 Score = 616 (221.9 bits), Expect = 7.7e-64, Sum P(2) = 7.7e-64
 Identities = 215/696 (30%), Positives = 331/696 (47%)

Query:   127 ASILDSGNFVLC---NDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSS-ASETNSSTGRF 182
             A + DSGN VL    N     +W+SF+ P+ T + G  +  GS+LF+S  S  + S GR+
Sbjct:   157 AVLFDSGNLVLRDGPNSSAAVLWQSFDHPSDTWLPGGKIRLGSQLFTSWESLIDPSPGRY 216

Query:   183 CLEQRDGILVLYPVRDSRQIYWV-SKLYWASDRVHGMVNLTPGGILQAGSADATQILARS 241
              LE         P   S    W  SK YW+S  ++  +    G     G+  +  +    
Sbjct:   217 SLE-------FDPKLHSLVTVWNRSKSYWSSGPLYDWLQSFKGFPELQGTKLSFTLNMDE 269

Query:   242 SYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNSF 301
             SY   S +    YR  +   G   L   H    S +R  +      N+C V   CG    
Sbjct:   270 SYITFSVDPQSRYRLVMGVSGQFMLQVWHVDLQS-WRVILSQP--DNRCDVYNSCGSFGI 326

Query:   302 CSNPTNSSTKGECFCFRGFNFINPEMKFLGCYRNFTDEEG-CKR-------KMPAEFYKI 353
             C+   N      C C  GF     + +F     +  D  G CKR       K   EF  I
Sbjct:   327 CNE--NREPP-PCRCVPGF-----KREFSQGSDDSNDYSGGCKRETYLHCYKRNDEFLPI 378

Query:   354 TSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANASCSKHKLPLIFAMKYQNVP 413
              +++++     A    S   + C+  C+ DC C A  YAN   +K  +    A   Q + 
Sbjct:   379 ENMKLATDPTTASVLTSGTFRTCASRCVADCSCQA--YANDG-NKCLVWTKDAFNLQQLD 435

Query:   414 A----TLFIKWSSGQANLSTNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFL---I 466
             A    T F++ +S  +N+ST  +       +H   K  ++ ++ A L + T  CF+    
Sbjct:   436 ANKGHTFFLRLAS--SNISTANNR----KTEHSKGKSIVLPLVLASLVA-TAACFVGLYC 488

Query:   467 AISSLLAYK--QRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGF--EEELGRGCF 522
              ISS +  K  QR  ++ +  +   L       +   +  ++  ATN F  +++LG G F
Sbjct:   489 CISSRIRRKKKQRDEKHSRELLEGGLIDDAGENMCYLNLHDIMVATNSFSRKKKLGEGGF 548

Query:   523 GAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL 582
             G VYKG +  G + VA+KRL     +G  +F+ E+  + +  HKNLVRLLG+C++  +KL
Sbjct:   549 GPVYKGKLPNGME-VAIKRLSKKSSQGLTEFKNEVVLIIKLQHKNLVRLLGYCVEGDEKL 607

Query:   583 LVYEFMSKGSLENLL-SNVESGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRN 640
             L+YE+MS  SL+ LL  +++S  + W  R++I     RG+ YLHE   ++IIH ++   N
Sbjct:   608 LIYEYMSNKSLDGLLFDSLKSRELDWETRMKIVNGTTRGLQYLHEYSRLRIIHRDLKASN 667

Query:   641 ILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGV 699
             ILLDD +  KIS+F  A+I    Q    T  + GT GYMSPE+   G+I+ KSD+YSFGV
Sbjct:   668 ILLDDEMNPKISDFGTARIFGCKQIDDSTQRIVGTFGYMSPEYALGGVISEKSDIYSFGV 727

Query:   700 VVLEIVCCR--SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETM--V 755
             ++LEI+  +  + F  N     ++    W   C   K +S ++ E         E M  +
Sbjct:   728 LLLEIISGKKATRFVHNDQKHSLIAYE-WESWCE-TKGVS-IIDEPMCCSYSLEEAMRCI 784

Query:   756 RVGLLCIQDEPNLRPSMKNVILML--EGTMEIPVVP 789
              + LLC+QD P  RP +  ++ ML  + T+ IP  P
Sbjct:   785 HIALLCVQDHPKDRPMISQIVYMLSNDNTLPIPKQP 820

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 649 (233.5 bits), Expect = 1.2e-63, P = 1.2e-63
 Identities = 230/776 (29%), Positives = 359/776 (46%)

Query:    52 GLFQFGFYKEGTGFS--VGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEE 109
             G ++ GF+      +  VG W        V+W A RD P  SS A L ++ +G ++  + 
Sbjct:    40 GFYELGFFSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLD- 98

Query:   110 SKHKLIANT----TSDEPASFASILDSGNFVLCND-RFDFIWESFNFPTHTIVGGQSLV- 163
              K  +I +T    TS++    A +LD+GNFV+ +D   + +W+SF    +T++   SL+ 
Sbjct:    99 GKQDVIWSTGKAFTSNK--CHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMY 156

Query:   164 ---NGSKLFSSASETNS--STGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDRVHGM 218
                NG K   +  ++NS  S G F LE    I     +R     YW     WA  R  G+
Sbjct:   157 DTSNGKKRVLTTWKSNSDPSPGEFSLEITPQIPTQGLIRRGSVPYWRCGP-WAKTRFSGI 215

Query:   219 VNLTPGGILQAGSADATQILARS-SYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNY 277
               +    +        T     S SYS    N  + Y  TL  +G +++    +   +N+
Sbjct:   216 SGIDASYVSPFSVVQDTAAGTGSFSYSTLR-NYNLSY-VTLTPEGKMKIL---WDDGNNW 270

Query:   278 RADIEWYVLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEM--K---FLGC 332
             +  +   + +N C + G CG    C      S   +C C +GF   + E   K     GC
Sbjct:   271 KLHLS--LPENPCDLYGRCGPYGLCVR----SDPPKCECLKGFVPKSDEEWGKGNWTSGC 324

Query:   333 YRNFTDEEGCKRKMPAE------FYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYC 386
              R        K  M  +      FY++T ++   L    +A   +N + C + CL +C C
Sbjct:   325 VRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPDLH--QFASF-LNAEQCYQGCLGNCSC 381

Query:   387 GAAIYANA-SCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNK 445
              A  Y +   C      L   +++ +    LFI+ +S               S+  G ++
Sbjct:   382 TAFAYISGIGCLVWNGELADTVQFLSSGEFLFIRLAS---------------SELAGSSR 426

Query:   446 KKLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFIIQSFSTGE 505
             +K++      L SI FL  + A   L  Y+ + N   K            F    F    
Sbjct:   427 RKIIVGTTVSL-SI-FLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNF----FEMHT 480

Query:   506 LERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT 563
             +  ATN F    +LG+G FG VYKG + +G +I  VKRL +   +G  +F  E+  + + 
Sbjct:   481 IRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEI-GVKRLASSSGQGTEEFMNEITLISKL 539

Query:   564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARGIT 621
              H+NLVRLLG+C+   +KLL+YEFM   SL+  + +  ++    W  R  I   +ARG+ 
Sbjct:   540 QHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLL 599

Query:   622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGYMSP 680
             YLH +  +++IH ++   NILLDD +  KIS+F LA++    Q    T  V GT GYMSP
Sbjct:   600 YLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSP 659

Query:   681 EWQNSGLITVKSDVYSFGVVVLEIVCCR--SNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
             E+  +GL + KSD+YSFGV++LEI+  +  S F +    +  +L  TW   C      S 
Sbjct:   660 EYAWAGLFSEKSDIYSFGVLMLEIISGKRISRF-IYGDESKGLLAYTWDSWCETGG--SN 716

Query:   739 LVGEDEEVDLRTLETM--VRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPI 792
             L+  D     +  E    V++GLLC+Q E   RP+   V+ ML    ++PV   PI
Sbjct:   717 LLDRDLTDTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQPI 772

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)]

 Score = 646 (232.5 bits), Expect = 2.6e-63, P = 2.6e-63
 Identities = 221/777 (28%), Positives = 364/777 (46%)

Query:    52 GLFQFGFYKEGTGFS--VGTWLVT-SPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTE 108
             G ++ GF+      +  VG W    +P + V+W A RD+P  ++ A L +  +G ++  E
Sbjct:    44 GTYELGFFSPNNSRNQYVGIWFKNITPRV-VVWVANRDKPVTNNAANLTINSNGSLILVE 102

Query:   109 ESKHKL--IANTTSDEPASFASILDSGNFVLCNDRFDF-IWESFNFPTHTIVGGQSLV-- 163
               ++ +  I  T S      A +L++GN VL +   +  +WESF     T++   S++  
Sbjct:   103 REQNVVWSIGETFSSNELR-AELLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYD 161

Query:   164 ---NGSKLFSS-ASETNSSTGRFCLEQRDGILVL-YPVRDSRQIYWVSKLYWASDRVHGM 218
                N  ++ SS  + T+ S G F  E    +    + +R SR  YW     WA  R  G+
Sbjct:   162 VPNNKKRVLSSWKNPTDPSPGEFVAELTTQVPPQGFIMRGSRP-YWRGGP-WARVRFTGI 219

Query:   219 VNLTPGGILQAG-SADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNY 277
               +    + +   S D        +YS++  N  + Y  TL   G L++    + + S +
Sbjct:   220 PEMDGSHVSKFDISQDVAAGTGSLTYSLERRNSNLSY-TTLTSAGSLKII---WNNGSGW 275

Query:   278 RADIEWYVLQNQCLVKGFCGFNSFC--SNPTNSSTKGECFCFRGF-----NFINPEMKFL 330
               D+E  V  + C V   CG    C  SNP       +C C +GF        N      
Sbjct:   276 VTDLEAPV--SSCDVYNTCGPFGLCIRSNPP------KCECLKGFVPKSDEEWNKRNWTG 327

Query:   331 GCYR--NFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAKLS-VNEKDCSKSCLNDCYCG 387
             GC R  N + +        A    I  +  +      Y  LS +NE+DC + CL +C C 
Sbjct:   328 GCMRRTNLSCDVNSSATAQANNGDIFDIVANVKPPDFYEYLSLINEEDCQQRCLGNCSCT 387

Query:   388 AAIYANA-SCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKKHGDNKK 446
             A  Y     C      L+  M+        F+   +G   LS  L++    S+  G N+ 
Sbjct:   388 AFSYIEQIGCLVWNRELVDVMQ--------FV---AGGETLSIRLAS----SELAGSNRV 432

Query:   447 KLVSVLAACLGSITFLCFLIAISSLLAYKQRVNQYQKLRINSSLGPSQEFI----IQSFS 502
             K++  +A+ +    F+  + A      YK + N    + + +S    +E +    +  F 
Sbjct:   433 KII--VASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQDVNFFD 490

Query:   503 TGELERATNGF--EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAV 560
                +   TN F  E +LG+G FG VYKG++ +G +I A+KRL +   +G  +F  E+  +
Sbjct:   491 MQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEI-AIKRLSSTSGQGLEEFMNEIILI 549

Query:   561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--SNVESGPIWRDRVRIALDVAR 618
              +  H+NLVRLLG C++  +KLL+YEFM+  SL   +  S  +    W  R  I   +A 
Sbjct:   550 SKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIAC 609

Query:   619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGY 677
             G+ YLH +  ++++H ++   NILLD+ +  KIS+F LA++    Q    T  V GT GY
Sbjct:   610 GLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGY 669

Query:   678 MSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
             MSPE+  +G+ + KSD+Y+FGV++LEI+  +      +      LL  + ++ +     S
Sbjct:   670 MSPEYAWTGMFSEKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLLE-FAWDSWCESGGS 728

Query:   738 KLVGEDEEVDLRTLETM--VRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPI 792
              L+ +D        E    V++GLLCIQ +   RP++  V+ ML  TM++P    P+
Sbjct:   729 DLLDQDISSSGSESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQPV 785

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 644 (231.8 bits), Expect = 4.2e-63, P = 4.2e-63
 Identities = 231/772 (29%), Positives = 352/772 (45%)

Query:    54 FQFGFYK--EGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEES 110
             F+FGF+     TG   G W    P  TV+W A  + P   S+  + ++ +G LV+     
Sbjct:    44 FRFGFFSPVNSTGRYAGIWFNNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRG 103

Query:   111 KHKLIANTTSDEPAS--FASILDSGNFVLC---NDRFDFIWESFNFPTHTIVGGQSLVNG 165
             +     N      A+  +A +L++GN VL    N   + +WESF  P +  +   SL   
Sbjct:   104 QVHWSTNVLVPVAANTFYARLLNTGNLVLLGTTNTGDEILWESFEHPQNIYLPTMSLATD 163

Query:   166 SK------LFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLY-WASDRVHGM 218
             +K      L S  S  + S GR+      G++   P+     + W   L  W S   +G 
Sbjct:   164 TKTGRSLKLRSWKSPFDPSPGRYSA----GLI---PLPFPELVVWKDDLLMWRSGPWNGQ 216

Query:   219 VNL-TPGGILQAGSADATQILA-RSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSN 276
               +  P    +    + T     R S S+  +  T++Y   LD +G +      F  D N
Sbjct:   217 YFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNTLLYHFLLDSEGSV------FQRDWN 270

Query:   277 YRADIEWY----VLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGC 332
                  EW     V   +C     CG   F S   N  +   C C RGF    P+      
Sbjct:   271 VAIQ-EWKTWLKVPSTKCDTYATCG--QFASCRFNPGSTPPCMCIRGFK---PQSYAEWN 324

Query:   333 YRNFTDEEGCKRKMPAEFYKITSLEISQL--GGMAYAKLSV---------NEKDCSKSCL 381
               N+T  +GC RK P +     + + S+   G +   K+ V         NE+DC +SCL
Sbjct:   325 NGNWT--QGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQRSGANEQDCPESCL 382

Query:   382 NDCYCGAAIYANA-SCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSALPIVSKK 440
              +C C A  +     C      L+   ++       +I+ +  +    TN S +  V+  
Sbjct:   383 KNCSCTAYSFDRGIGCLLWSGNLMDMQEFSGTGVVFYIRLADSEFKKRTNRSIVITVTLL 442

Query:   441 HGDNKKKLVSVLAACLGSITFLCFLIAISSLLAYKQRV-NQYQKLRINSSLGPS--QEFI 497
              G       + L A  G++    + IA         R+ N+  +   ++ +G     ++ 
Sbjct:   443 VG-------AFLFA--GTVVLALWKIAKHREKNRNTRLLNERMEALSSNDVGAILVNQYK 493

Query:   498 IQSFSTGE---LERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK 552
             ++     E   L  ATN F    +LG+G FGAVYKG + EG  I AVKRL     +G  +
Sbjct:   494 LKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDI-AVKRLSRTSGQGVEE 552

Query:   553 FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN-VESGPI-WRDRV 610
             F  E+  + +  H+NLVRLLGFC++  +++LVYEFM +  L+  L + V+   + W+ R 
Sbjct:   553 FVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRF 612

Query:   611 RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT- 669
              I   + RG+ YLH +  ++IIH ++   NILLD++L  KIS+F LA+I   N+  + T 
Sbjct:   613 NIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTV 672

Query:   670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN 729
              V GT GYM+PE+   GL + KSDV+S GV++LEIV  R N     +      LS + + 
Sbjct:   673 RVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSF-YNDGQNPNLSAYAWK 731

Query:   730 CFIAKELSKLVGED--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
              +   E   LV     EE     +   V VGLLC+QD  N RPS+  VI ML
Sbjct:   732 LWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWML 783

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 643 (231.4 bits), Expect = 5.4e-63, P = 5.4e-63
 Identities = 227/776 (29%), Positives = 356/776 (45%)

Query:    54 FQFGFY--KEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEES 110
             F+ GF+  K  T   VG W       TV+W A R++P +     L +  DG LV+   ++
Sbjct:    51 FELGFFTPKNSTLRYVGIWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQN 110

Query:   111 KHKLIANTTSDEPASFASILDSGNFVLCND--RFDFIWESFNFPTHTIVGGQSL-VNGS- 166
             +     N   +   + A +  +G+ VLC+D  R  + WESFN PT T + G  + VN S 
Sbjct:   111 ETIWSTNVEPESNNTVAVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSL 170

Query:   167 ---KLFSS-ASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVS-KLYWASDRVHGMVNL 221
                + F    SE++ S G++ +    GI    PV     + W   K  W S   +  +  
Sbjct:   171 GENRAFIPWKSESDPSPGKYSM----GI---DPVGALEIVIWEGEKRKWRSGPWNSAIFT 223

Query:   222 TPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYR--A 279
                 +L+    +       SS   +  +    Y A+ D    LR +      +  +R   
Sbjct:   224 GIPDMLRF--TNYIYGFKLSSPPDRDGSVYFTYVAS-DSSDFLRFWIRPDGVEEQFRWNK 280

Query:   280 DIE-WYVLQ----NQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFINPEMKFLGCYR 334
             DI  W +LQ     +C     CG  S C + +     G+C C  GF  ++ +      + 
Sbjct:   281 DIRNWNLLQWKPSTECEKYNRCGNYSVCDD-SKEFDSGKCSCIDGFEPVHQDQ-----WN 334

Query:   335 NFTDEEGCKRKMPAEFYKITSLEISQLGGMAYAK-----------LSVNEKDCSKSCLND 383
             N     GC+R++P    +  SL   Q  G    K           L  N + C   C  D
Sbjct:   335 NRDFSGGCQRRVPLNCNQ--SLVAGQEDGFTVLKGIKVPDFGSVVLHNNSETCKDVCARD 392

Query:   384 CYCGA-AIYANASCSKHKLPLIFAMKYQNVPATLFIKWSSGQANLSTNLSAL-PIVSKKH 441
             C C A A+     C      LI    ++    ++ I+ +  +       S L  IV    
Sbjct:   393 CSCKAYALVVGIGCMIWTRDLIDMEHFERGGNSINIRLAGSKLGGGKENSTLWIIVFSVI 452

Query:   442 GDNKKKL-VSVLAACLGSI-TFLCFL--IAISSLLAYKQRVNQYQKLRINSSLGPSQEFI 497
             G     L + +L     S+  FL     I +S ++  +   +   K+ +   +       
Sbjct:   453 GAFLLGLCIWILWKFKKSLKAFLWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPD--- 509

Query:   498 IQSFSTGELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA 555
             +  FS   +  AT  F EE  LG+G FG VYKG+  EG +I AVKRL    ++G  +F+ 
Sbjct:   510 LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREI-AVKRLSGKSKQGLEEFKN 568

Query:   556 EMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPI-WRDRVRIA 613
             E+  + +  H+NLVRLLG C++ ++K+L+YE+M   SL+  L    + G + WR R  + 
Sbjct:   569 EILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVI 628

Query:   614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT-GVK 672
               +ARG+ YLH +  ++IIH ++   NILLD  +  KIS+F +A+I    Q    T  V 
Sbjct:   629 GGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVV 688

Query:   673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-VYNCF 731
             GT GYM+PE+   G+ + KSDVYSFGV++LEIV  R N     +    ++   W +++  
Sbjct:   689 GTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQG 748

Query:   732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG-TMEIP 786
               KE+   + +D   D+      + VG+LC QD    RP+M +V+LMLE  T ++P
Sbjct:   749 KTKEMIDPIVKDTR-DVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLP 803

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q39202	RLK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.3259	0.9482	0.9242	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00034874001 SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (792 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	811
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-39
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-39
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-26
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	8e-24
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-21
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-19
pfam01453	109	pfam01453, B_lectin, D-mannose binding lectin	4e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-17
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	9e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-14
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-13
smart00108	114	smart00108, B_lectin, Bulb-type mannose-specific l	2e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-13
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-12
cd00028	116	cd00028, B_lectin, Bulb-type mannose-specific lect	4e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-09
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-07
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
cd01098	84	cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain	2e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-04
pfam00954	110	pfam00954, S_locus_glycop, S-locus glycoprotein fa	3e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.001
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.001
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.001
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.002
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	0.002
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.003
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.004
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 7e-48
 Identities = 62/191 (32%), Positives = 101/191 (52%), Gaps = 7/191 (3%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLGFC 575
           LG G FG VY     +  K VA+K ++         +   E+  +++ +H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
              +   LV E+   GSL++LL   E      + +RI L +  G+ YLH      IIH +
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117

Query: 636 INPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSD 693
           + P NILLD D+   K+++F L+K+L  +   ++  + GT  YM+PE     G  + KSD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 694 VYSFGVVVLEI 704
           ++S GV++ E+
Sbjct: 177 IWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (409), Expect = 1e-44
 Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 13/202 (6%)

Query: 513 FEEELGRGCFGAVYKG---SICEGNKI-VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKN 567
             ++LG G FG VYKG      EG +  VAVK L E   EE   +F  E + +++  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           +VRLLG C Q     +V E+M  G L + L         +D +++AL +A+G+ YL    
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE--- 119

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG---YMSPEWQN 684
               +H ++  RN L+ ++L  KIS+F L++ +  +      G  G +    +M+PE   
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177

Query: 685 SGLITVKSDVYSFGVVVLEIVC 706
            G  T KSDV+SFGV++ EI  
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  156 bits (397), Expect = 5e-43
 Identities = 70/198 (35%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 513 FEEELGRGCFGAVYKG----SICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKN 567
             ++LG G FG VYKG            VAVK L E+  E+   +F  E   +R+  H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEE 626
           +V+LLG C +    ++V E+M  G L + L       +   D +  AL +ARG+ YL  +
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
                IH ++  RN L+ ++L  KIS+F L++ L  +    V G K    +M+PE    G
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 687 LITVKSDVYSFGVVVLEI 704
             T KSDV+SFGV++ EI
Sbjct: 180 KFTSKSDVWSFGVLLWEI 197

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  153 bits (390), Expect = 5e-42
 Identities = 70/197 (35%), Positives = 101/197 (51%), Gaps = 8/197 (4%)

Query: 513 FEEELGRGCFGAVYKG--SICEGNKI--VAVKRLENPVEEGERK-FQAEMAAVRRTHHKN 567
             ++LG G FG VYKG      G K   VAVK L+    E + + F  E   +R+  H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           +V+LLG C +     +V E+M  G L + L          D +  AL +ARG+ YL  + 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
               IH ++  RN L+ ++L  KIS+F L++ L  +      G K    +M+PE    G 
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 688 ITVKSDVYSFGVVVLEI 704
            T KSDV+SFGV++ EI
Sbjct: 180 FTSKSDVWSFGVLLWEI 196

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  146 bits (371), Expect = 2e-39
 Identities = 84/284 (29%), Positives = 133/284 (46%), Gaps = 40/284 (14%)

Query: 515 EELGRGCFGAVYKG---SICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           ++LG G FG VYKG           VAVK L E+  EE  + F  E   +++  H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNV-------ESGPI-WRDRVRIALDVARGITY 622
           LLG C +     LV E+M  G L + L          E   +  +D +  A+ +A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG-----Y 677
           L      + +H ++  RN L+ + L  KIS+F L++ +  +        K T G     +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD----YYRKKTGGKLPIRW 173

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKEL 736
           M+PE    G+ T KSDV+SFGV++ EI     + +   +S  +V+    ++   +    L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVL---EYLRKGYR---L 226

Query: 737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            K     +E+     E M    L C Q +P  RP+   ++  LE
Sbjct: 227 PKPEYCPDEL----YELM----LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  145 bits (369), Expect = 3e-39
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 11/203 (5%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRL 571
             E+LG G FG VY     +  K+VA+K ++    + +R+    E+  +++  H N+VRL
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
                +   KL LV E+   G L +LL   + G +  D  R     +   + YLH +   
Sbjct: 63  YDVF-EDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK--- 116

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            I+H ++ P NILLD+    K+++F LA+ L P +   +T   GT  YM+PE        
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYG 174

Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
              D++S GV++ E++  +  F 
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFP 197

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  144 bits (366), Expect = 9e-39
 Identities = 81/267 (30%), Positives = 124/267 (46%), Gaps = 19/267 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
              +LG G FG VYK       KIVAVK L   +   + ++  + E+  +RR  H N+VR
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEV 629
           L+          LV E+   G L + L     GP+   +  +IAL + RG+ YLH     
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL-I 688
            IIH ++ P NILLD++   KI++F LAK L+ +    +T   GT  YM+PE    G   
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
             K DV+S GV++ E++  +  F        + L         I + L   +  DE    
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQL---------IRRILGPPLEFDEPKWS 227

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNV 775
              E    +   C+  +P+ RP+ + +
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (320), Expect = 1e-32
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 11/195 (5%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E LGRG FG+VY     +  +++AVK   L    EE     + E+  +    H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 573 GFCMQTSKK-LLVY-EFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           G      K  L ++ E++S GSL +LL     G +    +R     +  G+ YLH     
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSN--- 120

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLI 688
            I+H +I   NIL+D     K+++F  AK L   +TG  TG V+GT  +M+PE       
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 689 TVKSDVYSFGVVVLE 703
              +D++S G  V+E
Sbjct: 181 GRAADIWSLGCTVIE 195

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 2e-32
 Identities = 68/193 (35%), Positives = 101/193 (52%), Gaps = 11/193 (5%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
               +G+G FG V  G    G K VAVK L++     +  F AE + +    H NLV+LL
Sbjct: 10  LGATIGKGEFGDVMLG-DYRGQK-VAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLL 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQI 631
           G  +Q +   +V E+M+KGSL + L +     I    ++  ALDV  G+ YL E+     
Sbjct: 67  GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           +H ++  RN+L+ + L AK+S+F LAK     Q      VK T    +PE       + K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTK 179

Query: 692 SDVYSFGVVVLEI 704
           SDV+SFG+++ EI
Sbjct: 180 SDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 1e-30
 Identities = 69/202 (34%), Positives = 106/202 (52%), Gaps = 6/202 (2%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG G FG V+ G    G   VAVK L+ P       F  E   +++  
Sbjct: 2   EIPRESLKLERKLGAGQFGEVWMG-TWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLR 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           H  LV+L   C +     +V E+MSKGSL + L + E   +     V +A  +A G+ YL
Sbjct: 60  HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL 119

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                   IH ++  RNIL+ ++L  KI++F LA+++  ++     G K    + +PE  
Sbjct: 120 ESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KSDV+SFG+++ EIV
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (295), Expect = 2e-29
 Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 18/208 (8%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E  R     E +LG G FG V++G + +    VA+K L++     ++ FQ E+ A++R  
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLR 60

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           HK+L+ L   C       ++ E M KGSL   L + E G +      + +A  VA G+ Y
Sbjct: 61  HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAY 119

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-----MPNQTGIVTGVKGTRGY 677
           L E+     IH ++  RNIL+ + L  K+++F LA+++     + +   I    K T   
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT--- 171

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +PE  + G  + KSDV+SFG+++ E+ 
Sbjct: 172 -APEAASHGTFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 6/202 (2%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E++R +     +LG G FG V++G +      VAVK L+ P     + F AE   +++  
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEG-LWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLR 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           H  L++L   C       +V E M  GSL   L       +     + +A  VA G+ YL
Sbjct: 60  HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             +     IH ++  RN+L+ ++   K+++F LA+++  +      G K    + +PE  
Sbjct: 120 EAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
                ++KSDV+SFG+++ EIV
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 3e-26
 Identities = 78/291 (26%), Positives = 134/291 (46%), Gaps = 53/291 (18%)

Query: 516 ELGRGCFGAVYKG---SICEGNKI--VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLV 569
           ELG+G FG VY+G    + +G     VA+K + EN       +F  E + ++  +  ++V
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLL---------SNVESGPIWRDRVRIALDVARGI 620
           RLLG        L+V E M+KG L++ L         +     P  +  +++A ++A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG---- 676
            YL  +   + +H ++  RN ++ + LT KI +F + + +   +T      KG +G    
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI--YETDYYR--KGGKGLLPV 185

Query: 677 -YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE 735
            +M+PE    G+ T KSDV+SFGVV+ E+                  L+   Y     +E
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT----------------LAEQPYQGLSNEE 229

Query: 736 LSKLVGED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           + K V +       E    + LE M     +C Q  P +RP+   ++  L+
Sbjct: 230 VLKFVIDGGHLDLPENCPDKLLELM----RMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  107 bits (269), Expect = 6e-26
 Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 19/196 (9%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E++G+G FG VYK       K VA+K ++   +E + K   E+  +++  H N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-------RIALDVARGITYLHEEC 627
            ++  +  +V EF S GSL++LL +        ++         +  ++ +G+ YLH   
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKS-------TNQTLTESQIAYVCKELLKGLEYLHSN- 117

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
              IIH +I   NILL      K+ +F L+  L  + T     + GT  +M+PE  N   
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVINGKP 173

Query: 688 ITVKSDVYSFGVVVLE 703
              K+D++S G+  +E
Sbjct: 174 YDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 7e-25
 Identities = 64/196 (32%), Positives = 108/196 (55%), Gaps = 14/196 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G+G FG VYKG + +GN  VAVK  R   P +  +RKF  E   +++  H N+V+L+
Sbjct: 1   EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDL-KRKFLQEAEILKQYDHPNIVKLI 58

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G C+Q     +V E +  GSL   L   ++    +  ++++LD A G+ YL  +     I
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR----GYMSPEWQNSGLI 688
           H ++  RN L+ ++   KIS+F +++     + GI T   G +     + +PE  N G  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 689 TVKSDVYSFGVVVLEI 704
           T +SDV+S+G+++ E 
Sbjct: 173 TSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (259), Expect = 9e-25
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
             +E+G G FG V+ G   E  K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK-VAIK----TIREGAMSEEDFIEEAQVMMKLSHPKLV 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C + S   LV+EFM  G L + L            + + LDV  G+ YL      
Sbjct: 63  QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 690 VKSDVYSFGVVVLEIVC-------CRSNFEV 713
            KSDV+SFGV++ E+          RSN EV
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENP-VEEGERKFQAEMA 558
            ++R T   + ELG G FG V+ G            +VAVK L+     +  + F+ E  
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL------------SNVESGPIW 606
            +    H+N+V+  G C +    ++V+E+M  G L   L             +   G + 
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120

Query: 607 R-DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
               ++IA+ +A G+ YL  +     +H ++  RN L+   L  KI +F +++ +     
Sbjct: 121 LSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD- 176

Query: 666 GIVTGVKGTR----GYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
                V G       +M PE       T +SDV+SFGVV+ EI
Sbjct: 177 --YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (264), Expect = 2e-24
 Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 24/280 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRR-THHKNL 568
              +LG G FG VY        K+VA+K L   +E   +   +F  E+  +    H  N+
Sbjct: 4   ILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--VRIALDVARGITYLHEE 626
           V+L  F        LV E++  GSLE+LL  +       +   + I   +   + YLH +
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 627 CEVQIIHCNINPRNILLDDSLT-AKISNFSLAKILMPNQT-----GIVTGVKGTRGYMSP 680
               IIH +I P NILLD      K+ +F LAK+L    +      + +   GT GYM+P
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 681 EW---QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
           E     +    +  SD++S G+ + E++     FE   +++        +         S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
            L   + E+  +    +++     +  +P  R S  + + 
Sbjct: 238 PLSPSNPELISKAASDLLKK---LLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (255), Expect = 3e-24
 Identities = 74/211 (35%), Positives = 110/211 (52%), Gaps = 35/211 (16%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
            L++ T G  E +G G FGAV +G    G K VAVK ++  V    + F  E A + + H
Sbjct: 4   NLQKLTLG--EIIGEGEFGAVLQGEYT-GQK-VAVKNIKCDVTA--QAFLEETAVMTKLH 57

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--------VRIALDV 616
           HKNLVRLLG  +     + V E MSKG+L N L         R R        ++ +LDV
Sbjct: 58  HKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRT-------RGRALVSVIQLLQFSLDV 109

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG---VKG 673
           A G+ YL  +   +++H ++  RNIL+ +   AK+S+F LA++      G+      VK 
Sbjct: 110 AEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKW 163

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           T    +PE       + KSDV+S+GV++ E+
Sbjct: 164 T----APEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 4e-24
 Identities = 62/194 (31%), Positives = 100/194 (51%), Gaps = 13/194 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           + +GRG FG VYKG   E    VA+K+  LE   EE  +    E+  ++   H N+V+ +
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
           G  ++TS  L ++ E+   GSL  ++     GP     V + +  V +G+ YLHE+    
Sbjct: 66  GS-IETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ---G 119

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLIT 689
           +IH +I   NIL       K+++F +A  L  + +     V GT  +M+PE  + SG  +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMSG-AS 177

Query: 690 VKSDVYSFGVVVLE 703
             SD++S G  V+E
Sbjct: 178 TASDIWSLGCTVIE 191

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (254), Expect = 7e-24
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 20/201 (9%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQA---EMAAVRRTHHKNLVRLL 572
           +G G FG VY     +  +++AVK  E  +++ + K  +    EM  +    H NLV+  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVK--EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEECEVQ 630
           G  +   K  +  E+ S G+LE LL   E G I  + V     L +  G+ YLH      
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSH---G 119

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG---YMSPEWQNSGL 687
           I+H +I P NI LD +   K+ +F  A  L  N T +   V+   G   YM+PE    G 
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 688 ITVK---SDVYSFGVVVLEIV 705
                  +D++S G VVLE+ 
Sbjct: 180 GKGHGRAADIWSLGCVVLEMA 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (253), Expect = 7e-24
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    ++LG G FG V+ G    G+  VA+K L+      E  F AE   +++  
Sbjct: 2   EVPRETLKLVKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQ 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYL 623
           H  LVRL     Q     ++ E+M  GSL + L   E   +  ++ + +A  +A G+ ++
Sbjct: 60  HPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             +     IH ++   NIL+ ++L  KI++F LA+++  N+     G K    + +PE  
Sbjct: 119 ERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KSDV+SFG+++ EIV
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  102 bits (255), Expect = 8e-24
 Identities = 67/220 (30%), Positives = 111/220 (50%), Gaps = 37/220 (16%)

Query: 513 FEEELGRGCFGAVYKGSICEGNK-----IVAVKRL-ENPVEEGERKFQAEMAAVRRTHHK 566
           F EELG G FG VYKG +   N+      VA+K L EN   + +++F+ E   +    H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLL------SNVESG--------PIWR-DRVR 611
           N+V LLG C +     +++E+++ G L   L      S+V +          +   D + 
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-------MPNQ 664
           IA+ +A G+ YL        +H ++  RN L+ + LT KIS+F L++ +       + ++
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           +  +  V+    +M PE    G  T +SD++SFGVV+ EI
Sbjct: 186 S--LLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 99.8 bits (249), Expect = 4e-23
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 26/202 (12%)

Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRLENPVEEGERKFQA---EMAAVRRTHHKNLV 569
           LG G FG VYKG  I EG K+   VA+K L    E   +  +    E   +    H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE--ETSPKANKEILDEAYVMASVDHPHVV 72

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IALDVARGITYL 623
           RLLG C+ +S+  L+ + M  G L + + N       +D +         + +A+G++YL
Sbjct: 73  RLLGICL-SSQVQLITQLMPLGCLLDYVRN------HKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEW 682
            E    +++H ++  RN+L+      KI++F LAK+L  ++      G K    +M+ E 
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
               + T KSDV+S+GV V E+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 8/192 (4%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGF 574
           ELG G  G V K       KI+AVK +   + E  +K    E+  + + +   +V   G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQIIH 633
                   +  E+M  GSL+ +L  V+ G I    + +IA+ V +G+TYLHE+   +IIH
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK--HKIIH 124

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NIL++     K+ +F ++  L+ +     T V GT  YM+PE       +VKSD
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFV-GTSSYMAPERIQGNDYSVKSD 181

Query: 694 VYSFGVVVLEIV 705
           ++S G+ ++E+ 
Sbjct: 182 IWSLGLSLIELA 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 6e-23
 Identities = 61/192 (31%), Positives = 94/192 (48%), Gaps = 11/192 (5%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLG- 573
            LG+G  G VYK       KI A+K++    +E  RK    E+  +R      +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEECEVQI 631
           F  +    + V E+M  GSL +LL  V       + V   IA  + +G+ YLH +    I
Sbjct: 68  FYKEGEISI-VLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTK--RHI 121

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH +I P N+L++     KI++F ++K+L        T V GT  YMSPE       +  
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180

Query: 692 SDVYSFGVVVLE 703
           +D++S G+ +LE
Sbjct: 181 ADIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 7e-23
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)

Query: 514 EEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLV 569
           E+ +G G FG V +G +    K    VA+K L+    + +R  F  E + + +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           RL G   ++   +++ E+M  GSL+  L   +        V +   +A G+ YL E   V
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG------YMSPEWQ 683
              H ++  RNIL++ +L  K+S+F L++ L             T+G      + +PE  
Sbjct: 129 ---HRDLAARNILVNSNLVCKVSDFGLSRRL-----EDSEATYTTKGGKIPIRWTAPEAI 180

Query: 684 NSGLITVKSDVYSFGVVVLEI 704
                T  SDV+SFG+V+ E+
Sbjct: 181 AYRKFTSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 98.6 bits (245), Expect = 7e-23
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 6/202 (2%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +    ++LG G FG V+ G      K VAVK L+ P     + F  E   ++   
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAFLEEANLMKTLQ 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYL 623
           H  LVRL     +     ++ E+M+KGSL + L + E G +   + +  +  +A G+ Y+
Sbjct: 60  HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             +     IH ++   N+L+ +SL  KI++F LA+++  N+     G K    + +PE  
Sbjct: 120 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KSDV+SFG+++ EIV
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 69/273 (25%), Positives = 121/273 (44%), Gaps = 26/273 (9%)

Query: 511 NGFEE--ELGRGCFGAVYKGSICEGNKIVAVK---RLENPVEEGERKFQAEMAAVRRTHH 565
               E   LG G  G+V K  +     I A+K      NP  + +++   E+   +    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKS 58

Query: 566 KNLVRLLGFCM--QTSKKLLVYEFMSKGSLENLLSNVES-GPIWRDRV--RIALDVARGI 620
             +V+  G  +   +S   +  E+   GSL+++   V+  G    ++V  +IA  V +G+
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
           +YLH     +IIH +I P NILL      K+ +F ++  L+ +  G  TG   T  YM+P
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAP 172

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSK 738
           E       ++ SDV+S G+ +LE+   R  F  E       + LLS      +I    + 
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS------YIVNMPNP 226

Query: 739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS 771
            + ++    ++  E        C++ +P  RP+
Sbjct: 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +    ++LG G FG V+ G+   GN  VAVK L+ P       F  E   +++  
Sbjct: 2   EIPRESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLR 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           H  LV+L    +      +V E+MSKGSL + L + E   +   + V +A  VA G+ Y+
Sbjct: 60  HDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                +  IH ++   NIL+ D L  KI++F LA+++  N+     G K    + +PE  
Sbjct: 119 ER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
             G  T+KSDV+SFG+++ E+V
Sbjct: 176 LYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAEMAAVR 561
           E+ER     + +LG G +G VY+G   + +  VAVK L+     VEE    F  E A ++
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMK 57

Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGS-LENLLSNVESGPIWRDRVRIALDVARGI 620
              H NLV+LLG C +     ++ EFM+ G+ L+ L             + +A  ++  +
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K    + +P
Sbjct: 118 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 174

Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E       ++KSDV++FGV++ EI
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 34/228 (14%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRL-ENPVEEGERKFQAEMA 558
           EL R      + LG G FG V K      +       VAVK L ++  E+      +EM 
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME 67

Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSL-------------ENLLSNVESGP 604
            ++    HKN++ LLG C Q     +V E+ + G+L              +         
Sbjct: 68  MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 605 --IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
               +D V  A  VARG+ +L  +   + IH ++  RN+L+ +    KI++F LA+    
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR---- 180

Query: 663 NQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           +   I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 72/232 (31%), Positives = 109/232 (46%), Gaps = 50/232 (21%)

Query: 517 LGRGCFGAVYKGSI--CEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G     +G+ +   VAVK L E+  E+ E  F  E   + + +H+N+VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
           L+G   +   + ++ E M+ G L++ L      P        +D +  A DVA+G  YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 625 EECEVQIIHCNINPRNILLDD---SLTAKISNFSLA-------------KILMPNQTGIV 668
           E      IH +I  RN LL        AKI++F +A             + ++P      
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP------ 184

Query: 669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-------CRSNFEV 713
             +K    +M PE    G+ T K+DV+SFGV++ EI          R+N EV
Sbjct: 185 --IK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 65/198 (32%), Positives = 107/198 (54%), Gaps = 13/198 (6%)

Query: 517 LGRGCFGAVYKGSIC--EGNKI-VAVKRLENPVEEGER--KFQAEMAAVRRTHHKNLVRL 571
           +G+G FG VY G++   +G KI  AVK L N + + E   +F  E   ++   H N++ L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 572 LGFCM-QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
           LG C+      L+V  +M  G L N + +    P  +D +   L VA+G+ YL  +   +
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNSGL 687
            +H ++  RN +LD+S T K+++F LA+ +   +   V   TG K    +M+ E   +  
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178

Query: 688 ITVKSDVYSFGVVVLEIV 705
            T KSDV+SFGV++ E++
Sbjct: 179 FTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.5 bits (240), Expect = 4e-22
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 37/227 (16%)

Query: 517 LGRGCFGAVYKGSIC------EGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLV 569
           LG G FG VY+G+         G   VAVK L     + E+ +F  E   +   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLL--SNVESGP----IWRDRVRIALDVARGITYL 623
           +LLG C+    + ++ E M  G L + L  + VE         ++ + I LDVA+G  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 624 HEECEVQIIHCNINPRNILL-----DDSLTAKISNFSLAKILMPNQTGIVTG-----VKG 673
            +   +  IH ++  RN L+     D     KI +F LA+ +  +      G     V+ 
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-------CRSNFEV 713
              +M+PE    G  T +SDV+SFGV++ EI+          +N EV
Sbjct: 179 ---WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.9 bits (238), Expect = 6e-22
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 9/202 (4%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L    +      +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 60  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 117

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 118 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174

Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 92.8 bits (230), Expect = 7e-21
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   + +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGT-WNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLR 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYL 623
           H  LV L    +      +V EFM KGSL + L   +   +   + V +A  +A G+ Y+
Sbjct: 60  HDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                +  IH ++   NIL+ D+L  KI++F LA+++  N+     G K    + +PE  
Sbjct: 119 ER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
             G  T+KSDV+SFG+++ E+V
Sbjct: 176 LYGRFTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 93.1 bits (231), Expect = 1e-20
 Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 34/217 (15%)

Query: 513 FEEELGRGCFGAVYKGSIC-EGNKI-VAVKRL-ENPVEEGERKFQAEMAAV-RRTHHKNL 568
           FE+ +G G FG V +  I  +G K+  A+K L E   E   R F  E+  + +  HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIW------------RDRVRIA 613
           + LLG C       +  E+   G+L + L     +E+ P +            +  ++ A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            DVA G+ YL E+   Q IH ++  RN+L+ ++L +KI++F L++       G    VK 
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKK 175

Query: 674 TRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIV 705
           T G +   W      N  + T KSDV+SFGV++ EIV
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 52/297 (17%)

Query: 513 FEEELGRGCFGAVYKGSI-CEGNK---IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKN 567
           F ++LG G FG V        G+     VAVK L +  EE  R  F+ E+  +R   H+N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 568 LVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDR------VRIALDVARG 619
           +V+  G C +   +   L+ E++  GSL + L         RD+      +  +  + +G
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL------QRHRDQINLKRLLLFSSQICKG 121

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--- 676
           + YL  +   + IH ++  RNIL++     KIS+F LAK+L P        VK       
Sbjct: 122 MDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL-PEDKDYYY-VKEPGESPI 176

Query: 677 -YMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAK 734
            + +PE   +   +  SDV+SFGV + E+      +       A+ + +        I  
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS---PPAEFLRMIGIAQGQMIVT 233

Query: 735 ELSKLVGE-----------DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            L +L+ E           DE  DL     M      C + EP  RPS  ++IL+++
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDL-----MKL----CWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 18/211 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V+ G    G   VA+K +     EG   E  F  E   + +  H NLV
Sbjct: 8   FLKELGSGQFGVVHLGK-WRGKIDVAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLV 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C +     +V E+M+ G L N L   +        + +  DV   + YL      
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG-- 120

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
             IH ++  RN L+ +    K+S+F LA+ ++ +Q     G K    +  PE  +    +
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 690 VKSDVYSFGVVVLEIVCC-------RSNFEV 713
            KSDV+SFGV++ E+           SN EV
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.0 bits (228), Expect = 3e-20
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 48/296 (16%)

Query: 513 FEEELGRGCFGAVYKGSI-CEGNKI-VAVKRL-ENPVEEGERKFQAEMAAV-RRTHHKNL 568
           F++ +G G FG V K  I  +G ++  A+KR+ E   ++  R F  E+  + +  HH N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIW------------RDRVRIA 613
           + LLG C       L  E+   G+L + L     +E+ P +            +  +  A
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            DVARG+ YL ++   Q IH ++  RNIL+ ++  AKI++F L++       G    VK 
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 180

Query: 674 TRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY 728
           T G +   W      N  + T  SDV+S+GV++ EIV         ++ A++       Y
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240

Query: 729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
                  L K +  D+EV     + M +    C +++P  RPS   +++ L   +E
Sbjct: 241 ------RLEKPLNCDDEV----YDLMRQ----CWREKPYERPSFAQILVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E++LG G FG V+  +  +  K VAVK ++ P       F AE   ++   
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK-PGSMSVEAFLAEANVMKTLQ 59

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYL 623
           H  LV+L     +     ++ EFM+KGSL + L + E       + +  +  +A G+ ++
Sbjct: 60  HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            +      IH ++   NIL+  SL  KI++F LA+++  N+     G K    + +PE  
Sbjct: 119 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 175

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KSDV+SFG++++EIV
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.3 bits (224), Expect = 5e-20
 Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 11/195 (5%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V  G    G   VA+K     ++EG   E +F  E   + +  H+ LV
Sbjct: 8   FLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMKLSHEKLV 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C +     +V E+MS G L N L            + +  DV  G+ YL  +   
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--- 119

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           Q IH ++  RN L+DD    K+S+F L++ ++ ++     G K    +  PE       +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179

Query: 690 VKSDVYSFGVVVLEI 704
            KSDV++FGV++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.8 bits (225), Expect = 6e-20
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 57/302 (18%)

Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVR 570
           LG G FG V K +        G   VAVK L+      E R   +E   +++ +H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVESGPIWRDRVR----- 611
           L G C Q    LL+ E+   GSL + L               N  S  +     R     
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 612 ----IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
                A  ++RG+ YL    E++++H ++  RN+L+ +    KIS+F L++ +       
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED--- 181

Query: 668 VTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV- 721
            + VK ++G     +M+ E     + T +SDV+SFGV++ EIV    N    ++   +  
Sbjct: 182 -SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
           LL T               G   E      E M  + L C + EP+ RP+  ++   LE 
Sbjct: 241 LLKT---------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285

Query: 782 TM 783
            M
Sbjct: 286 MM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 13/194 (6%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             + +G+G FG V  G    GNK VAVK ++N  +   + F AE + + +  H NLV+LL
Sbjct: 10  LLQTIGKGEFGDVMLGDY-RGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLL 65

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQ 630
           G  ++    L +V E+M+KGSL + L +     +  D  ++ +LDV   + YL       
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---N 122

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            +H ++  RN+L+ +   AK+S+F L K     Q      VK T    +PE       + 
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178

Query: 691 KSDVYSFGVVVLEI 704
           KSDV+SFG+++ EI
Sbjct: 179 KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 15/196 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLG 573
           E +GRG FG V+ G +   N  VAVK     +  + + KF  E   +++  H N+VRL+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--VRIALDVARGITYLHEECEVQI 631
            C Q     +V E +  G     L     GP  + +  +++  + A G+ YL  +     
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR----GYMSPEWQNSGL 687
           IH ++  RN L+ +    KIS+F +++     + G+     G +     + +PE  N G 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172

Query: 688 ITVKSDVYSFGVVVLE 703
            + +SDV+SFG+++ E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 77/295 (26%), Positives = 135/295 (45%), Gaps = 47/295 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEG------NKIVAVKRLENPVEEGER-KFQAEM 557
           E+ R       ELG+G FG VY+G I +G         VA+K +       ER +F  E 
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------SNVESGPIWRD 608
           + ++  +  ++VRLLG   Q    L++ E M++G L++ L         + V++ P  + 
Sbjct: 61  SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120

Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
            +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +        
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-- 175

Query: 669 TGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
              KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L
Sbjct: 176 --RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------L 217

Query: 724 STWVYNCFIAKELSKLVGEDEEVDL--RTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           +   Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I
Sbjct: 218 AEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 29/269 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V+ G      K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIK-VAIKA----INEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECE 628
           +L G C Q     +V EFM  G L N L     G + +D +  +  DV  G+ YL     
Sbjct: 63  QLYGVCTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERN-- 119

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
              IH ++  RN L+  +   K+S+F + + ++ ++    +G K    +  PE  N    
Sbjct: 120 -SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 689 TVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD 747
           + KSDV+SFGV++ E+    +  FE   S  +VV + +  +  +  K  S  V E     
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEMISRGFRLYRPKLASMTVYE----- 232

Query: 748 LRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                    V   C  ++P  RP+   ++
Sbjct: 233 ---------VMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 18/211 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERK-FQAEMAAVRRTHHKNLVRLL 572
           E +G+G FG V K       KI+  K ++   + E E++   +E+  +R   H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 573 GFCMQTSKKLL--VYEFMSKGSLENLLSN-------VESGPIWRDRVRIALDVARGITYL 623
              +  S + L  V E+   G L  L+         +E   IWR    I   +   +   
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLLALYEC 121

Query: 624 H--EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           H   +    ++H ++ P NI LD +   K+ +F LAKIL  + +   T V GT  YMSPE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
             N      KSD++S G ++ E+      F 
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 69/228 (30%), Positives = 111/228 (48%), Gaps = 37/228 (16%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI----CEGNKIVAVKRLE---NPVEEGERKFQAEM 557
           EL  +   F EELG   FG +YKG +     +  ++VA+K L+   NP + GE  FQ E 
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE--FQQEA 58

Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-----------SNVESGPIW 606
           + +   HH N+V LLG   Q     +++E++++G L   L           S+ E G + 
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 607 R-----DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM 661
                 D + IA+ +A G+ YL        +H ++  RNIL+ + L  KIS+  L++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 662 PN-----QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
                  Q   +  ++    +M PE    G  +  SD++SFGVV+ EI
Sbjct: 176 SADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 41/229 (17%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAE--MAAVRR-------- 562
           F + +G G F  V      E NK  A+K L+      +R+   E  +  V+         
Sbjct: 5   FGKIIGEGSFSTVVLAKEKETNKEYAIKILD------KRQLIKEKKVKYVKIEKEVLTRL 58

Query: 563 THHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGIT 621
             H  +++L  +  Q  + L  V E+   G L   +    S    +     A ++   + 
Sbjct: 59  NGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDE-KCTRFYAAEILLALE 116

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK--------- 672
           YLH      IIH ++ P NILLD  +  KI++F  AK+L PN +                
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 673 ----------GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                     GT  Y+SPE  N       SD+++ G ++ +++  +  F
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin

 Score = 83.2 bits (206), Expect = 4e-19
 Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 10/111 (9%)

Query: 76  NITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLI--ANTTSDEPASFASILDS 132
           N TV+W A R  P   S+  LIL  DG LVL   +   +++  +NT+       A + D 
Sbjct: 1   NQTVVWVANRLNPLTDSSYTLILQSDGNLVLY--DGNGRVVWSSNTSGKGSGCVAVLQDD 58

Query: 133 GNFVLCNDRFDFIWESFNFPTHTIVGGQSLVN-----GSKLFSSASETNSS 178
           GN VL ++    +W+SF+ PT T++ GQ   N       +L S  S T+ S
Sbjct: 59  GNLVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109

These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 515 EELGRGCFGAVYKGSICEGN---KIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           +ELG G FG+V KG     +     VAVK L +  +  G+++F  E + + +  H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
           L+G C +    +LV E    G L   L      P+  D   +A  VA G+ YL E     
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYL-ESK--H 115

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--GIVTGVKGTRGYMSPEWQNSGLI 688
            +H ++  RN+LL +   AKIS+F +++ L          T  +    + +PE  N G  
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 689 TVKSDVYSFGVVVLEIV 705
           + KSDV+S+GV + E  
Sbjct: 176 SSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 6e-19
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 10/199 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V      +  K+ A+K L+    ++  E +    E   + R +H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           +  QT +KL LV E+   G L + LS        R R   A ++   + YLH      II
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSL---GII 115

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           + ++ P NILLD     K+++F LAK L    +   T   GT  Y++PE           
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGKAV 174

Query: 693 DVYSFGVVVLEIVCCRSNF 711
           D +S GV++ E++  +  F
Sbjct: 175 DWWSLGVLLYEMLTGKPPF 193

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 91.4 bits (227), Expect = 8e-19
 Identities = 69/275 (25%), Positives = 129/275 (46%), Gaps = 22/275 (8%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E  + RG  GA YKG   +      VK + N V        A+M    +  H N+V+L+G
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEI-NDVNSIPSSEIADM---GKLQHPNIVKLIG 750

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
            C       L++E++   +L  +L N+     W  R +IA+ +A+ + +LH  C   ++ 
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNLS----WERRRKIAIGIAKALRFLHCRCSPAVVV 806

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            N++P  I++D      +   SL  +L  +    ++       Y++PE + +  IT KSD
Sbjct: 807 GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSD 860

Query: 694 VYSFGVVVLEIVCCRS----NFEVNVSTADVVLLSTWVY-NCFIAKELSKLVGEDEEVDL 748
           +Y FG++++E++  +S     F V+ S   +V  + + Y +C +   +   +  D  V+ 
Sbjct: 861 IYGFGLILIELLTGKSPADAEFGVHGS---IVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM 783
             +  ++ + L C   +P  RP   +V+  LE   
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.9 bits (215), Expect = 9e-19
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRLENPVEEGERKFQA---EMAAVRRTHHKNLV 569
           LG G FG V+KG  I EG+ I   VA+K +++    G + FQ     M A+    H  +V
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVES-GPIWRDRVRIALDVARGITYLHEEC 627
           RLLG C   S +L V +    GSL +++  + +S  P  +  +   + +A+G+ YL E  
Sbjct: 73  RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQIAKGMYYLEEHR 129

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVKGTRGYMSPEWQNSG 686
              ++H N+  RNILL      +I++F +A +L P+      +  K    +M+ E    G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 687 LITVKSDVYSFGVVVLEIV 705
             T +SDV+S+GV V E++
Sbjct: 187 RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 22/204 (10%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERK------FQAEMAAVRRTHHKN 567
           +G G FG+VY G      +++AVK++E P       +RK         E+A ++   H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES--GPIWRDRVRIALDVARGITYLHE 625
           +V+ LG  +      +  E++  GS+  LL+N  +    + R+ VR  L   +G+ YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLHN 124

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-----VKGTRGYMSP 680
                IIH +I   NIL+D+    KIS+F ++K L  N     T      ++G+  +M+P
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E       T K+D++S G +V+E+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 86.9 bits (215), Expect = 1e-18
 Identities = 76/298 (25%), Positives = 137/298 (45%), Gaps = 45/298 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEG--NKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G    I +G     VAVK +       ER +F  E +
Sbjct: 2   EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG---------PIWRDR 609
            ++     ++VRLLG   +    L+V E M+ G L++ L ++            P  ++ 
Sbjct: 62  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F + + +   +T    
Sbjct: 122 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYR 176

Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +M+PE    G+ T  SD++SFGVV+ EI                  L+
Sbjct: 177 --KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LA 218

Query: 725 TWVYNCFIAKELSKLVGEDEEVDL--RTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
              Y     +++ K V +   +D      E +  +  +C Q  P +RP+   ++ +L+
Sbjct: 219 EQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE------NPVEEGERKFQAEMAAVRRTHHKNL 568
           E LG+G +G VY G   +G +++AVK++E         E+   K Q E+  ++   H N+
Sbjct: 6   EVLGKGAYGTVYCGLTNQG-QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP--IWRDRVRIALDVARGITYLHEE 626
           V+ LG C+  +   +  EF+  GS+ ++L+     P  ++    +  LD   G+ YLH  
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNN 121

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM-----PNQTGIVTGVKGTRGYMSPE 681
           C   ++H +I   N++L  +   K+ +F  A+ L         + ++  + GT  +M+PE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 682 WQNSGLITVKSDVYSFGVVVLEI 704
             N      KSD++S G  V E+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 26/216 (12%)

Query: 505 ELERATNGFEEELGRGCFGAVYK----GSICEGNKI-VAVKRLENPVEEGERKFQAEMAA 559
           E  R    F + LG G FG V +    G       + VAVK L+      ER  +A M+ 
Sbjct: 31  EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSE 88

Query: 560 VR-RTH---HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIAL 614
           ++  +H   H+N+V LLG C      L++ E+   G L N L    ES     D +  + 
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 615 DVARGITYL-HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--- 670
            VA+G+ +L  + C    IH ++  RN+LL      KI +F LA+ +M +   +V G   
Sbjct: 149 QVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204

Query: 671 --VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             VK    +M+PE   + + T +SDV+S+G+++ EI
Sbjct: 205 LPVK----WMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 57/194 (29%), Positives = 101/194 (52%), Gaps = 13/194 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E LG+G FG V+KG++ +    VAVK   E+  +E + KF +E   +++  H N+V+L+G
Sbjct: 1   ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
            C Q     +V E +  G   + L   +     +  V+ ALD A G+ YL  +     IH
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIH 116

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR----GYMSPEWQNSGLIT 689
            ++  RN L+ ++   KIS+F +++     +   +    G +     + +PE  N G  +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 690 VKSDVYSFGVVVLE 703
            +SDV+S+G+++ E
Sbjct: 173 SESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 20/198 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRL 571
             +G G +G V K       +IVA+K+ +   E+ E   +    E+  +R+  H+N+V L
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP--IWRDRVR-IALDVARGITYLHEECE 628
                +  +  LV+E++ +     LL  +E+ P  +  D VR     + + I Y H    
Sbjct: 66  KEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             IIH +I P NIL+ +S   K+ +F  A+ L       +T    TR Y +PE      +
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE------L 172

Query: 689 TVKSDVYSFGVVVLEIVC 706
            V    Y   V V  I C
Sbjct: 173 LVGDTNYGKPVDVWAIGC 190

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.4 bits (208), Expect = 6e-18
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 517 LGRGCFGAVYKGSIC-EGNKI-VAVKRL-ENPVEEGERKFQAEMAAV-RRTHHKNLVRLL 572
           +G G FG V K  I  +G ++  A+KR+ E   ++  R F  E+  + +  HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIW------------RDRVRIALDVA 617
           G C       L  E+   G+L + L     +E+ P +            +  +  A DVA
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
           RG+ YL ++   Q IH ++  RNIL+ ++  AKI++F L++       G    VK T G 
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172

Query: 678 MSPEWQ-----NSGLITVKSDVYSFGVVVLEIV 705
           +   W      N  + T  SDV+S+GV++ EIV
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 9/198 (4%)

Query: 514 EEELGRGCFGAVYKGSI-CEGNK--IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLV 569
           ++ +G G FG V++G +   G K   VA+K L+    E +R+ F +E + + +  H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           RL G   +    +++ E+M  G+L+  L + +        V +   +A G+ YL    ++
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDM 126

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL--MPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +H ++  RNIL++ +L  K+S+F L+++L   P  T   +G K    + +PE      
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 688 ITVKSDVYSFGVVVLEIV 705
            T  SDV+SFG+V+ E++
Sbjct: 187 FTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.1 bits (208), Expect = 8e-18
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKI---VAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG+V +G + + +     VAVK  +L+        +F +E A ++   H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 572 LGFCMQTSKK------LLVYEFMSKGSLENLL--SNVESGPIW---RDRVRIALDVARGI 620
           +G C + S        +++  FM  G L + L  S +   P     +  ++  +D+A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN----QTGIVTGVKGTRG 676
            YL        IH ++  RN +L + +T  +++F L+K +       Q  I    K    
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPVK 180

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           +++ E     + T KSDV++FGV + EI
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.0 bits (208), Expect = 9e-18
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 17/203 (8%)

Query: 513 FEEELGRGCFGAVYKGSIC-------EGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           F ++LG+G FG+V    +C          ++VAVK+L++   E  R F+ E+  ++   H
Sbjct: 8   FIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64

Query: 566 KNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYL 623
            N+V+  G C    ++   LV E++  GSL + L         R  +  A  + +G+ YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPE 681
             +   + +H ++  RNIL++     KI +F L K+L  ++        G     + +PE
Sbjct: 125 GSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 682 WQNSGLITVKSDVYSFGVVVLEI 704
                  +V SDV+SFGVV+ E+
Sbjct: 182 SLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.3 bits (211), Expect = 1e-17
 Identities = 71/237 (29%), Positives = 104/237 (43%), Gaps = 30/237 (12%)

Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE 547
           SS   S      + S  ELER        +G G  G VYK       ++ A+K +    E
Sbjct: 58  SSSSASGSAPSAAKSLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE 112

Query: 548 EG-ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW 606
           +   R+   E+  +R  +H N+V+         +  ++ EFM  GSLE          I 
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-------THIA 165

Query: 607 RDRVRIALDVAR----GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            ++     DVAR    GI YLH      I+H +I P N+L++ +   KI++F +++IL  
Sbjct: 166 DEQF--LADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-- 218

Query: 663 NQT-GIVTGVKGTRGYMSPEWQNSGLITVK-----SDVYSFGVVVLEIVCCRSNFEV 713
            QT        GT  YMSPE  N+ L          D++S GV +LE    R  F V
Sbjct: 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275

Length = 353

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH------HKNL 568
            ++G+G FG V+K       ++ A+K+++  + +  R+ + E  A+             +
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQID--LSKMNRREREE--AIDEARVLAKLDSSYI 61

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEEC 627
           +R     +   K  +V E+   G L  LL      P+  D+V R  + +  G+ +LH + 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK- 120

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +I+H +I   N+ LD     KI +  +AK+L  N T     + GT  Y+SPE      
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPELCEDKP 177

Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFEVN 714
              KSDV++ GVV+ E    +  F+ N
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL-----ENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E LG G FG+VY+G   +     AVK +         +E  ++ + E+A + +  H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 570 RLLGFCMQTSKKLLVY-EFMSKGSLENLLSNVES--GPIWRDRVRIALDVARGITYLHEE 626
           + LG   +    L ++ E +  GSL  LL    S   P+ R   R  L    G+ YLH+ 
Sbjct: 66  QYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLHDR 121

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS- 685
                +H +I   NIL+D +   K+++F +AK ++          KG+  +M+PE     
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--SFAKSFKGSPYWMAPEVIAQQ 176

Query: 686 GLITVKSDVYSFGVVVLEIV 705
           G   + +D++S G  VLE+ 
Sbjct: 177 GGYGLAADIWSLGCTVLEMA 196

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 81.4 bits (202), Expect = 5e-17
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKF-QAEMAAVRRTHHKNLVRLL 572
           +++G+G FG VY        K+  +K ++ + + E ER+    E+  +++ +H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 573 GFCMQTSKKLL-VYEFMSKGSLENLLSN--VESGP-----IWRDRVRIALDVARGITYLH 624
               +   KL  V E+   G L   +     E  P     I    V++ L     + YLH
Sbjct: 66  E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH 120

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQ 683
                +I+H +I P+NI L  +   K+ +F ++K+L        T V GT  Y+SPE  Q
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           N      KSD++S G V+ E+   +  FE
Sbjct: 177 NKPY-NYKSDIWSLGCVLYELCTLKHPFE 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.2 bits (201), Expect = 8e-17
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 8/168 (4%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLGF 574
           +G G  G V+K    E  + VA+K++     EG    QA  E+ A++   H  +V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQIIH 633
               S  +LV E+M    L  +L + E  P+   +V+     + +G+ Y+H      I+H
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEER-PLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
            ++ P N+L+      KI++F LA++    +  + +    TR Y +PE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 13/201 (6%)

Query: 514 EEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLV 569
           EE +G G FG V +G +    K    VA+K L++   E +R+ F +E + + +  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
            L G   ++   +++ EFM  G+L++ L   +        V +   +A G+ YL    E+
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILM-----PNQTGIVTGVKGTRGYMSPEWQN 684
             +H ++  RNIL++ +L  K+S+F L++ L      P  T  + G    R + +PE   
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR-WTAPEAIA 184

Query: 685 SGLITVKSDVYSFGVVVLEIV 705
               T  SDV+S+G+V+ E++
Sbjct: 185 YRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 52/311 (16%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVEEGE-RKFQAE 556
           E+ R      + LG GCFG V           + N++  VAVK L++   E +     +E
Sbjct: 14  EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73

Query: 557 MAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-----------NVESGP 604
           M  ++    HKN++ LLG C Q     ++ E+ SKG+L   L            N    P
Sbjct: 74  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133

Query: 605 I----WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-I 659
                ++D V  A  VARG+ YL  +   + IH ++  RN+L+ +    KI++F LA+ I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
              +     T  +    +M+PE     + T +SDV+SFGV++ EI      F +  S   
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI------FTLGGSP-- 242

Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQDEPNLRPSMKN 774
                   Y     +EL KL+ E   +D  +     L  M+R    C    P+ RP+ K 
Sbjct: 243 --------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHAVPSQRPTFKQ 291

Query: 775 VILMLEGTMEI 785
           ++  L+  + +
Sbjct: 292 LVEDLDRILAL 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 56/194 (28%), Positives = 99/194 (51%), Gaps = 13/194 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRL 571
           E +G+G FG VYKG      ++VA+K ++  +EE E      Q E+  + +     + R 
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
            G  ++ +K  ++ E++  GS  +LL   + GP+    +   L ++ +G+ YLH E   +
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSE---R 121

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE         
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180

Query: 691 KSDVYSFGVVVLEI 704
           K+D++S G+  +E+
Sbjct: 181 KADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 18/261 (6%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGF 574
           +LG G  G+V K        ++A K +    +   RK    E+  +       +V   G 
Sbjct: 12  DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQIIH 633
            +  +   +  EFM  GSL+ +    + GPI  + + +IA+ V  G+TYL+     +I+H
Sbjct: 72  FLNENNICMCMEFMDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMH 127

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P NIL++     K+ +F ++  L+     I     GT  YMSPE    G  TVKSD
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 694 VYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN---CFIAKELSKLVGEDEEVDLRT 750
           V+S G+ ++E+   +  F  +    D       + +     + +   +L   D   DLR 
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244

Query: 751 LETMVRVGLLCIQDEPNLRPS 771
                     C+  +P  RP+
Sbjct: 245 FVD------ACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 81/295 (27%), Positives = 129/295 (43%), Gaps = 54/295 (18%)

Query: 517 LGRGCFGAVYKGSICEGNK-------IVAVKRL-ENPVEEGERKFQAEMAAVRRT-HHKN 567
           LG GCFG V +      +K        VAVK L +N  ++      +EM  ++    HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVESGPI-WRDRVRI 612
           ++ LLG C Q     ++ E+ +KG+L   L              + V    + ++D V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK 672
           A  VARG+ YL      + IH ++  RN+L+ +    KI++F LA+        I    K
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192

Query: 673 GTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV 727
            + G     +M+PE     + T +SDV+SFG+++ EI      F +  S           
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI------FTLGGSP---------- 236

Query: 728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLL--CIQDEPNLRPSMKNVILMLE 780
           Y     +EL KL+ E   +D  +  T     L+  C    P  RP+ K ++  L+
Sbjct: 237 YPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 85/306 (27%), Positives = 132/306 (43%), Gaps = 60/306 (19%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRL-ENPVEEGERKFQAE 556
           E  R      + LG GCFG V        +K        VAVK L ++  E+      +E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 557 MAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVE 601
           M  ++    HKN++ LLG C Q     ++ E+ SKG+L   L              + V 
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 602 SGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
              + ++D V     VARG+ YL  +   + IH ++  RN+L+ ++   KI++F LA+  
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-- 185

Query: 661 MPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
             +   I    K T G     +M+PE     + T +SDV+SFGV++ EI      F +  
Sbjct: 186 --DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI------FTLGG 237

Query: 716 STADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLLCIQDEPNLRP 770
           S           Y     +EL KL+ E   +D        L  M+R    C    P+ RP
Sbjct: 238 SP----------YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD---CWHAIPSHRP 284

Query: 771 SMKNVI 776
           + K ++
Sbjct: 285 TFKQLV 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 41/214 (19%)

Query: 517 LGRGCFGAVY----KGSICEG-NKIVAVKRLEN-PVEEGERKFQAEMAAVRRTHHKNLVR 570
           LGRG FG V+    KG   EG   +V VK L+    E  + +F+ E+   R+  HKN+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL-------SNVESGPI-WRDRVRIALDVARGITY 622
           LLG C +     ++ E+   G L+  L         ++  P+  + +V +   +A G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK------------ILMPNQTGIVTG 670
           L      + +H ++  RN L+      K+S  SL+K             L+P +      
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------ 183

Query: 671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
                 +++PE       + KSDV+SFGV++ E+
Sbjct: 184 ------WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 3e-16
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 23/192 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQA----EMAAVRRTHHKNL 568
           E+LG G +G VYK    +  +IVA+K  RL+N  EEG     +    E++ ++   H N+
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEG---IPSTALREISLLKELKHPNI 60

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEEC 627
           V+LL       K  LV+E+     L+  L     GP+  + ++ I   + RG+ Y H   
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYCHS-- 116

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +I+H ++ P+NIL++     K+++F LA+            V  T  Y +PE      
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE------ 168

Query: 688 ITVKSDVYSFGV 699
           I + S  YS  V
Sbjct: 169 ILLGSKHYSTAV 180

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 53/193 (27%), Positives = 97/193 (50%), Gaps = 8/193 (4%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             E+LG G +G+VYK    E  ++VA+K +  PVEE  ++   E++ +++     +V+  
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYY 64

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G   + +   +V E+   GS+ +++          +   I     +G+ YLH     + I
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKI 121

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITVK 691
           H +I   NILL++   AK+++F ++  L        T V GT  +M+PE  Q  G    K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNN-K 179

Query: 692 SDVYSFGVVVLEI 704
           +D++S G+  +E+
Sbjct: 180 ADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.7 bits (196), Expect = 4e-16
 Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 37/287 (12%)

Query: 513 FEEELGRGCFGAVYKG---SIC-EGNKI-VAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
            + ELG G FG V+     ++C E +KI VAVK L++  +   + F  E   +    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--------VESGP----IWRDRVRIALD 615
           +V+  G C++    ++V+E+M  G L   L           E            + IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 616 VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKG 673
           +A G+ YL  +     +H ++  RN L+ ++L  KI +F +++ +       V G  +  
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA 733
            R +M PE       T +SDV+S GVV+ EI          +S  +V+        C   
Sbjct: 186 IR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECITQ 237

Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
               +++           + M    L C Q EP++R ++K +  +L+
Sbjct: 238 ---GRVLQRPRTCPKEVYDLM----LGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 26/214 (12%)

Query: 513 FEEELGRGCFGAV-----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
            + ELG G FG V     Y  S  +   +VAVK L++P     + FQ E   +    H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--------VESGPIWRD-------RVRI 612
           +V+  G C      ++V+E+M  G L   L          V+  P            + I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-- 670
           A  +A G+ YL  +     +H ++  RN L+  +L  KI +F +++ +       V G  
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           +   R +M PE       T +SDV+SFGV++ EI
Sbjct: 186 MLPIR-WMPPESIMYRKFTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 516 ELGRGCFGAVYKGS----ICEGNK-IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           ELG G FG V+       + E +K +VAVK L+   E   + FQ E   +    H+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL-------------SNVESGPIWRDR-VRIALDV 616
             G C +    L+V+E+M  G L   L              +V  G +   + + IA  +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGT 674
           A G+ YL     +  +H ++  RN L+   L  KI +F +++ +       V G  +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           R +M PE       T +SD++SFGVV+ EI
Sbjct: 189 R-WMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 17/216 (7%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E E   NG    LG+G +G VY          +A+K +        +    E+A      
Sbjct: 4   EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK 63

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGIT 621
           H+N+V+ LG   +     +  E +  GSL  LL + + GP+  +   I      +  G+ 
Sbjct: 64  HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLK 122

Query: 622 YLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGI---VTGVKGTRGY 677
           YLH+    QI+H +I   N+L++  S   KIS+F  +K L     GI        GT  Y
Sbjct: 123 YLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGTLQY 175

Query: 678 MSPEWQNSGL--ITVKSDVYSFGVVVLEIVCCRSNF 711
           M+PE  + G       +D++S G  ++E+   +  F
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.9 bits (194), Expect = 5e-16
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 39/229 (17%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E+  +T  F EELG   FG VYKG +      E  + VA+K L++  E   R+ F+ E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------------SNVESG 603
              R  H N+V LLG   +     +++ + S   L   L                 V+S 
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 604 PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK----- 658
               D V I   +A G+ +L       ++H ++  RN+L+ D L  KIS+  L +     
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 659 ---ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
               LM N    +        +MSPE    G  ++ SD++S+GVV+ E+
Sbjct: 178 DYYKLMGNSLLPIR-------WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 78.6 bits (193), Expect = 7e-16
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 17/196 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRL 571
           E++G+G FG V+KG      K+VA+K ++  +EE E      Q E+  + +     + + 
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECE 628
            G  ++ +K  ++ E++  GS  +LL   E GP+  D  +IA    ++ +G+ YLH E  
Sbjct: 68  YGSYLKDTKLWIIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSE-- 120

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
            + IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE       
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178

Query: 689 TVKSDVYSFGVVVLEI 704
             K+D++S G+  +E+
Sbjct: 179 DSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 41/233 (17%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R    +  ++G+G FG V++         E   +VAVK L E    + +  FQ E A
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------SNVESGPIWR-- 607
            +    H N+V+LLG C       L++E+M+ G L   L         S   S    R  
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 608 ----------DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
                     +++ IA  VA G+ YL E    + +H ++  RN L+ +++  KI++F L+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 658 KILMPNQTGIVTGVKGTRG------YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           + +           K +        +M PE       T +SDV+++GVV+ EI
Sbjct: 178 RNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.0 bits (193), Expect = 8e-16
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 23/200 (11%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRL-----ENPVEEGERKFQAEMAAVRRTHHKNL 568
            E +G+G FG VYK      N++VA+K +     E+ +E+     Q E+  + +     +
Sbjct: 6   LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED----IQQEIQFLSQCRSPYI 61

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA---LDVARGITYLHE 625
            +  G  ++ SK  ++ E+   GS  +LL   + G +  D   IA    +V  G+ YLHE
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKL--DETYIAFILREVLLGLEYLHE 116

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQN 684
           E     IH +I   NILL +    K+++F ++  L    +   T V GT  +M+PE  + 
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172

Query: 685 SGLITVKSDVYSFGVVVLEI 704
           SG    K+D++S G+  +E+
Sbjct: 173 SGYDE-KADIWSLGITAIEL 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 19/201 (9%)

Query: 515 EELGRGCFGAVYKG-SICEGNKI--VAVK-----RLENPVEEGERKFQAEMAAVRRTHHK 566
           ++LG G FG V +G     G K+  VAVK     +L + +++    F  E A +    H+
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHE 56

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHE 625
           NL+RL G  +     + V E    GSL + L     G      +   A+ +A G+ YL  
Sbjct: 57  NLIRLYGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGTRGYMSPEWQ 683
           +   + IH ++  RNILL      KI +F L + L  N+   V    +K    + +PE  
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Query: 684 NSGLITVKSDVYSFGVVVLEI 704
            +   +  SDV+ FGV + E+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 40/232 (17%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI-----------------VAVKRLENPVE 547
           E  R     +E+LG G FG V+   +CE   +                 VAVK L   V 
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT 57

Query: 548 EGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-------- 598
           +  R  F  E+  + R  + N++RLLG C+      ++ E+M  G L   LS        
Sbjct: 58  KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF 117

Query: 599 ----NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF 654
               N+ S  I  + + +A+ +A G+ YL     +  +H ++  RN L+ +  T KI++F
Sbjct: 118 THANNIPSVSI-ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADF 173

Query: 655 SLAKILMPNQTGIVTG--VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +++ L       + G  V   R +M+ E    G  T  SDV++FGV + E+
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V    +    K+ A K+L+       +GE+    E   + +   + +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  +T   L LV   M+ G L+  + NV        R    A  +  G+ +LH+    +I
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P N+LLDD    +IS+  LA + +     I  G  GT GYM+PE     +    
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI-KGRAGTPGYMAPEVLQGEVYDFS 174

Query: 692 SDVYSFGVVVLEIVCCRSNF 711
            D ++ G  + E++  RS F
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 34/210 (16%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHH-KNLVRL 571
             E+GRG FG V K        I+AVKR+ + V+E E+K    ++  V R+     +V+ 
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHE 625
            G   +     +  E M   SL+     V    + +  +      +IA+   + + YL E
Sbjct: 69  YGALFREGDCWICMELMDI-SLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKE 125

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNF--------SLAKILMPNQTGIVTGVKGTRGY 677
             E++IIH ++ P NILLD +   K+ +F        S+AK          T   G R Y
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----------TRDAGCRPY 173

Query: 678 MSPEWQNSGLIT---VKSDVYSFGVVVLEI 704
           M+PE  +        V+SDV+S G+ + E+
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 54/200 (27%), Positives = 107/200 (53%), Gaps = 19/200 (9%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL-----ENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E +GRG +GAVY+G      ++VA+K +     ++ V + +R+  A ++ +R++   N+ 
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREV-ALLSQLRQSQPPNIT 65

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEE 626
           +  G  ++  +  ++ E+   GS+  L+   ++GPI      I++   +V   + Y+H  
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPI--AEKYISVIIREVLVALKYIH-- 118

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
            +V +IH +I   NIL+ ++   K+ +F +A +L  N +   T V GT  +M+PE    G
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEG 176

Query: 687 -LITVKSDVYSFGVVVLEIV 705
                K+D++S G+ + E+ 
Sbjct: 177 KYYDTKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 27/202 (13%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G  G VYK +     K VA+K  RL    +E       E+  ++   H N+V   
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN---EILIMKDCKHPNIVDYY 81

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
                   +L +V E+M  GSL ++++             +  +V +G+ YLH +    +
Sbjct: 82  D-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NV 137

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           IH +I   NILL    + K+++F  A  L      +  +V    GT  +M+PE     +I
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPE-----VI 188

Query: 689 T-----VKSDVYSFGVVVLEIV 705
                  K D++S G++ +E+ 
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 32/282 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKI--VAVKRLE---NPVEEGERKFQAEMAAVRRTHHKNLV 569
           +E+G G FG V  G    G     V VK L     P E+    F  E+   R  +H N++
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVL 58

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGITYLHE 625
           + LG C+++   LLV EF   G L+N L +    V          R+A +VA G+ +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSPEWQN 684
             +   IH ++  RN  L   L+ KI ++ LA    P    I          +++PE   
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 685 S-------GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
                      T KS+++S GV + E+         ++S   V+          + ++  
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL-------KQVVREQDI 228

Query: 738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
           KL     ++DL+  +    V   C  D P  RP+ + V  +L
Sbjct: 229 KL--PKPQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 11/169 (6%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKFQA-EMAAVRRTHHKNLVRLLGF 574
           +G G +G V K    E  +IVA+K+ LE+  ++  +K    E+  +++  H+NLV L+  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             +  +  LV+EF+    L++ L    +G +   RVR  L  + RGI + H      IIH
Sbjct: 69  FRRKKRLYLVFEFVDHTVLDD-LEKYPNG-LDESRVRKYLFQILRGIEFCHSH---NIIH 123

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILM-PNQTGIVTGVKGTRGYMSPE 681
            +I P NIL+  S   K+ +F  A+ L  P +  + T    TR Y +PE
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 17/196 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRL 571
           E +G+G FG V+KG      ++VA+K ++  +EE E      Q E+  + +     + + 
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECE 628
            G  ++ +K  ++ E++  GS  +LL    +GP   D  +IA    ++ +G+ YLH E  
Sbjct: 68  YGSYLKGTKLWIIMEYLGGGSALDLL---RAGPF--DEFQIATMLKEILKGLDYLHSE-- 120

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
            + IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE       
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178

Query: 689 TVKSDVYSFGVVVLEI 704
             K+D++S G+  +E+
Sbjct: 179 DSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 9/214 (4%)

Query: 514 EEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLV 569
           E+ +G G FG V  G +    K    VA+K L+    E +R+ F +E + + +  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
            L G   ++   ++V E+M  GSL+  L   +        V +   +A G+ YL    ++
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + +PE      
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
            T  SDV+S+G+V+ E++         +S  DV+
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 36/229 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVEEGE-RKFQAE 556
           EL R      + LG GCFG V        +K        VAVK L++   + +     +E
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 557 MAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---------------V 600
           M  ++    HKN++ LLG C Q     ++ E+ SKG+L   L                  
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 601 ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
           E    ++D V  A  VARG+ YL  +   + IH ++  RN+L+ +    KI++F LA+  
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR-- 182

Query: 661 MPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             +   I    K T G     +M+PE     + T +SDV+SFGV++ EI
Sbjct: 183 --DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 36/210 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHH-KNLVRLL 572
           EELGRG +G V K        I+AVKR+   V   E+K    ++    R+      V   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHEE 626
           G   +     +  E M   SL+     V    +    +      +IA+ + + + YLH +
Sbjct: 67  GALFREGDVWICMEVMDT-SLDKFYKKVYDKGL---TIPEDILGKIAVSIVKALEYLHSK 122

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNF--------SLAKILMPNQTGIVTGVKGTRGYM 678
             V  IH ++ P N+L++ +   K+ +F        S+AK          T   G + YM
Sbjct: 123 LSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----------TIDAGCKPYM 170

Query: 679 SPEW----QNSGLITVKSDVYSFGVVVLEI 704
           +PE      N     VKSDV+S G+ ++E+
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 10/195 (5%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
            ++G G +G VYK       +IVA+K+++   E       A  E+  ++  +H N+++LL
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
                     LV+EFM    L  L+ +     +    ++     + +G+ + H      I
Sbjct: 65  DVFRHKGDLYLVFEFM-DTDLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           +H ++ P N+L++     K+++F LA+          T    TR Y +PE        + 
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 691 KSDVYSFGVVVLEIV 705
             D++S G +  E++
Sbjct: 179 PVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.6 bits (186), Expect = 8e-15
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 17/196 (8%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNLVRLL 572
           E+G G FGAVY       N++VA+K++    ++   K+Q    E+  +++  H N +   
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
           G  ++     LV E+   GS  ++L  V   P+    +  I     +G+ YLH       
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHSHER--- 136

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSGLI 688
           IH +I   NILL +  T K+++F  A ++ P  + +     GT  +M+PE     + G  
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQY 191

Query: 689 TVKSDVYSFGVVVLEI 704
             K DV+S G+  +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.9 bits (184), Expect = 9e-15
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 22/206 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL---ENPVEEGERKFQA---EMAAVRRTHHKNL 568
           ++LG G F + Y+    +   ++AVK++    N   E E   +A   E+  + R +H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA--LDVARGITYLHEE 626
           +R+LG   + S   L  E+M+ GS+ +LLS    G  +++ V I     + RG++YLHE 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GA-FKEAVIINYTEQLLRGLSYLHEN 122

Query: 627 CEVQIIHCNINPRNILLDDS-LTAKISNFSLAKILMPNQTGIVTG-----VKGTRGYMSP 680
              QIIH ++   N+L+D +    +I++F  A  L    TG   G     + GT  +M+P
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG--AGEFQGQLLGTIAFMAP 177

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVC 706
           E           DV+S G V++E+  
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMAT 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 25/207 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKI--VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG+V +G + + + I  VAVK ++  +    E E  F +E   ++   H N++RL
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65

Query: 572 LGFCMQTSKK------LLVYEFMSKGSLENLL--SNVESGPIW---RDRVRIALDVARGI 620
           +G C+QT +       +++  FM  G L + L  S +   P +   +  V+   D+A G+
Sbjct: 66  IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIVTGVKGTRGY 677
            YL  +     IH ++  RN +L++++   +++F L+K +      + G +   K    +
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--KMPVKW 180

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEI 704
           ++ E     + T KSDV+SFGV + EI
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 69/283 (24%), Positives = 128/283 (45%), Gaps = 38/283 (13%)

Query: 517 LGRGCFGAVYKGSICEGN---KIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRL 571
           LG+G FG+V +  +   +   + VAVK L+  +       +F  E A ++   H N+++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 572 LGFCMQTSKK------LLVYEFMSKGSLEN--LLSNVESGPI---WRDRVRIALDVARGI 620
           +G  +++  K      +++  FM  G L    L+S +   P     +  VR  +D+A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIVTGVKGTRGY 677
            YL  +     IH ++  RN +L++++T  +++F L+K +      + G  +  K    +
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS--KLPVKW 181

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
           ++ E     + T  SDV++FGV + EI+         V  ++       +YN  I     
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIK---- 230

Query: 738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
              G   +     LE +  +   C   EP  RPS +++   LE
Sbjct: 231 ---GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 25/208 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVR---RTHHKNLVRLL 572
           LG+G +G+VYK      N+  A+K ++   + + ER  +  +  +R     +H N++   
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKER--EDAVNEIRILASVNHPNIISYK 65

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSN-------VESGPIWRDRVRIALDVARGITYLHE 625
              +  +K  +V E+   G L   +S        +    IWR    I + + RG+  LHE
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQALHE 121

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQN 684
           +   +I+H ++   NILL  +   KI +  ++K+L  N      G   T  YM+PE W+ 
Sbjct: 122 Q---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG---TPHYMAPEVWKG 175

Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFE 712
               + KSD++S G ++ E+      FE
Sbjct: 176 RPY-SYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 32/270 (11%)

Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I +G  +   VA+K L EN   +  ++   E   +       + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   LV + M  G L + +   +     +D +   + +A+G++YL E   V++
Sbjct: 75  LGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LA++L  ++T     G K    +M+ E       T 
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190

Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDV+S+GV V E++                      Y+   A+E+  L+ + E +    
Sbjct: 191 QSDVWSYGVTVWELMT----------------FGAKPYDGIPAREIPDLLEKGERLPQPP 234

Query: 751 LET----MVRVGLLCIQDEPNLRPSMKNVI 776
           + T    M+ V   C   +   RP  + ++
Sbjct: 235 ICTIDVYMIMVK--CWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ----------AEMAAVRRTH 564
           E +G+G +G VY        +++AVK++E P     R             +E+  ++   
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALD-VARGITYL 623
           H N+V+ LGF        +  E++  GS+ + L     G      VR   + V  G+ YL
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYL 124

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK----ILMPNQTGIVTGVKGTRGYMS 679
           H +    I+H ++   N+L+D     KIS+F ++K    I   +Q      ++G+  +M+
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMA 178

Query: 680 PEW-QNSGL-ITVKSDVYSFGVVVLEI 704
           PE   +     + K D++S G VVLE+
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYKG   +  +IVA+K  RLE+  E        E++ ++   H N+V L 
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGP-IWRDRVRIAL-DVARGITYLHEECEVQ 630
              MQ S+  L++EF+S   L+  L ++  G  +  + V+  L  + +GI + H     +
Sbjct: 66  DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG----TRGYMSPE-WQNS 685
           ++H ++ P+N+L+D+    K+++F LA+       GI   V      T  Y +PE    S
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-----GIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNF 711
              +   D++S G +  E+   +  F
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL E    ++
Sbjct: 75  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RL 130

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L  ++      G K    +M+ E     + T 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 191 QSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 37/211 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVR---------RTH 564
            E+G G +G VYK       + VA+K++  P+ EEG       ++ +R            
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-----IPLSTLREIALLKQLESFE 59

Query: 565 HKNLVRLLGFC--MQTSKKL---LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVAR 618
           H N+VRLL  C   +T ++L   LV+E + +  L   LS      +  + ++ +   + R
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTR 675
           G+ +LH      I+H ++ P+NIL+      KI++F LA+I    M      +T V  T 
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-----LTSVVVTL 170

Query: 676 GYMSPE--WQNSGLITVKSDVYSFGVVVLEI 704
            Y +PE   Q+S    V  D++S G +  E+
Sbjct: 171 WYRAPEVLLQSSYATPV--DMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 50/201 (24%), Positives = 99/201 (49%), Gaps = 19/201 (9%)

Query: 520 GCFGAVYKGSICEGN----KIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGF 574
           G FG ++ G + +      + V VK +++   E +      E   +    H+N++ +L  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 575 CMQ-TSKKLLVYEFMSKGSLENLLSNVESGPIW-------RDRVRIALDVARGITYLHEE 626
           C++      ++Y +M+ G+L+  L     G          +  V +A+ +A G++YLH+ 
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
               +IH +I  RN ++D+ L  KI++ +L++ L P     + G    R   +M+ E   
Sbjct: 137 ---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL-GDNENRPVKWMALESLV 192

Query: 685 SGLITVKSDVYSFGVVVLEIV 705
           +   +  SDV+SFGV++ E++
Sbjct: 193 NKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 70/264 (26%), Positives = 118/264 (44%), Gaps = 33/264 (12%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNLVRLL 572
           E+G G FGAVY  +    N++VAVK++    ++   K+Q    E+  +++  H N +   
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
           G  ++     LV E+   GS  +LL  V   P+    +  I     +G+ YLH      +
Sbjct: 88  GCYLKEHTAWLVMEY-CLGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSGLI 688
           IH +I   NILL +    K+++F  A    P  + +     GT  +M+PE     + G  
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQY 197

Query: 689 TVKSDVYSFGVVVLEIVCCRSN-FEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD 747
             K DV+S G+  +E+   +   F +N  +A        +Y+  IA+  S  +  +E  D
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYH--IAQNDSPTLQSNEWTD 247

Query: 748 LRTLETMVRVGLLCIQDEPNLRPS 771
                +       C+Q  P  RP+
Sbjct: 248 -----SFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 33/205 (16%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLL 572
           + +G G +G VYK       ++VA+K +   +E G+     Q E++ ++   H N+V   
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEV 629
           G  ++  K  +V E+   GSL+++   V  GP+     +IA    +  +G+ YLH   E 
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIY-QVTRGPLSEL--QIAYVCRETLKGLAYLH---ET 120

Query: 630 QIIHCNINPRNILLDDSLTAKISNF--------SLAKILMPNQTGIVTGVKGTRGYMSPE 681
             IH +I   NILL +    K+++F        ++AK     ++ I     GT  +M+PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK----RKSFI-----GTPYWMAPE 171

Query: 682 W---QNSGLITVKSDVYSFGVVVLE 703
               +  G    K D+++ G+  +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 24/198 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G FG V         + VA+K++  P       +R ++ E+  ++   H+N++ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
             +   + +  V E +    L  LL    S P+ +  ++     + RG+ Y+H      +
Sbjct: 77  IFISPLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHS---AGV 129

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQNSGL 687
           +H ++ P NIL++++   KI +F LA+I  P  TG V+    TR Y +PE    WQ    
Sbjct: 130 VHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPEIMLTWQKYD- 184

Query: 688 ITVKSDVYSFGVVVLEIV 705
             V+ D++S G +  E++
Sbjct: 185 --VEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 38/184 (20%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAE---MAAVRRT------HHKN 567
           LG G +  VYK    E  +IVA+K+++     GERK   +     A+R         H N
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQELKHPN 63

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA---------- 617
           ++ LL      S   LV+EFM    LE          + +D+  I L  A          
Sbjct: 64  IIGLLDVFGHKSNINLVFEFME-TDLEK---------VIKDK-SIVLTPADIKSYMLMTL 112

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
           RG+ YLH      I+H ++ P N+L+      K+++F LA+    +    +T    TR Y
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVVTRWY 168

Query: 678 MSPE 681
            +PE
Sbjct: 169 RAPE 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 10/195 (5%)

Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  + EG  +   VA+K L E    +   +F  E   +    H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+  + +L V + M  G L + +   +     +  +   + +A+G+ YL E    ++
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RL 130

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LA++L  ++      G K    +M+ E  +    T 
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 190

Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV + E++
Sbjct: 191 QSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 52/203 (25%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLLG 573
           E +G G +G VYKG   +  ++ A+K + +  E+ E + + E+  +++ +HH+N+    G
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 574 FCMQTS------KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
             ++ S      +  LV EF   GS+ +L+ N +   +  D +  I  ++ RG+ +LH  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----- 681
              ++IH +I  +N+LL ++   K+ +F ++  L     G      GT  +M+PE     
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 682 WQNSGLITVKSDVYSFGVVVLEI 704
                    +SD++S G+  +E+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVRL 571
             +ELG+G +G+VYK         +A+K +   ++E +  +   E+  + +     +V  
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLS-NVESGPIWRDRV-RIALDVARGITYLHEECEV 629
            G         +  E+M  GSL+ L +  V +  I  D + RI   V +G+ +L EE   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPN--QTGIVTGVKGTRGYMSPEWQNSG- 686
            IIH ++ P N+L++ +   K+ +F ++  L+ +  +T I     G + YM+PE   SG 
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177

Query: 687 -----LITVKSDVYSFGVVVLEI 704
                  TV+SDV+S G+ +LE+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 17/199 (8%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERK----FQAEMAAVRRTHHKNLVRL 571
           LG+G FG VY     +  + +AVK++  +P     +K     + E+  ++   H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 572 LGFCMQTSKKLLVY-EFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
            G C++  + L ++ E+M  GS+++ L     G +     R     +  G+ YLH     
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN--- 123

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMP---NQTGIVTGVKGTRGYMSPEWQNSG 686
            I+H +I   NIL D +   K+ +F  +K L     + TG+ + V GT  +MSPE  +  
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVISGE 182

Query: 687 LITVKSDVYSFGVVVLEIV 705
               K+DV+S G  V+E++
Sbjct: 183 GYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 8/117 (6%)

Query: 39  SPSSEPSSWTSPSGLFQFGFYK-EGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLI 97
           +  S   +  S + LF+ GF+              +S   TV+W A RD P VS +  L 
Sbjct: 2   NTLSSGQTLVSGNSLFELGFFTLIMQNDYNLILYKSSSR-TVVWVANRDNP-VSDSCTLT 59

Query: 98  LTMDG-LVLQTEESKHKLI--ANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNF 151
           L  DG LVL   +   +++  +NTT         +LD GN V+ +   +F+W+SF++
Sbjct: 60  LQSDGNLVL--YDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114

Length = 114

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 78/286 (27%), Positives = 122/286 (42%), Gaps = 40/286 (13%)

Query: 515 EELGRGCFGAVYKGSICEG--NKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           +E+G G FG V  G +  G     V VK L  +   + + KF  E    R   H NL++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESG----PIWRDRVRIALDVARGITYLHEEC 627
           LG C + +  LLV EF   G L+  L +        P      R+A ++A G+ +LH+  
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKI-------LMPNQTGIVTGVKGTRGYMSP 680
               IH ++  RN LL   LT KI ++ L+         + P+Q  +         +++P
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL------RWIAP 171

Query: 681 EWQN---SGLITV----KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA 733
           E  +     L+ V    +S+V+S GV + E+    S    ++S   V+  +       + 
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231

Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
           K   KL   D     R  E M    L     +P  RPS + V L+L
Sbjct: 232 KPRLKLPLSD-----RWYEVMQFCWL-----QPEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 9/193 (4%)

Query: 516 ELGRGCFGAVYKGSI-CEGNKI-VAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLL 572
           ELG G FG V KG       +I VA+K L+N  E+  R +   E   + +  +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G C +    +LV E  S G L   LS  +      + V +   V+ G+ YL  +     +
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFV 117

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQT--GIVTGVKGTRGYMSPEWQNSGLITV 690
           H ++  RN+LL +   AKIS+F L+K L  + +     +  K    + +PE  N    + 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 691 KSDVYSFGVVVLE 703
           +SDV+S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 20/215 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHH-KNLVR 570
              E+G G  G VYK    +   ++AVK++     +E  ++   ++  V ++H    +V+
Sbjct: 19  NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEV 629
             G+ +  S   +  E MS   L+ LL  ++ GPI  D + ++ + + + + YL E+   
Sbjct: 79  CYGYFITDSDVFICMELMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH-- 134

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW----QNS 685
            +IH ++ P NILLD S   K+ +F ++  L+ ++    T   G   YM+PE       +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPN 192

Query: 686 GLITVKSDVYSFGVVVLEIVC-------CRSNFEV 713
               +++DV+S G+ ++E+         C++ FEV
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 60/273 (21%), Positives = 121/273 (44%), Gaps = 32/273 (11%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA----EMAAVRRTHHKNLV 569
           E+++G+G F  VYK       ++VA+K+++   E  + K +     E+  +++  H N++
Sbjct: 7   EKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG-------PIWRDRVRIALDVARGITY 622
           + L   ++ ++  +V E    G L  ++ + +          IW+  V++       + +
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----CSALEH 121

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +H +   +I+H +I P N+ +  +   K+ +  L +      T   + V GT  YMSPE 
Sbjct: 122 MHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
            +      KSD++S G ++ E+   +S F       ++  L   +  C    +   L  +
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKC----DYPPLPAD 231

Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
               +LR L +       CI  +P  RP +  V
Sbjct: 232 HYSEELRDLVSR------CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 63/197 (31%), Positives = 93/197 (47%), Gaps = 17/197 (8%)

Query: 516 ELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLVRL 571
           ELG G FG V KG   + +  K VAVK L+N   +   K +   E   +++  +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEECE 628
           +G C +    +LV E    G L   L    +V    I      +   V+ G+ YL E   
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI----TELVHQVSMGMKYLEET-- 114

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQNSG 686
              +H ++  RN+LL     AKIS+F L+K L    N     T  K    + +PE  N  
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 687 LITVKSDVYSFGVVVLE 703
             + KSDV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 51/203 (25%), Positives = 104/203 (51%), Gaps = 18/203 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLLG 573
           E +G G +G VYKG   +  ++ A+K ++   +E E + + E+  +++ +HH+N+    G
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 70

Query: 574 FCMQTS------KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
             ++ +      +  LV EF   GS+ +L+ N +   +  + +  I  ++ RG+++LH+ 
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----- 681
              ++IH +I  +N+LL ++   K+ +F ++  L     G      GT  +M+PE     
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 682 WQNSGLITVKSDVYSFGVVVLEI 704
                    KSD++S G+  +E+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 12/202 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LG+G FG V    +    K+ A K+L     +  + ++  M   R   + H + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNV-ESGPIWRD--RVRIALDVARGITYLHEECEV 629
           +  QT   L LV   M+ G L   + NV E  P + +         +  G+ +LH+    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +II+ ++ P N+LLD+    +IS+  LA  L   Q+    G  GT G+M+PE        
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175

Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D ++ GV + E++  R  F
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.3 bits (180), Expect = 4e-13
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 27/185 (14%)

Query: 537 VAVK--RLENPVEEGERK-FQAEMAAVRRTHHKNLVRLL--GFCMQTSKKLL--VYEFMS 589
           VA+K  R + P EE +R  F+ E A   R +H N+V LL  G        LL  V+E++ 
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAVFEYVP 62

Query: 590 KGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL---DD 645
             +L  +L+    G +   +  R+ L V   +   H +    I+H ++ P+NI++     
Sbjct: 63  GRTLREVLAA--DGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117

Query: 646 SLTAKISNFSLAKILMPN------QTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFG 698
              AK+ +F +   L+P        T   T  V GT  Y +PE      +T  SD+Y++G
Sbjct: 118 RPHAKVLDFGIGT-LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 699 VVVLE 703
           ++ LE
Sbjct: 177 LIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 13/206 (6%)

Query: 518 GRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-RKFQAEMAAVRRTHHKNLVRLLGF 574
           G+G FG V      +  K+ A+K    +  VE+G  R    E   ++  +H  LV L  +
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW-Y 67

Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQII 632
             Q  + + LV + +  G L   LS  +      ++V+    ++   + YLH +    II
Sbjct: 68  SFQDEENMYLVVDLLLGGDLRYHLS--QKVKFSEEQVKFWICEIVLALEYLHSK---GII 122

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I P NILLD+     I++F++A  + P+   + T   GT GYM+PE       +V  
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAV 180

Query: 693 DVYSFGVVVLEIVCCRSNFEVNVSTA 718
           D +S GV   E +  +  +  +  T 
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTI 206

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 40/213 (18%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--------EMAAVRR-THH 565
           ++LG G FG+VY     E  ++VA+K++       ++KF +        E+ ++R+   H
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57

Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLH 624
            N+V+L     +  +   V+E+M +G+L  L+ + +  P     +R I   + +G+ ++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL--MPNQTGIVTGVKGTRGYMSPEW 682
              +    H ++ P N+L+      KI++F LA+ +   P  T  V     TR Y +PE 
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV----STRWYRAPE- 168

Query: 683 QNSGLITVKSDVYS-------FGVVVLEIVCCR 708
                I ++S  YS        G ++ E+   R
Sbjct: 169 -----ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 53/196 (27%), Positives = 93/196 (47%), Gaps = 17/196 (8%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNLVRLL 572
           E+G G FGAVY       +++VA+K++    ++   K+Q    E+  +++  H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
           G  ++     LV E+   GS  +LL  V   P+    +  +     +G+ YLH      +
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSGLI 688
           IH ++   NILL +    K+ +F  A I+ P    +     GT  +M+PE     + G  
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQY 191

Query: 689 TVKSDVYSFGVVVLEI 704
             K DV+S G+  +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 25/268 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLV 569
           ++E LG G  G VYK       +I+AVK +  P++   E +++  +E+  + +     ++
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYII 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
              G     ++  +  EFM  GSL+      E   +     RIA+ V +G+TYL     +
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSLDVYRKIPE--HVLG---RIAVAVVKGLTYL---WSL 114

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +I+H ++ P N+L++     K+ +F ++  L+     I     GT  YM+PE  +     
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYG 171

Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL-VGEDEEVDL 748
           + SDV+S G+  +E+   R  +   +      L+   +  C + ++   L VG+  E   
Sbjct: 172 IHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK-- 228

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                 V     C++ +P  RP+ +N++
Sbjct: 229 -----FVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.5 bits (172), Expect = 5e-13
 Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 17/196 (8%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNLVRLL 572
           E+G G FGAVY       N++VA+K++    ++   K+Q    E+  ++R  H N +   
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
           G  ++     LV E+   GS  +LL  V   P+    +  I     +G+ YLH      +
Sbjct: 92  GCYLREHTAWLVMEY-CLGSASDLLE-VHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSGLI 688
           IH +I   NILL +    K+++F  A I  P  + +     GT  +M+PE     + G  
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQY 201

Query: 689 TVKSDVYSFGVVVLEI 704
             K DV+S G+  +E+
Sbjct: 202 DGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 59/272 (21%), Positives = 121/272 (44%), Gaps = 30/272 (11%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRL---ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           E+++GRG F  VY+ +     K VA+K++   E    +  +    E+  +++ +H N+++
Sbjct: 7   EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSN-------VESGPIWRDRVRIALDVARGITYL 623
            L   ++ ++  +V E    G L  ++         +    +W+  V++       + ++
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHM 122

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           H     +++H +I P N+ +  +   K+ +  L +    ++T     + GT  YMSPE  
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED 743
           +      KSD++S G ++ E+   +S F  +    ++  L   +  C    +   L  E 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLFSLCQKIEQC----DYPPLPTEH 232

Query: 744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
               LR L +M      CI  +P+ RP +  V
Sbjct: 233 YSEKLRELVSM------CIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAV 560
           EL+  +   E  LG G FG + +G +   +K    VA+  L     + +R+ F AE   +
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N+VRL G   + +  ++V E+MS G+L++ L   E   +    + +   +A G+
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGM 120

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG---- 676
            YL    E+  +H  +    +L++  L  KIS F         Q      +  T      
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSP 171

Query: 677 --YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             + +PE       +  SDV+SFG+V+ E++
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 71/277 (25%), Positives = 127/277 (45%), Gaps = 42/277 (15%)

Query: 513 FEEELGRGCFGAVYKGSICE-GNKIVAVKRLENPVEEGERKFQAEMAAVRR-------TH 564
             E +G G    VY  +IC   N+ VA+KR++  +E    K Q  +  +R+        +
Sbjct: 5   LIEVIGVGATAVVYA-AICLPNNEKVAIKRID--LE----KCQTSVDELRKEVQAMSQCN 57

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIAL---DVARGI 620
           H N+V+     +   +  LV  ++S GSL +++ S+   G +  D   IA    +V +G+
Sbjct: 58  HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL--DEAIIATVLKEVLKGL 115

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGY 677
            YLH       IH +I   NILL +  + KI++F ++  L         +     GT  +
Sbjct: 116 EYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 678 MSPE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE 735
           M+PE   Q  G    K+D++SFG+  +E+    + +        V++L+       +  +
Sbjct: 173 MAPEVMEQVHGY-DFKADIWSFGITAIELATGAAPYS-KYPPMKVLMLT-------LQND 223

Query: 736 LSKL-VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS 771
              L  G D +   ++   M+    LC+Q +P+ RP+
Sbjct: 224 PPSLETGADYKKYSKSFRKMIS---LCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 34/272 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG+G FG        E + +V  K   L    E+  R    E+  +    H N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL--DVARGITYLHEECEVQII 632
            M  +  L+  E+ + G+L + +   + G ++ + + +     +   ++Y+H+     I+
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKA---GIL 123

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I   NI L  +   K+ +F ++KI + ++  +   V GT  YMSPE         KS
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKI-LGSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182

Query: 693 DVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV-----GEDEEVD 747
           D+++ G V+ E++  +  F+                    A     LV     G    V 
Sbjct: 183 DIWALGCVLYELLTLKRTFD--------------------ATNPLNLVVKIVQGNYTPVV 222

Query: 748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
                 ++ +    +Q +P  RP+   V+   
Sbjct: 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 24/235 (10%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V    +    K+ A KRLE       +GE     E   + + + + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  +T   L LV   M+ G L+  + N+ +     +R    A ++  G+  LH E     
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NT 123

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P NILLDD    +IS+  LA + +P +   + G  GT GYM+PE  N+   T+ 
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA-VKIP-EGESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV 746
            D +  G ++ E++  +S F                      +E+ + V E EEV
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVK-------------REEVDRRVLETEEV 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 506 LERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR- 562
           L   T  FE  E +G G +G VYK    +  ++VA+K + + +E+ E + + E   +R+ 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59

Query: 563 THHKNLVRLLGFCMQTS-----KKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR----- 611
           ++H N+    G  ++ +      +L LV E    GS+ +L+  +        R++     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---KRLKEEWIA 116

Query: 612 -IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF----SLAKILMPNQTG 666
            I  +  RG+ YLHE    ++IH +I  +NILL  +   K+ +F     L   L    T 
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173

Query: 667 IVTGVKGTRGYMSPE-----WQNSGLITVKSDVYSFGVVVLE 703
           I     GT  +M+PE      Q       +SDV+S G+  +E
Sbjct: 174 I-----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 67/258 (25%), Positives = 112/258 (43%), Gaps = 48/258 (18%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-------------------IVAVKRLENP 545
           +  R    F+E+LG G FG V+   +CE                      +VAVK L   
Sbjct: 1   KFPRGHLLFKEKLGEGQFGEVH---LCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD 57

Query: 546 VEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN----- 599
             +  R  F  E+  + R    N++RLLG C+      ++ E+M  G L   LS+     
Sbjct: 58  ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDD 117

Query: 600 -VESG------------PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS 646
             E+G              +   + +AL +A G+ YL     +  +H ++  RN L+ ++
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGEN 174

Query: 647 LTAKISNFSLAKILMPNQTGIVTG--VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           LT KI++F +++ L       + G  V   R +M+ E    G  T  SDV++FGV + EI
Sbjct: 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIR-WMAWECILMGKFTTASDVWAFGVTLWEI 233

Query: 705 V-CCRSNFEVNVSTADVV 721
           +  C+      ++   V+
Sbjct: 234 LMLCKEQPYGELTDEQVI 251

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 11/201 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V    +    K+ A K+LE       +GE     E   + + + + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           +  +T   L LV   M+ G L+  + ++ E+G      V  A ++  G+  LH+E   +I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P NILLDD    +IS+  LA  +   QT  + G  GT GYM+PE   +   T  
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFS 181

Query: 692 SDVYSFGVVVLEIVCCRSNFE 712
            D ++ G ++ E++  +S F+
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 39/232 (16%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-------------------IVAVKRLENP 545
           E  R    F+E+LG G FG V+   +CE                      +VAVK L   
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVH---LCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED 57

Query: 546 VEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE--S 602
             +  R  F  E+  + R    N++RLL  C+ +    ++ E+M  G L   LS  E   
Sbjct: 58  ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 603 GPIWRDRVRI--------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF 654
                D V I        A  +A G+ YL     +  +H ++  RN L+  + T KI++F
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADF 174

Query: 655 SLAKILMPNQTGIVTG--VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +++ L       + G  V   R +MS E    G  T  SDV++FGV + EI
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIR-WMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin

 Score = 63.5 bits (155), Expect = 4e-12
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 9/109 (8%)

Query: 49  SPSGLFQFGFYKEGT--GFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVL 105
           S   LF+ GF+K               S   TV+W A RD P   S+  L L  DG LV+
Sbjct: 12  SSGSLFELGFFKLIMQSRDYNLILYKGSSR-TVVWVANRDNP-SGSSCTLTLQSDGNLVI 69

Query: 106 QTEESKHKLI--ANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFP 152
              +    ++  +NTT         +LD GN VL +   +F+W+SF++P
Sbjct: 70  --YDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 27/209 (12%)

Query: 517 LGRGCFGAVYKGSICEG---NKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           +GRG FG V+   +C      K+V +K++  E   ++     Q E   ++   H N++  
Sbjct: 8   VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITY-------LH 624
               ++    ++V E+   G+L   +         + R    LD    + +       LH
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI---------QKRCNSLLDEDTILHFFVQILLALH 115

Query: 625 EECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                 I+H ++  +NILLD   +  KI +F ++KIL          V GT  Y+SPE  
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELC 173

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                  KSD+++ G V+ E+   +  FE
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 14/174 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            ++G G +G VYK    +  ++VA+K  R+EN  E        E+  +++  H N+VRL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 573 GFCMQTSKKL----LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEEC 627
              + TSK      +V+E+M    L  LL + E       +++     +  G+ YLH   
Sbjct: 65  --EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV-KFTESQIKCYMKQLLEGLQYLHSN- 119

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
              I+H +I   NIL+++    K+++F LA+      +   T    T  Y  PE
Sbjct: 120 --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 10/205 (4%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC--EGNKI-VAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG VY+G     E  KI VAVK  +N      R KF  E   +
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-NVESGPIWRDRVRIALDVARG 619
           R+  H ++V+L+G   + +   +V E    G L + L  N  S  +    +  +  ++  
Sbjct: 62  RQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDL-ASLILYSYQLSTA 119

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + YL      + +H +I  RN+L+      K+ +F L++ L        +  K    +M+
Sbjct: 120 LAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEI 704
           PE  N    T  SDV+ FGV + EI
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 17/200 (8%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTH---HKNLVR 570
           E+G G +G VYK         VA+K +     E         E+A ++R     H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 571 LLGFCM-----QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLH 624
           L+  C      + +K  LV+E + +  L   L  V    +  + ++ +     RG+ +LH
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
             C   I+H ++ P NIL+      K+++F LA+I        +T V  T  Y +PE   
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLL 180

Query: 685 SGLITVKSDVYSFGVVVLEI 704
                   D++S G +  E+
Sbjct: 181 QSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)

Query: 515 EELGRGCFGAVYK-GSICEGNKIVAVKR--LENPV--------EEGERKFQAEMAAVRRT 563
           E LG G FG VYK      G  ++A+K   + NP         ++      +E+  ++  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 564 -HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-------NVESGPIWRDRVRIALD 615
             H N+VR     ++  +  +V + +    L    +             IW   V++ L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124

Query: 616 VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR 675
               + YLH+E   +I+H ++ P NI+L +     I++F LAK   P     +T V GT 
Sbjct: 125 ---ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGTI 177

Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            Y  PE   +     K+DV++FG ++ ++ 
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.1 bits (161), Expect = 9e-12
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 516 ELGRGCFGAVYKGSIC----EGN---KIVAVKRLENPVEEGER--KFQAEMAAVRRTHHK 566
           +LG G FG V    +C    EG+   + VAVK L+ P   G      + E+  +R  +H+
Sbjct: 11  DLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHE 66

Query: 567 NLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
           N+V+  G C +       L+ EF+  GSL+  L   ++    + +++ A+ + +G+ YL 
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG----YMSP 680
                Q +H ++  RN+L++     KI +F L K +  ++    T VK        + +P
Sbjct: 127 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK-EYYT-VKDDLDSPVFWYAP 181

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E        + SDV+SFGV + E++
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 20/198 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       +IVA+K  RLE   E        E++ ++  +H N+VRLL
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
                 +K  LV+EF+    L+  + +     +    ++  L  + +GI Y H     ++
Sbjct: 65  DVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RV 120

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAK---ILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           +H ++ P+N+L+D     K+++F LA+   + +   T  V     T  Y +PE      I
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPE------I 170

Query: 689 TVKSDVYSFGVVVLEIVC 706
            + S  YS  V +  I C
Sbjct: 171 LLGSRQYSTPVDIWSIGC 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V    +    K+ A K+LE       +GE     E   + + + + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  +T   L LV   M+ G L+  + N+ +     +R    A ++  G+  LH E   +I
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RI 123

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P NILLDD    +IS+  LA  +   +T  + G  GT GYM+PE   +   T  
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFS 181

Query: 692 SDVYSFGVVVLEIVCCRSNFE 712
            D +  G ++ E++  +S F 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 41/146 (28%), Positives = 79/146 (54%), Gaps = 5/146 (3%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA-EMAAVRRTHHKNLVRLLG 573
           E+LG G +  VYKG      +IVA+K +    EEG       E++ ++   H+N+VRL  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQII 632
                +K +LV+E+M K   + + ++   G +  + V+     + +GI + HE    +++
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 633 HCNINPRNILLDDSLTAKISNFSLAK 658
           H ++ P+N+L++     K+++F LA+
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 19/199 (9%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E     A K ++   EE    F  E+  +    H N+V L    
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQIIHC 634
              +K  ++ EF   G+L++++  +E   +   ++R +   +   + +LH     ++IH 
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127

Query: 635 NINPRNILLDDSLTAKISNFS----LAKILMPNQTGIVTGVKGTRGYMSPEWQN-----S 685
           ++   NILL      K+++F         L    T I     GT  +M+PE         
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACETFKD 182

Query: 686 GLITVKSDVYSFGVVVLEI 704
                K+D++S G+ ++E+
Sbjct: 183 NPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNLVR 570
           + +G +G V+   K S      I A+K ++      + +      E   + +     +V+
Sbjct: 1   ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  +  Q  K L LV E++  G L +LL NV S      R+ IA ++   + YLH     
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHS---N 112

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTGVK------GTRGYMSPEW 682
            IIH ++ P NIL+D +   K+++F L+K+ L+  Q  +    K      GT  Y++PE 
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 683 QNSGLITVKSDVYSFGVVVLEIVC 706
                 +   D +S G ++ E + 
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 25/204 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-------FQAEMAAVRRTHHKNLV 569
           LGRG FG VY     +  + +AVK++  P +   ++        + E+  ++   H  +V
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQV--PFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 570 RLLGFCMQ--TSKKLLVY-EFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHE 625
           +  G C++    KKL ++ E+M  GS+++ L     G +  +  R     + +G++YLH 
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTRRYTRQILQGVSYLHS 124

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAK----ILMPNQTGIVTGVKGTRGYMSPE 681
                I+H +I   NIL D +   K+ +F  +K    I M + TGI + V GT  +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM-SGTGIKS-VTGTPYWMSPE 179

Query: 682 WQNSGLITVKSDVYSFGVVVLEIV 705
             +      K+DV+S    V+E++
Sbjct: 180 VISGEGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK---NLVRLLG 573
           LG+G FG V    +    K+ A K+LE      +RK +A     +R   K     V  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQI 631
           +  +T   L LV   M+ G L+  + N+ +      R +  A ++  G+  L  E   +I
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P NILLDD    +IS+  LA  +   +T  V G  GT GYM+PE  N+   T  
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTFS 181

Query: 692 SDVYSFGVVVLEIVCCRSNF 711
            D +  G ++ E++  +S F
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 42/123 (34%), Positives = 70/123 (56%), Gaps = 14/123 (11%)

Query: 586 EFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQIIHCNINPRNILLD 644
           E M  GSL+ +L   ++G I  + + +I++ V RG+TYL E+   +I+H ++ P NIL++
Sbjct: 79  EHMDGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVN 134

Query: 645 DSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVV 701
                K+ +F ++  L   M N         GTR YMSPE       TV+SD++S G+ +
Sbjct: 135 SRGEIKLCDFGVSGQLIDSMANS------FVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 702 LEI 704
           +E+
Sbjct: 189 VEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.4 bits (156), Expect = 5e-11
 Identities = 51/206 (24%), Positives = 100/206 (48%), Gaps = 11/206 (5%)

Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA+K++    +  +     E+  +R
Sbjct: 13  SVGDPKKKYTRFEK-IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 127

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+   T V GT  +M+
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 183

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E+V
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 39/147 (26%), Positives = 76/147 (51%), Gaps = 8/147 (5%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G V+K    E ++IVA+KR  L++  E        E+  ++   HKN+VRL 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
                  K  LV+E+  +  L+    +   G I  + V+     + +G+ + H      +
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAK 658
           +H ++ P+N+L++ +   K+++F LA+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 11/201 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V    +    K+ A K+L+      + GE+    E   + + +   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
           +  ++   L LV   M+ G L+  + NV    +  +RV   +  +  GI +LH    + I
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P N+LLDD    ++S+  LA  L   +T  +T   GT GYM+PE       +  
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYP 174

Query: 692 SDVYSFGVVVLEIVCCRSNFE 712
            D ++ G  + E+V  R+ F+
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 8/191 (4%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLGF 574
           +G G +G V K    E  +IVA+K+ ++  E  E K     E+  +R    +N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             +  K  LV+E++ K  LE LL  + +G    ++VR  +  + + I + H+     I+H
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE-LLEEMPNGVP-PEKVRSYIYQLIKAIHWCHKN---DIVH 123

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+L+  +   K+ +F  A+ L        T    TR Y SPE           D
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183

Query: 694 VYSFGVVVLEI 704
           ++S G ++ E+
Sbjct: 184 MWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 13/203 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
              + T  KL LV+EF+ +  L+  +       I    ++  L  + +G+ + H     +
Sbjct: 66  D-VIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---R 120

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLI 688
           ++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE        
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYY 178

Query: 689 TVKSDVYSFGVVVLEIVCCRSNF 711
           +   D++S G +  E+V  R+ F
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 18/201 (8%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
            E++G G +G VYK      N+ +A+K  RLE   E        E++ ++   H N+VRL
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA----LDVARGITYLHEEC 627
                   +  LV+E++      +L  +++S P +    R+       + RGI Y H   
Sbjct: 67  QDVVHSEKRLYLVFEYLDL----DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121

Query: 628 EVQIIHCNINPRNILLDDSLTA-KISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQN 684
             +++H ++ P+N+L+D    A K+++F LA+   +P +T   T    T  Y +PE    
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLG 177

Query: 685 SGLITVKSDVYSFGVVVLEIV 705
           S   +   D++S G +  E+V
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)

Query: 516 ELGRGCFGAVYKG-SICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTH---HKNLV 569
           E+G G +G V+K   +  G + VA+KR+     E         E+A +R      H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 570 RLLGFCM-----QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYL 623
           RL   C      + +K  LV+E + +  L   L  V    +  + ++ +   + RG+ +L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           H     +++H ++ P+NIL+  S   K+++F LA+I   +    +T V  T  Y +PE  
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 181

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
                    D++S G +  E+   +  F  +
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 11/196 (5%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLGF 574
           ELG G  G V K        I+A K +   ++   R +   E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEECEVQII 632
                +  +  E M  GSL+ +L   +  P   + +  ++++ V RG+ YL E+   QI+
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKEAKRIP---EEILGKVSIAVLRGLAYLREKH--QIM 126

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NIL++     K+ +F ++  L+ +   +     GTR YMSPE       +V+S
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQS 183

Query: 693 DVYSFGVVVLEIVCCR 708
           D++S G+ ++E+   R
Sbjct: 184 DIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL---ENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G FG +Y       ++   +K +   + PV+E E   + E+  + +  H N+V    
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFFA 66

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR------VRIALDVARGITYLHEEC 627
              +  +  +V E+   G L   + N + G ++ +       V+I+L    G+ ++H+  
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISL----GLKHIHDR- 120

Query: 628 EVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
             +I+H +I  +NI L  + + AK+ +F +A+ L  +   +     GT  Y+SPE   + 
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEICQNR 177

Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVN 714
               K+D++S G V+ E+   +  FE N
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 31/210 (14%)

Query: 516 ELGRGCFGA--VYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
            +G+       V+       N +VAVK+  L++  +E  +  Q E+   R+  H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNV--ESGPIWRDRVRIAL---DVARGITYLHEE 626
           +   +  S+  +V   M+ GS E+LL     E  P     + IA    DV   + Y+H +
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP----ELAIAFILKDVLNALDYIHSK 120

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG-TRG------YMS 679
                IH ++   +ILL       +S    + + M         V    +       ++S
Sbjct: 121 ---GFIHRSVKASHILLSGDGKVVLSGLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 680 PE--WQNSGLITVKSDVYSFGVVVLEIVCC 707
           PE   QN      KSD+YS G     I  C
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVG-----ITAC 201

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.3 bits (155), Expect = 1e-10
 Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 31/207 (14%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G V         + VA+K++ N    + + +R  + E+  +R   H+N++ LL 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLD 66

Query: 574 FCMQTSKKL-------LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHE 625
             +             +V E M    L  ++ +    P+  D ++     + RG+ YLH 
Sbjct: 67  --ILRPPSPEDFNDVYIVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHS 121

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ--TGIVTGVKGTRGYMSPE-- 681
                +IH ++ P NIL++ +   KI +F LA+ + P++   G +T    TR Y +PE  
Sbjct: 122 ---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178

Query: 682 --WQN-SGLITVKSDVYSFGVVVLEIV 705
                 +  I    D++S G +  E++
Sbjct: 179 LSSSRYTKAI----DIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 515 EELGRGCFGAV----YKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLV 569
             LG G FG V    Y  +     ++VAVK L+    ++    ++ E+  ++  +H+N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 570 RLLGFCMQTSKK--LLVYEFMSKGSLENLL--SNVESGPIWRDRVRIALDVARGITYLHE 625
           +  G C +   K   L+ E++  GSL + L    +    +    +  A  +  G+ YLH 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL----LLFAQQICEGMAYLHS 125

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQ 683
           +     IH ++  RN+LLD+    KI +F LAK +            G     + + E  
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
                +  SDV+SFGV + E++
Sbjct: 183 KENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 11/206 (5%)

Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA+K++    +  +     E+  +R
Sbjct: 13  SVGDPKKKYTRFEK-IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              H N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 127

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+   T V GT  +M+
Sbjct: 128 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 183

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E+V
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 13/207 (6%)

Query: 507 ERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRT 563
           E   + FE+  ELG G  G V+K S      I+A K +   ++   R +   E+  +   
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGIT 621
           +   +V   G      +  +  E M  GSL+ +L      P   +++  ++++ V +G+T
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP---EQILGKVSIAVIKGLT 117

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           YL E+   +I+H ++ P NIL++     K+ +F ++  L+ +   +     GTR YMSPE
Sbjct: 118 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPE 172

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                  +V+SD++S G+ ++E+   R
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 17/200 (8%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL----ENPVEEGE-RKFQAEMAAVRRTHHKNLVRL 571
           LG+G FG VY     +  + +AVK++    E+P    E    + E+  ++   H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 572 LGFCMQTSKKLL--VYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECE 628
            G      ++ L    E M  GS+++ L +   G +  +  R     +  G++YLH    
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN-- 125

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMP---NQTGIVTGVKGTRGYMSPEWQNS 685
             I+H +I   NIL D     K+ +F  +K L     + TG+ + V GT  +MSPE  + 
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVISG 183

Query: 686 GLITVKSDVYSFGVVVLEIV 705
                K+D++S G  V+E++
Sbjct: 184 EGYGRKADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 56/272 (20%), Positives = 121/272 (44%), Gaps = 30/272 (11%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           E+++GRG F  VY+ +       VA+K+++  + ++   R     E+  +++ +H N+++
Sbjct: 7   EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSN-------VESGPIWRDRVRIALDVARGITYL 623
                ++ ++  +V E    G L  ++ +       +    +W+  V++       + ++
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHM 122

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           H     +++H +I P N+ +  +   K+ +  L +    ++T     + GT  YMSPE  
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED 743
           +      KSD++S G ++ E+   +S F  +    ++  L   +  C    +   L  + 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLYSLCKKIEQC----DYPPLPSDH 232

Query: 744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
              +LR L  M      CI  +P  RP +  V
Sbjct: 233 YSEELRQLVNM------CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 44/194 (22%), Positives = 96/194 (49%), Gaps = 14/194 (7%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   +     + VAVK+++   ++       E+  +R   H N+V +    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQIIHC 634
           +   +  +V EF+  G+L +++++     +  +++  + L V + +++LH +    +IH 
Sbjct: 86  LVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSFLHAQ---GVIHR 139

Query: 635 NINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           +I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      +
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTE 195

Query: 692 SDVYSFGVVVLEIV 705
            D++S G++V+E+V
Sbjct: 196 VDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 47/193 (24%), Positives = 94/193 (48%), Gaps = 12/193 (6%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   +     K VAVK+++   ++       E+  +R  HH+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V R ++YLH +    +IH +
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNE--EQIATVCLSVLRALSYLHNQ---GVIHRD 143

Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPYGTEV 199

Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E++
Sbjct: 200 DIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 30/229 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR----RTHHKNLVRLL 572
           LG+G FG V    + E  ++ AVK L+  V   +   +  M   R      +H  L +L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 573 GFCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
             C QT  +L  V EF++ G L  +    +S      R R  A ++   + +LH++    
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYMSPEWQNS 685
           II+ ++   N+LLD     K+++F + K       GI  G       GT  Y++PE    
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK------EGIFNGKTTSTFCGTPDYIAPEILQE 170

Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVST-------ADVVLLSTWV 727
            L     D ++ GV++ E++C  + FE             D V+  TW+
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNE--EQIAAVCLAVLKALSVLHAQ---GVIHRD 141

Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPELISRLPYGPEV 197

Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 198 DIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 61.3 bits (148), Expect = 5e-10
 Identities = 46/194 (23%), Positives = 93/194 (47%), Gaps = 12/194 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E++G+G  G V+        + VA+K++    +  +     E+  ++   + N+V  L  
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQI 631
            +   +  +V E+++ GSL ++++         D  +IA    +  + + +LH     Q+
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QV 136

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH +I   N+LL    + K+++F     + P Q+   T V GT  +M+PE         K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 692 SDVYSFGVVVLEIV 705
            D++S G++ +E+V
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 61.3 bits (148), Expect = 5e-10
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 11/206 (5%)

Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA++++    +  +     E+  +R
Sbjct: 14  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 128

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+   T V GT  +M+
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 184

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 60.8 bits (148), Expect = 7e-10
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 20/152 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLEN-----PVEEGERKFQAEMAAVRRTHHKNLV 569
           +G G +G VY+       +IVA+K  R++N     P+    R    E+  +    H N+V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPI-SSLR----EITLLLNLRHPNIV 69

Query: 570 RLLGFCM--QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
            L    +        LV E+  +  L +LL N+ + P    +V+ + L + RG+ YLHE 
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPT-PFSESQVKCLMLQLLRGLQYLHEN 127

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
               IIH ++   N+LL D    KI++F LA+
Sbjct: 128 F---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.8 bits (148), Expect = 7e-10
 Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 39/224 (17%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKI-------------------VAVKRLENPVEEGERK- 552
           F E+LG G FG V+   +CE + +                   VAVK L     +  R+ 
Sbjct: 9   FVEKLGEGQFGEVH---LCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65

Query: 553 FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIWRDR 609
           F  E+  + R    N+ RLLG C       ++ E+M  G L   L       SG     +
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 610 -------VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
                  + +A  +A G+ YL     +  +H ++  RN L+  + T KI++F +++ L  
Sbjct: 126 SLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 663 NQTGIVTG--VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           +    V G      R +M+ E    G  T KSDV++FGV + EI
Sbjct: 183 SDYYRVQGRAPLPIR-WMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 17/198 (8%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E   + A K +E   EE    +  E+  +   +H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
               K  ++ EF   G+++ ++  ++ G        I   +   + YLH     +IIH +
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD 135

Query: 636 INPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNSG 686
           +   N+LL      K+++F ++    K L    + I     GT  +M+P     E     
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDT 190

Query: 687 LITVKSDVYSFGVVVLEI 704
               K+D++S G+ ++E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 45/148 (30%), Positives = 82/148 (55%), Gaps = 11/148 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
           E+LG G +  VYKG      K+VA+K +    EEG   F A  E + ++   H N+V LL
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIV-LL 68

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
              + T + L LV+E++     + +  +   G +  + V++ L  + RG++Y+H+     
Sbjct: 69  HDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQLLRGLSYIHQR---Y 123

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAK 658
           I+H ++ P+N+L+ D+   K+++F LA+
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 21/202 (10%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL----ENPVEEGE-RKFQAEMAAVRRTHHKNLVRL 571
           LG+G FG VY     +  + +A K++    E+P    E    + E+  ++   H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 572 LGFCMQ--TSKKLLVY-EFMSKGSLENLLS--NVESGPIWRDRVRIALDVARGITYLHEE 626
            G C++    K L ++ E+M  GS+++ L      +  + R   R  L+   G++YLH  
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE---GMSYLHSN 125

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP---NQTGIVTGVKGTRGYMSPEWQ 683
               I+H +I   NIL D +   K+ +F  +K L     + TGI + V GT  +MSPE  
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVI 181

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           +      K+DV+S G  V+E++
Sbjct: 182 SGEGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 2e-09
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 27/195 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL----ENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           LG+G +G V+K       ++VA+K++     N  +  +R F+  M       H N+V+LL
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD-AQRTFREIMFLQELGDHPNIVKLL 73

Query: 573 G-FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD--RVRIALDVARGITYLHEECE 628
                +  K + LV+E+M     E  L  V    I  D  +  I   + + + Y+H    
Sbjct: 74  NVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKALKYIHSG-- 126

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILM----PNQTGIVTGVKGTRGYMSPEWQN 684
             +IH ++ P NILL+     K+++F LA+ L       +  ++T    TR Y +PE   
Sbjct: 127 -NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE--- 182

Query: 685 SGLITVKSDVYSFGV 699
              I + S  Y+ GV
Sbjct: 183 ---ILLGSTRYTKGV 194

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 19/199 (9%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E   + A K ++   EE    +  E+  +    H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHC 634
              +   ++ EF + G+++ ++  +E  P+   ++R+        + YLHE    +IIH 
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127

Query: 635 NINPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNS 685
           ++   NIL       K+++F ++    + +    + I     GT  +M+P     E    
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKD 182

Query: 686 GLITVKSDVYSFGVVVLEI 704
                K+DV+S G+ ++E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.4 bits (144), Expect = 3e-09
 Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 14/206 (6%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           +GRG FG V          I A+K ++  V   +E    F+ E   +  ++   + +L  
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ- 67

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           +  Q    L LV E+   G L +LL+  E      D  +  L  A  +  +H   ++  +
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYL--AELVLAIHSVHQMGYV 124

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS------G 686
           H +I P N+L+D +   K+++F  A  L  N+        GT  Y++PE   +      G
Sbjct: 125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFE 712
              V+ D +S GV+  E++  RS F 
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 23/220 (10%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLEN-------PVEEGERKFQAEMAAVRRTHHK 566
           LG G +G V+   K    +  K+ A+K L+           E  R  +  + AVRR    
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF- 66

Query: 567 NLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
            LV L  +  QT  KL L+ ++++ G L   L   E       RV IA ++   + +LH+
Sbjct: 67  -LVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLHQ 123

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
              + II+ +I   NILLD      +++F L+K  +  +        GT  YM+PE    
Sbjct: 124 ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 686 GLITVKS--DVYSFGVVVLEIVCCRSNFEVN---VSTADV 720
           G        D +S GV+  E++   S F V+    S +++
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 54/200 (27%), Positives = 82/200 (41%), Gaps = 46/200 (23%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKF----QAEMAAVRRTHHKN 567
              +LG G FG VYK    +  ++VA+K++    E +G   F      E+  +++  H N
Sbjct: 12  ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPN 68

Query: 568 LVRLLGFCMQTSKKL--------LVYEFMSKGSLENLLSNVESGPIWRDRVR-------- 611
           +V L+   ++   K         +V  +M    L  LL N          V+        
Sbjct: 69  VVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN--------PSVKLTESQIKC 119

Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-----MPNQTG 666
             L +  GI YLHE     I+H +I   NIL+D+    KI++F LA+        P   G
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 667 IV-----TGVKGTRGYMSPE 681
                  T +  TR Y  PE
Sbjct: 177 GGGTRKYTNLVVTRWYRPPE 196

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 12/102 (11%)

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +R +  VA+G+ +L  +     IH ++  RN+LL D   AKI +F LA+ +M +   +
Sbjct: 213 DLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269

Query: 668 VTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           V G     VK    +M+PE     + TV+SDV+S+G+++ EI
Sbjct: 270 VKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 59/265 (22%), Positives = 114/265 (43%), Gaps = 32/265 (12%)

Query: 525 VYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK 581
           +YKG     NK V ++  +   +  +      + E+  +RR    N++++ GF +     
Sbjct: 36  IYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 582 L----LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNIN 637
           L    L+ E+ ++G L  +L   E    ++ ++ +A+D  +G+  L++       + N+ 
Sbjct: 94  LPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 638 PRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL--ITVKSDVY 695
             + L+ ++   KI    L KIL       V  +     Y S +  N      T+K D+Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIY 206

Query: 696 SFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMV 755
           S GVV+ EI   +  FE N++T +       +Y+  I K  S       ++ L     + 
Sbjct: 207 SLGVVLWEIFTGKIPFE-NLTTKE-------IYDLIINKNNS------LKLPLDCPLEIK 252

Query: 756 RVGLLCIQDEPNLRPSMKNVILMLE 780
            +   C   +   RP++K ++  L 
Sbjct: 253 CIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.8 bits (139), Expect = 5e-09
 Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 20/199 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLL 572
           + +G G +G VYK       ++ A+K ++  +E GE     Q E+  ++   H N+V   
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
           G  ++  K  +  EF   GSL+++     +GP+   ++  ++ +  +G+ YLH + +   
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKGK--- 127

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---GTRGYMSPE---WQNS 685
           +H +I   NILL D+   K+++F ++  +    T  +   K   GT  +M+PE    +  
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 686 GLITVKSDVYSFGVVVLEI 704
           G      D+++ G+  +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 6e-09
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G V      +  + VA+K+L  P       +R ++ E+  ++   H+N++ LL 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81

Query: 574 -FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
            F   +S +      LV   M    L N++   +   +  D ++ +   + RG+ Y+H  
Sbjct: 82  VFTPASSLEDFQDVYLVTHLMGA-DLNNIV---KCQKLSDDHIQFLVYQILRGLKYIH-- 135

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----W 682
               IIH ++ P NI +++    KI +F LA+      TG V     TR Y +PE    W
Sbjct: 136 -SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 190

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            +        D++S G ++ E++  ++ F
Sbjct: 191 MH---YNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 15/173 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL----ENPVEEGERKFQA-EMAAVRRTHHKNLV 569
            ++G G +G V+K    E  +IVA+K+     ++PV    +K    E+  +++  H NLV
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIALREIRMLKQLKHPNLV 63

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECE 628
            L+    +  K  LV+E+     L  L  N    P     ++ I     + + + H+   
Sbjct: 64  NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVP--EHLIKKIIWQTLQAVNFCHKH-- 119

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
              IH ++ P NIL+      K+ +F  A+IL        T    TR Y +PE
Sbjct: 120 -NCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 17/212 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK---FQAEMAAVRRTHHKNLVRL 571
           + + +G FG+VY           A+K L+      + +    +AE A +        V  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
           L +  Q+   L LV E+++ G   +L+  +  G +  D  +    +V  G+  LH+    
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR--- 116

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            IIH +I P N+L+D +   K+++F L++  + N+  +     GT  Y++PE        
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGDD 171

Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
             SD +S G V+ E +     F     T D V
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAE--TPDAV 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 31/228 (13%)

Query: 515 EELGRGCFGAVYKGSICEGNKI--VAVKRLE---NPVEEGERKFQAEMAAVRRTHHKNLV 569
           +E+G G FG V    I     +  V VK L+   +  E+ E   Q +    R   H N++
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGD--PYRILQHPNIL 58

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-------VRIALDVARGITY 622
           + LG C++    LLV+E+   G L++ LS  +    W  R        R+A ++A G+T+
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ----WHRRNSQLLLLQRMACEIAAGVTH 114

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSP 680
           +H+      +H ++  RN  L   LT K+ ++ +       +  I T         +++P
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY-KEDYIETEDDKCVPLRWLAP 170

Query: 681 EWQNS---GLITVK----SDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
           E       GLIT +    S+V++ GV + E+    +    ++S  +V+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 50/199 (25%), Positives = 97/199 (48%), Gaps = 20/199 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLL 572
           + +G G +G VYK       ++ AVK ++  +E G+     Q E+  V+   H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
           G  +   K  +  E+   GSL+++     +GP+   ++  +  +  +G+ YLH + +   
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---GTRGYMSPE---WQNS 685
           +H +I   NILL D+   K+++F +A  +    T  +   K   GT  +M+PE    + +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFIGTPYWMAPEVAAVEKN 183

Query: 686 GLITVKSDVYSFGVVVLEI 704
           G      D+++ G+  +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 27/209 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEM------AAVRRTHHKNLVR 570
           LG+G FG V    +   +++ AVK L+  V   +   +  M      A   +  H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLTQ 60

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECE 628
           L   C QT  +L  V E+++ G L  +     SG     R R  A ++  G+ +LHE   
Sbjct: 61  LHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER-- 115

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYMSPEWQ 683
             II+ ++   N+LLD     KI++F + K       GI+ GV      GT  Y++PE  
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKIADFGMCK------EGILGGVTTSTFCGTPDYIAPEIL 168

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           +        D ++ GV++ E++  +S FE
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV----EE-----GERKFQAEMAAVRRTHHKN 567
           +G+G FG VY+    +  +I A+K L        +E     GER        + RT    
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI------LVRTLLDE 54

Query: 568 LVRLLG--FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
              ++G  F  QT   L LV ++MS G L   L         R +  IA ++   + +LH
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH 113

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTGVKGTRGYMSPE-- 681
           +     I++ ++ P NILLD +    + +F L+K  L  N+T       GT  Y++PE  
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVL 168

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
               G  T   D +S GV+V E+ C  S F
Sbjct: 169 LDEKGY-TKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 53/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLE----------NPVEEGERKFQAEMAAVRRT 563
           ++ LG+G FG VY   + +  K VA +RL+          NP E  +   +A++  + + 
Sbjct: 5   QQRLGKGSFGTVY---LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL--LSKL 59

Query: 564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDR--VRIALDVARGI 620
            H  +V+     ++     ++ E+     L+  L  +  +G    +       + +  G+
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            Y+H+    +I+H ++  +NI L ++L  KI +F ++++LM     + T   GT  YMSP
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM-GSCDLATTFTGTPYYMSP 174

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           E         KSD++S G ++ E+ C    FE
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 46/150 (30%), Positives = 82/150 (54%), Gaps = 15/150 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQA--EMAAVRRTHHKNLVR 570
           ++LG G +  VYKG      ++VA+K  RLE+  EEG   F A  E + ++   H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGA-PFTAIREASLLKDLKHANIV- 66

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECE 628
            L   + T K L LV+E++    L+  + +   G +    VR+ L  + RG+ Y H+   
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGG-LSMHNVRLFLFQLLRGLAYCHQR-- 122

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAK 658
            +++H ++ P+N+L+ +    K+++F LA+
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 574 -FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEE 626
            F    S +      LV   M    L N+   V+   +  D V+  +  + RG+ Y+H  
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMG-ADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS- 138

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----W 682
               IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W
Sbjct: 139 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV----ATRWYRAPEIMLNW 192

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            +        D++S G ++ E++  R+ F
Sbjct: 193 MH---YNQTVDIWSVGCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 61/239 (25%), Positives = 107/239 (44%), Gaps = 31/239 (12%)

Query: 507 ERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRR 562
           +R  + F+   ++G G +G VYK    +  ++VA+K  RL+N  E        E+  +R+
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62

Query: 563 THHKNLVRL----------LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI 612
            +H+N+V L          L F        LV+E+M      +L+  +ESG +      I
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHI 118

Query: 613 A------LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
                  L+   G+ Y H++     +H +I   NILL++    K+++F LA++    ++ 
Sbjct: 119 KSFMKQLLE---GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 667 IVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             T    T  Y  PE            DV+S G ++ E+   +  F+ N   A + L+S
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 26/202 (12%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPV--------EEGERKFQAEMAAVRRTHH 565
           LG+G FG V+   K +  +  ++ A+K L+            + ER   AE+      +H
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57

Query: 566 KNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYL 623
             +V+L  +  QT  KL L+ +F+  G L   LS  +      + V+  L ++A  + +L
Sbjct: 58  PFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHL 114

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           H    + II+ ++ P NILLD+    K+++F L+K  + ++    +   GT  YM+PE  
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVV 170

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N    T  +D +SFGV++ E++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLLG 573
           E +G+G +G VYK +  +   + AVK L+ P+ + + + +AE   ++   +H N+V+  G
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 574 FCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVRIA---LDVARGITYLHE 625
              +  K +     LV E  + GS+  L+  +       D   I+        G+ +LH 
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP----- 680
               +IIH ++   NILL      K+ +F ++  L   +    T V GT  +M+P     
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202

Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E Q       + DV+S G+  +E+
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 4/98 (4%)

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
           + +A  + YLHE+    I+H ++  +N+ L  +   K+ +  +A++L  NQ  + + + G
Sbjct: 109 VQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIG 164

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           T  YMSPE  ++     KSDV++ G  V E+   +  F
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 11/194 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR--LLG- 573
           +G+G FG V         K  AVK L+  +    RK Q  + A R    KN+    L+G 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 574 -FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
            +  QT++KL  V +F++ G L   L    S P  R R   A ++A  + YLH    + I
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INI 117

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P NILLD      +++F L K  +  Q+   T   GT  Y++PE          
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 692 SDVYSFGVVVLEIV 705
            D +  G V+ E++
Sbjct: 177 VDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 17/161 (10%)

Query: 513 FEEELGRGCFGAVYK--GSICEGNKIVAVKRLENPVEEGERKFQA---EMAAVRRTHHKN 567
            E  +GRG +G VYK      +  K  A+K+ +   E+     Q+   E+A +R   H+N
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHEN 63

Query: 568 LVRLLGFCMQ-TSKKL-LVYEFMSKGSLE--NLLSNVESGPIWRDRVRIAL-DVARGITY 622
           +V L+   ++   K + L++++      +        +   I    V+  L  +  G+ Y
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY 123

Query: 623 LHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLAKI 659
           LH      ++H ++ P NIL+     +    KI +  LA++
Sbjct: 124 LHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 54.5 bits (132), Expect = 8e-08
 Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 53/218 (24%)

Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENP-------VE--EGERKFQAEMAA 559
           F + LG G FG V    +KGS     K  A+K L          VE    E++       
Sbjct: 5   FIKTLGTGSFGRVMLVRHKGS----GKYYALKILSKAKIVKLKQVEHVLNEKR------I 54

Query: 560 VRRTHHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
           ++   H  LV L G   Q    L LV E++  G L + L         R   R    VAR
Sbjct: 55  LQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL---------RKSGRFPEPVAR 104

Query: 619 --------GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG 670
                    + YLH      I++ ++ P N+LLD     KI++F  AK +      +   
Sbjct: 105 FYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-- 159

Query: 671 VKGTRGYMSPE-WQNSGLITVKS-DVYSFGVVVLEIVC 706
             GT  Y++PE   + G    K+ D ++ G+++ E++ 
Sbjct: 160 --GTPEYLAPEIILSKG--YGKAVDWWALGILIYEMLA 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 52/171 (30%), Positives = 82/171 (47%), Gaps = 13/171 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR--LLG- 573
           +G+G FG V         K  AVK L+      ++K Q  + A R    KN+    L+G 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 574 -FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
            +  QT+ KL  V ++++ G L   L    S P  R R   A ++A  + YLH    + I
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNI 117

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILM-PNQTGIVTGVKGTRGYMSPE 681
           I+ ++ P NILLD      +++F L K  +  ++T   +   GT  Y++PE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 36/213 (16%)

Query: 517 LGRGCFGAV----YKGSICEGNKIVAVKRL--ENPVEEGE--------RKFQAEMAAVRR 562
           LGRG FG V    YK +     ++ A+K L   + +   E        R F+        
Sbjct: 7   LGRGHFGKVLLAEYKKT----GELYAIKALKKGDIIARDEVESLMCEKRIFET----ANS 58

Query: 563 THHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGI 620
             H  LV L   C QT   +  V E+ + G   +L+ ++ +      R    A  V  G+
Sbjct: 59  ERHPFLVNLFA-CFQTEDHVCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGL 114

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YLHE    +I++ ++   N+LLD     KI++F L K  M   ++T       GT  ++
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPEFL 168

Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +PE       T   D +  GV++ E++   S F
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 12/193 (6%)

Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V         + VAVK ++   ++       E+  +R   H+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  ++ EF+  G+L +++S             +   V + + YLH +    +IH +
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTRLNE--EQIATVCESVLQALCYLHSQ---GVIHRD 142

Query: 636 INPRNILLDDSLTAKISNFSL-AKIL--MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F   A+I   +P +  +V    GT  +M+PE  +      + 
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRTPYGTEV 198

Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 199 DIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 515 EELGRGCFGAVYKG---SICEGNKI----VAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
           E LG+G F  ++KG    + +  ++    V +K L+         F    + + +  HK+
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-NVESGPI-WRDRVRIALDVARGITY-LH 624
           LV   G C+   + ++V E++  GSL+  L  N     I W+      L+VA+ + + LH
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALH 114

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR------GYM 678
              +  + H N+  +N+LL      K  N    K+  P   GI   V           ++
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP---GISITVLPKEILLERIPWV 171

Query: 679 SPE-WQNSGLITVKSDVYSFGVVVLEIVC 706
            PE  +N   +++ +D +SFG  + EI  
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 52/198 (26%), Positives = 91/198 (45%), Gaps = 28/198 (14%)

Query: 585 YEFMSKGSLENLLS-NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL 643
           Y+  +   ++NLLS +   G    D +     VARG+ +L  +     +H ++  RN+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLL 270

Query: 644 DDSLTAKISNFSLAKILMPNQTGIVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFG 698
                 KI +F LA+ +M +   +  G     VK    +M+PE     L T  SDV+S+G
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYG 326

Query: 699 VVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK-ELSKLVGEDEEVDLRTLETMVRV 757
           +++ EI      F +  +    +++ +  YN   +   ++K     +EV     + MV+ 
Sbjct: 327 ILLWEI------FSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEV----YDIMVK- 375

Query: 758 GLLCIQDEPNLRPSMKNV 775
              C   EP  RPS  ++
Sbjct: 376 ---CWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +GRG FG V         K+ A+K L     ++  +  F  E   +    +   V  L +
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110

Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW----RDRVRIALDVARGITYLHEECEV 629
             Q  + L +V E+M  G L NL+SN +    W       V +ALD    + ++H +   
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRD--- 167

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNS- 685
                 + P N+LLD S   K+++F     +  N+ G+V   T V GT  Y+SPE   S 
Sbjct: 168 ------VKPDNMLLDKSGHLKLADF--GTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 686 ---GLITVKSDVYSFGVVVLEIVCCRSNF 711
              G    + D +S GV + E++   + F
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRL 571
            ++G+G +G V+     +  +IVA+KR++  +       R    E   +  T  + LV+L
Sbjct: 7   TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
           L +  Q  + L L  E++  G    LL+N   G +  D  R  + ++   +  LHE   +
Sbjct: 67  L-YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE---L 120

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT---GVKGTRGYMSPEWQNSG 686
             IH ++ P N L+D S   K+++F L+K       GIVT    V G+  YM+PE     
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEVLRGK 173

Query: 687 LITVKSDVYSFGVVVLEIVC 706
                 D +S G ++ E +C
Sbjct: 174 GYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 19/152 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT------HHKNL 568
           ++LG G +  VYKG     + +VA+K +    EEG     A   A+R         H N+
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-----APCTAIREVSLLKDLKHANI 66

Query: 569 VRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEE 626
           V L    + T K L LV+E++ K  L+  L +     I    V++ L  + RG+ Y H  
Sbjct: 67  VTLHDI-IHTEKSLTLVFEYLDK-DLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +++H ++ P+N+L+++    K+++F LA+
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 37/207 (17%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEG-ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG G FG V    +   N+  A+K +   + VE G +    +E   +   +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 574 FCMQTSK-KLLVY---EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGIT-------- 621
              +T K K  +Y   E+   G L  +L         RDR       AR           
Sbjct: 59  --YRTFKDKKYIYMLMEYCLGGELWTIL---------RDRGLFDEYTARFYIACVVLAFE 107

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT-GVKGTRGYMSP 680
           YLH      II+ ++ P N+LLD +   K+ +F  AK L   ++G  T    GT  Y++P
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAP 161

Query: 681 E-WQNSGLITVKSDVYSFGVVVLEIVC 706
           E   N G      D +S G+++ E++ 
Sbjct: 162 EIILNKGY-DFSVDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 40/210 (19%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAE----MAAVRRTHHKN--- 567
           +GRG FG V         ++ A+K L     ++  +  F  E    MA      H N   
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA------HANSEW 104

Query: 568 LVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD----RVRIALDVARGITY 622
           +V+L  +  Q  K L +V E+M  G L NL+SN +    W       V +ALD    + +
Sbjct: 105 IVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGF 163

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMS 679
                    IH ++ P N+LLD S   K+++F    + M +  G+V   T V GT  Y+S
Sbjct: 164 ---------IHRDVKPDNMLLDKSGHLKLADFGTC-MKM-DANGMVRCDTAV-GTPDYIS 211

Query: 680 PEWQNS----GLITVKSDVYSFGVVVLEIV 705
           PE   S    G    + D +S GV + E++
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 16/203 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAE--MAAVRRTHHKNLVRL 571
           +GRG FG VY     +  K+ A+K L+     +++GE     E  M ++  T     +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           + +   T  KL  + + M+ G L   LS  + G      +R  A ++  G+ ++H     
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNRF-- 117

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLI 688
            +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE  Q     
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAY 173

Query: 689 TVKSDVYSFGVVVLEIVCCRSNF 711
              +D +S G ++ +++   S F
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 30/215 (13%)

Query: 515 EELGRGCFGAVYKGS-ICEGNKIVAVKRLENPV--------EEGERKFQAEMAAVRRTHH 565
           E LG+G F  +YKG    + +  +     E  V              F    + + +  H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
           K+LV+L G C++  + ++V E++  G L+  L   ++      ++ +A  +A  + YL +
Sbjct: 61  KHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119

Query: 626 ECEVQIIHCNINPRNILL-DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY------- 677
           +   +++H N+  +NIL+    L      F   K+  P   GI   V  +R         
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPF--IKLSDP---GIPITV-LSREERVERIPW 170

Query: 678 MSPEWQNSGL--ITVKSDVYSFGVVVLEIVCCRSN 710
           ++PE   +G   +T+ +D +SFG  +LEI C    
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI-CSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAE--MAAVRRTHHKNLVRL 571
           +GRG FG VY     +  K+ A+K L+     +++GE     E  M ++  T     +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           + +   T  KL  + + M+ G L   LS  + G      +R  A ++  G+ ++H     
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNRF-- 117

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G+  
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 173

Query: 690 VKS-DVYSFGVVVLEIVCCRSNFE 712
             S D +S G ++ +++   S F 
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFR 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 25/183 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           LG G  G V+     + +K VAVK++     +  +    E+  +RR  H N+V++     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 577 QTSKKL--------------LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
            +   L              +V E+M    L N+L   E GP+  +  R+    + RG+ 
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL---EQGPLSEEHARLFMYQLLRGLK 128

Query: 622 YLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPN--QTGIVTGVKGTRGYM 678
           Y+H      ++H ++ P N+ ++ + L  KI +F LA+I+ P+    G ++    T+ Y 
Sbjct: 129 YIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 679 SPE 681
           SP 
Sbjct: 186 SPR 188

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 30/210 (14%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V         + VA+K+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 574 -FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
            F    S        LV  +M        L  +   P+  D+V+ +   +  G+ Y+H  
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCGLKYIHS- 135

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----W 682
               IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W
Sbjct: 136 --AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILNW 189

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            +        D++S G ++ E++  ++ F+
Sbjct: 190 MH---YNQTVDIWSVGCIMAEMLTGKTLFK 216

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 27/208 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLLG 573
           E +G+G +G V+K    +     AVK L+ P+ + + + +AE   ++  + H N+V+  G
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 574 FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWR-DRVR------IALDVARGIT 621
              +   K      LV E  + GS+ +L+     G + R +R+       I  +   G+ 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP- 680
           +LH     + IH ++   NILL      K+ +F ++  L   +    T V GT  +M+P 
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194

Query: 681 ----EWQNSGLITVKSDVYSFGVVVLEI 704
               E Q       + DV+S G+  +E+
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 15/202 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR----RTHHKNLVRLL 572
           LG+G FG V    +   N+  A+K L+  V   +   +  M   R       H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL- 61

Query: 573 GFC-MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
            FC  QT + L  V E+++ G L  +     SG     R R  A ++  G+ +LH++   
Sbjct: 62  -FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKK--- 115

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++   N+LLD     KI++F + K  M N  G  +   GT  Y++PE        
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEILKGQKYN 174

Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D +SFGV++ E++  +S F
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 25/209 (11%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G V   +       VA+K++  P E     +R  + E+  +RR  H+N++ +L 
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLR-EIKILRRFKHENIIGILD 70

Query: 574 FCMQTSKKL-------LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHE 625
             +             +V E M      +L   +++  +  D ++  L  + RG+ Y+H 
Sbjct: 71  --IIRPPSFESFNDVYIVQELMET----DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHS 124

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN--QTGIVTGVKGTRGYMSPEWQ 683
                ++H ++ P N+LL+ +   KI +F LA+I  P    TG +T    TR Y +PE  
Sbjct: 125 ---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181

Query: 684 -NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            NS   T   D++S G ++ E++  R  F
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 26/209 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +GRG FG V         K+ A+K L     ++  +  F  E   +    +   V  L  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110

Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD----RVRIALDVARGITYLHEECEV 629
             Q  K L +V E+M  G L NL+SN +    W       V +ALD       +H    +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IH---SM 161

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNS- 685
            +IH ++ P N+LLD     K+++F     +  ++TG+V   T V GT  Y+SPE   S 
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADF--GTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 686 ---GLITVKSDVYSFGVVVLEIVCCRSNF 711
              G    + D +S GV + E++   + F
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 4/98 (4%)

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  +  VARG+ +L      + IH ++  RNILL ++   KI +F LA+ +  +   +
Sbjct: 174 DLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230

Query: 668 VTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             G  +    +M+PE     + T +SDV+SFGV++ EI
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVRL 571
           +++G G +G V           VA+K+L  P +     +R ++ E+  ++   H+N++ L
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGL 79

Query: 572 LG-FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLH 624
           L  F    S        LV  FM    L  L+ + +      DR++ +   + +G+ Y+H
Sbjct: 80  LDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLS---EDRIQFLVYQMLKGLKYIH 135

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--- 681
                 IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE   
Sbjct: 136 A---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRAPEVIL 188

Query: 682 -WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
            W +    T   D++S G ++ E++  +  F+ +
Sbjct: 189 NWMH---YTQTVDIWSVGCIMAEMLTGKPLFKGH 219

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 8e-07
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 11/148 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLG 573
           E+LG G +  V+KG       +VA+K +    EEG       E++ ++   H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWR-DRVRIAL-DVARGITYLHEECEVQ 630
             + T K L LV+E++ K  L+  +   + G I     V+I L  + RG+ Y H     +
Sbjct: 72  I-VHTDKSLTLVFEYLDK-DLKQYMD--DCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAK 658
           ++H ++ P+N+L+++    K+++F LA+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 27/202 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--GERKFQAEMAAVRRTHHKNLVRLLG- 573
           +G G +G+V         + VAVK+L  P +     R+   E+  ++   H+N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 574 FCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
           F   TS     +  LV   M    L N+   V+   +  + V+  +  + RG+ Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLMG-ADLNNI---VKCQKLSDEHVQFLIYQLLRGLKYIHS-- 136

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    +I +F LA+      TG V     TR Y +PE    W 
Sbjct: 137 -AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV----ATRWYRAPEIMLNWM 191

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           +    TV  D++S G ++ E++
Sbjct: 192 HYNQ-TV--DIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 12/156 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
           E+LG G +  VYKG      ++VA+K +    EEG   F A  E + ++   H N+V LL
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV-LL 68

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
              + T + L  V+E+M     + ++ +   G +    VR+ +  + RG+ Y+H +    
Sbjct: 69  HDIIHTKETLTFVFEYMHTDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---H 123

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKI-LMPNQT 665
           I+H ++ P+N+L+      K+++F LA+   +P+QT
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 12/208 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF---QAEMAAVRRTHHKNLVRLLG 573
           +GRG +  V    + +  +I A+K ++  +   +      Q E     +  +   +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 574 FCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
            C QT  +L  V E+++ G L   +      P    R   A +++  + YLHE     II
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHER---GII 118

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           + ++   N+LLD     K++++ + K  L P  T   +   GT  Y++PE          
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFS 176

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            D ++ GV++ E++  RS F++ V ++D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDI-VGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 4/98 (4%)

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  +  VARG+ +L      + IH ++  RNILL ++   KI +F LA+ +  +   +
Sbjct: 175 DLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231

Query: 668 VTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             G  +    +M+PE     + T +SDV+SFGV++ EI
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 17/170 (10%)

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  +  VA+G+ +L      + IH ++  RNILL ++   KI +F LA+ +  +   +
Sbjct: 180 DLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236

Query: 668 VTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW 726
             G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V +   
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEE 290

Query: 727 VYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
              C   KE +++   D      T   M +  L C   EP+ RP+   ++
Sbjct: 291 F--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELV 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

 Score = 46.3 bits (110), Expect = 2e-06
 Identities = 18/81 (22%), Positives = 35/81 (43%), Gaps = 6/81 (7%)

Query: 342 CKRKMPA-EFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYANAS--CSK 398
           C        F K+  +++      A A  +++ ++C ++CL++C C A  Y N S  C  
Sbjct: 5   CGGDGSTDGFLKLPDVKLP---DNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLL 61

Query: 399 HKLPLIFAMKYQNVPATLFIK 419
               L       +   TL+++
Sbjct: 62  WNGLLNNLRSLSSGGGTLYLR 82

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.9 bits (116), Expect = 5e-06
 Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 5/145 (3%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLG 573
           ++LG G +  V+KG       +VA+K +    EEG       E++ ++   H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
                    LV+E++    L+  L N  +     +       + RG++Y H+    +I+H
Sbjct: 71  IIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILH 126

Query: 634 CNINPRNILLDDSLTAKISNFSLAK 658
            ++ P+N+L+++    K+++F LA+
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV----EEGERKFQAEMAAVRRTHHKNLVRLL 572
           LG+G FG V         K  A+K L+  V    +E       E   ++ T H  L  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTAL- 60

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
            +  QT  +L  V E+ + G L   LS         DR R    ++   + YLH      
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC---D 115

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYMSPEWQNS 685
           +++ ++   N++LD     KI++F L K       GI  G       GT  Y++PE    
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPEVLED 169

Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNF 711
                  D +  GVV+ E++C R  F
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 5/117 (4%)

Query: 600 VESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           V   P+  D V++ L  + RG+ YLH      I+H +I P N+L++ +   KI +F LA+
Sbjct: 95  VSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151

Query: 659 ILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
           +  P+++  +T    T+ Y +PE    S   T   D++S G +  E++  R  F+  
Sbjct: 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 49/208 (23%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 515 EELGRGCFG-AVYKGSICEGN----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           +++G G FG A+   S  +G     K + + ++     E  RK   E+A +    H N+V
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPNIV 62

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-----VRIALDVARGITYLH 624
           +      +     +V ++   G L   ++         D+     V+I L     + ++H
Sbjct: 63  QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL----ALKHVH 118

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
           +    +I+H +I  +NI L    T K+ +F +A++L  +   +     GT  Y+SPE   
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICE 174

Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           +     KSD+++ G V+ E+   +  FE
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 33/214 (15%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH------KNLVR 570
           +GRG FG V    +   +K+ A+K L N  E  +R   AE A  R             + 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKR---AETACFREERDVLVNGDNQWIT 64

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC-- 627
            L +  Q    L LV ++   G L  LLS  E         R+  D+AR   YL E    
Sbjct: 65  TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--------RLPEDMAR--FYLAEMVIA 114

Query: 628 -----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
                ++  +H +I P NIL+D +   ++++F     LM + T   +   GT  Y+SPE 
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174

Query: 683 -----QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                   G    + D +S GV + E++   + F
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.5 bits (115), Expect = 8e-06
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 12/200 (6%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNLVRLLG 573
           LG+G FG V         K  A+K L+  V   + +      E   ++ T H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  QT  +L  V E+++ G L   LS         DR R    ++   + YLH     +I
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSALDYLHSG---KI 116

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++   N++LD     KI++F L K  + +   + T   GT  Y++PE          
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175

Query: 692 SDVYSFGVVVLEIVCCRSNF 711
            D +  GVV+ E++C R  F
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 19/178 (10%)

Query: 537 VAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-FCMQTSKK-----LLVYEFM 588
           VAVK+L  P +      +A  E+  ++  +HKN++ LL  F  Q S +      LV E M
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 589 SKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHCNINPRNILLDDSL 647
                   L  V    +  +R+   L  +  GI +LH      IIH ++ P NI++    
Sbjct: 109 DAN-----LCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 160

Query: 648 TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           T KI +F LA+    N   ++T    TR Y +PE           D++S G ++ E+V
Sbjct: 161 TLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 11/209 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF---QAEMAAVRRTHHKNLVRLLG 573
           +GRG +  V    + + ++I A+K ++  +   +      Q E     +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
            C QT+ +L LV E+++ G L   +      P    R   A ++   + +LHE     II
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER---GII 118

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           + ++   N+LLD     K++++ + K  L P  T   +   GT  Y++PE          
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFS 176

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADV 720
            D ++ GV++ E++  RS F++     D+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIITDNPDM 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 13/201 (6%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----HHKNLVRLL 572
           LG+G FG V+   +   N+  A+K L+  V   +   +  M   R       H  L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 573 GFC-MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
            +C  QT + L  V E+++ G L   + +     + R     A ++  G+ +LH +    
Sbjct: 62  -YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-YAAEIICGLQFLHSK---G 116

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           I++ ++   NILLD     KI++F + K  M       T   GT  Y++PE         
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYNT 175

Query: 691 KSDVYSFGVVVLEIVCCRSNF 711
             D +SFGV++ E++  +S F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 12/102 (11%)

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  +  VA+G+++L  +     IH ++  RNILL      KI +F LA+ +  +   +
Sbjct: 215 DLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271

Query: 668 VTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           V G     VK    +M+PE   + + T +SDV+S+G+++ EI
Sbjct: 272 VKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.1 bits (115), Expect = 1e-05
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 18/198 (9%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +GRG +G V      E N+ VA+K++ N  +   + +R  + E+  +R   H+N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71

Query: 574 FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                 ++      +VYE M    L  ++ +  S  +  D  +  L  + RG+ Y+H   
Sbjct: 72  IMPPPHREAFNDVYIVYELMDT-DLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHS-- 126

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSG 686
              ++H ++ P N+LL+ +   KI +F LA+         +T    TR Y +PE   N  
Sbjct: 127 -ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCS 184

Query: 687 LITVKSDVYSFGVVVLEI 704
             T   DV+S G +  E+
Sbjct: 185 EYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 40/175 (22%), Positives = 74/175 (42%), Gaps = 27/175 (15%)

Query: 556 EMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS-------KGSLENLLSNVESGPI-WR 607
           E   ++  +H +++R+        K  LV   ++          L   L+   S P+   
Sbjct: 107 EAMLLQNVNHPSVIRM--------KDTLVSGAITCMVLPHYSSDLYTYLTK-RSRPLPID 157

Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK--ILMPNQT 665
             + I   +  G+ YLH +   +IIH ++   NI ++D     I +   A+  ++ P   
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF- 213

Query: 666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSN-FEVNVSTAD 719
               G+ GT    +PE         K+D++S G+V+ E++   S  FE   ST +
Sbjct: 214 ---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265

Length = 357

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 14/195 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ-AEMAAVRR-THHKNLVRLLGF 574
           +G G F  V K    +  K  A+K ++   +  E+     E+ A+RR + H N++RL+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 575 CM-QTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
              + + +L LV+E M   +L  L+      P+   RV+  +  + + + ++H      I
Sbjct: 67  LFDRKTGRLALVFELMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN---GI 121

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
            H +I P NIL+ D    K+++F   + +        T    TR Y +PE     G    
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTRWYRAPECLLTDGYYGP 178

Query: 691 KSDVYSFGVVVLEIV 705
           K D+++ G V  EI+
Sbjct: 179 KMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 40/180 (22%), Positives = 83/180 (46%), Gaps = 20/180 (11%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVR 570
            E +G G +G V         K VA+K++ +  +     +R  + E+  +R   H N++ 
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIA 68

Query: 571 LLGFCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLH 624
           +    ++          +V + M +  L +++ +    P+  + +R  L  + RG+ Y+H
Sbjct: 69  IRDI-LRPPGADFKDVYVVMDLM-ESDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT---GIVTGVKGTRGYMSPE 681
                 +IH ++ P N+L+++    +I +F +A+ L  + T     +T    TR Y +PE
Sbjct: 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 28/208 (13%)

Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG+G FG V           Y   I     I+A   + + V E           ++ T H
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR--------VLQNTRH 54

Query: 566 KNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYL 623
             L  L  +  QT  +L  V E+ + G L   LS         +R R    ++   + YL
Sbjct: 55  PFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYL 111

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           H      +++ +I   N++LD     KI++F L K  + +   + T   GT  Y++PE  
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 167

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                    D +  GVV+ E++C R  F
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 17/197 (8%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN-----LVRL 571
           +G+G FG V            AVK L+      ++K Q  + A R    KN     LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD-RVRI-ALDVARGITYLHEECE 628
             +  QT++KL  V ++++ G L     +++    + + R R  A +VA  I YLH    
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS--- 114

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           + II+ ++ P NILLD      +++F L K  +  +    +   GT  Y++PE       
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPY 173

Query: 689 TVKSDVYSFGVVVLEIV 705
               D +  G V+ E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 46.2 bits (110), Expect = 4e-05
 Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 49/194 (25%)

Query: 537 VAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG-FCMQTSKK-----LLVYEF 587
           VA+K+L  P   V   +R ++ E+  ++  +HKN++ LL  F  Q S +      LV E 
Sbjct: 44  VAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL 102

Query: 588 MSKGSLENLLSNVESGPIWRDRVRIALDVAR----------GITYLHEECEVQIIHCNIN 637
           M        L  V         +++ LD  R          GI +LH      IIH ++ 
Sbjct: 103 MDAN-----LCQV---------IQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLK 145

Query: 638 PRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI-----TVKS 692
           P NI++    T KI +F LA+      + ++T    TR Y +PE     +I         
Sbjct: 146 PSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE-----VILGMGYKENV 198

Query: 693 DVYSFGVVVLEIVC 706
           D++S G ++ E++ 
Sbjct: 199 DIWSVGCIMGEMIR 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 4/100 (4%)

Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
           + D V  +  VA G+ +L  +     +H ++  RN+L+ +    KI +F LA+ +M +  
Sbjct: 238 YMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN 294

Query: 666 GIVTGVKG-TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
            I  G       +M+PE   + L T  SDV+SFG+++ EI
Sbjct: 295 YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 53/213 (24%), Positives = 102/213 (47%), Gaps = 34/213 (15%)

Query: 515 EELGRGCFGAVYKGSI-----------CEGNKI-VAVKRLENPVEEGERKFQAEMAAVRR 562
           E LGRG    +Y G +               +I V +K L+    +    F    + +R+
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---SNVESGPIWRDRVRIALDVARG 619
             HK++V L G C++  + ++V EF+  G L+  +   S+V + P W  + ++A  +A  
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP-W--KFKVAKQLASA 117

Query: 620 ITYLHEECEVQIIHCNINPRNILL-DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG-- 676
           ++YL ++    ++H N+  +NILL  + +  +   F   K+  P   GI   V   +   
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDP---GIPITVLSRQECV 169

Query: 677 ----YMSPEW-QNSGLITVKSDVYSFGVVVLEI 704
               +++PE  ++S  +++ +D +SFG  + EI
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 48/193 (24%), Positives = 88/193 (45%), Gaps = 14/193 (7%)

Query: 523 GAVYKGSICEG-----NKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
           G+  +G +C        + VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 33  GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      IIH
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIH 149

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           D
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207

Query: 694 VYSFGVVVLEIVC 706
           ++S G ++ E++ 
Sbjct: 208 IWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 53/197 (26%), Positives = 89/197 (45%), Gaps = 24/197 (12%)

Query: 523 GAVYKGSICEG-----NKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
           G+  +G +C       ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 26  GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85

Query: 575 CMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECE 628
             Q S +      LV E M        L  V    +  +R+   L  +  GI +LH    
Sbjct: 86  TPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHS--- 137

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             IIH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE       
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 689 TVKSDVYSFGVVVLEIV 705
               D++S G ++ E+V
Sbjct: 196 KENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.8 bits (108), Expect = 6e-05
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 15/196 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEM-AAVRRTHHKNLVRLL 572
           +G+G FG V         K  AVK L+      ++ E+   +E    ++   H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
            F  QT+ KL  V ++++ G L   L           R R  A ++A  + YLH    + 
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHS---LN 116

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           I++ ++ P NILLD      +++F L K  +  N  G  +   GT  Y++PE  +     
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 690 VKSDVYSFGVVVLEIV 705
              D +  G V+ E++
Sbjct: 175 RTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 58/239 (24%), Positives = 110/239 (46%), Gaps = 23/239 (9%)

Query: 510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN-- 567
              F   LG+G FG V        +++ A+K L+  V   +   +  M   R    ++  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 568 -LVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD--RVRIALDVARGITYL 623
             +  L  C QT  +L  V E+++ G   +L+ +++    +++   V  A +++ G+ +L
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGG---DLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV-KGTRGYMSPE- 681
           H      II+ ++   N++LD     KI++F + K  M +  G+ T    GT  Y++PE 
Sbjct: 118 HRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEI 172

Query: 682 --WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
             +Q  G      D +++GV++ E++  +  F+      D +  S   +N    K LSK
Sbjct: 173 IAYQPYGK---SVDWWAYGVLLYEMLAGQPPFD--GEDEDELFQSIMEHNVSYPKSLSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 37/213 (17%)

Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG+G FG V           Y   I +   IVA   + + + E           ++ + H
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR--------VLQNSRH 54

Query: 566 KNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYL 623
             L  L  +  QT  +L  V E+ + G L   LS         DR R    ++   + YL
Sbjct: 55  PFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYL 111

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYM 678
           H E  V  ++ ++   N++LD     KI++F L K       GI  G       GT  Y+
Sbjct: 112 HSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEYL 163

Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +PE           D +  GVV+ E++C R  F
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 40/152 (26%), Positives = 71/152 (46%), Gaps = 14/152 (9%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G FG V+K    +  +IVA+K+  +EN  E        E+  ++   H+N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 575 CMQTSKK--------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           C   +           LV+EF     L  LLSN        +  ++   +  G+ Y+H  
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +I+H ++   NIL+      K+++F LA+
Sbjct: 139 ---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 34/164 (20%), Positives = 67/164 (40%), Gaps = 35/164 (21%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--------------EMAAVRR 562
           LG G +G V K       KIVA+K+++      +                   E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR--------IAL 614
             H+N++ L+   ++     LV + M+   L+ ++           ++R        I L
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR---------KIRLTESQVKCILL 126

Query: 615 DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
            +  G+  LH+      +H +++P NI ++     KI++F LA+
Sbjct: 127 QILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 44.6 bits (105), Expect = 8e-05
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 6/97 (6%)

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
           G+ ++HE+   +++H +I  +NI L  +   K+ +F  A++L        T V GT  Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167

Query: 679 SPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
            PE W+N      KSD++S G ++ E+   +  F+ N
Sbjct: 168 PPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 27/156 (17%)

Query: 519 RGCFGAVYKGSICEGNKIVAVKRL-------ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           RG FG VY G     +K+ AVK +       +N V +     QAE  A+  +    +V L
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ----VQAERDALALSKSPFIVHL 69

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLS-----NVESGPIWRDRVRIALDVARGITYLHE 625
             + +Q++  + LV E++  G +++LL      + E    +   V +ALD      YLH 
Sbjct: 70  Y-YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHR 122

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM 661
                IIH ++ P N+L+ +    K+++F L+K+ +
Sbjct: 123 H---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 47/203 (23%), Positives = 103/203 (50%), Gaps = 25/203 (12%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF- 574
           +G G FG VY+    + ++ VA+K+ L++P  +       E+  ++  +H N++ L  + 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128

Query: 575 ---CMQTSKKLL----VYEFMSK---GSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
              C + ++K +    V EF+ +     +++   N  + P++  ++  +  + R + Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYIH 187

Query: 625 EECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            +    I H ++ P+N+L+D ++ T K+ +F  AK L+  Q  +      +R Y +PE  
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV--SYICSRFYRAPELM 242

Query: 684 -NSGLITVKSDVYSFGVVVLEIV 705
             +   T   D++S G ++ E++
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 35/103 (33%), Positives = 45/103 (43%), Gaps = 12/103 (11%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERKFQAEMAA 559
           E  R      + LGRG FG V + S     K      VAVK L+      E K  A M  
Sbjct: 3   EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYK--ALMTE 60

Query: 560 VRRT----HHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLL 597
           ++      HH N+V LLG C +    L+V  E+   G+L N L
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 61/233 (26%), Positives = 111/233 (47%), Gaps = 25/233 (10%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LG+G FG V        +++ A+K L+  V   +   +  M   R    +     +  L 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD--RVRIALDVARGITYLHEECEVQ 630
            C QT  +L  V E+++ G   +L+  ++    +++   V  A ++A G+ +LH +    
Sbjct: 68  SCFQTMDRLYFVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---G 121

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV-KGTRGYMSPE---WQNSG 686
           II+ ++   N++LD     KI++F + K  M +  G+ T    GT  Y++PE   +Q  G
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 687 LITVKS-DVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
               KS D ++FGV++ E++  ++ FE      D +  S   +N    K +SK
Sbjct: 180 ----KSVDWWAFGVLLYEMLAGQAPFE--GEDEDELFQSIMEHNVAYPKSMSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 54/175 (30%), Positives = 82/175 (46%), Gaps = 18/175 (10%)

Query: 517 LGRGCFGAVYKGSICEG---NKIVAVKRLENPVEEGERKFQAEMAAVRR----THHKNLV 569
           LG+G +G V++     G    KI A+K L+       +K  A   A R       H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
            L+ +  QT  KL L+ E++S G L   L     G    D     L +++  + +LH++ 
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ- 119

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV-KGTRGYMSPE 681
              II+ ++ P NILLD     K+++F L K  +    G VT    GT  YM+PE
Sbjct: 120 --GIIYRDLKPENILLDAQGHVKLTDFGLCKESI--HEGTVTHTFCGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 16/209 (7%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENP--VEEGE--RKFQAEMAAVRRTHHKNLV 569
           LG G +G V+   K S  +  K+ A+K L+    V++ +     + E   +        +
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
             L +  QT  KL L+ ++++ G L   LS  E        V+I   ++   + +LH+  
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHK-- 123

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
            + II+ +I   NILLD +    +++F L+K    ++        GT  YM+P+    G 
Sbjct: 124 -LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182

Query: 688 ITVKS--DVYSFGVVVLEIVCCRSNFEVN 714
                  D +S GV++ E++   S F V+
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVD 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.5 bits (103), Expect = 3e-04
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 7/91 (7%)

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIVTGVKGT 674
            G+ Y+H      ++H ++ P N+L++     KI +F LA+    N     G +T    T
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 675 RGYMSPEWQNSGLITVKS-DVYSFGVVVLEI 704
           R Y +PE   S     K+ DV+S G ++ E+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 49/210 (23%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPV----EEGERKFQAEMAAVRRTHHKNLV 569
           LG G +G V+   K +  +  K+ A+K L+        +     + E   +        +
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
             L +  QT  KL L+ +++S G +   L   ++     D VR    ++   + +LH+  
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHK-- 123

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
            + I++ +I   NILLD      +++F L+K  +  +        GT  YM+PE     +
Sbjct: 124 -LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-----I 177

Query: 688 ITVKS------DVYSFGVVVLEIVCCRSNF 711
           I  K       D +S G+++ E++   S F
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family

 Score = 40.3 bits (95), Expect = 3e-04
 Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 7/81 (8%)

Query: 241 SSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQCLVKGFCGFNS 300
             Y+ + +N ++  R TL  +G L  +   +  +S       W   ++QC V G CG   
Sbjct: 34  VYYTYRMTNNSIYSRLTLSSEGSLERF--TWIPNSQDWNLF-WSAPKDQCDVYGRCGPYG 90

Query: 301 FCSNPTNSSTKGECFCFRGFN 321
           +C    + +T  +C C +GF 
Sbjct: 91  YC----DVNTSPKCNCIKGFV 107

In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 13/201 (6%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LG+G FG V    +    +  AVK L+  V   +   +  M   R          +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 574 FCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
              QT + L  V EF++ G L   + +     ++R     A ++  G+ +LH +    II
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSK---GII 118

Query: 633 HCNINPRNILLDDSLTAKISNFSLAK--ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           + ++   N++LD     KI++F + K  +   N+    +   GT  Y++PE       T 
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQGLKYTF 175

Query: 691 KSDVYSFGVVVLEIVCCRSNF 711
             D +SFGV++ E++  +S F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 33/214 (15%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK------NLVR 570
           +GRG FG V    +    +I A+K L N  E  +R   AE A  R   +         + 
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKIL-NKWEMLKR---AETACFREERNVLVNGDCQWIT 64

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR-----GITYLH 624
            L +  Q    L LV ++   G L  LLS  E         R+  D+AR      +  +H
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIH 116

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGTRGYMSPEW 682
              ++  +H +I P N+LLD +   ++++F     L  NQ G V      GT  Y+SPE 
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADF--GSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 683 QNS-----GLITVKSDVYSFGVVVLEIVCCRSNF 711
             +     G    + D +S GV + E++   + F
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 10/193 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQ-AEMAAVRRTHHKNLVRLLG 573
           +G+G FG V +    +  +I A+K +     V   E     AE   + + +   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q+ +KL LV  F++ G L + L       + R R   A ++   +  LH+     +I
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALENLHK---FNVI 115

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           + ++ P NILLD      + +F L K+ M +     T   GT  Y++PE       T   
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAV 174

Query: 693 DVYSFGVVVLEIV 705
           D ++ GV++ E++
Sbjct: 175 DWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 75/314 (23%), Positives = 114/314 (36%), Gaps = 65/314 (20%)

Query: 516 ELGRGC--FGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           E+GRG     +VY         +V V+   LEN  EE  +  Q E+       H N++  
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQ 630
                  S   ++  FM+ GS  +LL       +    +  I     RG+ YLH+     
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---G 121

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL--- 687
            IH NI   +IL+       +S  S    L+ N      G K    Y  P++  S L   
Sbjct: 122 YIHRNIKASHILISGDGLVSLSGLSHLYSLVRN------GQKAKVVYDFPQFSTSVLPWL 175

Query: 688 -----------ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL--------STWVY 728
                        VKSD+YS G+   E+   R  F+  + T   +LL        S    
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDI 233

Query: 729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGL--------------------------LCI 762
             F  +E S++      VD    E++V  G+                          LC+
Sbjct: 234 TTFPCEE-SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL 292

Query: 763 QDEPNLRPSMKNVI 776
           Q +P  RPS  +++
Sbjct: 293 QQDPEKRPSASSLL 306

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.1 bits (99), Expect = 8e-04
 Identities = 34/102 (33%), Positives = 47/102 (46%), Gaps = 11/102 (10%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC----EGNKI-VAVKRLENPVEEGERKFQAEMAA 559
           E  R    F + LG G FG V + +      E N + VAVK L+      ER  +A M+ 
Sbjct: 34  EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER--EALMSE 91

Query: 560 VR----RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL 597
           ++       HKN+V LLG C      L++ E+   G L N L
Sbjct: 92  LKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 9e-04
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 53/227 (23%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA----EMAAVRR-----THHKN 567
           +GRG FG V+     +  ++ A+K L        RK       ++A VR          +
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVL--------RKSDMIKRNQIAHVRAERDILADADS 60

Query: 568 --LVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
             +V+L  +  Q  + L LV E+M  G L NLL   +  P    R  IA  V   +  +H
Sbjct: 61  PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL-ALDSVH 118

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-----------------ILMPNQTGI 667
           +   +  IH +I P NIL+D     K+++F L K                 +L  +   +
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 668 VTGVK-----------GTRGYMSPEWQNSGLITVKSDVYSFGVVVLE 703
                           GT  Y++PE        ++ D +S GV++ E
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 9e-04
 Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 30/180 (16%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH------KNLVR 570
           +GRG FG V    +    ++ A+K L N  E  +R   AE A  R          +  + 
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKIL-NKWEMLKR---AETACFREERDVLVNGDRRWIT 64

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GIT 621
            L +  Q    L LV ++   G L  LLS  E         R+  D+AR         I 
Sbjct: 65  NLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAID 116

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
            +H+   +  +H +I P N+LLD +   ++++F     L+ + T       GT  Y+SPE
Sbjct: 117 SVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 20/124 (16%)

Query: 574 FC-MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           FC  +T + L +V E++  G    LL N+ + P+   R+  A  V   + YLH      I
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHN---YGI 122

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTG-------------VKGTRGY 677
           +H ++ P N+L+      K+++F L+KI LM   T +  G             V GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 678 MSPE 681
           ++PE
Sbjct: 183 IAPE 186

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 15/205 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR----RTHHKNLVRLL 572
           LG+G FG V    +   +++ A+K L+  V   +      M   R       H  L  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 573 GFCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
             C QT  +L  V E+++ G L  +     S      R R  A +V   + +LH      
Sbjct: 63  C-CFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---G 116

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKI-LMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +I+ ++   NILLD     K+++F + K  ++   T   T   GT  Y++PE        
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELEYG 174

Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
              D ++ GV++ E++  +  FE +
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEAD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVR 570
           +E +G+G +G V         + VA+K++ +  E   +  R  + E+  +R   H ++V 
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63

Query: 571 LLGFCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLH 624
           +    +  S++      +V+E M     + + +N +  P   +  +  L  + R + Y+H
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP---EHHQFFLYQLLRALKYIH 120

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPEW 682
                 + H ++ P+NIL +     KI +F LA++   +    +  T    TR Y +PE 
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 683 QNS--GLITVKSDVYSFGVVVLEIVCCRSNF 711
             S     T   D++S G +  E++  +  F
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.1 bits (97), Expect = 0.002
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 36/157 (22%)

Query: 520 GCFGAVYKGSICEGNKIVAVKRLEN-PVEEG-----ERKFQAEMAAVRRTHHKNLVRL-- 571
           G +G VY+    +  +IVA+K+L+    +EG      R+    +       H N+V +  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL----QHPNIVTVKE 71

Query: 572 --LGFCMQTSKKLLVYEFMS---KGSLEN-----LLSNVESGPIWRDRVRIALDVARGIT 621
             +G  +   K  +V E++    K  +E      L S V+          + L +  G+ 
Sbjct: 72  VVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKC---------LMLQLLSGVA 120

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +LH+     I+H ++   N+LL++    KI +F LA+
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 39/208 (18%)

Query: 515 EELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQ-----AEMAAVRRTHH 565
           E LG G FG V    +KG+     +  A+K L+    E  +  Q      E + +    H
Sbjct: 24  ETLGTGSFGRVRIAKHKGT----GEYYAIKCLKK--REILKMKQVQHVAQEKSILMELSH 77

Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR------- 618
             +V ++      ++   + EF+  G L   L         R   R   DVA+       
Sbjct: 78  PFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---------RKAGRFPNDVAKFYHAELV 128

Query: 619 -GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
               YLH +    II+ ++ P N+LLD+    K+++F  AK  +P++T  +    GT  Y
Sbjct: 129 LAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC---GTPEY 181

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           ++PE   S       D ++ GV++ E +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 8/176 (4%)

Query: 540 KRLENPV-EEGERKFQAEMAAV-RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL 597
           K  E+ V + G+R   A  A + R  +H ++++L G         L+     K  L   L
Sbjct: 115 KTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYL 173

Query: 598 SNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
           +   +  I  D + I   V R I YLHE    +IIH +I   NI ++      + +F  A
Sbjct: 174 AAKRNIAIC-DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229

Query: 658 KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR-SNFE 712
              +        G  GT    +PE           D++S G+V+ E+  C  S FE
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285

Length = 391

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 30/206 (14%)

Query: 513 FEEELGRGCFGAVYKGSICEGN-KIVAVKRLENPVEEGERKFQ---AEMAAVRRTHHKNL 568
           F   LG G FG V   +    +   VA+KR E      +++     +E   +   +H   
Sbjct: 34  FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDV----ARGITYLH 624
           V L G     S   LV EF+  G     L         R   R   DV    A  I  + 
Sbjct: 94  VNLYGSFKDESYLYLVLEFVIGGEFFTFL---------RRNKRFPNDVGCFYAAQIVLIF 144

Query: 625 EECE-VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
           E  + + I++ ++ P N+LLD     K+++F  AK++    T   T + GT  Y++PE  
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEI- 199

Query: 684 NSGLITV----KSDVYSFGVVVLEIV 705
              L+ V     +D ++ G+ + EI+
Sbjct: 200 ---LLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 37/118 (31%), Positives = 52/118 (44%), Gaps = 16/118 (13%)

Query: 517 LGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMAA-VRRTHHKNLV 569
           LG G FG V + S    +K      VAVK L+      E K   +E+   +   +H N+V
Sbjct: 15  LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74

Query: 570 RLLGFCMQTSKKLLV-YEFMSKGSLENLLSN--------VESGPIWRDRVRIALDVAR 618
            LLG C + +  L+V  EF   G+L N L           E  P  R R R  ++ +R
Sbjct: 75  NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.004
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 19/196 (9%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G FG V+           A+K +  P     + E+    E   ++   H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 574 FCMQTSKKLL--VYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
           F  +  ++ L  + E++  G L + L N  SG          A ++   + YLH +   +
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---E 121

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLIT 689
           I++ ++ P NILLD     K+++F  AK L      +     GT  Y++PE  Q+ G   
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGHNK 177

Query: 690 VKSDVYSFGVVVLEIV 705
              D ++ G+++ E++
Sbjct: 178 A-VDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	811
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
PF00954	110	S_locus_glycop: S-locus glycoprotein family; Inter	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
PF08276	66	PAN_2: PAN-like domain; InterPro: IPR013227 PAN do	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.22
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.21
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
cd00129	80	PAN_APPLE PAN/APPLE-like domain; present in N-term	99.1
cd01098	84	PAN_AP_plant Plant PAN/APPLE-like domain; present	99.04
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.02
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.94
KOG3087	229	consensus Serine/threonine protein kinase [General	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.7
COG4248	637	Uncharacterized protein with protein kinase and he	98.67
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.65
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.51
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
PRK09902	216	hypothetical protein; Provisional	98.48
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.42
smart00108	114	B_lectin Bulb-type mannose-specific lectin.	98.28
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
cd00028	116	B_lectin Bulb-type mannose-specific lectin. The do	98.16
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.12
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.06
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.02
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.01
PF01636	239	APH: Phosphotransferase enzyme family This family	97.93
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
smart00473	78	PAN_AP divergent subfamily of APPLE domains. Apple	97.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.78
PLN02876	822	acyl-CoA dehydrogenase	97.64
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.58
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.57
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.49
PRK10593	297	hypothetical protein; Provisional	97.48
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.35
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.34
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.26
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.16
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.14
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.07
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.9
PRK05231	319	homoserine kinase; Provisional	96.89
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.39
cd01100	73	APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d	96.2
PLN02236	344	choline kinase	96.12
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.99
PF01453	114	B_lectin: D-mannose binding lectin; InterPro: IPR0	95.93
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	95.86
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.65
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.64
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.63
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.09
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.08
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.02
COG2334	331	Putative homoserine kinase type II (protein kinase	94.91
PRK12396	409	5-methylribose kinase; Reviewed	94.8

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-53  Score=457.63  Aligned_cols=287  Identities=40%  Similarity=0.720  Sum_probs=249.3

Q ss_pred             cccccChhHHHHHHhhhh--hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecE
Q 003555          497 IIQSFSTGELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF  574 (811)
Q Consensus       497 ~~~~~~~~el~~~~~~~~--~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~  574 (811)
                      ..+.|++.||..||.+|.  ..||+|+||.||+|.+.++ +.||||++.....+..++|.+|+.++.+++|||||+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            467799999999999998  5899999999999999875 8999999876443325669999999999999999999999


Q ss_pred             Eeccc-ceeEEEeecCCCCHHHHhhcCCC-CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEE
Q 003555          575 CMQTS-KKLLVYEFMSKGSLENLLSNVES-GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKIS  652 (811)
Q Consensus       575 ~~~~~-~~~lV~ey~~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~  652 (811)
                      |.+.+ +++||||||++|+|+++|+.... .++|.+|++|+.++|+||+|||+.+.++|+|||||++|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99999 59999999999999999998766 88999999999999999999999999999999999999999999999999


Q ss_pred             ecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh
Q 003555          653 NFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI  732 (811)
Q Consensus       653 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~  732 (811)
                      |||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.. ...+..|+...+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~-~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG-ELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc-cccHHHHHHHHHH
Confidence            999997643312211111179999999999999999999999999999999999999888654222 2236788888888


Q ss_pred             hcccchhcCCccc---cCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          733 AKELSKLVGEDEE---VDL-RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       733 ~~~~~~~~~~~~~---~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                      .+.+.+++|+...   ... ....++.+++.+|++.+|.+||+|.||+++|+.....
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            8899999999853   232 6788899999999999999999999999999665444

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=393.19  Aligned_cols=255  Identities=35%  Similarity=0.509  Sum_probs=211.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCCccceecEEeccc-ceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~ey  587 (811)
                      ..+.+.||+|+||+||+|.+.. ...||||++.....  ...+.|.+|+.+|++++|||||+++|+|.+.. ...|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g-~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRG-TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCC-ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3445679999999999999964 23499999975432  22669999999999999999999999999988 79999999


Q ss_pred             cCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCC-eeecCCCCCcEEECCCC-CeEEEecCCccccCCCC
Q 003555          588 MSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQ-IIHCNINPRNILLDDSL-TAKISNFSLAKILMPNQ  664 (811)
Q Consensus       588 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dik~~NIll~~~~-~~kL~DFGla~~~~~~~  664 (811)
                      |++|+|.++|+.. ...+++..+++|+.|||+||.|||++   + ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999984 67789999999999999999999999   6 99999999999999997 99999999998754322


Q ss_pred             CccccccccCCCccCccccc--cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          665 TGIVTGVKGTRGYMSPEWQN--SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                       ...+...||+.|||||++.  ...++.|+|||||||+||||+||+.||..... ...      +... ..      -..
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~------~~~v-~~------~~~  263 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQV------ASAV-VV------GGL  263 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHH------HHHH-Hh------cCC
Confidence             2334478999999999999  56999999999999999999999999986543 111      0000 00      112


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      +...+......+..++.+||+.||..||++.+++.+|+....
T Consensus       264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            233344477889999999999999999999999999987544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-45  Score=388.62  Aligned_cols=265  Identities=28%  Similarity=0.421  Sum_probs=225.0

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccc
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  580 (811)
                      ....++.+....+.++||+|.||.||.|.+.. ...||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p  275 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP  275 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence            34456777888899999999999999999964 468999999755 3446789999999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHhhc-CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          581 KLLVYEFMSKGSLENLLSN-VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~-~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      .+||||||+.|+|.+||.. .+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||||+.
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence            9999999999999999997 456688899999999999999999999   999999999999999999999999999997


Q ss_pred             cCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ...+.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+... ...+.+..       +..     
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~-------le~-----  419 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLEL-------LER-----  419 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHH-------Hhc-----
Confidence            66666666666777889999999999999999999999999999999 55555432 22222111       111     


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                        +.+...+..++..+.+|+..||+.+|++|||++.+...|+.....
T Consensus       420 --GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  420 --GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence              123455677889999999999999999999999999999876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=368.11  Aligned_cols=255  Identities=30%  Similarity=0.417  Sum_probs=215.8

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEeccc
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS  579 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  579 (811)
                      .+..||+.     .+.||+|..|+|||++++.+++.+|+|.+... .....+++.+|++++++.+||+||.++|.|....
T Consensus        76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            44445543     47799999999999999999999999999543 4455688999999999999999999999999998


Q ss_pred             -ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          580 -KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       580 -~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                       ...|+||||++|+|++++... +..++....+|+.+|++||.|||+.  .+||||||||+|||++..|.+||+|||.++
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence             499999999999999999874 5688899999999999999999973  399999999999999999999999999999


Q ss_pred             ccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-ccchhhHHHHHHHhhhhcccc
Q 003555          659 ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVS-TADVVLLSTWVYNCFIAKELS  737 (811)
Q Consensus       659 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~-~~~~~~l~~~~~~~~~~~~~~  737 (811)
                      .+...   ...+..||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+ ......+            +.
T Consensus       228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L------------l~  292 (364)
T KOG0581|consen  228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL------------LC  292 (364)
T ss_pred             Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH------------HH
Confidence            87544   34567899999999999999999999999999999999999999976522 1222222            23


Q ss_pred             hhcCC-ccccChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          738 KLVGE-DEEVDLR-TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 ~~~~~-~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .++++ ....+.. .++++..++..||++||.+||++.|+++.
T Consensus       293 ~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  293 AIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            34442 2333443 78899999999999999999999999853

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=360.80  Aligned_cols=199  Identities=26%  Similarity=0.442  Sum_probs=180.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |.+.++||+|+||+||+|+++..+..||||.+.+.  ..+..+.+..|+.+|+.++|+|||++++++..++..+||||||
T Consensus        12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC   91 (429)
T KOG0595|consen   12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC   91 (429)
T ss_pred             ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence            45567899999999999999999999999999765  5666778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC------CCeEEEecCCccccCC
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS------LTAKISNFSLAKILMP  662 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~------~~~kL~DFGla~~~~~  662 (811)
                      .+|+|.+||+.. ..+.+.....++.|||.||++||++   +||||||||.||||+..      -.+||+|||+|+.+.+
T Consensus        92 ~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   92 NGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            999999999974 4678889999999999999999999   99999999999999754      5689999999998764


Q ss_pred             CCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV  715 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~  715 (811)
                      ..  ...+.+|++-|||||++...+|+.|+|+||+|++|||+++|+.||+...
T Consensus       168 ~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  168 GS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            33  3456889999999999999999999999999999999999999998553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-43  Score=376.31  Aligned_cols=248  Identities=23%  Similarity=0.346  Sum_probs=215.2

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      .+|...+.||+|||+.||.++..+.++.||+|++.+.   .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4566678999999999999999888999999999753   2334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |+|++++|.++++ .+..+++.+...+++||+.||.|||+.   +|+|||||..|+||+++.++||+|||||..+..+..
T Consensus        98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999999 477899999999999999999999999   999999999999999999999999999998865533


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      . ..+.+||+.|+|||++....++..+||||+||+||-|+.|++||+...-.+                .+..+......
T Consensus       174 r-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----------------ty~~Ik~~~Y~  236 (592)
T KOG0575|consen  174 R-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----------------TYNKIKLNEYS  236 (592)
T ss_pred             c-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----------------HHHHHHhcCcc
Confidence            2 345899999999999999999999999999999999999999998542111                12222223333


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .+...+.+..+||..+|+.+|.+|||+++|+.
T Consensus       237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            45567778899999999999999999999984

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-44  Score=389.36  Aligned_cols=263  Identities=25%  Similarity=0.409  Sum_probs=222.1

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCC---EEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGN---KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      |......+++.||.|.||.|++|+++..+   ..||||.|+... +....+|+.|+.+|.+++||||++|.|+.......
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            33333444577999999999999997655   479999998754 45567899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      +||.|||+||+|+.||+....++.+.+...|+++||.||+||.+.   ++|||||.++||||+.+..+|++|||+++.+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence            999999999999999999988899999999999999999999998   99999999999999999999999999999776


Q ss_pred             CCCCcccc--ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          662 PNQTGIVT--GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       662 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      .+.....+  +-.-+.+|.|||.+...++|.++|||||||+|||.++ |.+|+-.. .+.+.+.-.              
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-SNQdVIkaI--------------  847 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVIKAI--------------  847 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-chHHHHHHH--------------
Confidence            55433222  2344679999999999999999999999999999987 67776432 222221110              


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      -.+-++..+++++..|.+|+++|||+|..+||.+.||+.+|++++.-|
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            012245678899999999999999999999999999999999876654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.4e-43  Score=392.63  Aligned_cols=269  Identities=29%  Similarity=0.455  Sum_probs=225.7

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecE
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGF  574 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~  574 (811)
                      ....++.+....+.++||+|+||.||+|+...     ....||||.+++.... ...+|++|++++..++|+|||+|+|+
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV  557 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV  557 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            44456667777788999999999999998743     2357999999987665 77899999999999999999999999


Q ss_pred             EecccceeEEEeecCCCCHHHHhhcCC-------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcE
Q 003555          575 CMQTSKKLLVYEFMSKGSLENLLSNVE-------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNI  641 (811)
Q Consensus       575 ~~~~~~~~lV~ey~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NI  641 (811)
                      |.+++.+++|+|||..|+|.+||....             ..++..+.+.|+.|||.||.||-++   .+|||||..+|+
T Consensus       558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC  634 (774)
T KOG1026|consen  558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC  634 (774)
T ss_pred             EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence            999999999999999999999996431             1256789999999999999999999   999999999999


Q ss_pred             EECCCCCeEEEecCCccccCCCCCcccc-ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 003555          642 LLDDSLTAKISNFSLAKILMPNQTGIVT-GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTAD  719 (811)
Q Consensus       642 ll~~~~~~kL~DFGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~  719 (811)
                      ||.++..+||+||||++.....+.+... ...-+.+|||||.|..+++|.+||||||||+|||+++ |+.|+...... +
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-E  713 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-E  713 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-H
Confidence            9999999999999999987766665544 4556889999999999999999999999999999998 66777644322 1


Q ss_pred             hhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCCC
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPV  787 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  787 (811)
                      .       ..+..++++       +..+..++.+++.|+..||+.+|.+||+++||-..|+...+...
T Consensus       714 V-------Ie~i~~g~l-------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  714 V-------IECIRAGQL-------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             H-------HHHHHcCCc-------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            1       122222222       34566788999999999999999999999999999988665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-43  Score=358.65  Aligned_cols=254  Identities=23%  Similarity=0.283  Sum_probs=205.4

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh-------hHHHHHHHHHHHhccCCCCccceecEEeccc
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE-------GERKFQAEMAAVRRTHHKNLVRLLGFCMQTS  579 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  579 (811)
                      .+..|-+.+.||+|+||.|-+|..+.+++.||||++++....       .....++|+++|++|+|||||++.+++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            445566789999999999999999999999999999753211       2234579999999999999999999999999


Q ss_pred             ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC---CCeEEEecCC
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS---LTAKISNFSL  656 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~---~~~kL~DFGl  656 (811)
                      ..|+||||+++|+|.+++-.. ..+.+..-..++.|++.|+.|||++   +|+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999999763 3455556677999999999999999   99999999999999755   8899999999


Q ss_pred             ccccCCCCCccccccccCCCccCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          657 AKILMPNQTGIVTGVKGTRGYMSPEWQNSGL---ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       657 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      |+...  +...+.+.+||+.|.|||++.++.   +..+.|+||+||+||-+++|.+||...........+       ...
T Consensus       326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ-------I~~  396 (475)
T KOG0615|consen  326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ-------ILK  396 (475)
T ss_pred             hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-------Hhc
Confidence            99865  334466789999999999987664   334889999999999999999999865443311100       001


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +++    ........+..++..+++.+||..||++|||+.|+++
T Consensus       397 G~y----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  397 GRY----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             Ccc----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            111    0111224467789999999999999999999999874

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-43  Score=340.98  Aligned_cols=263  Identities=21%  Similarity=0.341  Sum_probs=213.6

Q ss_pred             hHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceec-EEecccc
Q 003555          504 GELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLG-FCMQTSK  580 (811)
Q Consensus       504 ~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~  580 (811)
                      +....+.+.+.++||+|.||+|||+....+++.||.|.++-.  ..+.......|+.+|++|+|||||++++ -+.++.+
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            344556788899999999999999999999999999998733  3344557899999999999999999998 4555555


Q ss_pred             -eeEEEeecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccC-CCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          581 -KLLVYEFMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECE-VQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       581 -~~lV~ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~-~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                       .+||||||..|+|...++..   ...+.++.+++++.|++.||.++|...+ .-|+||||||.||+|+.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             89999999999999998643   4567899999999999999999999422 239999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       656 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      +++.+..... .....+|||.||+||.+....|+.|+||||+||++|||+..+.||...    ....+...    ...++
T Consensus       174 L~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~K----I~qgd  244 (375)
T KOG0591|consen  174 LGRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKK----IEQGD  244 (375)
T ss_pred             hHhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHH----HHcCC
Confidence            9998765433 345678999999999999999999999999999999999999999865    12222111    11111


Q ss_pred             cchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..      .-.+..++..+.+|+..|+..||+.||+...+++.+..
T Consensus       245 ~~------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  245 YP------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             CC------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            11      11235788999999999999999999996666655544

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4e-41  Score=331.59  Aligned_cols=259  Identities=20%  Similarity=0.302  Sum_probs=208.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |+...++|+|+||+|||++++++++.||||++....  ....+-.++|+++|++++|+|+|.++++|.....++||+||+
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            444568999999999999999999999999986432  333456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +. ++.+-|.....+.+.....+++.|+++|+.|+|++   +++||||||+||||+.++.+||+|||+|+.+.. .....
T Consensus        84 dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y  158 (396)
T KOG0593|consen   84 DH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY  158 (396)
T ss_pred             ch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence            88 55556666677788889999999999999999999   999999999999999999999999999998763 23345


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC-----
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE-----  742 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-----  742 (811)
                      +..+.|+.|.|||.+-+ .+|....|||++||++.||++|.+.|....+.++...+.....+.. ... .+++..     
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~-prh-q~iF~~N~~F~  236 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI-PRH-QSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC-HHH-HHHhccCCcee
Confidence            66778999999998876 6899999999999999999999999987665555443332222111 100 011110     


Q ss_pred             -----c-------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          743 -----D-------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       743 -----~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                           .       +..-+....-+.+++..||+.||.+|++-+|++
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence                 0       111233455789999999999999999999987

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=360.96  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=215.7

Q ss_pred             ChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEeccc
Q 003555          502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS  579 (811)
Q Consensus       502 ~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  579 (811)
                      .+.||......+.+.||+|.||+||+|++..   .||||+++.  ...+..+.|++|+..+++-+|.||+-++|+|....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            4455666666778999999999999999964   599999864  45566788999999999999999999999999888


Q ss_pred             ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      . .||+.+|++.+|..+|+..+..+.....++|+.|||+||.|||.+   +|||||||..||+|.+++.+||+|||++..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence            7 999999999999999999888899999999999999999999999   999999999999999999999999999875


Q ss_pred             cCCC-CCccccccccCCCccCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          660 LMPN-QTGIVTGVKGTRGYMSPEWQNSG---LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       660 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      -..- .........|...|||||+++..   +|+.++||||||+|+|||++|..||. ....+..+...       -.+.
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmV-------GrG~  609 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMV-------GRGY  609 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEe-------cccc
Confidence            3221 12223445688899999988644   69999999999999999999999998 32222221000       0000


Q ss_pred             cchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                         +............++|.+|+..||..++++||.+.+|+.+|+.+..
T Consensus       610 ---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  610 ---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               0001122344567789999999999999999999999999987655

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=387.12  Aligned_cols=261  Identities=30%  Similarity=0.481  Sum_probs=219.2

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCE-----EEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEeccc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS  579 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~-----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  579 (811)
                      +......+.+.||+|+||.||.|...+...     .||||.+++. ..+.+.+|.+|..+|++++|||||+++|+|.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            445666677889999999999999865433     4999999865 4566778999999999999999999999999999


Q ss_pred             ceeEEEeecCCCCHHHHhhcC------CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          580 KKLLVYEFMSKGSLENLLSNV------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                      ..+|++|||++|+|..||++.      ...+.....+.|+.|||+|+.|||++   ++|||||.++|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            999999999999999999987      56678999999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCCCcccccc-ccCCCccCccccccCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCccchhhHHHHHHHhh
Q 003555          654 FSLAKILMPNQTGIVTGV-KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR-SNFEVNVSTADVVLLSTWVYNCF  731 (811)
Q Consensus       654 FGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~-~p~~~~~~~~~~~~l~~~~~~~~  731 (811)
                      ||||+.+...+....... .-+..|||||.+..+.+|.|+|||||||+|||++|.. .||.. ....+...       . 
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-~~n~~v~~-------~-  916 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-RSNFEVLL-------D-  916 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-cchHHHHH-------H-
Confidence            999996655555443333 4567999999999999999999999999999999954 55543 22222111       0 


Q ss_pred             hhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                            -+-+.+++.+..+++.+++|+..||+.+|++||++..|++.++....
T Consensus       917 ------~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  917 ------VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ------HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                  11233566788899999999999999999999999999998876443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=340.22  Aligned_cols=240  Identities=22%  Similarity=0.276  Sum_probs=202.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ...+.+.||+|+||.||.++.++.++.+|+|++++..   ....+...+|..+|.+++||.||+++-.+++.+.+|||+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            4456789999999999999999999999999997642   2346678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+.||.|..+|.+ +..+++....-++.+|+.||.|||++   +||||||||+|||||++|.++|+|||+++...... .
T Consensus       106 ~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~  180 (357)
T KOG0598|consen  106 YLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-D  180 (357)
T ss_pred             ccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-C
Confidence            9999999999986 44556666666788999999999999   99999999999999999999999999999654333 2


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc-cc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED-EE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~  745 (811)
                      ...+.+||+.|||||++....++..+|.||+||++|||++|.+||.......-                ...+.... ..
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----------------~~~I~~~k~~~  244 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----------------YDKILKGKLPL  244 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----------------HHHHhcCcCCC
Confidence            34458999999999999999999999999999999999999999986532211                11122222 22


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCC
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRP  770 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RP  770 (811)
                      .+.....++.+++...|+.||++|.
T Consensus       245 ~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCccCCHHHHHHHHHHhccCHHHhc
Confidence            2334677889999999999999995

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-40  Score=344.24  Aligned_cols=265  Identities=21%  Similarity=0.268  Sum_probs=215.8

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~  585 (811)
                      .++-.++||+|.||.||||+...+++.||+|++....  ++......+||.+|++|+||||++|.+...+.  ...|||+
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF  197 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF  197 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence            4445588999999999999999999999999987544  44456788999999999999999999999876  6899999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |||++ +|.-++....-.++..++..++.||+.||.|+|.+   +|+|||||.+|||||.+|.+||+|||||+++.....
T Consensus       198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            99998 99999998777899999999999999999999999   999999999999999999999999999998887777


Q ss_pred             ccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHH----hhhhcccc--h
Q 003555          666 GIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN----CFIAKELS--K  738 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~----~~~~~~~~--~  738 (811)
                      ...+..+-|.-|.|||++.+. .|+.+.|+||.||||.||+.|++.|....+.++...+.+....    .|...++-  .
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence            778888999999999987665 7999999999999999999999999876655544332222110    11100110  1


Q ss_pred             hcCCccc-------cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          739 LVGEDEE-------VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       739 ~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+.+...       .-.......++|+..+|..||.+|.|+.++++.
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1111111       111234567889999999999999999998853

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=340.85  Aligned_cols=255  Identities=25%  Similarity=0.365  Sum_probs=207.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEeccc--ceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS--KKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~ey~  588 (811)
                      ....+.||+|+||+||++...+.++..|||.+........+.+.+|+.+|++++|||||+++|......  .+.+.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            445678999999999999999888999999987543333677999999999999999999999855544  689999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-CCCeEEEecCCccccCC--CCC
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMP--NQT  665 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~~~~--~~~  665 (811)
                      ++|+|.+++.+....+++..+.++..||++||+|||++   +|+||||||+||||+. ++.+||+|||+++....  ...
T Consensus        99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence            99999999998766789999999999999999999999   9999999999999999 79999999999987653  222


Q ss_pred             ccccccccCCCccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGL-ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .......||+.|||||++.++. ...++|||||||++.||+||++||.......      .+........       ..+
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~~~ig~~~-------~~P  242 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EALLLIGRED-------SLP  242 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHHHHHhccC-------CCC
Confidence            3344578999999999998643 3459999999999999999999997530000      1111100011       112


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..+...+....+++..|++.+|+.|||+++++...--
T Consensus       243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            4455677889999999999999999999999977643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=345.91  Aligned_cols=267  Identities=26%  Similarity=0.363  Sum_probs=218.0

Q ss_pred             hHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhH-HHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          504 GELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       504 ~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      .|+.+....|.|+||+|-||.|.++.... ...||||.++....... ++|..|+++|.+++||||++++|+|..++.++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            35666677788999999999999999854 68999999987655544 88999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCC-chHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          583 LVYEFMSKGSLENLLSNVESGP-IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~-~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      +|+|||++|+|..||.++.... .-....+|+.|||.||+||.+-   ++|||||.++|+|+|.++++||+|||+++.+.
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            9999999999999998864333 4566678999999999999998   99999999999999999999999999999877


Q ss_pred             CCCCcccc-ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          662 PNQTGIVT-GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC--CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       662 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt--g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ..+.+... ...-+.+|||||.+..+++|.++|||+||+.|||+++  ...||.....++-.    +-.......+....
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~~  764 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQV  764 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcce
Confidence            66655443 4567889999999999999999999999999999864  66787643322111    11111111111111


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .    +..+.-+...+++++..||..+..+||+++++...|+..
T Consensus       765 ~----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  765 V----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             e----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1    122556778899999999999999999999999988754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-39  Score=333.34  Aligned_cols=269  Identities=27%  Similarity=0.399  Sum_probs=208.1

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhc--cCCCCccceecEEeccc----ceeEEE
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR--THHKNLVRLLGFCMQTS----KKLLVY  585 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lV~  585 (811)
                      .+.+.||+|+||.||||++.  ++.||||++.   .+....|++|-.+.+.  ++|+||+++++.-..+.    +++||+
T Consensus       213 ~l~eli~~Grfg~V~KaqL~--~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD--NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhHHHhhcCccceeehhhcc--CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            45688999999999999995  4899999985   4556678777766554  58999999999987766    889999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhcc------CCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC------EVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ||.++|+|.+||..  ..++|....+|+..+++||+|||+..      +++|+|||||.+||||..++++.|+|||+|..
T Consensus       288 ~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             eeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99999999999985  56899999999999999999999875      57899999999999999999999999999999


Q ss_pred             cCCCCC-ccccccccCCCccCccccccCC-CC-----cccchHHHHHHHHHHHhCCCCCCCCCCccchhhHH--------
Q 003555          660 LMPNQT-GIVTGVKGTRGYMSPEWQNSGL-IT-----VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS--------  724 (811)
Q Consensus       660 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~t-----~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~--------  724 (811)
                      +.+... ......+||.+|||||++.+.. +.     .+.||||+|.|||||++...-++.....+...-+.        
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            876554 3445588999999999987652 22     37899999999999999776554211111111111        


Q ss_pred             -HHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCCCC
Q 003555          725 -TWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV  788 (811)
Q Consensus       725 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  788 (811)
                       +.++..+..++.+..+...-... .....+++.++.||+.||+-|.|+.=|.+.+..+..+...
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence             12222333333333222211112 4566789999999999999999999999888777666543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=358.83  Aligned_cols=266  Identities=28%  Similarity=0.423  Sum_probs=217.5

Q ss_pred             hHHHHHHhhhhhhcCcccceeEEEEEEcCCCE---E-EEEEEccC---CchhhHHHHHHHHHHHhccCCCCccceecEEe
Q 003555          504 GELERATNGFEEELGRGCFGAVYKGSICEGNK---I-VAVKRLEN---PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM  576 (811)
Q Consensus       504 ~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~---~-vAvK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~  576 (811)
                      .||......+.++||+|+||.||+|+++..+.   . ||||..+.   ...+..++|.+|+++|++++|+|||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34555556667999999999999999976422   3 89999874   44677889999999999999999999999999


Q ss_pred             cccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCC
Q 003555          577 QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL  656 (811)
Q Consensus       577 ~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGl  656 (811)
                      .....+||||+|.||+|+++|......++..++++++.+.|.||+|||++   +++||||.++|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence            99999999999999999999998777799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCcccc-ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          657 AKILMPNQTGIVT-GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       657 a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      ++...  ...... ...-+..|+|||.+....++.++|||||||++||+++ |..|+......    .+..+    ....
T Consensus       309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~k----I~~~  378 (474)
T KOG0194|consen  309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAK----IVKN  378 (474)
T ss_pred             ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHH----HHhc
Confidence            98643  111111 2246789999999999999999999999999999998 77887654322    11111    1011


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCCCC
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV  788 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  788 (811)
                            +-+...+...+..+..++..|+..+|++||+|.++.+.|+.+.....+
T Consensus       379 ------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  379 ------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                  112233445667788888899999999999999999999887665543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=341.60  Aligned_cols=267  Identities=20%  Similarity=0.281  Sum_probs=217.8

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhH-HHHHHHHHHHhccC-CCCccceecEEeccc-ceeE
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTH-HKNLVRLLGFCMQTS-KKLL  583 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~l  583 (811)
                      ...+|...++||.|.||.||+|+....++.||||++++.....+ -.-++|+..|++|+ ||||++|.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34568888999999999999999999999999999976544333 34678999999998 999999999999988 8999


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |||||+. +|.+++++.+..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+||.....
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence            9999976 99999999888889999999999999999999999   9999999999999999999999999999986433


Q ss_pred             CCccccccccCCCccCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHh----hhh-cccc
Q 003555          664 QTGIVTGVKGTRGYMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNC----FIA-KELS  737 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~----~~~-~~~~  737 (811)
                        ...+..+.|+-|.|||++ ..+.|+.+.|+|++||+++|+.+-++.|.+..+.++...+-+.+..-    +.. ..+.
T Consensus       164 --pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  164 --PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             --CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence              345667889999999964 67789999999999999999999999998876665543332221110    000 0111


Q ss_pred             hhcCC--------c-cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          738 KLVGE--------D-EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       738 ~~~~~--------~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ..+.-        . ...-+..+.++.+++..|++-||.+|||++|.+++-
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            11111        0 122334778899999999999999999999999764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.5e-39  Score=352.03  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEc-----CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEeccc
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTS  579 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  579 (811)
                      ....+.+.++||+|+||.||+|.+.     ..++.||||++.... ....+.+.+|+.+++++ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3456777899999999999999852     234579999997543 33456799999999999 8999999999987654


Q ss_pred             -ceeEEEeecCCCCHHHHhhcCC---------------------------------------------------------
Q 003555          580 -KKLLVYEFMSKGSLENLLSNVE---------------------------------------------------------  601 (811)
Q Consensus       580 -~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------------  601 (811)
                       ..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             5789999999999999997532                                                         


Q ss_pred             ----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-cccccccCCC
Q 003555          602 ----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRG  676 (811)
Q Consensus       602 ----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~  676 (811)
                          ..+++..+.+++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                1255677889999999999999998   9999999999999999999999999999865433221 1223456788


Q ss_pred             ccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHH
Q 003555          677 YMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMV  755 (811)
Q Consensus       677 y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  755 (811)
                      |+|||.+.+..++.++|||||||++|||++ |..||.........       ......+.       ....+......+.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-------~~~~~~~~-------~~~~~~~~~~~l~  307 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-------CQRLKDGT-------RMRAPENATPEIY  307 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-------HHHHhcCC-------CCCCCCCCCHHHH
Confidence            999999998999999999999999999997 99998754322111       01111111       1111223456789


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          756 RVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       756 ~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      +++.+||+.||.+||++.||+++|+.+.+
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=342.35  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=212.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      .+.|.+.||+|+|++|++|+.++.++.+|||++.+..   +...+....|-.+|.+| .||.|++|+-.|.++..+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            4567899999999999999999999999999997532   23345577888899999 8999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+++|+|.++|.+. +.+++.....++.+|+.||+|||+.   +||||||||+|||||+++++||+|||.|+.+.+...
T Consensus       154 e~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  154 EYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            999999999999985 4577777788999999999999999   999999999999999999999999999998764322


Q ss_pred             c----------cc--cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          666 G----------IV--TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       666 ~----------~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      .          ..  ...+||..|.+||++.....+..+|+|+|||+||+|+.|++||....+-   ..           
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---li-----------  295 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LI-----------  295 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HH-----------
Confidence            1          11  3478999999999999999999999999999999999999999854321   11           


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                        +.+++.-....++..++.+.+|+.+.|..||.+|++.++|-+..
T Consensus       296 --FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 --FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             --HHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence              12333334445666678899999999999999999999987653

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9e-39  Score=310.26  Aligned_cols=269  Identities=20%  Similarity=0.270  Sum_probs=213.6

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +|.-.++||+|.||.||+|++..+++.||||+++...  ........+|++.|+.++|+||+.+++++.+.+..-||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            3555689999999999999999999999999997542  22345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      |+. +|+..+++....++..++..++.++.+||+|||++   .|+||||||.|+|++.+|.+||+|||+|+.+.+.....
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence            987 99999999888888899999999999999999999   99999999999999999999999999999887655433


Q ss_pred             ccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh---hccc---chhc
Q 003555          668 VTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI---AKEL---SKLV  740 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---~~~~---~~~~  740 (811)
                       +..+-|+-|.|||.+.+ ..|+...|+||.||++.||+.|.+-|....+-++.    ..+.+.+-   ++.+   ..+.
T Consensus       159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL----~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL----SKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH----HHHHHHcCCCCcccCccccccc
Confidence             23377999999997765 47999999999999999999988877655433322    11211111   1111   1111


Q ss_pred             C---------Cc-cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCCCC
Q 003555          741 G---------ED-EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV  788 (811)
Q Consensus       741 ~---------~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~  788 (811)
                      |         +. ...-+.......+++..++..||.+|++++|.+++= .....|.|
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~p  290 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLP  290 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCC
Confidence            1         00 112234456779999999999999999999999764 23334444

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=345.11  Aligned_cols=249  Identities=21%  Similarity=0.309  Sum_probs=213.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      |.-.++||+|+-|.||.+.....++.||||++........+-+.+|+.+|+..+|+|||.++..+..+++.++|||||++
T Consensus       275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g  354 (550)
T KOG0578|consen  275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG  354 (550)
T ss_pred             hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence            33347899999999999999999999999999766556667789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+.+...  .+++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+..... ....
T Consensus       355 gsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T  428 (550)
T KOG0578|consen  355 GSLTDVVTKT--RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST  428 (550)
T ss_pred             Cchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence            9999999853  488999999999999999999999   999999999999999999999999999988765543 4566


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|||||+.....|.+|.||||||++++||+-|.+||-.+.+-....++             ...-.+........
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI-------------a~ng~P~lk~~~kl  495 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------ATNGTPKLKNPEKL  495 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH-------------hhcCCCCcCCcccc
Confidence            89999999999999999999999999999999999999999754322211110             11111223335566


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +..+.+++.+||+.|+.+||++.|+++.
T Consensus       496 S~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  496 SPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            7889999999999999999999999853

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=342.11  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=220.7

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .|.+.+.||+|.||.||||+.+.+.+.||+|.+.+  ..+...+.+.+|++++++++|||||.+++.+....+.++|.||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            35667899999999999999999999999999865  3455667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +.+ +|..+|.. ...+.++++..|+.+++.||.|||+.   .|+|||+||.|||++.++.+|++|||+|+.+.. ....
T Consensus        83 a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v  156 (808)
T KOG0597|consen   83 AVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV  156 (808)
T ss_pred             hhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence            988 99999987 55678899999999999999999999   999999999999999999999999999998654 4456


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .+...||+.|||||..++.+|+..+|.||+||++||+.+|++||....    ...+            ...+.......+
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~L------------v~~I~~d~v~~p  220 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQL------------VKSILKDPVKPP  220 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHH------------HHHHhcCCCCCc
Confidence            677899999999999999999999999999999999999999997431    1111            122222333345


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhc-ccCCCCCCCCCCcc
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM--LEG-TMEIPVVPFPILSN  795 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~-~~~~~~~~~p~~~~  795 (811)
                      ......+..++...|++||..|.+-.+++..  .++ ......|..|.+..
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~s  271 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDS  271 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccC
Confidence            5777889999999999999999999998743  233 33334444444433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=330.13  Aligned_cols=259  Identities=22%  Similarity=0.341  Sum_probs=209.1

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ...|++.++||.|.-++||+|+....++.||||++.-.. ......+++|+..|+.++||||++++..|..++..++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            345778899999999999999999889999999986432 2336889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          587 FMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||.+|++.++++.. ...+.+..+..|++++++||.|||++   +.||||||+.||||+.+|.+||+|||.+-.+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999999865 56688899999999999999999999   999999999999999999999999998766544332


Q ss_pred             c---cccccccCCCccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch--
Q 003555          666 G---IVTGVKGTRGYMSPEWQNS--GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK--  738 (811)
Q Consensus       666 ~---~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~--  738 (811)
                      .   ......||++|||||++..  ..|+.|+|||||||..+||.+|..||....+..-.  +.     .+ ....-.  
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~-----tL-qn~pp~~~  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LL-----TL-QNDPPTLL  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HH-----Hh-cCCCCCcc
Confidence            1   1245789999999998543  36899999999999999999999999754332211  10     00 011000  


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......+........+.+++..||+.||++|||++++++
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111112223445568899999999999999999999983

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=343.38  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=210.0

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC----ch-hhHHHHHHHHHHHhccC-CCCccceecEEecccce
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP----VE-EGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~  581 (811)
                      ...+.+.+.||+|.||.|+.|.....++.||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            34567788999999999999999988899999977543    11 34556778999999998 99999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC-CCeEEEecCCcccc
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-LTAKISNFSLAKIL  660 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~-~~~kL~DFGla~~~  660 (811)
                      ++||||+.+|+|.+++.+ ...+.+.+...+++||+.|++|||+.   +|+||||||+|||+|.+ +++||+|||++...
T Consensus        96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            999999999999999998 77788889999999999999999999   99999999999999999 99999999999976


Q ss_pred             CCCCCccccccccCCCccCccccccCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGL-IT-VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      . .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......   +.             ..
T Consensus       172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~-------------~k  234 (370)
T KOG0583|consen  172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY-------------RK  234 (370)
T ss_pred             C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH-------------HH
Confidence            4 2334456789999999999998877 75 78999999999999999999998622110   01             11


Q ss_pred             hcCCccccChHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          739 LVGEDEEVDLRT-LETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       739 ~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                      +.......+... +.++..++.+|++.+|..|+++.+|+
T Consensus       235 i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  235 IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            222223333344 78899999999999999999999999

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.7e-38  Score=333.67  Aligned_cols=259  Identities=23%  Similarity=0.320  Sum_probs=208.8

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEc---CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      +....+.+.+.||+|+||.||+|.++   ..+..||+|.++... ......|.+|+..+++++|+||+++++++..++..
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            44566778899999999999999875   345689999987643 34456799999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++||||+++|+|.+++......+++.+++.++.||+.||+|||+.   +++||||||+|||++.++.+|++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999999987666788999999999999999999998   99999999999999999999999999876542


Q ss_pred             CCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ...........++..|+|||.+.+..++.++|||||||++||+++ |+.||.......    +..    ......     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~~~----~~~~~~-----  225 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----VIK----AVEDGF-----  225 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHH----HHHCCC-----
Confidence            222111122345678999999999999999999999999999875 999986432211    001    001110     


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                        ....+...+..+.+++..||+.+|.+||++++|.+.|+..
T Consensus       226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              1112334566789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=338.51  Aligned_cols=238  Identities=27%  Similarity=0.412  Sum_probs=200.1

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLE  594 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~  594 (811)
                      +=||+|+.|.||+|+++  ++.||||+++.-       -..+++-|++|+|+||+.+.|+|....-++||||||..|-|.
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            55999999999999995  589999997532       235788899999999999999999999999999999999999


Q ss_pred             HHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccccC
Q 003555          595 NLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT  674 (811)
Q Consensus       595 ~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt  674 (811)
                      +.|+. +..+......++..+||.||.|||.+   +|||||||.-||||..+..+||+|||-++.....  .......||
T Consensus       201 ~VLka-~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT  274 (904)
T KOG4721|consen  201 EVLKA-GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT  274 (904)
T ss_pred             HHHhc-cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence            99987 44566677889999999999999999   9999999999999999999999999999876433  233457899


Q ss_pred             CCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHH
Q 003555          675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETM  754 (811)
Q Consensus       675 ~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  754 (811)
                      ..|||||++++.+.++|.||||||||||||+||..||.......-.       |..  ..+.     -.+..+..+++.+
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-------wGV--GsNs-----L~LpvPstcP~Gf  340 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-------WGV--GSNS-----LHLPVPSTCPDGF  340 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-------Eec--cCCc-----ccccCcccCchHH
Confidence            9999999999999999999999999999999999999754322110       000  0000     0123466778888


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          755 VRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       755 ~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      .-|+++||+..|++||++++++..|+-
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            999999999999999999999999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=338.58  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=223.5

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccc
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  580 (811)
                      .+..|+++......++||.|.||.||.|.++...-.||||.|+.+. -..++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            4566778777788899999999999999999988899999998654 346889999999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHhhcCCC-CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVES-GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      .|||+|||.+|+|.+||.+... .......+.|+.||+.||.||..+   ++|||||.++|.|+.++..+||+|||++++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            9999999999999999988643 345567789999999999999999   999999999999999999999999999999


Q ss_pred             cCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      +..+......+..-++.|.|||-+....++.|+|||+|||+||||.| |..|+....-..        ++..+..+    
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq--------VY~LLEkg----  482 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYGLLEKG----  482 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH--------HHHHHhcc----
Confidence            87666555556667889999999999999999999999999999987 666765432111        11111111    


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                         -+.+.+..+++.+++|++.||+-+|.+||++.|+-+.+|...
T Consensus       483 ---yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  483 ---YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ---ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence               123345677889999999999999999999999998887644

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-37  Score=334.24  Aligned_cols=263  Identities=25%  Similarity=0.377  Sum_probs=202.9

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcC----------------CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccc
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICE----------------GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVR  570 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~----------------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~  570 (811)
                      ...+.+.++||+|+||.||++.+.+                .+..||+|.+.... .....+|.+|+.++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3456678899999999999998643                23479999987543 344567999999999999999999


Q ss_pred             eecEEecccceeEEEeecCCCCHHHHhhcCC------------------CCCchHHHHHHHHHHHHHHHHHhhccCCCee
Q 003555          571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVE------------------SGPIWRDRVRIALDVARGITYLHEECEVQII  632 (811)
Q Consensus       571 l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~iv  632 (811)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..+++++.||+.||.|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            9999999999999999999999999986431                  2356788899999999999999998   999


Q ss_pred             ecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhC--CC
Q 003555          633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCC--RS  709 (811)
Q Consensus       633 H~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg--~~  709 (811)
                      ||||||+|||+++++.+||+|||+++.+...... ......++..|+|||.+....++.++||||||+++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865433321 22234567899999999888899999999999999999874  45


Q ss_pred             CCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       710 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ||.......    ....+........ ....   ...++..+..+.+++.+||+.+|.+|||+.||.+.|++
T Consensus       241 p~~~~~~~~----~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQ----VIENAGEFFRDQG-RQVY---LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHH----HHHHHHHHhhhcc-cccc---ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            665432111    1111111111110 0000   11123445678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-37  Score=344.77  Aligned_cols=260  Identities=24%  Similarity=0.370  Sum_probs=204.8

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEE-----cCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEecc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT  578 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  578 (811)
                      +....+.+.++||+|+||.||+|+.     .+.+..||||+++... ....+.+.+|+.+++.+ +||||++++++|.++
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3445677889999999999999974     3345689999997432 33456788999999999 899999999999999


Q ss_pred             cceeEEEeecCCCCHHHHhhcCC---------------------------------------------------------
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVE---------------------------------------------------------  601 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------------  601 (811)
                      +..++||||+++|+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999986432                                                         


Q ss_pred             -----------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          602 -----------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       602 -----------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                                       ..+++..+.+++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                             1356778889999999999999998   99999999999999999999999999998664333


Q ss_pred             Ccc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          665 TGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       665 ~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      ... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.........   ...    ...+ ..     
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~---~~~----~~~~-~~-----  335 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF---YKM----IKEG-YR-----  335 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH---HHH----HHhC-cc-----
Confidence            211 122345678999999999999999999999999999998 78888643222111   111    1111 00     


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                       ...+.....++.+|+.+||+.||++||++.||+++|+..
T Consensus       336 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             011112345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=309.77  Aligned_cols=235  Identities=22%  Similarity=0.242  Sum_probs=204.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch---hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +++.+.||.|+||.|.+++.+.++..+|+|++++...   ...+...+|..+|+.+.||+++++++.+.+.+..+|||||
T Consensus        46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey  125 (355)
T KOG0616|consen   46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY  125 (355)
T ss_pred             hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence            3456789999999999999999999999999976432   3345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      .++|.|..+|++ ..+++++...-++.||+.||+|||+.   .|++|||||+|||||.+|.+||.|||.|+.+...    
T Consensus       126 v~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----  197 (355)
T KOG0616|consen  126 VPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----  197 (355)
T ss_pred             cCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----
Confidence            999999999987 44577788888999999999999999   9999999999999999999999999999976432    


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .-+.+||+.|+|||++..+.+...+|.|+|||++|||+.|.+||....+..                ...+++......+
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~KI~~~~v~fP  261 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEKILEGKVKFP  261 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHHHHhCcccCC
Confidence            456889999999999999999999999999999999999999998654321                1234455555667


Q ss_pred             hHHHHHHHHHHHHcccCCCCCC
Q 003555          748 LRTLETMVRVGLLCIQDEPNLR  769 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~R  769 (811)
                      ......+.+|+...|+.|-.+|
T Consensus       262 ~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  262 SYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cccCHHHHHHHHHHHhhhhHhh
Confidence            7777888999999999999998

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.2e-38  Score=330.79  Aligned_cols=249  Identities=30%  Similarity=0.506  Sum_probs=197.1

Q ss_pred             hhhhcCcccceeEEEEEEc----CCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          513 FEEELGRGCFGAVYKGSIC----EGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~----~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.||.|.||.||+|.+.    ..+..|+||.++.. ..+..+.|.+|++.+++++|+||++++|++.+.+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999997    34578999999654 334578899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-
Q 003555          588 MSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-  665 (811)
                      +++|+|.++|... ...+++.++++|+.||++||+|||+.   +++|+||+++||++++++.+||+|||++........ 
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9999999999987 56788999999999999999999998   999999999999999999999999999987632222 


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+...... .      ... .......       .
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-~------~~~-~~~~~~~-------~  224 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-E------IIE-KLKQGQR-------L  224 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-H------HHH-HHHTTEE-------T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc-c------ccc-ccccccc-------c
Confidence            22233457789999999999999999999999999999999 67887543111 1      111 1111111       1


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ..+...+..+.+++..||+.+|.+||+|.++++.|
T Consensus       225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            12334567788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-37  Score=330.42  Aligned_cols=246  Identities=21%  Similarity=0.313  Sum_probs=199.2

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhh---HHHHHHHHHHHhccCCCCccceecEEec----ccceeEEEee
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLVRLLGFCMQ----TSKKLLVYEF  587 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ey  587 (811)
                      ..||+|++|.||+|..  +++.||||+++......   .+.|.+|+.+|++++||||++++|++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            4699999999999998  46899999997543322   4678899999999999999999999877    3467899999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++|+|.+++... ..+++...++++.+++.||.|||+.  .+++||||||+|||+++++.+||+|||+++.+....   
T Consensus       104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            9999999999863 4678899999999999999999974  277899999999999999999999999998653321   


Q ss_pred             ccccccCCCccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          668 VTGVKGTRGYMSPEWQNS--GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+    +..    ......      ....
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----~~~----~i~~~~------~~~~  242 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----IYD----LIINKN------NSLK  242 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----HHH----HHHhcC------CCCC
Confidence             23457899999999876  689999999999999999999999997542111    001    111111      1112


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      .+...+..+.+++.+||+.||.+|||++|+++.|+...
T Consensus       243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            23345678999999999999999999999999997653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-38  Score=320.09  Aligned_cols=250  Identities=19%  Similarity=0.313  Sum_probs=212.4

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .+.+|.|.+.||+|.||.|-+|.....++.||||.+++..   +++.-.+.+|+++|+.|+||||+.++++|.+.+...|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            3557888999999999999999998889999999987643   4555678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ||||..+|.|.+|+.+ +..+++.+...+++||..|+.|+|.+   .++|||||.+|||||+|+++||+|||++..+...
T Consensus       131 vMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  131 VMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999999987 55688899999999999999999999   9999999999999999999999999999876433


Q ss_pred             CCccccccccCCCccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLI-TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                        ...+..+|++.|.+||++.+.+| .+..|-|||||+||-|+.|.-||+..+...                 +...+..
T Consensus       207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-----------------lvrQIs~  267 (668)
T KOG0611|consen  207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-----------------LVRQISR  267 (668)
T ss_pred             --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-----------------HHHHhhc
Confidence              34567899999999999998887 478999999999999999999998643211                 1111111


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ..-..++.+....-||+|||..+|++|.|+.+|....
T Consensus       268 GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  268 GAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            1112333445677899999999999999999998654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-37  Score=331.77  Aligned_cols=250  Identities=24%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +...+.||+|+||.||+|....+++.||||.+....   ......+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            345678999999999999998889999999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++|+|..++.... ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||++.......  
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence            99999998886543 3578889999999999999999998   99999999999999999999999999998653222  


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+    ..        .+.......
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~--------~~~~~~~~~  224 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV----DR--------RVKEDQEEY  224 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH----HH--------HhhcccccC
Confidence            223456899999999999999999999999999999999999999754332111101    00        001111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  777 (811)
                      +......+.+|+.+||+.||.+||+     ++++++
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            3345667899999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=378.38  Aligned_cols=269  Identities=24%  Similarity=0.468  Sum_probs=212.0

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccc
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  580 (811)
                      +++.++... ....+.||+|+||.||+|+...+++.||||+++.....    ...|++.+++++|||||+++|+|.+.+.
T Consensus       683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        683 ITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             hhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            444454432 33456899999999999999888899999998643222    2345888999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .++||||+++|+|.++++.    ++|..+.+|+.|||+||+|||+.+.++|+||||||+||+++.++.+++. ||.+...
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~  832 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL  832 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence            9999999999999999963    7799999999999999999997777799999999999999999988886 6665443


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ...     ....+++.|||||++.+..++.|+|||||||++|||++|+.||+......  ..+..|............++
T Consensus       833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  905 (968)
T PLN00113        833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWI  905 (968)
T ss_pred             ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhhee
Confidence            211     22357899999999999999999999999999999999999996432221  22334444333333333333


Q ss_pred             CCc----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          741 GED----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       741 ~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      ++.    ...+..+..++.+++.+|++.+|++||+|+||+++|+......
T Consensus       906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            332    2335566778999999999999999999999999998865533

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=332.11  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=226.2

Q ss_pred             hhHHHHHHhhhhhhcCcccceeEEEEEEcCC----CEEEEEEEccC-CchhhHHHHHHHHHHHhccCCCCccceecEEec
Q 003555          503 TGELERATNGFEEELGRGCFGAVYKGSICEG----NKIVAVKRLEN-PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ  577 (811)
Q Consensus       503 ~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~----~~~vAvK~l~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  577 (811)
                      --+|.++.....+.||+|.||.||+|...+-    .-.||||..+. ...+..+.|++|..+|++++||||++++|+|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            3467777788889999999999999998543    22699999886 445567789999999999999999999999986


Q ss_pred             ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          578 TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       578 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      . ..+||||.++-|.|.+||......++......++.||+.||+|||+.   ..|||||.++|||+.....+||+|||++
T Consensus       463 ~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  463 Q-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             c-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence            5 56899999999999999999888888899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhccc
Q 003555          658 KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       658 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      +.+..+.....+...-+..|||||.+.-..+|.++|||.|||.+|||+. |.+||..-...+-...+             
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------------  605 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------------  605 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------------
Confidence            9988777766666667889999999999999999999999999999986 88999865444322111             


Q ss_pred             chhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       737 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                        --++++..++.++..++.|+.+||..+|.+||++.|+...|+...+
T Consensus       606 --EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  606 --ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence              1134566788899999999999999999999999999887766433

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=329.17  Aligned_cols=246  Identities=25%  Similarity=0.364  Sum_probs=208.3

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      .-.+.||+|.||.||||.....++.||+|++.-. .....+++++|+.++.+++++||.+++|.+..+..++++||||.+
T Consensus        16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g   95 (467)
T KOG0201|consen   16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG   95 (467)
T ss_pred             ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence            3347899999999999999999999999998744 344467899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |++.+.|... ..+.+....-|++++..||.|||.+   +.+|||||+.||||..+|.+||+|||.+-.+....... ..
T Consensus        96 Gsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~t  170 (467)
T KOG0201|consen   96 GSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KT  170 (467)
T ss_pred             cchhhhhccC-CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cc
Confidence            9999999863 3336777788999999999999999   99999999999999999999999999998765444433 67


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      .+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..-...+         .+..      .+..+...
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------pk~~------PP~L~~~~  235 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------PKSA------PPRLDGDF  235 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------cCCC------CCcccccc
Confidence            89999999999999889999999999999999999999999765543221111         1111      11223366


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...+.+++..||++||++||++.++++
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            778999999999999999999999884

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.1e-37  Score=323.32  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=209.3

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ....+.+.++||+|+||.||+|...+.++.||+|+++.. ....+++.+|++.+++++|+||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            344566778999999999999999888899999998743 3345679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          587 FMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |+++++|.+++.... ..+.+..++.++.|+++||+|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999999997643 4578889999999999999999998   999999999999999999999999999987644332


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..|+.......    +    ....... .      ..
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~----~~~~~~~-~------~~  224 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----V----YELLEKG-Y------RM  224 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----H----HHHHHCC-C------CC
Confidence            22223345678999999988899999999999999999998 888886432111    0    0111100 0      11


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            12233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-37  Score=342.46  Aligned_cols=261  Identities=25%  Similarity=0.395  Sum_probs=205.3

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEecc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT  578 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  578 (811)
                      +....+.+.+.||+|+||.||+|+...     +.+.||||+++... ......+.+|+.+++.+ +|+||++++++|.+.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            345567788999999999999998633     23579999997543 33456788999999999 899999999999999


Q ss_pred             cceeEEEeecCCCCHHHHhhcCC---------------------------------------------------------
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVE---------------------------------------------------------  601 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~~~---------------------------------------------------------  601 (811)
                      ...++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999986421                                                         


Q ss_pred             ------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc-c
Q 003555          602 ------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-V  668 (811)
Q Consensus       602 ------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~-~  668 (811)
                                  ..+++.++++|+.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++......... .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        1246678899999999999999998   99999999999999999999999999998654332211 1


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ....++..|||||.+....++.++|||||||++|||++ |+.||..........   .    .... ..      ....+
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~---~----~~~~-~~------~~~~~  337 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY---K----MVKR-GY------QMSRP  337 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH---H----HHHc-cc------CccCC
Confidence            22345678999999988899999999999999999997 999987543221110   0    0000 00      00111


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      ...+.++.+++.+||+.+|.+||++.+|+++|+.+.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            123567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-37  Score=337.14  Aligned_cols=242  Identities=21%  Similarity=0.249  Sum_probs=199.7

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +.||+|+||.||+++...+++.||||+++...   ......+.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999889999999987432   233456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV  671 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  671 (811)
                      +|.+++.. ...+.+.+...++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~  155 (323)
T cd05571          81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence            99999976 34577888899999999999999998   99999999999999999999999999987532221 122345


Q ss_pred             ccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHH
Q 003555          672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL  751 (811)
Q Consensus       672 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (811)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +...            +.......+....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~------------~~~~~~~~p~~~~  219 (323)
T cd05571         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFEL------------ILMEEIRFPRTLS  219 (323)
T ss_pred             ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHHH------------HHcCCCCCCCCCC
Confidence            69999999999999999999999999999999999999996432111    0000            1111112233456


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          752 ETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      ..+.+++.+||+.||++||     ++.++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            7789999999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=303.65  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=213.9

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ce
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KK  581 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~  581 (811)
                      .+.+|.+.++||+|||+-||+++.-.+++.+|+|++.....++.+..++|++..++++|||+++++++...+.     +.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            3456788899999999999999988888999999998887888999999999999999999999999886544     48


Q ss_pred             eEEEeecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          582 LLVYEFMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      ||+++|...|+|.+.+...   +...++.+.+.|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999998764   34578999999999999999999998 3459999999999999999999999999987


Q ss_pred             ccCCCCCcc--------ccccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH
Q 003555          659 ILMPNQTGI--------VTGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV  727 (811)
Q Consensus       659 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~  727 (811)
                      ...-.-...        -..-..|..|.|||.+.   +..+++++|||||||+||+|+.|..||+......+.+.+..  
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv--  255 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV--  255 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee--
Confidence            643211110        11234788999999774   45688999999999999999999999986544332222110  


Q ss_pred             HHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                          ...   ++.-+   -....++.+.+++++|++.||.+||++.+++..++.+.
T Consensus       256 ----~n~---q~s~P---~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  256 ----QNA---QISIP---NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----ecc---ccccC---CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                000   01111   12237889999999999999999999999999988754

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-38  Score=301.38  Aligned_cols=246  Identities=22%  Similarity=0.284  Sum_probs=211.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .++++.||+|.||.||.|+.+.+.-.||+|++.+.   ..+.++++.+|+++-+.|+||||+++++++.+....||++||
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy  103 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY  103 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence            45678999999999999999999999999998653   234467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      .+.|+|...|...+ ...++.....++.|+|.||.|+|..   +|+||||||+|+|++.++..||+|||-+..-.   ..
T Consensus       104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~  177 (281)
T KOG0580|consen  104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN  177 (281)
T ss_pred             cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence            99999999998654 3467788889999999999999998   99999999999999999999999999987532   33


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      .....+||..|.+||...+..++...|+|++|++.||++.|.+||+.....+.                ..++...+...
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----------------YkrI~k~~~~~  241 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----------------YKRIRKVDLKF  241 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----------------HHHHHHccccC
Confidence            45568899999999999999999999999999999999999999986542211                12222223334


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +........+++..|+..+|.+|.+..|++..
T Consensus       242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 PSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            55677889999999999999999999998853

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=332.33  Aligned_cols=244  Identities=20%  Similarity=0.231  Sum_probs=201.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||.||+|....+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            456788999999999999999888999999986422   23455688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++... ..+.+.....++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++.....    
T Consensus        83 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          83 VPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            9999999999763 4577888899999999999999998   9999999999999999999999999999865332    


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......    +    ..        .+.......+
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~----~~--------~i~~~~~~~~  218 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----I----YE--------KILAGKLEFP  218 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H----HH--------HHHhCCcCCC
Confidence            123468999999999998889999999999999999999999997542211    0    00        0111111222


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPS-----MKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  778 (811)
                      ......+.+++.+||+.||.+||+     ++|+++.
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            334567889999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-37  Score=321.47  Aligned_cols=251  Identities=26%  Similarity=0.378  Sum_probs=202.9

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.++||+|+||.||++.++. ...+|+|.++.. ......+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            45667889999999999999865 467999988643 2335678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +|+|.+++......+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||+++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            9999999986555678899999999999999999998   9999999999999999999999999999865433322222


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||........   + ...    ....       ....+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~-~~i----~~~~-------~~~~~~  224 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---V-EMI----SRGF-------RLYRPK  224 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---H-HHH----HCCC-------CCCCCC
Confidence            3345678999999988889999999999999999999 8888864322111   0 111    0000       001111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .....+.+++.+||+.+|++||++++++++|.
T Consensus       225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            23457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=335.79  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=213.9

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+++.||.|+-|.|-+|++..+|+.+|||++.+..   ......+.+|+.+|+-+.|||++++++++.+..++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            345688999999999999999999999999996542   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++|.|+++|.. ++.+.+.+..+++.||..|+.|+|..   +|+||||||+|+|||+++++||+|||+|..-.++  ..
T Consensus        94 v~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--kl  167 (786)
T KOG0588|consen   94 VPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KL  167 (786)
T ss_pred             cCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--cc
Confidence            999999999987 45677899999999999999999998   9999999999999999999999999999864333  23


Q ss_pred             ccccccCCCccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          668 VTGVKGTRGYMSPEWQNSGLI-TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ..+.+|++.|.|||++.+.+| ..++||||.||+||.|++|+.||+...  -.. +             +.++-.+..+.
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~-L-------------LlKV~~G~f~M  231 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRV-L-------------LLKVQRGVFEM  231 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHH-H-------------HHHHHcCcccC
Confidence            566789999999999999887 479999999999999999999998321  111 1             11122223344


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh--hcccCCCCC
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILML--EGTMEIPVV  788 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L--~~~~~~~~~  788 (811)
                      +-+.+.++.+|+.+|+..||.+|.|++||++.-  .+...++.+
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            556777889999999999999999999999753  454444443

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=334.17  Aligned_cols=240  Identities=20%  Similarity=0.228  Sum_probs=197.3

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||+|+||.||+|+...+++.||+|++...   .......+.+|+.++++++|+||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999988899999998642   233456788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus        81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g  155 (312)
T cd05585          81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG  155 (312)
T ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence            999976 34578888999999999999999998   99999999999999999999999999998643222 22334568


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      |+.|+|||.+.+..++.++|||||||++|||++|+.||......       ...         ..+.......+......
T Consensus       156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~---------~~~~~~~~~~~~~~~~~  219 (312)
T cd05585         156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMY---------RKILQEPLRFPDGFDRD  219 (312)
T ss_pred             CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHH---------HHHHcCCCCCCCcCCHH
Confidence            99999999999999999999999999999999999999743211       100         11111122223345667


Q ss_pred             HHHHHHHcccCCCCCCCC---HHHHHH
Q 003555          754 MVRVGLLCIQDEPNLRPS---MKNVIL  777 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs---~~evl~  777 (811)
                      +.+++..||+.||.+||+   +.|++.
T Consensus       220 ~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         220 AKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            889999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.2e-37  Score=327.62  Aligned_cols=263  Identities=20%  Similarity=0.239  Sum_probs=203.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|+||.||+|+.+.+++.||||+++..  .....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            55678899999999999999988999999998643  2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++.|..+.. ....+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        83 ~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          83 EKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            9977765543 345678889999999999999999998   999999999999999999999999999987644333333


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHH-------h-hhhcccchhc
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN-------C-FIAKELSKLV  740 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~-------~-~~~~~~~~~~  740 (811)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+......       . ..........
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            4457899999999998888999999999999999999999999754332211111100000       0 0000000000


Q ss_pred             CCc----c----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          741 GED----E----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       741 ~~~----~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .+.    .    ......+..+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000    0    001123567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=341.32  Aligned_cols=255  Identities=26%  Similarity=0.387  Sum_probs=215.4

Q ss_pred             hhhhcCcccceeEEEEEEcCCCE----EEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          513 FEEELGRGCFGAVYKGSICEGNK----IVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      -.++||+|+||+||||.+...++    +||||++... ..+...+++.|+.+|.+++|+||++|+|+|..+. ..||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            35789999999999999855443    6999988653 4556789999999999999999999999998877 8899999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      |+.|+|.+|++.++..+-.+..+.|..|||+||.|||++   .+|||||.++||||..-..+||.|||+++.+.++... 
T Consensus       779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            999999999999888888899999999999999999999   9999999999999999999999999999998766543 


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......-.+.|||-|.+....++.++|||||||.+||++| |..|++.....+ ..       ..+.       ...++.
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~-------dlle-------~geRLs  920 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IP-------DLLE-------KGERLS  920 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hh-------HHHh-------ccccCC
Confidence            3334556778999999999999999999999999999998 778887543221 10       0111       122345


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      .++....++..++.+||..|+..||+++++...+.....-|
T Consensus       921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            57788899999999999999999999999999887754444

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-37  Score=336.57  Aligned_cols=245  Identities=20%  Similarity=0.227  Sum_probs=201.8

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .+.+.+.||+|+||.||+|+...+++.||||++....   ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            4567789999999999999999889999999986432   2334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++++|.+++... ..+.+.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        99 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         99 FVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             CCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            99999999999863 4567788888999999999999998   99999999999999999999999999998653322  


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                        ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    .    ..        .+.......
T Consensus       173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~----~~--------~i~~~~~~~  234 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----I----YE--------KILAGRLKF  234 (329)
T ss_pred             --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----H----HH--------HHhcCCcCC
Confidence              23568999999999999999999999999999999999999996432111    0    00        111111222


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPS-----MKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~  778 (811)
                      +......+.+++..||+.||.+||+     +++++..
T Consensus       235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            2234567889999999999999997     6777643

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=320.85  Aligned_cols=256  Identities=24%  Similarity=0.366  Sum_probs=208.1

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCC---CEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEG---NKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ..+.+.+.||+|+||.||+|.+...   ...||||.++... .....+|.+|+.++++++|+||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            4566788999999999999998643   4589999987543 34456799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++......+++..+++++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999987666788999999999999999999998   99999999999999999999999999998765222


Q ss_pred             C-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          665 T-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       665 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      . .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......    +....    ....       
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~----~~~~-------  225 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKAV----EDGY-------  225 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHHH----HcCC-------
Confidence            1 11222345678999999998899999999999999999998 888885432111    10110    0000       


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ....+...+..+.+++.+|++.+|++||++.||+++|+.+
T Consensus       226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111234456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=320.18  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=208.6

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      |+....+.+.++||+|++|.||+|.... ++.||||.++... ...+++.+|+.++++++|+||+++++++...+..++|
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            3455667888999999999999999765 5789999987533 3467799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          585 YEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999997643 4578999999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      ..........+..|+|||.+.+..++.++||||||+++|||++ |+.||.......   .+ .    ... ...      
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-~----~~~-~~~------  221 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL-Q----QVD-QGY------  221 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH-H----HHH-cCC------
Confidence            2222222334568999999998899999999999999999999 888886432111   01 0    000 000      


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ....+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            011223445788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=336.32  Aligned_cols=250  Identities=21%  Similarity=0.305  Sum_probs=204.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||.||+|+....++.||||+++...   ....+.+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            456789999999999999999888999999986432   23446788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++... ..+.+.+...++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....    .
T Consensus        83 ~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~  154 (333)
T cd05600          83 VPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y  154 (333)
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence            9999999999753 4567888899999999999999998   999999999999999999999999999986533    2


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc--cc
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED--EE  745 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~--~~  745 (811)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..+          ...+...  ..
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------~~~~~~~~~~~  224 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW----------KETLQRPVYDD  224 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc----------cccccCCCCCc
Confidence            23456899999999999889999999999999999999999999754322111111000          0000000  00


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .......++.+++.+||+.+|.+||+++++++.
T Consensus       225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            112346778899999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-36  Score=323.44  Aligned_cols=254  Identities=28%  Similarity=0.455  Sum_probs=206.8

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCC-----EEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGN-----KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .+.+.+.||+|+||.||+|.....+     ..||+|.+.... ......|.+|+..+++++|+||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            4567899999999999999986544     689999986433 3445679999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCC
Q 003555          584 VYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT  648 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~  648 (811)
                      +|||+++++|.+++....               ..+++..++.++.||+.||+|||+.   +++|+||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCc
Confidence            999999999999997532               3466788899999999999999998   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHH
Q 003555          649 AKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTW  726 (811)
Q Consensus       649 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~  726 (811)
                      +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+    +.. 
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~----~~~-  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE----VIE-  237 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH-
Confidence            99999999986543332 22333456889999999988899999999999999999998 999987532211    101 


Q ss_pred             HHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          727 VYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                         ....+..       ...+...+.++.+|+.+||+.+|.+||+++||++.|++
T Consensus       238 ---~i~~~~~-------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 ---MIRSRQL-------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHcCCc-------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               1111111       11233556789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.5e-37  Score=332.38  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=205.5

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ...+.+.++||+|+||.||+++....+..||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            344566788999999999999999889999999987542 3445679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++++|.+++... ..+.+..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++.......  
T Consensus        84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  158 (331)
T cd06649          84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  158 (331)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence            99999999999763 3577888899999999999999985  269999999999999999999999999997653321  


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhc------------
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK------------  734 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~------------  734 (811)
                       .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+    +...........            
T Consensus       159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCccccCccc
Confidence             233568999999999998899999999999999999999999996432211    000000000000            


Q ss_pred             ---------------------ccch-hcCC-ccc-cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          735 ---------------------ELSK-LVGE-DEE-VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       735 ---------------------~~~~-~~~~-~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                                           .+.. +... ... .......++.+++.+||+.||++|||++|+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                 0000 0000 000 1123456789999999999999999999998653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7e-37  Score=332.81  Aligned_cols=243  Identities=22%  Similarity=0.251  Sum_probs=200.1

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +.||+|+||.||++....+++.||||++...   .......+.+|+.+++.++|+||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999888999999998643   2334567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV  671 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  671 (811)
                      +|..++... ..+.+.+...++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~  155 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF  155 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence            999998763 4577889999999999999999998   99999999999999999999999999987543221 222345


Q ss_pred             ccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHH
Q 003555          672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL  751 (811)
Q Consensus       672 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (811)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..            .+.......+....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~------------~~~~~~~~~p~~~~  219 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFE------------LILMEDIKFPRTLS  219 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----HHH------------HhccCCccCCCCCC
Confidence            68999999999998899999999999999999999999996432211    000            00111112233456


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          752 ETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      ..+.+++.+||+.||.+||     ++.|+++.
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            6788999999999999997     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-36  Score=329.58  Aligned_cols=260  Identities=22%  Similarity=0.355  Sum_probs=207.2

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCE----EEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNK----IVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      ....+...+.||+|+||.||+|++..+++    .||||+++... ....+++.+|+.+++.++|+||++++|+|... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            34556677899999999999999765444    49999987543 34567899999999999999999999999865 56


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++|+||+++|+|.+++......+.+..+++++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence            799999999999999988766788899999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          662 PNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       662 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      ...... .....++..|+|||.+....++.++||||||+++|||++ |+.||.......    +...    ....     
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~----~~~~-----  227 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI----LEKG-----  227 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----HhCC-----
Confidence            433221 122334678999999999999999999999999999998 899986432111    1010    0000     


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                        .....+......+.+++..||+.+|.+||++.+++..|.....-
T Consensus       228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence              01111223445788999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.9e-37  Score=332.72  Aligned_cols=242  Identities=21%  Similarity=0.244  Sum_probs=198.8

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +.||+|+||.||+++...+++.||+|+++...   ......+.+|+.++++++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999998889999999986432   234456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV  671 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  671 (811)
                      +|..++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~  155 (323)
T cd05595          81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF  155 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence            999988763 4577889999999999999999998   99999999999999999999999999987532221 122345


Q ss_pred             ccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHH
Q 003555          672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL  751 (811)
Q Consensus       672 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (811)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||........   . .            .+.......+....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~-~------------~~~~~~~~~p~~~~  219 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F-E------------LILMEEIRFPRTLS  219 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---H-H------------HHhcCCCCCCCCCC
Confidence            689999999999999999999999999999999999999964322110   0 0            00111112233446


Q ss_pred             HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          752 ETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      ..+.+++.+||+.||.+||     ++.++++
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            6788999999999999998     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2e-36  Score=316.59  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=201.1

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ++||+|+||.||+|+...+++.||+|.+.... .+....+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999998888999999876443 44557799999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc-cccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVK  672 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~~~  672 (811)
                      .+++......+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........... ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            999976555678899999999999999999998   999999999999999999999999999876432211111 1112


Q ss_pred             cCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHH
Q 003555          673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL  751 (811)
Q Consensus       673 gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (811)
                      .+..|+|||.+.+..++.++||||||+++|||++ |..||........        .......       .....+...+
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~--------~~~~~~~-------~~~~~~~~~~  222 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT--------REAIEQG-------VRLPCPELCP  222 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH--------HHHHHcC-------CCCCCcccCC
Confidence            3457999999988889999999999999999998 7888754321110        0000000       0111223345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          752 ETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ..+.+++.+|++.+|++||++.+|.++|+
T Consensus       223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            67899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=314.51  Aligned_cols=264  Identities=22%  Similarity=0.303  Sum_probs=201.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHH--hccCCCCccceecEEeccc----ceeEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAV--RRTHHKNLVRLLGFCMQTS----KKLLV  584 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~g~~~~~~----~~~lV  584 (811)
                      ..+.+.||+|.||.||+|.+.  |+.||||++..   .++..+.+|.++.  ..|+|+||+.+++.-..++    .++||
T Consensus       213 I~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  213 IVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eEEEEEecCccccceeecccc--CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            445678999999999999995  57899999863   3445555655555  4569999999999877554    67999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhcc-----CCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      .+|.++|||.+||.+  ..++....++++..+|.||+|||-+.     +|.|.|||||.+||||..++.+.|+|+|||..
T Consensus       288 TdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             eecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            999999999999985  56778899999999999999999763     78999999999999999999999999999987


Q ss_pred             cCCCCC---ccccccccCCCccCccccccCC----C--CcccchHHHHHHHHHHHhC----------CCCCCCCCCccch
Q 003555          660 LMPNQT---GIVTGVKGTRGYMSPEWQNSGL----I--TVKSDVYSFGVVVLEIVCC----------RSNFEVNVSTADV  720 (811)
Q Consensus       660 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDV~S~Gvll~elltg----------~~p~~~~~~~~~~  720 (811)
                      ......   ......+||.+|||||++....    +  -..+||||||.++||+...          +.||....+.+..
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            654422   1234578999999999875442    1  1368999999999999752          4566654444332


Q ss_pred             hhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          721 VLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       721 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                      .   +.....+-.++++..+..+ ..+.+....|.++++.||..+|.-|-|+--+-+.|.++.+.
T Consensus       446 ~---eeMrkVVCv~~~RP~ipnr-W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  446 F---EEMRKVVCVQKLRPNIPNR-WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             H---HHHhcceeecccCCCCCcc-cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            1   1111111122333333222 22556778999999999999999999999999888776653

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.5e-36  Score=319.36  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=206.0

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ...+.+.++||+|+||.||+|...+ +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4456677999999999999999764 5679999986432 3457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++... ....++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.........
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999999754 34577889999999999999999998   9999999999999999999999999999876443322


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.||.......    .....    ... .      ...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~~----~~~-~------~~~  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSAL----QRG-Y------RMP  224 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHHH----HcC-C------CCC
Confidence            2233456778999999988889999999999999999998 888986432211    10110    000 0      011


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      .....+..+.+++.+|++.+|++||+++++.++|+.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            122345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-36  Score=318.47  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=210.4

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ...+.+.++||.|+||.||+|.... ++.+|+|.+..........+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            3457778999999999999999987 789999999876665677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++.... ..+.+.++..++.||+.||.|||+.   +++|+||||+||++++++.+||+|||++........ 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999999998643 4578899999999999999999998   999999999999999999999999999986543222 


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......++..|+|||.+....++.++||||||+++++|++ |+.||......+.   + ..    ...       .....
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~-~~----~~~-------~~~~~  224 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---Y-DQ----ITA-------GYRMP  224 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---H-HH----HHh-------CCcCC
Confidence            2223456778999999988889999999999999999998 7888864331110   0 00    000       01112


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      .+...+..+.+++.+|++.+|.+|||++++++.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            233455778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-36  Score=337.97  Aligned_cols=261  Identities=25%  Similarity=0.364  Sum_probs=205.8

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCC-----CEEEEEEEccCCch-hhHHHHHHHHHHHhccC-CCCccceecEEeccc
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEG-----NKIVAVKRLENPVE-EGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTS  579 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~  579 (811)
                      .+..+.+.++||+|+||.||+|+....     ...||||+++.... ...+.+.+|+.+++++. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            344566789999999999999987432     34799999975433 33467999999999996 999999999999999


Q ss_pred             ceeEEEeecCCCCHHHHhhcCC----------------------------------------------------------
Q 003555          580 KKLLVYEFMSKGSLENLLSNVE----------------------------------------------------------  601 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------  601 (811)
                      ..+|||||+++|+|.++|....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999986421                                                          


Q ss_pred             -------------------------------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC
Q 003555          602 -------------------------------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD  644 (811)
Q Consensus       602 -------------------------------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~  644 (811)
                                                           ..+++..+.+++.||++||+|||+.   +|+|+||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                                 1255677789999999999999998   999999999999999


Q ss_pred             CCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhh
Q 003555          645 DSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVL  722 (811)
Q Consensus       645 ~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~  722 (811)
                      +++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.........  
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence            9999999999999865433221 1223456788999999988899999999999999999997 88888643222111  


Q ss_pred             HHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          723 LSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       723 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                           ......+       .....+......+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus       350 -----~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         350 -----YNKIKSG-------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -----HHHHhcC-------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                 0000111       0111223446678999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=343.52  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=212.4

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC-CCCccceecE-Eec------ccce
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HKNLVRLLGF-CMQ------TSKK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~  581 (811)
                      +..+.+.|.+|||+.||.|++..++..+|+|++-...++..+...+|+++|++|+ |+|||.+++. ...      .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            3456688999999999999999887999999987777788889999999999996 9999999993 221      1367


Q ss_pred             eEEEeecCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          582 LLVYEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      +|.||||.+|.|-+++... ...+.+.++++|+.++++|+++||.. +++|||||||-+||||+.++..||||||.+...
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            9999999999999999754 45589999999999999999999985 788999999999999999999999999998754


Q ss_pred             CCCCC--cc---c---cccccCCCccCcccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHH
Q 003555          661 MPNQT--GI---V---TGVKGTRGYMSPEWQ---NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN  729 (811)
Q Consensus       661 ~~~~~--~~---~---~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~  729 (811)
                      .....  ..   .   -...-|+.|+|||++   .+..+++|+|||+|||+||-|+....||+...              
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------------  262 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------------  262 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------
Confidence            32221  00   0   013468999999965   67789999999999999999999999997431              


Q ss_pred             hhhhcccchhcCCcccc--ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCCC
Q 003555          730 CFIAKELSKLVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPV  787 (811)
Q Consensus       730 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~  787 (811)
                            ...++.....+  .+.++..|.+||..||++||.+||++-+|+..+-.+...+.
T Consensus       263 ------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  263 ------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                  12233333333  35899999999999999999999999999998877655443

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-36  Score=335.75  Aligned_cols=258  Identities=18%  Similarity=0.178  Sum_probs=198.6

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..|.+.++||+|+||.||++.....++.||||+..      ...+.+|+.++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            34667789999999999999999999999999753      235688999999999999999999999999999999998


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      . ++|..++... ..+.+..++.|+.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       166 ~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~  240 (391)
T PHA03212        166 K-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY  240 (391)
T ss_pred             C-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence            6 6898888763 4577889999999999999999998   999999999999999999999999999975433222233


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc----hhhHHHHHHHhhh---------hcc
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD----VVLLSTWVYNCFI---------AKE  735 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~----~~~l~~~~~~~~~---------~~~  735 (811)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+........    ...+.........         ...
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            446799999999999988999999999999999999999988753321110    0011000000000         000


Q ss_pred             cchhc---------C--Ccc--ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          736 LSKLV---------G--EDE--EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       736 ~~~~~---------~--~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +....         .  .+.  .........+.+++.+||+.||.+|||++|+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000         0  000  001134567889999999999999999999985

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-36  Score=300.95  Aligned_cols=261  Identities=18%  Similarity=0.245  Sum_probs=204.4

Q ss_pred             hhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh--hHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEEeec
Q 003555          513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--GERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVYEFM  588 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ey~  588 (811)
                      ..++|++|.||.||+|+++.+++.||+|+++...+.  -.-.-.+|+.+|.+++|||||.+-.+....  +..|||||||
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~  159 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV  159 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence            347899999999999999999999999999754321  123578999999999999999999988754  4799999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +. +|..++......+...+..-+..|+++|++|||++   .|+|||||++|+|+.+.|.+||+|||+|+.+... ....
T Consensus       160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~  234 (419)
T KOG0663|consen  160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPY  234 (419)
T ss_pred             Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccC
Confidence            88 99999999888888899999999999999999999   9999999999999999999999999999987544 3345


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhccc---c
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAKEL---S  737 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~---~  737 (811)
                      +..+-|.-|.|||++.+ ..|+...|+||+||++.||+++++.|....+.++...+....       |.-+..-..   .
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~  314 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM  314 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence            66778999999997755 469999999999999999999999998765544332211111       000000000   0


Q ss_pred             hhcCC-----ccccChH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          738 KLVGE-----DEEVDLR-TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 ~~~~~-----~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .....     +..+... ..+.-.+|+...+..||.+|-|++|-++.
T Consensus       315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            00000     0011111 34667889999999999999999998854

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-36  Score=317.15  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=204.2

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..+.+.+.||+|+||+||+|...+ +..+|||.++... ....++.+|+.++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            345677899999999999998754 4569999987432 33567999999999999999999999999998999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++......+.+.+++.++.||+.||+|||+.   +++|+||||+||++++++.+||+|||.++..........
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            99999999987555678999999999999999999998   999999999999999999999999999986544332222


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    ....    .....       .....
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~----~~~~~-------~~~~~  223 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TVEK----VSQGL-------RLYRP  223 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHH----HhcCC-------CCCCC
Confidence            23446678999999988889999999999999999998 888886433211    0010    01110       01111


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ......+.+++.+||+.+|.+||++.+|+..|+
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            223578899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.8e-36  Score=327.75  Aligned_cols=267  Identities=22%  Similarity=0.312  Sum_probs=204.7

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      +....|.+.++||+|+||.||++.+..++..+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            44566778899999999999999999888999999887542 33456799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++... ..+.+.....++.|++.||.|||+.  .+|+|+||||+|||+++++.+||+|||++...... 
T Consensus        82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999999763 3467788889999999999999974  26999999999999999999999999999764322 


Q ss_pred             CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh----hc------
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI----AK------  734 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~----~~------  734 (811)
                        ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+.........    ..      
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence              122346899999999999888999999999999999999999999754321110000000000000    00      


Q ss_pred             -----------------ccch-hcCC-cccc-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          735 -----------------ELSK-LVGE-DEEV-DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 -----------------~~~~-~~~~-~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                                       .... +... .... ......++.+++.+||+.||++||+++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                             0000 0000 0000 11234568899999999999999999999743

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-36  Score=329.78  Aligned_cols=260  Identities=25%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEecc-c
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT-S  579 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~  579 (811)
                      ...+.+.+.||+|+||.||+|...+     .++.||+|+++... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4567888999999999999997543     23689999987543 23346788999999999 899999999988754 5


Q ss_pred             ceeEEEeecCCCCHHHHhhcCC----------------------------------------------------------
Q 003555          580 KKLLVYEFMSKGSLENLLSNVE----------------------------------------------------------  601 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~----------------------------------------------------------  601 (811)
                      ..++++||+++++|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            6789999999999999986422                                                          


Q ss_pred             --CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc-ccccccCCCcc
Q 003555          602 --SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYM  678 (811)
Q Consensus       602 --~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~  678 (811)
                        ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              2467888999999999999999998   99999999999999999999999999998764332211 22345677899


Q ss_pred             CccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHH
Q 003555          679 SPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRV  757 (811)
Q Consensus       679 aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  757 (811)
                      |||.+.+..++.++|||||||++|||++ |..||......+.   +..    ..... .      ....+.....++.++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~-~------~~~~~~~~~~~~~~l  308 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---FCR----RLKEG-T------RMRAPEYATPEIYSI  308 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---HHH----HHhcc-C------CCCCCccCCHHHHHH
Confidence            9999999999999999999999999998 9999865322211   100    00000 0      011122345678999


Q ss_pred             HHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          758 GLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       758 ~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      +.+||+.+|++||++.||+++|+.+.+
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.4e-36  Score=319.97  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=207.5

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCC-----CEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecccc
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEG-----NKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  580 (811)
                      ...++.+.+.||+|+||.||+|...+.     .+.||||.++..... ..+.+.+|++++++++|+||+++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            345677889999999999999987543     478999999765444 56789999999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHhhcCC-------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC
Q 003555          581 KLLVYEFMSKGSLENLLSNVE-------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL  647 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~  647 (811)
                      .++||||+++++|.+++....             ..+.+.++..++.||+.||.|||+.   +++|+||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence            999999999999999997542             2356788899999999999999998   999999999999999999


Q ss_pred             CeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHH
Q 003555          648 TAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLST  725 (811)
Q Consensus       648 ~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~  725 (811)
                      .+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......    ...
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----~~~  235 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----VIE  235 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHH
Confidence            9999999999765332221 1223345788999999999999999999999999999998 999986432221    001


Q ss_pred             HHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          726 WVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..    ..+..       ...+......+.+++.+||+.+|.+||++.||++.|+.
T Consensus       236 ~~----~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 CI----TQGRL-------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HH----HcCCc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            10    11111       11122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.5e-36  Score=321.43  Aligned_cols=261  Identities=24%  Similarity=0.431  Sum_probs=209.8

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEc-----CCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      ++..+.+.+.||+|+||.||++...     .+...+|+|.+........+.+.+|++++++++|+||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3455667789999999999999852     23467999999876666677899999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCC------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCe
Q 003555          582 LLVYEFMSKGSLENLLSNVE------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTA  649 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~  649 (811)
                      ++||||+++++|.+++....            ..+++.+++.++.||+.||+|||++   +++||||||+||++++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999997432            2478899999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHH
Q 003555          650 KISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWV  727 (811)
Q Consensus       650 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~  727 (811)
                      ||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||....... .  +    
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~--~----  232 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-V--I----  232 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-H--H----
Confidence            99999999865433221 1222345778999999998899999999999999999998 888886432211 0  0    


Q ss_pred             HHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                       .....+...       ..+...+..+.+++.+||+.+|.+||++.||++.|+.+...
T Consensus       233 -~~i~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         233 -ECITQGRVL-------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -HHHHcCCcC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence             011111111       11122345789999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-36  Score=324.54  Aligned_cols=262  Identities=18%  Similarity=0.255  Sum_probs=201.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      |.+.++||+|+||.||+|....+++.||+|+++... ......+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            566789999999999999999889999999986432 2334578899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      + +|.+++......+.+.....++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus        87 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~~  161 (288)
T cd07871          87 S-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYS  161 (288)
T ss_pred             c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cccc
Confidence            5 99999977666678889999999999999999998   99999999999999999999999999997643221 1223


Q ss_pred             ccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhh-hhcccchhc
Q 003555          670 GVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCF-IAKELSKLV  740 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~-~~~~~~~~~  740 (811)
                      ...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.........       +... .........
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            4567899999998765 568999999999999999999999997543322111110000       0000 000001100


Q ss_pred             CCc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          741 GED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       741 ~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .+.      .........++.+++.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000      0011223457889999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.6e-36  Score=324.92  Aligned_cols=263  Identities=19%  Similarity=0.242  Sum_probs=199.6

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .|.+.++||+|+||.||+|+...+++.||||++..... .....+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            45667899999999999999988889999999864332 33456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      + ++|.+++......+....+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ....
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  160 (303)
T cd07869          86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTY  160 (303)
T ss_pred             C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-CccC
Confidence            6 588888877666678888999999999999999998   9999999999999999999999999998754322 1222


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhc-------------
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK-------------  734 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~-------------  734 (811)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......................             
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            34568999999998765 4578899999999999999999999975432211111000000000000             


Q ss_pred             -ccchhcCCccc---cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          735 -ELSKLVGEDEE---VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       735 -~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                       ...........   ........+.+++..||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000000000   00112356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5e-36  Score=329.78  Aligned_cols=247  Identities=26%  Similarity=0.340  Sum_probs=195.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.++||+|+||.||+|+...+++.||||++.... ....+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            345688999999999999998888999999986443 3345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|....     ...+..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus       156 ~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  226 (353)
T PLN00034        156 GGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DPCN  226 (353)
T ss_pred             CCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cccc
Confidence            99986543     234567788999999999999998   99999999999999999999999999998654322 1223


Q ss_pred             ccccCCCccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          670 GVKGTRGYMSPEWQNS-----GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      ...||..|+|||.+..     ...+.++|||||||++|||++|+.||......+.. .+..   ..        ......
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~---~~--------~~~~~~  294 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA-SLMC---AI--------CMSQPP  294 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHH---HH--------hccCCC
Confidence            4578999999998743     23456899999999999999999999733222111 0000   00        001111


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ........++.+++.+||+.||++||++.|+++.
T Consensus       295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2233456778999999999999999999999975

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.3e-37  Score=333.37  Aligned_cols=248  Identities=21%  Similarity=0.222  Sum_probs=202.6

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCC-EEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGN-KIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~-~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      ....+.+.++||+|+||.||+|+....+ ..||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3445777899999999999999876544 68999998542   2234567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       108 lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            999999999999999763 4577888899999999999999998   999999999999999999999999999986532


Q ss_pred             CCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    .    ...        +...
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~----~~~--------i~~~  243 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----I----YQK--------ILEG  243 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----H----HHH--------HhcC
Confidence            2    234568999999999988889999999999999999999999997542211    0    000        1111


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      ....+......+.+++.+|++.+|++|+     +++++++.
T Consensus       244 ~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1112233456688999999999999995     89988764

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=315.90  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.+.||+|+||.||+|.++. +..+|+|.+.... .....+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            45678899999999999998864 5689999986432 234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++......+++..+..++.||+.||+|||+.   +++|+||||+||++++++.+||+|||+++...........
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            9999999987666778999999999999999999998   9999999999999999999999999999865433222222


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   . .   . ....       .....+.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-~---~-~~~~-------~~~~~~~  224 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V-E---S-VSAG-------YRLYRPK  224 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H-H---H-HHcC-------CcCCCCC
Confidence            2334568999999988899999999999999999999 7888864322110   0 0   0 0000       0111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ..+..+.+++.+||+.+|++||++.|++++|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            3566899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.1e-36  Score=318.65  Aligned_cols=258  Identities=24%  Similarity=0.324  Sum_probs=204.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCE----EEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNK----IVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      .+.+.+.||+|+||+||+|.+...++    .+++|.+..... ....++..|+..+++++|+||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence            34556889999999999999865554    488888764332 334678889999999999999999998864 457899


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      +||+++|+|.+++......+++..+..++.||+.||+|||+.   +++|+||||+|||+++++.+||+|||+++......
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            999999999999987666788999999999999999999998   99999999999999999999999999998764333


Q ss_pred             C-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          665 T-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       665 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      . .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.......    +.+..    .....      
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~----~~~~~------  229 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLL----EKGER------  229 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHH----HCCCc------
Confidence            2 22234557789999999988899999999999999999998 998886432111    11111    11110      


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                       ...+......+.+++.+|++.+|.+||++.|+++.|+....-+
T Consensus       230 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         230 -LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence             0111123456788999999999999999999999998866543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4e-36  Score=319.54  Aligned_cols=246  Identities=22%  Similarity=0.322  Sum_probs=198.8

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||+|+||+||++....+++.||+|++....   ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999998888999999986432   22335678899999999999999999999999999999999999999


Q ss_pred             HHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          594 ENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       594 ~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ..++...   ...+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            9887542   34578899999999999999999998   999999999999999999999999999976543322 2234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..|++.|+|||.+.+..++.++||||||+++|||++|+.||............   .         ..........+...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~  224 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---K---------QRILNDSVTYPDKF  224 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH---H---------HhhcccCCCCcccC
Confidence            57899999999999999999999999999999999999999754322111100   0         01111111223345


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      +..+.+++..||+.||++||     +++++++.
T Consensus       225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            67789999999999999999     67777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.2e-36  Score=327.16  Aligned_cols=241  Identities=21%  Similarity=0.299  Sum_probs=193.8

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhc-cCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|+....++.||||+++...   ....+.+..|..++.. .+|+||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998888999999986432   2233455667777665 4899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|..++... ..+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~  155 (316)
T cd05592          81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence            9999998763 4577888899999999999999998   99999999999999999999999999998643322 22334


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   .+ .            .+.......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~-~------------~i~~~~~~~~~~~  219 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LF-D------------SILNDRPHFPRWI  219 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HH-H------------HHHcCCCCCCCCC
Confidence            568999999999998899999999999999999999999997543211   00 0            0111111223344


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMK-NVI  776 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~-evl  776 (811)
                      ...+.+++..||+.+|.+||++. +++
T Consensus       220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         220 SKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            56788999999999999999986 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.5e-36  Score=321.12  Aligned_cols=259  Identities=25%  Similarity=0.412  Sum_probs=209.5

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      ..+.+.+.||+|+||.||+|....     ....+++|.++.......+.+.+|+..+++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            345566889999999999998532     345799999987666667789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCC
Q 003555          584 VYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT  648 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~  648 (811)
                      ||||+++++|.+++....               ..+++..++.++.||+.||+|||++   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999996532               2367889999999999999999999   9999999999999999999


Q ss_pred             eEEEecCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHH
Q 003555          649 AKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTW  726 (811)
Q Consensus       649 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~  726 (811)
                      +||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    .   
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~---  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----V---  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----H---
Confidence            99999999986543322 11223456788999999998999999999999999999998 999886432211    0   


Q ss_pred             HHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          727 VYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                       ..........       ......+..+.+++.+||+.+|.+||++++|+++|+.+...
T Consensus       235 -~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 -IECITQGRVL-------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -HHHHhCCCCC-------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             0111111111       11223456789999999999999999999999999987553

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=321.92  Aligned_cols=249  Identities=18%  Similarity=0.217  Sum_probs=202.0

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .+.+.||+|+||.||+++-+++++.+|+|++++..   ....+..+.|-.+|....++.||+|+-.|.+.+.+||||||.
T Consensus       144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl  223 (550)
T KOG0605|consen  144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL  223 (550)
T ss_pred             hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence            34578999999999999999999999999998643   344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC------
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP------  662 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~------  662 (811)
                      +||++..+|.+. ..+.+......+.+++.|+.-||+.   ++|||||||+|+|||..|++||+||||+.-+..      
T Consensus       224 PGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~  299 (550)
T KOG0605|consen  224 PGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES  299 (550)
T ss_pred             CCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence            999999999874 4566777777888999999999999   999999999999999999999999999853211      


Q ss_pred             ----------------CCCc-----c-------------------ccccccCCCccCccccccCCCCcccchHHHHHHHH
Q 003555          663 ----------------NQTG-----I-------------------VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVL  702 (811)
Q Consensus       663 ----------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~  702 (811)
                                      .+..     .                   ....+|||.|||||++.+..|+..+|.|||||++|
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Imy  379 (550)
T KOG0605|consen  300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMY  379 (550)
T ss_pred             hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHH
Confidence                            0000     0                   01246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 003555          703 EIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS---MKNVIL  777 (811)
Q Consensus       703 elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~  777 (811)
                      |||.|-+||....+.+..-.+..|.......            .......+..+||.+|+. ||++|.-   ++||-+
T Consensus       380 EmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  380 EMLVGYPPFCSETPQETYRKIVNWRETLKFP------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence            9999999999876655443333332111111            112234788999999998 9999965   666654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-36  Score=343.45  Aligned_cols=249  Identities=16%  Similarity=0.223  Sum_probs=203.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCC-CEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEG-NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      |.+.+.||+|+||.||+|....+ ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            66778999999999999998766 67899998765555556678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-
Q 003555          590 KGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-  665 (811)
Q Consensus       590 ~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-  665 (811)
                      +|+|.++|.+.   ...+.+.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988643   23467888889999999999999998   999999999999999999999999999987643322 


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......       .... ...+..       ..
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~-~~~~~~-------~~  290 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQ-VLYGKY-------DP  290 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhCCC-------CC
Confidence            12334569999999999999999999999999999999999999996432111       0000 001111       11


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .+......+.+++..||+.+|++||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            12234567899999999999999999999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=331.03  Aligned_cols=242  Identities=21%  Similarity=0.271  Sum_probs=205.8

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ....|.++||+|.||.|+++..+.+++.+|||++++..   ....+..+.|.+++... +||.|+.++..+...++.+.|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            34566789999999999999999999999999998753   45566788888888777 599999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+.||++..+.+  ...+++....-++..|+.||.|||++   +|||||||.+|||||.+|.+||+||||++......
T Consensus       448 mey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            99999999444433  45677777788999999999999999   99999999999999999999999999999754222


Q ss_pred             CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                       ..+.+.+||+.|||||++.+..|+...|.|||||+||||+.|..||..+.+++-                ...++....
T Consensus       523 -~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~----------------FdsI~~d~~  585 (694)
T KOG0694|consen  523 -DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV----------------FDSIVNDEV  585 (694)
T ss_pred             -CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHhcCCC
Confidence             246678999999999999999999999999999999999999999986654321                122333334


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      ..+...+.+.+.|+.++|..+|++|.-+
T Consensus       586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            4566778899999999999999999877

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-37  Score=326.48  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=213.7

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecccc-eeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK-KLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e  586 (811)
                      .|...+++|+|+||.++..+++.+++.+++|.+.-  ......+...+|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~   84 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME   84 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence            46677899999999999999999999999998853  334444578999999999999999999999999988 999999


Q ss_pred             ecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          587 FMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |++||+|.+.+.+.+ ..+.++.+.+++.|++.|+.|||++   .|+|||||+.||+++.++.+||.|||+|+.+.+.. 
T Consensus        85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            999999999998876 4567888999999999999999988   99999999999999999999999999999886554 


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......||+.||.||++.+.+|..|+|||||||++|||++-+++|.......    +        ..+......   ..
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----L--------i~ki~~~~~---~P  225 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----L--------ILKINRGLY---SP  225 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----H--------HHHHhhccC---CC
Confidence            23456789999999999999999999999999999999999999998643221    1        111111111   23


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+..++.++..++..|++.+|..||++.+++.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            455678899999999999999999999999865

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.3e-36  Score=329.29  Aligned_cols=263  Identities=18%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l  583 (811)
                      |.+.++||+|+||.||+|+...+++.||||++...  .......+.+|+.++++++||||+++++++....     ..++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            45678999999999999999888999999998643  2234457889999999999999999999986432     4799


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ||||+. ++|.+++... ..+++..+..++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 v~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          82 VFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             EEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            999996 5899988753 4578899999999999999999999   9999999999999999999999999999865332


Q ss_pred             CCc--cccccccCCCccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhh
Q 003555          664 QTG--IVTGVKGTRGYMSPEWQNS--GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFI  732 (811)
Q Consensus       664 ~~~--~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~  732 (811)
                      ...  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+....       .....
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            211  1234568999999998865  678999999999999999999999996543211100000000       00000


Q ss_pred             hcccchh---cCCcc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          733 AKELSKL---VGEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       733 ~~~~~~~---~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .......   +....     ...+.....+.+++.+||+.+|++||+++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000   00000     0011234567899999999999999999999854

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.3e-36  Score=315.80  Aligned_cols=256  Identities=23%  Similarity=0.393  Sum_probs=206.0

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCC---EEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGN---KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ..+...+.||+|+||.||+|+...++   ..+|+|+++... ......+.+|++++++++|+|++++.+++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            34556789999999999999986544   379999987543 34456799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++......+++.++..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999987666788999999999999999999998   99999999999999999999999999998664332


Q ss_pred             Ccccc--ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          665 TGIVT--GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       665 ~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      .....  ....+..|+|||.+....++.++|||||||++|||++ |+.||.......    +   . ......       
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~----~---~-~~i~~~-------  226 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----V---M-KAINDG-------  226 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH----H---H-HHHhcC-------
Confidence            22111  1223567999999988889999999999999999997 999986432211    0   0 001100       


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ............+.+++.+|++.+|.+||++.+|++.|+++
T Consensus       227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            01111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.1e-36  Score=315.74  Aligned_cols=255  Identities=20%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..+.+.++||+|+||.||+|+...+++.||+|++..........+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            45677899999999999999998888999999987655555667889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++.. ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.+||+|||++....... ...
T Consensus        89 ~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~  163 (267)
T cd06646          89 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKR  163 (267)
T ss_pred             CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-ccc
Confidence            99999999875 34567889999999999999999998   99999999999999999999999999998653222 112


Q ss_pred             cccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          669 TGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ....++..|+|||.+.   ...++.++|||||||++|||++|+.|+............        ....   .......
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~---~~~~~~~  232 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSN---FQPPKLK  232 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCC---CCCCCCc
Confidence            3346888999999874   345788999999999999999999998643222111000        0000   0001111


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ........+.+++.+||+.+|++||+++++++.|
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1223456889999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.3e-36  Score=314.34  Aligned_cols=241  Identities=21%  Similarity=0.359  Sum_probs=193.1

Q ss_pred             hhcCcccceeEEEEEEcCC------------CEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          515 EELGRGCFGAVYKGSICEG------------NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~------------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      +.||+|+||.||+|+....            ...||+|.+..........|.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4699999999999986432            2369999987655556678899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCC-------eEEEecC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT-------AKISNFS  655 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~-------~kL~DFG  655 (811)
                      +||||+++++|..++......+++..+++++.||++||+|||+.   +|+||||||+|||++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999987666688999999999999999999998   9999999999999987664       8999999


Q ss_pred             CccccCCCCCccccccccCCCccCccccc-cCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          656 LAKILMPNQTGIVTGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIV-CCRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       656 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~ell-tg~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      ++......     ....++..|+|||.+. ...++.++|||||||++|||+ .|+.|+......+.    ..     ...
T Consensus       158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~-----~~~  223 (262)
T cd05077         158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ER-----FYE  223 (262)
T ss_pred             CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HH-----HHh
Confidence            98754322     2345788899999876 567899999999999999998 57777653221110    00     000


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .        ...........+.+|+.+||+.||.+||++.+|++.|+
T Consensus       224 ~--------~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 G--------QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             c--------CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0        00111123457889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.8e-36  Score=317.82  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=202.2

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccc
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  580 (811)
                      ....+.+.++||+|+||.||+|....     .++.||||++.... .....++.+|+.+++.++|+||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            34557778999999999999998642     34689999986432 2345678999999999999999999999999999


Q ss_pred             eeEEEeecCCCCHHHHhhcCCC---------CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEE
Q 003555          581 KLLVYEFMSKGSLENLLSNVES---------GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI  651 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~---------~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL  651 (811)
                      .++||||+++++|.+++.....         ..++..++.++.|++.||.|||+.   +++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999975322         246778899999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHH
Q 003555          652 SNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYN  729 (811)
Q Consensus       652 ~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~  729 (811)
                      +|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||....... .  + .    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-~--~-~----  232 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-V--L-R----  232 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-H--H-H----
Confidence            9999997654322211 112345778999999998899999999999999999999 677876432111 0  0 0    


Q ss_pred             hhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          730 CFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ........       ..+......+.+++.+|++.+|++||++.|++++|++
T Consensus       233 ~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVMEGGLL-------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHcCCcC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            01111111       1122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-36  Score=327.46  Aligned_cols=243  Identities=20%  Similarity=0.257  Sum_probs=197.6

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|+...+++.||||+++...   ....+.+..|.+++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999998888999999986532   23345677888888866 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++... ..+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (321)
T cd05591          81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT  155 (321)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence            9999998763 4577888899999999999999999   99999999999999999999999999987543222 12234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||........   + .            .+.......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~-~------------~i~~~~~~~p~~~  219 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---F-E------------SILHDDVLYPVWL  219 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---H-H------------HHHcCCCCCCCCC
Confidence            5689999999999988999999999999999999999999975432110   0 0            0111111122234


Q ss_pred             HHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRP-------SMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RP-------s~~evl~~  778 (811)
                      ...+.+++..||+.+|.+||       +++++++.
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            56788999999999999999       78888743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-36  Score=326.94  Aligned_cols=242  Identities=21%  Similarity=0.273  Sum_probs=196.3

Q ss_pred             hhcCcccceeEEEEEEc---CCCEEEEEEEccCCc----hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          515 EELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV----EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ++||+|+||.||+++..   ..++.||||+++...    ......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999864   356789999986432    22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++... ..+.+.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  156 (323)
T cd05584          82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V  156 (323)
T ss_pred             CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence            9999999999763 4466778888999999999999998   999999999999999999999999999875432221 2


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||........                ...+.......+
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----------------~~~~~~~~~~~~  220 (323)
T cd05584         157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----------------IDKILKGKLNLP  220 (323)
T ss_pred             ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCCCCCC
Confidence            2345689999999999888899999999999999999999999975322110                011111122233


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      ......+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            34556789999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=318.08  Aligned_cols=251  Identities=25%  Similarity=0.325  Sum_probs=202.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ++..++||+|+||+||++....+++.||||++....   ......+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            455688999999999999998888999999986432   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-  157 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence            99999999886543 4578889999999999999999998   999999999999999999999999999986532221 


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                       .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...........+    ..        .+.......
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~----~~--------~~~~~~~~~  224 (285)
T cd05605         158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV----ER--------RVKEDQEEY  224 (285)
T ss_pred             -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH----HH--------Hhhhccccc
Confidence             23346899999999998888999999999999999999999999754322111000    00        011111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      +......+.+++..||+.||.+||     +++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            334567789999999999999999     78888643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=6.3e-36  Score=332.03  Aligned_cols=263  Identities=22%  Similarity=0.363  Sum_probs=207.4

Q ss_pred             hHHHHHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCch-hhHHHHHHHHHHHhccC-CCCccceecEEe
Q 003555          504 GELERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPVE-EGERKFQAEMAAVRRTH-HKNLVRLLGFCM  576 (811)
Q Consensus       504 ~el~~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~  576 (811)
                      .++....+.+.++||+|+||.||+|++..     ..+.||||+++.... ...+.+.+|+.++.++. |+||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            45566667778999999999999999642     346899999975433 33457889999999997 999999999999


Q ss_pred             cccceeEEEeecCCCCHHHHhhcCC-------------------------------------------------------
Q 003555          577 QTSKKLLVYEFMSKGSLENLLSNVE-------------------------------------------------------  601 (811)
Q Consensus       577 ~~~~~~lV~ey~~~gsL~~~l~~~~-------------------------------------------------------  601 (811)
                      ..+..++|+||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999996532                                                       


Q ss_pred             ------------------------------------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCC
Q 003555          602 ------------------------------------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPR  639 (811)
Q Consensus       602 ------------------------------------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~  639 (811)
                                                                ..+++...+.++.||+.||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                      1245667788999999999999998   9999999999


Q ss_pred             cEEECCCCCeEEEecCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 003555          640 NILLDDSLTAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVST  717 (811)
Q Consensus       640 NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~  717 (811)
                      |||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986533222 11223456788999999988889999999999999999998 88888643221


Q ss_pred             cchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       718 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      +.   +    ......+       .+...+......+.+++..||+.+|.+||+++||++.|+.+.
T Consensus       349 ~~---~----~~~~~~~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 EQ---F----YNAIKRG-------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HH---H----HHHHHcC-------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            11   0    0000001       011122334578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-36  Score=329.78  Aligned_cols=243  Identities=20%  Similarity=0.242  Sum_probs=198.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +.||+|+||.||++.....++.||+|+++...   ......+..|+++++.++|+||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999998889999999986432   233456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhh-ccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      +|..++... ..+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (325)
T cd05594          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT  155 (325)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence            999988763 457788999999999999999997 6   89999999999999999999999999987543222 12234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +...            +.......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~------------i~~~~~~~p~~~  219 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFEL------------ILMEEIRFPRTL  219 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH----HHHH------------HhcCCCCCCCCC
Confidence            569999999999999999999999999999999999999996432211    0000            001111122334


Q ss_pred             HHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      ...+.+++.+||+.||++|+     ++.++++.
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            56788999999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-36  Score=326.71  Aligned_cols=237  Identities=21%  Similarity=0.313  Sum_probs=194.0

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||+||+|+.+.+++.||||+++..   .....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999988899999998643   223445677888888876 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~  155 (320)
T cd05590          81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST  155 (320)
T ss_pred             chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence            9999998764 4577888999999999999999998   99999999999999999999999999987543222 12334


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..    .        +.......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~----~--------i~~~~~~~~~~~  219 (320)
T cd05590         156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD----LFE----A--------ILNDEVVYPTWL  219 (320)
T ss_pred             cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH----HHH----H--------HhcCCCCCCCCC
Confidence            568999999999998899999999999999999999999997543211    000    0        111111122234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      ...+.+++.+||+.||.+||++
T Consensus       220 ~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         220 SQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CHHHHHHHHHHcccCHHHCCCC
Confidence            5678899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-36  Score=332.09  Aligned_cols=251  Identities=22%  Similarity=0.238  Sum_probs=204.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||+||++.....++.||||+++...   .+..+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            456789999999999999999889999999987532   23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++......+.+.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            999999999987666788899999999999999999998   99999999999999999999999999998765443333


Q ss_pred             ccccccCCCccCccccc------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          668 VTGVKGTRGYMSPEWQN------SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      .....||+.|+|||++.      ...++.++|||||||++|||++|+.||.........       ...........   
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-------~~i~~~~~~~~---  229 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY-------NNIMNFQRFLK---  229 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH-------HHHHcCCCccC---
Confidence            33457899999999876      456789999999999999999999999754322110       00000000000   


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                        ....+.....+.+++..|++ +|.+||++++++.
T Consensus       230 --~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 --FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              01122345678889999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-35  Score=313.13  Aligned_cols=255  Identities=27%  Similarity=0.422  Sum_probs=204.4

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ....+.+.++||+|+||.||+|++.++ ..||+|+++... ...+.+.+|++++++++|+||+++++++. ....++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   80 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence            345678889999999999999988654 569999987432 34567899999999999999999999875 456799999


Q ss_pred             ecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          587 FMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||.++.......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999999997643 3468899999999999999999998   999999999999999999999999999986644332


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||.......   ..     ......       ...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~-----~~~~~~-------~~~  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL-----DQVERG-------YRM  222 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH-----HHHhcC-------CCC
Confidence            22233456778999999988889999999999999999999 777876432111   00     000000       011


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .........+.+++.+|++.+|++||++++++++|+..
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            12334566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-35  Score=309.29  Aligned_cols=247  Identities=25%  Similarity=0.371  Sum_probs=200.5

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      +.||+|+||.||+|... +++.||+|++.... .+....+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46999999999999975 46789999987544 33445789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++......+.+..++.++.|++.+|.|||+.   +++|+||||+||++++++.+||+|||++...............+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            999987666678999999999999999999998   99999999999999999999999999997543322222222344


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLE  752 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (811)
                      +..|+|||.+....++.++||||||+++||+++ |..||.......    ...    .....       .....+...+.
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~----~~~~~-------~~~~~~~~~~~  221 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----ARE----QVEKG-------YRMSCPQKCPD  221 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHH----HHHcC-------CCCCCCCCCCH
Confidence            678999999988889999999999999999998 888986432111    000    00000       01112233467


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          753 TMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       753 ~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .+.+++.+|++.+|++||++.|+++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            8999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-36  Score=333.35  Aligned_cols=255  Identities=20%  Similarity=0.225  Sum_probs=203.0

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      ....+.+.++||+|+||.||+++...+++.||+|++...   .......+.+|+.+++.++|+||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            345667778999999999999999988999999998642   22334567899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ||||+++|+|.+++...  .++......++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999999753  466778888999999999999998   9999999999999999999999999999876443


Q ss_pred             CCccccccccCCCccCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSG----LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      .........||+.|+|||.+.+.    .++.++|||||||++|||++|+.||........   .     ........ .+
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~-----~~i~~~~~-~~  266 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y-----SKIMDHKN-SL  266 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---H-----HHHHcCCC-cC
Confidence            32223346799999999987643    478999999999999999999999975432110   0     00000000 00


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNL--RPSMKNVILM  778 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  778 (811)
                         ........+..+.+++..||+.+|.+  ||++.|++..
T Consensus       267 ---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 ---TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ---CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence               00112234678889999999999987  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.6e-36  Score=317.15  Aligned_cols=256  Identities=25%  Similarity=0.377  Sum_probs=203.8

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCC-----CEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEG-----NKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      -..+.+.++||+|+||.||+|.....     ++.||||+++..... ..+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            34577889999999999999987542     468999999754433 346688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcC---------------CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC
Q 003555          582 LLVYEFMSKGSLENLLSNV---------------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS  646 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~  646 (811)
                      ++++||+++++|.+++...               ...+.+..+.+++.|++.||.|||+.   +|+||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            9999999999999998532               12356778889999999999999998   99999999999999999


Q ss_pred             CCeEEEecCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHH
Q 003555          647 LTAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLS  724 (811)
Q Consensus       647 ~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~  724 (811)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+    . 
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~-  235 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----V-  235 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH----H-
Confidence            9999999999886543322 12233456789999999988889999999999999999998 777776432111    0 


Q ss_pred             HHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          725 TWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                         .........       ...+...+..+.+++..|++.+|.+||++.+|++.|+.
T Consensus       236 ---~~~i~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 ---IEMIRNRQV-------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHHHHcCCc-------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               011111111       11233456678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.2e-36  Score=314.46  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=206.5

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCC---CEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEG---NKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ..+.+.+.||+|+||.||+|.....   ...+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            4566778999999999999987533   3479999987543 34456899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++......+++.+++.++.|++.||+|||+.   +++|+||||+|||++.++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999987666678899999999999999999998   99999999999999999999999999998765433


Q ss_pred             Cccc--cccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          665 TGIV--TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       665 ~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ....  ....++..|+|||.+.+..++.++||||||+++||+++ |..||......+..    ...    ... .     
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~----~~~----~~~-~-----  226 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI----KAI----EEG-Y-----  226 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH----HHH----hCC-C-----
Confidence            2221  12233568999999998889999999999999999886 99998643322110    110    000 0     


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                       ........+..+.+++.+|++.+|.+||+|.++++.|+..
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 -RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             0111223456788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.1e-36  Score=327.69  Aligned_cols=252  Identities=18%  Similarity=0.212  Sum_probs=200.2

Q ss_pred             hhhhhhcCcccceeEEEEEEc---CCCEEEEEEEccCCc----hhhHHHHHHHHHHHhcc-CCCCccceecEEeccccee
Q 003555          511 NGFEEELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV----EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  582 (811)
                      +.+.++||+|+||.||+++..   ..++.||+|++.+..    ....+.+..|+.+++++ +|+||+++++++.+.+..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            456789999999999998864   356899999986421    23345688899999999 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +||||+++|+|.+++.. ...+.+.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          82 LILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            99999999999999976 34577888999999999999999998   999999999999999999999999999987544


Q ss_pred             CCCccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+..            .+..
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~------------~~~~  225 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR------------RILK  225 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH------------HHhc
Confidence            433333456799999999998765 478899999999999999999999975432221111110            0111


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      .....+......+.+++.+||+.||++||     +++++++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11122334556788999999999999999     67777643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-35  Score=310.72  Aligned_cols=247  Identities=24%  Similarity=0.336  Sum_probs=198.9

Q ss_pred             hcCcccceeEEEEEEc--CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCC
Q 003555          516 ELGRGCFGAVYKGSIC--EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGS  592 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~--~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gs  592 (811)
                      +||+|+||.||+|.+.  +.+..||+|++.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999875  445679999987543 334567999999999999999999999885 457899999999999


Q ss_pred             HHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc--ccc
Q 003555          593 LENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI--VTG  670 (811)
Q Consensus       593 L~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~--~~~  670 (811)
                      |.+++......+++..+++++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........  ...
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999987666788999999999999999999998   99999999999999999999999999998654332211  122


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ..++..|+|||.+....++.++||||||+++||+++ |+.||.......    .    .......       .....+..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~----~~~~~~~-------~~~~~~~~  222 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----V----MSFIEQG-------KRLDCPAE  222 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----H----HHHHHCC-------CCCCCCCC
Confidence            234578999999988889999999999999999996 999986432211    0    0001111       11122344


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ....+.+++..||+.+|++||++.+|.+.|+.
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            56788899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=334.69  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=204.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      |.+.++||+|+||+||+|+...+++.||||+++...   ......+.+|+.++..++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            556789999999999999999889999999986432   23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC---
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ---  664 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~---  664 (811)
                      +++++|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        83 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          83 MPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999999874 5678889999999999999999998   99999999999999999999999999998754433   


Q ss_pred             -------------------------CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 003555          665 -------------------------TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD  719 (811)
Q Consensus       665 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~  719 (811)
                                               ........||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                     1122345689999999999999999999999999999999999999975432211


Q ss_pred             hhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS-MKNVILM  778 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~  778 (811)
                      ...+        ..  .....  ...........+.+++..|++ +|.+||+ ++|+++.
T Consensus       239 ~~~i--------~~--~~~~~--~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 YNKI--------IN--WKESL--RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH--------hc--cCCcc--cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1000        00  00000  001111246778899999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.2e-36  Score=318.32  Aligned_cols=264  Identities=22%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             HHHhhhhhhcCcccceeEEEEEE----cCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecc--cc
Q 003555          508 RATNGFEEELGRGCFGAVYKGSI----CEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SK  580 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~  580 (811)
                      ..++.+.++||+|+||.||+++.    ...++.||+|.++... ......+.+|+.++++++|+|++++.+++.+.  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            34566778899999999999985    3456789999987543 34456799999999999999999999999875  56


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .++||||+++++|.+++......+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence            7899999999999999976555678999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCc--cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--------chhhHHHHHHHh
Q 003555          661 MPNQTG--IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTA--------DVVLLSTWVYNC  730 (811)
Q Consensus       661 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~--------~~~~l~~~~~~~  730 (811)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++++.|........        ......... ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HH
Confidence            433221  1223456778999999888889999999999999999999887653321100        000000000 00


Q ss_pred             hhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          731 FIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ....       ............+.+++.+|++.+|.+||+++++++.|+.+
T Consensus       239 ~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEG-------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcC-------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000       01112233567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.6e-36  Score=319.12  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=195.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEc-CCCEEEEEEEccCCc--hhhHHHHHHHHHHHhcc---CCCCccceecEEec-----c
Q 003555          510 TNGFEEELGRGCFGAVYKGSIC-EGNKIVAVKRLENPV--EEGERKFQAEMAAVRRT---HHKNLVRLLGFCMQ-----T  578 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~-~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~  578 (811)
                      .|.+.++||+|+||.||+|+.. .+++.||||+++...  ......+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            3566789999999999999984 456889999886432  22234566777777665   69999999999853     3


Q ss_pred             cceeEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      ...++|+||++ ++|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            46899999997 59999987643 4478889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc-
Q 003555          658 KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL-  736 (811)
Q Consensus       658 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-  736 (811)
                      +.....  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..... ....... 
T Consensus       158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~~~~~  234 (290)
T cd07862         158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGEEDWP  234 (290)
T ss_pred             EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCChhhch
Confidence            865432  223345689999999999888999999999999999999999999976543222111111000 0000000 


Q ss_pred             ------chhcCCcc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 ------SKLVGEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 ------~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                            ...+....     ...+.....+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                  00011100     111234567789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-35  Score=314.64  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=205.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.+.++||+|+||.||+|.....+..+|+|.+........+.+.+|+++++.++|+|++++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            56678899999999999999988899999999766666677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++.+....+++..+..++.||++||.|||+.   +++|+||||+||+++.++.+||+|||++....... .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~  162 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS  162 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence            999999876566788999999999999999999998   99999999999999999999999999987643221 12233


Q ss_pred             cccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          671 VKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       671 ~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ..++..|+|||.+.     ...++.++|||||||++|||++|+.||..........   ..    .. .     ......
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~----~~-~-----~~~~~~  229 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL---KI----AK-S-----EPPTLA  229 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH---HH----hh-c-----CCCCCC
Confidence            56889999999873     4457889999999999999999999987533211110   00    00 0     001111


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+......+.+++.+||+.+|.+||++.++++.
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122345678999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5e-36  Score=326.23  Aligned_cols=245  Identities=19%  Similarity=0.280  Sum_probs=195.3

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+++...+++.||+|+++..   ..+..+.+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999988999999998753   233445678899888776 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++... ..+.+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~  155 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST  155 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence            9999988753 4577889999999999999999998   99999999999999999999999999997532221 12234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccch-hhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV-VLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ..||..|+|||.+.+..++.++|||||||++|||++|+.||......... .....+....        +.......+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~~~~~p~~  227 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQIRIPRS  227 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcCCCCCCCC
Confidence            57899999999999999999999999999999999999999642211110 0011111111        11112223344


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      ....+.+++.+||+.||.+||+.
T Consensus       228 ~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         228 LSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCHHHHHHHHHHhcCCHHHcCCC
Confidence            56678899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.4e-36  Score=317.61  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             HHhhhhhhcCcccceeEEEEEEc----CCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSIC----EGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~----~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      ..+.+.++||+|+||.||+|...    ..++.||+|.+... ..+....+.+|+.++++++|+||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            44567789999999999999863    34578999999743 33445679999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCC----------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC
Q 003555          584 VYEFMSKGSLENLLSNVE----------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL  647 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~  647 (811)
                      ||||+++++|.+++....                ..+++.+.+.++.|++.||+|||++   +++|+||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999999985321                2356788899999999999999998   999999999999999999


Q ss_pred             CeEEEecCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHH
Q 003555          648 TAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLST  725 (811)
Q Consensus       648 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~  725 (811)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......    .+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~----~~~~  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ----EVIE  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence            999999999987543322 12233445778999999988889999999999999999998 88888643211    0101


Q ss_pred             HHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          726 WVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                          .......       ...+......+.+++.+|++.+|.+||++.+|.++|.+
T Consensus       238 ----~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 ----MVRKRQL-------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHcCCc-------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                1111111       11222345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-36  Score=316.27  Aligned_cols=241  Identities=22%  Similarity=0.360  Sum_probs=194.6

Q ss_pred             hhcCcccceeEEEEEEcCCCE-------EEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          515 EELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~-------~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.||+|+||.||+|.....+.       .||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998865433       4889988765555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCC--------eEEEecCCccc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT--------AKISNFSLAKI  659 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~--------~kL~DFGla~~  659 (811)
                      +++|+|.+++......+.+..++.++.||+.||+|||+.   +|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987666788999999999999999999998   9999999999999987665        69999999875


Q ss_pred             cCCCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCC-CCCCCCCCccchhhHHHHHHHhhhhcccc
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCR-SNFEVNVSTADVVLLSTWVYNCFIAKELS  737 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  737 (811)
                      ....     ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+...... ...   .            
T Consensus       158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~---~------------  216 (258)
T cd05078         158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKL---Q------------  216 (258)
T ss_pred             cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHH---H------------
Confidence            4332     22457889999998876 45799999999999999999996 444322111 100   0            


Q ss_pred             hhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       738 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                       ........+.....++.+++.+||+.+|++||+++++++.|+
T Consensus       217 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         217 -FYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -HHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             001111222233467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-36  Score=316.49  Aligned_cols=240  Identities=20%  Similarity=0.338  Sum_probs=191.4

Q ss_pred             hcCcccceeEEEEEEcCC------------------------CEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccce
Q 003555          516 ELGRGCFGAVYKGSICEG------------------------NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL  571 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~------------------------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l  571 (811)
                      +||+|+||.||+|.+...                        ...||+|.+..........|.+|+.++++++|+||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999986321                        13599999876555556788999999999999999999


Q ss_pred             ecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC----
Q 003555          572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL----  647 (811)
Q Consensus       572 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~----  647 (811)
                      ++++.+....++||||+++++|..++......+++..++.++.||++||+|||+.   +|+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999987666788999999999999999999998   999999999999997643    


Q ss_pred             ---CeEEEecCCccccCCCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHH-hCCCCCCCCCCccchhh
Q 003555          648 ---TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIV-CCRSNFEVNVSTADVVL  722 (811)
Q Consensus       648 ---~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~ell-tg~~p~~~~~~~~~~~~  722 (811)
                         .+||+|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.........  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE--  231 (274)
T ss_pred             ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH--
Confidence               4899999998654222     12346788999998765 56899999999999999995 688888644322110  


Q ss_pred             HHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          723 LSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       723 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                        ...             ......+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       232 --~~~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 --RFY-------------EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHH-------------HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              000             0000111112346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.1e-35  Score=316.28  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             HHhhhhhhcCcccceeEEEEEEc-----CCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      ..+.+.++||+|+||.||++...     ..+..+|+|.+..........+.+|++++++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            34556789999999999999753     2356899999887666777889999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCC--------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCe
Q 003555          584 VYEFMSKGSLENLLSNVE--------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTA  649 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~  649 (811)
                      |+||+++++|.+++....              ..+.+..++.++.||+.||+|||+.   +++|+||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            999999999999997643              2367889999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHH
Q 003555          650 KISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWV  727 (811)
Q Consensus       650 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~  727 (811)
                      ||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.........       
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------  234 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI-------  234 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH-------
Confidence            99999999765433221 1122345678999999988899999999999999999998 88888543221100       


Q ss_pred             HHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                       .......       ....+...+..+.+++.+||+.+|.+||++.||++.|++
T Consensus       235 -~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         235 -ECITQGR-------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HHHHcCc-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             0000000       011122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-36  Score=326.31  Aligned_cols=244  Identities=22%  Similarity=0.263  Sum_probs=195.8

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHH---hccCCCCccceecEEecccceeEEE
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAV---RRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      .+.+.||+|+||.||+|....+++.||||+++...   ....+.+.+|+.++   ++++|+||+++++++.+++..++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            45678999999999999998889999999986432   22334566666554   5678999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+++++|..++..  ..+++.....++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05589          82 EYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-  155 (324)
T ss_pred             cCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-
Confidence            99999999998864  4678899999999999999999998   99999999999999999999999999987533222 


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........   +     .        .+......
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~-----~--------~i~~~~~~  219 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---F-----D--------SIVNDEVR  219 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---H-----H--------HHHhCCCC
Confidence            122345689999999999999999999999999999999999999975422110   0     0        01111111


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      .+......+.+++.+||+.||.+||     ++.++++
T Consensus       220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            2233456788999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.2e-36  Score=314.79  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=206.0

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCE---EEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~---~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ..+.+.+.||+|+||.||+|.+...++   .||||.+... ......+|..|+.++++++|+||+++.+++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            346778999999999999999876543   6999998754 344467899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++......+++.+++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999987666788999999999999999999998   99999999999999999999999999987654322


Q ss_pred             Ccc-ccc-c--ccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          665 TGI-VTG-V--KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       665 ~~~-~~~-~--~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      ... ... .  ..+..|+|||.+....++.++||||||+++||+++ |..||.......    ....+.     ..    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~i~-----~~----  227 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAIE-----QD----  227 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHHHH-----cC----
Confidence            211 111 1  12457999999998899999999999999999886 999986432111    111110     00    


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                        .....+...+..+.+++..||+.+|.+||++.+|+++|+..
T Consensus       228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              01111233456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=318.38  Aligned_cols=263  Identities=23%  Similarity=0.346  Sum_probs=202.2

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCC--------------CEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccce
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEG--------------NKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRL  571 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~--------------~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l  571 (811)
                      ....+.+.++||+|+||.||++.....              ...||+|.++.. .......+.+|++++++++|+|++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            445677889999999999999987532              235999998754 33445679999999999999999999


Q ss_pred             ecEEecccceeEEEeecCCCCHHHHhhcCC-----------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE-----------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       572 ~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      ++++...+..++||||+++++|.+++....           ....+..+++++.|++.||+|||+.   +++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            999999999999999999999999986532           1256788899999999999999998   99999999999


Q ss_pred             EEECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCc
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC--CRSNFEVNVST  717 (811)
Q Consensus       641 Ill~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt--g~~p~~~~~~~  717 (811)
                      |++++++.+||+|||++......... ......++..|+|||.+....++.++||||||++++||++  +..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            99999999999999999865433221 1222345778999999988889999999999999999998  45566533221


Q ss_pred             cchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       718 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ...    ........... ....   ...+...+..+.+|+.+|++.+|.+||+|.+|++.|+
T Consensus       240 ~~~----~~~~~~~~~~~-~~~~---~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVI----ENTGEFFRNQG-RQIY---LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHH----HHHHHhhhhcc-cccc---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            100    00000010000 0000   0112234568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-35  Score=310.53  Aligned_cols=246  Identities=28%  Similarity=0.382  Sum_probs=197.5

Q ss_pred             hcCcccceeEEEEEE--cCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          516 ELGRGCFGAVYKGSI--CEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~--~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +||+|+||.||+|.+  ..+++.+|+|+++...  ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999975  3456899999986433  334567999999999999999999999885 45678999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc--cc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI--VT  669 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~--~~  669 (811)
                      +|.+++... ..+++..+..++.|++.||+|||++   +|+|+||||+||++++++.+||+|||+++.........  ..
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999753 4578899999999999999999998   99999999999999999999999999998764433211  12


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ...++..|+|||.+....++.++||||||+++|||++ |+.||.......    +...    ...+.       ....+.
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~----i~~~~-------~~~~~~  221 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQM----IESGE-------RMECPQ  221 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHH----HHCCC-------CCCCCC
Confidence            2334678999999988889999999999999999998 899987532211    1111    11111       111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..+.++.+++.+|++.+|++||++.+|+++|++
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            456778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.1e-36  Score=305.30  Aligned_cols=264  Identities=23%  Similarity=0.309  Sum_probs=204.8

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCC-ccceecEEeccc------
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKN-LVRLLGFCMQTS------  579 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------  579 (811)
                      ..+...++||+|+||+||+|+.+.+++.||+|++.-..+  .......+|+.++++++|+| |+++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            345556789999999999999999999999999875433  23466789999999999999 999999999877      


Q ss_pred             ceeEEEeecCCCCHHHHhhcCC---CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCC
Q 003555          580 KKLLVYEFMSKGSLENLLSNVE---SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL  656 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~---~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGl  656 (811)
                      ..++|+||++. +|..++....   ...+...+..++.||++||+|||++   +|+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            78899999977 9999998765   3566678889999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCCccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          657 AKILMPNQTGIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       657 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      |+...-. ....+..++|..|.|||++.+. .|+...||||+||++.||++++..|....+.++...+...... ...+.
T Consensus       167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt-P~e~~  244 (323)
T KOG0594|consen  167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT-PNEKD  244 (323)
T ss_pred             HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC-CCccC
Confidence            9965422 2224556789999999988776 7999999999999999999999999876553322211111100 00000


Q ss_pred             cc-------------hhcCCc--cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          736 LS-------------KLVGED--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       736 ~~-------------~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +.             +...+.  ...-+.......+++.+||+.+|.+|.|++..+.+
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00             000000  00011112478899999999999999999999875

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-35  Score=312.41  Aligned_cols=257  Identities=20%  Similarity=0.324  Sum_probs=206.8

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC---CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .+.+.++||+|+||.||+|+...+++.||||.+..   ........+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            35567899999999999999988889999998753   223445678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          587 FMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       587 y~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |+++++|.+++...   ...++...+..++.||++||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            99999999988542   33467788899999999999999998   9999999999999999999999999998865432


Q ss_pred             CCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      .. ......++..|+|||.+.+..++.++|+||||+++|||++|+.||........  .+..    ......      ..
T Consensus       160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--~~~~----~~~~~~------~~  226 (267)
T cd08228         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF--SLCQ----KIEQCD------YP  226 (267)
T ss_pred             hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH--HHHH----HHhcCC------CC
Confidence            21 12235688899999999888899999999999999999999999864322211  1100    000000      01


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..........+.+++.+||+.+|++||++++|++.|+.+
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            111224457799999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-35  Score=315.42  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=197.4

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||+|+||.||++.....++.||+|++....   ......+..|++++++++|+||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999999889999999986421   22344567799999999999999999999999999999999999999


Q ss_pred             HHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccc
Q 003555          594 ENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK  672 (811)
Q Consensus       594 ~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  672 (811)
                      .+++.... ..+.+..+..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            99886543 3577888899999999999999998   99999999999999999999999999998654322  223456


Q ss_pred             cCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHH
Q 003555          673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLE  752 (811)
Q Consensus       673 gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (811)
                      |+..|+|||.+.+..++.++|||||||++|||++|+.||..........   ..... .....    ..   ........
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~---~~~~~-~~~~~----~~---~~~~~~~~  224 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE---ELKRR-TLEDE----VK---FEHQNFTE  224 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---HHHHH-hhccc----cc---cccccCCH
Confidence            8999999999988889999999999999999999999997533221111   11000 00000    00   01123456


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          753 TMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       753 ~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ++.+++..||+.||.+||+++|+++.+.
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            7899999999999999999987764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=312.92  Aligned_cols=253  Identities=23%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             hhhhhcCcccceeEEEEEEcCCC---EEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccc------
Q 003555          512 GFEEELGRGCFGAVYKGSICEGN---KIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK------  580 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------  580 (811)
                      .+.+.||+|+||.||+|.+..++   ..||||+++..  .......+.+|+..++.++|+||+++++++.+.+.      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            45688999999999999986543   68999998743  23445689999999999999999999999876554      


Q ss_pred             eeEEEeecCCCCHHHHhhcC-----CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          581 KLLVYEFMSKGSLENLLSNV-----ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                      .++|+||+++++|..++...     ...+++.....++.|++.||.|||+.   +++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            79999999999999998543     23467888999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          656 LAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       656 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      +++......... .....++..|+|||.+....++.++||||||+++|||++ |..||......    .+....    ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~----~~  230 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYL----RH  230 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----Hc
Confidence            998764433221 112335678999999988889999999999999999999 78888543211    111111    11


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .       .....+......+.+++.+|++.||.+||++.||++.|+.+
T Consensus       231 ~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 G-------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             C-------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1       11112334566899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.2e-36  Score=317.83  Aligned_cols=269  Identities=25%  Similarity=0.375  Sum_probs=204.2

Q ss_pred             HhhhhhhcCcccceeEEEEEEc----CCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSIC----EGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~----~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  583 (811)
                      .+.+.+.||+|+||.||++...    ..++.||||++........+.+.+|++++++++|+||+++++++...  ...++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            4556788999999999999853    35678999999876666678899999999999999999999987543  46789


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |+||+++++|.+++.+....+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||+++.....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999999999987666688999999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCcc--ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          664 QTGI--VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       664 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++|..++.......... .............+.+.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM-MGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh-cccccccccchHHHHHHHh
Confidence            2211  111223456999999988889999999999999999999887654321110000 0000000000000001111


Q ss_pred             C--ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          742 E--DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       742 ~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .  ...........+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1  1111234456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.6e-36  Score=325.39  Aligned_cols=250  Identities=19%  Similarity=0.269  Sum_probs=199.2

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+++....++.||||+++..   ..+....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999988999999998743   223345688899999988 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+++... ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST  155 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence            9999988753 4678899999999999999999998   99999999999999999999999999987532221 12234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccch-hhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV-VLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||+........ .....+.....        .......+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~p~~  227 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQIRIPRS  227 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCCCCCCCC
Confidence            57899999999999999999999999999999999999999743221100 00111111111        1111222334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPS------MKNVIL  777 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs------~~evl~  777 (811)
                      ....+.+++.+||+.||.+||+      ++++++
T Consensus       228 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         228 LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            4567899999999999999997      677763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8e-37  Score=311.22  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=195.7

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeEEEeec
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLLVYEFM  588 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~ey~  588 (811)
                      .+.+|.|+||.||+|+....++.||||++-...    +.-.+|+++|+++.|||||+++-++....     ...||||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            378999999999999999989999999975332    23356999999999999999998887543     346999999


Q ss_pred             CCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC-CCeEEEecCCccccCCCC
Q 003555          589 SKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-LTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       589 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~-~~~kL~DFGla~~~~~~~  664 (811)
                      +. +|.++++..   +..++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ |.+||+|||.|+.+.+++
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            88 999998753   44555566677899999999999998   99999999999999955 999999999999987766


Q ss_pred             CccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc-------
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL-------  736 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-------  736 (811)
                      ..  .....|+.|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+....++...+.+... ....+++       
T Consensus       181 pn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG-~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  181 PN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG-TPTREDIKSMNPNY  257 (364)
T ss_pred             Cc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC-CCCHHHHhhcCccc
Confidence            54  344578999999977654 799999999999999999999999987655444433222211 0001111       


Q ss_pred             -----chhcCCcc-c-cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          737 -----SKLVGEDE-E-VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       737 -----~~~~~~~~-~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                           .++..... + .......+.++++.++++.+|.+|.++.|++..
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                 00110000 1 233456688999999999999999999998743

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=312.86  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--------------hhHHHHHHHHHHHhccCCCCccceecEE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--------------EGERKFQAEMAAVRRTHHKNLVRLLGFC  575 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~  575 (811)
                      .|.+.++||+|.||.|-+|....+++.||||++.+...              ...+...+|+.+|++++|+|||+|+++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            46667899999999999999999999999999854211              1235788999999999999999999999


Q ss_pred             ecc--cceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          576 MQT--SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       576 ~~~--~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                      .+.  +..|||+|||..|.+...-.. ...++..+..++++++..||+|||.+   +|+||||||+|+||+++|++||+|
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeec
Confidence            875  478999999998877644332 22277889999999999999999999   999999999999999999999999


Q ss_pred             cCCccccCCCC----CccccccccCCCccCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHH
Q 003555          654 FSLAKILMPNQ----TGIVTGVKGTRGYMSPEWQNSG----LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST  725 (811)
Q Consensus       654 FGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~  725 (811)
                      ||.+.......    ........||+.|||||...++    ..+.+.||||+||.||.|+.|+.||-....-    .+  
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----~l--  327 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----EL--  327 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----HH--
Confidence            99998663221    1234457899999999976653    2467899999999999999999999753211    11  


Q ss_pred             HHHHhhhhcccchhcCCcccc--ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          726 WVYNCFIAKELSKLVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       726 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                                ..+++...+.+  .++..+.+.+|++++|++||+.|.+..+|....
T Consensus       328 ----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  328 ----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                      12233333322  335678899999999999999999999998665

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.5e-35  Score=314.63  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=202.7

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      ..+.+.+.||+|+||.||+|.+..     ....||+|.+.... ...+..|.+|+.++++++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            345567899999999999999976     56789999986443 444567999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCC------CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC---CeEEEe
Q 003555          583 LVYEFMSKGSLENLLSNVES------GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL---TAKISN  653 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~------~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~---~~kL~D  653 (811)
                      +||||+++++|.+++.....      .+++..+++++.||+.||+|||+.   +++|+||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence            99999999999999976532      467899999999999999999998   999999999999998654   699999


Q ss_pred             cCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhh
Q 003555          654 FSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCF  731 (811)
Q Consensus       654 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~  731 (811)
                      ||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |+.||.......    +...    .
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~----~~~~----~  234 (277)
T cd05036         163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE----VMEF----V  234 (277)
T ss_pred             CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHH----H
Confidence            9999876322211 1112234568999999988899999999999999999997 888887432211    1010    0


Q ss_pred             hhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ...       .....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       235 ~~~-------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGG-------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcC-------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            000       111223344567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.1e-35  Score=310.43  Aligned_cols=254  Identities=29%  Similarity=0.425  Sum_probs=203.3

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ....+.+.++||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence            34567788999999999999998764 56799999875332 3567999999999999999999999875 456789999


Q ss_pred             ecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          587 FMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999999997643 3478899999999999999999998   999999999999999999999999999987644332


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+   .+ ...    ...       ...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~-~~~----~~~-------~~~  222 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VL-EQV----ERG-------YRM  222 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HH-HHH----HcC-------CCC
Confidence            22233445678999999988889999999999999999999 888886432111   01 110    000       011


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..+...+..+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1223445679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-35  Score=309.86  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=205.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|++|.||+|+...+++.|++|.+...  .......+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            34568899999999999999988999999987532  3455678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++++|.+++... ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++....... .
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~  157 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F  157 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence            999999999875 45677889999999999999999998   999999999999999999999999999986643322 1


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....|++.|+|||+..+..++.++||||||++++||++|+.||.......    .    .......       ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~----~~~~~~~-------~~~~~~  222 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----L----ILKIIRG-------VFPPVS  222 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----H----HHHHHcC-------CCCCCc
Confidence            233468889999999998899999999999999999999999997543111    0    0000011       111122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......+.+++.+|++.+|++||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            2456678999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.3e-35  Score=312.11  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=199.4

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCE--EEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecc------cce
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNK--IVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SKK  581 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~  581 (811)
                      .+.++||+|+||.||+|++...++  .||+|.++..  .....+.+..|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            356889999999999999876654  6999988653  344457789999999999999999999988542      246


Q ss_pred             eEEEeecCCCCHHHHhhcC-----CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCC
Q 003555          582 LLVYEFMSKGSLENLLSNV-----ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL  656 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGl  656 (811)
                      ++|+||+++|+|.+++...     ...+++.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987432     23467888999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          657 AKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       657 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      ++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......    .+    ......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~----~~~~~~~  230 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EI----YDYLRQG  230 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HH----HHHHHcC
Confidence            98764333211 122345778999999998899999999999999999999 78888643211    11    1111111


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .       ...........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       231 ~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 N-------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C-------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1       1112234456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-35  Score=314.40  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=207.1

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCE----EEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNK----IVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      ...+.+.++||+|+||+||+|++...++    .||+|.++.. .....+++.+|+.+++.++|+||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3455667899999999999999765544    4899998653 344567899999999999999999999999754 568


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +++||+++|+|.+++......+.+..++.++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999999999987666788999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          663 NQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       663 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      .... ......++..|+|||...+..++.++||||||+++|||++ |..||......    .+....    ...      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~----~~~------  227 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR----EIPDLL----EKG------  227 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHH----HCC------
Confidence            3221 1122345678999999988889999999999999999998 88888643211    111111    010      


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                       .....+......+.+++..||+.||++||++.+++..|+.+...+
T Consensus       228 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         228 -ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence             011112334567889999999999999999999999998876655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-35  Score=312.56  Aligned_cols=247  Identities=23%  Similarity=0.318  Sum_probs=200.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLE  594 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~  594 (811)
                      ..||+|+||.||+|++.+++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            57999999999999998888999999988766667788999999999999999999999999999999999999999999


Q ss_pred             HHhhcCCCCC--chHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-CCCeEEEecCCccccCCCCCcccccc
Q 003555          595 NLLSNVESGP--IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGIVTGV  671 (811)
Q Consensus       595 ~~l~~~~~~~--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~  671 (811)
                      +++......+  .+..+..++.||+.||+|||+.   +|+|+||||+||+++. ++.+||+|||++........ .....
T Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~  169 (268)
T cd06624          94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETF  169 (268)
T ss_pred             HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccC
Confidence            9998654444  6788888999999999999998   9999999999999976 77999999999876533222 22234


Q ss_pred             ccCCCccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          672 KGTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       672 ~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      .++..|+|||.+...  .++.++||||||+++|||++|+.||..........    +.         ..........+..
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~---------~~~~~~~~~~~~~  236 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FK---------VGMFKIHPEIPES  236 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hh---------hhhhccCCCCCcc
Confidence            578999999987654  37889999999999999999999986432211110    00         0001111122334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..+++.+++.+||+.+|.+||++.|++..
T Consensus       237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         237 LSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            56778999999999999999999999853

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.8e-36  Score=322.80  Aligned_cols=241  Identities=22%  Similarity=0.280  Sum_probs=194.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhc-cCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|+...+++.||||+++...   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999888999999986532   2334556778888876 4999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+++... ..+.+.+...++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT  155 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence            9999999763 4567888899999999999999998   99999999999999999999999999987532221 12234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||..|+|||.+.+..++.++|||||||++|||++|+.||.......    +...    ...        .....+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~----i~~--------~~~~~~~~~  219 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQS----IRM--------DNPCYPRWL  219 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHh--------CCCCCCccC
Confidence            568999999999999899999999999999999999999997532211    1000    000        011112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMK-NVI  776 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~-evl  776 (811)
                      ...+.+++.+||+.+|.+||++. ++.
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            56788999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.3e-36  Score=331.81  Aligned_cols=252  Identities=19%  Similarity=0.214  Sum_probs=196.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||+||+|+....++.||||++...   .......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            34567899999999999999999999999998643   223456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--  665 (811)
                      +++|+|.+++... ..+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          83 IPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999999999764 3467778888999999999999998   999999999999999999999999999764321000  


Q ss_pred             --------------------------------------------ccccccccCCCccCccccccCCCCcccchHHHHHHH
Q 003555          666 --------------------------------------------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVV  701 (811)
Q Consensus       666 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll  701 (811)
                                                                  .......||+.|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                        001234699999999999888899999999999999


Q ss_pred             HHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHH--cccCCCCCCCCHHHHHHH
Q 003555          702 LEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLL--CIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       702 ~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~evl~~  778 (811)
                      |||++|+.||..............       ....   +  ..........++.+++.+  |+..+|..||++.|++..
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~-------~~~~---~--~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN-------WENT---L--HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc-------cccc---c--CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999975433221110000       0000   0  001111234566777776  566677779999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.4e-36  Score=323.96  Aligned_cols=242  Identities=20%  Similarity=0.284  Sum_probs=197.7

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|....+++.||||+++...   ......+..|..+++.+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999888999999987432   23345677888888887 799999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++... ..+++.++..++.||+.||+|||+.   +|+||||||+||++++++.+||+|||+++....... ....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  155 (318)
T cd05570          81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST  155 (318)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence            9999998763 4578899999999999999999998   999999999999999999999999999875322221 2233


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.||.......    +    ...        +.......+...
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~----~----~~~--------i~~~~~~~~~~~  219 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE----L----FQS--------ILEDEVRYPRWL  219 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH----H----HHH--------HHcCCCCCCCcC
Confidence            568999999999999999999999999999999999999997432111    0    000        111111122334


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSM-----KNVIL  777 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~-----~evl~  777 (811)
                      ...+.+++.+||+.||.+||++     .++++
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            5678999999999999999999     88865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.8e-36  Score=324.71  Aligned_cols=241  Identities=20%  Similarity=0.246  Sum_probs=195.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCC-CccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHK-NLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e  586 (811)
                      +.+.+.||+|+||.||+|+....++.||||++...   .....+.+..|..++..++|+ +|+++++++.+.+..++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            45678899999999999999988899999998643   233456788899999999765 58889999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++|+|.+++... ..+.+.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~  156 (324)
T cd05587          82 YVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K  156 (324)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence            99999999999763 4567888999999999999999998   99999999999999999999999999987532211 1


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   + .            .+.......
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-~------------~i~~~~~~~  220 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F-Q------------SIMEHNVSY  220 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-H------------HHHcCCCCC
Confidence            22345689999999999999999999999999999999999999975432110   0 0            011111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      +......+.+++.+||+.+|.+||+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            23345678899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-35  Score=317.87  Aligned_cols=260  Identities=28%  Similarity=0.408  Sum_probs=207.0

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCC-----CEEEEEEEccCC-chhhHHHHHHHHHHHhcc-CCCCccceecEEecc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEG-----NKIVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT  578 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  578 (811)
                      +....+.+.+.||+|+||.||++.....     ...+|+|.+... ..+...++.+|+.++.++ +|+||+++++++.++
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3344566778999999999999997643     378999998753 334456789999999999 899999999999999


Q ss_pred             cceeEEEeecCCCCHHHHhhcC---------------CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 003555          579 SKKLLVYEFMSKGSLENLLSNV---------------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL  643 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll  643 (811)
                      +..++||||+++++|.+++...               ...+++..+++++.||+.||.|||+.   +|+|+||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence            9999999999999999999642               23467889999999999999999998   99999999999999


Q ss_pred             CCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchh
Q 003555          644 DDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVV  721 (811)
Q Consensus       644 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~  721 (811)
                      ++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+   
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  242 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  242 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence            99999999999999876433221 1222345678999999988899999999999999999998 888876432111   


Q ss_pred             hHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       722 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                       +    .......       .....+......+.+++.+|++.+|.+|||+.|+++.|++..
T Consensus       243 -~----~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -L----FKLLKEG-------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -H----HHHHHcC-------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence             0    0111111       011123344567889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.9e-36  Score=325.04  Aligned_cols=238  Identities=21%  Similarity=0.269  Sum_probs=191.8

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHH-HHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMA-AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||+||+|+...+++.||||++....   ....+++..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999889999999986432   222344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|..++.. ...+.+.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (323)
T cd05575          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST  155 (323)
T ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence            999999976 34567888889999999999999998   99999999999999999999999999987532221 22334


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +   .         ..+........+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~---~---------~~i~~~~~~~~~~~  219 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----M---Y---------DNILNKPLRLKPNI  219 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH----H---H---------HHHHcCCCCCCCCC
Confidence            568999999999999999999999999999999999999997532111    0   0         01111111223344


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMK  773 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~  773 (811)
                      ...+.+++.+||+.+|.+||++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCC
Confidence            67789999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-35  Score=312.42  Aligned_cols=259  Identities=23%  Similarity=0.318  Sum_probs=207.5

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCC---CEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEG---NKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      ....+.+.++||+|+||.||+|...+.   ...||||...... .+..+.+.+|+.++++++|+||+++++++.+ +..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            445567788999999999999997543   3479999887554 4556789999999999999999999998875 4578


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +||||+++++|.+++......+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999999987666678999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..........++..|+|||.+....++.++||||||+++||+++ |..||........   + ...    ...       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~-~~~----~~~-------  224 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---I-GRI----ENG-------  224 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---H-HHH----HcC-------
Confidence            33222223334568999999988889999999999999999986 9999864432211   0 100    000       


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      .....+...+..+.+++.+|+..+|.+||++.++++.|++...
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0111223445678999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-35  Score=310.06  Aligned_cols=257  Identities=19%  Similarity=0.321  Sum_probs=207.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .+.+.+.||+|+||.||+|....+++.+|||.+...   ......++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            356778999999999999999888899999987642   22344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          587 FMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       587 y~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |+++++|.+++...   ...+++..+..++.||++||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            99999999998642   34567889999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++|..||........  ....         ..... ...
T Consensus       160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~---------~~~~~-~~~  226 (267)
T cd08229         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLCK---------KIEQC-DYP  226 (267)
T ss_pred             Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHhh---------hhhcC-CCC
Confidence            21 22335688999999999888899999999999999999999999864322110  0000         00000 001


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..........+.+++.+|++.+|.+||||.+|+++++.+
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            111224566899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.1e-36  Score=322.77  Aligned_cols=241  Identities=21%  Similarity=0.265  Sum_probs=194.5

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|+....++.||||+++...   ......+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999888999999987532   23345667788887754 899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++.. ...+++.+...++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (316)
T cd05620          81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST  155 (316)
T ss_pred             CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence            999999876 34577888899999999999999998   99999999999999999999999999987532211 12334


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +...+            .......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~------------~~~~~~~~~~~  219 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESI------------RVDTPHYPRWI  219 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH------------HhCCCCCCCCC
Confidence            568999999999999999999999999999999999999997432211    10000            00111122234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMK-NVI  776 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~-evl  776 (811)
                      ..++.+++.+||+.||++||++. ++.
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            56788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-35  Score=328.42  Aligned_cols=262  Identities=20%  Similarity=0.281  Sum_probs=200.1

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeEE
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLLV  584 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV  584 (811)
                      .+.++||+|+||.||++....+++.||||++...  .....+.+.+|+.+++.++|+||+++++++...+     ..++|
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            4568899999999999999888899999998643  2234567899999999999999999999998776     78999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      +||+. ++|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          83 TELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            99997 578888765 34578889999999999999999998   99999999999999999999999999998754433


Q ss_pred             CccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHH-------hhhhccc
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN-------CFIAKEL  736 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~  736 (811)
                      ........+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+......       .......
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            3333445688999999988764 5789999999999999999999999765432211111000000       0000000


Q ss_pred             chhcCCc---------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          737 SKLVGED---------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       737 ~~~~~~~---------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..+....         ........+++.+++.+||+.||.+|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000000         01122235678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6e-36  Score=325.32  Aligned_cols=239  Identities=23%  Similarity=0.280  Sum_probs=192.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHH-HHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMA-AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||+||+|+...+++.||||++....   .....++..|.. +++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999998889999999986432   233345556655 46778999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++.. ...+.+.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~  155 (325)
T cd05604          81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT  155 (325)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence            999998875 34577888999999999999999998   9999999999999999999999999998753221 122234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +    ..        .+........+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~----~~--------~~~~~~~~~~~~~  219 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----M----YD--------NILHKPLVLRPGA  219 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----H----HH--------HHHcCCccCCCCC
Confidence            568999999999999999999999999999999999999997532111    0    00        0111111222345


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKN  774 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~e  774 (811)
                      ...+.+++.+|++.+|.+||++.+
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCCC
Confidence            567889999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.5e-35  Score=308.81  Aligned_cols=249  Identities=20%  Similarity=0.330  Sum_probs=207.1

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.++||+|+||.||+|....+++.+|+|.++....  .+++.+|++++++++|+||+++++++.+....++++||++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            46677899999999999999988889999999865432  6789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++......+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........ ...
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN  157 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence            9999999987667788999999999999999999998   999999999999999999999999999987643321 223


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||............             ..........+..
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~~~~~~~  224 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------PNKPPPTLSDPEK  224 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------ccCCCCCCCchhh
Confidence            345788999999998889999999999999999999999999754322111000             0000111122334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ....+.+++.+|++.+|.+||+++||++
T Consensus       225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            4567899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-35  Score=308.19  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=200.4

Q ss_pred             hhcCcccceeEEEEEEcCCC---EEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGN---KIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      ++||+|+||.||+|+....+   ..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999875544   7899999875443 35678999999999999999999999875 4568999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc--c
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI--V  668 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~--~  668 (811)
                      ++|.+++.... .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........  .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998644 678899999999999999999998   99999999999999999999999999998764433221  1


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......    .+...+.    ...       ....+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~----~~~-------~~~~~  220 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLE----SGE-------RLPRP  220 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHH----cCC-------cCCCC
Confidence            12234568999999988899999999999999999998 89998643221    1111111    110       11122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      ......+.+++.+|++.+|.+||++.+|++.|++..
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            334567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-35  Score=315.28  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=204.9

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCC----------------EEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccc
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGN----------------KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVR  570 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~----------------~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~  570 (811)
                      ...+.+.++||+|+||.||++.+...+                ..||+|++.... ....+.+.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            345677899999999999999876533                568999987543 345678999999999999999999


Q ss_pred             eecEEecccceeEEEeecCCCCHHHHhhcCC----------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVE----------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       571 l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      +++++..++..++|+||+++++|.+++.+..          ..+++..++.++.|++.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999997643          2567889999999999999999998   99999999999


Q ss_pred             EEECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCc
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC--CRSNFEVNVST  717 (811)
Q Consensus       641 Ill~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt--g~~p~~~~~~~  717 (811)
                      |+++.++.++|+|||+++........ ......++..|+|||.+....++.++|||||||++|||++  +..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            99999999999999999865433221 2233456788999999988889999999999999999998  56666532211


Q ss_pred             cchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       718 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .    .................    ...+...+.++.+++.+|++.+|.+||++.||++.|+
T Consensus       241 ~----~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q----VIENAGHFFRDDGRQIY----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H----HHHHHHhcccccccccc----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1    10111111111111000    1112234568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-35  Score=309.92  Aligned_cols=256  Identities=27%  Similarity=0.418  Sum_probs=206.1

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ++...++++.++||+|+||.||+|..++ ++.||+|.+.... .....+.+|+.++++++|+|++++++++. .+..++|
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII   78 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence            4556778889999999999999999765 5789999987433 34567899999999999999999999864 4578999


Q ss_pred             EeecCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          585 YEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      +||+++++|.+++... ...+++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999998754 34578889999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .........++..|+|||.+....++.++||||||+++||+++ |+.||........   . .    .....       .
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~-~----~~~~~-------~  220 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---I-Q----NLERG-------Y  220 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---H-H----HHHcC-------C
Confidence            3222233456778999999988889999999999999999999 9999864322110   0 0    00000       0


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ........+.++.+++.+|++.+|++||++++++..|+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111122345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-35  Score=311.25  Aligned_cols=253  Identities=26%  Similarity=0.414  Sum_probs=203.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHH--HHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER--KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |.+.+.||+|+||+||+++....++.||+|++.........  ...+|+..+++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            35678999999999999999999999999999765433332  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++.. ...+++..+..++.||++||++||+.   +|+|+||||+||++++++.++|+|||.+... .......
T Consensus        81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~  155 (260)
T PF00069_consen   81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENF  155 (260)
T ss_dssp             TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEB
T ss_pred             ccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccc
Confidence            99999999983 45678899999999999999999999   9999999999999999999999999999864 2222334


Q ss_pred             cccccCCCccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          669 TGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ....++..|+|||.+. ....+.++||||+|+++++|++|+.|+...........+......     .    ........
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----~----~~~~~~~~  226 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-----P----LPSSSQQS  226 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-----H----HHHHTTSH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-----c----cccccccc
Confidence            4567899999999988 888999999999999999999999999865211111111110000     0    00000001


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......+.+++..||+.||++||++.++++
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111378999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.2e-35  Score=309.05  Aligned_cols=254  Identities=29%  Similarity=0.448  Sum_probs=202.6

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ....+.+.++||+|++|.||+|....+ ..+|+|++.... ...+.+.+|+.++++++|+|++++++++. .+..++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            344577788999999999999998664 469999886432 34567889999999999999999999875 456789999


Q ss_pred             ecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          587 FMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      |+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999999997643 3467899999999999999999998   999999999999999999999999999986543332


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   .. ...    . ...      ..
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-~~~----~-~~~------~~  222 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL-EQV----E-RGY------RM  222 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-HHH----H-cCC------CC
Confidence            22223456778999999988889999999999999999999 888886432211   00 100    0 000      01


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..+...+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1123456778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.5e-36  Score=329.56  Aligned_cols=254  Identities=20%  Similarity=0.234  Sum_probs=201.0

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ...+.+.++||+|+||.||+++...+++.||+|++.+.   .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            45567778999999999999999988999999998642   223345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++|+|.+++...  .+.......++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            9999999999999753  467788889999999999999998   99999999999999999999999999998764333


Q ss_pred             CccccccccCCCccCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSG----LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ........||+.|+|||.+...    .++.++|||||||++|||++|+.||........   ...     ...... . +
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---~~~-----i~~~~~-~-~  266 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---YSK-----IMDHKN-S-L  266 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH---HHH-----HHhCCc-c-c
Confidence            3223456799999999988654    378899999999999999999999975432111   000     000000 0 0


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNL--RPSMKNVILM  778 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  778 (811)
                        ...........+.+++..|++.++.+  ||++.|+++.
T Consensus       267 --~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 --NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              00112234667888899999866544  8999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=332.33  Aligned_cols=251  Identities=20%  Similarity=0.209  Sum_probs=199.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||+||+|+....++.||||++...   .......+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            45568899999999999999988999999998642   123445688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      +++|+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        83 ~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          83 LPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            9999999999763 4578889999999999999999998   9999999999999999999999999998764321100 


Q ss_pred             ------------------------------------cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 003555          667 ------------------------------------IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSN  710 (811)
Q Consensus       667 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p  710 (811)
                                                          ......||+.|+|||++....++.++|||||||++|||++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                01124589999999999989999999999999999999999999


Q ss_pred             CCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 003555          711 FEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS---MKNVILM  778 (811)
Q Consensus       711 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~  778 (811)
                      |.........    ..+    ...  ...+.  ........+.+.+++..|+. +|.+|++   +.|+++.
T Consensus       239 f~~~~~~~~~----~~i----~~~--~~~~~--~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         239 FCSDNPQETY----RKI----INW--KETLQ--FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCHHHHH----HHH----HcC--CCccC--CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9754322111    000    000  00000  00111235677889999996 8999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-35  Score=315.22  Aligned_cols=265  Identities=22%  Similarity=0.324  Sum_probs=202.6

Q ss_pred             hhhhhcCcccceeEEEEEE----cCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEE
Q 003555          512 GFEEELGRGCFGAVYKGSI----CEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLV  584 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~----~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV  584 (811)
                      .+.+.||+|+||+||++..    ...++.||+|.+.... ......+.+|++++++++|+||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678899999999988653    3456789999987543 34567789999999999999999999998764  357899


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++..  ..+++.++..++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||+++......
T Consensus        87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            999999999999975  3588999999999999999999998   99999999999999999999999999998654322


Q ss_pred             Cc--cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          665 TG--IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       665 ~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      ..  ......++..|+|||.+....++.++||||||+++|||++|+.|+.........  ...............+..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh--hhcccccccchhhhhhhhhc
Confidence            21  112234566799999998888999999999999999999999998643221100  00000000000111111111


Q ss_pred             c--cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          743 D--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       743 ~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      .  ...+......+.+++..|++.+|++||++++|+++|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1  1123345678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=313.15  Aligned_cols=258  Identities=25%  Similarity=0.430  Sum_probs=206.5

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCC-----CEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEeccc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEG-----NKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS  579 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  579 (811)
                      +....+.+.+.||+|+||.||+|.....     ...||+|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            3445666778999999999999998643     3789999987543 344567889999999999999999999999999


Q ss_pred             ceeEEEeecCCCCHHHHhhcCC---------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeE
Q 003555          580 KKLLVYEFMSKGSLENLLSNVE---------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK  650 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~k  650 (811)
                      ..++||||+++++|.+++....         ..+.+..++.++.||+.||.|||+.   +++|+||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            9999999999999999996532         2356788999999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHH
Q 003555          651 ISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVY  728 (811)
Q Consensus       651 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~  728 (811)
                      |+|||+++........ ......++..|+|||.+....++.++|||||||++||+++ |..||.......    ...   
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~---  232 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE----VLK---  232 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH----HHH---
Confidence            9999999865443321 2233456789999999988889999999999999999998 888886432111    101   


Q ss_pred             HhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                       ......       ....+......+.+++.+||+.+|.+|||+.+++..|+.
T Consensus       233 -~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         233 -FVIDGG-------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -HHhcCC-------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence             111111       111222346788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-35  Score=316.13  Aligned_cols=260  Identities=23%  Similarity=0.382  Sum_probs=206.9

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEc-----CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEecc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT  578 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  578 (811)
                      +....+.+.+.||+|+||.||++...     .....||||+++... ....+.+.+|+.+++++ +|+||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34455677889999999999999852     334589999987543 33456789999999999 799999999999999


Q ss_pred             cceeEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      +..++||||+++++|.+++.... ..+++.++..++.||+.||+|||++   +|+|+||||+|||++.++.+||+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999997643 3378999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          658 KILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       658 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      +........ ......++..|+|||.+....++.++|||||||++|||++ |..||..........   ..    .... 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~---~~----~~~~-  260 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY---KL----IKEG-  260 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH---HH----HHcC-
Confidence            865433221 1222346778999999988889999999999999999998 888886433221110   00    0000 


Q ss_pred             cchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .      ....+......+.+++.+|++.+|++||++.|+++.|+..
T Consensus       261 ~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 Y------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             C------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0      0011123356789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.4e-35  Score=313.61  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=205.9

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..|.+.++||.|+||.||+|+....++.||+|.+........+.+.+|+.+++.++|+|++++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45677889999999999999999888999999998766667788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|..++.+....+.+..+..++.|++.+|+|||+.   +++|+||||+||+++.++.+||+|||++...... ....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  167 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRR  167 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-cccc
Confidence            99999998877666788999999999999999999998   9999999999999999999999999998754222 1122


Q ss_pred             cccccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          669 TGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      ....++..|+|||.+.     ...++.++|||||||++|||++|+.||.........   ..    .      .......
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~----~------~~~~~~~  234 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LK----I------AKSEPPT  234 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH---HH----H------hcCCCcc
Confidence            3456788999999874     345788999999999999999999998643221100   00    0      0000111


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...+......+.+++.+||+.+|++||+++|+++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1112344567889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=338.97  Aligned_cols=252  Identities=19%  Similarity=0.260  Sum_probs=203.2

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc-------
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-------  579 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------  579 (811)
                      ..|.+.+.||+|+||+||+|+...+++.||||++...  .......+.+|+..+..++|+|++++.+.+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            3677789999999999999999888999999998643  3445567889999999999999999988775432       


Q ss_pred             -ceeEEEeecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          580 -KKLLVYEFMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       580 -~~~lV~ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                       ..++||||+++|+|.+++...   ...+.+.....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence             367999999999999999753   23467888899999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          656 LAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       656 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      +++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......       ... ......
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~~~-~~~~~~  260 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-------EVM-HKTLAG  260 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHH-HHHhcC
Confidence            9987543322 2233467999999999999999999999999999999999999999743211       111 001111


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .       ....+......+.+++..||+.+|.+||++.+++..
T Consensus       261 ~-------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 R-------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C-------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1       111233456789999999999999999999999864

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-35  Score=321.78  Aligned_cols=238  Identities=21%  Similarity=0.258  Sum_probs=191.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHH-HHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMA-AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|+...+++.||+|++....   ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999986432   222344555554 57889999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++.. ...+.......++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (321)
T cd05603          81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST  155 (321)
T ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence            999998875 34567788888999999999999998   99999999999999999999999999987532221 22334


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......    .+.            ..+.......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~------------~~i~~~~~~~~~~~  219 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMY------------DNILHKPLQLPGGK  219 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHH------------HHHhcCCCCCCCCC
Confidence            56899999999999889999999999999999999999999753211    010            01111122233445


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMK  773 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~  773 (811)
                      ...+.+++.+||+.+|.+||+..
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCC
Confidence            66789999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.4e-35  Score=316.42  Aligned_cols=256  Identities=28%  Similarity=0.404  Sum_probs=202.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCE--EEEEEEccCC-chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNK--IVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      +.+.+.||+|+||.||+|...+++.  .+++|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++|+|
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            4567889999999999999876654  4789888743 344556799999999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEE
Q 003555          587 FMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI  651 (811)
Q Consensus       587 y~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL  651 (811)
                      |+++++|.+++....               ..+.+..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence            999999999996532               2366888999999999999999998   9999999999999999999999


Q ss_pred             EecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHh
Q 003555          652 SNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNC  730 (811)
Q Consensus       652 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~  730 (811)
                      +|||++......  ........+..|+|||.+....++.++|||||||++|||++ |+.||.......    +    ...
T Consensus       161 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----~----~~~  230 (297)
T cd05089         161 ADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----L----YEK  230 (297)
T ss_pred             CCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----H----HHH
Confidence            999998642211  11111223557999999988889999999999999999997 999986432211    0    000


Q ss_pred             hhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          731 FIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      ...+       .....+......+.+++.+|++.+|.+||+++++++.|+......
T Consensus       231 ~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         231 LPQG-------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HhcC-------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            0000       011112234567889999999999999999999999998865543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4e-35  Score=308.52  Aligned_cols=251  Identities=27%  Similarity=0.468  Sum_probs=195.9

Q ss_pred             hhcCcccceeEEEEEEcC---CCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEec-ccceeEEEeecC
Q 003555          515 EELGRGCFGAVYKGSICE---GNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ-TSKKLLVYEFMS  589 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ey~~  589 (811)
                      +.||+|+||.||+|.+.+   ....||+|++... .....+.+.+|+.+++.++|+|++++++++.. ++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998743   2357999998643 33456788999999999999999999998764 456789999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc---
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG---  666 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~---  666 (811)
                      +++|.+++........+..++.++.||++||+|||+.   +++||||||+|||+++++.+||+|||+++........   
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            9999999987655677888899999999999999998   9999999999999999999999999999865432211   


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCC-CCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS-NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~-p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......++..|+|||.+....++.++||||||+++|||++|+. ||.... .   ..+....    ..+.       ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~---~~~~~~~----~~~~-------~~~  222 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-S---FDITVYL----LQGR-------RLL  222 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-H---HHHHHHH----hcCC-------CCC
Confidence            1123345778999999988889999999999999999999654 444221 1   1111111    0000       011


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      .+...+..+.+++..||+.+|++||++.||++.|+...
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            11223467889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.2e-36  Score=324.26  Aligned_cols=242  Identities=21%  Similarity=0.279  Sum_probs=192.9

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHH-HHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMA-AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||+||+|+...+++.||+|++....   ......+..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999888999999986432   222334455544 56788999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|.+++... ..+.......++.||++||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~  155 (325)
T cd05602          81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST  155 (325)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence            9999999763 4466777788999999999999998   99999999999999999999999999997543221 22334


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||........   + .            .+........+..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-~------------~i~~~~~~~~~~~  219 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y-D------------NILNKPLQLKPNI  219 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---H-H------------HHHhCCcCCCCCC
Confidence            5699999999999999999999999999999999999999974322110   0 0            0111111223345


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...+.+++.+||+.+|.+||++.+.+.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         220 TNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            667899999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1e-35  Score=323.22  Aligned_cols=241  Identities=21%  Similarity=0.265  Sum_probs=195.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      +.+.+.||+|+||.||+|+...+++.||||++....   ....+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            456688999999999999999888999999987532   23344567788888777 58999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++|+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++...... .
T Consensus        82 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~  156 (323)
T cd05616          82 YVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-V  156 (323)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-C
Confidence            99999999998763 4577889999999999999999998   99999999999999999999999999997543222 1


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    +..            .+.......
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~------------~i~~~~~~~  220 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ------------SIMEHNVAY  220 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH----HHH------------HHHhCCCCC
Confidence            2234568999999999999999999999999999999999999997543211    100            011111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      +.....++.+++.+|++.+|.+|++.
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            33456678999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-35  Score=316.89  Aligned_cols=264  Identities=27%  Similarity=0.398  Sum_probs=209.0

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEc-------CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEE
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSIC-------EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFC  575 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~-------~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~  575 (811)
                      ++....+.+.+.||+|+||.||+|+..       .....||+|.+.... .....++.+|+.+++.+ +|+||+++++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            355666778899999999999999752       223579999987543 34457799999999999 899999999999


Q ss_pred             ecccceeEEEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          576 MQTSKKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       576 ~~~~~~~lV~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      ......++||||+++++|.+++....               ..+++..++.++.||+.||.|||++   +++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            99999999999999999999997632               2356788899999999999999998   99999999999


Q ss_pred             EEECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTA  718 (811)
Q Consensus       641 Ill~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~  718 (811)
                      |++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence            99999999999999999876433222 1223446678999999988889999999999999999998 67777533211 


Q ss_pred             chhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          719 DVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       719 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                            ... .......       ....+......+.+++.+||+.+|.+||++.||++.|+.+..+.
T Consensus       247 ------~~~-~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         247 ------ELF-KLLKEGH-------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ------HHH-HHHHcCC-------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence                  111 1111110       11112345577889999999999999999999999998876554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=309.18  Aligned_cols=253  Identities=20%  Similarity=0.314  Sum_probs=208.1

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.++||+|+||.||+|....+++.+|+|.+........+.+.+|+.++++++|+||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            35567889999999999999988888999999976655667889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++......++..++..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++....... ....
T Consensus        84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  159 (262)
T cd06613          84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRK  159 (262)
T ss_pred             CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hccc
Confidence            9999999987656788899999999999999999998   99999999999999999999999999997654322 1123


Q ss_pred             ccccCCCccCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          670 GVKGTRGYMSPEWQNSG---LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ...++..|+|||.+...   .++.++||||||+++|||++|+.||............        ....   ........
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--------~~~~---~~~~~~~~  228 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--------SKSN---FPPPKLKD  228 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------Hhcc---CCCccccc
Confidence            35678899999998776   8899999999999999999999999754322111100        0000   01111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .......+.+++.+|++.+|.+||++++|+.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            3345678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=307.31  Aligned_cols=248  Identities=31%  Similarity=0.500  Sum_probs=206.2

Q ss_pred             hhcCcccceeEEEEEEcCC---CEEEEEEEccCCchhh-HHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEG---NKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|.....   +..||+|.++...... .+.+.+|++.++.++|+|++++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999866   7899999997654433 67899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcC--------CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          591 GSLENLLSNV--------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       591 gsL~~~l~~~--------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      ++|.+++...        ...+++.++..++.|+++||+|||++   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        46688999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          663 NQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       663 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ... .......++..|+|||.+....++.++||||||++++||++ |..||.......    +    ......       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~----~~~~~~-------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----V----LEYLRK-------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH----H----HHHHHc-------
Confidence            332 22234567889999999988889999999999999999999 588887542111    1    011111       


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ......+...+..+.+++.+|++.+|.+||++.|+++.|+
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111223344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-36  Score=326.22  Aligned_cols=239  Identities=23%  Similarity=0.273  Sum_probs=194.2

Q ss_pred             hhcCcccceeEEEEEEc---CCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          515 EELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.||+|+||.||+++..   ..++.||+|++....  ......+..|++++++++|+||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            57999999999998763   456899999986432  2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++.. ...+++..+..++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+++...... ....
T Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~  156 (318)
T cd05582          82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY  156 (318)
T ss_pred             CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence            9999999975 34578899999999999999999998   99999999999999999999999999998654332 1223


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...|++.|+|||.+....++.++|||||||++|||++|+.||........   . .            .+.......+..
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~-~------------~i~~~~~~~p~~  220 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---M-T------------MILKAKLGMPQF  220 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---H-H------------HHHcCCCCCCCC
Confidence            45789999999999888899999999999999999999999975322110   0 0            011111122333


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKN  774 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~e  774 (811)
                      ....+.+++.+||+.||++||++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            4567889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=310.49  Aligned_cols=248  Identities=20%  Similarity=0.324  Sum_probs=219.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      -|.+++.||+|.|..|-+|++.-.++.||||++.+...  -...++.+|++-|+-++|||||+||++...+..+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            46778999999999999999999999999999976432  2345789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE-CCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL-DDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll-~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      -.+|+|.+|+.++..++.+....+++.||+.|+.|+|+.   .+|||||||+||.+ ..-|.+||.|||++..+.++.. 
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-  174 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-  174 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence            999999999999999999999999999999999999998   99999999999976 5778999999999998877654 


Q ss_pred             cccccccCCCccCccccccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLIT-VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                       .+..+|+..|.|||++.+..|+ ++.|||||||+||-|++|+.||+.....+.                +..++|=...
T Consensus       175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmImDCKYt  237 (864)
T KOG4717|consen  175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMIMDCKYT  237 (864)
T ss_pred             -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhhhccccc
Confidence             4567899999999999888776 588999999999999999999986544432                3344555566


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+...+.++.+||..||+.||.+|.+.+||+..
T Consensus       238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            677889999999999999999999999999743

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.9e-35  Score=320.22  Aligned_cols=265  Identities=27%  Similarity=0.397  Sum_probs=208.7

Q ss_pred             hHHHHHHhhhhhhcCcccceeEEEEEEcC-------CCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecE
Q 003555          504 GELERATNGFEEELGRGCFGAVYKGSICE-------GNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGF  574 (811)
Q Consensus       504 ~el~~~~~~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~  574 (811)
                      .++...++.+.++||+|+||.||++....       ....||+|.++... ....+++.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            35566678889999999999999998632       12379999887543 34457899999999999 89999999999


Q ss_pred             EecccceeEEEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCC
Q 003555          575 CMQTSKKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPR  639 (811)
Q Consensus       575 ~~~~~~~~lV~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~  639 (811)
                      +.+.+..++++||+++|+|.+++....               ..+.+..++.++.||+.||+|||+.   +++||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence            999999999999999999999997532               2366888999999999999999998   9999999999


Q ss_pred             cEEECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 003555          640 NILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVST  717 (811)
Q Consensus       640 NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~  717 (811)
                      |||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999999865432211 1122334567999999998899999999999999999998 77887543211


Q ss_pred             cchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       718 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      +       .. ......       .....+......+.+++.+|++.+|.+||++.|++..|+......
T Consensus       244 ~-------~~-~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 E-------LF-KLLKEG-------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             H-------HH-HHHHcC-------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1       10 011111       011122334567889999999999999999999999998866443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.1e-35  Score=308.69  Aligned_cols=254  Identities=18%  Similarity=0.299  Sum_probs=204.1

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..+.+.++||+|+||.||+|+...+++.||+|.++.........+.+|+.+++.++|+||+++++.+.+.+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45677899999999999999998888999999987655555567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++... ..+++.+...++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...... ....
T Consensus        89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~  163 (267)
T cd06645          89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR  163 (267)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence            999999998753 4578899999999999999999998   9999999999999999999999999998765322 2222


Q ss_pred             cccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          669 TGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ....|+..|+|||.+.   ...++.++|||||||++|||++|+.||....+.....   ..     .....   ......
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~-----~~~~~---~~~~~~  232 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LM-----TKSNF---QPPKLK  232 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hh-----hccCC---CCCccc
Confidence            3456899999999874   4568899999999999999999999986433221110   00     00000   000011


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ........+.+++.+|++.+|++||++++|++.
T Consensus       233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            111234578899999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-35  Score=322.30  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=202.7

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEc-----CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEecc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT  578 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~  578 (811)
                      +....+.+.+.||+|+||.||+|...     ..++.||||+++... ......+.+|+.++.++ +|+||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            34556788899999999999999842     345789999997543 33456788999999999 789999999988654


Q ss_pred             -cceeEEEeecCCCCHHHHhhcCC--------------------------------------------------------
Q 003555          579 -SKKLLVYEFMSKGSLENLLSNVE--------------------------------------------------------  601 (811)
Q Consensus       579 -~~~~lV~ey~~~gsL~~~l~~~~--------------------------------------------------------  601 (811)
                       ...++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             46789999999999999986421                                                        


Q ss_pred             ----------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-ccccc
Q 003555          602 ----------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-GIVTG  670 (811)
Q Consensus       602 ----------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~  670 (811)
                                ..+++.++.+++.||++||+|||+.   +|+||||||+||++++++.+||+|||++........ .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                      1245677888999999999999998   999999999999999999999999999986533222 11222


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||.........       ........       ....+..
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~-------~~~~~~~  306 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-------CRRLKEGT-------RMRAPDY  306 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH-------HHHHhccC-------CCCCCCC
Confidence            345678999999988899999999999999999997 88888643221110       00011110       0111112


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      ....+.+++..||+.+|.+||++.||++.|+.+.+
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34568899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.5e-35  Score=314.93  Aligned_cols=250  Identities=18%  Similarity=0.282  Sum_probs=205.2

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      ++.+.++||+|+||.||+|.....++.||+|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            45666889999999999999988889999999876555556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++.+  ..+.+.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus       101 ~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~  174 (296)
T cd06654         101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS  174 (296)
T ss_pred             CCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccC
Confidence            9999999864  3467889999999999999999998   999999999999999999999999999886543221 122


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...+++.|+|||.+.+..++.++|||||||++|||++|+.||..........   ..    ....      ......+..
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~---~~----~~~~------~~~~~~~~~  241 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LI----ATNG------TPELQNPEK  241 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH---HH----hcCC------CCCCCCccc
Confidence            3468899999999988889999999999999999999999997543221110   00    0000      001111234


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ....+.+++.+||+.+|++||++.|+++.
T Consensus       242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            45678899999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-35  Score=324.83  Aligned_cols=252  Identities=19%  Similarity=0.216  Sum_probs=195.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||+||++.....++.||||++....   ......+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            445688999999999999999889999999986432   23345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--  665 (811)
                      +++|+|.+++.. ...+++.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        83 ~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          83 LPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            999999999986 34678889999999999999999998   999999999999999999999999999876432110  


Q ss_pred             --------------------------------ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 003555          666 --------------------------------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEV  713 (811)
Q Consensus       666 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~  713 (811)
                                                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001234699999999999999999999999999999999999999975


Q ss_pred             CCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 003555          714 NVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQ--DEPNLRPSMKNVILM  778 (811)
Q Consensus       714 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPs~~evl~~  778 (811)
                      ........        ..........+.+    .......+.+++.+++.  .++..||+++||++.
T Consensus       239 ~~~~~~~~--------~i~~~~~~~~~p~----~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQETYK--------KVMNWKETLIFPP----EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHHHHH--------HHHcCcCcccCCC----cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            43221110        0000000000111    11233456666666333  344567999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-35  Score=313.00  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=207.6

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcC----CCEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEec--ccce
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICE----GNKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQ--TSKK  581 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~----~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~  581 (811)
                      ..+.+.+.||+|+||.||+|++..    .++.||||.++..... ..+.|.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            345667899999999999999753    3679999999755443 56789999999999999999999999987  5578


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            999999999999999987666788999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCc--cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          662 PNQTG--IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       662 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      .....  ......++..|+|||.+.+..++.++||||||++++||++|+.|+.............  .........+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~  238 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLEL  238 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHHHH
Confidence            32221  1112345667999999988899999999999999999999999986432211000000  0000000000011


Q ss_pred             cCC--ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          740 VGE--DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       740 ~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      +..  ....+.....++.+++.+|++.+|.+||+|.||+++|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111  1111223446799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.3e-35  Score=313.34  Aligned_cols=256  Identities=27%  Similarity=0.422  Sum_probs=202.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      +.+.+.||+|+||.||+|+...     +...+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+.+..++|
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            3456889999999999998743     23579999886543 33456799999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCC-----------------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcE
Q 003555          585 YEFMSKGSLENLLSNVE-----------------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNI  641 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NI  641 (811)
                      +||+++++|.+++....                       ..+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence            99999999999986421                       2356788899999999999999998   999999999999


Q ss_pred             EECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 003555          642 LLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTAD  719 (811)
Q Consensus       642 ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~  719 (811)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||....... 
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence            9999999999999999865433221 1122345678999999888889999999999999999998 888886432111 


Q ss_pred             hhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                         +    +...... .      ....+......+.+++.+|++.+|.+||++.|+++.|+++..
T Consensus       238 ---~----~~~~~~~-~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---L----FNLLKTG-Y------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---H----HHHHhCC-C------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               1    1111100 0      011122345678899999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=308.48  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=202.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-----hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-----EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +...+.||+|++|.||++....+++.||+|.+....     ......+.+|+.++++++|+||+++++++.+++..++|+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            455689999999999999998888999999876432     122356889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+++++|.+++... ..++.....+++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++.......
T Consensus        84 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          84 EYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            999999999999763 3467788899999999999999998   999999999999999999999999999986543222


Q ss_pred             ccc--cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          666 GIV--TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       666 ~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      ...  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.........       ..... .      ...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~-~------~~~  225 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-------FKIAT-Q------PTN  225 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-------HHHhc-c------CCC
Confidence            111  2345788999999999888999999999999999999999998643221110       00000 0      011


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...+......+.+++.+||+.+|.+||++.|+++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            12233456678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.1e-35  Score=311.75  Aligned_cols=259  Identities=22%  Similarity=0.359  Sum_probs=207.5

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcC----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEec-ccc
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICE----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ-TSK  580 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~  580 (811)
                      ...++.+.+.||+|+||.||+|....    .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45567778999999999999999875    25789999987543 3445678999999999999999999999876 467


Q ss_pred             eeEEEeecCCCCHHHHhhcCC-------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          581 KLLVYEFMSKGSLENLLSNVE-------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                      .++++||+++++|.+++....       ..+.+..++.++.||+.||+|||+.   +++|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999997642       3467899999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhh
Q 003555          654 FSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCF  731 (811)
Q Consensus       654 FGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~  731 (811)
                      ||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||......    .+..+..   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~---  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----EMAAYLK---  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----HHHHHHH---
Confidence            99998764433221 122345778999999988889999999999999999999 99998643221    1111110   


Q ss_pred             hhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       732 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                       ..       .........+..+.+++.+|++.+|++||++.+++++|+...
T Consensus       234 -~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         234 -DG-------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -cC-------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence             00       011112234567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.5e-35  Score=306.54  Aligned_cols=248  Identities=27%  Similarity=0.377  Sum_probs=201.6

Q ss_pred             hhcCcccceeEEEEEEcC-CC--EEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICE-GN--KIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~-~~--~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      ++||+|++|.||+|.+.. ++  ..||||.+..... ...+.+.+|+.++++++|+||+++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            469999999999999855 23  3699999987655 667789999999999999999999999988 889999999999


Q ss_pred             CCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc--c
Q 003555          591 GSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG--I  667 (811)
Q Consensus       591 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~--~  667 (811)
                      ++|.+++.+.. ..+.+.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999998754 4678999999999999999999998   9999999999999999999999999999876443221  1


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||......+    ......    .      .......
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~~----~------~~~~~~~  222 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKID----K------EGERLER  222 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----h------cCCcCCC
Confidence            123456789999999998899999999999999999998 999986432211    000000    0      0011111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      +...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            2234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.3e-35  Score=312.30  Aligned_cols=260  Identities=24%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEeccc
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS  579 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  579 (811)
                      +...++.+.++||+|+||.||+|..++     .+..||+|.+.... ......+.+|+..+++++|+||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            345567778999999999999997653     24589999886433 233456889999999999999999999999999


Q ss_pred             ceeEEEeecCCCCHHHHhhcCC---------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeE
Q 003555          580 KKLLVYEFMSKGSLENLLSNVE---------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK  650 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~k  650 (811)
                      ..++||||+++|+|.+++....         ..+.+..+..++.||+.||.|||++   +|+||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997532         2235677889999999999999998   999999999999999999999


Q ss_pred             EEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHH
Q 003555          651 ISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVY  728 (811)
Q Consensus       651 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~  728 (811)
                      |+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+    ...   
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~---  232 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLK---  232 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH---
Confidence            9999999865432221 1122345678999999988899999999999999999998 677876432111    000   


Q ss_pred             HhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                       .......       ...+......+.+++.+|++.+|++||++.++++.|++..
T Consensus       233 -~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         233 -FVMDGGY-------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             -HHHcCCC-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence             0001100       1112233568999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-35  Score=320.31  Aligned_cols=244  Identities=20%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|+...+++.||+|+++...   .+..+.+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999989999999997532   23345688999999888 699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|..++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  155 (327)
T cd05617          81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST  155 (327)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence            9999988753 4578899999999999999999998   99999999999999999999999999997532221 12234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .........        .......+...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~--------~~~~~~~p~~~  226 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVI--------LEKPIRIPRFL  226 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHH--------HhCCCCCCCCC
Confidence            568999999999999999999999999999999999999996433221110 011111111        11112223344


Q ss_pred             HHHHHHHHHHcccCCCCCCCCH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      ...+.+++.+||+.||.+||++
T Consensus       227 ~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         227 SVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CHHHHHHHHHHhccCHHHcCCC
Confidence            5678899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-35  Score=307.16  Aligned_cols=239  Identities=22%  Similarity=0.408  Sum_probs=193.4

Q ss_pred             hhcCcccceeEEEEEEcCCC----------EEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          515 EELGRGCFGAVYKGSICEGN----------KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~----------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      +.||+|+||.||+|.+...+          ..|++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999997665          35888887654333 6789999999999999999999999988 778999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-------CeEEEecCCc
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-------TAKISNFSLA  657 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-------~~kL~DFGla  657 (811)
                      +||+++++|.+++......+++..++.++.||+.||+|||+.   +|+|+||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999987665788899999999999999999998   999999999999999887       7999999999


Q ss_pred             cccCCCCCccccccccCCCccCccccccC--CCCcccchHHHHHHHHHHHhC-CCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          658 KILMPNQTGIVTGVKGTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCC-RSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       658 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      .....     .....++..|+|||.+...  .++.++||||||+++|||++| ..|+.........    ..    ....
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~----~~----~~~~  222 (259)
T cd05037         156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE----RF----YQDQ  222 (259)
T ss_pred             ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH----HH----HhcC
Confidence            86543     1223467789999998776  789999999999999999994 6666543211110    00    0000


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                               ...+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 ---------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ---------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                     0001111268889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-35  Score=307.50  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=207.2

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +....+.+.++||+|+||.||+|...+ ++.||||.+.... ...+++.+|+.++++++|+||+++++++.+....++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            445567778999999999999999864 5789999987432 34567999999999999999999999999989999999


Q ss_pred             eecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          586 EFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      ||+++++|.+++.... ..+++..+..++.|++.||.|||++   +++|+||||+||++++++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999998754 4578899999999999999999998   99999999999999999999999999998765332


Q ss_pred             CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      ........++..|+|||.+.+..++.++||||||++++|+++ |+.||.......   .+ ...    . ...      .
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~-~~~----~-~~~------~  222 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL-EQV----E-RGY------R  222 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-HHH----H-cCC------C
Confidence            222223345678999999998889999999999999999998 898886432111   11 000    0 000      1


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ...+...+..+.+++.+|++.+|.+||+++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            11122235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.5e-35  Score=317.06  Aligned_cols=263  Identities=19%  Similarity=0.267  Sum_probs=201.6

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +|.+.++||+|+||.||+|+....++.||+|+++... ......+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            3566789999999999999998888999999986433 233456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++ +|.+++......+.+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  161 (309)
T cd07872          87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTY  161 (309)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-ccc
Confidence            86 89998877666678889999999999999999998   99999999999999999999999999997643222 122


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhc-ccchh
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAK-ELSKL  739 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~-~~~~~  739 (811)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........       +...... .....
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            23467899999998754 468899999999999999999999997654332211110000       0000000 00000


Q ss_pred             cCCc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          740 VGED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      -...      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000      0011234557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-35  Score=308.41  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=197.2

Q ss_pred             hhcCcccceeEEEEEEcCCCE--EEEEEEccCC-chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNK--IVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|++.+++.  .+|+|.++.. .......+.+|++++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999977654  5789988743 344556899999999999 899999999999999999999999999


Q ss_pred             CCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          591 GSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       591 gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                      ++|.+++....               ..+.+.++..++.|++.||+|||+.   +++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999997532               2356889999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       656 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      ++......  ........+..|+|||.+....++.++||||||+++|||++ |+.||.......       .. ......
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~-~~~~~~  227 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY-EKLPQG  227 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HH-HHHhCC
Confidence            98632111  11111233567999999988889999999999999999997 999986432111       00 000010


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      .       ...........+.+++.+|++.+|.+||++.+++..|+.+.
T Consensus       228 ~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 Y-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C-------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0       11112234457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-35  Score=320.65  Aligned_cols=241  Identities=20%  Similarity=0.267  Sum_probs=195.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      +++.+.||+|+||+||+|....+++.||||++....   ....+.+..|..+++.+. |++|+++.+++.+.+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456788999999999999999889999999986432   233456788899988885 5778889999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++|+|.+++... ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 y~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-  156 (323)
T cd05615          82 YVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-  156 (323)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence            99999999998763 4578899999999999999999998   999999999999999999999999999875432221 


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    +..            .+.......
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~----~~~------------~i~~~~~~~  220 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQ------------SIMEHNVSY  220 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHH------------HHHhCCCCC
Confidence            2234568999999999998899999999999999999999999997543211    000            011111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      +......+.+++.+||+.+|.+|++.
T Consensus       221 p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            23345678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-34  Score=311.42  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcC----------------CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccc
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICE----------------GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVR  570 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~----------------~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~  570 (811)
                      ...+.+.++||+|+||.||++...+                +...||+|++.... .....++.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3456778899999999999986432                34579999997543 344578999999999999999999


Q ss_pred             eecEEecccceeEEEeecCCCCHHHHhhcCC----------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVE----------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       571 l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      +++++.+.+..++||||+++++|.+++....          ..+++.....++.||+.||+|||+.   +++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            9999999999999999999999999997642          1255678999999999999999998   99999999999


Q ss_pred             EEECCCCCeEEEecCCccccCCCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCc
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC--CRSNFEVNVST  717 (811)
Q Consensus       641 Ill~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt--g~~p~~~~~~~  717 (811)
                      ||+++++.++|+|||+++.+....... .....++..|+|||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            999999999999999998654332211 122344678999998888889999999999999999998  66777543221


Q ss_pred             cchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       718 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ...    ............. ..   ...+......+.+++.+||+.+|.+||++.||++.|+
T Consensus       241 ~~~----~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVI----ENTGEFFRDQGRQ-VY---LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH----HHHHHHHhhcccc-cc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            110    1000101000000 00   0112234478899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.2e-35  Score=316.34  Aligned_cols=256  Identities=28%  Similarity=0.412  Sum_probs=201.1

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCE--EEEEEEccCC-chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNK--IVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ..+.+.+.||+|+||.||+|.+...+.  .+|+|.++.. .......+.+|+.++.++ +|+||+++++++.+++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            345677899999999999999876554  5688887643 334556889999999999 899999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCe
Q 003555          585 YEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTA  649 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~  649 (811)
                      +||+++++|.+++....               ..+++.+++.++.||+.||+|||+.   +++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            99999999999997532               2457888999999999999999998   99999999999999999999


Q ss_pred             EEEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHH
Q 003555          650 KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVY  728 (811)
Q Consensus       650 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~  728 (811)
                      ||+|||+++.....  .......++..|+|||.+....++.++|||||||++|||++ |..||......+    ...   
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~---  234 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYE---  234 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH----HHH---
Confidence            99999998642111  11111234667999999988889999999999999999998 999986432211    000   


Q ss_pred             HhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                       .....       .....+......+.+++.+|++.+|++||++.+++++|+...+
T Consensus       235 -~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         235 -KLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             -HHhcC-------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             00000       0111122345578899999999999999999999999876433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=310.29  Aligned_cols=252  Identities=21%  Similarity=0.299  Sum_probs=205.9

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.++||.|+||.||+|....+++.||+|.+........+.+.+|+.++++++|+|++++++.+.+....++||||++
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            46777899999999999999988889999999876666667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++......+++.....++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........ ...
T Consensus        86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~  161 (280)
T cd06611          86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD  161 (280)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence            9999999987666788999999999999999999999   999999999999999999999999999876432221 223


Q ss_pred             ccccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          670 GVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      ...++..|+|||.+.     ...++.++||||||+++|||++|+.||........   +...     ...     .....
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~-----~~~~~  228 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---LLKI-----LKS-----EPPTL  228 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH---HHHH-----hcC-----CCCCc
Confidence            356889999999864     34577899999999999999999999975322110   0000     000     00111


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..+......+.+++..||+.+|.+||++.++++.
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            1122345678899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-35  Score=327.12  Aligned_cols=259  Identities=18%  Similarity=0.169  Sum_probs=197.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.+.||+|+||.||++.+...++.||||...      ...+.+|++++++++|+||+++++++..++..++|||++.
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            3556688999999999999999888999999642      2346789999999999999999999999999999999995


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-cc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-IV  668 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-~~  668 (811)
                       ++|.+++......+++.+++.|+.||++||.|||+.   +|+||||||+||||+.++.+||+|||+++........ ..
T Consensus       244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence             699999876556788999999999999999999998   9999999999999999999999999999875433221 22


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc----hhhHHHHHHHhhh-hcccch-----
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD----VVLLSTWVYNCFI-AKELSK-----  738 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~----~~~l~~~~~~~~~-~~~~~~-----  738 (811)
                      ....||..|+|||.+.+..++.++|||||||+||||++|..++........    ...+...+..... ......     
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            345699999999999999999999999999999999998876533221110    0011111111000 000000     


Q ss_pred             ---hc------CCcccc-------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          739 ---LV------GEDEEV-------DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       739 ---~~------~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                         ..      ......       .......+.+|+.+||+.||++|||+.|+++.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               00      000000       00123468899999999999999999999864

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.5e-35  Score=325.65  Aligned_cols=257  Identities=21%  Similarity=0.209  Sum_probs=202.0

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      +....+.+.+.||+|+||.||+++...+++.||+|++...   .......+.+|+.+++.++||||+++++.+.+++..+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            3445677788999999999999999999999999998642   2233456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +||||+++|+|.+++...  .++...+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       120 lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         120 MVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            999999999999999753  467778888999999999999999   999999999999999999999999999987654


Q ss_pred             CCCccccccccCCCccCccccccC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSG----LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ..........||+.|+|||.+...    .++.++|||||||++|||++|+.||........   .    ...........
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~----~~i~~~~~~~~  267 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y----SKIMNHKNSLT  267 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---H----HHHHcCCCccc
Confidence            333333456799999999988654    378999999999999999999999975432110   0    00000000000


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHh
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNL--RPSMKNVILML  779 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L  779 (811)
                           ..........+.+++..|++..+.+  ||+++|+++..
T Consensus       268 -----~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 -----FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -----CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                 0112245667889999999854443  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.5e-35  Score=316.69  Aligned_cols=262  Identities=27%  Similarity=0.400  Sum_probs=207.0

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcC-------CCEEEEEEEccCC-chhhHHHHHHHHHHHhcc-CCCCccceecEE
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICE-------GNKIVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFC  575 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~  575 (811)
                      ++....+.+.++||+|+||.||++....       ....+|+|.++.. ......++.+|+.+++++ +|+||+++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4555678888999999999999998643       2247999999754 234456788999999999 799999999999


Q ss_pred             ecccceeEEEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          576 MQTSKKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       576 ~~~~~~~lV~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      .+.+..++||||+++++|.+++....               ..+++.++++++.||+.||+|||+.   +++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence            99999999999999999999997542               2467889999999999999999998   99999999999


Q ss_pred             EEECCCCCeEEEecCCccccCCCCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTA  718 (811)
Q Consensus       641 Ill~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~  718 (811)
                      |++++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... 
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence            999999999999999997654322111 122234568999999988889999999999999999998 77887532211 


Q ss_pred             chhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          719 DVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       719 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      .   +   . ......       .....+......+.+++.+|++.+|.+||++.+|++.|+.+..
T Consensus       250 ~---~---~-~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         250 E---L---F-KLLKEG-------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             H---H---H-HHHHcC-------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            1   0   0 000111       0112223445688899999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=319.56  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=208.2

Q ss_pred             hcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHHH
Q 003555          516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN  595 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~~  595 (811)
                      +||+|.||+||-|++.+++..+|||-+.....+....+..|+.+.++|+|+|||+++|.+.+++..-+.||-.+||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999999999999999987777777889999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCC--chHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-CCCCeEEEecCCccccCCCCCccccccc
Q 003555          596 LLSNVESGP--IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVK  672 (811)
Q Consensus       596 ~l~~~~~~~--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~~~  672 (811)
                      +|+..-+.+  .+...--...||++||.|||++   .|||||||-+|||++ -.|.+||+|||-++.+. +-........
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccccc
Confidence            998764444  4666667889999999999999   999999999999996 67999999999999764 3334456678


Q ss_pred             cCCCccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          673 GTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       673 gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ||..|||||++..+  .|..++|||||||.+.||.||++||.........    .     +.-    .+....+.++.+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----M-----FkV----GmyKvHP~iPeel  804 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----M-----FKV----GMYKVHPPIPEEL  804 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----h-----hhh----cceecCCCCcHHH
Confidence            99999999998765  4889999999999999999999999754332211    0     000    1122334567788


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..+...++++|+.++|.+||+++++++
T Consensus       805 saeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  805 SAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            899999999999999999999999985

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=298.58  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=215.8

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +....+.++||+|+||.|||+.++..++.||||.+.  .+.+..++..|+.++++.+.+++|+++|.+.....+++||||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            344667799999999999999999999999999984  556788999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      |..|+..+.++..+..+++.++..++...++||+|||..   .-+|||||+.||||+.+|.+||+|||.|-.+. +....
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT-DTMAK  185 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT-DTMAK  185 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh-hhHHh
Confidence            999999999999888999999999999999999999998   88999999999999999999999999997653 22234


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....||+-|||||++..-.|..++||||||+...||.-|++|+....+......++.             ...+....+
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-------------~PPPTF~KP  252 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-------------KPPPTFKKP  252 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-------------CCCCCCCCh
Confidence            4567899999999999999999999999999999999999999986544332221110             001112335


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...+.++-++++.||-++|++|-|+-++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            677889999999999999999999988774

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-35  Score=328.49  Aligned_cols=250  Identities=18%  Similarity=0.201  Sum_probs=194.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||+||+|+....++.||||++....   ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            345688999999999999999889999999986432   23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC---
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ---  664 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~---  664 (811)
                      +++|+|.+++.+. ..+.+.....++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....   
T Consensus        83 ~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          83 IPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999999999764 3467778888999999999999998   99999999999999999999999999975321100   


Q ss_pred             -------------------------------------------CccccccccCCCccCccccccCCCCcccchHHHHHHH
Q 003555          665 -------------------------------------------TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVV  701 (811)
Q Consensus       665 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll  701 (811)
                                                                 ........||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                       0001224689999999999989999999999999999


Q ss_pred             HHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 003555          702 LEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS---MKNVIL  777 (811)
Q Consensus       702 ~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~  777 (811)
                      |||++|+.||.............        .... ..   ...........+.+++.+++ .+|.+|++   +.|+++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~--------~~~~-~~---~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVI--------NWQT-SL---HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHH--------ccCC-Cc---CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            99999999997543221111000        0000 00   00111223456667777765 49999987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-35  Score=305.50  Aligned_cols=248  Identities=29%  Similarity=0.401  Sum_probs=204.3

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..+.+.+.||+|+||.||+|...  ++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            45667789999999999999874  57899999976544 5678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++++|.+++.... ..+.+..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||+++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            9999999997644 3578999999999999999999998   999999999999999999999999999986532211  


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                        ....+..|+|||.+....++.++||||||+++||+++ |+.||.......    +...    ....       .....
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~----~~~~-------~~~~~  220 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPH----VEKG-------YRMEA  220 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH----HhcC-------CCCCC
Confidence              2345678999999988889999999999999999997 888886432111    1011    1110       01111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      +...+..+.+++.+|++.+|.+||+++|++.+|+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            22345788999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=320.44  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=208.4

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCC---EEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGN---KIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~---~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      -+....+.|+||+|.||.|++|.+...+   -.||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ...+
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            3455567799999999999999996533   36999999865544 67899999999999999999999999988 7789


Q ss_pred             EEEeecCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          583 LVYEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      +|+|.++.|+|.+.|++. +..+.......++.|||.||.||..+   .+|||||.++|+||-....+||+||||.+-+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999999883 44456777888999999999999999   99999999999999999999999999999876


Q ss_pred             CCCC-ccccc-cccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          662 PNQT-GIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       662 ~~~~-~~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      .++. +.+.. ..-...|.|||.++..+++.++|||+|||.+|||+| |..||.......                 +.+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-----------------IL~  326 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-----------------ILK  326 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-----------------HHH
Confidence            5443 33332 345668999999999999999999999999999998 456776432211                 112


Q ss_pred             hcC--CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          739 LVG--EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       739 ~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+|  +++..+..++++++++++.||..+|++||++..|...
T Consensus       327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            222  3345577899999999999999999999999999733

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-35  Score=308.88  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCE----EEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNK----IVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      ...+.+.+.||+|+||.||+|..+..++    .||+|.+.... .....++.+|+.++++++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3456677899999999999999865443    69999887543 3455789999999999999999999999987 7889


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|+||+++|+|.+++......+++..++.++.||+.||+|||+.   +++|+||||+||++++++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999987666788999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCcc-ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          663 NQTGI-VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       663 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ..... .....++..|+|||.+....++.++||||||+++||+++ |+.||......+    +...    ....      
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~----~~~~------  227 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----IPDL----LEKG------  227 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHH----HhCC------
Confidence            32211 122334678999999988889999999999999999998 999987542211    1111    0110      


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                       .....+......+.+++.+||..+|.+||++.++++.|+.+..
T Consensus       228 -~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 -ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             0111122344578899999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-34  Score=307.69  Aligned_cols=249  Identities=23%  Similarity=0.357  Sum_probs=204.0

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+...+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45666788999999999999998888999999987433 34456799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++..  ..+.+..+..++.||++||.|||+.   +++|+||+|+||++++++.+||+|||++........ .
T Consensus        84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            999999999864  4567888999999999999999998   999999999999999999999999999986543221 1


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.........    ..     ....      ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~-----~~~~------~~~~~~  222 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----FL-----IPKN------SPPTLE  222 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----hh-----hhcC------CCCCCC
Confidence            22345788999999998888999999999999999999999998643221100    00     0000      011122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......+.+++.+|++.+|.+||+|.++++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            2345678899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.2e-35  Score=311.30  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=200.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +...+.||+|+||+||+|....+++.||+|.++...   ......+.+|++++++++|+|++++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            344578999999999999999889999999986432   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999999887543 3578999999999999999999998   99999999999999999999999999997643221  


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..........   .. ..        .........
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~-~~--------~~~~~~~~~  224 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EV-DR--------RVLETEEVY  224 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH-HH--------hhhcccccc
Confidence            1234568999999999988899999999999999999999999997543221110   00 00        001111112


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  777 (811)
                      .......+.+|+..|++.+|.+||+     +.+++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            2334567789999999999999999     566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.5e-35  Score=321.08  Aligned_cols=254  Identities=19%  Similarity=0.185  Sum_probs=199.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||+||+++....++.||+|.+...   .......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            45678999999999999999988899999998642   122344588899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++|+|.+++......+.+..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999987666778888899999999999999998   99999999999999999999999999998765443333


Q ss_pred             ccccccCCCccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          668 VTGVKGTRGYMSPEWQNS-----GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .....||+.|+|||.+..     ..++.++|||||||++|||++|+.||.........       ...........+   
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~~~~---  229 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHEERFQF---  229 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-------HHHHcCCCcccC---
Confidence            334569999999998765     56788999999999999999999999743221110       000000000000   


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNL--RPSMKNVILM  778 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~  778 (811)
                       .......++.+.+++.+|+..++++  |++++++++.
T Consensus       230 -p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 -PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             0111123567888999988865544  5688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-35  Score=317.35  Aligned_cols=254  Identities=20%  Similarity=0.192  Sum_probs=198.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      |.+.+.||+|+||+||+++....++.||||++...   .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            55678999999999999999988899999998632   223345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++|+|.+++.+....+.+..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999987666788888999999999999999999   99999999999999999999999999997654433322


Q ss_pred             ccccccCCCccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          668 VTGVKGTRGYMSPEWQNS-----GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .....||+.|+|||.+..     ..++.++|||||||++|||++|+.||......+..       ...........+.  
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-------~~i~~~~~~~~~~--  230 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKEHFQFP--  230 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH-------HHHHcCCCcccCC--
Confidence            233568999999998763     45788999999999999999999999753221110       0000001111111  


Q ss_pred             ccccChHHHHHHHHHHHHcccC--CCCCCCCHHHHHHH
Q 003555          743 DEEVDLRTLETMVRVGLLCIQD--EPNLRPSMKNVILM  778 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~--dP~~RPs~~evl~~  778 (811)
                        ......++.+.+++.+|+..  ++..||++++++..
T Consensus       231 --~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 --PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              11122455677788876654  44458899998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8e-35  Score=306.05  Aligned_cols=256  Identities=27%  Similarity=0.424  Sum_probs=205.6

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ++..+++.+.++||+|+||.||++.... +..+|+|.+... ....+.+.+|+.++++++|+|++++.+++.+ ...+++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            3455677888999999999999998754 467999988743 3345678999999999999999999999887 778999


Q ss_pred             EeecCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          585 YEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |||+++++|.+++... ....++..+..++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999764 34467888999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .........++..|+|||.+....++.++|+||||+++||+++ |+.||.......    +...    ....       .
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~----~~~~-------~  220 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRA----LERG-------Y  220 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH----HHHH----HhCC-------C
Confidence            3222233456678999999988889999999999999999999 888886432111    0010    0010       0


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ...........+.+++.+|++.+|++||++.+++++|+.
T Consensus       221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111123345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=328.79  Aligned_cols=251  Identities=20%  Similarity=0.189  Sum_probs=196.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      |.+.++||+|+||.||++....+++.||||++...   .......+.+|+.++++++|+||+++++++.+....++||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            45568999999999999999988999999998542   223346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--  665 (811)
                      +++|+|.+++... ..+.+.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus        83 ~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          83 LPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999999999763 4567788888999999999999998   999999999999999999999999999964321100  


Q ss_pred             ----------c----------------------------------cccccccCCCccCccccccCCCCcccchHHHHHHH
Q 003555          666 ----------G----------------------------------IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVV  701 (811)
Q Consensus       666 ----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll  701 (811)
                                .                                  ......||+.|+|||.+.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                      0                                  00124689999999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 003555          702 LEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLR---PSMKNVILM  778 (811)
Q Consensus       702 ~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~  778 (811)
                      |||++|+.||...........+        ..  ....+.  ..........+.+++..|++ +|.+|   |++.|+++.
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i--------~~--~~~~~~--~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKI--------IN--WRETLY--FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHH--------Hc--cCCccC--CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            9999999999754322111000        00  000000  00111235678889999997 66654   699998865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-34  Score=305.95  Aligned_cols=252  Identities=27%  Similarity=0.394  Sum_probs=192.2

Q ss_pred             hhcCcccceeEEEEEEcC--CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICE--GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +.||+|+||.||+|...+  ....+|+|+++... ......+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            369999999999998754  34579999987543 344567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCC----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          592 SLENLLSNVE----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       592 sL~~~l~~~~----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +|.+++....    ....+..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    2345677788999999999999998   99999999999999999999999999997543322211


Q ss_pred             -ccccccCCCccCccccccC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          668 -VTGVKGTRGYMSPEWQNSG-------LITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       668 -~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                       .....++..|+|||++...       .++.++||||||+++|||++ |+.||.........    ..    ........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~~----~~~~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TY----TVREQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----HH----HhhcccCC
Confidence             2234577889999987532       35789999999999999996 99999643322110    00    01111111


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ...+  .......+.+.+++..|+ .+|++|||++||++.|+
T Consensus       230 ~~~~--~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKP--RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCC--ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111  111223456778889998 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-35  Score=316.47  Aligned_cols=252  Identities=23%  Similarity=0.283  Sum_probs=214.8

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh---hHHHHHHHHHHHhccC-CCCccceecEEeccccee
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~  582 (811)
                      ....|.+.++||+|.||.||+++.+.+++.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            345677789999999999999999999999999999765443   3468999999999998 999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC----CCCeEEEecCCcc
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD----SLTAKISNFSLAK  658 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~----~~~~kL~DFGla~  658 (811)
                      +|||++.+|.|.+.+...  ..++.....++.||+.+++|||+.   +|+||||||+|+|+..    ++.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  388899999999999999999998   9999999999999963    3589999999999


Q ss_pred             ccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          659 ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       659 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ....  .......+||+.|+|||++....++..+||||+||++|.|++|..||...........        ....+.  
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~--------i~~~~~--  255 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA--------ILRGDF--  255 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH--------HHcCCC--
Confidence            8765  4456778999999999999999999999999999999999999999986654332211        111111  


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                        +-..+.-...++.+.+++..++..||..|+++.++++
T Consensus       256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence              1122334456788999999999999999999999998

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.8e-35  Score=319.95  Aligned_cols=254  Identities=20%  Similarity=0.201  Sum_probs=198.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||.||+++.+..++.+|+|++.+.   .......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            45678999999999999999988899999998532   122234588899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++|+|.+++.+....+.+..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999987666778888999999999999999998   99999999999999999999999999997654433333


Q ss_pred             ccccccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          668 VTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.........       ............   
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~-------~~i~~~~~~~~~---  229 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------GKIMNHKERFQF---  229 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCccccC---
Confidence            33457999999999875     346889999999999999999999999754221110       000000000000   


Q ss_pred             ccccChHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEP--NLRPSMKNVILM  778 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP--~~RPs~~evl~~  778 (811)
                       ..........+.+++.+|+..++  ..||+++|+++.
T Consensus       230 -p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 -PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             01112345677888888775544  447899999866

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-35  Score=329.20  Aligned_cols=251  Identities=18%  Similarity=0.198  Sum_probs=196.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      |.+.++||+|+||.||+++....++.||||++....   ......+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            456689999999999999999889999999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC---
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ---  664 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~---  664 (811)
                      +++|+|.+++... ..+.......++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+....   
T Consensus        83 ~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          83 IPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999999999763 3566778888999999999999998   99999999999999999999999999975331000   


Q ss_pred             ---------------------------------------CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHH
Q 003555          665 ---------------------------------------TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV  705 (811)
Q Consensus       665 ---------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ell  705 (811)
                                                             ........||+.|||||.+.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                   00011346999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 003555          706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRP---SMKNVILM  778 (811)
Q Consensus       706 tg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~~  778 (811)
                      +|+.||...........+        ....  ....  ..........+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       239 ~G~~Pf~~~~~~~~~~~i--------~~~~--~~~~--~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAETQLKV--------INWE--TTLH--IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHHHHHHH--------hccC--cccc--CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999764332211100        0000  0000  0011123456677777766 4999999   88888854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=302.40  Aligned_cols=248  Identities=27%  Similarity=0.404  Sum_probs=201.0

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ++||+|+||.||++.+.+ ++.||+|++..... .....+.+|+.++++++|+||+++++++.+....++|+||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999977 89999999875433 3567899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc-cccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVK  672 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~~~  672 (811)
                      .+++.......++..++.++.+++.+|+|||++   +++||||||+||+++.++.+||+|||+++.......... ....
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            999977655678889999999999999999999   999999999999999999999999999986532221111 1123


Q ss_pred             cCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHH
Q 003555          673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL  751 (811)
Q Consensus       673 gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (811)
                      ++..|+|||.+.+..++.++|+||||+++|||++ |..||.........    ..    ....       .....+...+
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----~~----~~~~-------~~~~~~~~~~  221 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----ER----IESG-------YRMPAPQLCP  221 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----HH----HhcC-------CCCCCCccCC
Confidence            3567999999988889999999999999999999 77787543221110    00    0000       0111122345


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          752 ETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..+.+++.+|++.+|.+||++.||++.|++
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=8.1e-35  Score=310.86  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=202.7

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      ...+.+.++||+|+||.||++....     .+..||+|.+.... .+...++.+|+.++++++|+||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            3445667899999999999998743     46789999987543 34557799999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCC---------------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          582 LLVYEFMSKGSLENLLSNVE---------------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      ++|+||+++++|.+++....                     ..+.+..++.++.||+.||+|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999997432                     1356778899999999999999998   99999999999


Q ss_pred             EEECCCCCeEEEecCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTA  718 (811)
Q Consensus       641 Ill~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~  718 (811)
                      |++++++.+||+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876533221 11222335678999999988899999999999999999997 777875332111


Q ss_pred             chhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          719 DVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       719 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                             .. ........       ...+.....++.+++.+|++.+|.+||++.|+++.|+.
T Consensus       241 -------~~-~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -------VI-YYVRDGNV-------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -------HH-HHHhcCCC-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                   10 01111111       01122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.6e-35  Score=307.43  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=198.6

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecc------ccee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT------SKKL  582 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~  582 (811)
                      .+.+.++||+|+||.||+|.....++.||+|++... ......+.+|+.+++++ +|+||+++++++...      ...+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            456678899999999999999988999999998643 34456788999999998 799999999998753      3578


Q ss_pred             EEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          583 LVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      +||||+++++|.+++.... ..+.+..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||+++...
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999999998643 4577888999999999999999998   99999999999999999999999999998653


Q ss_pred             CCCCccccccccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      ... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||...........        ..... 
T Consensus       163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--------~~~~~-  232 (272)
T cd06637         163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--------IPRNP-  232 (272)
T ss_pred             ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--------HhcCC-
Confidence            322 2223456889999999875     34578899999999999999999999964322111100        00000 


Q ss_pred             chhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                           ............+.+++.+||+.+|.+||++.|+++
T Consensus       233 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         233 -----APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -----CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                 001112234457889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-34  Score=309.35  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      |....+++.++||+|+||+||++....+++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+..++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            34456778899999999999999998888999999876432 34567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      |||+++++|.+++... ..+.+.....++.+++.+|.|||+.  .+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          82 MEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             EecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            9999999999998763 4578889999999999999999973  279999999999999999999999999987542221


Q ss_pred             CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccch----hhHHHHHHHhhhhcccchhc
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV----VLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~----~~l~~~~~~~~~~~~~~~~~  740 (811)
                         .....|+..|+|||.+.+..++.++|||||||++||+++|+.||.......+.    ..+....         ..+.
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~  226 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL---------QQIV  226 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH---------HHHh
Confidence               12346899999999988889999999999999999999999999754332111    0011111         1111


Q ss_pred             CC-cccc-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          741 GE-DEEV-DLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       741 ~~-~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      .. .... .......+.+++.+|++.||.+||++.|++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            00 1111 112456789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-34  Score=312.86  Aligned_cols=262  Identities=23%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.++||+|+||.||++....++..+|+|.+.... .....++.+|++++++++|+||+++++++.+++..++|+||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            456688999999999999998888999999986542 3345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++... ..+.+..+..++.||++||.|||+.  .+++|+||||+|||+++++.+||+|||++.......   ..
T Consensus        83 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~  156 (308)
T cd06615          83 GGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN  156 (308)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---cc
Confidence            99999999764 4567888899999999999999973  289999999999999999999999999987543221   23


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhh----------------
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA----------------  733 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~----------------  733 (811)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||...........+..........                
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP  236 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence            3568899999999888889999999999999999999999986432211100000000000000                


Q ss_pred             ----cccchhcCCc-ccc-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          734 ----KELSKLVGED-EEV-DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       734 ----~~~~~~~~~~-~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                          .....+.... ... .......+.+++.+||+.+|++||+++||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000000000 000 11245578999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-34  Score=313.36  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=205.1

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEc-------CCCEEEEEEEccCCc-hhhHHHHHHHHHHHhcc-CCCCccceecEEe
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSIC-------EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCM  576 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~-------~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~  576 (811)
                      +....+.+.++||+|+||.||+++..       .....||+|+++... .....++.+|+.+++++ +|+||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34456677899999999999999753       234579999987532 34456789999999999 6999999999999


Q ss_pred             cccceeEEEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcE
Q 003555          577 QTSKKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNI  641 (811)
Q Consensus       577 ~~~~~~lV~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NI  641 (811)
                      +.+..++|+||+++|+|.+++....               ..+.+.++.+++.||+.||.|||+.   +++|+||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence            9999999999999999999997532               2467888999999999999999998   999999999999


Q ss_pred             EECCCCCeEEEecCCccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 003555          642 LLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTAD  719 (811)
Q Consensus       642 ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~  719 (811)
                      |+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ 
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            9999999999999999865432221 1122234567999999988889999999999999999999 788885432111 


Q ss_pred             hhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                         +..    ......       ....+......+.+++.+|++.+|++||++.|+++.|+....
T Consensus       245 ---~~~----~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ---LFK----LLREGH-------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHH----HHHcCC-------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               101    111110       111223445678899999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.6e-35  Score=305.29  Aligned_cols=251  Identities=27%  Similarity=0.443  Sum_probs=202.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.+.||+|+||.||+|.+.. ++.+|+|.+.... .....+.+|++++++++|+|++++++++......++|+||++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            45667899999999999998864 5689999986432 335678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++......+.+..+..++.|++.+|+|||+.   +++|+||||+||+++.++.+||+|||+++...........
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence            9999999987666678899999999999999999998   9999999999999999999999999999865433222222


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||.......       ..... ... . ...     .+.
T Consensus       160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~-~~~-~-~~~-----~~~  224 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETI-NAG-F-RLY-----KPR  224 (256)
T ss_pred             CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHH-hCC-C-CCC-----CCC
Confidence            3345678999999988889999999999999999998 888886432111       00000 000 0 000     111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .....+.+++.+||+.+|.+||++.|++++|.
T Consensus       225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            23467999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.8e-34  Score=306.82  Aligned_cols=250  Identities=23%  Similarity=0.357  Sum_probs=198.9

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.||+|+||.||+|....+++.||+|.+... .....+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            35568899999999999999888899999998644 34445679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|..+.     .+++.....++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++.......   ..
T Consensus        83 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~  151 (279)
T cd06619          83 GGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AK  151 (279)
T ss_pred             CCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---cc
Confidence            99997653     345778889999999999999998   99999999999999999999999999997653322   23


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...|+..|+|||.+.+..++.++||||||+++|||++|+.||............... ........      ........
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~  224 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDED------PPVLPVGQ  224 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhccC------CCCCCCCc
Confidence            356899999999998888999999999999999999999999653322211100000 00000000      00001122


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...++.+++.+|++.+|.+||+++|+++.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            44578899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.6e-34  Score=303.00  Aligned_cols=257  Identities=20%  Similarity=0.334  Sum_probs=207.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .+.+.+.||+|+||.||+|....+++.||+|.++..   .....+.+.+|++++++++|+|++++++++.+.+..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            356778999999999999999888899999988532   23335679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          587 FMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       587 y~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |+++++|.+++...   ...+.+.++..++.+|++||.|||+.   +++|+||+|+||+++.++.++|+|||+++.....
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            99999999998643   34467889999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++|+.||.......  ..+..    ........      
T Consensus       160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~----~~~~~~~~------  226 (267)
T cd08224         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCK----KIEKCDYP------  226 (267)
T ss_pred             Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH--HHHHh----hhhcCCCC------
Confidence            21 1233468889999999988889999999999999999999999986432110  00000    00011000      


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..........+.+++.+|++.+|++||++.+|+++|+.+
T Consensus       227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            011124556788999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.2e-34  Score=310.95  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=205.4

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..+.+.++||+|+||.||+|.....++.||+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            45666789999999999999998888999999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++.+  ..+.+.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~  172 (297)
T cd06656          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (297)
T ss_pred             CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence            99999999864  3467889999999999999999998   999999999999999999999999999976543322 12


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ....+++.|+|||.+.+..++.++||||||+++|++++|+.||...........             ...........+.
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------------~~~~~~~~~~~~~  239 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------------IATNGTPELQNPE  239 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------------eccCCCCCCCCcc
Confidence            334688899999999888899999999999999999999999965432211100             0000000111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .....+.+++.+||+.+|.+||+++++++
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            34566889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.8e-35  Score=339.51  Aligned_cols=257  Identities=18%  Similarity=0.262  Sum_probs=202.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.++||+|+||.||+|.....++.||||++....   ....+++.+|++++++++||||+++++++.+++..++||||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            556789999999999999998889999999986432   23356799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC----------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          588 MSKGSLENLLSNVE----------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       588 ~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      +++++|.+++....          ...++..+++++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence            99999999986421          2234667889999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCC-----------------ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccch
Q 003555          658 KILMPNQT-----------------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV  720 (811)
Q Consensus       658 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~  720 (811)
                      +.......                 .......||+.|||||.+.+..++.++|||||||++|||++|+.||.......  
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k--  238 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK--  238 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence            86521110                 01112469999999999999999999999999999999999999997532111  


Q ss_pred             hhHHHHHHHhhhhcccchhcCCcc-ccChHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhhcccC
Q 003555          721 VLLSTWVYNCFIAKELSKLVGEDE-EVDLRTLETMVRVGLLCIQDEPNLRP-SMKNVILMLEGTME  784 (811)
Q Consensus       721 ~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~  784 (811)
                      ...     .    ..   ...+.. ......+..+.+++.+|++.||++|| +++++++.|+...+
T Consensus       239 i~~-----~----~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISY-----R----DV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhh-----h----hh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            000     0    00   000000 00123456688999999999999995 67777777766433

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-34  Score=306.33  Aligned_cols=249  Identities=27%  Similarity=0.430  Sum_probs=199.3

Q ss_pred             hhcCcccceeEEEEEEcCCC------EEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          515 EELGRGCFGAVYKGSICEGN------KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~------~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.||+|+||.||+|+..+..      +.+|||.+.... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999986433      689999886543 34466789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcC------CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-----CeEEEecCC
Q 003555          588 MSKGSLENLLSNV------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-----TAKISNFSL  656 (811)
Q Consensus       588 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-----~~kL~DFGl  656 (811)
                      +++++|.+++.+.      ...+.+.+++.++.||+.||+|||+.   +++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999753      23367889999999999999999998   999999999999999877     899999999


Q ss_pred             ccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          657 AKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       657 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      ++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    .....    .. 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~----~~~~~----~~-  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE----VLQHV----TA-  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----HHHHH----hc-
Confidence            9865433221 1223345778999999999999999999999999999998 898886432111    10100    00 


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                            ..........+..+.+++.+||+.+|.+||++.+|+++|++
T Consensus       229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                  01112233456788999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-34  Score=311.38  Aligned_cols=249  Identities=18%  Similarity=0.304  Sum_probs=204.9

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.+.++||.|++|.||+|....+++.||+|.+........+.+.+|+.+++.++|+|++++++++.+.+..++|+||+++
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            45567899999999999999888999999998765555567889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|.+++..  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++........ ....
T Consensus       101 ~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~  174 (296)
T cd06655         101 GSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRST  174 (296)
T ss_pred             CcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCC
Confidence            999999874  3578899999999999999999999   999999999999999999999999999886543322 1233


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..++..|+|||.+.+..++.++|||||||++|||++|+.||............        .... .    .....+...
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--------~~~~-~----~~~~~~~~~  241 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------ATNG-T----PELQNPEKL  241 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------HhcC-C----cccCCcccC
Confidence            46888999999999888999999999999999999999999754332211100        0000 0    011112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...+.+++.+||+.+|.+||++.++++.
T Consensus       242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         242 SPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            5678899999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-34  Score=310.33  Aligned_cols=246  Identities=20%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ..+||+|+||.||++.....++.||||++........+.+.+|+..++.++|+||+++++.+..++..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            46799999999999999888899999998766566667899999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++..  ..+.+.++..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||++........ ......|
T Consensus       107 ~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~  180 (292)
T cd06658         107 TDIVTH--TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVG  180 (292)
T ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeec
Confidence            999864  3477889999999999999999998   999999999999999999999999999876432221 2233568


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      +..|+|||.+.+..++.++||||||+++|||++|+.||........   + ..         ..................
T Consensus       181 ~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~-~~---------~~~~~~~~~~~~~~~~~~  247 (292)
T cd06658         181 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M-RR---------IRDNLPPRVKDSHKVSSV  247 (292)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H-HH---------HHhcCCCccccccccCHH
Confidence            8999999999888899999999999999999999999874322110   0 00         001111111112234557


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          754 MVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +.+++..|++.+|.+|||++|+++.
T Consensus       248 ~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         248 LRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhC
Confidence            8889999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=298.99  Aligned_cols=260  Identities=21%  Similarity=0.325  Sum_probs=202.1

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEec-----ccceeEEEe
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ-----TSKKLLVYE  586 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lV~e  586 (811)
                      .+.||+|+||.|..+..+.+++.||||++..  ...-..++-.+|+++|+.++|+||+.+.+++..     -+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            4789999999999999999999999999974  334456788999999999999999999998865     347899999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC-C
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ-T  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~-~  665 (811)
                      +|+. +|...++. +..++.....-+++||++||+|+|+.   +|+||||||+|+|++.+...||+|||+|+...... .
T Consensus       107 lMet-DL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~  181 (359)
T KOG0660|consen  107 LMET-DLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED  181 (359)
T ss_pred             HHhh-HHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence            9954 89999986 33367777778899999999999999   99999999999999999999999999999875431 2


Q ss_pred             ccccccccCCCccCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhcccc
Q 003555          666 GIVTGVKGTRGYMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAKELS  737 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~  737 (811)
                      ..++...-|..|.|||++ ....||...||||.||++.||++|++.|.+.....+...+.+..       ......+...
T Consensus       182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar  261 (359)
T KOG0660|consen  182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR  261 (359)
T ss_pred             cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence            335667889999999965 56689999999999999999999999997654433321111110       0111111111


Q ss_pred             hhcCC---cc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          738 KLVGE---DE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 ~~~~~---~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..+..   ..     ..-+......++|+.+||..||.+|+|++|.++.
T Consensus       262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11111   11     1122445678899999999999999999999753

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-34  Score=317.32  Aligned_cols=190  Identities=20%  Similarity=0.274  Sum_probs=166.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .|.+.+.||+|+||.||+|+....++.||+|.....      ....|+.++++++|+||+++++++.+....++|+||+.
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            466778999999999999999888889999985432      23568999999999999999999999999999999995


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                       ++|.+++......+++..+..|+.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~  214 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFL  214 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--cccc
Confidence             589999887666788999999999999999999998   9999999999999999999999999999753221  1223


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF  711 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~  711 (811)
                      ...||..|+|||.+.+..++.++|||||||++|||+++..++
T Consensus       215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            456899999999999999999999999999999999876655

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-34  Score=311.08  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=202.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCE----EEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNK----IVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +...+.||+|+||.||+|.+..+++    .||+|.+..... ....++.+|+.++++++|+||+++++++... ..++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~   87 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT   87 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence            3455789999999999999866554    579998865432 3345789999999999999999999998754 467999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+++|+|.+++......+.+..++.++.|++.||+|||+.   +|+|+||||+||++++++.+||+|||+++.......
T Consensus        88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  164 (303)
T cd05110          88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK  164 (303)
T ss_pred             hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccc
Confidence            99999999999987666678889999999999999999998   999999999999999999999999999987643322


Q ss_pred             c-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          666 G-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       666 ~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......    .....    ....       .
T Consensus       165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~----~~~~-------~  229 (303)
T cd05110         165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLL----EKGE-------R  229 (303)
T ss_pred             ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----HCCC-------C
Confidence            1 1223445778999999988899999999999999999997 888886432111    11111    0000       0


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCCC
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      ..........+.+++..|+..+|++||++++++++|+.+.+-+
T Consensus       230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            1111223457889999999999999999999999998764443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-34  Score=309.36  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=200.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +...+.||+|+||+||++.....++.||||.+....   .+....+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            345578999999999999999989999999986432   22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++.... ..+.+..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999986543 3577889999999999999999998   999999999999999999999999999876432221 


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                       .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..............    .. . ...      ...
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----~~-~-~~~------~~~  224 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LV-K-EVQ------EEY  224 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----hh-h-hhh------hhc
Confidence             2234689999999999988999999999999999999999999975432211100000    00 0 000      011


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~  777 (811)
                      .......+.+++..||+.||.+||+     ++|+++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            2234556889999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-34  Score=303.40  Aligned_cols=249  Identities=18%  Similarity=0.251  Sum_probs=203.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.++||+|+||.||++....+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+++..++||||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            45668999999999999999988899999988543 33455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++|.+++... ...++......++.||+.||.|||+.   +|+|+||||+||++++++.++|+|||++........ ..
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  157 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA  157 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence            99999998653 33467888899999999999999998   999999999999999999999999999976543221 12


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........       .. .......       ...+.
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~-~~~~~~~-------~~~~~  222 (255)
T cd08219         158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-------IL-KVCQGSY-------KPLPS  222 (255)
T ss_pred             ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-------HH-HHhcCCC-------CCCCc
Confidence            335688899999999888899999999999999999999999974321110       00 0001111       11122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .....+.+++.+||+.+|.+||++.+++..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-34  Score=304.63  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=201.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch---------hhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---------EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      +.+.+.||+|+||.||+|....+++.||+|.+.....         +..+.+.+|+.++++++|+||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            3456789999999999999988889999998864322         1235688999999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||+++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            9999999999999999764 4567788889999999999999998   99999999999999999999999999998764


Q ss_pred             CCCC-----ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc
Q 003555          662 PNQT-----GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       662 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      ....     .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.........       ..      .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~------~  224 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-------FK------I  224 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-------HH------H
Confidence            3211     1112245788999999998888999999999999999999999999753221110       00      0


Q ss_pred             chhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..  ......+......+.+++.+||+.+|.+||++.||++
T Consensus       225 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GE--NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hc--cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            00  1111223345678899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-34  Score=301.54  Aligned_cols=249  Identities=30%  Similarity=0.482  Sum_probs=203.9

Q ss_pred             hhhhcCcccceeEEEEEEcCCC----EEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          513 FEEELGRGCFGAVYKGSICEGN----KIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~----~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.||.|+||.||+++....+    ..||+|.+...... ..+.+..|+..+++++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            5678999999999999998765    88999999765433 567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCC-CchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++...... +++.++..++.|++.||+|||+.   +++|+||||+||++++++.++|+|||+++........
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            9999999999875544 88999999999999999999999   9999999999999999999999999999876544332


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||......    .+...    .....       ...
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~----~~~~~----~~~~~-------~~~  224 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE----EVLEY----LKKGY-------RLP  224 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HhcCC-------CCC
Confidence            2223347789999999988889999999999999999998 67777642111    01010    11111       111


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      .....+..+.+++.+|++.+|++|||+.|+++.|
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1223566789999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-34  Score=303.78  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=190.4

Q ss_pred             hhcCcccceeEEEEEEcC--CCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICE--GNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      ++||+|+||.||+|....  ....+|+|.+... ..+....+.+|+..++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997644  2357999987643 3344567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCC----CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          592 SLENLLSNVES----GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       592 sL~~~l~~~~~----~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      +|.+++.....    ...+.....++.||+.||+|||+.   +|+||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976432    235677889999999999999998   9999999999999999999999999998754332211 


Q ss_pred             cccccccCCCccCccccc-------cCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          667 IVTGVKGTRGYMSPEWQN-------SGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ......++..|+|||++.       ...++.++|||||||++|||++ |..||......+   .+...     .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~-----~~~~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQV-----VREQDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH-----hhccCcc
Confidence            112334567899999764       3456889999999999999999 677775432111   01000     0111111


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      +..  ...+......+.+++..|+ .||.+||+++||+++|.
T Consensus       230 ~~~--~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPK--PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC--CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111  1122344566777888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=289.47  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=204.0

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      ...+.+.++||+|.|+.||++....+++.+|+|.+..  -...+.+++.+|+.+.+.|+||||++|...+.+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4457778999999999999999998899889887742  23446788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC---CCCCeEEEecCCccccCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMP  662 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~---~~~~~kL~DFGla~~~~~  662 (811)
                      |+|.+++|..-+-.. ...++...-..++||+++|.|+|.+   +|||||+||+|++|.   ..--+||+|||+|..+..
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            999999997766542 3345566677899999999999999   999999999999995   334699999999998762


Q ss_pred             CCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                        .....+..|||+|||||+++..+++..+|||+.||+||-|+.|..||.......    +    ++    +.+....+-
T Consensus       166 --g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----l----ye----~I~~g~yd~  231 (355)
T KOG0033|consen  166 --GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----L----YE----QIKAGAYDY  231 (355)
T ss_pred             --ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----H----HH----HHhccccCC
Confidence              223456789999999999999999999999999999999999999998643221    1    11    111111222


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                      ....-....++..+|+.+||..||.+|.|+.|.+
T Consensus       232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             CCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence            2223345667889999999999999999999876

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.6e-34  Score=338.82  Aligned_cols=260  Identities=20%  Similarity=0.273  Sum_probs=202.5

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecc
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT  578 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  578 (811)
                      +..++.....|.+.++||+|+||+||+++....++.||+|.+...  .......+..|+.++++++|||||++++++.+.
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            344455556678889999999999999999998999999998643  334456789999999999999999999988653


Q ss_pred             --cceeEEEeecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccC----CCeeecCCCCCcEEECC----
Q 003555          579 --SKKLLVYEFMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECE----VQIIHCNINPRNILLDD----  645 (811)
Q Consensus       579 --~~~~lV~ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dik~~NIll~~----  645 (811)
                        ...+|||||+++++|.++|...   ...+++..++.|+.||+.||.|||+...    .+|+||||||+||||+.    
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence              4689999999999999999753   2457889999999999999999998521    25999999999999964    


Q ss_pred             -------------CCCeEEEecCCccccCCCCCccccccccCCCccCcccccc--CCCCcccchHHHHHHHHHHHhCCCC
Q 003555          646 -------------SLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS--GLITVKSDVYSFGVVVLEIVCCRSN  710 (811)
Q Consensus       646 -------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~elltg~~p  710 (811)
                                   .+.+||+|||+++.+....  ......||+.|+|||++..  ..++.++|||||||+||||++|+.|
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                         3459999999998653322  2234578999999998754  4588999999999999999999999


Q ss_pred             CCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          711 FEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       711 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      |.........   ..    .....       + ..........+.+|+..||+.+|.+||++.|++.
T Consensus       243 F~~~~~~~ql---i~----~lk~~-------p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        243 FHKANNFSQL---IS----ELKRG-------P-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcCCcHHHH---HH----HHhcC-------C-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9743221111   00    00000       0 0011223567899999999999999999999984

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.6e-34  Score=314.39  Aligned_cols=259  Identities=19%  Similarity=0.228  Sum_probs=196.2

Q ss_pred             hhhhcCcc--cceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          513 FEEELGRG--CFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       513 ~~~~LG~G--~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.++||+|  +|++||++....+++.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999999999999999986432  334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          589 SKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       589 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      ++++|.+++... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++++||+........... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999754 34578899999999999999999998   9999999999999999999999999865443211110 


Q ss_pred             -----cccccccCCCccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhh--------
Q 003555          667 -----IVTGVKGTRGYMSPEWQNS--GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF--------  731 (811)
Q Consensus       667 -----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~--------  731 (811)
                           ......++..|+|||.+.+  ..++.++|||||||++|||++|+.||.........  . .......        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~-~~~~~~~~~~~~~~~  235 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--L-EKLNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--H-HHhcCCccccccccc
Confidence                 0112346778999998865  45889999999999999999999999743221100  0 0000000        


Q ss_pred             -hhccc-------------chhc-----CC------ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          732 -IAKEL-------------SKLV-----GE------DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       732 -~~~~~-------------~~~~-----~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                       ..+..             ....     ..      ...........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence             00000             0000     00      00112234567889999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-34  Score=301.56  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=206.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |.+.+.||+|+||.||.++...+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            45668899999999999999888999999987643  3455667899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++++|.+++... ...+++.++..++.|++++|+|||+.   +++|+||+|+||++++++.+||+|||++........ .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~  157 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M  157 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence            999999999865 34578899999999999999999998   999999999999999999999999999987643332 2


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....++..|+|||.+.+...+.++||||||+++|||++|+.||........       ... ...+..       ....
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-------~~~-~~~~~~-------~~~~  222 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-------VVK-IVQGNY-------TPVV  222 (256)
T ss_pred             ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHH-HHcCCC-------CCCc
Confidence            2345689999999999888889999999999999999999999865322110       000 011111       1112


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ......+.+++.+|++.+|.+||+++|+++.+
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            34456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-34  Score=309.22  Aligned_cols=260  Identities=23%  Similarity=0.296  Sum_probs=195.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhcc---CCCCccceecEEecc-----cc
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRT---HHKNLVRLLGFCMQT-----SK  580 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-----~~  580 (811)
                      |.+.++||+|+||+||+|+...+++.||+|.++....  .....+.+|+.+++++   +|+||+++++++...     ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            4566889999999999999998899999999864322  2234566677776655   799999999988643     35


Q ss_pred             eeEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      .++|+||+++ +|.+++.... ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            7899999985 8988887643 3478899999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccc--
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS--  737 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~--  737 (811)
                      .....  ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+..... ......+.  
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~~~  234 (288)
T cd07863         158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWPRD  234 (288)
T ss_pred             ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhhCccc
Confidence            54222  22335678999999999888999999999999999999999999965433221111111000 00000000  


Q ss_pred             -----hhcCCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          738 -----KLVGED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       738 -----~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                           ......     ....+...+.+.+++.+||+.||++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 000000     0112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=303.88  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=204.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.||.|++|.||+|+...+++.||+|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            556788999999999999999889999999986543 3445678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++...  .+.+..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++...... ....
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  156 (274)
T cd06609          83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN  156 (274)
T ss_pred             CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence            99999999864  678899999999999999999998   99999999999999999999999999998765332 2223


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||.........    .    ......       .......
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~----~----~~~~~~-------~~~~~~~  221 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL----F----LIPKNN-------PPSLEGN  221 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH----H----HhhhcC-------CCCCccc
Confidence            456788999999998888999999999999999999999999754321100    0    000000       0111111


Q ss_pred             -HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          750 -TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       750 -~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                       ....+.+++.+||+.+|++||+++++++.
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             45678899999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-34  Score=301.77  Aligned_cols=247  Identities=27%  Similarity=0.350  Sum_probs=198.4

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEe-cccceeEEEee
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM-QTSKKLLVYEF  587 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~ey  587 (811)
                      ..+.+.+.||+|+||.||++...  ++.||+|.++..  ...+.+.+|+.++++++|+|++++++++. +++..++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            45667789999999999999874  578999998643  23567899999999999999999999865 44578999999


Q ss_pred             cCCCCHHHHhhcCCC-CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVES-GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++..... .+.+..++.++.||+.||+|||++   +++||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999976443 477899999999999999999998   99999999999999999999999999987643222  


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                        ....++..|+|||.+....++.++||||||+++|||++ |+.||.......    +....    ..+       ....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~----~~~-------~~~~  219 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRV----EKG-------YKMD  219 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH----hcC-------CCCC
Confidence              22345668999999988889999999999999999997 888886432110    10100    000       0111


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      .....+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7e-34  Score=301.86  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ..+...++||.|+||.||+|.....++.||||.+... .......+.+|+.++++++|+||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            3455668899999999999999888899999998643 345567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++..  ..+.+.+...++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06640          84 LGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence            999999999874  3567888899999999999999998   999999999999999999999999999976543322 2


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........         ....      .......
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---------~~~~------~~~~~~~  222 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---------LIPK------NNPPTLT  222 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---------hhhc------CCCCCCc
Confidence            223457889999999988889999999999999999999999987433221100         0000      0112223


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......+.+++..||+.+|.+||+++++++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            4566788999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-34  Score=307.38  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=198.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|++|.||+|+...+++.||||+++...  ....+.+.+|+.++++++|+||+++++++.+++..++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            445678999999999999998888999999986432  233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          589 SKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       589 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      + ++|.+++....  ..+++..+..++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||++....... .
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~  156 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R  156 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence            7 68988886543  4577889999999999999999998   99999999999999999999999999997653221 1


Q ss_pred             cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhh-hcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFI-AKELS  737 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~-~~~~~  737 (811)
                      ......+++.|+|||.+.+ ..++.++||||||++++||++|+.||................       +.... .....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2223456889999998765 457899999999999999999999997543221111000000       00000 00000


Q ss_pred             hhcCCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          738 KLVGED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       738 ~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......     .........++.+++.+||+.||.+|||+++|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000     0011124567789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-35  Score=284.79  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=201.4

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--------hhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEE
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--------EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV  584 (811)
                      .+.||+|..++|-++.++.+++..|+|++....        .+-.+.-.+|+.+|+++ .||+|+.+.+++......++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            467999999999999999999999999885321        11223456799999998 799999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      +|.|+.|.|+++|.. ...++++...+|+.|+.+|+.|||..   +||||||||+|||+|++.++||+|||.+..+.+++
T Consensus       102 Fdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge  177 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE  177 (411)
T ss_pred             hhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCch
Confidence            999999999999986 45678899999999999999999999   99999999999999999999999999999886655


Q ss_pred             CccccccccCCCccCcccccc------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          665 TGIVTGVKGTRGYMSPEWQNS------GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      .  ....+||++|+|||.++.      ..|+...|.|++||+||-|+.|.+||-...   +..++     ++..+++.. 
T Consensus       178 k--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlML-----R~ImeGkyq-  246 (411)
T KOG0599|consen  178 K--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLML-----RMIMEGKYQ-  246 (411)
T ss_pred             h--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHHH-----HHHHhcccc-
Confidence            3  567899999999998753      357889999999999999999999996431   11111     111122211 


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                         -+.+.-.+.+....+|+.+||+.||++|.|++|.++
T Consensus       247 ---F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  247 ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence               111223355677899999999999999999999874

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.2e-34  Score=317.57  Aligned_cols=261  Identities=22%  Similarity=0.232  Sum_probs=196.7

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc------c
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------K  580 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~  580 (811)
                      ..|.+.+.||+|+||.||++.....++.||||++...  .......+.+|+.+++.++|+||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4466678999999999999999888999999998643  2344567889999999999999999999986543      4


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .++||||+++ +|...+..   .++...+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            6999999976 56666543   366788889999999999999999   9999999999999999999999999999764


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHH---------------
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST---------------  725 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~---------------  725 (811)
                      ....  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............               
T Consensus       174 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         174 CTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            3221  22345689999999999999999999999999999999999999975432211100000               


Q ss_pred             HHHHhhhhc------ccchhc-----CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          726 WVYNCFIAK------ELSKLV-----GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       726 ~~~~~~~~~------~~~~~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .........      ...+..     .............+.+++.+||+.||++|||+.|++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000000      000000     00001111234568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.9e-34  Score=310.01  Aligned_cols=262  Identities=18%  Similarity=0.248  Sum_probs=200.7

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .|.+.++||+|+||.||+|+...+++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            3566788999999999999998888999999986432 333456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      + ++|.+++......+.+.....++.||++||+|||+.   +|+|+||||+||++++++.+||+|||++....... ...
T Consensus        87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~  161 (301)
T cd07873          87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY  161 (301)
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Ccc
Confidence            7 599999887666678889999999999999999998   99999999999999999999999999997543221 112


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC------
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG------  741 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~------  741 (811)
                      ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+........ ........+..+..      
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI-LGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-cCCCChhhchhhhccccccc
Confidence            23457889999998765 45788999999999999999999999754322111000000 00000000000000      


Q ss_pred             ---Cc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 ---ED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ---~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                         +.      ..........+.+++.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               00      0111234557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-34  Score=308.54  Aligned_cols=246  Identities=18%  Similarity=0.263  Sum_probs=201.0

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ..+||+|+||.||++....+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            35799999999999999888899999998655455567788999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      ..++..  ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....... .......+
T Consensus       106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~  179 (297)
T cd06659         106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG  179 (297)
T ss_pred             HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence            998864  4577889999999999999999998   99999999999999999999999999987543322 12233568


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      +..|+|||.+.+..++.++||||||+++|||++|+.||.........    ...    ...     ..............
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~~~----~~~-----~~~~~~~~~~~~~~  246 (297)
T cd06659         180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----KRL----RDS-----PPPKLKNAHKISPV  246 (297)
T ss_pred             CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHH----hcc-----CCCCccccCCCCHH
Confidence            89999999998888999999999999999999999999743221110    000    000     00011112234456


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          754 MVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +.+++.+|++.+|.+||+++++++.
T Consensus       247 l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         247 LRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhC
Confidence            8899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-34  Score=304.76  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=202.7

Q ss_pred             HhhhhhhcCcccceeEEEEEEcC-----CCEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .+...+.||+|+||.||+|+.+.     ..+.||+|.+.....+ ....+.+|++++++++|+||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            44556789999999999999753     3467999998754433 45789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCCC--------CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          584 VYEFMSKGSLENLLSNVES--------GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~--------~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                      ||||+++++|.+++.....        .+.+..+..++.||+.||+|||+.   +|+|+||||+||+++.++.++|+|||
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence            9999999999999976441        478999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhc
Q 003555          656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       656 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      +++..............++..|+|||.+.+...+.++||||||+++|||++ |..||.......       .. .....+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~-~~~~~~  234 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VL-NRLQAG  234 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HH-HHHHcC
Confidence            987554333333334456778999999888888999999999999999999 677875322111       00 001111


Q ss_pred             ccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       735 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      ...      .......+..+.+++.+||+.+|.+||++.|++++|+
T Consensus       235 ~~~------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLE------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcC------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            110      0112234568899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.1e-34  Score=307.90  Aligned_cols=259  Identities=22%  Similarity=0.271  Sum_probs=200.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-----hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-----EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +.+.+.||+|+||.||+|....+++.||||++.....     .....+..|++++++++|+||+++++++.+.+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            4456789999999999999988889999999865432     23456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+ +++|.+++......+++..+..++.||++||.|||++   +++|+||+|+||+++.++.+||+|||+++.......
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999 8899999987554688999999999999999999999   999999999999999999999999999987643321


Q ss_pred             ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh---hc------c
Q 003555          666 GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI---AK------E  735 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---~~------~  735 (811)
                       ......++..|+|||.+.+ ..++.++|||||||+++||++|..+|......+..   .... ....   ..      .
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~  232 (298)
T cd07841         158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIF-EALGTPTEENWPGVTS  232 (298)
T ss_pred             -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHH-HHcCCCchhhhhhccc
Confidence             2223456788999998754 46789999999999999999998777643322111   0100 0000   00      0


Q ss_pred             cchhcCC--c-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          736 LSKLVGE--D-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       736 ~~~~~~~--~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .......  .     ..........+.+++.+||+.+|.+||++.|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000  0     01112345788999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-34  Score=317.87  Aligned_cols=260  Identities=22%  Similarity=0.228  Sum_probs=196.8

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc------ce
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------KK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~  581 (811)
                      .|.+.+.||+|+||.||++.....++.||||++...  .......+.+|+.+++.++|+||+++++++....      ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            466678999999999999999888899999998753  2334567889999999999999999999886443      46


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++||||+++ +|.+.+..   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          98 YLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             EEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            999999976 67666643   366788889999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH---------------
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW---------------  726 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~---------------  726 (811)
                      ..  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...............               
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             Cc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            22  2223456899999999999889999999999999999999999999754322111000000               


Q ss_pred             HHHhhhh-cccc-----h-----hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          727 VYNCFIA-KELS-----K-----LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       727 ~~~~~~~-~~~~-----~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ....... ....     .     ...............+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            0000000 0000     0     0000011122234678999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-34  Score=299.42  Aligned_cols=249  Identities=22%  Similarity=0.318  Sum_probs=202.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecc-cceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT-SKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~ey  587 (811)
                      |.+.+.||+|++|.||+++...+++.||+|++...  .....+.+.+|++++++++|+|++++++.+... ...++||||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            45678999999999999999888899999998643  234456789999999999999999999887644 457899999


Q ss_pred             cCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +++++|.+++... ...+++.++..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++....... .
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~  157 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-D  157 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-C
Confidence            9999999999764 34478899999999999999999998   99999999999999999999999999998664322 2


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......+++.|+|||.+.+..++.++||||||++++||++|+.||.......       .... ...+..       ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-------~~~~-~~~~~~-------~~~  222 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------LVYR-IIEGKL-------PPM  222 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHH-HHhcCC-------CCC
Confidence            2334568899999999999999999999999999999999999986432111       1000 111111       112


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +......+.+++.+|++.+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            33456789999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.4e-34  Score=300.74  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=202.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |...+.||+|+||.||+|....+++.||+|.++....  ...+.+.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            4556889999999999999988889999999875443  36678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc-
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~-  667 (811)
                      ++++|.+++... ..+.+..+..|+.+++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......... 
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~  157 (264)
T cd06626          82 SGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG  157 (264)
T ss_pred             CCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc
Confidence            999999999863 3467888999999999999999998   99999999999999999999999999998765433222 


Q ss_pred             --ccccccCCCccCccccccCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          668 --VTGVKGTRGYMSPEWQNSGL---ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       668 --~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                        .....++..|+|||.+....   .+.++||||||++++|+++|+.||.........      ...  ...      ..
T Consensus       158 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~------~~~--~~~------~~  223 (264)
T cd06626         158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI------MFH--VGA------GH  223 (264)
T ss_pred             ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH------HHH--Hhc------CC
Confidence              12356788999999987766   889999999999999999999999643211110      000  000      11


Q ss_pred             cccc--ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          743 DEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       743 ~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ....  .......+.+++.+|++.+|.+||++.|++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111  1123567789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.8e-34  Score=306.16  Aligned_cols=264  Identities=19%  Similarity=0.266  Sum_probs=204.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |.+.+.||+|+||.||+|+...+++.||||++....  ....+.+.+|+.++++++|+||+++++++.++...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            456788999999999999998888999999986543  344578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                       +++|.+++......+++.++..++.||++||+|||+.   +++|+||||+||+++.++.++|+|||++...........
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence             9999999987666788999999999999999999998   999999999999999999999999999987654432233


Q ss_pred             cccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH-------HHHhhh-hcccchh
Q 003555          669 TGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-------VYNCFI-AKELSKL  739 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~-------~~~~~~-~~~~~~~  739 (811)
                      ....++..|+|||.+.+. .++.++||||+|++++||++|+.+|...............       .+.... ......+
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            445689999999987654 4689999999999999999998777543321111000000       000000 0000000


Q ss_pred             cCCc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          740 VGED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       740 ~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ....      .....+....+.+++.+|++.+|++||++++++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000      01112345789999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.1e-34  Score=301.42  Aligned_cols=253  Identities=23%  Similarity=0.367  Sum_probs=201.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcC-CCEEEEEEEccCC----------chhhHHHHHHHHHHHhc-cCCCCccceecEEecc
Q 003555          511 NGFEEELGRGCFGAVYKGSICE-GNKIVAVKRLENP----------VEEGERKFQAEMAAVRR-THHKNLVRLLGFCMQT  578 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~  578 (811)
                      +.+.+.||+|+||.||+|.+.. .++.+|+|.+...          ......++.+|+.++.+ ++|+||+++++++.+.
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4566889999999999999987 6789999987421          22234567788888875 7999999999999999


Q ss_pred             cceeEEEeecCCCCHHHHhhc---CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          579 SKKLLVYEFMSKGSLENLLSN---VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                      +..++||||+++++|.+++..   ....+++..+++++.|++.+|.|||+.  .+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence            999999999999999998853   344577889999999999999999963  179999999999999999999999999


Q ss_pred             CccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       656 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      ++.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||........   . .    ......
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~-~----~~~~~~  229 (269)
T cd08528         160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---A-T----KIVEAV  229 (269)
T ss_pred             ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---H-H----HHhhcc
Confidence            998754332  33445688999999999888899999999999999999999999864321110   0 0    001111


Q ss_pred             cchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ....      ........+.+++.+|++.||.+||++.||..+++.
T Consensus       230 ~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         230 YEPL------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             CCcC------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1100      011335678899999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-34  Score=320.29  Aligned_cols=262  Identities=18%  Similarity=0.232  Sum_probs=200.8

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcC--CCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICE--GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      +....+.+.++||+|+||.||++...+  .++.||||.+...     +...+|+.++++++|+||+++++++......++
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            344567788999999999999998643  3468999988642     345689999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |||++. ++|.+++.. ...+++.+++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       164 v~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        164 VMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            999986 588888843 45678999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc-------
Q 003555          664 QT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE-------  735 (811)
Q Consensus       664 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~-------  735 (811)
                      .. .......||+.|+|||++....++.++|||||||++|||++|+.||...........+..... ......       
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCcc
Confidence            22 222345799999999999999999999999999999999999999975443221111111111 000000       


Q ss_pred             -------cchh---cCCcccc-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          736 -------LSKL---VGEDEEV-----DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       736 -------~~~~---~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                             +.+.   .......     .......+.+++.+||+.||++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   0000   0000000     11224567889999999999999999999965

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=326.91  Aligned_cols=258  Identities=19%  Similarity=0.269  Sum_probs=191.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecc--------cce
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--------SKK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~  581 (811)
                      .|.+.++||+|+||.||+|.....++.||||++....    ....+|+.+++.++|+||+++++++...        ...
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            4667789999999999999998888999999885322    2345799999999999999999886432        135


Q ss_pred             eEEEeecCCCCHHHHhhc---CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-CeEEEecCCc
Q 003555          582 LLVYEFMSKGSLENLLSN---VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLA  657 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-~~kL~DFGla  657 (811)
                      ++||||+++ +|.+++..   ....+++.....++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            689999985 77776653   245577888999999999999999998   999999999999999654 7999999999


Q ss_pred             cccCCCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc-
Q 003555          658 KILMPNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE-  735 (811)
Q Consensus       658 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~-  735 (811)
                      +.+.....  .....||+.|+|||.+.+ ..++.++|||||||++|||++|..||......+.......... ....+. 
T Consensus       219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~-~p~~~~~  295 (440)
T PTZ00036        219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG-TPTEDQL  295 (440)
T ss_pred             hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCCHHHH
Confidence            87643322  223568999999998765 4689999999999999999999999976543322111110000 000000 


Q ss_pred             ------cchh-----cCCc--cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          736 ------LSKL-----VGED--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       736 ------~~~~-----~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                            ...+     ....  ...+...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                  0000     0000  00112234678999999999999999999999843

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-34  Score=300.66  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=201.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-----hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-----EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +...+.||+|+||.||+|....+++.|++|.+....     .+..+.+.+|+.++++++|+||+++++++.++...++|+
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            345578999999999999998778999999875432     335578999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+++++|.+++... ..+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          82 ELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            999999999999764 3467889999999999999999998   99999999999999999999999999988654332 


Q ss_pred             ccccccccCCCccCccccccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGL-ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                       ......++..|+|||.+.... ++.++|+||||+++|||++|+.||.........       .......       ...
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~-------~~~  221 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-------FKIGRSK-------ELP  221 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-------HHHHhcc-------cCC
Confidence             223456889999999887766 899999999999999999999999754311110       0000000       111


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..+......+.+++.+||+.+|.+||+++++++
T Consensus       222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            223344577889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=307.41  Aligned_cols=264  Identities=20%  Similarity=0.293  Sum_probs=204.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|+||.||+|.+.++++.||||+++..  ..+..+.+.+|++++++++|+||+++++++.+++..++|+||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            56678899999999999999988899999998643  2334578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++.|..++.. ...+++.++..++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++...........
T Consensus        83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          83 ERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence            98777666554 45578899999999999999999998   999999999999999999999999999987654443233


Q ss_pred             cccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh--------hcccc--
Q 003555          669 TGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI--------AKELS--  737 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~--------~~~~~--  737 (811)
                      ....++..|+|||++... .++.++||||||+++|||++|+.||......+....+.........        .....  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            445678899999998877 8899999999999999999999998754322211111110000000        00000  


Q ss_pred             hhcCCc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          738 KLVGED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 ~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +.....      ...+.....++.+++..||+.+|++||+++++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000000      01112236789999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-34  Score=328.46  Aligned_cols=259  Identities=17%  Similarity=0.230  Sum_probs=189.9

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCC------CCccceecEEecc-cce
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH------KNLVRLLGFCMQT-SKK  581 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~~~-~~~  581 (811)
                      ..|.+.++||+|+||+||+|.+...++.||||+++.. ....+++..|+.++++++|      .+++++++++... ...
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            4566778999999999999999888899999998643 2233455667777766654      4588888888765 467


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC--------------
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL--------------  647 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~--------------  647 (811)
                      ++|||++ +++|.+++.+. ..+.+..+..|+.||+.||.|||++  .+|+||||||+|||++.++              
T Consensus       208 ~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             EEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            8999987 66888888763 4578889999999999999999973  2899999999999998665              


Q ss_pred             --CeEEEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHH
Q 003555          648 --TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST  725 (811)
Q Consensus       648 --~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~  725 (811)
                        .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus       284 ~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~  359 (467)
T PTZ00284        284 PCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK  359 (467)
T ss_pred             CceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence              49999999876422    122346799999999999999999999999999999999999999976443221111111


Q ss_pred             --------HHHHhhhhcccchhcC-------------------CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          726 --------WVYNCFIAKELSKLVG-------------------EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       726 --------~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                              |.... .......+..                   ............+.+|+..||+.||.+|||++|+++
T Consensus       360 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        360 TLGRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HcCCCCHHHHhhc-cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence                    00000 0000000000                   000001112356789999999999999999999986

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-34  Score=308.17  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=201.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|+||.||+|...+.++.||+|++....  ....+.+.+|+++++.++|+||+++++++.+++..++|+||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            456689999999999999998888999999886432  223567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.++... ...+.+.++..++.||+.||+|||+.   +++|+||+|+||++++++.+||+|||++....... ...
T Consensus        83 ~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~  157 (286)
T cd07846          83 DHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY  157 (286)
T ss_pred             CccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence            99999887765 34478999999999999999999998   99999999999999999999999999998654333 222


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC------
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG------  741 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~------  741 (811)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... .. ......+      
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~  235 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL-IP-RHQEIFQKNPLFA  235 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC-ch-hhHHHhccchHhh
Confidence            33557889999998765 457889999999999999999999986543221111111100000 00 0000000      


Q ss_pred             ----Cc-------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 ----ED-------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ----~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                          +.       ....+.....+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                00       0112234677999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.7e-34  Score=302.93  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=201.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .+++.+.||+|+||.||++.....++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            356778999999999999999888899999988643 2334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC--CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          589 SKGSLENLLSNV--ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       589 ~~gsL~~~l~~~--~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      ++++|..++...  ...+++..+..++.||+.||.|||+.  .+|+|+||||+||+++.++.+||+|||++.......  
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            999999998764  23578899999999999999999963  289999999999999999999999999997653221  


Q ss_pred             cccccccCCCccCccccccC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          667 IVTGVKGTRGYMSPEWQNSG------LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                       .....++..|+|||.+.+.      .++.++|+|||||++|||++|+.||.........    .         .+..+.
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~---------~~~~~~  223 (286)
T cd06622         158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF----A---------QLSAIV  223 (286)
T ss_pred             -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH----H---------HHHHHh
Confidence             2234578899999987544      3588999999999999999999999653221100    0         001111


Q ss_pred             CC-ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          741 GE-DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       741 ~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .. ....+......+.+++.+|++.+|.+||++.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            11 11233446778899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.5e-34  Score=300.27  Aligned_cols=249  Identities=19%  Similarity=0.275  Sum_probs=204.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |.+.++||+|+||.||+++...+++.||+|++...  .....+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            45678999999999999999888899999998642  2344568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++++|.+++.... ...++.++++++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~  157 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L  157 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence            9999999987643 3467889999999999999999998   999999999999999999999999999986543221 1


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....|++.|+|||.+.+...+.++|+||||++++||++|+.||......+       ..... ..+       .....+
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~-~~~-------~~~~~~  222 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------LVLKI-IRG-------SYPPVS  222 (256)
T ss_pred             hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-------HHHHH-hcC-------CCCCCc
Confidence            223457889999999988889999999999999999999999986432111       11000 001       111123


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......+.+++.+|++.+|.+||++.||++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            3456678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6e-34  Score=308.62  Aligned_cols=196  Identities=21%  Similarity=0.338  Sum_probs=160.8

Q ss_pred             hhhcCcccceeEEEEEEcC--CCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEec--ccceeEEEeecC
Q 003555          514 EEELGRGCFGAVYKGSICE--GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ--TSKKLLVYEFMS  589 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ey~~  589 (811)
                      .++||+|+||+||+|+..+  .++.||+|.++..  .....+.+|+.++++++|+||+++++++..  +...++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            3689999999999999754  4578999998643  233567889999999999999999998864  346789999986


Q ss_pred             CCCHHHHhhcCC--------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----CCCCCeEEEecCCc
Q 003555          590 KGSLENLLSNVE--------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLA  657 (811)
Q Consensus       590 ~gsL~~~l~~~~--------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll----~~~~~~kL~DFGla  657 (811)
                      + +|.+++....        ..+++..+..++.||+.||.|||++   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 8888875321        2366788889999999999999999   99999999999999    46689999999999


Q ss_pred             cccCCCCC--ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 003555          658 KILMPNQT--GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNV  715 (811)
Q Consensus       658 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~  715 (811)
                      +.......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643322  12334678999999998876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-34  Score=304.47  Aligned_cols=251  Identities=20%  Similarity=0.257  Sum_probs=196.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEe-----cccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCM-----QTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~l  583 (811)
                      ++.+.+.||+|+||.||++.....++.+|+|+++.. ......+.+|+.+++++ +|+||+++++++.     .++..++
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            455668899999999999999888899999998643 23346788999999999 6999999999884     3456899


Q ss_pred             EEeecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          584 VYEFMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      ||||+++++|.+++...   ...+.+..+..++.|+++||.|||+.   +++||||||+||++++++.+||+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            99999999999988632   34567888899999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCCccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNS-----GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      ..... ......|+..|+|||.+..     ..++.++|||||||++|||++|+.|+..........   .          
T Consensus       175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~---~----------  240 (286)
T cd06638         175 TSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF---K----------  240 (286)
T ss_pred             ccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh---h----------
Confidence            43221 2233468999999998753     457889999999999999999999987543211110   0          


Q ss_pred             cchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...........+......+.+++.+||+.+|++||++.||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0000000111112234578899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.3e-34  Score=300.46  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.||+|+||.||++.+...++.||+|++.... .+..+++.+|++++++++|+||+++++.+..++..++|+||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456689999999999999998888999999987543 3556779999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhh-ccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++|.+++......+......+++.|++.||+|||+ .   +++|+||||+||++++++.+||+|||.+........   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---  156 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---  156 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---
Confidence            999999998765667888899999999999999999 7   999999999999999999999999999876532221   


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC-ccccC
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE-DEEVD  747 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~  747 (811)
                      ....++..|+|||.+.+..++.++||||||+++++|++|+.||..........  ....         ...... .....
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~  225 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI--FELL---------QYIVNEPPPRLP  225 (265)
T ss_pred             hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH--HHHH---------HHHhcCCCCCCC
Confidence            12568889999999988899999999999999999999999996542211110  0110         001111 11111


Q ss_pred             hH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LR-TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .. ....+.+++..|+..+|.+||++.+++..
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11 56678999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-33  Score=297.57  Aligned_cols=252  Identities=23%  Similarity=0.365  Sum_probs=189.1

Q ss_pred             hhcCcccceeEEEEEEcCCC--EEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGN--KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~--~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      ++||+|+||.||+|....+.  ..+++|.++... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999864432  357788776433 345678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCC---CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-cc
Q 003555          592 SLENLLSNVE---SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-GI  667 (811)
Q Consensus       592 sL~~~l~~~~---~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-~~  667 (811)
                      +|.+++.+..   ..........++.||+.||+|||+.   +++||||||+|||++.++.+||+|||++........ ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997642   2345567788999999999999998   999999999999999999999999999864322211 12


Q ss_pred             ccccccCCCccCcccccc-------CCCCcccchHHHHHHHHHHHhC-CCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          668 VTGVKGTRGYMSPEWQNS-------GLITVKSDVYSFGVVVLEIVCC-RSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvll~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      .....++..|+|||++..       ..++.++||||||+++|||+++ ..||.......   .+    . ....+....+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~----~-~~~~~~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VL----N-HVIKDQQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HH----H-HHHhhccccc
Confidence            234567889999998743       2457899999999999999975 55665322111   01    1 1111111222


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .++  .......+.+.+++..|+ .+|.+||++++|++.|.
T Consensus       230 ~~~--~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKP--QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCC--ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222  112234567788899999 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.5e-34  Score=299.68  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=194.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-----hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-----EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  583 (811)
                      +...+.||+|+||.||+|.....++.||+|++....     .+....+.+|+.++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            345688999999999999998888999999885321     23345688999999999999999999988763  56789


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ++||+++++|.+++... ..+++.....++.|++.||+|||+.   +|+|+||+|+||+++.++.+||+|||+++.....
T Consensus        84 ~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          84 FMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            99999999999999764 3467888899999999999999998   9999999999999999999999999999865332


Q ss_pred             CC--ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          664 QT--GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       664 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++|+.||.........       .....       ..
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-------~~~~~-------~~  225 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-------FKIAT-------QP  225 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-------HHHhc-------CC
Confidence            11  1122345888999999998888999999999999999999999999743221111       00000       00


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .....+....+.+.+++ .|+..+|++||+++||++
T Consensus       226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            01122233345556666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.6e-34  Score=306.23  Aligned_cols=259  Identities=19%  Similarity=0.252  Sum_probs=199.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|+||.||+|+....++.||+|+++...  ......+.+|+.++++++|+||+++++++.+....++|+||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            456688999999999999999888999999986432  223456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++ +|.+++......+++.....++.||++||.|||+.   +|+|+||||+||+++.++.+||+|||+++...... ...
T Consensus        82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~  156 (284)
T cd07839          82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCY  156 (284)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCc
Confidence            74 88888876566688999999999999999999998   99999999999999999999999999998653322 122


Q ss_pred             cccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh--------------h
Q 003555          669 TGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI--------------A  733 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~--------------~  733 (811)
                      ....++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........  + ........              .
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--L-KRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--H-HHHHHHhCCCChHHhHHhhhccc
Confidence            334578899999987664 4789999999999999999999986533222111  0 00000000              0


Q ss_pred             cccchhcCCc---cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          734 KELSKLVGED---EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 ~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..........   .+..+.....+.+++.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000000   0112234578889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.8e-35  Score=320.76  Aligned_cols=251  Identities=20%  Similarity=0.209  Sum_probs=195.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||.||++.....++.||||++...   ..+....+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            34567899999999999999988999999998642   223346788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--  665 (811)
                      +++|+|.+++.+. ..+++.....++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  
T Consensus        83 ~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          83 LPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999999999763 4577888899999999999999998   999999999999999999999999999875432110  


Q ss_pred             --------------------------------ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 003555          666 --------------------------------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEV  713 (811)
Q Consensus       666 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~  713 (811)
                                                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001134699999999999999999999999999999999999999975


Q ss_pred             CCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 003555          714 NVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS---MKNVILM  778 (811)
Q Consensus       714 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~  778 (811)
                      ........        .....  ...+.-  ........++.+++.+++. +|.+|++   +.|+++.
T Consensus       239 ~~~~~~~~--------~i~~~--~~~~~~--p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYR--------KVMNW--KETLVF--PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHH--------HHHcC--CCceec--CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            43221110        00000  000000  0011234567788888664 9999985   5666543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-34  Score=315.18  Aligned_cols=261  Identities=20%  Similarity=0.224  Sum_probs=197.2

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc------cc
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SK  580 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~  580 (811)
                      ..|.+.+.||+|+||.||++.....++.||||++....  ......+.+|+.+++.++|+||+++++++...      ..
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            34666789999999999999998888999999987532  33456788999999999999999999987643      35


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .++||||+++ +|.+++..   .+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             EEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            7999999976 77777653   366788889999999999999998   9999999999999999999999999999864


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHH--------H------
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST--------W------  726 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~--------~------  726 (811)
                      ...  .......+|..|+|||.+.+..++.++|||||||++|||++|+.||..............        .      
T Consensus       177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            322  122345689999999999999999999999999999999999999975432211100000        0      


Q ss_pred             -HHHhhhhcc------cchhcCC-----ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          727 -VYNCFIAKE------LSKLVGE-----DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       727 -~~~~~~~~~------~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                       .........      ..++...     ...........+.+++.+||+.||.+|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             000000000      0000000     001111234578899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.4e-34  Score=299.91  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch----------hhHHHHHHHHHHHhccCCCCccceecEEecccce
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE----------EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      ...+.||+|+||.||+|....+++.||||.++....          ...+.+.+|+.++++++|+|++++++++...+..
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   83 (272)
T cd06629           4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL   83 (272)
T ss_pred             eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence            345789999999999999988889999998753211          1234678899999999999999999999999999


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++|+||+++++|.+++.+. ..+.+..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||+++...
T Consensus        84 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  159 (272)
T cd06629          84 SIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSD  159 (272)
T ss_pred             EEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence            9999999999999999875 4577888899999999999999998   99999999999999999999999999998653


Q ss_pred             CCCCc-cccccccCCCccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          662 PNQTG-IVTGVKGTRGYMSPEWQNSGL--ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       662 ~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ..... ......++..|+|||.+....  ++.++|+||||+++||+++|..||.........       .... ......
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~-~~~~~~  231 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-------FKLG-NKRSAP  231 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH-------HHhh-ccccCC
Confidence            32211 123356889999999877654  789999999999999999999998633211100       0000 000000


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+.  ..........+.+++..|++.+|.+||++.+|++.
T Consensus       232 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         232 PIP--PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111  11223446788999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.4e-34  Score=303.94  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=200.9

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|+||.||+|+...+++.||+|++....  ....+.+.+|+.++++++|+|++++++++......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            456688999999999999998888999999886432  233466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++.|..++.. ...+++..+..++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||++........ ..
T Consensus        83 ~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~  157 (286)
T cd07847          83 DHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY  157 (286)
T ss_pred             CccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence            99988887765 34578899999999999999999998   999999999999999999999999999987643321 12


Q ss_pred             cccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHh-------hhhccc-chh
Q 003555          669 TGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNC-------FIAKEL-SKL  739 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~~-~~~  739 (811)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.......       ...... ...
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            23457889999998765 567899999999999999999999997544322211111000000       000000 000


Q ss_pred             cCCcc--c-----cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          740 VGEDE--E-----VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ~~~~~--~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..+..  .     ........+.+++.+||+.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000  0     01123567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-33  Score=290.91  Aligned_cols=251  Identities=19%  Similarity=0.224  Sum_probs=206.6

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      -...++.+.||.|.-|+||++.+.+.+...|+|++.+..   .....+.+.|-++|+.++||.++.|++.+..+...+||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            334556789999999999999999989999999997643   33445678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCC-CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC-
Q 003555          585 YEFMSKGSLENLLSNVES-GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-  662 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~-  662 (811)
                      ||||+||+|..+++++.. .+++....-++.+|+-||+|||-.   +||+|||||+||||.++|++.|+||.|+..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999999987644 466677777889999999999998   999999999999999999999999998754310 


Q ss_pred             --------------------------------CCC----------------------ccccccccCCCccCccccccCCC
Q 003555          663 --------------------------------NQT----------------------GIVTGVKGTRGYMSPEWQNSGLI  688 (811)
Q Consensus       663 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~  688 (811)
                                                      ...                      ......+||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                      00113569999999999999999


Q ss_pred             CcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc--ChHHHHHHHHHHHHcccCCC
Q 003555          689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV--DLRTLETMVRVGLLCIQDEP  766 (811)
Q Consensus       689 t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP  766 (811)
                      +.+.|.|+|||++|||+.|..||......+..                ..++......  .+..+..+.+||+..|.+||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl----------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL----------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhH----------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence            99999999999999999999999876544322                2223332222  33567789999999999999


Q ss_pred             CCCCC----HHHHHH
Q 003555          767 NLRPS----MKNVIL  777 (811)
Q Consensus       767 ~~RPs----~~evl~  777 (811)
                      ++|.-    +.||-+
T Consensus       377 ~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhhccccchHHhhc
Confidence            99988    777754

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=315.00  Aligned_cols=241  Identities=22%  Similarity=0.259  Sum_probs=188.7

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhcc---CCCCccceecEEecccceeEEEeecCC
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT---HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      ||+|+||+||+|+....++.||||++....   ......+..|..++.+.   +|+||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999889999999986422   12233455666676655   699999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+++.. ...+++.....++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~  155 (330)
T cd05586          81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT  155 (330)
T ss_pred             ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence            999999876 44577888999999999999999998   99999999999999999999999999997543222 12234


Q ss_pred             cccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          671 VKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ..||..|+|||.+.+. .++.++|||||||++|||++|+.||.......       . ......+.. .+      ....
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~-~~~i~~~~~-~~------~~~~  220 (330)
T cd05586         156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------M-YRNIAFGKV-RF------PKNV  220 (330)
T ss_pred             ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------H-HHHHHcCCC-CC------CCcc
Confidence            5699999999988654 47999999999999999999999997532111       0 000011100 00      0112


Q ss_pred             HHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 003555          750 TLETMVRVGLLCIQDEPNLRP----SMKNVIL  777 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RP----s~~evl~  777 (811)
                      ....+.+++.+||+.+|.+||    ++.++++
T Consensus       221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            356778999999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-33  Score=301.95  Aligned_cols=245  Identities=18%  Similarity=0.269  Sum_probs=201.1

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      .++||+|++|.||++....+++.+|+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            46899999999999999888899999998755555567789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++..  ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++....... .......|
T Consensus       104 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  177 (285)
T cd06648         104 TDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVG  177 (285)
T ss_pred             HHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccccccC
Confidence            999986  4577889999999999999999998   99999999999999999999999999887543322 12233458


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      +..|+|||.+.+..++.++||||||+++|||++|+.||........   . .    .....     ..............
T Consensus       178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~-~----~~~~~-----~~~~~~~~~~~~~~  244 (285)
T cd06648         178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---M-K----RIRDN-----LPPKLKNLHKVSPR  244 (285)
T ss_pred             CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---H-H----HHHhc-----CCCCCcccccCCHH
Confidence            8999999999888899999999999999999999999864322110   0 0    00000     00111112224567


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH
Q 003555          754 MVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +.+++.+||+.+|++||++.++++
T Consensus       245 l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         245 LRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHHHHHHcccChhhCcCHHHHcc
Confidence            999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.5e-34  Score=296.80  Aligned_cols=248  Identities=21%  Similarity=0.316  Sum_probs=201.9

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      |.+.+.||+|+||.||++.....++.+|||.+...  ..+..+.+.+|+.++++++|+|++++++.+...+..++|+||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            45668899999999999999888999999998643  2344677999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC-CCeEEEecCCccccCCCCCc
Q 003555          589 SKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-LTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       589 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~-~~~kL~DFGla~~~~~~~~~  666 (811)
                      ++++|.+++.... ..+++..+.+++.+++++|+|||++   +++|+||+|+||+++++ +.+||+|||++.......  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--  156 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--  156 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence            9999999998653 3478889999999999999999998   99999999999999854 568999999998754322  


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......++..|+|||.+....++.++||||||+++|+|++|+.||........    ....    ....       ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~----~~~~-------~~~~  221 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL----VLKI----MSGT-------FAPI  221 (256)
T ss_pred             cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH----HHHH----HhcC-------CCCC
Confidence            12234688899999999888899999999999999999999999865422110    0000    0000       1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .......+.+++.+||+.+|.+|||++|+++.
T Consensus       222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            22346678899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=306.52  Aligned_cols=241  Identities=25%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccC---CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      .+.||.|+||.||-|++..+.+.||||++.-   ...+...++..|+..|++++|||.+.+.|++..+...+||||||-|
T Consensus        31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG  110 (948)
T KOG0577|consen   31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG  110 (948)
T ss_pred             HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence            3679999999999999999999999999863   3445567899999999999999999999999999999999999965


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                       +-.++|.-.+..+-+.++..|+.+.+.||+|||+.   +.||||||+.||||++.|.+||+|||.|....+.+     .
T Consensus       111 -SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-----s  181 (948)
T KOG0577|consen  111 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-----S  181 (948)
T ss_pred             -cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh-----c
Confidence             77888877777888899999999999999999999   99999999999999999999999999998765544     4


Q ss_pred             cccCCCccCcccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          671 VKGTRGYMSPEWQ---NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       671 ~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .+|||.|||||++   ..+.|+-|+|||||||...||.-.++|.-...-..   .+..      ++.+-     ...-..
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---ALYH------IAQNe-----sPtLqs  247 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYH------IAQNE-----SPTLQS  247 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---HHHH------HHhcC-----CCCCCC
Confidence            6799999999976   45689999999999999999999988875321111   1111      11111     111125


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .+.++.++.++..||++-|.+|||.+++++
T Consensus       248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  248 NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            678889999999999999999999998873

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-33  Score=298.62  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEEeec
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVYEFM  588 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ey~  588 (811)
                      .+.++||.|++|.||++.+...++.+|+|.+.... ......+.+|++++++++|+||+++++++.+.  ...++||||+
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   83 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC   83 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence            44578999999999999998888999999987432 34567799999999999999999999998654  3689999999


Q ss_pred             CCCCHHHHhhc---CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          589 SKGSLENLLSN---VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       589 ~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ++++|.+++..   ....++......++.||+.||+|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            99999998754   234467888999999999999999998   999999999999999999999999999876432221


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-cchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST-ADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                         ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+...    .... .+....
T Consensus       161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~  232 (287)
T cd06621         161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNP-ELKDEP  232 (287)
T ss_pred             ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCch-hhccCC
Confidence               2345788999999998889999999999999999999999999755321 111111111111    0111 111111


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .......+.+.+++.+||+.+|.+|||+.||++
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            111234678899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-33  Score=297.23  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc------hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV------EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      +...+.||+|++|.||+|....+++.||+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            344578999999999999998888999999986432      12356789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-CeEEEecCCccccCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMPN  663 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-~~kL~DFGla~~~~~~  663 (811)
                      +||+++++|.+++.+. ..+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++ .+||+|||++......
T Consensus        82 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          82 VEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            9999999999999763 3567889999999999999999999   999999999999998775 6999999999876433


Q ss_pred             CCc---cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          664 QTG---IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       664 ~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ...   ......++..|+|||.+.+..++.++||||+|++++||++|..||.........    .......       ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~-------~~  226 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL----ALIFKIA-------SA  226 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH----HHHHHHh-------cc
Confidence            211   112346788999999998888999999999999999999999998643221111    1000000       00


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......+......+.+++.+|++.+|.+||++.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            1112234456678899999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=302.89  Aligned_cols=251  Identities=20%  Similarity=0.302  Sum_probs=205.0

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .++.+.+.||+|+||.||++....+++.||+|.+........+.+.+|+.++++++|+|++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            35666789999999999999988778899999986554455677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++.+  ..+.+.++..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++........ ..
T Consensus        99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~  172 (293)
T cd06647          99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR  172 (293)
T ss_pred             CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence            99999999975  3467888999999999999999999   999999999999999999999999999876543322 22


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ....+++.|+|||.+....++.++||||||+++||+++|+.||............       ...+      ........
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~------~~~~~~~~  239 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNG------TPELQNPE  239 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCC------CCCCCCcc
Confidence            3346888999999998888999999999999999999999999754332211100       0000      00011122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .....+.+++.+||+.+|.+||++.+++.+
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            345578899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-33  Score=303.60  Aligned_cols=246  Identities=24%  Similarity=0.345  Sum_probs=198.9

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .+.+.++||+|+||+||+|+...+++.||+|++...   ..+...++.+|+.+++.++|+|++++.+++.+.+..++|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            366778999999999999999888899999988532   23344678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |++ |+|.+++......+++..+..++.||+.||.|||+.   +|+|+||+|+||++++++.+||+|||++......   
T Consensus        96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---  168 (307)
T cd06607          96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---  168 (307)
T ss_pred             hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence            997 578887766556688999999999999999999998   9999999999999999999999999998764322   


Q ss_pred             cccccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          667 IVTGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                        ....++..|+|||.+.   ...++.++||||||+++|||++|+.||........   +    ... ....      ..
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~----~~~-~~~~------~~  232 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L----YHI-AQND------SP  232 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---H----HHH-hcCC------CC
Confidence              2345788999999874   45688999999999999999999999864321110   0    000 0000      00


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..........+.+++.+||+.+|.+||++.+|+..
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11122356678999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=309.32  Aligned_cols=259  Identities=20%  Similarity=0.256  Sum_probs=194.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc------cce
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SKK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~  581 (811)
                      .|.+.+.||+|+||+||+|....+++.||||++....  ....+.+.+|+.++++++|+||+++++++...      ...
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            4666788999999999999998888999999986532  23345678999999999999999999987543      356


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++++|++ +++|.+++..  ..+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus        96 ~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          96 YLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence            8999987 6799888864  3578899999999999999999998   99999999999999999999999999998653


Q ss_pred             CCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH-------Hhhhh
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY-------NCFIA  733 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~  733 (811)
                      ..    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....       .....
T Consensus       170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            22    234568999999998866 5689999999999999999999999965432211110000000       00000


Q ss_pred             cccchhcCCccccC--------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          734 KELSKLVGEDEEVD--------LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       734 ~~~~~~~~~~~~~~--------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .............+        ......+.+++.+||+.||.+|||+.|++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000000        0123357899999999999999999999854

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-33  Score=298.07  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc------hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV------EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      ...+.||+|+||+||+|... +++.+|||.++...      .+....+.+|++++++++|+||+++++++.+.+..++|+
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             cccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            45678999999999999875 46789999886332      223356889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC-
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ-  664 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~-  664 (811)
                      ||+++++|.+++.+. ..+.+..+..++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||++....... 
T Consensus        82 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          82 EFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             ecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            999999999999764 3467888889999999999999998   99999999999999999999999999987643211 


Q ss_pred             ----CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          665 ----TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       665 ----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                          ........++..|+|||.+.+..++.++||||||+++|||++|+.||............          ....   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~----------~~~~---  224 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI----------GAHR---  224 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh----------hhcc---
Confidence                11123356889999999999888999999999999999999999999743221111000          0000   


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......+......+.+++.+||+.+|.+||++.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0111223345677899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-33  Score=306.08  Aligned_cols=194  Identities=22%  Similarity=0.345  Sum_probs=159.5

Q ss_pred             hhcCcccceeEEEEEEcC--CCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEec--ccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICE--GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ--TSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ey~~~  590 (811)
                      .+||+|+||.||+|+..+  .+..||+|.++..  .....+.+|+.++++++|+||+++++++..  +...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999764  3478999998643  234567899999999999999999999854  4567899999875


Q ss_pred             CCHHHHhhcC--------CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE----CCCCCeEEEecCCcc
Q 003555          591 GSLENLLSNV--------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLAK  658 (811)
Q Consensus       591 gsL~~~l~~~--------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll----~~~~~~kL~DFGla~  658 (811)
                       +|.+++...        ...+++..+..++.||+.||.|||+.   +|+||||||+|||+    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777776422        12356788889999999999999998   99999999999999    567899999999998


Q ss_pred             ccCCCCC--ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 003555          659 ILMPNQT--GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVN  714 (811)
Q Consensus       659 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~  714 (811)
                      .......  .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            7643322  12234568999999998866 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-33  Score=292.81  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=207.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +...+.||+|++|.||++....+++.+++|++..........+.+|+..+++++|+|++++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            34557899999999999999888899999999766555678899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|.+++......+++..+..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||.+........  ...
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~  156 (253)
T cd05122          82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT  156 (253)
T ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence            999999987656788999999999999999999998   999999999999999999999999999987654332  234


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..++..|+|||.+.....+.++||||||+++++|++|+.||...........        ........     .......
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~  223 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK--------IATNGPPG-----LRNPEKW  223 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH--------HHhcCCCC-----cCccccc
Confidence            5688999999999888899999999999999999999999875422111100        00000000     1111223


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...+.+++.+|++.+|++||++.|+++.
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            5678999999999999999999999853

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-33  Score=296.95  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=204.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.||.|+||+||+|....++..+|+|++.... ......+.+|++.++.++|+|++++++.+...+..++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            456788999999999999998888999999986432 3356789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCC--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          590 KGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       590 ~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      +++|.+++....  ..+.+.....++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++......... 
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            999999997642  4578889999999999999999998   9999999999999999999999999999876543322 


Q ss_pred             --cccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          667 --IVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       667 --~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                        ......|+..|+|||.+... ..+.++|+||||+++|||++|+.||.........   ....     ..... .... 
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~-----~~~~~-~~~~-  229 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL---MLTL-----QNDPP-SLET-  229 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH---HHHh-----cCCCC-CcCC-
Confidence              12334688999999988766 7899999999999999999999999754322111   0100     00000 0000 


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .......+..+.+++..|++.+|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0001244677899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-33  Score=296.63  Aligned_cols=249  Identities=21%  Similarity=0.294  Sum_probs=197.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-----chhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-----VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  583 (811)
                      +.+.+.||+|+||.||+|...++++.||||.+...     ..+..+.+.+|+.++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            44568899999999999999888899999987532     123346788999999999999999999988764  45789


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ||||+++++|.+++... ..+++....+++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          84 FMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            99999999999999764 3467788899999999999999998   9999999999999999999999999999865432


Q ss_pred             CC--ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          664 QT--GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       664 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..  .......++..|+|||.+.+..++.++||||||+++|||++|+.||........   .    .... .      ..
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~----~~~~-~------~~  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---I----FKIA-T------QP  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---H----HHHh-c------CC
Confidence            11  112234588899999999888899999999999999999999999964321110   0    0000 0      00


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .....+......+.+++.+|+. +|++||+++||++.
T Consensus       226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1122244556678889999985 89999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=304.01  Aligned_cols=248  Identities=19%  Similarity=0.209  Sum_probs=200.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch---hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||+||+|.....++.||+|.+.....   ...+.+.+|+++++.++|+||+++++.+.++...++||||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            4556789999999999999988889999999865432   2456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +.+++|.+++.... ..+++..+..++.||++||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            99999999997643 4578888999999999999999998   9999999999999999999999999998754321110


Q ss_pred             ----------------------------cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 003555          667 ----------------------------IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTA  718 (811)
Q Consensus       667 ----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~  718 (811)
                                                  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                        0112357889999999988889999999999999999999999997543221


Q ss_pred             chhhHHHHHHHhhhhcccchhcCCcccc--ChHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 003555          719 DVVLLSTWVYNCFIAKELSKLVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPS----MKNVIL  777 (811)
Q Consensus       719 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~  777 (811)
                      ..                ..+.......  .......+.+++.+|++.+|++||+    ++|++.
T Consensus       240 ~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         240 TF----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11                0011111111  1125678999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.2e-33  Score=302.30  Aligned_cols=242  Identities=22%  Similarity=0.239  Sum_probs=200.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||.||++.....++.||+|.+....   .+..+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            456688999999999999998888999999986432   23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++... ..++...+..++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||+++.....    
T Consensus        83 ~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          83 VPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            9999999999764 4677889999999999999999998   9999999999999999999999999999875433    


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....+++.|+|||.+.+...+.++||||||+++|||++|+.||.......    .    .        ..+.......+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~----~--------~~~~~~~~~~~  218 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----I----Y--------EKILEGKVRFP  218 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----H----H--------HHHhcCCccCC
Confidence            233468899999999988888999999999999999999999987543110    0    0        00111112223


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRP-----SMKNVI  776 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl  776 (811)
                      ......+.+++.+||+.+|.+||     +++|++
T Consensus       219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            33467888999999999999999     777776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.2e-33  Score=296.74  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ..+.+.++||+|+||.||+|....+++.||||.+.... ......+.+|+.++++++|+||+++++++.++...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34566788999999999999998888999999876432 34456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++..  ..+++.....++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            999999999874  3577899999999999999999998   999999999999999999999999999876543221 1


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....++..|+|||.+.+...+.++|||||||++|||++|..|+.......    ....    ....       ......
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~----~~~~-------~~~~~~  222 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLFL----IPKN-------NPPTLE  222 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----HHHH----HhcC-------CCCCCC
Confidence            223457889999999988889999999999999999999999986432111    0000    0000       011122


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......+.+++.+|++.+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            3445678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=311.87  Aligned_cols=246  Identities=23%  Similarity=0.353  Sum_probs=197.8

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEcc--C--CchhhHHHHHHHHHHHhccCCCCccceecEEecccc--eeEEE
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLE--N--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK--KLLVY  585 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~  585 (811)
                      +|.++||+|+|-+||||.+...+-.||--.++  +  ...+..+.|..|+.+|+.|+|+||++++....+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45688999999999999998877777743322  1  234455789999999999999999999999887654  78999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-CCCCeEEEecCCccccCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-~~~~~kL~DFGla~~~~~~~  664 (811)
                      |.+..|+|..|+++.+ ..+.+....+++||++||.|||++ .|+|+|||||.+||+|+ ..|.+||+|+|||.......
T Consensus       123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            9999999999999854 466788899999999999999998 67999999999999998 56899999999999865433


Q ss_pred             CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .   ....|||.|||||... ..|+...||||||+.|+||+|+..||.......+.       +..+..+..-..+..  
T Consensus       201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI-------YKKV~SGiKP~sl~k--  267 (632)
T KOG0584|consen  201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI-------YKKVTSGIKPAALSK--  267 (632)
T ss_pred             c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH-------HHHHHcCCCHHHhhc--
Confidence            2   2378999999999877 88999999999999999999999999865544322       222222221111111  


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                          -...++.++|..||.. ..+|||+.|++.
T Consensus       268 ----V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 ----VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                1134688999999998 999999999985

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-33  Score=295.40  Aligned_cols=246  Identities=31%  Similarity=0.447  Sum_probs=197.4

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ..+.+.+.||+|+||.||+|..  .++.||+|.++...  ....+.+|+.++++++|+|++++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            3467788999999999999975  45789999986432  346789999999999999999999998654 479999999


Q ss_pred             CCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++++|.+++.... ..+.+..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999997643 3467889999999999999999998   9999999999999999999999999998754321    


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......+..|+|||.+.+..++.++|+||||+++|||++ |+.||.......    .   . ...... .      ....
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~---~-~~~~~~-~------~~~~  218 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----V---K-ECVEKG-Y------RMEP  218 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----H---H-HHHhCC-C------CCCC
Confidence            112334568999999988899999999999999999998 888886432211    0   0 000000 0      1111


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ....+..+.+++.+||+.+|.+||++++|+..|+.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            22345778899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=302.42  Aligned_cols=259  Identities=19%  Similarity=0.299  Sum_probs=197.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.||+|++|.||+|..+.+++.||||.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            4566889999999999999988889999999864332 223457789999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      + +|.+++......+.+.....++.||++||.|||+.   +|+|+||||+||+++.++.+||+|||+++...... ....
T Consensus        87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (291)
T cd07844          87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYS  161 (291)
T ss_pred             C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-cccc
Confidence            5 99999987666778889999999999999999998   99999999999999999999999999987542211 1112


Q ss_pred             ccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh---hcccch-------
Q 003555          670 GVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI---AKELSK-------  738 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---~~~~~~-------  738 (811)
                      ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+..   ........   ......       
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL---HKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH---HHHHHhcCCCChhhhhhhhhcccc
Confidence            2346788999998765 458899999999999999999999996543211111   00100000   000000       


Q ss_pred             ------hcCCcc--c--cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 ------LVGEDE--E--VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ------~~~~~~--~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                            ......  .  ........+.+++.+||+.+|++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                  000000  0  01112267789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4e-33  Score=302.03  Aligned_cols=253  Identities=24%  Similarity=0.306  Sum_probs=202.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .+...+.||+|+||.||+|+...+++.||+|++...   ..+....+.+|++++++++|+|++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            355668899999999999999888899999998643   23344578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++ +|.+++......+++.++..++.||+.||.|||+.   +|+|+||+|+||+++.++.+||+|||++......   
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9974 88888876566688999999999999999999998   9999999999999999999999999998754322   


Q ss_pred             cccccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          667 IVTGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                        ....++..|+|||.+.   .+.++.++|||||||++|||++|+.||........   +....     ....      .
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~-----~~~~------~  242 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA-----QNES------P  242 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHH-----hccC------C
Confidence              2345788999999863   45688999999999999999999999864321111   10100     0000      0


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                      ..........+.+++.+|++.+|.+||++.+|++.+-.....
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            011223456789999999999999999999999866444333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.2e-33  Score=297.16  Aligned_cols=253  Identities=24%  Similarity=0.386  Sum_probs=197.7

Q ss_pred             hhhhhcCcccceeEEEEEEcC---CCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc------c
Q 003555          512 GFEEELGRGCFGAVYKGSICE---GNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------K  580 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~  580 (811)
                      .+.+.||+|+||.||+|.+..   .++.||||++...  .....+++.+|+.++++++|+||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            456789999999999998753   3578999998653  2345667899999999999999999999886543      2


Q ss_pred             eeEEEeecCCCCHHHHhhcCC-----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecC
Q 003555          581 KLLVYEFMSKGSLENLLSNVE-----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS  655 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFG  655 (811)
                      .++++||+++|+|..++....     ..+++....+++.||+.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence            378899999999998875321     2356788899999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCCc-cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          656 LAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       656 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      +++........ ......++..|++||.+....++.++||||||+++|||++ |+.||......    .+....    ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~----~~~~~~----~~  230 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS----EIYNYL----IK  230 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH----HHHHHH----Hc
Confidence            99865433221 1122345678999999988889999999999999999999 78887643211    111111    01


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .       .....+......+.+++.+|++.+|.+||++.|+++.|+++
T Consensus       231 ~-------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 G-------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C-------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0       01111234557899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=297.88  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=199.6

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEeccc------ce
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTS------KK  581 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~  581 (811)
                      ..+.+.+.||+|+||.||+|..+..++.+++|++..... ....+.+|+.+++++ +|+||+++++++.+..      ..
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            346667899999999999999988889999999875433 456799999999999 7999999999997654      48


Q ss_pred             eEEEeecCCCCHHHHhhcCC---CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          582 LLVYEFMSKGSLENLLSNVE---SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~---~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      ++||||+++++|.+++....   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccce
Confidence            99999999999999987543   5678889999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCCccccccccCCCccCcccccc-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          659 ILMPNQTGIVTGVKGTRGYMSPEWQNS-----GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       659 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      ...... .......++..|+|||.+..     ..++.++||||||++++||++|+.||........   +...     ..
T Consensus       162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~  232 (275)
T cd06608         162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---LFKI-----PR  232 (275)
T ss_pred             ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---HHHh-----hc
Confidence            643222 22234568899999998643     3467899999999999999999999964322111   1000     00


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .     ..............+.+++.+||+.||++|||+.|+++
T Consensus       233 ~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 N-----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             c-----CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0     01111112235678899999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-33  Score=295.44  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=202.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEec--ccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ--TSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e  586 (811)
                      |.+.+.||.|+||.||++....+++.||+|.+...  .....+.+.+|++++++++|+||+++++++..  +...+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            45568899999999999999888899999998642  34445678899999999999999999998764  346789999


Q ss_pred             ecCCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHh-----hccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          587 FMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLH-----EECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       587 y~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH-----~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      |+++++|.+++...   ...+++...+.++.||+.||.|||     +.   +++|+||+|+||++++++.+||+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999999754   355788999999999999999999     65   99999999999999999999999999998


Q ss_pred             ccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          659 ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       659 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ....... ......++..|+|||.+....++.++||||||+++++|++|+.||......    .+...    .....   
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~---  226 (265)
T cd08217         159 ILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL----QLASK----IKEGK---  226 (265)
T ss_pred             cccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH----HHHHH----HhcCC---
Confidence            7643332 123356899999999998888999999999999999999999999754311    11111    11111   


Q ss_pred             hcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                          ....+......+.+++.+|++.+|.+||++.+|+++
T Consensus       227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                112233456788999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=299.84  Aligned_cols=261  Identities=19%  Similarity=0.232  Sum_probs=201.9

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEEee
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVYEF  587 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ey  587 (811)
                      .+.++||+|+||.||+|+....++.+|+|++....  ......+.+|+.++++++|+|++++++++.+.  +..++|+||
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   81 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY   81 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence            45678999999999999998888999999997553  33456788999999999999999999999988  789999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++ +|.+++......+++..++.++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++..........
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence            985 89999887656788999999999999999999998   99999999999999999999999999998765443323


Q ss_pred             ccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch--------
Q 003555          668 VTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK--------  738 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~--------  738 (811)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...... ........        
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  236 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-PTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-Cchhhccccccchhhh
Confidence            334567889999997654 46789999999999999999999999754432211111110000 00000000        


Q ss_pred             hcCCcc--------ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 LVGEDE--------EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......        .....+...+.+++.+||+.+|.+||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000000        001112667899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-33  Score=296.89  Aligned_cols=246  Identities=22%  Similarity=0.361  Sum_probs=199.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccC---CCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTH---HKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+... ......++.+|+.++++++   |+|++++++++.++...++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            45568899999999999999888899999998654 3344567889999999986   9999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+++++|.+++...  .+++...+.++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06917          83 YAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-  156 (277)
T ss_pred             cCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence            99999999998753  577899999999999999999998   999999999999999999999999999987654332 


Q ss_pred             cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..........        . ....      ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--------~-~~~~------~~~~  221 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--------L-IPKS------KPPR  221 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------c-cccC------CCCC
Confidence            2233468889999998765 457899999999999999999999997532211100        0 0000      0001


Q ss_pred             cCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          746 VDL-RTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       746 ~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ... .....+.+++.+||+.+|.+||++.|++.
T Consensus       222 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LEDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111 14567889999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.3e-34  Score=297.45  Aligned_cols=247  Identities=23%  Similarity=0.276  Sum_probs=203.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||.|+||.||+|....+++.||+|.+....   ....+.+.+|++++++++||||+++++.+.++...++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            456688999999999999998888999999986432   24567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++++|.+++... ..+.+.....++.||++||.|||+.   +++|+||+|+||++++++.++|+|||++.......  .
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~  155 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L  155 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence            9999999999764 4677889999999999999999998   99999999999999999999999999998754332  2


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........     ......        ........+
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~--------~~~~~~~~~  222 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-----DQIRAK--------QETADVLYP  222 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-----HHHHHH--------hccccccCc
Confidence            2345688899999999888899999999999999999999999975543211     111000        000122233


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSM--KNVI  776 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~--~evl  776 (811)
                      ......+.+++.+||+.+|.+||++  +|++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            3456789999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.7e-33  Score=299.61  Aligned_cols=250  Identities=20%  Similarity=0.262  Sum_probs=196.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecc-----cceeEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT-----SKKLLV  584 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lV  584 (811)
                      +.+.+.||+|+||.||++....+++.+|+|++... ......+.+|+.+++++ +|+|++++++++...     +..++|
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            44567899999999999999888999999998643 23346778899999999 899999999998754     357999


Q ss_pred             EeecCCCCHHHHhhc---CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          585 YEFMSKGSLENLLSN---VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      +||+++++|.+++..   ....+.+..+..++.|++.||.|||+.   +++|+||||+||++++++.+||+|||++....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999998864   234578899999999999999999998   99999999999999999999999999988654


Q ss_pred             CCCCccccccccCCCccCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNSG-----LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      .... ......|+..|+|||.+...     .++.++|||||||++|||++|+.||.........   ...     .....
T Consensus       180 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~---~~~-----~~~~~  250 (291)
T cd06639         180 STRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---FKI-----PRNPP  250 (291)
T ss_pred             cccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH---HHH-----hcCCC
Confidence            3221 11234578899999987543     3688999999999999999999998753221111   000     00000


Q ss_pred             chhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       737 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                           ............+.+++.+|++.+|++||++.|+++.
T Consensus       251 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         251 -----PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -----CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                 0111122344578999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.2e-33  Score=298.08  Aligned_cols=245  Identities=18%  Similarity=0.282  Sum_probs=200.3

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ..+||+|+||.||++....+++.||||++..........+.+|+.++++++|+|++++++.+..++..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            47899999999999999888999999998765555667799999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++..  ..+.+.....++.|++.+|+|||+.   +++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus       105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  178 (292)
T cd06657         105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG  178 (292)
T ss_pred             HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence            998864  3467888999999999999999998   999999999999999999999999999876543221 1233457


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      +..|+|||.+.+..++.++||||||+++|||++|..||.........    ....         ................
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~~  245 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM----KMIR---------DNLPPKLKNLHKVSPS  245 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHH---------hhCCcccCCcccCCHH
Confidence            89999999998888999999999999999999999998743221110    0000         0011111111223456


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHH
Q 003555          754 MVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +.+++.+||+.+|.+||++.++++
T Consensus       246 l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         246 LKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHhCCcccCcCHHHHhc
Confidence            788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.3e-33  Score=295.83  Aligned_cols=249  Identities=19%  Similarity=0.299  Sum_probs=201.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|+||.||+|..+.++..||+|.+...  .....+.+.+|+.++++++|+||+++++.+.+....++|+||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            45568899999999999999988899999998642  2234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-CeEEEecCCccccCCCCCc
Q 003555          589 SKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       589 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-~~kL~DFGla~~~~~~~~~  666 (811)
                      ++++|.+++.... ..+++..+..++.|+++||.|||+.   +++|+||||+||++++++ .+||+|||.+....... .
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~  157 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E  157 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence            9999999997643 3468899999999999999999998   999999999999999875 56999999998654322 1


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......|++.|+|||.+.+..++.++||||||++++||++|+.||.......       ...... ...       ....
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~-~~~-------~~~~  222 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-------LVLKIC-QGY-------FAPI  222 (257)
T ss_pred             cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHh-ccc-------CCCC
Confidence            2223468899999999988889999999999999999999999986432111       111100 011       1112


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+.....+.+++.+|++.+|++||++.|+++.
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            23445679999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.4e-33  Score=299.97  Aligned_cols=259  Identities=19%  Similarity=0.230  Sum_probs=196.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      |.+.++||+|+||.||+|.....++.||+|++..... .....+.+|+.+++.++|+||+++.+++.+++..++|+||+.
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            4566889999999999999988889999999865432 334567899999999999999999999999999999999996


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                       ++|.+++......+.+.++..++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....... ...
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~  161 (291)
T cd07870          87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYS  161 (291)
T ss_pred             -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCC
Confidence             688777765555667788889999999999999998   999999999999999999999999999976432211 122


Q ss_pred             ccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh-------------hcc
Q 003555          670 GVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI-------------AKE  735 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~-------------~~~  735 (811)
                      ...++..|+|||.+.+. .++.++||||||+++|||++|+.||.........  +.. .+....             ...
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ--LEK-IWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH--HHH-HHHHcCCCChhhhhhhhhcccc
Confidence            34578899999988654 5788999999999999999999999754322111  000 000000             000


Q ss_pred             cchhcCCcc-------ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          736 LSKLVGEDE-------EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       736 ~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .........       .........+.+++.+|++.||.+|||+.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000       001112457789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-33  Score=303.12  Aligned_cols=254  Identities=18%  Similarity=0.190  Sum_probs=201.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +.+.+.||+|+||.||++.....++.||+|.+....   ......+.+|+.+++.++|+||+++++.+.+++..++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            445688999999999999999888999999986543   23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--  665 (811)
                      +++++|.+++... ..+.+..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.......  
T Consensus        83 ~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          83 VEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             CCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            9999999999764 4577888889999999999999998   999999999999999999999999999874211100  


Q ss_pred             ------------ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhh
Q 003555          666 ------------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       666 ------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                                  .......++..|+|||.+....++.++|+||||+++|||++|+.||.......       ... ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~-~~~~  230 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFG-QVIS  230 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH-HHHh
Confidence                        01112457889999999988889999999999999999999999996432110       000 0000


Q ss_pred             cccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..   ....  ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       231 ~~---~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DD---IEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cc---cCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00   0001  1112345678999999999999999998777777765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.6e-33  Score=298.51  Aligned_cols=261  Identities=21%  Similarity=0.293  Sum_probs=197.2

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +..+.||+|++|.||+|+...+++.||||++....  ......+.+|++++++++|+||+++++++.+.+..++||||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   82 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence            45578999999999999998888999999886432  2334678999999999999999999999999999999999996


Q ss_pred             CCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                       ++|.+++... ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++........ ..
T Consensus        83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~  157 (284)
T cd07860          83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY  157 (284)
T ss_pred             -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence             5899988654 34578899999999999999999998   999999999999999999999999999876533221 12


Q ss_pred             cccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH-------Hhhh-----hcc
Q 003555          669 TGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY-------NCFI-----AKE  735 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~-----~~~  735 (811)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|+.||.................       ....     ...
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            233568899999987654 468899999999999999999999975432221111100000       0000     000


Q ss_pred             cchhcCCc-cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          736 LSKLVGED-EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       736 ~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ........ ....+.....+.+++.+|++.||.+||+++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000 0111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.3e-33  Score=294.05  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=206.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.||+|++|.||+|+....++.||||++..... .....+.+|+..+.+++|+|++++++++...+..++|+||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            4456889999999999999998889999999875543 456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhh-ccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++|.+++... ..++...+..++.|+++||+|||+ .   +++|+||+|+||+++.++.++|+|||++......... .
T Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~  157 (264)
T cd06623          83 GGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C  157 (264)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence            99999999864 557889999999999999999999 8   9999999999999999999999999999876433322 2


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ....++..|+|||.+....++.++||||||+++|||++|+.||....... ...+.....     ..      .....+.
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~-----~~------~~~~~~~  225 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAIC-----DG------PPPSLPA  225 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC-HHHHHHHHh-----cC------CCCCCCc
Confidence            24567889999999998899999999999999999999999997553211 111111000     00      0111222


Q ss_pred             H-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          749 R-TLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       749 ~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      . .+..+.+++..|++.+|++||++.|+++.
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            3 56789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=298.54  Aligned_cols=261  Identities=22%  Similarity=0.279  Sum_probs=198.5

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.++||.|++|.||+|....+++.||+|++....  ......+.+|++.+++++|+|++++++++.+++..++||||++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~   81 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD   81 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence            45678999999999999998888999999986432  2334678899999999999999999999999999999999995


Q ss_pred             CCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                       ++|.+++.... ..+.+..++.++.||++||+|||+.   +++|+||+|+||+++.++.++|+|||+++....... ..
T Consensus        82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~  156 (283)
T cd07835          82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY  156 (283)
T ss_pred             -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence             69999987644 3578999999999999999999998   999999999999999999999999999976532211 12


Q ss_pred             cccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhh-hhcccchh
Q 003555          669 TGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCF-IAKELSKL  739 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~-~~~~~~~~  739 (811)
                      ....++..|+|||.+.+. .++.++||||||+++|||++|+.||................       +... ........
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            223568899999987654 57899999999999999999999997543221111100000       0000 00000000


Q ss_pred             cC-----CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          740 VG-----EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..     ............+.+++.+|++.+|.+||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00     001112334467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.5e-33  Score=297.05  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=204.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.+.+.||+|++|.||+|.+...++.||+|++..... ..+.+.+|++.+++++|+|++++++.+...+..++|+||+++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            5566889999999999999987789999999875443 567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|.+++......+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ ....
T Consensus       100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  175 (286)
T cd06614         100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNS  175 (286)
T ss_pred             CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcc
Confidence            999999987554788999999999999999999998   999999999999999999999999999876543221 2223


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.|+..........   .     .......     ........
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~---~-----~~~~~~~-----~~~~~~~~  242 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF---L-----ITTKGIP-----PLKNPEKW  242 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH---H-----HHhcCCC-----CCcchhhC
Confidence            457889999999988889999999999999999999999986432221110   0     0000110     01111224


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...+.+++.+|++.+|.+||++.+++..
T Consensus       243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         243 SPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            5678999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.5e-33  Score=298.14  Aligned_cols=263  Identities=19%  Similarity=0.247  Sum_probs=200.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~  585 (811)
                      .+.+.+.||+|+||.||+|+...+++.+|+|.++...  ......+.+|+.++++++|+||+++++++...  ...++|+
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4666789999999999999998888999999986432  22234678899999999999999999998877  7899999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+++ +|.+++......+++.++..++.||+.||+|||+.   +++|+||||+||+++.++.+||+|||++....... 
T Consensus        86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  160 (293)
T cd07843          86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-  160 (293)
T ss_pred             hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence            99985 99999887666688999999999999999999998   99999999999999999999999999998764332 


Q ss_pred             ccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhh----
Q 003555          666 GIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIA----  733 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~----  733 (811)
                      .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+....       +.....    
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            122334578899999987654 46899999999999999999999997543221111000000       000000    


Q ss_pred             --cccchhcCC--ccccChH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          734 --KELSKLVGE--DEEVDLR-TLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 --~~~~~~~~~--~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                        .........  ....... ..+.+.+++..||+.+|++|||+.|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence              000000000  0011111 3667889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=326.69  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=214.2

Q ss_pred             hhHHHHHHhhhhhhcCcccceeEEEEEEcC-------CCEEEEEEEccCCch-hhHHHHHHHHHHHhcc-CCCCccceec
Q 003555          503 TGELERATNGFEEELGRGCFGAVYKGSICE-------GNKIVAVKRLENPVE-EGERKFQAEMAAVRRT-HHKNLVRLLG  573 (811)
Q Consensus       503 ~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~-------~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g  573 (811)
                      .-|+.+....+.+.||+|+||.|++|....       ....||||.++.... ...+.+..|+++|+.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            456666666777899999999999998641       145799999986544 4557799999999999 6999999999


Q ss_pred             EEecccceeEEEeecCCCCHHHHhhcCC---------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCC
Q 003555          574 FCMQTSKKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINP  638 (811)
Q Consensus       574 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~  638 (811)
                      +|.+.+..++|.||+..|+|.++|+..+               ..+.....+.++.|||.||+||++.   +++||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998776               3477889999999999999999999   999999999


Q ss_pred             CcEEECCCCCeEEEecCCccccCCCCCccccccc--cCCCccCccccccCCCCcccchHHHHHHHHHHHhCC-CCCCCCC
Q 003555          639 RNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK--GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR-SNFEVNV  715 (811)
Q Consensus       639 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~-~p~~~~~  715 (811)
                      +|||+.++..+||+|||+|+...+..........  -+..|||||.+....++.|+|||||||+||||+|.. .|+....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999976655554433333  355699999999999999999999999999999954 5554311


Q ss_pred             CccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          716 STADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       716 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ...+.       .+.+..+       .+.+.+..+..+++++++.||+.+|++||++.++++.++..
T Consensus       527 ~~~~l-------~~~l~~G-------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEEL-------LEFLKEG-------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHHH-------HHHHhcC-------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11111       1111111       23344556688999999999999999999999999999884

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-33  Score=300.70  Aligned_cols=267  Identities=20%  Similarity=0.228  Sum_probs=201.5

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEeccc----
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS----  579 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----  579 (811)
                      .....+.+.++||+|+||.||+|..+.+++.||||+++...  ......+.+|+.++++++|+|++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34456677889999999999999999888999999986432  233457788999999999999999999987655    


Q ss_pred             ------ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          580 ------KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       580 ------~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                            ..++|+||+++ +|..++......+++..+..++.||+.||+|||+.   +|+|+||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999986 78787776555688999999999999999999998   999999999999999999999999


Q ss_pred             cCCccccCCCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh
Q 003555          654 FSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI  732 (811)
Q Consensus       654 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~  732 (811)
                      ||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...... ..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~-~~  238 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS-PC  238 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CC
Confidence            99998765433222233456788999997754 45789999999999999999999999754322111111100000 00


Q ss_pred             hcccchh--------cCCc-------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          733 AKELSKL--------VGED-------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       733 ~~~~~~~--------~~~~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......+        .+..       .......+..+.+++..||+.+|.+||++++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000        0000       0001123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.2e-33  Score=296.45  Aligned_cols=259  Identities=20%  Similarity=0.261  Sum_probs=196.5

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccC-CCCccceecEEecc--cceeEEEee
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQT--SKKLLVYEF  587 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~ey  587 (811)
                      .+.++||+|+||.||+|....+++.||+|+++... ........+|+..+.++. |+|++++++++.+.  +..++|+||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            45678999999999999998888999999987542 223344567899999885 99999999999987  889999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++ ++|.+++......+++.++..++.||+.||+|||+.   +++|+||+|+||+++. +.+||+|||+++.......  
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~--  154 (282)
T cd07831          82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP--  154 (282)
T ss_pred             CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence            97 588888876556788999999999999999999998   9999999999999999 9999999999986543222  


Q ss_pred             ccccccCCCccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhcccchh
Q 003555          668 VTGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAKELSKL  739 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~~~  739 (811)
                      .....++..|+|||.+. +..++.++|||||||++|||++|..||......+.........       ............
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07831         155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY  234 (282)
T ss_pred             cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence            12345788999999654 4567899999999999999999999997543322111010000       000000000000


Q ss_pred             cCCc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          740 VGED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..+.      .......+..+.+++.+||+.+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000      0112245688999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.6e-33  Score=297.16  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=196.7

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEec------ccce
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQ------TSKK  581 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~  581 (811)
                      ..+.+.+.||+|+||.||+|.....++.+|+|.+... .....++..|+.+++++ +|+||+++++++..      ....
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            3455668999999999999999888899999998643 23446788999999998 79999999999863      3567


Q ss_pred             eEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          582 LLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      +++|||+++++|.+++.... ..+.+..+..++.||+.||.|||+.   +|+|+||+|+||++++++.++|+|||++...
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            99999999999999997643 3467778889999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      .... .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||............            
T Consensus       172 ~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~------------  238 (282)
T cd06636         172 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI------------  238 (282)
T ss_pred             hccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH------------
Confidence            3221 1123356889999999875     346788999999999999999999999643322111000            


Q ss_pred             cchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       736 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                       .... ............+.+++..||+.+|.+||++.|+++
T Consensus       239 -~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 -PRNP-PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -hhCC-CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             0000 000111234567999999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.7e-33  Score=294.57  Aligned_cols=246  Identities=19%  Similarity=0.278  Sum_probs=199.3

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCch---hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||+|+||.||+++...+++.+|+|.+.....   ...+.+.+|+.++++++|+||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988889999999865433   4556789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-------c
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-------G  666 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-------~  666 (811)
                      .+++.+.. .+++..+..++.||++||+|||+.   +++|+||+|+||++++++.+||+|||++........       .
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998644 678899999999999999999998   999999999999999999999999999876543211       1


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......++..|+|||.......+.++||||||++++|+++|+.||.......       .. .....+..    .  ...
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~-~~~~~~~~----~--~~~  222 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IF-QNILNGKI----E--WPE  222 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HH-HHHhcCCc----C--CCc
Confidence            2233567889999999888889999999999999999999999997543211       00 00000000    0  000


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .......+.+++.+|++.+|.+||++.++.+.|+
T Consensus       223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1113677899999999999999999977766664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=305.47  Aligned_cols=250  Identities=21%  Similarity=0.299  Sum_probs=209.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      .++...||.|+||.||||..++.+-..|-|++.....+..++|+-|+++|....||+||+|++.+.-.+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            45567899999999999999988778899999888888889999999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |-.+..+-.....+.+.++.-+++|++.||.|||++   +|||||||+.|||++-+|.++|+|||.+-.... .......
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDs  189 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDS  189 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhhcc
Confidence            999999998888899999999999999999999999   999999999999999999999999998864321 1122345


Q ss_pred             cccCCCccCcccc-----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          671 VKGTRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       671 ~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ..||+.|||||+.     +..+|+.++|||||||.|.||.-+.+|-....+.. . .+           ++.+--.+.+-
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-V-ll-----------KiaKSePPTLl  256 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-V-LL-----------KIAKSEPPTLL  256 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-H-HH-----------HHhhcCCCccc
Confidence            7899999999964     56689999999999999999999888754322111 0 00           01111111222


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .+......+.+++..||..||..||++.++++
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            35567788999999999999999999999874

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.9e-33  Score=302.09  Aligned_cols=265  Identities=20%  Similarity=0.292  Sum_probs=199.7

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhcc-CCCCccceecEEecc--ccee
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT--SKKL  582 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~  582 (811)
                      ...+.+.+.||+|+||.||+|....+++.+|||++...  .......+.+|+.+++++ +|+||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            34567789999999999999999888899999988542  233445678899999999 999999999998654  3679


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +||||++ ++|.+++...  .+.+..+..++.||+.||+|||+.   +|+|+||||+||+++.++.+||+|||+++....
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            9999997 4999988763  667888899999999999999998   999999999999999999999999999987643


Q ss_pred             CCC----ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHh
Q 003555          663 NQT----GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNC  730 (811)
Q Consensus       663 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~  730 (811)
                      ...    .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....       ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            322    12233568899999997654 567899999999999999999999996543322110000000       000


Q ss_pred             ---hhhcccchhcCCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          731 ---FIAKELSKLVGED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       731 ---~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                         .....+.......     ..........+.+++.+|++.+|.+|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               0000000000000     01112246678999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.4e-33  Score=291.80  Aligned_cols=241  Identities=20%  Similarity=0.231  Sum_probs=197.7

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||.|+||.||+++....++.||+|++....   ....+.+.+|+.++++++|+||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999998888999999986432   23456799999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++.+. ..+++..+..++.||+.||+|||+.   +++|+||+|+||+++.++.+||+|||+++......  ......+
T Consensus        81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~  154 (262)
T cd05572          81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG  154 (262)
T ss_pred             HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence            9999764 3477888999999999999999998   99999999999999999999999999998764332  1223467


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc--CCccccChHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV--GEDEEVDLRTL  751 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  751 (811)
                      +..|+|||.+....++.++|+||||+++|||++|..||........     ...         ....  ......+....
T Consensus       155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~---------~~~~~~~~~~~~~~~~~  220 (262)
T cd05572         155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----EIY---------NDILKGNGKLEFPNYID  220 (262)
T ss_pred             CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----HHH---------HHHhccCCCCCCCcccC
Confidence            8899999998888899999999999999999999999975432111     000         0111  11112233336


Q ss_pred             HHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 003555          752 ETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RPs-----~~evl~  777 (811)
                      ..+.+++.+||+.+|.+||+     ++|+++
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            78999999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5e-33  Score=296.08  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=192.9

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHH-HhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAA-VRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|+||.||+++...+++.||+|+++... .+...++..|+.. ++.++|+|++++++++..++..++||||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            455688999999999999999889999999987543 2344566667665 56679999999999999999999999999


Q ss_pred             CCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          589 SKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       589 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      + ++|.+++...   ...+++..+..++.||+.||+|||++  .+++||||||+||+++.++.+||+|||++....... 
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            7 5888887542   34578899999999999999999985  279999999999999999999999999998653221 


Q ss_pred             ccccccccCCCccCcccccc----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          666 GIVTGVKGTRGYMSPEWQNS----GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                       ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.||.........  +..    . ....      
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~----~-~~~~------  224 (283)
T cd06617         159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--LKQ----V-VEEP------  224 (283)
T ss_pred             -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH--HHH----H-HhcC------
Confidence             1223457889999998754    45688999999999999999999998643221111  000    0 0000      


Q ss_pred             Ccccc-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 EDEEV-DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                       .... ....++.+.+++..||+.+|.+||++++++.
T Consensus       225 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 -SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0011 1234567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.4e-33  Score=293.96  Aligned_cols=244  Identities=25%  Similarity=0.331  Sum_probs=196.0

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||+|+||+||++.....++.||+|.+....   ......+.+|++++++++|+|++++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999998888999999986432   23345678899999999999999999999999999999999999999


Q ss_pred             HHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccc
Q 003555          594 ENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK  672 (811)
Q Consensus       594 ~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  672 (811)
                      .+++.... ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++......  .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence            99997644 3578889999999999999999998   9999999999999999999999999998765432  1223345


Q ss_pred             cCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHH
Q 003555          673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLE  752 (811)
Q Consensus       673 gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  752 (811)
                      ++..|+|||.+.+..++.++||||||+++++|++|+.||...........+.    .        .........+.....
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~--------~~~~~~~~~~~~~~~  223 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK----R--------RTLEMAVEYPDKFSP  223 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH----h--------ccccccccCCccCCH
Confidence            7889999999888889999999999999999999999997543321111110    0        001111122333466


Q ss_pred             HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          753 TMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       753 ~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      .+.+++.+||+.+|.+||     ++.+++.
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            789999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-33  Score=306.03  Aligned_cols=260  Identities=23%  Similarity=0.296  Sum_probs=203.1

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC-C-----CCccceecEEecccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-H-----KNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l  583 (811)
                      +|.+.+.||+|.||.|-||.+..+++.||||++++. ..-..+-..|+.+|..|+ |     -|+|++++++...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            677789999999999999999999999999999753 344556778999999986 4     589999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC--CCCeEEEecCCcccc
Q 003555          584 VYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD--SLTAKISNFSLAKIL  660 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~--~~~~kL~DFGla~~~  660 (811)
                      |+|.+.. +|.++|+... .+++...+..|+.||+.||.+||+.   +|||+||||+||||.+  ...+||+|||.|...
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999866 9999998764 5578899999999999999999998   9999999999999964  347999999999864


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH-------H----
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY-------N----  729 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~-------~----  729 (811)
                      ...-.    ....++.|.|||++.+.+|+.+.|+|||||++.||++|.+.|.+..+.+....+.+...       .    
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            32221    44568899999999999999999999999999999999888876655443322111110       0    


Q ss_pred             ---hhhh-cc------cch----------------hcCC-----c-----cccChHHHHHHHHHHHHcccCCCCCCCCHH
Q 003555          730 ---CFIA-KE------LSK----------------LVGE-----D-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMK  773 (811)
Q Consensus       730 ---~~~~-~~------~~~----------------~~~~-----~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  773 (811)
                         .... ..      ...                ..+.     .     ..........+.+++.+||+.||..|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence               0000 00      000                0000     0     001123456789999999999999999999


Q ss_pred             HHHHH
Q 003555          774 NVILM  778 (811)
Q Consensus       774 evl~~  778 (811)
                      |.++.
T Consensus       498 qal~H  502 (586)
T KOG0667|consen  498 QALNH  502 (586)
T ss_pred             HHhcC
Confidence            99854

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=274.39  Aligned_cols=249  Identities=20%  Similarity=0.365  Sum_probs=200.1

Q ss_pred             hhhhcCcccceeEEEEEEcCCCEEEEEEEccC-CchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCC
Q 003555          513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLEN-PVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +...||.|..|+|++.+....+..+|||.... ...+..++++..+.++..- .+|+||+.+|+|..+...++.||.|.-
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~  175 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST  175 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence            45679999999999999999999999999865 4556667788888877665 489999999999999999999999855


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                       .++.+|.+....+.+...-++...+.+||.||.++  .+|+|||+||+|||+|+.|++||+|||++-.+....  ..+.
T Consensus       176 -C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk--Ahtr  250 (391)
T KOG0983|consen  176 -CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK--AHTR  250 (391)
T ss_pred             -HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccc--cccc
Confidence             67777776666666777778999999999999987  599999999999999999999999999998764332  2344


Q ss_pred             cccCCCccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          671 VKGTRGYMSPEWQNS---GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ..|-+.|||||.+..   ..|+.++|||||||.|+||.||+.||.....+-+..  ...     ...+     .+.+...
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l--tkv-----ln~e-----PP~L~~~  318 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL--TKV-----LNEE-----PPLLPGH  318 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH--HHH-----HhcC-----CCCCCcc
Confidence            568899999998754   468899999999999999999999998765443221  111     0011     1222223


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...+..+.+++..||++|+++||...++++.
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            3367788999999999999999999998753

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.4e-33  Score=295.40  Aligned_cols=262  Identities=20%  Similarity=0.295  Sum_probs=199.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.++||+|++|.||+|+...+++.||||+++.... .....+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            4556899999999999999998899999999875432 335677889999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcCC--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          590 KGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       590 ~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      + +|.+++....  ..+.+..+..++.||+.||.|||+.   +++|+||||+||++++++.+||+|||++....... ..
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~  156 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NT  156 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cc
Confidence            5 8988887543  4578899999999999999999998   99999999999999999999999999997653221 11


Q ss_pred             ccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhh-hcccch
Q 003555          668 VTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFI-AKELSK  738 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~-~~~~~~  738 (811)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....       +.... ......
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            223456889999998755 457899999999999999999999997654322111110000       00000 000000


Q ss_pred             hcCCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 LVGED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .....     ....+.....+.+++..|++.+|.+||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000     0111234567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9.9e-33  Score=293.29  Aligned_cols=243  Identities=21%  Similarity=0.252  Sum_probs=190.3

Q ss_pred             hcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHH---hccCCCCccceecEEecccceeEEEeecC
Q 003555          516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAV---RRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .||+|+||.||++.....++.+|+|.+....   ......+.+|..++   ...+|+|++.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999998888999999886432   12223344454433   33479999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|.+++... ..+.+.....++.|++.||.|||+.   +|+|+||||+||++++++.+||+|||++.......   ..
T Consensus        81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~  153 (279)
T cd05633          81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (279)
T ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence            99999998763 4578899999999999999999998   99999999999999999999999999987543222   12


Q ss_pred             ccccCCCccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ...|+..|+|||.+. +..++.++|||||||+++||++|+.||......... .+..    ..        .......+.
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~----~~--------~~~~~~~~~  220 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR----MT--------LTVNVELPD  220 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH----Hh--------hcCCcCCcc
Confidence            346899999999876 456899999999999999999999999754322111 1100    00        001112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRP-----SMKNVILM  778 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~  778 (811)
                      ....++.+++..||+.||.+||     +++|+++.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            4567889999999999999999     59999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=292.07  Aligned_cols=261  Identities=21%  Similarity=0.322  Sum_probs=198.9

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEeecC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.||+|+||+||+|+..+.++.||||++..... .......+|+..+++++ |+|++++++++.+++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            456889999999999999988889999999865432 23344567999999999 999999999999999999999999 


Q ss_pred             CCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      +++|.+++.... ..+.+.++..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|||++........  .
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  155 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y  155 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence            789999887654 4678999999999999999999998   999999999999999999999999999986543221  2


Q ss_pred             cccccCCCccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHH---------HHHHhhhhcccch
Q 003555          669 TGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST---------WVYNCFIAKELSK  738 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~---------~~~~~~~~~~~~~  738 (811)
                      ....++..|+|||.+. ...++.++|+||||++++||++|+.||......+.......         |............
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07830         156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF  235 (283)
T ss_pred             CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence            2345788999999764 45679999999999999999999999865433221110000         0000000001100


Q ss_pred             hcCCcc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          739 LVGEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       739 ~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+....     ...+.....+.+++.+|++.+|++||+++|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000     0011124678999999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-33  Score=295.00  Aligned_cols=260  Identities=19%  Similarity=0.273  Sum_probs=203.1

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.||+|++|.||+|....+++.+|+|++.....  .....+.+|+.++++++|+||+++++++..++..++|+||++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD   81 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence            345789999999999999988899999999865432  345678899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      + +|.+++......+++..+..++.||+.||.|||+.   +|+|+||||+||++++++.+||+|||.+....... ....
T Consensus        82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~  156 (283)
T cd05118          82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT  156 (283)
T ss_pred             C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence            6 89888877656788999999999999999999998   99999999999999999999999999998765443 1223


Q ss_pred             ccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC-------
Q 003555          670 GVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG-------  741 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-------  741 (811)
                      ...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+......... .............       
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL-GTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc-CCCchHhcccchhhhhhhhh
Confidence            34578899999988766 78999999999999999999999986543322111100000 0000000000000       


Q ss_pred             ----C----ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 ----E----DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ----~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                          .    ..........++.+++..||+.+|.+||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                0    01122345678999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.8e-33  Score=295.11  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=195.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|+||.||++.....++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            345578999999999999999888999999986432 344567899999999996 999999999999999999999998


Q ss_pred             CCCCHHHHh---hc-CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          589 SKGSLENLL---SN-VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       589 ~~gsL~~~l---~~-~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      .. +|.++.   .. ....+++.....++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            75 554433   22 234577889999999999999999974  289999999999999999999999999997654322


Q ss_pred             CccccccccCCCccCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSG---LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      .  .....|+..|+|||.+...   .++.++|||||||++|||++|+.||......     . ....... ......+  
T Consensus       163 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~~~~~~~-~~~~~~~--  231 (288)
T cd06616         163 A--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----F-DQLTQVV-KGDPPIL--  231 (288)
T ss_pred             c--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----H-HHHhhhc-CCCCCcC--
Confidence            1  1234578899999988766   6899999999999999999999999643210     0 0000000 0000000  


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                       ...........+.+++.+|++.+|.+||++++|++.
T Consensus       232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         232 -SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011123456789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.2e-33  Score=297.20  Aligned_cols=262  Identities=16%  Similarity=0.198  Sum_probs=188.3

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCC---CEEEEEEEccCCchhh--H---------HHHHHHHHHHhccCCCCccce
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEG---NKIVAVKRLENPVEEG--E---------RKFQAEMAAVRRTHHKNLVRL  571 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l  571 (811)
                      +....+.+.++||+|+||.||+|...++   ...+|+|+........  +         .....+...+..++|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3344577789999999999999998776   5667777643221111  1         122334455667799999999


Q ss_pred             ecEEeccc----ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC
Q 003555          572 LGFCMQTS----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL  647 (811)
Q Consensus       572 ~g~~~~~~----~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~  647 (811)
                      ++++....    ..++++|++.. ++.+.+... ....+..+..|+.|+++||+|||+.   +|+||||||+|||++.++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            99776543    34677777644 666666542 2345677889999999999999998   999999999999999999


Q ss_pred             CeEEEecCCccccCCCCCc------cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchh
Q 003555          648 TAKISNFSLAKILMPNQTG------IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV  721 (811)
Q Consensus       648 ~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~  721 (811)
                      .++|+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||+++||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999876432211      1123469999999999999999999999999999999999999997653322211


Q ss_pred             hHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhh
Q 003555          722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE  780 (811)
Q Consensus       722 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~  780 (811)
                      .....  . .    ..++..... ........+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~--~-~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKC--D-F----IKRLHEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHH--H-H----HHHhhhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            10000  0 0    011110100 11123567899999999999999999999998764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.4e-32  Score=287.89  Aligned_cols=249  Identities=27%  Similarity=0.365  Sum_probs=205.7

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEEee
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVYEF  587 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ey  587 (811)
                      ...+.||+|++|.||+|....+++.|++|++....  ....+.+.+|+..+++++|+||+++++.+.+.  ...++|+||
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~   82 (260)
T cd06606           3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY   82 (260)
T ss_pred             eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence            44578999999999999998888999999986543  24567899999999999999999999999988  889999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      +++++|.+++.... .+++..+..++.|++++|+|||+.   +++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          83 VSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence            99999999998754 788999999999999999999998   9999999999999999999999999999876544321 


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......++..|+|||.+.....+.++||||||+++++|++|+.||.......      ........       .......
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-------~~~~~~~  225 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKIGS-------SGEPPEI  225 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhccc-------cCCCcCC
Confidence            1234568889999999988889999999999999999999999997544111      00110000       0111122


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +......+.+++.+|++.+|.+||++.|+++
T Consensus       226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            3344678999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=288.05  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=204.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|++|.||+++....++.||+|.+.....  .....+.+|++++++++|+|++++++++.+++..++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            4556889999999999999988889999999876543  45568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ++++|.+++... ..+++..+..++.|++.+|.|||+.   +|+|+||+|+||+++.++.+||+|||++......... .
T Consensus        82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~  156 (254)
T cd06627          82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-D  156 (254)
T ss_pred             CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-c
Confidence            999999999764 5678999999999999999999998   9999999999999999999999999999876543321 2


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ....++..|+|||.......+.++|||++|+++++|++|+.|+.........       ... ..       ......+.
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-------~~~-~~-------~~~~~~~~  221 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-------FRI-VQ-------DDHPPLPE  221 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-------HHH-hc-------cCCCCCCC
Confidence            3356788999999988888899999999999999999999998743311100       000 00       11112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .....+.+++.+||+.+|++||++.|++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            44678889999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=289.41  Aligned_cols=244  Identities=21%  Similarity=0.281  Sum_probs=191.9

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHH-hccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAV-RRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      +.||+|+||.||+|.....++.||||.+....   ......+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999998888999999986432   22233445555444 455899999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|.+++... ..+++..+..++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||+++....     ...
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~  152 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK  152 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence            9999999763 3567888999999999999999998   999999999999999999999999999875432     123


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..++..|+|||.+.+..++.++||||||+++|||++|..||.......   ..     .......    ...........
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~-----~~~~~~~----~~~~~~~~~~~  220 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VF-----DNILSRR----INWPEEVKEFC  220 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HH-----HHHHhcc----cCCCCcccccC
Confidence            457889999999888888999999999999999999999996432211   00     0011110    00111112234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          751 LETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       751 ~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ...+.+++.+||+.+|++||++.++.+.|
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            67889999999999999999887666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.8e-33  Score=298.75  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=197.8

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeEEE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~  585 (811)
                      .+.+.+.||+|+||.||+|.....++.||+|+++...  ......+.+|+.++++++|+||+++++++.+.  +..++||
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM   87 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence            3556688999999999999998888999999986432  22234567899999999999999999998765  4689999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||+.+ +|.+++......+++.++..++.||++||+|||+.   +++|+||||+||++++++.+||+|||++....... 
T Consensus        88 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-  162 (309)
T cd07845          88 EYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-  162 (309)
T ss_pred             ecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence            99975 89999887666788999999999999999999999   99999999999999999999999999998764332 


Q ss_pred             ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhcccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAKELS  737 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~  737 (811)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................       +.........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            12223345788999998765 567899999999999999999999997543222111110000       0000000000


Q ss_pred             hhc--C-Ccc----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          738 KLV--G-EDE----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 ~~~--~-~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...  . ...    .........+.+++.+|++.||++|||++|++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000  0 000    0011235677899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-32  Score=296.96  Aligned_cols=263  Identities=20%  Similarity=0.256  Sum_probs=196.1

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEeccc--------
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS--------  579 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------  579 (811)
                      .+.+.++||+|+||.||+|+...+++.||||++....  ......+.+|+.++++++|+||+++++++...+        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            3666789999999999999998889999999885432  223445678999999999999999999987654        


Q ss_pred             ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ..++||||+.+ +|.+++......+++.++..++.||+.||+|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            34999999975 88888876555688999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCc---cccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcc
Q 003555          660 LMPNQTG---IVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE  735 (811)
Q Consensus       660 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~  735 (811)
                      .......   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.. .........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  247 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ-LCGSITPEV  247 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HhCCCChhh
Confidence            6432221   12234578899999987654 478899999999999999999999875433211111110 000000000


Q ss_pred             cc-----------hhcCCccc------cChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          736 LS-----------KLVGEDEE------VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       736 ~~-----------~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ..           ........      ........+.+++.+||+.||.+||+++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00           00000000      00112346779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.3e-32  Score=294.28  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=196.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      +...++||+|+||+||+|+...+++.||+|++....   ......+.+|+.++++++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            333467999999999999998889999999986432   23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +. ++|.+++......+.+.++..++.||+.+|.|||+.   +++|+||+|+||++++++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            96 588888876566678899999999999999999998   999999999999999999999999999864322     


Q ss_pred             ccccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcc
Q 003555          668 VTGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      .....|+..|+|||.+.   ...++.++||||||+++|||++|..|+.........       .... ....      ..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-------~~~~-~~~~------~~  239 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIA-QNDS------PT  239 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-------HHHH-hcCC------CC
Confidence            12346888999999874   456888999999999999999999998654221111       0000 0000      01


Q ss_pred             ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       745 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .........+.+++.+||+.+|.+||++.+++..
T Consensus       240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122334568899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-33  Score=299.35  Aligned_cols=263  Identities=18%  Similarity=0.233  Sum_probs=196.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcC--CCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICE--GNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~--~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  583 (811)
                      +.+.++||+|+||.||+|....  .++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            4566889999999999999987  78899999987633   34456788999999999999999999999988  78999


Q ss_pred             EEeecCCCCHHHHhhcCC----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC----CCCeEEEecC
Q 003555          584 VYEFMSKGSLENLLSNVE----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD----SLTAKISNFS  655 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~----~~~~kL~DFG  655 (811)
                      ||||+++ +|.+++....    ..+....+..++.||+.||.|||+.   +|+||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999986 6766664321    2467788899999999999999998   9999999999999999    9999999999


Q ss_pred             CccccCCCCC--ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccch------hhHHHH
Q 003555          656 LAKILMPNQT--GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV------VLLSTW  726 (811)
Q Consensus       656 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~------~~l~~~  726 (811)
                      +++.......  .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.........      ..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            9987543322  11223567889999997765 45789999999999999999999999755433200      000000


Q ss_pred             HHHhhh-----------hcccch---hcCCc----cc----cC--hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          727 VYNCFI-----------AKELSK---LVGED----EE----VD--LRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       727 ~~~~~~-----------~~~~~~---~~~~~----~~----~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ......           ......   .....    ..    ..  .....++.+++.+||+.||++|||+.|++.
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000           000000   00000    00    00  033457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-32  Score=295.07  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             HHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC---CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEE
Q 003555          508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       508 ~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ..++...+.||+|+||.||+|+...+++.+|+|.+..   .......++.+|+.+++.++|+|++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            3445566889999999999999988889999998863   2233456788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~  664 (811)
                      +||+. ++|.+++......+.+.++..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++...... 
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            99997 588888765555678889999999999999999998   9999999999999999999999999998765332 


Q ss_pred             CccccccccCCCccCccccc---cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          665 TGIVTGVKGTRGYMSPEWQN---SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                          ....++..|+|||.+.   ...++.++|||||||++|||++|+.||.........   ...     .....     
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~-----~~~~~-----  231 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHI-----AQNES-----  231 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH---HHH-----hhcCC-----
Confidence                2345788999999864   356788999999999999999999998643211110   000     00000     


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      . ..........+.+++.+||+.+|.+||++.+++...
T Consensus       232 ~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 P-ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             C-CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            0 011224556788999999999999999999999664

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-32  Score=287.55  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=203.7

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|+||.||+++...+++.+|+|++...  ......++.+|++++++++|+||+++.+++.+....++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            45568899999999999999888899999998643  2344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcC---CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          589 SKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       589 ~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ++++|.+++.+.   ...+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||+++.....  
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--  156 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--  156 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence            999999998653   24567888999999999999999998   9999999999999999999999999999876443  


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                       ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......    +..    ......       ...
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~----~~~~~~-------~~~  220 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----LRY----KVQRGK-------YPP  220 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHhcCC-------CCC
Confidence             2223457889999999998899999999999999999999999997543211    100    001111       112


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ........+.+++..|++.+|.+||++.|+++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            233566789999999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2e-32  Score=286.59  Aligned_cols=249  Identities=21%  Similarity=0.354  Sum_probs=205.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.+.||+|+||.||++....+++.||+|++....  .+....+.+|++++++++|+|++++.+.+.++...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            345678999999999999998888999999987543  255677999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCC---CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC
Q 003555          589 SKGSLENLLSNVE---SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       589 ~~gsL~~~l~~~~---~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ++++|.+++....   ..+++..+..++.+++.||.|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  157 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-  157 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence            9999999998753   6678999999999999999999998   99999999999999999999999999998754432 


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......|++.|+|||......++.++|+||+|+++++|++|+.||.......       ... .......       ..
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~-~~~~~~~-------~~  222 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LAL-KILKGQY-------PP  222 (258)
T ss_pred             ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHH-HHhcCCC-------CC
Confidence            12233568889999999888889999999999999999999999986443111       100 0111111       11


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+......+.+++.+||+.+|++||++.|+++.
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            122445678999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-32  Score=315.53  Aligned_cols=269  Identities=15%  Similarity=0.216  Sum_probs=190.3

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcCCCE-EEEEE------------------EccCCchhhHHHHHHHHHHHhccCC
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-IVAVK------------------RLENPVEEGERKFQAEMAAVRRTHH  565 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~-~vAvK------------------~l~~~~~~~~~~~~~E~~~l~~l~h  565 (811)
                      +.....|.+.++||+|+||+||++..+.... .+++|                  .+. ........+.+|+.++++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            3345668888999999999999987643322 12222                  111 122334568899999999999


Q ss_pred             CCccceecEEecccceeEEEeecCCCCHHHHhhcCC----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcE
Q 003555          566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNI  641 (811)
Q Consensus       566 ~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NI  641 (811)
                      +||+++++++.+.+..++|+|++.. +|.+++....    ......+...|+.||+.||.|||+.   +|+||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            9999999999999999999999854 7777765432    2234566778999999999999998   999999999999


Q ss_pred             EECCCCCeEEEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchh
Q 003555          642 LLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV  721 (811)
Q Consensus       642 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~  721 (811)
                      |++.++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||++|||++|..++..........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999998765443333344679999999999999999999999999999999999886543222111111


Q ss_pred             hHHHHHHHhhh-hc-------ccchhcCC-----cccc------ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          722 LLSTWVYNCFI-AK-------ELSKLVGE-----DEEV------DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       722 ~l~~~~~~~~~-~~-------~~~~~~~~-----~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+...+..... .+       .+.+.+..     ....      .......+.+++.+||+.||.+|||+.|++..
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11111110000 00       00000000     0000      01123456778999999999999999999864

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-32  Score=294.01  Aligned_cols=252  Identities=22%  Similarity=0.389  Sum_probs=195.7

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .+.+.++||+|+||.||+|.....++.||||+++... .....++..|+.++.+.. |+||+++++++.++...++||||
T Consensus        16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   95 (296)
T cd06618          16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL   95 (296)
T ss_pred             hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence            3566789999999999999998878999999986532 334456777887777764 99999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +++ +|.+++......+++..+..++.||++||+|||+.  .+|+||||+|+||++++++.+||+|||++........  
T Consensus        96 ~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~--  170 (296)
T cd06618          96 MST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--  170 (296)
T ss_pred             cCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc--
Confidence            864 78888776556778899999999999999999973  2899999999999999999999999999876533222  


Q ss_pred             ccccccCCCccCccccccCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          668 VTGVKGTRGYMSPEWQNSGL----ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.......+.  +.    .. ......     .
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~----~~-~~~~~~-----~  238 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV--LT----KI-LQEEPP-----S  238 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHH--HH----HH-hcCCCC-----C
Confidence            12235788999999886553    788999999999999999999999643211110  10    00 000000     0


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ........+++.+++.+||+.+|.+||++.++++.
T Consensus       239 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            01111345678999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-32  Score=293.91  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeec
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      +.+.++||+|++|+||+|....+++.||+|++....  ....+.+.+|++++++++|+||+++++++.++...++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            456688999999999999998888999999986432  233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCC-CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-CCCeEEEecCCccccCCCCCc
Q 003555          589 SKGSLENLLSNVES-GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       589 ~~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~~~~~~~~  666 (811)
                      + ++|.+++..... ...+.....++.||+.||+|||++   +++|+||+|+||+++. ++.+||+|||++....... .
T Consensus        84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~  158 (294)
T PLN00009         84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R  158 (294)
T ss_pred             c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence            6 478887765332 246777888999999999999998   9999999999999985 5679999999997643221 1


Q ss_pred             cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc---------
Q 003555          667 IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL---------  736 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---------  736 (811)
                      ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........... .....+         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSLPDY  237 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccchhh
Confidence            1233457889999998765 45789999999999999999999999754322211110000000 000000         


Q ss_pred             chh----cCCc-cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 SKL----VGED-EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 ~~~----~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...    .... ....+.....+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000    0000 0012234567899999999999999999999986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=286.82  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=198.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-----chhhHHHHHHHHHHHhccCCCCccceecEEecc--cceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-----VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l  583 (811)
                      +.+.+.||+|+||.||+|.+...++.||+|.+...     ..+..+.+.+|+.++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            55678999999999999999888899999987422     233456789999999999999999999998764  45789


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |+||+++++|.+++... ..+.+....+++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||+++.....
T Consensus        84 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          84 FVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            99999999999998763 3467888899999999999999998   9999999999999999999999999999865321


Q ss_pred             CC--ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          664 QT--GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       664 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..  .......++..|+|||.+.+...+.++|+|||||+++||++|+.||.........       ....       ...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~-------~~~  225 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI-------FKIA-------TQP  225 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH-------HHHH-------cCC
Confidence            11  1122356889999999998888999999999999999999999999643211110       0000       001


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .....+....+.+.+++.+|++ +|..||+..+++.
T Consensus       226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1122344566789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.3e-32  Score=299.44  Aligned_cols=261  Identities=21%  Similarity=0.227  Sum_probs=197.5

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecc------cc
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SK  580 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~  580 (811)
                      ..+...+.||+|+||.||+|....+++.||||++...  .......+.+|+.++++++|+||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4456678899999999999999988999999998643  233445678899999999999999999988643      35


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .++||||+.+ +|.+.+...   ++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             EEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            6999999965 888887643   67788889999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHH--------H------
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST--------W------  726 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~--------~------  726 (811)
                      ....  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..        +      
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            3322  12334578899999999999999999999999999999999999975432111000000        0      


Q ss_pred             -HHHhhhhc------ccchhcCCc------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          727 -VYNCFIAK------ELSKLVGED------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       727 -~~~~~~~~------~~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                       ........      ...++....      ..........+.+++.+||+.||++||++.|++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00000000      000000000      00012345678899999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-32  Score=292.68  Aligned_cols=255  Identities=19%  Similarity=0.214  Sum_probs=200.7

Q ss_pred             hhhhhhcCcccceeEEEEEEc---CCCEEEEEEEccCCc----hhhHHHHHHHHHHHhcc-CCCCccceecEEeccccee
Q 003555          511 NGFEEELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV----EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  582 (811)
                      +.+.+.||+|++|.||+++..   ..++.||||.++...    ....+.+.+|+.++.++ +|+||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            345688999999999999864   345789999986432    23345688999999999 6999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +||||+++++|.+++... ..+.+.....++.|++++|.|||+.   +++|+||+|+||+++.++.++|+|||+++....
T Consensus        82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            999999999999998753 4567888889999999999999998   999999999999999999999999999987654


Q ss_pred             CCCccccccccCCCccCccccccCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGL--ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ..........|+..|+|||.+.+..  .+.++||||||+++|||++|..||..........   .....         ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~~---------~~  225 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS---EISRR---------IL  225 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH---HHHHH---------HH
Confidence            4333233456889999999887655  7889999999999999999999986432211111   11100         11


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ......+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         226 KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11111223345678899999999999999999988887755

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.7e-32  Score=292.37  Aligned_cols=261  Identities=18%  Similarity=0.207  Sum_probs=194.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccC-CCCccceecEEecccc-----ee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSK-----KL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~-----~~  582 (811)
                      +.+.+.||+|+||.||+|....+++.||||+++...  ......+.+|+.++++++ |+||+++++++...+.     .+
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            455678999999999999998889999999876432  223467889999999995 6999999999987665     79


Q ss_pred             EEEeecCCCCHHHHhhcCC----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-CCCeEEEecCCc
Q 003555          583 LVYEFMSKGSLENLLSNVE----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLA  657 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla  657 (811)
                      +||||+++ +|.+++....    ..+++..+..++.||++||.|||+.   +|+||||+|+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999986 8988886532    3468899999999999999999998   9999999999999998 899999999999


Q ss_pred             cccCCCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc
Q 003555          658 KILMPNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       658 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      +...... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||...........+..... .......
T Consensus       159 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (295)
T cd07837         159 RAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TPTEQVW  236 (295)
T ss_pred             eecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CCChhhC
Confidence            8653221 11222356788999998754 4578999999999999999999999975432211110000000 0000000


Q ss_pred             ------chh--cCC-c----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 ------SKL--VGE-D----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 ------~~~--~~~-~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                            ...  ... .    ....+....++.+++..||+.+|.+||+++|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                  000  000 0    0011234567899999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.8e-32  Score=293.26  Aligned_cols=257  Identities=22%  Similarity=0.248  Sum_probs=191.5

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      .+.+|.|+++.||+  ...+++.||||++...  ..+..+.+.+|+.++++++|+||+++++++.+.+..+++|||++++
T Consensus         7 ~~~~~~~~~v~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           7 GKCFEDLMIVHLAK--HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hHhhcCCceEEEEE--ecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34455555544444  4457889999998654  3455678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-----
Q 003555          592 SLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-----  665 (811)
Q Consensus       592 sL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-----  665 (811)
                      +|.+++... ...+.+.....++.||++||+|||++   +|+|+||||+||+++.++.+||+|||.+........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999999864 34567888889999999999999999   999999999999999999999999998875532211     


Q ss_pred             -ccccccccCCCccCcccccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhh----h------
Q 003555          666 -GIVTGVKGTRGYMSPEWQNS--GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF----I------  732 (811)
Q Consensus       666 -~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~----~------  732 (811)
                       .......++..|+|||.+..  ..++.++|||||||++|||++|+.||.........  + .......    .      
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--L-EKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHHhccCccccccCchhh
Confidence             11223457788999998865  35789999999999999999999999754322111  0 0000000    0      


Q ss_pred             -hcccch----hcC------CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          733 -AKELSK----LVG------EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       733 -~~~~~~----~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                       ...+..    ..+      ............+.+++.+||+.+|++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             000000    000      0011233445678899999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=299.32  Aligned_cols=259  Identities=20%  Similarity=0.280  Sum_probs=196.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l  583 (811)
                      .+.+.++||+|+||.||+|+...+++.||||+++.. .......+.+|+.++++++|+||+++++++....     ..++
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   85 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI   85 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence            456678999999999999999888899999998643 2334567889999999999999999999876543     5799


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      |+||+++ +|..++..  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          86 VQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             Eehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            9999975 88887754  3577888999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCc--cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhh---hcccc
Q 003555          664 QTG--IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI---AKELS  737 (811)
Q Consensus       664 ~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~---~~~~~  737 (811)
                      ...  ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........    ........   .+...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~----~~~~~~~~~~~~~~~~  235 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL----NLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHcCCCCHHHHH
Confidence            221  1223568899999997654 56899999999999999999999999643221110    00000000   00000


Q ss_pred             hh-----------cCCcc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          738 KL-----------VGEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 ~~-----------~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .+           .....     ...+.....+.+++.+||+.+|.+||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00           00000     0112335678999999999999999999999976

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.8e-32  Score=287.93  Aligned_cols=242  Identities=22%  Similarity=0.260  Sum_probs=190.0

Q ss_pred             hcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHH---HHhccCCCCccceecEEecccceeEEEeecC
Q 003555          516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMA---AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .||+|+||.||++.....++.||+|.+....   ......+..|..   .++...|+||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999998888999999886432   122233444433   4445689999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +++|..++.. ...+.+..+..++.|+++||.|||+.   +|+|+||||+||+++.++.+||+|||++.......   ..
T Consensus        81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~  153 (278)
T cd05606          81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH  153 (278)
T ss_pred             CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence            9999999875 34578999999999999999999998   99999999999999999999999999987653222   12


Q ss_pred             ccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ...|+..|+|||.+.++ .++.++||||||+++|||++|+.||......... ..    ...        ........+.
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~----~~~--------~~~~~~~~~~  220 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI----DRM--------TLTMAVELPD  220 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HH----HHH--------hhccCCCCCC
Confidence            34689999999988654 6899999999999999999999999754322111 00    000        0001112222


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      ..+..+.+++.+|++.+|.+||     ++.++++
T Consensus       221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            3467899999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-32  Score=291.96  Aligned_cols=247  Identities=22%  Similarity=0.314  Sum_probs=203.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      |.+.+.||+|+||.||+|+...+++.||+|++...   .....+.+.+|+.++++++ |+||+++++++.+++..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            45668899999999999999888899999998642   2344567889999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC-
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-  665 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~-  665 (811)
                      |+++++|.+++.+. ..+.+..+..|+.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          83 YAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            99999999999864 3688999999999999999999998   999999999999999999999999999986543321 


Q ss_pred             ------------------ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH
Q 003555          666 ------------------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV  727 (811)
Q Consensus       666 ------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~  727 (811)
                                        .......++..|+|||......++.++||||||++++|+++|+.||.......   .+    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----  231 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TF----  231 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HH----
Confidence                              11223457889999999888889999999999999999999999997543111   00    


Q ss_pred             HHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 003555          728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSM----KNVIL  777 (811)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~  777 (811)
                               ..........+....+.+.+++.+||+.+|.+||++    +++++
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 ---------QKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---------HHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                     001111122233446778999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-32  Score=298.30  Aligned_cols=263  Identities=19%  Similarity=0.286  Sum_probs=198.4

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc-----cee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKL  582 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~  582 (811)
                      .|.+.+.||+|+||+||+|+...+++.||||++...  .......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            355667899999999999999888999999998643  2334567788999999999999999999886543     479


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|+||+. ++|.+++... ..+.+.....++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||+++....
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          86 IVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            9999996 6899888763 4578899999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH-------Hhhhhc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY-------NCFIAK  734 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~~  734 (811)
                      .. .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.................       ......
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         161 KG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             Cc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            22 12233457889999998764 4689999999999999999999999965422111100000000       000000


Q ss_pred             ccchhc---CCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          735 ELSKLV---GED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 ~~~~~~---~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .....+   ...     ....+.....+.+++.+||+.+|++||+++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000   000     01122346778999999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-33  Score=298.24  Aligned_cols=247  Identities=19%  Similarity=0.260  Sum_probs=208.1

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh--hHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .+.+.++||+|.|++|..|++...+..||||.+.+....  ....+.+|+++|..++|||||+++.+...+...++||||
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey  136 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY  136 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence            355678999999999999999999999999999765332  234589999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      +.+|.++++|.+... ........++.|+.+|++|||++   .|+|||||++||||+.+.++||+|||++..+...  ..
T Consensus       137 a~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~~  210 (596)
T KOG0586|consen  137 ASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--LM  210 (596)
T ss_pred             ccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc--cc
Confidence            999999999987543 44477788999999999999999   9999999999999999999999999999987533  34


Q ss_pred             ccccccCCCccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          668 VTGVKGTRGYMSPEWQNSGLI-TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ....+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||+...-..                -..+.+.....+
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----------------Lr~rvl~gk~rI  274 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----------------LRPRVLRGKYRI  274 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----------------ccchheeeeecc
Confidence            566889999999999888765 579999999999999999999998542111                011122223344


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +.....++.++++++|-.+|.+|++++++.+.
T Consensus       275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            55667788999999999999999999999754

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=289.44  Aligned_cols=261  Identities=23%  Similarity=0.286  Sum_probs=201.2

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+.+.||+|++|.||+|+....++.||+|.+....  ....+.+..|+.++++++|+|++++++++.+.+..++|+||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            34578999999999999999888999999987543  3345678899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                       ++|.+++......+++..+.+++.|++.||+|||+.   +|+|+||+|+||++++++.+||+|||+++....... ...
T Consensus        82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (282)
T cd07829          82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT  156 (282)
T ss_pred             -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence             599999987655688999999999999999999998   999999999999999999999999999986543221 222


Q ss_pred             ccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhh-----hccc
Q 003555          670 GVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFI-----AKEL  736 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~-----~~~~  736 (811)
                      ...++..|+|||.+.+. .++.++||||||++++||++|+.||...........+....       +....     ....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            34457789999988766 88999999999999999999999986543221111110000       00000     0000


Q ss_pred             chhcCCcc-ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 SKLVGEDE-EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 ~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ........ ...+.....+.+++..||+.+|++||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000 111123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-32  Score=288.37  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=195.8

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhcc---CCCCccceecEEecccc-----e
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRT---HHKNLVRLLGFCMQTSK-----K  581 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~  581 (811)
                      .+.+.||+|+||.||+|+.+.+++.||+|++.....  .....+.+|+.+++++   +|+|++++++++...+.     .
T Consensus         2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   81 (287)
T cd07838           2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL   81 (287)
T ss_pred             eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence            456789999999999999988889999999864322  2234566787777665   69999999999988776     8


Q ss_pred             eEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          582 LLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      +++|||+.+ +|.+++.... ..+++..+..++.||++||.|||+.   +++|+||+|+||+++.++.+||+|||++...
T Consensus        82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            999999975 8999887643 3578999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc----
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL----  736 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~----  736 (811)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+..   .............    
T Consensus       158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL---DKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH---HHHHHHcCCCChHhcCC
Confidence            33221  22345788999999999889999999999999999999999998754332211   1111100000000    


Q ss_pred             -----chhcCCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          737 -----SKLVGED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       737 -----~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                           .......     ....+.....+.+++.+||+.||.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 0000000     1112234577889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.4e-32  Score=294.73  Aligned_cols=257  Identities=23%  Similarity=0.295  Sum_probs=193.5

Q ss_pred             hhcCcc--cceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          515 EELGRG--CFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G--~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      ++||+|  +||+||++++...++.||||++...  ..+..+.+.+|+.+++.++|+||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            567777  9999999999888999999998643  233456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc--
Q 003555          591 GSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI--  667 (811)
Q Consensus       591 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~--  667 (811)
                      ++|.+++.+.. ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+|++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 3477888889999999999999998   99999999999999999999999998654332211100  


Q ss_pred             ----ccccccCCCccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHh-hhh-------
Q 003555          668 ----VTGVKGTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNC-FIA-------  733 (811)
Q Consensus       668 ----~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~-~~~-------  733 (811)
                          .....++..|+|||.+.+.  .++.++|||||||++|||++|+.||..........   ...... ...       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL---QKLKGPPYSPLDITTFP  237 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH---HHhcCCCCCCccccccc
Confidence                0112345679999998664  47899999999999999999999997543221110   000000 000       


Q ss_pred             -------------------cccc-----hhcCC--ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          734 -------------------KELS-----KLVGE--DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 -------------------~~~~-----~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                                         ....     .....  ...........+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                               0000     00000  01112345678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.9e-32  Score=285.40  Aligned_cols=240  Identities=18%  Similarity=0.219  Sum_probs=188.1

Q ss_pred             hhhhh--cCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeec
Q 003555          512 GFEEE--LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       512 ~~~~~--LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .+.+.  ||+|+||.||++..+.+++.+|+|.+.......   .  |+.....+ +|+|++++++.+...+..++||||+
T Consensus        17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~   91 (267)
T PHA03390         17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI   91 (267)
T ss_pred             ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence            34444  599999999999998889999999986432111   1  22222212 7999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-CeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-~~kL~DFGla~~~~~~~~~~  667 (811)
                      ++++|.+++.... .+.+.++..++.||++||.|||+.   +++|+||||+||+++.++ .++|+|||+++.....    
T Consensus        92 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----  163 (267)
T PHA03390         92 KDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----  163 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----
Confidence            9999999997643 678999999999999999999998   999999999999999888 9999999998765322    


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......  .....+..          .........
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~----------~~~~~~~~~  230 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLK----------RQQKKLPFI  230 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHH----------hhcccCCcc
Confidence             12358899999999988889999999999999999999999997432221  11111111          011111222


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPS-MKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~  777 (811)
                      ......+.+++..||+.+|.+||+ ++|+++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            245678899999999999999996 688874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.1e-32  Score=297.43  Aligned_cols=265  Identities=19%  Similarity=0.289  Sum_probs=199.7

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEec----cccee
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ----TSKKL  582 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~  582 (811)
                      ..+.+.+.||+|+||.||+|+....++.||+|++....  ......+.+|+.++++++|+||+++.+++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            34556688999999999999999889999999987532  2345678889999999999999999998763    34679


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|+||+. ++|.+++... ..+++.....++.||+.||.|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999996 5899998753 4478899999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc---cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH-------HHHhh
Q 003555          663 NQTG---IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-------VYNCF  731 (811)
Q Consensus       663 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~-------~~~~~  731 (811)
                      ....   ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+...       .....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            2221   1234568899999998755 46889999999999999999999999654322111000000       00000


Q ss_pred             hhcccch---hcCCccc-----cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          732 IAKELSK---LVGEDEE-----VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       732 ~~~~~~~---~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .......   .......     ........+.+++..||+.+|++||++++++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000000   0111111     112346789999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.7e-32  Score=289.18  Aligned_cols=251  Identities=19%  Similarity=0.230  Sum_probs=196.0

Q ss_pred             hhhhhhcCcccceeEEEEEEc---CCCEEEEEEEccCCc----hhhHHHHHHHHHHHhcc-CCCCccceecEEeccccee
Q 003555          511 NGFEEELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV----EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~---~~~~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  582 (811)
                      +.+.+.||+|+||.||++...   .+++.||+|++....    ....+.+.+|+.+++++ +|+||+++++.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            345688999999999999874   356889999986432    22346788999999999 6999999999999988999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|+||+++++|.+++... ..+.+.....++.||++||.|||+.   +++||||+|+|||+++++.+||+|||+++....
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          82 LILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            999999999999999763 4566788888999999999999998   999999999999999999999999999987644


Q ss_pred             CCCccccccccCCCccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ..........|+..|+|||.+...  .++.++||||||+++|||++|+.||..........   .....         ..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~~~~~---------~~  225 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA---EISRR---------IL  225 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH---HHHHH---------hh
Confidence            333333345688999999987653  46789999999999999999999986432221111   11110         11


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~  777 (811)
                      ......+......+.+++.+|++.+|.+||     ++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         226 KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            111112333456788999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-32  Score=298.22  Aligned_cols=263  Identities=20%  Similarity=0.306  Sum_probs=203.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l  583 (811)
                      +.+.+.||+|+||.||+|+....++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            456789999999999999998888999999987543  445578999999999999999999999998775     7899


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ||||+++ +|.+++.... .+++..+..++.||+.||+|||+.   +|+|+||||+|||++.++.++|+|||++......
T Consensus        82 v~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          82 VTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             Eecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9999985 8999887643 678899999999999999999998   9999999999999999999999999999876543


Q ss_pred             CC--ccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH-------Hhhhh
Q 003555          664 QT--GIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY-------NCFIA  733 (811)
Q Consensus       664 ~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~  733 (811)
                      ..  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+.....       .....
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence            21  123345678899999998877 889999999999999999999999975543211100000000       00000


Q ss_pred             cccchhcC---Ccc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          734 KELSKLVG---EDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       734 ~~~~~~~~---~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......+.   ...     .........+.+++.+||+.+|.+||+++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000000   000     1112245678999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.9e-32  Score=296.77  Aligned_cols=260  Identities=18%  Similarity=0.209  Sum_probs=195.8

Q ss_pred             hhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhh--------------HHHHHHHHHHHhccCCCCccceecEEecc
Q 003555          513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG--------------ERKFQAEMAAVRRTHHKNLVRLLGFCMQT  578 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~  578 (811)
                      +.+.||+|+||+||+|.....++.||||+++......              ...+.+|++++++++|+||+++++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4567999999999999998888999999886432211              12578999999999999999999999999


Q ss_pred             cceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       579 ~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      +..++||||++ ++|.+++.. ...+++.....++.||+.||+|||+.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcccee
Confidence            99999999997 599999875 34577889999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCC-------------CccccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHH
Q 003555          659 ILMPNQ-------------TGIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS  724 (811)
Q Consensus       659 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~  724 (811)
                      ......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~  247 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF  247 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            654111             1112234568889999988654 46899999999999999999999997553322111110


Q ss_pred             HHHHHhhhhcccchh---------cC---Cc-cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          725 TWVYNCFIAKELSKL---------VG---ED-EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       725 ~~~~~~~~~~~~~~~---------~~---~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..... .....+...         ..   .. ..........+.+++..||+.+|++||+++|++..
T Consensus       248 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        248 ELLGT-PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHhCC-CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            00000 000000000         00   00 01112335678899999999999999999999964

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1e-33  Score=325.19  Aligned_cols=247  Identities=25%  Similarity=0.329  Sum_probs=202.2

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      ..+||.|.||.||-|...++++..|||-+.-  ......+...+|+.++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            3579999999999999999999999997753  23445567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC---ccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT---GIV  668 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~---~~~  668 (811)
                      +|.+.+...+ ..++.....+..|++.|++|||++   +||||||||.||+|+.+|.+|++|||.|..+.+...   ...
T Consensus      1320 sLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred             cHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence            9999998632 233444455778999999999999   999999999999999999999999999998765431   234


Q ss_pred             cccccCCCccCccccccC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          669 TGVKGTRGYMSPEWQNSG---LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ....||+-|||||++.+.   ....+.||||+|||++||+||++||...+.+-        +.-      +.--.+..++
T Consensus      1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--------aIM------y~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--------AIM------YHVAAGHKPQ 1461 (1509)
T ss_pred             HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--------HHH------hHHhccCCCC
Confidence            567899999999988654   35678999999999999999999997543221        110      1112233455


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ++...+.+-.+++..||+.||++|-++.|++..
T Consensus      1462 ~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            666678888999999999999999888877653

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=5.9e-32  Score=296.05  Aligned_cols=262  Identities=18%  Similarity=0.265  Sum_probs=195.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEeccc------cee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------KKL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~  582 (811)
                      +.+.+.||+|+||.||+|+....++.||||++....  ......+.+|+.++++++|+||+++++++....      ..+
T Consensus        17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~   96 (342)
T cd07879          17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY   96 (342)
T ss_pred             eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence            444578999999999999998888999999986432  223456889999999999999999999987543      468


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|+||+.. +|..++.   ..+.+..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        97 lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          97 LVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             EEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            99999975 7777653   3467888999999999999999998   999999999999999999999999999976432


Q ss_pred             CCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH----------Hhh
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY----------NCF  731 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~----------~~~  731 (811)
                      .    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........   .....          ...
T Consensus       170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         170 E----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             C----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHHHHh
Confidence            1    223457889999998765 46889999999999999999999999754221111   00000          000


Q ss_pred             hhcccchhcCC-----cc---ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hhcccCCC
Q 003555          732 IAKELSKLVGE-----DE---EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM--LEGTMEIP  786 (811)
Q Consensus       732 ~~~~~~~~~~~-----~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~  786 (811)
                      ...........     ..   ...+.....+.+++.+||+.||.+||+++|++..  ++...+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            00000000000     00   0011234568899999999999999999999954  66654443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=6.5e-32  Score=291.58  Aligned_cols=263  Identities=22%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--hhHHHHHHHHHHHhccCCCCccceecEEeccc--------
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS--------  579 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--------  579 (811)
                      .+.+.++||+|+||.||+|+...+++.||||++.....  .....+.+|++++++++|+||+++++++.+..        
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            45667889999999999999988889999998854322  22346788999999999999999999876543        


Q ss_pred             ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ..++|+||+.. +|...+......+++.++..++.||++||.|||+.   +|+|+||||+||++++++.+||+|||+++.
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence            46999999875 78887776566788999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCCCc----------cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH
Q 003555          660 LMPNQTG----------IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY  728 (811)
Q Consensus       660 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~  728 (811)
                      .......          ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... .
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~-~  243 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL-C  243 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-h
Confidence            5432211          1123456888999997754 45889999999999999999999999754332111110000 0


Q ss_pred             Hhhhhcc------cch----hcCCcc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          729 NCFIAKE------LSK----LVGEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       729 ~~~~~~~------~~~----~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .......      ...    ......     .........+.+++.+||+.+|.+|||+.|++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0000000      000    000000     001122367889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=6.9e-32  Score=283.59  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=196.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC-----chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-----VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      |.+.++||+|+||.||++.....+..+++|.++..     ......++..|+.++++++||||+++++++.+.+..++|+
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            56678999999999999998766666666665431     2233456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHhhc---CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          586 EFMSKGSLENLLSN---VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       586 ey~~~gsL~~~l~~---~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++ +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998864   234578899999999999999999998   9999999999999976 5699999999987543


Q ss_pred             CCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      ... ......|+..|+|||.+....++.++|+||||+++|+|++|+.||......    ..   ... ..       ...
T Consensus       158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~----~~---~~~-~~-------~~~  221 (260)
T cd08222         158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL----SV---VLR-IV-------EGP  221 (260)
T ss_pred             Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HH---HHH-HH-------cCC
Confidence            322 223355788999999988888899999999999999999999998642211    00   000 00       011


Q ss_pred             ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       743 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ....+......+.+++.+|++.+|++||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11223455678899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.4e-33  Score=286.50  Aligned_cols=241  Identities=24%  Similarity=0.324  Sum_probs=202.9

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      .+.||+|+||.||-++...+++.+|.|++.+.   ..+++.-.++|-.+|.+++.+.||.+--.+...+.++||+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            46899999999999999999999999998643   345566788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          591 GSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       591 gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      |+|.-+|.+.. ..+++....-.+.+|+-||++||..   .||+||+||+|||||+.|+++|+|.|+|..+.....  ..
T Consensus       270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~~  344 (591)
T KOG0986|consen  270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--IR  344 (591)
T ss_pred             CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--cc
Confidence            99999998765 4567777778999999999999999   999999999999999999999999999998765543  34


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch-hcCCccccCh
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK-LVGEDEEVDL  748 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~  748 (811)
                      ..+||.+|||||++.++.|+...|.|||||+||||+-|+.||....+.....             ++.+ .+....+.+.
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-------------Evdrr~~~~~~ey~~  411 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-------------EVDRRTLEDPEEYSD  411 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-------------HHHHHHhcchhhccc
Confidence            4589999999999999999999999999999999999999997543322111             1111 1222234456


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      ..++++..|....|+.||.+|.--
T Consensus       412 kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  412 KFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             ccCHHHHHHHHHHHccCHHHhccC
Confidence            677888899999999999998543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.4e-31  Score=279.37  Aligned_cols=237  Identities=24%  Similarity=0.249  Sum_probs=195.8

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCch---hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      ||+|+||.||++.....++.+|+|.+.....   .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999988889999999865432   2456789999999999999999999999999999999999999999


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG  673 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g  673 (811)
                      .+++.... .+++.....++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  155 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG  155 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence            99998643 578899999999999999999998   99999999999999999999999999998754332 12234567


Q ss_pred             CCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       674 t~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      +..|+|||...+...+.++|+||||+++||+++|+.||......    ....            .+.......+......
T Consensus       156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~------------~~~~~~~~~~~~~~~~  219 (250)
T cd05123         156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYE------------KILKDPLRFPEFLSPE  219 (250)
T ss_pred             CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHH------------HHhcCCCCCCCCCCHH
Confidence            88999999998888899999999999999999999999644221    0000            0111122223334677


Q ss_pred             HHHHHHHcccCCCCCCCCHHH
Q 003555          754 MVRVGLLCIQDEPNLRPSMKN  774 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs~~e  774 (811)
                      +.+++.+||+.||++||++.+
T Consensus       220 l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         220 ARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHhcCCHhhCCCccc
Confidence            899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=297.67  Aligned_cols=199  Identities=29%  Similarity=0.456  Sum_probs=174.6

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEeccc------ceeEEEe
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------KKLLVYE  586 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lV~e  586 (811)
                      .+.||+|+||.||+|+++..|+.||||.+... .....+...+|+++|++++|+|||+++++-.+..      ...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            47899999999999999999999999998753 3444567789999999999999999998866543      5689999


Q ss_pred             ecCCCCHHHHhhcCC--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC----CCCCeEEEecCCcccc
Q 003555          587 FMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD----DSLTAKISNFSLAKIL  660 (811)
Q Consensus       587 y~~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~----~~~~~kL~DFGla~~~  660 (811)
                      ||.+|+|+..|.+.+  .++++.+.+.+..+++.||.|||++   +|+||||||.||++-    ..-..||+|||.|+.+
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999998764  4588999999999999999999999   999999999999983    3446899999999987


Q ss_pred             CCCCCccccccccCCCccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST  717 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~  717 (811)
                      ..+.  ......||..|++||... .+.++...|.|||||++||..||..||......
T Consensus       175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            5544  567789999999999988 589999999999999999999999999765443

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=8.5e-32  Score=294.81  Aligned_cols=262  Identities=20%  Similarity=0.258  Sum_probs=195.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecc-----------
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT-----------  578 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----------  578 (811)
                      ++.+.+.||+|+||.||+|.....++.||+|++........+.+.+|++++++++|+||+++++++...           
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            456678999999999999999988999999998765556677899999999999999999999876543           


Q ss_pred             ---cceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-CCCCeEEEec
Q 003555          579 ---SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNF  654 (811)
Q Consensus       579 ---~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-~~~~~kL~DF  654 (811)
                         ...++|+||++ ++|.+++..  ..+.+.....++.||++||.|||+.   +|+||||||+||+++ +++.+||+||
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCc
Confidence               34689999997 489888864  3567889999999999999999998   999999999999997 5668999999


Q ss_pred             CCccccCCCCCc--cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH-----
Q 003555          655 SLAKILMPNQTG--IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-----  726 (811)
Q Consensus       655 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~-----  726 (811)
                      |+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||..............-     
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999865332211  1123457889999997644 56888999999999999999999999754322111100000     


Q ss_pred             --HHHhh---hhcccc----hhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          727 --VYNCF---IAKELS----KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       727 --~~~~~---~~~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                        .....   ......    ..........+....++.+++.+||+.||.+||+++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence              00000   000000    0000000111234467889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=268.69  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=202.0

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGS  592 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~gs  592 (811)
                      .+.||+|+++.|--++...++..+|||++.+.......+..+|++++.+. .|+||+.|++++.++...|||||-|.+|+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            37899999999999999888999999999988777788999999999998 59999999999999999999999999999


Q ss_pred             HHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC---CeEEEecCCccccCC------C
Q 003555          593 LENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL---TAKISNFSLAKILMP------N  663 (811)
Q Consensus       593 L~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~---~~kL~DFGla~~~~~------~  663 (811)
                      |..++.+ +..+++.+.-++..+|+.||.|||.+   +|.|||+||+|||-.+..   -+||+||.+..-..-      .
T Consensus       163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            9999987 44577888899999999999999999   999999999999996443   589999988754321      1


Q ss_pred             CCccccccccCCCccCcccc-----ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccch
Q 003555          664 QTGIVTGVKGTRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ........+|+..|||||+.     ....|+.+.|.|||||+||-|++|.+||......+-.... ...-+.....-...
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr-Ge~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR-GEVCRVCQNKLFES  317 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC-CCccHHHHHHHHHH
Confidence            22334457899999999954     2336889999999999999999999999765433211000 00000011111112


Q ss_pred             hcCCccccCh----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          739 LVGEDEEVDL----RTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +-+...+++.    ..+.+..+++...+-.++.+|.++.+++.
T Consensus       318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            2222222222    34567788999999999999999999886

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=4.4e-32  Score=310.67  Aligned_cols=246  Identities=24%  Similarity=0.378  Sum_probs=185.5

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhccCCCCccceecEEec----------------
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ----------------  577 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------------  577 (811)
                      +.||+||||.|||++.+-+++.+|||++... .......+.+|+..+++|+|||||+++....+                
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            5799999999999999999999999999754 34445678999999999999999988653210                


Q ss_pred             -------------------------------------------------c------------------------------
Q 003555          578 -------------------------------------------------T------------------------------  578 (811)
Q Consensus       578 -------------------------------------------------~------------------------------  578 (811)
                                                                       +                              
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                             0                              


Q ss_pred             ------------------------cceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeec
Q 003555          579 ------------------------SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC  634 (811)
Q Consensus       579 ------------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~  634 (811)
                                              ..+||-||||+...|.+++.+..-.......++++++|+.||+|+|++   +||||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHR  721 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHR  721 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceeec
Confidence                                    113677899998778877775432224567789999999999999999   99999


Q ss_pred             CCCCCcEEECCCCCeEEEecCCccccC----------------C-CCCccccccccCCCccCccccccC---CCCcccch
Q 003555          635 NINPRNILLDDSLTAKISNFSLAKILM----------------P-NQTGIVTGVKGTRGYMSPEWQNSG---LITVKSDV  694 (811)
Q Consensus       635 Dik~~NIll~~~~~~kL~DFGla~~~~----------------~-~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV  694 (811)
                      ||||.||+||++..+||+|||+|....                . ......+...||.-|+|||++.+.   +|+.|+|+
T Consensus       722 DLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm  801 (1351)
T KOG1035|consen  722 DLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM  801 (1351)
T ss_pred             cCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh
Confidence            999999999999999999999998721                0 111234567899999999988655   49999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHH
Q 003555          695 YSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKN  774 (811)
Q Consensus       695 ~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e  774 (811)
                      ||+||||+||+.   ||....+...  .+     ..+..+.+    .............-.+++.++++.||.+|||+.|
T Consensus       802 YSLGIVlFEM~y---PF~TsMERa~--iL-----~~LR~g~i----P~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  802 YSLGIVLFEMLY---PFGTSMERAS--IL-----TNLRKGSI----PEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             HHHHHHHHHHhc---cCCchHHHHH--HH-----HhcccCCC----CCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            999999999984   5654322211  11     11111111    1111223344455678999999999999999999


Q ss_pred             HHH
Q 003555          775 VIL  777 (811)
Q Consensus       775 vl~  777 (811)
                      ++.
T Consensus       868 LL~  870 (1351)
T KOG1035|consen  868 LLN  870 (1351)
T ss_pred             Hhh
Confidence            984

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-31  Score=283.10  Aligned_cols=251  Identities=21%  Similarity=0.318  Sum_probs=198.6

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeE
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l  583 (811)
                      ....|.+.++||+||-+.||++...+ .+.+|+|++..  ...+...-|.+|+..|.+| .|.+|++|++|-..++..|+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34556778999999999999998865 56788887643  3445567799999999999 59999999999999999999


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~  663 (811)
                      ||||=+ .+|..+|.+....+....+..+..|++.++.++|++   +|||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus       438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            999854 499999988655544337778899999999999999   9999999999999854 69999999999988776


Q ss_pred             CCcc-ccccccCCCccCccccccC-----------CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhh
Q 003555          664 QTGI-VTGVKGTRGYMSPEWQNSG-----------LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF  731 (811)
Q Consensus       664 ~~~~-~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~  731 (811)
                      .... ....+||..||+||.+...           ++++++||||+||+||+|+.|+.||.....        .|     
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~-----  579 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QI-----  579 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HH-----
Confidence            6544 3457899999999976322           367899999999999999999999963211        11     


Q ss_pred             hhcccchhcCCccc--c-ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          732 IAKELSKLVGEDEE--V-DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       732 ~~~~~~~~~~~~~~--~-~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                        .++..+.++..+  + ......+++++++.||+.||.+||++.|+++.
T Consensus       580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              123444444321  1 11112239999999999999999999999864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-33  Score=271.90  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=194.7

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGS  592 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~gs  592 (811)
                      ..||.|+||+|+|-.++..++..|||+++.... ..+++++.|.+...+- +.||||+++|.+..++..++.||.|.- |
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence            679999999999999999999999999976543 6677888898876665 799999999999999999999999965 7


Q ss_pred             HHHHhhc----CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          593 LENLLSN----VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       593 L~~~l~~----~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      |+.+-+.    ....+.+.-.-.|.....+||.||.+.  .+|+|||+||+|||||..|.+||+|||++-.+...  ...
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S--iAk  224 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS--IAK  224 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--HHh
Confidence            7665432    134566667778888999999999987  59999999999999999999999999998765322  122


Q ss_pred             cccccCCCccCccccccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCcccc
Q 003555          669 TGVKGTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      +.-.|-..|||||.+...  .++.++||||||+.|+|+.||+.|+......-+.+      .. ...+....+...  ..
T Consensus       225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql------~~-Vv~gdpp~l~~~--~~  295 (361)
T KOG1006|consen  225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL------CQ-VVIGDPPILLFD--KE  295 (361)
T ss_pred             hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH------HH-HHcCCCCeecCc--cc
Confidence            334578899999987543  48999999999999999999999997543211111      11 111111111111  11


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..+....|++++..|+.+|..+||...++.++
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            34567889999999999999999999998753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.1e-31  Score=291.84  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=195.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecccc------ee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK------KL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~  582 (811)
                      |.+.+.||+|++|.||+|+...+++.||||++...  .....+.+.+|+.++++++|+|++++.+++...+.      .+
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY   96 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence            45568899999999999999988899999998643  22344667889999999999999999998876554      89


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|+||+ +++|.+++..  ..+++..+..++.||++||.|||+.   +|+|+||||+||++++++.+||+|||++.....
T Consensus        97 lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          97 LVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             EEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            999998 5699999875  4578899999999999999999998   999999999999999999999999999986533


Q ss_pred             CCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAK  734 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~  734 (811)
                      .    .....++..|+|||.+.+ ..++.++||||||+++||+++|+.||...........+....       .......
T Consensus       171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            2    233457889999998755 367899999999999999999999997543221111000000       0000000


Q ss_pred             ccchhcC---Ccc-----ccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          735 ELSKLVG---EDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 ~~~~~~~---~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      .....+.   ...     .........+.+++.+||+.+|.+|||+.||++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0000000   000     0011235689999999999999999999999753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=3.7e-31  Score=288.65  Aligned_cols=262  Identities=20%  Similarity=0.263  Sum_probs=192.5

Q ss_pred             hhhhhhcCcccceeEEEEEEcCC--CEEEEEEEccCCc--hhhHHHHHHHHHHHhcc-CCCCccceecEEecc----cce
Q 003555          511 NGFEEELGRGCFGAVYKGSICEG--NKIVAVKRLENPV--EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT----SKK  581 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~  581 (811)
                      +.+.+.||+|+||.||++.....  +..||+|++....  ....+.+.+|+.+++++ +|+||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            45568899999999999999877  7899999986432  22356788999999999 599999999876432    356


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.   +|+||||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          82 YLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             EEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            78888886 589999875 34578899999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc---cccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH-------HHHh
Q 003555          662 PNQTG---IVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-------VYNC  730 (811)
Q Consensus       662 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~-------~~~~  730 (811)
                      .....   ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............       ....
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32211   1233568999999997655 56899999999999999999999998754321100000000       0000


Q ss_pred             hhhcc---cchhcCCc-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          731 FIAKE---LSKLVGED-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       731 ~~~~~---~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .....   ........     ....+.....+.+++.+|++.+|.+||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000   00000000     0111123467889999999999999999999873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-32  Score=270.29  Aligned_cols=239  Identities=23%  Similarity=0.249  Sum_probs=197.8

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ..|.+.||+|.||.|-+++-+..++.+|+|++++..   ......-..|-++|+..+||.+..+--.+...++.+.||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            457799999999999999999999999999998653   23344567789999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      ..+|.|.-+|.+ ....++....-....|..||.|||++   +||.||||.+|.|||.+|.+||+|||+.+.--.. ...
T Consensus       250 anGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t  324 (516)
T KOG0690|consen  250 ANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT  324 (516)
T ss_pred             ccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence            999999999986 33455555555778999999999999   9999999999999999999999999999863322 234


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      +...+||+.|+|||++....|....|.|.+||+||||++|+.||.....+.    +.            .-++-.....+
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----LF------------eLIl~ed~kFP  388 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----LF------------ELILMEDLKFP  388 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----HH------------HHHHhhhccCC
Confidence            567899999999999999999999999999999999999999998543221    10            11122233445


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCC
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRP  770 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RP  770 (811)
                      .....+...|+.-.|.+||.+|.
T Consensus       389 r~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  389 RTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCCHHHHHHHHHHhhcChHhhc
Confidence            56667788888899999999994

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=269.77  Aligned_cols=257  Identities=22%  Similarity=0.315  Sum_probs=206.1

Q ss_pred             HHHHhhhhhhcCcccceeEEEEEEcCCC-----EEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecc-c
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGN-----KIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQT-S  579 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~fg~Vy~g~~~~~~-----~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~  579 (811)
                      .+.+.+....+-+|.||.||.|.+.+.+     +.|-+|.++....+ ....+..|--.+..+.|||++++.+++.+. .
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~  361 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA  361 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence            3444444567899999999999886543     34777877654433 345688999999999999999999999865 4


Q ss_pred             ceeEEEeecCCCCHHHHhhcC-----C--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEE
Q 003555          580 KKLLVYEFMSKGSLENLLSNV-----E--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKIS  652 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~-----~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~  652 (811)
                      ..+++|.++.-|+|..||...     .  ......+...++.|++.||+|||.+   +|||.||.++|.++|+..++||+
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence            679999999999999999832     2  2244667788999999999999999   99999999999999999999999


Q ss_pred             ecCCccccCCCCCccccc-cccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHh
Q 003555          653 NFSLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNC  730 (811)
Q Consensus       653 DFGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~  730 (811)
                      |=.+++.+.+.+.+.... -..+..||+||.+.+..++..+|||||||+||||+| |+.|+...++.+-        ..+
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--------~~y  510 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--------EHY  510 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--------HHH
Confidence            999999988877655443 335678999999999999999999999999999998 6677754332221        111


Q ss_pred             hhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          731 FIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       731 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      +..+       .+...+.++++++..++.-||...|++||+++|++.-|.+
T Consensus       511 lkdG-------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  511 LKDG-------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             Hhcc-------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            1111       2344577889999999999999999999999999988865

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.5e-31  Score=288.48  Aligned_cols=258  Identities=20%  Similarity=0.252  Sum_probs=194.2

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEeccc------ce
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------KK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~  581 (811)
                      +|.+.+.||+|+||.||+|....+++.||||++...  .......+.+|+.++++++|+||+++++++....      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF   95 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence            355568899999999999999888899999998543  2233456889999999999999999999987553      45


Q ss_pred             eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                      ++||||+ +++|.+++..  ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        96 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          96 YLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            8999998 6799988864  3577889999999999999999998   99999999999999999999999999998653


Q ss_pred             CCCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH-------HHHhhhh
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-------VYNCFIA  733 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~-------~~~~~~~  733 (811)
                      ..    .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...............       .......
T Consensus       170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         170 SE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             cC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence            22    223457889999998765 45889999999999999999999999754321111000000       0000000


Q ss_pred             cccchhcCC---c-----cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          734 KELSKLVGE---D-----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 ~~~~~~~~~---~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .........   .     ..........+.+++.+|++.||.+|||+.+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000   0     0111233456889999999999999999999983

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=305.45  Aligned_cols=256  Identities=21%  Similarity=0.211  Sum_probs=209.0

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEeccccee
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      +....+.+.+.||+|+||.|..++++.+++++|+|++.+.   .......|..|-.+|..-+.+=|+.+.-.|.+...+|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            3456677789999999999999999999999999999763   1233456888888998889999999999999999999


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      +|||||+||+|-.+|.+.. .+++....-++..|+-||.-||+.   ++|||||||+|||||..|++||+|||.+-.+..
T Consensus       152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            9999999999999999877 677777777888999999999998   999999999999999999999999999998887


Q ss_pred             CCCccccccccCCCccCccccc----c-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQN----S-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS  737 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  737 (811)
                      +........+|||.|++||++.    + +.|.+.+|.||+||++|||+.|..||+...-.+....+       ...++..
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI-------m~hk~~l  300 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI-------MNHKESL  300 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH-------hchhhhc
Confidence            7776677789999999999874    2 57899999999999999999999999864322211111       1111111


Q ss_pred             hhcCCccccChHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 003555          738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS---MKNVILM  778 (811)
Q Consensus       738 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~  778 (811)
                      .+.     .....++...+||...+. +|+.|..   ++++-..
T Consensus       301 ~FP-----~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  301 SFP-----DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             CCC-----cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            111     123467788888888775 7788877   7777643

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=7.4e-31  Score=285.47  Aligned_cols=258  Identities=20%  Similarity=0.297  Sum_probs=194.1

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEec-ccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ-TSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~ey  587 (811)
                      |.+.+.||+|+||.||++.....++.||||++...  .....+.+.+|+.++++++||||+++.+++.. ....++|+||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            45568999999999999999888999999987542  23345678899999999999999999998865 5578999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      + +++|.+++..  ..+.+.....++.||++||+|||+.   +|+|+||+|+||++++++.+||+|||++......    
T Consensus        92 ~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~----  161 (328)
T cd07856          92 L-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----  161 (328)
T ss_pred             h-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence            8 4589988864  2456677788999999999999998   9999999999999999999999999998754221    


Q ss_pred             ccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------HHhhhhcccchh
Q 003555          668 VTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFIAKELSKL  739 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~~~~~~~~  739 (811)
                      .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....       ..........+.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            123457889999998765 568999999999999999999999996543211111110000       000000000000


Q ss_pred             ---cCCccc-----cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          740 ---VGEDEE-----VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       740 ---~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                         ......     ..+.....+.+++.+|++.+|++||++++++..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               000000     112235788999999999999999999999765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=6.5e-31  Score=288.12  Aligned_cols=258  Identities=19%  Similarity=0.272  Sum_probs=192.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEecc------ccee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SKKL  582 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~  582 (811)
                      +.+.+.||+|+||.||+|....+++.||+|++....  ....+.+.+|+.++++++|+||+++++++...      ...+
T Consensus        19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   98 (345)
T cd07877          19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   98 (345)
T ss_pred             eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence            334578999999999999998888999999987532  23356788999999999999999999988643      2467


Q ss_pred             EEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      ++++++ +++|.+++..  ..+++..+..++.||++||+|||+.   +|+||||||+||++++++.+||+|||+++....
T Consensus        99 lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          99 LVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             EEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            788776 7799888864  3478889999999999999999998   999999999999999999999999999876432


Q ss_pred             CCCccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH-------HHHhhhhc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-------VYNCFIAK  734 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~-------~~~~~~~~  734 (811)
                      .    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...       ........
T Consensus       173 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         173 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            1    233467889999998765 56889999999999999999999999643322111000000       00000000


Q ss_pred             ---ccchhcCCcccc-----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          735 ---ELSKLVGEDEEV-----DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 ---~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                         .....+......     .......+.+++.+|++.+|.+||++.+++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence               000000000000     01234578899999999999999999998855

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=8.2e-32  Score=266.43  Aligned_cols=277  Identities=19%  Similarity=0.240  Sum_probs=198.2

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCC----EEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEec-ccceeE
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGN----KIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ-TSKKLL  583 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~----~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l  583 (811)
                      |+...+||+|.||.||||.-++++    +.+|||+++...  ........+|+.+++.++|+|++.|..++.. +...+|
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            555678999999999999765543    379999997432  2334567899999999999999999999987 678899


Q ss_pred             EEeecCCCCHHHHhhcCC----CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC----CCeEEEecC
Q 003555          584 VYEFMSKGSLENLLSNVE----SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS----LTAKISNFS  655 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~----~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~----~~~kL~DFG  655 (811)
                      ++||.+. +|.+.++-++    ..+....+..|+.||+.|+.|||++   -|+||||||.||||..+    |.+||+|||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999988 8888886443    3355677788999999999999999   99999999999999866    999999999


Q ss_pred             CccccCCCCCc--cccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccch-----hhHHHHH
Q 003555          656 LAKILMPNQTG--IVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV-----VLLSTWV  727 (811)
Q Consensus       656 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~-----~~l~~~~  727 (811)
                      +++.+...-..  .....+-|.-|.|||.+.+. .||.+.|||+.||++.||++-.+.|.........     ......+
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            99987644332  23346678999999987665 6999999999999999999998888654221110     1111111


Q ss_pred             HHhhh---hcccch----------hcCCc-ccc-C----------hHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          728 YNCFI---AKELSK----------LVGED-EEV-D----------LRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       728 ~~~~~---~~~~~~----------~~~~~-~~~-~----------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .+.+-   .+.+..          +-+-+ ... +          ........+|...+|+.||.+|.|+++.++..- -
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y-F  340 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY-F  340 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc-c
Confidence            11110   000000          00000 000 0          001123678999999999999999999886542 3


Q ss_pred             cCCCCCCCCC
Q 003555          783 MEIPVVPFPI  792 (811)
Q Consensus       783 ~~~~~~~~p~  792 (811)
                      .+-+.||.|.
T Consensus       341 ~~d~lpp~pt  350 (438)
T KOG0666|consen  341 TEDPLPPLPT  350 (438)
T ss_pred             ccCCCCCCcc
Confidence            3334444443

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=263.71  Aligned_cols=242  Identities=21%  Similarity=0.260  Sum_probs=197.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecc----cceeEEEeecC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT----SKKLLVYEFMS  589 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~~lV~ey~~  589 (811)
                      ++||-|-.|.|-.+..+.+++..|+|+|...     ...++|+++.-.. .|+|||.+++++.+.    ..+++|||.|+
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me  142 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME  142 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence            6899999999999999999999999998643     3456788876665 799999999998753    35689999999


Q ss_pred             CCCHHHHhhcCCC-CCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC---CCCCeEEEecCCccccCCCCC
Q 003555          590 KGSLENLLSNVES-GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       590 ~gsL~~~l~~~~~-~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~---~~~~~kL~DFGla~~~~~~~~  665 (811)
                      ||.|+..+.+.+. ..++++...|+.||+.|+.|||+.   +|.||||||+|+|..   .|-.+||+|||+|+.-.  ..
T Consensus       143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~--~~  217 (400)
T KOG0604|consen  143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ--EP  217 (400)
T ss_pred             chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC--CC
Confidence            9999999987654 478999999999999999999999   999999999999996   45679999999999643  23


Q ss_pred             ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ......+.|+.|.|||++...+++...|+||+||++|-|++|-+||.......    +.        .+...++.....+
T Consensus       218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----is--------pgMk~rI~~gqy~  285 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----IS--------PGMKRRIRTGQYE  285 (400)
T ss_pred             ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CC--------hhHHhHhhccCcc
Confidence            44567789999999999999999999999999999999999999998654311    10        0111111112212


Q ss_pred             c----ChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 V----DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~----~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      +    -...++...++++.+|..+|++|.|+.|++..
T Consensus       286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            2    23456788999999999999999999998754

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6e-32  Score=283.16  Aligned_cols=244  Identities=23%  Similarity=0.318  Sum_probs=198.5

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      .|.||+|.||+||-|+++..++.||||++.+  .....+..+++|+.+|++++||.||.+--.|...+..++|||-+.+-
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            4789999999999999999999999999864  34566788999999999999999999999999999999999999775


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC---CCeEEEecCCccccCCCCCccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~---~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      =|+-.|.....++++....-++.||+.||.|||.+   +|+|+||||+||||...   -.+||+|||.|+.......  .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--R  723 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--R  723 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--h
Confidence            55555665566777777777889999999999999   99999999999999643   4799999999998754433  3


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccCh
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL  748 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  748 (811)
                      ....||+.|+|||++.++.|...-|+||.||++|--++|..||....+..+.+.-..            -+..  ...-.
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------FMyP--p~PW~  789 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------FMYP--PNPWS  789 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------cccC--CCchh
Confidence            457899999999999999999999999999999999999999975433222211100            0111  11122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          749 RTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       749 ~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                      +.....+++|...||..-++|-+..+-+
T Consensus       790 eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  790 EISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            4556788899999999999998887654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=274.89  Aligned_cols=261  Identities=23%  Similarity=0.275  Sum_probs=207.0

Q ss_pred             cChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--Cchhh-----HHHHHHHHHHHhccCCCCccceec
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEG-----ERKFQAEMAAVRRTHHKNLVRLLG  573 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~-----~~~~~~E~~~l~~l~h~niv~l~g  573 (811)
                      |.-.-+...+|-+.+.||+|||+.||||.+...++.||||+-.-  ...+.     .+...+|..+.+.|.|+.||++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            55555667778888999999999999999988889999998642  21111     235678999999999999999999


Q ss_pred             EEec-ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC---CCCCe
Q 003555          574 FCMQ-TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTA  649 (811)
Q Consensus       574 ~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~---~~~~~  649 (811)
                      ++.- .+..+-|+|||++.+|+-||+. ...+++++...|+.||+.||.||.+. +++|+|-||||.||||-   .-|.+
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccccee
Confidence            9864 5578999999999999999987 44678899999999999999999986 78999999999999994   56899


Q ss_pred             EEEecCCccccCCCCCc------cccccccCCCccCccccc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 003555          650 KISNFSLAKILMPNQTG------IVTGVKGTRGYMSPEWQN----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD  719 (811)
Q Consensus       650 kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~  719 (811)
                      ||.|||+++.+..+...      ......||..|++||.+.    ..+++.|.||||.||++|..+.|++||.......+
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd  692 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD  692 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence            99999999998765443      234467999999999653    44689999999999999999999999986644433


Q ss_pred             hhhHHHHHHHhhhhcccchhcCCc---cccChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGED---EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                      .+..             ..++...   ....+....+...+|++||+..-++|....++.
T Consensus       693 ILqe-------------NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  693 ILQE-------------NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHhh-------------hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            2211             1111111   122345566788999999999999997766654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=273.12  Aligned_cols=245  Identities=20%  Similarity=0.250  Sum_probs=201.8

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch---hhHHHHHHHHHHHhcc-CCCCccceecEEecccc
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  580 (811)
                      -+.....+|...||+|+||.|-+|..+.+.+.+|||++++...   .+.+--+.|-++|... +-|.++++..++..-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4555667899999999999999999999999999999987532   2333445666677666 56889999999999999


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      +|.||||+.+|+|--++.+. ....++...-++.+||-||-|||++   +|++||||.+||+||.+|.+||+|||+.+.-
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999999999888763 3455677778899999999999999   9999999999999999999999999999863


Q ss_pred             CCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhc
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      .-+. ......+||+.|+|||++...+|....|.|||||+||||+.|++||+...+++-                ...+.
T Consensus       501 i~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el----------------F~aI~  563 (683)
T KOG0696|consen  501 IFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL----------------FQAIM  563 (683)
T ss_pred             ccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------HHHHH
Confidence            3222 234568899999999999999999999999999999999999999987654321                12233


Q ss_pred             CCccccChHHHHHHHHHHHHcccCCCCCCC
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRP  770 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  770 (811)
                      +..-..+...+.+...+....|.++|.+|.
T Consensus       564 ehnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            333445667788889999999999999983

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.3e-30  Score=270.07  Aligned_cols=221  Identities=20%  Similarity=0.202  Sum_probs=179.6

Q ss_pred             ccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHHHHhhc
Q 003555          520 GCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN  599 (811)
Q Consensus       520 G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~  599 (811)
                      |.+|.||++++..+++.||+|++....     .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999986532     234455556666799999999999999999999999999999999876


Q ss_pred             CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccccCCCccC
Q 003555          600 VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS  679 (811)
Q Consensus       600 ~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~a  679 (811)
                      . ..+++.....++.|+++||.|||+.   +|+||||||+||+++.++.++|+|||.+......    .....++..|+|
T Consensus        79 ~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a  150 (237)
T cd05576          79 F-LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA  150 (237)
T ss_pred             h-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence            4 3478899999999999999999998   9999999999999999999999999988655332    122345678999


Q ss_pred             ccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHH
Q 003555          680 PEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGL  759 (811)
Q Consensus       680 PE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  759 (811)
                      ||.+....++.++||||+|+++|||++|+.|+.........              .      .....+......+.+++.
T Consensus       151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~--------------~------~~~~~~~~~~~~~~~li~  210 (237)
T cd05576         151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT--------------H------TTLNIPEWVSEEARSLLQ  210 (237)
T ss_pred             CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc--------------c------cccCCcccCCHHHHHHHH
Confidence            99998888999999999999999999999887532111000              0      001122234567889999


Q ss_pred             HcccCCCCCCCCHH
Q 003555          760 LCIQDEPNLRPSMK  773 (811)
Q Consensus       760 ~cl~~dP~~RPs~~  773 (811)
                      +|++.||.+||++.
T Consensus       211 ~~l~~dp~~R~~~~  224 (237)
T cd05576         211 QLLQFNPTERLGAG  224 (237)
T ss_pred             HHccCCHHHhcCCC
Confidence            99999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.1e-32  Score=260.47  Aligned_cols=264  Identities=19%  Similarity=0.253  Sum_probs=201.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecc--------c
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--------S  579 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~  579 (811)
                      ++.-..+||+|.||.||+|+..++++.||+|++-.  ..+.-.....+|+.+|..++|+|++.++++|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            34444689999999999999999999999997532  1222235678999999999999999999999743        2


Q ss_pred             ceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ..+||+++|+. +|.-+|.+...+++...+.+++.++..||.|+|..   .|+|||+||.|+|++.++.+||+|||+++.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            47999999988 99999998778889999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC---ccccccccCCCccCcccccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH-------H
Q 003555          660 LMPNQT---GIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------Y  728 (811)
Q Consensus       660 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~-------~  728 (811)
                      +.....   ...+..+-|..|.+||.+.+ ..++++.|||.-||++.||+++.+.+....+......+....       |
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            654332   22445667899999997654 579999999999999999999999888765444333222211       1


Q ss_pred             Hhhhhcccchhc------CCccccChHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          729 NCFIAKELSKLV------GEDEEVDLRT------LETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       729 ~~~~~~~~~~~~------~~~~~~~~~~------~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      +....-.+.+.+      ......-.+.      ..+..+|+..++..||.+|+.+.+++.
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            111111111111      0000001111      236788999999999999999998874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=287.22  Aligned_cols=238  Identities=21%  Similarity=0.276  Sum_probs=194.6

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeec
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .+.+...+|.|+|+.|-.+.+...++..+||++.+.    ..+-.+|+.++... +|+||+++.+.+.++.+.++|||.+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            456677899999999999999999999999999755    22334566555544 8999999999999999999999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE-CCCCCeEEEecCCccccCCCCCcc
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL-DDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll-~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      .++-|.+.+......  ..++..|+.+|+.|+.|||++   +||||||||+|||+ ++.++++|+|||.++...+.    
T Consensus       399 ~g~ell~ri~~~~~~--~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEF--CSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             cccHHHHHHHhcchh--HHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            999887777653322  267778999999999999999   99999999999999 59999999999999976544    


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ....+-|..|.|||++....+++++|+||||++||+|++|+.||.......+   +             ...+. .....
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i-------------~~~i~-~~~~s  532 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---I-------------HTRIQ-MPKFS  532 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---H-------------HHhhc-CCccc
Confidence            2334678899999999999999999999999999999999999975433311   1             01111 11223


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...++...+|+.+||+.||.+||+|.++..
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            567788999999999999999999999874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=238.77  Aligned_cols=259  Identities=22%  Similarity=0.279  Sum_probs=195.9

Q ss_pred             hhhhcCcccceeEEEEEEcCCCEEEEEEEccC--CchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      -.|+||+|.||+||||+..+..+.||+|+++-  ..+.......+|+-+++.++|+|||++++....+...-||+|||..
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq   85 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence            34789999999999999999999999998863  2333456789999999999999999999999999999999999976


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                       +|..+.......++......++.|+.+||.|+|++   ++.|||+||.|.|++.+|..||+|||+++.+.-.-. ..+.
T Consensus        86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-cysa  160 (292)
T KOG0662|consen   86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CYSA  160 (292)
T ss_pred             -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-eeec
Confidence             89999888778888888889999999999999999   999999999999999999999999999997643221 2233


Q ss_pred             cccCCCccCccccccC-CCCcccchHHHHHHHHHHHhC-CCCCCCCCCccchhhHHHHHHHhhhhccc---chhcCCc--
Q 003555          671 VKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCC-RSNFEVNVSTADVVLLSTWVYNCFIAKEL---SKLVGED--  743 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~~--  743 (811)
                      ..-|.-|.+|+++.+. .|+...|+||-||++.|+-.- ++.|...... +.....-+......++.+   .++.|-.  
T Consensus       161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            4568899999987665 589999999999999999874 4445443333 222222222222222221   1111111  


Q ss_pred             ---------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          744 ---------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       744 ---------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                               .+.-+.....=.++....+.-+|..|.++++.++
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                     0111222223456667777789999999887764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=5e-30  Score=265.33  Aligned_cols=239  Identities=24%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             cceeEEEEEEcCCCEEEEEEEccCCchhh-HHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHHHHhhc
Q 003555          521 CFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN  599 (811)
Q Consensus       521 ~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~  599 (811)
                      +||.||+|+...+++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998878999999997655444 68899999999999999999999999999999999999999999999976


Q ss_pred             CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccccCCCccC
Q 003555          600 VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS  679 (811)
Q Consensus       600 ~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~a  679 (811)
                      ... +++..+..++.++++++.|||+.   +++|+||+|+||++++++.++|+|||.+.......  ......++..|++
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            433 77899999999999999999998   99999999999999999999999999998764432  2334567889999


Q ss_pred             ccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHH
Q 003555          680 PEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGL  759 (811)
Q Consensus       680 PE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  759 (811)
                      ||.+....++.++|||+||+++++|++|..||.........   ...    .......     ...........+.+++.
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~---~~~----~~~~~~~-----~~~~~~~~~~~~~~~i~  222 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL---FKK----IGKPKPP-----FPPPEWKISPEAKDLIR  222 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHH----HhccCCC-----CccccccCCHHHHHHHH
Confidence            99998888999999999999999999999998653211111   000    0000000     00000014568999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 003555          760 LCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       760 ~cl~~dP~~RPs~~evl~  777 (811)
                      +|+..+|.+||++.++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHccCCchhccCHHHHhh
Confidence            999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=3.2e-30  Score=304.31  Aligned_cols=144  Identities=27%  Similarity=0.366  Sum_probs=129.4

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      |.+.++||+|+||.||+|.+...++.||||+++...   ......+..|+.+++.++|+||+++++.+......+|||||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            456789999999999999999888999999986432   23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      +++++|.+++... ..+.+.....|+.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999763 3467788899999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.8e-30  Score=294.68  Aligned_cols=257  Identities=19%  Similarity=0.189  Sum_probs=168.6

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCC----CEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecE------Eeccc
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEG----NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF------CMQTS  579 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~----~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~  579 (811)
                      .+.+.++||+|+||.||+|++..+    +..||||++.....  .+....|  .+++..+.++..++..      +.++.
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence            456678999999999999999887    88999999764321  1111111  1222223333322221      24556


Q ss_pred             ceeEEEeecCCCCHHHHhhcCCCCC-------------------chHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCc
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGP-------------------IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~~~~~-------------------~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~N  640 (811)
                      ..+||+||+++++|.+++.......                   ....+..|+.||+.||+|||+.   +|+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence            8899999999999999987532111                   1223457899999999999998   99999999999


Q ss_pred             EEECC-CCCeEEEecCCccccCCCCCccccccccCCCccCccccccC----------------------CCCcccchHHH
Q 003555          641 ILLDD-SLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG----------------------LITVKSDVYSF  697 (811)
Q Consensus       641 Ill~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV~S~  697 (811)
                      ||+++ ++.+||+|||+++.+............+++.|||||.+...                      .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            99985 68999999999987654444444556789999999954322                      23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCccchhhHHHHHHHh-hhhcccchhcCCcc--------ccChHHHHHHHHHHHHcccCCCCC
Q 003555          698 GVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNC-FIAKELSKLVGEDE--------EVDLRTLETMVRVGLLCIQDEPNL  768 (811)
Q Consensus       698 Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~--------~~~~~~~~~l~~l~~~cl~~dP~~  768 (811)
                      ||+||||+++..+++..     ...+....... .....+........        +..........+|+.+||+.||++
T Consensus       366 GviL~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k  440 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ  440 (566)
T ss_pred             HHHHHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence            99999999876654321     11110000000 00000011111110        000011224558999999999999


Q ss_pred             CCCHHHHHHH
Q 003555          769 RPSMKNVILM  778 (811)
Q Consensus       769 RPs~~evl~~  778 (811)
                      |||+.|+++.
T Consensus       441 R~ta~e~L~H  450 (566)
T PLN03225        441 RISAKAALAH  450 (566)
T ss_pred             CCCHHHHhCC
Confidence            9999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-30  Score=284.35  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEec-----ccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQ-----TSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-----~~~~~l  583 (811)
                      +..|.+.||.|.+|.||+++..+.++.+|+|++.. .....+++..|..+++.. .|||++.++|++..     ++.++|
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            34567899999999999999999999999999864 345567888899999988 79999999999874     458999


Q ss_pred             EEeecCCCCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          584 VYEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      |||||.+|+..+++++. ...+.|..+..|++.++.||.+||.+   .++|||||-.||||+.++.+||.|||++..+..
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            99999999999999876 45578999999999999999999999   999999999999999999999999999986532


Q ss_pred             CCCccccccccCCCccCccccccC-----CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccc
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSG-----LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS  737 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  737 (811)
                       .........||+.|||||++...     .|+.++|+||||++..||--|.+|+-...+......+             .
T Consensus       176 -T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-------------p  241 (953)
T KOG0587|consen  176 -TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-------------P  241 (953)
T ss_pred             -ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-------------C
Confidence             22334457899999999987543     4778999999999999999999998765443221100             1


Q ss_pred             hhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       738 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ....+.+.-+....+++.++|..||.+|-.+||++.++++
T Consensus       242 RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1111223346678899999999999999999999998874

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.2e-29  Score=281.14  Aligned_cols=260  Identities=17%  Similarity=0.149  Sum_probs=177.7

Q ss_pred             HhhhhhhcCcccceeEEEEEEc----------------CCCEEEEEEEccCCchhhHH--------------HHHHHHHH
Q 003555          510 TNGFEEELGRGCFGAVYKGSIC----------------EGNKIVAVKRLENPVEEGER--------------KFQAEMAA  559 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~----------------~~~~~vAvK~l~~~~~~~~~--------------~~~~E~~~  559 (811)
                      .+.+.++||+|+||+||+|.+.                ..++.||||++........+              .+..|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            4556789999999999999752                23457999998654332222              33457777


Q ss_pred             HhccCCCCc-----cceecEEec--------ccceeEEEeecCCCCHHHHhhcCC-----------------------CC
Q 003555          560 VRRTHHKNL-----VRLLGFCMQ--------TSKKLLVYEFMSKGSLENLLSNVE-----------------------SG  603 (811)
Q Consensus       560 l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~ey~~~gsL~~~l~~~~-----------------------~~  603 (811)
                      +.+++|.++     ++++++|..        .+..+|||||+++++|.++|+...                       ..
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777776654     677888753        346899999999999999987431                       11


Q ss_pred             CchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccccCCCccCcccc
Q 003555          604 PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ  683 (811)
Q Consensus       604 ~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~  683 (811)
                      .++..+..++.|++.+|.|||+.   +|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            24567788999999999999998   999999999999999999999999999976543322222223457899999976


Q ss_pred             ccCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCCCCCccchhhHHH---HHHHhhhhcccc
Q 003555          684 NSGLI----------------------TVKSDVYSFGVVVLEIVCCRS-NFEVNVSTADVVLLST---WVYNCFIAKELS  737 (811)
Q Consensus       684 ~~~~~----------------------t~ksDV~S~Gvll~elltg~~-p~~~~~~~~~~~~l~~---~~~~~~~~~~~~  737 (811)
                      .....                      ..+.||||+||+++||+++.. |+..............   ..+.......  
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~--  460 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK--  460 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC--
Confidence            53321                      235799999999999999875 5542211100000000   0011110000  


Q ss_pred             hhcCCccccChHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 003555          738 KLVGEDEEVDLRTLETMVRVGLLCIQDEP---NLRPSMKNVILM  778 (811)
Q Consensus       738 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~  778 (811)
                          ..............+++..+|..+|   .+|+|++|+++.
T Consensus       461 ----~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        461 ----YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ----CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                0111122345678899999998766   689999999853

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-30  Score=261.41  Aligned_cols=273  Identities=17%  Similarity=0.220  Sum_probs=209.5

Q ss_pred             cccccccChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC-CC-----Cc
Q 003555          495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HK-----NL  568 (811)
Q Consensus       495 ~~~~~~~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----ni  568 (811)
                      ....-.|..+|....+|.+...+|+|.||.|-++.+...+..||||+++. ...-.+..+-|+++|+++. +.     -+
T Consensus        75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             CCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            33445677888888999999999999999999999988889999999873 3344556677999999993 22     26


Q ss_pred             cceecEEecccceeEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC--
Q 003555          569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD--  645 (811)
Q Consensus       569 v~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~--  645 (811)
                      |.+.+++.-.++.+||+|.+ +.|+.++|.... .......+..|+.|++++++|||+.   +++|.||||+|||+.+  
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE  229 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence            78888899999999999987 559999998754 3356788899999999999999999   9999999999999831  


Q ss_pred             ------------------CCCeEEEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhC
Q 003555          646 ------------------SLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCC  707 (811)
Q Consensus       646 ------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg  707 (811)
                                        +..+||+|||.|..-....    ...+.|..|.|||++.+-..+.++||||+||+|.|+.+|
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG  305 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTG  305 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecc
Confidence                              3469999999998643222    456789999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccchhhHHHHHHHh--------------hhhccc-----------chhcCCc------cccChHHHHHHHH
Q 003555          708 RSNFEVNVSTADVVLLSTWVYNC--------------FIAKEL-----------SKLVGED------EEVDLRTLETMVR  756 (811)
Q Consensus       708 ~~p~~~~~~~~~~~~l~~~~~~~--------------~~~~~~-----------~~~~~~~------~~~~~~~~~~l~~  756 (811)
                      ...|......+... ..+.+...              ...+.+           ....+..      ......+...+.+
T Consensus       306 ~~LFqtHen~EHLa-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD  384 (415)
T KOG0671|consen  306 ETLFQTHENLEHLA-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD  384 (415)
T ss_pred             ceecccCCcHHHHH-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence            99998655333221 11111110              000000           0000000      1123345667999


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 003555          757 VGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       757 l~~~cl~~dP~~RPs~~evl~  777 (811)
                      |+..||..||.+|+|+.|+++
T Consensus       385 Ll~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  385 LLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHccCccccccHHHHhc
Confidence            999999999999999999885

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-29  Score=236.86  Aligned_cols=199  Identities=27%  Similarity=0.419  Sum_probs=168.6

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCC-chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      .+.||+|++|.|=+-++..++...|+|++... ..+..++.+.|+.+..+. .+|.+|.++|...+....++.||.|.- 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            47899999999999999999999999999754 356677888999987665 899999999999999999999999976 


Q ss_pred             CHHHHhhc---CCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          592 SLENLLSN---VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       592 sL~~~l~~---~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      ||+.+-.+   ......+...-+|+..|..||.|||++  ..++|||+||+|||++.+|++|++|||++-.+.+.-  ..
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--Ak  205 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--AK  205 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--HH
Confidence            78777543   345567788889999999999999998  599999999999999999999999999998764322  12


Q ss_pred             cccccCCCccCccccc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 003555          669 TGVKGTRGYMSPEWQN----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST  717 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~----~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~  717 (811)
                      +-..|-..|||||.+.    ...|+.|+||||||+.+.||.+++.|++.....
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            2245778899999764    346899999999999999999999999865443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.5e-30  Score=267.49  Aligned_cols=244  Identities=20%  Similarity=0.207  Sum_probs=200.6

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      ..||-|+||.|=+...+......|+|++++.   ....+++...|-.+|...+.+.||+++..+.++...|++||-|-+|
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG  505 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG  505 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence            4699999999999998776556899988653   3455677889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV  671 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  671 (811)
                      .|...|.+. ..++.....-++..+.+|+.|||.+   +||+|||||+|.+||.+|-+||.|||+|+.+..+..  +-+.
T Consensus       506 ElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--TwTF  579 (732)
T KOG0614|consen  506 ELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--TWTF  579 (732)
T ss_pred             hhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCc--eeee
Confidence            999999884 4455566666788999999999999   999999999999999999999999999998765443  4457


Q ss_pred             ccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHH
Q 003555          672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL  751 (811)
Q Consensus       672 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  751 (811)
                      +||+.|.|||++.++..+..+|.|||||++|||++|++||....+......+..-         +    + ....+....
T Consensus       580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG---------i----d-~i~~Pr~I~  645 (732)
T KOG0614|consen  580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG---------I----D-KIEFPRRIT  645 (732)
T ss_pred             cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh---------h----h-hhhcccccc
Confidence            8999999999999999999999999999999999999999876554332111100         0    0 012234456


Q ss_pred             HHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 003555          752 ETMVRVGLLCIQDEPNLRPS-----MKNVILM  778 (811)
Q Consensus       752 ~~l~~l~~~cl~~dP~~RPs-----~~evl~~  778 (811)
                      ....++++.....+|.+|.-     +.||-+.
T Consensus       646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            67788999988999999976     5666543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=277.68  Aligned_cols=238  Identities=27%  Similarity=0.373  Sum_probs=186.7

Q ss_pred             hhcCccccee-EEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeecCCCC
Q 003555          515 EELGRGCFGA-VYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGS  592 (811)
Q Consensus       515 ~~LG~G~fg~-Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~~~gs  592 (811)
                      +.+|.|+-|+ ||+|..  .++.||||++-   .+-.....+|+..|+.- +|+|||++++.-.+....||..|.|.. +
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            6689999986 799999  46899999973   33445678899999887 799999999999999999999999966 9


Q ss_pred             HHHHhhcCCCC---CchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-----CCCeEEEecCCccccCCCC
Q 003555          593 LENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-----SLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       593 L~~~l~~~~~~---~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-----~~~~kL~DFGla~~~~~~~  664 (811)
                      |.++++.....   ..-.....+..|+++||++||+-   +||||||||.||||+.     ..+++|+|||+++.+..+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            99999874111   11134467889999999999997   9999999999999964     3589999999999986654


Q ss_pred             C--ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCccchhhHHHHHHHhhhhcccchhcC
Q 003555          665 T--GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCC-RSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       665 ~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      .  ....+..||.+|+|||.+....-+..+||||+||++|..++| ..||......+..+...        ...+..   
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~--------~~~L~~---  734 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG--------NYTLVH---  734 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC--------ccceee---
Confidence            3  234567899999999999999889999999999999999997 78997543322221100        000110   


Q ss_pred             CccccChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                        .+...++  +..+||.+|++++|..||++.+|+
T Consensus       735 --L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  735 --LEPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             --eccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence              0111112  788999999999999999999997

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=250.16  Aligned_cols=261  Identities=19%  Similarity=0.262  Sum_probs=198.9

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCc--hhhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeEEEe
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLLVYE  586 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~e  586 (811)
                      .+.||.|+||.||..++..+++.||+|++.+..  -...+.+.+|+++|..++|.|++..+++..-..     +.|+|+|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            367999999999999999999999999986532  234578999999999999999999998876543     6688888


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      .|.. +|...+-. ...++...+.-+.+||++||+|||+.   +|.||||||.|.|++.|...||+|||+++.-..++..
T Consensus       138 LmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  138 LMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            8855 78777765 34456666777889999999999999   9999999999999999999999999999987777766


Q ss_pred             cccccccCCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHH-------hhhhcccch
Q 003555          667 IVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN-------CFIAKELSK  738 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~-------~~~~~~~~~  738 (811)
                      .++.-.-|..|.|||++.+. .|+...||||.||++.|++-.+..|....+.+...++.+....       ..-++....
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence            66667789999999988765 6899999999999999999999999866555443222222110       000111111


Q ss_pred             hcCCc-----------cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          739 LVGED-----------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       739 ~~~~~-----------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ++...           ...+...-.+...+...++..||+.|.+..+.+..+
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            11111           011112233556777789999999999998887655

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=245.63  Aligned_cols=246  Identities=18%  Similarity=0.258  Sum_probs=193.5

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCC---chhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEee
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ++.+.||+|+|..|..++++.+.+.+|+|++++.   ..++....+.|-.+..+. +||.+|-+..++..+.+.+.|.||
T Consensus       253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey  332 (593)
T KOG0695|consen  253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY  332 (593)
T ss_pred             eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence            3457899999999999999999999999998753   334455677777777666 799999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~  667 (811)
                      .++|+|--++.+.++ +.++...-....|.-||.|||+.   +|+.||||..|||+|.+|.+||.|+|+.+...... ..
T Consensus       333 v~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~g-d~  407 (593)
T KOG0695|consen  333 VNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-DT  407 (593)
T ss_pred             ecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCC-cc
Confidence            999999877776544 44455555677899999999999   99999999999999999999999999998643322 23


Q ss_pred             ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccC
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .+..+||+.|+|||++.+..|....|.|++||+|+||+.|+.||+..........-.++..+...+        ....++
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kqirip  479 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQIRIP  479 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hccccc
Confidence            566899999999999999999999999999999999999999997432111111111222222211        222334


Q ss_pred             hHHHHHHHHHHHHcccCCCCCCC
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRP  770 (811)
Q Consensus       748 ~~~~~~l~~l~~~cl~~dP~~RP  770 (811)
                      ...+.+...+++.-|++||.+|.
T Consensus       480 rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhc
Confidence            44555677788889999999884

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3.4e-27  Score=238.04  Aligned_cols=212  Identities=32%  Similarity=0.530  Sum_probs=186.8

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHHH
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN  595 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~~  595 (811)
                      ||+|.+|.||++....+++.+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999877899999998754332 45789999999999999999999999999999999999999999999


Q ss_pred             HhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-CCCeEEEecCCccccCCCCCccccccccC
Q 003555          596 LLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGIVTGVKGT  674 (811)
Q Consensus       596 ~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt  674 (811)
                      ++.......++..+..++.+++++|.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  156 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT  156 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence            9987545678899999999999999999999   9999999999999999 89999999999987543321 22335578


Q ss_pred             CCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHH
Q 003555          675 RGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLET  753 (811)
Q Consensus       675 ~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  753 (811)
                      ..|++||..... ..+.+.|+|++|+++++|                                               ..
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~~  189 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------PE  189 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------HH
Confidence            899999988777 888999999999999998                                               46


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          754 MVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       754 l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      +.+++..|++.+|.+||++.++++.+
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            78899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.4e-27  Score=251.68  Aligned_cols=217  Identities=21%  Similarity=0.259  Sum_probs=176.1

Q ss_pred             ChhHHHHHHhhh-----hhhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceec
Q 003555          502 STGELERATNGF-----EEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG  573 (811)
Q Consensus       502 ~~~el~~~~~~~-----~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g  573 (811)
                      .|-.|.+++-.-     .+.||-|+||.|.++.-.++...+|+|.|++..   .......++|-.+|.....+=||+|+-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            444555555432     256999999999999998988899999997542   334456888999999999999999999


Q ss_pred             EEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       574 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                      .|.+.+.+|+||+|++||++-.+|.+.+- +.+....-++.+++.|+++.|..   ++|||||||+|||||.+|.+||.|
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeee
Confidence            99999999999999999999999986432 22333334667899999999998   999999999999999999999999


Q ss_pred             cCCccccC---------CCCC--------------------------------ccccccccCCCccCccccccCCCCccc
Q 003555          654 FSLAKILM---------PNQT--------------------------------GIVTGVKGTRGYMSPEWQNSGLITVKS  692 (811)
Q Consensus       654 FGla~~~~---------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ks  692 (811)
                      |||+.=++         .++.                                ......+||+.|+|||++....++..+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            99975321         0000                                001135699999999999999999999


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCCccchhh
Q 003555          693 DVYSFGVVVLEIVCCRSNFEVNVSTADVVL  722 (811)
Q Consensus       693 DV~S~Gvll~elltg~~p~~~~~~~~~~~~  722 (811)
                      |.||.||+||||+.|+.||....+.+....
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq~k  882 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQYK  882 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcceee
Confidence            999999999999999999988776655443

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=99.94  E-value=3.2e-28  Score=218.40  Aligned_cols=103  Identities=36%  Similarity=0.574  Sum_probs=74.2

Q ss_pred             CCeEEEeecCCCCCCCC--CcEEEEecCceEEEecCC-cceEeeccCCCC--CceeEEEecCCCeEEeeCCCceEEeecC
Q 003555           76 NITVIWTAFRDEPPVSS--NAKLILTMDGLVLQTEES-KHKLIANTTSDE--PASFASILDSGNFVLCNDRFDFIWESFN  150 (811)
Q Consensus        76 ~~tvVWvANr~~p~~~~--~~~l~~~~~G~l~l~~~~-~~~w~~~~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd  150 (811)
                      ++||||+|||++|+.++  .++|.|+.||+|+|.+.+ +.+|+++.+.+.  .+..|+|+|+|||||++..+.+||||||
T Consensus         1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~   80 (114)
T PF01453_consen    1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD   80 (114)
T ss_dssp             ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred             CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence            47999999999999653  589999999999999887 789998544433  4779999999999999999999999999


Q ss_pred             CCccccccCccccCCC------eEEecCCCCCCC
Q 003555          151 FPTHTIVGGQSLVNGS------KLFSSASETNSS  178 (811)
Q Consensus       151 ~PTDTlLpg~kl~~~~------~L~S~~s~~dps  178 (811)
                      |||||+||||+|+.+.      .|+||++.+|||
T Consensus        81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps  114 (114)
T PF01453_consen   81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS  114 (114)
T ss_dssp             SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred             CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence            9999999999998742      489999999996

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=3e-26  Score=234.53  Aligned_cols=199  Identities=27%  Similarity=0.422  Sum_probs=174.9

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh-hHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE-GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      .+.+.||+|++|+||++...++++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            3567899999999999999887899999999765544 677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      ++|.+++......+++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.............
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999987543378899999999999999999998   99999999999999999999999999998765442112234


Q ss_pred             cccCCCccCcccc-ccCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 003555          671 VKGTRGYMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNFEV  713 (811)
Q Consensus       671 ~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll~elltg~~p~~~  713 (811)
                      ..++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            5678899999988 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1.4e-26  Score=220.12  Aligned_cols=257  Identities=15%  Similarity=0.282  Sum_probs=194.7

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC-CCCccceecEEeccc--ceeEEE
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTS--KKLLVY  585 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lV~  585 (811)
                      ..|++.+++|+|.++.||.|....+++.++||++++   -..+.+.+|+.+|..|. |+||++++++..+..  ...||+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            356778999999999999999888889999999974   34578899999999996 999999999998754  568999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-CCCCeEEEecCCccccCCCC
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-~~~~~kL~DFGla~~~~~~~  664 (811)
                      ||..+.+...+-..    ++...+...+.++++||.|+|+.   +|.|||+||.|+++| +....+|+|+|+|...-+..
T Consensus       115 E~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  115 EYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            99999877665542    44566777899999999999999   999999999999999 45679999999998875554


Q ss_pred             CccccccccCCCccCccccc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchh-hHHHHH---------HHhh--
Q 003555          665 TGIVTGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV-LLSTWV---------YNCF--  731 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~-~l~~~~---------~~~~--  731 (811)
                      ...  -...++.|--||.+- -..++-.-|+|||||+|.+|+..+.||-......+.. .+....         ....  
T Consensus       188 eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  188 EYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             eee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            322  234567888999764 4568889999999999999999999997655544332 221111         1100  


Q ss_pred             hhcccchhcCCccc---------cCh-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          732 IAKELSKLVGEDEE---------VDL-RTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       732 ~~~~~~~~~~~~~~---------~~~-~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      ...+...+++....         .+. -...+.++++...|..|.++|||++|.+.
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            11112222221110         011 12367889999999999999999999764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2e-26  Score=241.23  Aligned_cols=137  Identities=25%  Similarity=0.415  Sum_probs=114.8

Q ss_pred             hhHHHH-HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC-----C---CCccceec
Q 003555          503 TGELER-ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-----H---KNLVRLLG  573 (811)
Q Consensus       503 ~~el~~-~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g  573 (811)
                      .+|.-. ++|.+.++||=|.|++||++.+....+.||+|+.+.. ..-.+..+.|+++|++++     |   ..||+|++
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            344444 7888899999999999999999999999999998632 333456788999999883     3   46999999


Q ss_pred             EEec----ccceeEEEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE
Q 003555          574 FCMQ----TSKKLLVYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL  643 (811)
Q Consensus       574 ~~~~----~~~~~lV~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll  643 (811)
                      +|..    +.+.++|+|++ |.+|..+|.... ..+....+.+|++||+.||.|||.+|  +|||.||||+|||+
T Consensus       150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            9975    45899999998 448888887654 55788999999999999999999997  99999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=5.8e-27  Score=249.22  Aligned_cols=195  Identities=21%  Similarity=0.260  Sum_probs=167.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch--------hhHHHHHHHHHHHhccC---CCCccceecEEeccc
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--------EGERKFQAEMAAVRRTH---HKNLVRLLGFCMQTS  579 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~  579 (811)
                      |...+++|+|+||.|+.|.++.....|+||.+.+..-        ...-..-.|+++|..++   |+||++++.+|.+++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            3345789999999999999999889999998864211        11123557999999997   999999999999999


Q ss_pred             ceeEEEeecC-CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          580 KKLLVYEFMS-KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       580 ~~~lV~ey~~-~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      .++|++|-.. +-+|++++.. ...+++++...|+.||+.|+++||++   +|||||||-+||.++.+|.+||+|||.|.
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchh
Confidence            9999999864 4589999986 56688899999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCCccccccccCCCccCccccccCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 003555          659 ILMPNQTGIVTGVKGTRGYMSPEWQNSGLI-TVKSDVYSFGVVVLEIVCCRSNFE  712 (811)
Q Consensus       659 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvll~elltg~~p~~  712 (811)
                      ....+   .....+||.+|.|||++.+.+| ...-|||++||+||-++....||.
T Consensus       719 ~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  719 YTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            65433   3445779999999999988876 567899999999999998888875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=3.4e-26  Score=240.33  Aligned_cols=270  Identities=18%  Similarity=0.206  Sum_probs=210.6

Q ss_pred             ccChhHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC------CCCccceec
Q 003555          500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH------HKNLVRLLG  573 (811)
Q Consensus       500 ~~~~~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g  573 (811)
                      ++..+|+....|.+.-..|+|=|++|..|.+...+..||||++... +--.+.=+.|+++|++|+      ..|.++|+.
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            4678899999999999999999999999999888889999999743 334456788999999994      468999999


Q ss_pred             EEecccceeEEEeecCCCCHHHHhhcCC--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC-CCeE
Q 003555          574 FCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-LTAK  650 (811)
Q Consensus       574 ~~~~~~~~~lV~ey~~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~-~~~k  650 (811)
                      .|...++++||+|-+.- +|.+.|+..+  .++....+..++.|+.-||..|..-   +|+|.||||.||||++. ..+|
T Consensus       502 ~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence            99999999999998754 9999998764  4567788889999999999999987   99999999999999854 5789


Q ss_pred             EEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHH---
Q 003555          651 ISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV---  727 (811)
Q Consensus       651 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~---  727 (811)
                      |||||.|.....++.   +...-+.-|.|||++.+-+|+...|+||.||.||||.||+..|.+.....-.-...+..   
T Consensus       578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            999999987654432   22334668999999999999999999999999999999999998765443221111100   


Q ss_pred             -HHhhhhccc---------------------------chhcCC-------------ccccChHHHHHHHHHHHHcccCCC
Q 003555          728 -YNCFIAKEL---------------------------SKLVGE-------------DEEVDLRTLETMVRVGLLCIQDEP  766 (811)
Q Consensus       728 -~~~~~~~~~---------------------------~~~~~~-------------~~~~~~~~~~~l~~l~~~cl~~dP  766 (811)
                       ..++..+.+                           ...+.+             .....+.....+.+|+..|+..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence             000000000                           000000             022245567788999999999999


Q ss_pred             CCCCCHHHHHH
Q 003555          767 NLRPSMKNVIL  777 (811)
Q Consensus       767 ~~RPs~~evl~  777 (811)
                      ++|.|.++.++
T Consensus       735 ~KRit~nqAL~  745 (752)
T KOG0670|consen  735 EKRITVNQALK  745 (752)
T ss_pred             hhcCCHHHHhc
Confidence            99999998875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-26  Score=225.58  Aligned_cols=254  Identities=22%  Similarity=0.218  Sum_probs=190.9

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhHHHHHHHHHHHhccCCCCccceecEEecc------cceeEEEe
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~lV~e  586 (811)
                      +.+|.|+- .|--+.+.-.+++||+|++..+  .....++..+|+..+..++|+|+++++.++.-.      .+.++|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            45778877 6777777667889999998643  234457788999999999999999999998643      36799999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      +|.. +|...+..   .++-.....|..|++.|++|||+.   +|+||||||+||++..+..+||.|||+|+.-...  .
T Consensus       102 ~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~  172 (369)
T KOG0665|consen  102 LMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--F  172 (369)
T ss_pred             hhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--c
Confidence            9976 88887762   344567778999999999999999   9999999999999999999999999999864333  3


Q ss_pred             cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHH---------------HHHHHhh
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS---------------TWVYNCF  731 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~---------------~~~~~~~  731 (811)
                      ..+....|+.|.|||++.+..+.+.+||||.||++.||++|+..|.+...-++.....               ..+....
T Consensus       173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv  252 (369)
T KOG0665|consen  173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV  252 (369)
T ss_pred             ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence            5566788999999999888889999999999999999999999887543222211110               1111111


Q ss_pred             hh--c----ccchhcCC-----ccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          732 IA--K----ELSKLVGE-----DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       732 ~~--~----~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..  +    ...+++..     ..+.+.-....+.+++.+||-.+|++|-++.++++.
T Consensus       253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            10  0    00111100     112233344567889999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-26  Score=250.21  Aligned_cols=249  Identities=20%  Similarity=0.304  Sum_probs=203.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      |....++|+|.+|.|||++++..++..|||.++-.......-.++|+-+++..+|+|||.++|-+......++.||||.+
T Consensus        17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg   96 (829)
T KOG0576|consen   17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG   96 (829)
T ss_pred             hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence            44567899999999999999999999999999887778888899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+.-+. ...+++.++..+++...+||+|||+.   +-+|||||-.|||+++.|.+|++|||.+-.+... ......
T Consensus        97 gslQdiy~~-TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~Krks  171 (829)
T KOG0576|consen   97 GSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKS  171 (829)
T ss_pred             Ccccceeee-cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-hhhhhc
Confidence            999998775 44577888899999999999999998   8899999999999999999999999998754321 233456


Q ss_pred             cccCCCccCcccc---ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcC-Ccccc
Q 003555          671 VKGTRGYMSPEWQ---NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG-EDEEV  746 (811)
Q Consensus       671 ~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~  746 (811)
                      ..||+.|||||+.   +.+.|..++|||+.|+...|+--.++|...-.+.... .+        ..+   ...+ +..+.
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-~L--------mTk---S~~qpp~lkD  239 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-FL--------MTK---SGFQPPTLKD  239 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-HH--------hhc---cCCCCCcccC
Confidence            7899999999964   5567899999999999999998777765432221111 00        000   1111 11223


Q ss_pred             ChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       747 ~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                      .....+.+.++++.|+.++|.+||+++.++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            445677889999999999999999998765

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.6e-25  Score=215.75  Aligned_cols=253  Identities=16%  Similarity=0.288  Sum_probs=189.3

Q ss_pred             HHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecE-EecccceeEEEe
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGF-CMQTSKKLLVYE  586 (811)
Q Consensus       509 ~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~e  586 (811)
                      ..|++.+.||+|.||.+-++.++..++.+++|.+... ....++|.+|..---.| .|.||+.-++. +...+.++.++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            4577889999999999999999999999999998654 33467899998766666 68999988765 556677889999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEE-C-CCCCeEEEecCCccccCCCC
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL-D-DSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll-~-~~~~~kL~DFGla~~~~~~~  664 (811)
                      |++.|+|.+-+..  .++-+..-.+++.|++.||.|+|++   ++||||||.+|||+ + +..++||+|||+.+..... 
T Consensus       103 ~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-  176 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-  176 (378)
T ss_pred             cCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence            9999999998875  4455677788999999999999999   99999999999999 2 4458999999998764321 


Q ss_pred             CccccccccCCCccCcccccc---C--CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          665 TGIVTGVKGTRGYMSPEWQNS---G--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~---~--~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                         ......+..|.|||....   +  ...+.+|||.|||+++.++||+.||......+..    =|.+..+..+.....
T Consensus       177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~----Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP----YWEWEQWLKRKNPAL  249 (378)
T ss_pred             ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch----HHHHHHHhcccCccC
Confidence               122334667999996532   2  3567899999999999999999999844332221    122222233322222


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      .+.    -....+++.++.++-+..++++|-...++.++-
T Consensus       250 P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  250 PKK----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             chh----hcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            211    112356778888899999999996666665554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=6.9e-25  Score=227.47  Aligned_cols=259  Identities=20%  Similarity=0.307  Sum_probs=193.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcC---CCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICE---GNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      +...++||+|.|++||++++..   .++.||+|.+..  .+....+.+|++.|..+ .+.||+++.+++..++...+|+|
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            4456889999999999999877   678999999853  34456689999999999 69999999999999999999999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-CCCCeEEEecCCccccC----
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM----  661 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-~~~~~kL~DFGla~~~~----  661 (811)
                      |++.....+++..    ++..++...++.+.+||+++|.+   +||||||||+|+|.+ ..+.-.|.|||+|....    
T Consensus       116 ~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             ccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            9999999999875    44678888999999999999999   999999999999998 56789999999997210    


Q ss_pred             -------------C-C----------------C---------CccccccccCCCccCcccc-ccCCCCcccchHHHHHHH
Q 003555          662 -------------P-N----------------Q---------TGIVTGVKGTRGYMSPEWQ-NSGLITVKSDVYSFGVVV  701 (811)
Q Consensus       662 -------------~-~----------------~---------~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvll  701 (811)
                                   + .                .         ........||++|.|||++ .....+.+.||||-||++
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                         0 0                0         0001124699999999975 566789999999999999


Q ss_pred             HHHHhCCCCCCCCCCccchh-hHHHHHH-----Hh-hhhcc--c----------------c----hhcCC-------ccc
Q 003555          702 LEIVCCRSNFEVNVSTADVV-LLSTWVY-----NC-FIAKE--L----------------S----KLVGE-------DEE  745 (811)
Q Consensus       702 ~elltg~~p~~~~~~~~~~~-~l~~~~~-----~~-~~~~~--~----------------~----~~~~~-------~~~  745 (811)
                      +-+++++.||-....+.+.+ .+.....     .+ ...+.  +                .    +.+.+       ...
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            99999999996543332211 1111100     00 00000  0                0    00000       001


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ........+++++.+|+..||.+|-|++|.++.
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            112223478999999999999999999998853

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=99.91  E-value=5.5e-24  Score=192.94  Aligned_cols=105  Identities=32%  Similarity=0.486  Sum_probs=92.3

Q ss_pred             ccccCCCeeeeeeEeCCCC--eEEEEEeccCCCCeEEEeecCCCCCCCCCcEEEEecCceEEEecCC-cceEeeccCCCC
Q 003555           46 SWTSPSGLFQFGFYKEGTG--FSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEES-KHKLIANTTSDE  122 (811)
Q Consensus        46 ~~~S~~g~F~lGFf~~~~~--~~lgIw~~~~~~~tvVWvANr~~p~~~~~~~l~~~~~G~l~l~~~~-~~~w~~~~~~~~  122 (811)
                      +|+|++|.|++|||++...  .+.+|||.+++ +++||+|||+.| .+..+.|.|+.||+|+|.+.+ .++|+++.....
T Consensus         9 ~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~   86 (116)
T cd00028           9 TLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVN   86 (116)
T ss_pred             EEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEecccCCC
Confidence            3499999999999998754  89999999887 899999999998 566889999999999998865 789998755434


Q ss_pred             CceeEEEecCCCeEEeeCCCceEEeecCCC
Q 003555          123 PASFASILDSGNFVLCNDRFDFIWESFNFP  152 (811)
Q Consensus       123 ~~~~a~LldsGNlVl~~~~~~~lWQSFd~P  152 (811)
                      ...+|+|+|+|||||++.++.++|||||||
T Consensus        87 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P  116 (116)
T cd00028          87 GNYVLVLLDDGNLVLYDSDGNFLWQSFDYP  116 (116)
T ss_pred             CceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence            566899999999999999999999999999

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=7.4e-25  Score=265.29  Aligned_cols=196  Identities=20%  Similarity=0.206  Sum_probs=140.4

Q ss_pred             ccCC-CCccceecEEe-------cccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeee
Q 003555          562 RTHH-KNLVRLLGFCM-------QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH  633 (811)
Q Consensus       562 ~l~h-~niv~l~g~~~-------~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  633 (811)
                      .++| .||+++++.+.       +....++++||+ .++|.++|......+++.+++.++.||++||.|||++   +|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            4456 57888888772       334567888887 5599999987666688999999999999999999998   9999


Q ss_pred             cCCCCCcEEECC-------------------CCCeEEEecCCccccCCCCC---------------ccccccccCCCccC
Q 003555          634 CNINPRNILLDD-------------------SLTAKISNFSLAKILMPNQT---------------GIVTGVKGTRGYMS  679 (811)
Q Consensus       634 ~Dik~~NIll~~-------------------~~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~a  679 (811)
                      |||||+||||+.                   ++.+||+|||+++.......               .......||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   45566667776654211000               00011357889999


Q ss_pred             ccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHH
Q 003555          680 PEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGL  759 (811)
Q Consensus       680 PE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  759 (811)
                      ||++.+..++.++|||||||+||||++|..|+.....     .......         ....+   ..........+++.
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~---------~~~~~---~~~~~~~~~~~~~~  246 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRH---------RVLPP---QILLNWPKEASFCL  246 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHH---------hhcCh---hhhhcCHHHHHHHH
Confidence            9999999999999999999999999998887642110     0000000         00111   00112334568888


Q ss_pred             HcccCCCCCCCCHHHHHHH
Q 003555          760 LCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       760 ~cl~~dP~~RPs~~evl~~  778 (811)
                      +||+.+|.+||+|.|+++.
T Consensus       247 ~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        247 WLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HhCCCChhhCcChHHHhhc
Confidence            9999999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=8.8e-24  Score=208.13  Aligned_cols=167  Identities=17%  Similarity=0.179  Sum_probs=127.5

Q ss_pred             CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccc
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  670 (811)
                      |+|.+++......+++.+++.|+.||++||.|||++   +      ||+|||++.++.+|+  ||+++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999987666789999999999999999999998   4      999999999999999  99998654322      


Q ss_pred             cccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHH
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT  750 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  750 (811)
                      ..|++.|||||.+.+..++.++|||||||++|||++|+.||.........  +......      ...............
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~------~~~~~~~~~~~~~~~  135 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI--LEILLNG------MPADDPRDRSNLESV  135 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH--HHHHHHH------hccCCccccccHHHH
Confidence            25889999999999999999999999999999999999999644321111  1111100      000000000111222


Q ss_pred             HH--HHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          751 LE--TMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       751 ~~--~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..  .+.+++.+||+.+|.+||++.|+++.+...
T Consensus       136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      136 SAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            22  689999999999999999999999987543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=9e-24  Score=205.67  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=196.4

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEcc--CCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ..++..+|.+...|..|+|++...  -+++|++.  .......++|..|.-.|+-+.||||+.++|.|.......+|..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            345677899999999999999653  35556653  34556668899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcCCCC-CchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~-~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~  666 (811)
                      |+.|+|...|++.... .+-.+..+++.+||+|++|||+. .+-|.---|..+.|++|++.+++|+= +-.+.     +.
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sf  341 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SF  341 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----ee
Confidence            9999999999986443 46778899999999999999986 44566667999999999999988751 11111     01


Q ss_pred             cccccccCCCccCccccccCCCC---cccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLIT---VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t---~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      ...+....+.||+||.+..++-+   ..+|+|||++++||+.|...||....+.+-..              -..+-+-+
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------------kialeglr  407 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------------KIALEGLR  407 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------------hhhhcccc
Confidence            11233467899999988766533   47999999999999999999997654432211              11122234


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcc
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..+++..+..+.+|+.-|++.||.+||.+..|+-.||..
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            456778889999999999999999999999999999874

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=99.89  E-value=9.1e-23  Score=184.50  Aligned_cols=104  Identities=28%  Similarity=0.458  Sum_probs=91.6

Q ss_pred             ccccCCCeeeeeeEeCCCC-eEEEEEeccCCCCeEEEeecCCCCCCCCCcEEEEecCceEEEecCC-cceEeeccCCCCC
Q 003555           46 SWTSPSGLFQFGFYKEGTG-FSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEES-KHKLIANTTSDEP  123 (811)
Q Consensus        46 ~~~S~~g~F~lGFf~~~~~-~~lgIw~~~~~~~tvVWvANr~~p~~~~~~~l~~~~~G~l~l~~~~-~~~w~~~~~~~~~  123 (811)
                      .|+|++|.|++|||.+... .+.+|||++.+ +++||+|||+.|+.+ ++.|.+.+||+|+|.+.+ .++|++++..+..
T Consensus         9 ~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~~   86 (114)
T smart00108        9 TLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSSNTTGANG   86 (114)
T ss_pred             EEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEecccCCCC
Confidence            4599999999999998755 89999999887 899999999998766 489999999999998775 7899987653455


Q ss_pred             ceeEEEecCCCeEEeeCCCceEEeecCC
Q 003555          124 ASFASILDSGNFVLCNDRFDFIWESFNF  151 (811)
Q Consensus       124 ~~~a~LldsGNlVl~~~~~~~lWQSFd~  151 (811)
                      ..+|+|+|+|||||++..+.++||||||
T Consensus        87 ~~~~~L~ddGnlvl~~~~~~~~W~Sf~~  114 (114)
T smart00108       87 NYVLVLLDDGNLVIYDSDGNFLWQSFDY  114 (114)
T ss_pred             ceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence            6689999999999999999999999997

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.4e-22  Score=216.57  Aligned_cols=163  Identities=18%  Similarity=0.160  Sum_probs=128.3

Q ss_pred             HhhhhhhcCcccceeEEEEEEcC-CCEEEEEEEccCC-----chhhHHHHHHHHHHHhccCCCCccceecEEecccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICE-GNKIVAVKRLENP-----VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .|.+.+.||+|+||+||+|.+.. +++.||||++...     .....+.|.+|+++|++++|+|+++.+..   .+..+|
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L   95 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL   95 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence            46677899999999999998865 5678899987532     12335679999999999999999853322   246799


Q ss_pred             EEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCC-CCCcEEECCCCCeEEEecCCccccCC
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNI-NPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Di-k~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      ||||+++++|... .. .      ....++.+++++|.|||+.   +|+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus        96 VmE~~~G~~L~~~-~~-~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         96 VRGWTEGVPLHLA-RP-H------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             EEEccCCCCHHHh-Cc-c------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            9999999999732 11 1      1246788999999999998   9999999 99999999999999999999997754


Q ss_pred             CCC-------ccccccccCCCccCccccccC
Q 003555          663 NQT-------GIVTGVKGTRGYMSPEWQNSG  686 (811)
Q Consensus       663 ~~~-------~~~~~~~gt~~y~aPE~~~~~  686 (811)
                      ...       ...+...++..|+|||.+...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            331       112456788899999987544

>PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation

Probab=99.87  E-value=2.4e-22  Score=180.14  Aligned_cols=109  Identities=28%  Similarity=0.514  Sum_probs=88.7

Q ss_pred             eeeeeeccCcccceeeecCCceeeeeecCcceeEEeeeeeeeecCcceEEEEEEeecCcEEEEEeeccCCCCcceeEEEe
Q 003555          205 VSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWY  284 (811)
Q Consensus       205 ~~~~yw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~Ld~dG~lr~~~w~~~~~~~~~w~~~w~  284 (811)
                      ++++ |++..|.++|++.....+...+.   ....+.++++.+.+.++++|++||.+|++|+|.|....   +.|...|.
T Consensus         2 rsG~-WnG~~f~g~p~~~~~~~~~~~fv---~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~---~~W~~~~~   74 (110)
T PF00954_consen    2 RSGP-WNGQRFSGIPEMSSNSLYNYSFV---SNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNEST---QSWSVFWS   74 (110)
T ss_pred             Cccc-cCCeEECCcccccccceeEEEEE---ECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCC---CcEEEEEE
Confidence            3343 99999999999986555443333   23334467777788999999999999999999997554   46999999


Q ss_pred             eeccccCCCCCCCCCCccCCCCCCCCCceeecCCCCcccC
Q 003555          285 VLQNQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFIN  324 (811)
Q Consensus       285 ~p~~~Cd~~g~CG~~g~C~~~~~~~~~~~C~C~~GF~~~~  324 (811)
                      +|.|+||+|+.||+||+|+.    +..+.|.||+||+|++
T Consensus        75 ~p~d~Cd~y~~CG~~g~C~~----~~~~~C~Cl~GF~P~n  110 (110)
T PF00954_consen   75 APKDQCDVYGFCGPNGICNS----NNSPKCSCLPGFEPKN  110 (110)
T ss_pred             ecccCCCCccccCCccEeCC----CCCCceECCCCcCCCc
Confidence            99999999999999999975    4577899999999975

This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1e-20  Score=204.67  Aligned_cols=261  Identities=18%  Similarity=0.179  Sum_probs=194.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCC-EEEEEEEccCCchhhHHHHHHHHHHHhccCC----CCccceecEE-ecccceeE
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGN-KIVAVKRLENPVEEGERKFQAEMAAVRRTHH----KNLVRLLGFC-MQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l  583 (811)
                      .+.+.++||+|+||.||++...... +.+|+|............+..|..++..+.+    +++..++... ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            5667899999999999999987664 6788888654433333377888888888863    6888888888 46778899


Q ss_pred             EEeecCCCCHHHHhhcCC-CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC-----CCeEEEecCCc
Q 003555          584 VYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-----LTAKISNFSLA  657 (811)
Q Consensus       584 V~ey~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~-----~~~kL~DFGla  657 (811)
                      ||+.. +.+|.++..... ..++....++|+.|++.+|.+||+.   +++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99976 669999886655 6788999999999999999999999   99999999999999754     46999999999


Q ss_pred             c--ccCCCCC----cc---ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHH
Q 003555          658 K--ILMPNQT----GI---VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY  728 (811)
Q Consensus       658 ~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~  728 (811)
                      +  .......    ..   .....||..|.+++...+...+++.|+||++.++.|++.|..||...........+.... 
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~-  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP-  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh-
Confidence            9  3322221    11   123569999999999999999999999999999999999999996543322211111100 


Q ss_pred             HhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccCC
Q 003555          729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       729 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                             .......   ........+.++...+-..+..++|....+...|+.....
T Consensus       254 -------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 -------RKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             -------hhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence                   0000100   1112234455555556668999999999999888765444

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.1e-19  Score=196.33  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=196.9

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh---hHHHHHHHHHHHhccCCC-CccceecEEecccceeEEEee
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHK-NLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .+.+.||.|+||.||++...   ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            45578999999999999986   78999998754333   467899999999999988 799999999777778999999


Q ss_pred             cCCCCHHHHhhcCC--CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC-CeEEEecCCccccCCCC
Q 003555          588 MSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMPNQ  664 (811)
Q Consensus       588 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~-~~kL~DFGla~~~~~~~  664 (811)
                      +.+++|.+++....  ..........++.|++.++.|+|+.   +++|||+||+||+++... .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997777544  2577888999999999999999999   899999999999999988 79999999998654433


Q ss_pred             Cc-----cccccccCCCccCcccccc---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhccc
Q 003555          665 TG-----IVTGVKGTRGYMSPEWQNS---GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       665 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      ..     ......|+..|+|||.+..   .......|+|++|++++++++|..|+...................... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence            22     2356789999999998887   688999999999999999999999976543310011111111111100 00


Q ss_pred             chhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 003555          737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       737 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......  .........+.+++..++..+|..|.++.+....
T Consensus       236 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSP--SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCc--cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000  0002233578889999999999999999987754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.9e-21  Score=223.36  Aligned_cols=252  Identities=17%  Similarity=0.211  Sum_probs=194.3

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCC--chhhH----HHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~--~~~~~----~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .+.+|.|++|.|+........+..+.|.....  ....+    ..+..|+.+-..+.|+|++..+..+.+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            46799999998888877665555555543210  11112    2256677788889999999988888887777777999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--  665 (811)
                      +++ +|..++... ..+...++..++.|+..|+.|||+.   +|.|||+|++|++++.++.+||+|||.+..+.....  
T Consensus       403 ~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             ccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            999 999999863 4566788889999999999999999   999999999999999999999999999988764433  


Q ss_pred             -ccccccccCCCccCccccccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCc
Q 003555          666 -GIVTGVKGTRGYMSPEWQNSGLITV-KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       666 -~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                       ....+..|+..|+|||.+.+..+.+ ..||||.|+++..|++|+.||......++....       ...........+.
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-------~~~~~~~~~~~~~  550 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-------NNYSDQRNIFEGP  550 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------hccccccccccCh
Confidence             4456788999999999999888876 589999999999999999999877655443100       0011111222222


Q ss_pred             cccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       744 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                      .......+.+...++.++|+.+|.+|-||++|++
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            2334455677889999999999999999999985

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=8.8e-20  Score=183.22  Aligned_cols=200  Identities=21%  Similarity=0.279  Sum_probs=173.0

Q ss_pred             HhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEEecccceeEEEeec
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      .+.+.++||+|.||..+.|+.--.+++||||.-..  ....-++..|....+.| ..++|...+-|..++.+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            46778999999999999999888899999997532  33345677788888777 5799999999988998999999987


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-----CCCCeEEEecCCccccCCC
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-----DSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-----~~~~~kL~DFGla~~~~~~  663 (811)
                       +-+|+++..-....++.+.++.|+.|+..-++|+|++   .+|.|||||+|+||.     +...+.|+|||+|+.....
T Consensus       107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp  182 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP  182 (449)
T ss_pred             -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence             5699999988888899999999999999999999999   999999999999996     3457999999999988654


Q ss_pred             CCc------cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 003555          664 QTG------IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV  715 (811)
Q Consensus       664 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~  715 (811)
                      ...      ......||.+||+-....+...+.+.|.=|+|-+++.++-|..||....
T Consensus       183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            432      2345679999999999999999999999999999999999999998643

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=2.8e-20  Score=178.91  Aligned_cols=206  Identities=19%  Similarity=0.236  Sum_probs=173.9

Q ss_pred             HHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCC-CCccceecEEecccceeEE
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH-KNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV  584 (811)
                      +....+.+.++||.|+||.+|.|.....++.||||.-+...  ...++..|..+.+.|++ ..|+.+..+..+...-.||
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            44556778899999999999999999999999999865432  23457778888888865 7888889999999999999


Q ss_pred             EeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC---CCCCeEEEecCCccccC
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILM  661 (811)
Q Consensus       585 ~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~---~~~~~kL~DFGla~~~~  661 (811)
                      |+.. +-+|++++.-.....+.+..+-++-|+..-++|+|.+   +.+||||||+|+|..   ....+.|+|||+|+.+.
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            9987 5699999887777888999999999999999999999   999999999999996   44679999999999876


Q ss_pred             CCCCc------cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 003555          662 PNQTG------IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST  717 (811)
Q Consensus       662 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~  717 (811)
                      .....      ......||.+|.+-....+...+.+.|+=|+|.+|..+--|..||......
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            43321      233467999999988777778899999999999999999999999865443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=7.4e-20  Score=200.33  Aligned_cols=217  Identities=23%  Similarity=0.365  Sum_probs=166.8

Q ss_pred             HhccCCCCccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCe-eecCCCC
Q 003555          560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI-IHCNINP  638 (811)
Q Consensus       560 l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~Dik~  638 (811)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+......+++.-...++++|++||.|||..   +| .|+.++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            4578999999999999999999999999999999999999888899999999999999999999987   44 9999999


Q ss_pred             CcEEECCCCCeEEEecCCccccCCC-CCccccccccCCCccCccccccC-------CCCcccchHHHHHHHHHHHhCCCC
Q 003555          639 RNILLDDSLTAKISNFSLAKILMPN-QTGIVTGVKGTRGYMSPEWQNSG-------LITVKSDVYSFGVVVLEIVCCRSN  710 (811)
Q Consensus       639 ~NIll~~~~~~kL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvll~elltg~~p  710 (811)
                      .|.++|..+.+||+|||+....... .........-...|.|||.+...       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998876421 11111222345679999988664       257789999999999999999999


Q ss_pred             CCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhcccC
Q 003555          711 FEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       711 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      |+......+...+...+.    . .....+.+......+..+.+..++..||..+|.+||++++|-..++....
T Consensus       158 ~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHHHH----h-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            987544443211111111    1 11111111111111334478999999999999999999999988876544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.79  E-value=2.7e-19  Score=177.50  Aligned_cols=139  Identities=14%  Similarity=0.144  Sum_probs=107.8

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh--h------------------------HHHHHHHHHHHhccCCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--G------------------------ERKFQAEMAAVRRTHHKN  567 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n  567 (811)
                      .+.||+|+||.||+|... +++.||||+++.....  .                        ......|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            367999999999999997 6789999998643211  1                        112245999999998887


Q ss_pred             ccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHH-hhccCCCeeecCCCCCcEEECCC
Q 003555          568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYL-HEECEVQIIHCNINPRNILLDDS  646 (811)
Q Consensus       568 iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dik~~NIll~~~  646 (811)
                      +.....+.  ....+|||||+++++|...+.. ...++.....+++.|++.+|.|| |+.   +|+||||||+|||++ +
T Consensus        81 v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          81 IPCPEPIL--LKSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCCcEEE--ecCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            74433222  2234899999999877655332 34567888999999999999999 677   999999999999998 4


Q ss_pred             CCeEEEecCCcccc
Q 003555          647 LTAKISNFSLAKIL  660 (811)
Q Consensus       647 ~~~kL~DFGla~~~  660 (811)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=2e-19  Score=180.27  Aligned_cols=173  Identities=12%  Similarity=0.112  Sum_probs=132.6

Q ss_pred             HHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHH---------HHHHHHHHhccCCCCccceecEE
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK---------FQAEMAAVRRTHHKNLVRLLGFC  575 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~g~~  575 (811)
                      ++...+++..+.||.|+||.||....  ++..+|||.+.......+..         +.+|+..+.+++|++|..+..++
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            45566777788999999999999655  35689999997543333322         68999999999999999998886


Q ss_pred             ecc--------cceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCC
Q 003555          576 MQT--------SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL  647 (811)
Q Consensus       576 ~~~--------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~  647 (811)
                      ...        ...+|||||++|.+|.++...     +    .....+++.+|..+|+.   +++|||+||+||+++.++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~-----~----~~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPEI-----S----EDVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhhc-----c----HHHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence            533        357899999999999887421     1    13456999999999999   999999999999999988


Q ss_pred             CeEEEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHH
Q 003555          648 TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV  705 (811)
Q Consensus       648 ~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ell  705 (811)
                       ++|+|||............             .+.....+..++|+|+||+.+.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence             9999999887542211110             0233344667999999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=1.2e-18  Score=179.82  Aligned_cols=228  Identities=19%  Similarity=0.275  Sum_probs=149.5

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccC---CchhhHHHHHHHHHHHhccCC----------CCccceecEEe----
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAEMAAVRRTHH----------KNLVRLLGFCM----  576 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~~----  576 (811)
                      .+.||.|+++.||.+++..+++.+|||+...   ......+++++|...+..+.+          -.++--++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            4679999999999999999999999998742   334456677777766666432          22222222221    


Q ss_pred             -----cc---c-----ceeEEEeecCCCCHHHHhhc---CCCC---CchHHHHHHHHHHHHHHHHHhhccCCCeeecCCC
Q 003555          577 -----QT---S-----KKLLVYEFMSKGSLENLLSN---VESG---PIWRDRVRIALDVARGITYLHEECEVQIIHCNIN  637 (811)
Q Consensus       577 -----~~---~-----~~~lV~ey~~~gsL~~~l~~---~~~~---~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik  637 (811)
                           ..   .     ..+++|+-+ .++|.+++..   ....   .....++.+..|+.+.+++||+.   +++|+||+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                 11   1     236778877 4488887542   2222   23456677889999999999999   99999999


Q ss_pred             CCcEEECCCCCeEEEecCCccccCCCCCccccccccCCCccCcccccc--------CCCCcccchHHHHHHHHHHHhCCC
Q 003555          638 PRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS--------GLITVKSDVYSFGVVVLEIVCCRS  709 (811)
Q Consensus       638 ~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvll~elltg~~  709 (811)
                      |+|++++.+|.++|+||+.........  ..  ...+..|.+||....        -.++.+.|.|++|+++|.|+|++.
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~--~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRY--RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEE--EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCcee--ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999998776533211  11  345578999996533        257889999999999999999999


Q ss_pred             CCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCC
Q 003555          710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLR  769 (811)
Q Consensus       710 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  769 (811)
                      ||..........    +            .+   .... +.++.+.+|+..+|+.+|++|
T Consensus       249 Pf~~~~~~~~~~----~------------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPE----W------------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSG----G------------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccccc----c------------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            998654332210    0            01   1123 678889999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=1.9e-18  Score=172.09  Aligned_cols=139  Identities=17%  Similarity=0.138  Sum_probs=109.8

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh--------------------------hHHHHHHHHHHHhccCCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--------------------------GERKFQAEMAAVRRTHHKN  567 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n  567 (811)
                      .+.||+|+||.||+|.+. +++.||||+++.....                          ....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 6789999998654211                          0123467899999999998


Q ss_pred             ccceecEEecccceeEEEeecCCCCHHHH-hhcCCCCCchHHHHHHHHHHHHHHHHHhh-ccCCCeeecCCCCCcEEECC
Q 003555          568 LVRLLGFCMQTSKKLLVYEFMSKGSLENL-LSNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDD  645 (811)
Q Consensus       568 iv~l~g~~~~~~~~~lV~ey~~~gsL~~~-l~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dik~~NIll~~  645 (811)
                      +.....+...  ..+|||||++++++... +.  ...++.....+++.|++.+|.+||+ .   +|+||||||+||+++ 
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            7544433332  34899999998865443 43  2345677889999999999999999 7   999999999999999 


Q ss_pred             CCCeEEEecCCccccC
Q 003555          646 SLTAKISNFSLAKILM  661 (811)
Q Consensus       646 ~~~~kL~DFGla~~~~  661 (811)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=7.8e-18  Score=164.96  Aligned_cols=184  Identities=15%  Similarity=0.112  Sum_probs=139.3

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh----hHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEeec
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE----GERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ey~  588 (811)
                      ...|++|+||+||.+..  ++..++.+.++....-    ....+.+|+++|++|+ |+++++++++    +..+++|||+
T Consensus         7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            46799999999997665  5677887777643321    1225889999999995 5889999886    4569999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCC-CCCcEEECCCCCeEEEecCCccccCCCCCc-
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNI-NPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Di-k~~NIll~~~~~~kL~DFGla~~~~~~~~~-  666 (811)
                      ++.+|...+..        ....++.|++++|.++|++   +|+|||| ||.|||++.++.++|+|||++....+.... 
T Consensus        81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            99998765421        1245778999999999999   9999999 799999999999999999999865433310 


Q ss_pred             ---c--------ccccccCCCccCccccccC-CCC-cccchHHHHHHHHHHHhCCCCCCCC
Q 003555          667 ---I--------VTGVKGTRGYMSPEWQNSG-LIT-VKSDVYSFGVVVLEIVCCRSNFEVN  714 (811)
Q Consensus       667 ---~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~S~Gvll~elltg~~p~~~~  714 (811)
                         .        ..-..+++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+.-..
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence               0        0113368888888843322 222 5779999999999999999886543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.75  E-value=5.8e-19  Score=201.31  Aligned_cols=251  Identities=21%  Similarity=0.258  Sum_probs=179.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc-hhhHHHHHHHHHH--HhccCCCCccceecEEecccceeEEEee
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAA--VRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ..+.+.||++.|=.|.+|++.++  .|+||++-+.. .-..+.|.++++-  ...++|||.+++.-.-......|||-+|
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            45668899999999999998764  48899875432 3344555554444  4445899999998887777788899999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC--CCCC
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQT  665 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~--~~~~  665 (811)
                      ..+ +|.+.|.. +..+...+..-|+.|++.||.-+|..   +|+|+|||.+||||+.=.-+.|+||..-+...  .++.
T Consensus       103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            876 88888875 55566777788999999999999999   99999999999999999899999998765432  2222


Q ss_pred             cccc----ccccCCCccCcccccc----------C-CCCcccchHHHHHHHHHHHhC-CCCCCCCCCccchhhHHHHHHH
Q 003555          666 GIVT----GVKGTRGYMSPEWQNS----------G-LITVKSDVYSFGVVVLEIVCC-RSNFEVNVSTADVVLLSTWVYN  729 (811)
Q Consensus       666 ~~~~----~~~gt~~y~aPE~~~~----------~-~~t~ksDV~S~Gvll~elltg-~~p~~~~~~~~~~~~l~~~~~~  729 (811)
                      ...+    +...-.+|+|||.+..          . ..+++-||||+||++.||++. +++|...       .+-.+...
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr~~  250 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYRSG  250 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHhcc
Confidence            2222    2223448999996532          1 267899999999999999985 7777531       11111100


Q ss_pred             hhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhccc
Q 003555          730 CFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                        ........+..-      +...+.+++..|++.||.+|.++++.++.-.+..
T Consensus       251 --~~~~~e~~Le~I------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  251 --NADDPEQLLEKI------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             --CccCHHHHHHhC------cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence              000111111110      1126788999999999999999999998855543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=7e-19  Score=192.12  Aligned_cols=226  Identities=21%  Similarity=0.229  Sum_probs=176.1

Q ss_pred             hcCcccceeEEEEEE---cCCCEEEEEEEccCCchh--hHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEeecC
Q 003555          516 ELGRGCFGAVYKGSI---CEGNKIVAVKRLENPVEE--GERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~---~~~~~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      .+|+|.||.|++..-   .+.+..+|+|.+++....  .......|-.++...+ |+.+|++.-.+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999986543   345678999988754321  1125566778888886 9999999999999999999999999


Q ss_pred             CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcccc
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  669 (811)
                      +|.|...+.+.. .............++-++.++|+.   +|+|||+|++||+++.+|.+++.|||+++........   
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---  153 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence            999999887643 344455556677899999999998   9999999999999999999999999999976544332   


Q ss_pred             ccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChH
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                        +||..|||||++.  ......|.||||++++||++|..||...                    .+..++......+.+
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~~~~~~p~~  209 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILKAELEMPRE  209 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhhhccCCchh
Confidence              7899999999988  5678999999999999999999999751                    112223333344555


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCH
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSM  772 (811)
Q Consensus       750 ~~~~l~~l~~~cl~~dP~~RPs~  772 (811)
                      ....+.+++..+...+|.+|.-.
T Consensus       210 l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  210 LSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhHHHHHHHHHHHhhCHHHHhcc
Confidence            66666777777777777777554

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=3e-17  Score=164.24  Aligned_cols=134  Identities=15%  Similarity=0.213  Sum_probs=106.2

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-----CCCCccceecEEeccc---c-eeEEE
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-----HHKNLVRLLGFCMQTS---K-KLLVY  585 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~lV~  585 (811)
                      +.||+|+||.||.  +++.... +||++........+.+.+|+..++.+     .||||++++|++.++.   . ..+|+
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            6799999999996  5555444 69988655445567899999999999     5799999999998864   3 33789


Q ss_pred             ee--cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHH-HHHhhccCCCeeecCCCCCcEEECC----CCCeEEEecCCcc
Q 003555          586 EF--MSKGSLENLLSNVESGPIWRDRVRIALDVARGI-TYLHEECEVQIIHCNINPRNILLDD----SLTAKISNFSLAK  658 (811)
Q Consensus       586 ey--~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dik~~NIll~~----~~~~kL~DFGla~  658 (811)
                      ||  +++++|.+++.+.  .+.+.  ..++.+++.++ +|||++   +|+||||||+|||++.    +..++|+||+-+.
T Consensus        85 e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             cCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            99  6689999999763  23333  45677888777 999999   9999999999999973    3489999954443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.5e-17  Score=191.30  Aligned_cols=199  Identities=20%  Similarity=0.222  Sum_probs=158.0

Q ss_pred             hHHHHHHhhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC---CCCccceecEEecccc
Q 003555          504 GELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH---HKNLVRLLGFCMQTSK  580 (811)
Q Consensus       504 ~el~~~~~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~  580 (811)
                      -++...++.+.+.||+|+||+||+|...+ ++.||||.-+....   .+|.--.+++.+|+   -+-|..+.....-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            35566677788999999999999999987 89999998664432   22222233333343   2334444444455667


Q ss_pred             eeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEEC-------CCCCeEEEe
Q 003555          581 KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD-------DSLTAKISN  653 (811)
Q Consensus       581 ~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~-------~~~~~kL~D  653 (811)
                      -+||+||.+.|+|.+++. ....++|...+.++.|+++.+.+||..   +|||+||||+|.||.       ++..++|+|
T Consensus       769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            799999999999999998 466788999999999999999999999   999999999999994       456799999


Q ss_pred             cCCccccCCCCC-ccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 003555          654 FSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSN  710 (811)
Q Consensus       654 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p  710 (811)
                      ||-+..+..-.. ......++|-.+--+|...+...+.+.|.|.|+.+++-|+.|+..
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999876543222 345667889999999999999999999999999999999988753

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.7e-16  Score=162.97  Aligned_cols=141  Identities=18%  Similarity=0.204  Sum_probs=109.4

Q ss_pred             hhhhhhcCcccceeEEEEE-EcCCCEEEEEEEccCCchh------------------------hHHHHHHHHHHHhccCC
Q 003555          511 NGFEEELGRGCFGAVYKGS-ICEGNKIVAVKRLENPVEE------------------------GERKFQAEMAAVRRTHH  565 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~-~~~~~~~vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h  565 (811)
                      +.+.+.||+|+||.||+|. ...+++.||||++......                        ....+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4566889999999999998 5566899999988643210                        11236789999999976


Q ss_pred             CC--ccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCC-eeecCCCCCcEE
Q 003555          566 KN--LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ-IIHCNINPRNIL  642 (811)
Q Consensus       566 ~n--iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dik~~NIl  642 (811)
                      .+  +++++++    ...++||||+++.+|...+.. .......+...++.||+.+|++||+.   + ++|+||||+||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl  181 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL  181 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence            33  3444443    245899999999888776533 22344456678999999999999999   8 999999999999


Q ss_pred             ECCCCCeEEEecCCcccc
Q 003555          643 LDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       643 l~~~~~~kL~DFGla~~~  660 (811)
                      ++ ++.++|+|||.+...
T Consensus       182 i~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CCCEEEEEChhhhcc
Confidence            99 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=3.4e-16  Score=158.97  Aligned_cols=134  Identities=16%  Similarity=0.278  Sum_probs=113.5

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCch--------hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVE--------EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      +.||+|++|.||+|..  .+..|+||+......        .....+.+|+.++..++|++++....++.+.+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999988  456788897643221        112457889999999999999888878777788899999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      |+++++|.+++....    . .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999987532    1 7889999999999999998   999999999999999 78999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=8.6e-16  Score=154.45  Aligned_cols=130  Identities=15%  Similarity=0.280  Sum_probs=107.3

Q ss_pred             hcCcccceeEEEEEEcCCCEEEEEEEccCCc---h-----hhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEee
Q 003555          516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---E-----EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      .||+|+||.||+|..  .+..|++|+.....   .     ....++.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999996  35778999854321   1     1235678899999999998876666666667778999999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      +++++|.+++.....        .++.+++.+|.+||+.   +++|+|++|+||+++ ++.+++.|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998865211        7899999999999998   999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=1.1e-15  Score=153.52  Aligned_cols=137  Identities=18%  Similarity=0.159  Sum_probs=108.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCch----------------------hhHHHHHHHHHHHhccCCCC-
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE----------------------EGERKFQAEMAAVRRTHHKN-  567 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~n-  567 (811)
                      +.+.+.||+|+||.||++... +++.||||++.....                      .....+..|+..+..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            566789999999999999885 578999998653210                      01123677899999998874 


Q ss_pred             -ccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC
Q 003555          568 -LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS  646 (811)
Q Consensus       568 -iv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~  646 (811)
                       ++..++    ....++||||+++++|......       .....++.+++.++.++|+.   +|+|+||||+||+++++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence             444443    2456899999999999876431       34567889999999999998   99999999999999999


Q ss_pred             CCeEEEecCCccccCC
Q 003555          647 LTAKISNFSLAKILMP  662 (811)
Q Consensus       647 ~~~kL~DFGla~~~~~  662 (811)
                      +.++|+|||++.....
T Consensus       162 ~~~~liDfg~~~~~~~  177 (198)
T cd05144         162 EKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CcEEEEECCccccCCC
Confidence            9999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=1.2e-15  Score=176.58  Aligned_cols=135  Identities=15%  Similarity=0.252  Sum_probs=109.7

Q ss_pred             hhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc------hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV------EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      ...+.||+|+||+||+|.+......+.++..+...      ....+.+.+|++++++++|++++....++.+....++||
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            34578999999999999985543222222211111      112356889999999999999998888888877889999


Q ss_pred             eecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       586 ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ||+++++|.+++.         ....++.+++++|.|||+.   +++||||||+|||+ +++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999885         3567999999999999998   99999999999999 678999999999975

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=8.3e-17  Score=172.77  Aligned_cols=171  Identities=23%  Similarity=0.298  Sum_probs=128.6

Q ss_pred             ceeEEEeecCCCCHHHHhhcC--CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          580 KKLLVYEFMSKGSLENLLSNV--ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       580 ~~~lV~ey~~~gsL~~~l~~~--~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      ..++.|++|...+|.+||.+.  ....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999754  3456788889999999999999   5   8999999999999999999999999998


Q ss_pred             cccCCCC-----CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccchhhHHHHHHHhh
Q 003555          658 KILMPNQ-----TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCF  731 (811)
Q Consensus       658 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~  731 (811)
                      .......     ....+...||+.||+||.+.+..|+.|+|||+||++|+|++. -...++....               
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t---------------  468 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT---------------  468 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------------
Confidence            8765544     234556789999999999999999999999999999999996 2223221110               


Q ss_pred             hhcccchhcCCccc-cChHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 003555          732 IAKELSKLVGEDEE-VDLRTLETMVRVGLLCIQDEPNLRPSMKNV  775 (811)
Q Consensus       732 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  775 (811)
                          +.++-+.... ........-..++.+++.+.|.+||++.++
T Consensus       469 ----~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  469 ----LTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ----hhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence                0111111000 001111233477889999999999954443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=2.1e-15  Score=155.17  Aligned_cols=196  Identities=19%  Similarity=0.211  Sum_probs=135.5

Q ss_pred             CCCCccceecEEec---------------------------ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHH
Q 003555          564 HHKNLVRLLGFCMQ---------------------------TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDV  616 (811)
Q Consensus       564 ~h~niv~l~g~~~~---------------------------~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~i  616 (811)
                      +|||||++.++|.+                           ....||||...+. +|.++|-..  .++.....-|+.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence            68999988887753                           2356899988766 899998642  34556667788999


Q ss_pred             HHHHHHHhhccCCCeeecCCCCCcEEE--CCCC--CeEEEecCCccccCCCC-----CccccccccCCCccCccccccCC
Q 003555          617 ARGITYLHEECEVQIIHCNINPRNILL--DDSL--TAKISNFSLAKILMPNQ-----TGIVTGVKGTRGYMSPEWQNSGL  687 (811)
Q Consensus       617 a~~L~yLH~~~~~~ivH~Dik~~NIll--~~~~--~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~  687 (811)
                      ++|+.|||.+   +|.|||+|.+||||  |++.  ...|+|||.+-.-....     ........|.-.-||||+....+
T Consensus       351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999   99999999999999  4444  57889999764321100     01112244677899999865432


Q ss_pred             ------CCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHc
Q 003555          688 ------ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLC  761 (811)
Q Consensus       688 ------~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  761 (811)
                            --.|+|.|+.|.+.||++....||....+.  ......     +.+.+       ....+......+.+++...
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem--~L~~r~-----Yqe~q-------LPalp~~vpp~~rqlV~~l  493 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM--LLDTRT-----YQESQ-------LPALPSRVPPVARQLVFDL  493 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchh--eechhh-----hhhhh-------CCCCcccCChHHHHHHHHH
Confidence                  124899999999999999999999852211  000000     01111       1122445566788999999


Q ss_pred             ccCCCCCCCCHHHHHHHh
Q 003555          762 IQDEPNLRPSMKNVILML  779 (811)
Q Consensus       762 l~~dP~~RPs~~evl~~L  779 (811)
                      |+.||.+||+..-....|
T Consensus       494 L~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  494 LKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hcCCccccCCccHHHhHH
Confidence            999999999976444333

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=1.9e-15  Score=172.99  Aligned_cols=203  Identities=20%  Similarity=0.242  Sum_probs=142.2

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCH
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      .+.|..|++|.||..+++...++.|+|+-++..      +.+-  ++.....+.+|                     |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence            367999999999999999888899995432110      0000  11112222222                     566


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCC--------
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--------  665 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~--------  665 (811)
                      ...++.....+.         +.+.+++|||+.   +|+|||+||+|.+|+.-|.+|+.|||+++.......        
T Consensus       139 ~tllk~~g~lPv---------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I  206 (1205)
T KOG0606|consen  139 ATLLKNIGPLPV---------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI  206 (1205)
T ss_pred             hhhcccCCCCcc---------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence            666665333221         227899999998   999999999999999999999999999986432110        


Q ss_pred             ----c--cccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          666 ----G--IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       666 ----~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                          +  .....+||+.|+|||++....|....|.|++|+++||.+-|..||....+++-...+   +.      ....+
T Consensus       207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---is------d~i~w  277 (1205)
T KOG0606|consen  207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---IS------DDIEW  277 (1205)
T ss_pred             HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh---hh------hhccc
Confidence                0  122457999999999999999999999999999999999999999876554321111   00      01111


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCCCC
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRP  770 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  770 (811)
                      .    +.+.....+..+++.+.|+.+|..|-
T Consensus       278 p----E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 P----EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             c----ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            1    12344556778888999999999994

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=2.1e-14  Score=142.75  Aligned_cols=135  Identities=19%  Similarity=0.243  Sum_probs=96.8

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchh--hHHH----------------------HHHHHHHHhccCCCC--
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--GERK----------------------FQAEMAAVRRTHHKN--  567 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--  567 (811)
                      .+.||+|+||+||+|... +++.||||++......  ....                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 5789999987643211  1111                      134566666664433  


Q ss_pred             ccceecEEecccceeEEEeecCCCCHHH-HhhcCCCCCchHHHHHHHHHHHHHHHHHhh-ccCCCeeecCCCCCcEEECC
Q 003555          568 LVRLLGFCMQTSKKLLVYEFMSKGSLEN-LLSNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDD  645 (811)
Q Consensus       568 iv~l~g~~~~~~~~~lV~ey~~~gsL~~-~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dik~~NIll~~  645 (811)
                      +.+.+++    ...++||||++++.+.. .+.....   ..+...++.+++.++.++|. .   +|+|+||||+||+++ 
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            4444433    24589999999954321 1111110   15677899999999999999 7   999999999999999 


Q ss_pred             CCCeEEEecCCcccc
Q 003555          646 SLTAKISNFSLAKIL  660 (811)
Q Consensus       646 ~~~~kL~DFGla~~~  660 (811)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=4.1e-14  Score=134.89  Aligned_cols=134  Identities=19%  Similarity=0.192  Sum_probs=114.6

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCC--CCccceecEEecccceeEEEeecCCC
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH--KNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      .+.||+|.++.||++...+  ..++||.......  ...+.+|+..++.++|  .++++++++...++..++++||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            3679999999999999854  6899999865433  5678999999999977  58999999888888899999999988


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      .+..+        +......++.+++++|++||.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654        3466778899999999999986445799999999999999999999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=2.4e-15  Score=173.10  Aligned_cols=253  Identities=21%  Similarity=0.302  Sum_probs=190.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCC-CEEEEEEEccCCc--hhhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEe
Q 003555          511 NGFEEELGRGCFGAVYKGSICEG-NKIVAVKRLENPV--EEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~-~~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      +++.+.||+|+|+.|-......+ ...+|+|.+....  ....+....|..+-..+. |+|++++++...+.+..+++.|
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~  101 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS  101 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence            45556799999999998877443 3468888776443  233344555777777776 9999999999999999999999


Q ss_pred             ecCCCCHHHHh-hcCCCCCchHHHHHHHHHHHHHHHHHh-hccCCCeeecCCCCCcEEECCCC-CeEEEecCCccccCC-
Q 003555          587 FMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITYLH-EECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMP-  662 (811)
Q Consensus       587 y~~~gsL~~~l-~~~~~~~~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dik~~NIll~~~~-~~kL~DFGla~~~~~-  662 (811)
                      |..++++.+.+ +......+....-..+.|+..++.|+| ..   ++.|+||||+|.+++..+ ..+++|||+|..+.. 
T Consensus       102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999 443335566777789999999999999 77   999999999999999999 999999999998776 


Q ss_pred             CC-Ccccccccc-CCCccCccccccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchh
Q 003555          663 NQ-TGIVTGVKG-TRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       663 ~~-~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      .. ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+..........  ..|....   ...   
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~~~~~---~~~---  250 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSWKSNK---GRF---  250 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--eeecccc---ccc---
Confidence            32 334445678 9999999988774 56778999999999999999999998665443221  1111000   000   


Q ss_pred             cCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~  777 (811)
                         .............++...++..+|..|.+.+++..
T Consensus       251 ---~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  251 ---TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---ccCccccCChhhhhcccccccCCchhccccccccc
Confidence               01112223445667777888899999999888753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.49  E-value=2e-13  Score=140.44  Aligned_cols=134  Identities=15%  Similarity=0.127  Sum_probs=105.0

Q ss_pred             hhcC-cccceeEEEEEEcCCCEEEEEEEccCCc-------------hhhHHHHHHHHHHHhccCCCCc--cceecEEecc
Q 003555          515 EELG-RGCFGAVYKGSICEGNKIVAVKRLENPV-------------EEGERKFQAEMAAVRRTHHKNL--VRLLGFCMQT  578 (811)
Q Consensus       515 ~~LG-~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~  578 (811)
                      ..|| .|+.|+||++...  +..++||+++...             ......+.+|+.++.+++|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4687 8999999999884  5678999775311             1223568889999999998885  6777765443


Q ss_pred             c----ceeEEEeecCC-CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          579 S----KKLLVYEFMSK-GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       579 ~----~~~lV~ey~~~-gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                      .    ..++|+|++++ .+|.+++...  .++.    ..+.+|+.+|.+||+.   +|+|+||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence            2    22599999997 6999998652  2222    2467899999999999   999999999999999989999999


Q ss_pred             cCCccc
Q 003555          654 FSLAKI  659 (811)
Q Consensus       654 FGla~~  659 (811)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999875

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=4.6e-13  Score=135.15  Aligned_cols=211  Identities=21%  Similarity=0.312  Sum_probs=145.3

Q ss_pred             hhHHHHHHHHHHHhccCCCCccceecEEeccc-----ceeEEEeecCCCCHHHHhhcCC---CCCchHHHHHHHHHHHHH
Q 003555          548 EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-----KKLLVYEFMSKGSLENLLSNVE---SGPIWRDRVRIALDVARG  619 (811)
Q Consensus       548 ~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lV~ey~~~gsL~~~l~~~~---~~~~~~~~~~i~~~ia~~  619 (811)
                      ..++....-+..|-++-|.|||++..|..+..     +..++.|||+.|+|..+|++..   ..+......+++.||..|
T Consensus       109 ~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsa  188 (458)
T KOG1266|consen  109 EQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSA  188 (458)
T ss_pred             hCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            33444555566677778999999999886543     5789999999999999998653   345667778899999999


Q ss_pred             HHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccC---CCCCccccccccCCCccCccccccCCCCcccchHH
Q 003555          620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM---PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYS  696 (811)
Q Consensus       620 L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S  696 (811)
                      |.|||+ |.|+|+|+++..+.|++..++-+|+.--.-.....   ...........+-++|.|||+-.....+-.+|||+
T Consensus       189 l~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~  267 (458)
T KOG1266|consen  189 LSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK  267 (458)
T ss_pred             hhhhhc-cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence            999998 57899999999999999999999985322111100   00111122245678999999988888889999999


Q ss_pred             HHHHHHHHHhCCCCCC-CCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 003555          697 FGVVVLEIVCCRSNFE-VNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV  775 (811)
Q Consensus       697 ~Gvll~elltg~~p~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev  775 (811)
                      ||+..+||--+..-.. ...........         . .....+...         .-..++..|++..|..||+|+++
T Consensus       268 fgmcAlemailEiq~tnseS~~~~ee~i---------a-~~i~~len~---------lqr~~i~kcl~~eP~~rp~ar~l  328 (458)
T KOG1266|consen  268 FGMCALEMAILEIQSTNSESKVEVEENI---------A-NVIIGLENG---------LQRGSITKCLEGEPNGRPDARLL  328 (458)
T ss_pred             hhHHHHHHHHheeccCCCcceeehhhhh---------h-hheeeccCc---------cccCcCcccccCCCCCCcchhhh
Confidence            9999999976654321 11111000000         0 000000000         11245677999999999999988


Q ss_pred             HHH
Q 003555          776 ILM  778 (811)
Q Consensus       776 l~~  778 (811)
                      +..
T Consensus       329 lfH  331 (458)
T KOG1266|consen  329 LFH  331 (458)
T ss_pred             hcC
Confidence            743

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=2.1e-12  Score=144.52  Aligned_cols=140  Identities=22%  Similarity=0.296  Sum_probs=101.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhh----------------------------------------HHHHH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG----------------------------------------ERKFQ  554 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~----------------------------------------~~~~~  554 (811)
                      +.||+|++|.||+|++++ ++.||||+.+....+.                                        +-+|.
T Consensus       123 ~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            469999999999999975 6899999986542111                                        11245


Q ss_pred             HHHHHHhcc----CCCCccceecEEec-ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHH-HHHHHhhccC
Q 003555          555 AEMAAVRRT----HHKNLVRLLGFCMQ-TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR-GITYLHEECE  628 (811)
Q Consensus       555 ~E~~~l~~l----~h~niv~l~g~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~-~L~yLH~~~~  628 (811)
                      +|+..+.++    +|.+-+.+-.++.+ ....+|||||+++++|.+++.......   .+.+++..++. .+..+|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence            566655555    23344444444433 346799999999999988765322222   34567777666 46788887  


Q ss_pred             CCeeecCCCCCcEEECCCCCeEEEecCCccccC
Q 003555          629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       629 ~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~  661 (811)
                       +++|+|+||.||++++++.++|.|||++..+.
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             99999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=3.8e-12  Score=139.99  Aligned_cols=254  Identities=20%  Similarity=0.224  Sum_probs=188.5

Q ss_pred             hhHHHHHHhhhhhhcCc--ccceeEEEEEE--cCCCEEEEEEEccCCch--hhHHHHHHHHHHHhcc-CCCCccceecEE
Q 003555          503 TGELERATNGFEEELGR--GCFGAVYKGSI--CEGNKIVAVKRLENPVE--EGERKFQAEMAAVRRT-HHKNLVRLLGFC  575 (811)
Q Consensus       503 ~~el~~~~~~~~~~LG~--G~fg~Vy~g~~--~~~~~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~  575 (811)
                      ..+.......+.+.+|.  |.+|.||.+..  ..+...+|+|+-+....  .....-.+|+...+++ .|+|.++....+
T Consensus       108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            34566667777889999  99999999998  77788999998554333  3344456677777777 599999988888


Q ss_pred             ecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHH----HHHHHhhccCCCeeecCCCCCcEEECCC-CCeE
Q 003555          576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR----GITYLHEECEVQIIHCNINPRNILLDDS-LTAK  650 (811)
Q Consensus       576 ~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dik~~NIll~~~-~~~k  650 (811)
                      ...+..++-+|++. .+|..+-+.....+.....+.+..+..+    ||.++|..   .++|-|+||.||++..+ ...+
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceee
Confidence            89999999999886 6888888776555566677777777777    99999998   99999999999999999 8999


Q ss_pred             EEecCCccccCCCCCcc----ccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHH
Q 003555          651 ISNFSLAKILMPNQTGI----VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW  726 (811)
Q Consensus       651 L~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~  726 (811)
                      +.|||+...+.......    .....|...|++||... +.++...|+|++|.+++|..++..........       .|
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SW  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cc
Confidence            99999998877654221    22346778899999665 56688999999999999999988776543111       11


Q ss_pred             HHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 003555          727 VYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI  776 (811)
Q Consensus       727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl  776 (811)
                      .       .......+ .+.-.....++..++.++++.+|..|++.+.+.
T Consensus       336 ~-------~~r~~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  336 S-------QLRQGYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             c-------ccccccCc-hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            0       00111111 111111223344488889999999999987665

>PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions []

Probab=99.26  E-value=3e-12  Score=102.66  Aligned_cols=59  Identities=25%  Similarity=0.537  Sum_probs=49.5

Q ss_pred             ccceeeeeeecccCCCccccccccCChhhHHhhcccCcccccceecc----cccccccccceec
Q 003555          347 PAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYAN----ASCSKHKLPLIFA  406 (811)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~y~~----~~C~~~~~~l~~~  406 (811)
                      .++|+++.+|++|+.... ....++++++|+..||+||||+||+|.+    ++|++|.++|+|.
T Consensus         4 ~d~F~~l~~~~~p~~~~~-~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~   66 (66)
T PF08276_consen    4 GDGFLKLPNMKLPDFDNA-IVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL   66 (66)
T ss_pred             CCEEEEECCeeCCCCcce-eeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence            479999999998876433 2335699999999999999999999974    6899999999874

These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.22  E-value=9.7e-11  Score=129.94  Aligned_cols=170  Identities=15%  Similarity=0.219  Sum_probs=129.6

Q ss_pred             EEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCch
Q 003555          527 KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW  606 (811)
Q Consensus       527 ~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~  606 (811)
                      .|..+.++.+|.|+..+....+......+-++.|+.++||||++++.....+...|||+|.+.  .|..++.+..    .
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~  103 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----K  103 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----H
Confidence            567777788999998876655445567888999999999999999999999999999999874  5777776533    3


Q ss_pred             HHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccccCCCccCccccccC
Q 003555          607 RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG  686 (811)
Q Consensus       607 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  686 (811)
                      ....-.+.||+.||.|||+.|  +++|++|....|+|+..|..||++|.+......... ......--..|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence            455667889999999999775  899999999999999999999999988765322111 11111112245566543222


Q ss_pred             CCCcccchHHHHHHHHHHHhC
Q 003555          687 LITVKSDVYSFGVVVLEIVCC  707 (811)
Q Consensus       687 ~~t~ksDV~S~Gvll~elltg  707 (811)
                      .  -..|.|.||++++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            1  346999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=5.3e-11  Score=116.17  Aligned_cols=130  Identities=19%  Similarity=0.178  Sum_probs=97.2

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCcc-ceecEEecccceeEEEeecCCCCH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV-RLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      +.|+.|.++.||+++..  ++.|++|....... ....+..|+..++.+.+.+++ +++.+.  ....++||||+++.++
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            56899999999999874  67899999754322 234568899999988665554 455443  3345899999999887


Q ss_pred             HHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhcc--CCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          594 ENLLSNVESGPIWRDRVRIALDVARGITYLHEEC--EVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       594 ~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ....         .....+..+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6430         112345679999999999972  22369999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.21  E-value=9e-11  Score=132.75  Aligned_cols=142  Identities=15%  Similarity=0.171  Sum_probs=93.3

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhh----------------------------------H------HHHH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG----------------------------------E------RKFQ  554 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~----------------------------------~------~~~~  554 (811)
                      +.||+|++|+||+|+++++++.||||++++...+.                                  .      -+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            47999999999999998878999999987542110                                  1      1244


Q ss_pred             HHHHHHhccC----CCCccceecEEec-ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHH-HHHHHhhccC
Q 003555          555 AEMAAVRRTH----HKNLVRLLGFCMQ-TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR-GITYLHEECE  628 (811)
Q Consensus       555 ~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~-~L~yLH~~~~  628 (811)
                      +|+..+.+++    +.+.+.+-.++.+ ....+|||||++|+.|.++-.-.....+..   .++...+. -+.-++..  
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Qif~~--  279 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQVFRD--  279 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHHHHhC--
Confidence            4555554442    4444444444444 456789999999999987532111122111   12221111 12223334  


Q ss_pred             CCeeecCCCCCcEEECCCC----CeEEEecCCccccCC
Q 003555          629 VQIIHCNINPRNILLDDSL----TAKISNFSLAKILMP  662 (811)
Q Consensus       629 ~~ivH~Dik~~NIll~~~~----~~kL~DFGla~~~~~  662 (811)
                       +++|+|+||.||+++.++    .+++.|||+...+..
T Consensus       280 -GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        280 -GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence             999999999999999888    999999999987644

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=6.2e-11  Score=130.54  Aligned_cols=244  Identities=20%  Similarity=0.165  Sum_probs=175.4

Q ss_pred             hhhhhcCcccceeEEEEEEc-CCCEEEEEEEccCCchhhHH--HHHHHHHHHhcc-CCCCccceecEEecccceeEEEee
Q 003555          512 GFEEELGRGCFGAVYKGSIC-EGNKIVAVKRLENPVEEGER--KFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       512 ~~~~~LG~G~fg~Vy~g~~~-~~~~~vAvK~l~~~~~~~~~--~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ey  587 (811)
                      ++...||.|.|+.|++.... .++..+++|.+.+.......  .-..|+.+...+ .|.+++++...+...+..++--||
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            33468999999999998766 67789999988765433332  234566666665 688889888777777788899999


Q ss_pred             cCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC-CCeEEEecCCccccCCCCCc
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-LTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~-~~~kL~DFGla~~~~~~~~~  666 (811)
                      ++++++...+. ....+....++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||.+..+.   ..
T Consensus       348 ~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~---~~  420 (524)
T KOG0601|consen  348 CEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA---FS  420 (524)
T ss_pred             hcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc---ee
Confidence            99998877662 233456778899999999999999998   99999999999999876 889999999986421   11


Q ss_pred             cccccccCCCc-cCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccc
Q 003555          667 IVTGVKGTRGY-MSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       667 ~~~~~~gt~~y-~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......+..| .+|+......+-.+.|++|||.-+.|.+++..........                   ..+......
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------------------~~i~~~~~p  481 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------------------LTIRSGDTP  481 (524)
T ss_pred             cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------------------eeeeccccc
Confidence            11222334445 4666777788999999999999999999887654322111                   111111111


Q ss_pred             cChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhhc
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       746 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ..+.....+..+...++..++..||.+.++..+.+.
T Consensus       482 ~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  482 NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            122223556667777999999999999988766543

>cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins

Probab=99.10  E-value=6.2e-11  Score=98.09  Aligned_cols=66  Identities=15%  Similarity=0.206  Sum_probs=56.9

Q ss_pred             ccceeeeeeecccCCCccccccccCChhhHHhhccc---Ccccccceecc--cccccccccc-eecccccCCccceEEe
Q 003555          347 PAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLN---DCYCGAAIYAN--ASCSKHKLPL-IFAMKYQNVPATLFIK  419 (811)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~A~~y~~--~~C~~~~~~l-~~~~~~~~~~~~~y~k  419 (811)
                      +..|+++.+++.|+...       +++++|++.|++   ||||+||+|.+  .+|.+|.++| .+.+.+.+.+.++|+|
T Consensus         8 ~g~fl~~~~~klpd~~~-------~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r   79 (80)
T cd00129           8 AGTTLIKIALKIKTTKA-------NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN   79 (80)
T ss_pred             CCeEEEeecccCCcccc-------cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence            35788888888777532       689999999999   99999999963  5899999999 9999888778999998

Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins

Probab=99.04  E-value=2e-10  Score=97.79  Aligned_cols=78  Identities=22%  Similarity=0.445  Sum_probs=58.0

Q ss_pred             CccccC-ccceeeeeeecccCCCccccccccCChhhHHhhcccCcccccceecc--cccccccccceecccccCCccceE
Q 003555          341 GCKRKM-PAEFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLNDCYCGAAIYAN--ASCSKHKLPLIFAMKYQNVPATLF  417 (811)
Q Consensus       341 ~C~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~A~~y~~--~~C~~~~~~l~~~~~~~~~~~~~y  417 (811)
                      .|.+.. ..+|+.+.+++.++   ..+...++++++|++.||+||+|+||+|.+  ++|++|..++.+.+.....+.++|
T Consensus         4 ~C~~~~~~~~f~~~~~~~~~~---~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~y   80 (84)
T cd01098           4 NCGGDGSTDGFLKLPDVKLPD---NASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLY   80 (84)
T ss_pred             ccCCCCCCCEEEEeCCeeCCC---chhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEE
Confidence            464432 24666666555543   333226789999999999999999999974  789999999998776555568899


Q ss_pred             Eeec
Q 003555          418 IKWS  421 (811)
Q Consensus       418 ~k~~  421 (811)
                      ||++
T Consensus        81 iKv~   84 (84)
T cd01098          81 LRLA   84 (84)
T ss_pred             EEeC
Confidence            9974

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.02  E-value=3.6e-09  Score=104.13  Aligned_cols=136  Identities=15%  Similarity=0.141  Sum_probs=97.5

Q ss_pred             hhcCcccceeEEEEEEcC------CCEEEEEEEccCCc----------------------hhhHHHH----HHHHHHHhc
Q 003555          515 EELGRGCFGAVYKGSICE------GNKIVAVKRLENPV----------------------EEGERKF----QAEMAAVRR  562 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~------~~~~vAvK~l~~~~----------------------~~~~~~~----~~E~~~l~~  562 (811)
                      ..||.|.-+.||.|...+      .+..+|||+.+...                      ....+.+    .+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998654      24689999753110                      0011223    379999999


Q ss_pred             cCC--CCccceecEEecccceeEEEeecCCCCHHH-HhhcCCCCCchHHHHHHHHHHHHHHHHH-hhccCCCeeecCCCC
Q 003555          563 THH--KNLVRLLGFCMQTSKKLLVYEFMSKGSLEN-LLSNVESGPIWRDRVRIALDVARGITYL-HEECEVQIIHCNINP  638 (811)
Q Consensus       563 l~h--~niv~l~g~~~~~~~~~lV~ey~~~gsL~~-~l~~~~~~~~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dik~  638 (811)
                      +..  -+++..+.+    ...+|||||+.+..+.. .|.+.  .+...+..++..+++.+|..| |+.   +++|+||++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence            854  456666754    56789999998754422 23221  223345567889999999999 777   999999999


Q ss_pred             CcEEECCCCCeEEEecCCcccc
Q 003555          639 RNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       639 ~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .||++++ +.+.|+|||.+...
T Consensus       154 ~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEEC-CcEEEEECCCceeC
Confidence            9999974 68999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.01  E-value=2e-09  Score=109.86  Aligned_cols=142  Identities=16%  Similarity=0.210  Sum_probs=109.9

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCch-hhHHHHHHHHHHHhccCCC--CccceecEEeccc---ceeEEEeec
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVE-EGERKFQAEMAAVRRTHHK--NLVRLLGFCMQTS---KKLLVYEFM  588 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~---~~~lV~ey~  588 (811)
                      +.|+.|..+.||++...+ ++.+++|....... .....+..|+++++.+++.  ++++++.+..+..   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            568999999999998854 47899998764322 2456789999999999764  4577887776643   568999999


Q ss_pred             CCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhcc-----------------------------------------
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC-----------------------------------------  627 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------------  627 (811)
                      ++.++.+.+..  ...+..++..++.+++++|..||+..                                         
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99988776542  23556677788888888888888531                                         


Q ss_pred             ------------CCCeeecCCCCCcEEECC--CCCeEEEecCCccc
Q 003555          628 ------------EVQIIHCNINPRNILLDD--SLTAKISNFSLAKI  659 (811)
Q Consensus       628 ------------~~~ivH~Dik~~NIll~~--~~~~kL~DFGla~~  659 (811)
                                  ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        246899999999999998  67789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=6.9e-09  Score=111.73  Aligned_cols=168  Identities=16%  Similarity=0.218  Sum_probs=133.9

Q ss_pred             ceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCccceecEEe----cccceeEEEeecCC-CCHHHH
Q 003555          522 FGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM----QTSKKLLVYEFMSK-GSLENL  596 (811)
Q Consensus       522 fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lV~ey~~~-gsL~~~  596 (811)
                      -.+.||+...-++..|++|+++....+.......-++..+++.|.|+|++.+++.    .+...++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3678999999899999999996544444445556788999999999999999887    34478999999986 478887


Q ss_pred             hhcCC--------------CCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          597 LSNVE--------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       597 l~~~~--------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      .+...              .+..+...+.++.|++.||.++|+.   +..-+-|.+++||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            65432              1234678899999999999999999   999999999999999999999999998877654


Q ss_pred             CCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCC
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSN  710 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p  710 (811)
                      +....               +..   -.+-|.=.||.+++.|-||...
T Consensus       446 d~~~~---------------le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTEP---------------LES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCcc---------------hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            43111               111   2378999999999999999765

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=1.3e-08  Score=96.58  Aligned_cols=131  Identities=18%  Similarity=0.289  Sum_probs=103.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEc-cCCc--h---h--hHHHHHHHHHHHhccCCCCccceecEEecccceeEEEe
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPV--E---E--GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l-~~~~--~---~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      ..+++|+-+.+|.+.+.+  ..+.+|.- .+..  +   +  ..+.-.+|+.+|.+++--.|.--+=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            357899999999997743  34666632 2211  1   1  12346789999999987777766667778888899999


Q ss_pred             ecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       587 y~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      |+++..|.+.+...        +..++..|-.-+.-||..   +|+|+||.++||++.... +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999999764        367888888999999999   999999999999998775 99999999974

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.87  E-value=2.1e-08  Score=94.44  Aligned_cols=141  Identities=18%  Similarity=0.294  Sum_probs=106.4

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEE-ccC----Cc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEE
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKR-LEN----PV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~-l~~----~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      .+.|-+|+-+.|+++...  ++...||. +.+    +.   .-..++..+|++.|.+++--.|.--.-++.+...-.|+|
T Consensus        12 l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             ceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            356889999999999984  46666663 222    11   122356788999999987667766666677777778999


Q ss_pred             eecCC-CCHHHHhhcCCCCCchHHH-HHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC---CCeEEEecCCccc
Q 003555          586 EFMSK-GSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS---LTAKISNFSLAKI  659 (811)
Q Consensus       586 ey~~~-gsL~~~l~~~~~~~~~~~~-~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~---~~~kL~DFGla~~  659 (811)
                      ||+++ .++.+++...-........ ..++..|-+.+.-||.+   .|+|+||..+||+|..+   ..+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 5788888765433333444 78999999999999999   99999999999999644   3468999999864

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.72  E-value=1.6e-07  Score=97.84  Aligned_cols=132  Identities=19%  Similarity=0.138  Sum_probs=97.5

Q ss_pred             eeEEEEEEcCCCEEEEEEEccCCch-hhH----------HHHHHHHHHHhccCCCCc--cceecEEec-----ccceeEE
Q 003555          523 GAVYKGSICEGNKIVAVKRLENPVE-EGE----------RKFQAEMAAVRRTHHKNL--VRLLGFCMQ-----TSKKLLV  584 (811)
Q Consensus       523 g~Vy~g~~~~~~~~vAvK~l~~~~~-~~~----------~~~~~E~~~l~~l~h~ni--v~l~g~~~~-----~~~~~lV  584 (811)
                      ..|++...  +++.+.||+...... +..          ..+.+|...+.++...+|  +..+++...     ....+||
T Consensus        36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            34667665  467899997643221 111          247899999998855444  445666543     2356899


Q ss_pred             EeecCCC-CHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECC-------CCCeEEEecC
Q 003555          585 YEFMSKG-SLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-------SLTAKISNFS  655 (811)
Q Consensus       585 ~ey~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~-------~~~~kL~DFG  655 (811)
                      +|++++- +|.+++... ........+..++.+++..+.-||+.   +|+|+|++++|||++.       +..+.|+||+
T Consensus       114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            9999986 899998642 23344567778999999999999999   9999999999999975       5789999999


Q ss_pred             Cccc
Q 003555          656 LAKI  659 (811)
Q Consensus       656 la~~  659 (811)
                      .++.
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.70  E-value=4.5e-09  Score=121.65  Aligned_cols=242  Identities=15%  Similarity=0.108  Sum_probs=158.1

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc---hhhHHHHHHHHHHHhccCCCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +-+-+|.++.++.+.-...+...++|......   ....+....+-.++-..+||-++...--+.......|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            46778888888877655544444444432111   111112222222222223444444433334456778999999999


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCC---------
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP---------  662 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~---------  662 (811)
                      +|...|+.... .+.......+..+..++.|||..   .+.|+|++|.|++...++..+++|||......-         
T Consensus       890 ~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg  965 (1205)
T KOG0606|consen  890 DLPSKLHNSGC-LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG  965 (1205)
T ss_pred             CchhhhhcCCC-cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence            99999987542 22222333455678899999997   799999999999999999999999984332110         


Q ss_pred             ------------CC---------CccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccchh
Q 003555          663 ------------NQ---------TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV  721 (811)
Q Consensus       663 ------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~~~~~~~~~~~  721 (811)
                                  ..         ........||+.|.+||...+......+|.|++|+.++|.++|..||......... 
T Consensus       966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f- 1044 (1205)
T KOG0606|consen  966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF- 1044 (1205)
T ss_pred             ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh-
Confidence                        00         01122356899999999999999999999999999999999999999865443211 


Q ss_pred             hHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHH
Q 003555          722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMK  773 (811)
Q Consensus       722 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~  773 (811)
                                  +.+.....+-.........++.+++...+..+|.+|-.|.
T Consensus      1045 ------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1045 ------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             ------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence                        1111111111233445566777888888899999997766

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.67  E-value=4.9e-07  Score=95.28  Aligned_cols=258  Identities=16%  Similarity=0.158  Sum_probs=152.3

Q ss_pred             hhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhcc-CCCCccceecEE-------ecccceeEEE
Q 003555          514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFC-------MQTSKKLLVY  585 (811)
Q Consensus       514 ~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------~~~~~~~lV~  585 (811)
                      +..||+|+-+.+|-.-.-.+   -+-|+..........+...|   |... .||-+-.-+.+=       ..+...-++|
T Consensus        16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CccccCCccceeeecchhhc---hhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            46799999999996432211   23465554444333333332   2222 344332211110       1112245677


Q ss_pred             eecCCC-CHHHHhhcC-----CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          586 EFMSKG-SLENLLSNV-----ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       586 ey~~~g-sL~~~l~~~-----~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ..+++. .+..++.-.     -....|...++.++.+|.+.+-||+.   +.+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence            777664 233333211     12246999999999999999999999   999999999999999999999998665443


Q ss_pred             cCCCCCccccccccCCCccCccccc-----cCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCccch-hhHH-HHHHHhh
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCC-RSNFEVNVSTADV-VLLS-TWVYNCF  731 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvll~elltg-~~p~~~~~~~~~~-~~l~-~~~~~~~  731 (811)
                      .  .+........|...|.+||...     +-.-+...|.|.||+++++++.| +.||.......+. .-+. ......+
T Consensus       167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            3  2222334567899999999654     33457789999999999999987 8898753221110 0000 1111100


Q ss_pred             h-h-cccchhcCCccccChH-HHHHHHHHHHHcccC--CCCCCCCHHHHHHHhhcc
Q 003555          732 I-A-KELSKLVGEDEEVDLR-TLETMVRVGLLCIQD--EPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       732 ~-~-~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~--dP~~RPs~~evl~~L~~~  782 (811)
                      . . +............+.. ....+.-+..+|+..  ++.-|||++.++..|..+
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            0 0 0001111111111222 223455566677765  367899999999888653

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=2.5e-07  Score=90.82  Aligned_cols=124  Identities=19%  Similarity=0.218  Sum_probs=81.5

Q ss_pred             EEEEEEcCCCEEEEEEEccCCc--------------------------hhhHHHHHHHHHHHhccCCC--CccceecEEe
Q 003555          525 VYKGSICEGNKIVAVKRLENPV--------------------------EEGERKFQAEMAAVRRTHHK--NLVRLLGFCM  576 (811)
Q Consensus       525 Vy~g~~~~~~~~vAvK~l~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~  576 (811)
                      ||.|...+ +..+|||..+...                          ........+|++.|.++...  ++++++.+  
T Consensus         2 Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    2 VYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             EEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            89998865 5799999653210                          01123567899999999766  46666654  


Q ss_pred             cccceeEEEeecC--CCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHH-hhccCCCeeecCCCCCcEEECCCCCeEEEe
Q 003555          577 QTSKKLLVYEFMS--KGSLENLLSNVESGPIWRDRVRIALDVARGITYL-HEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       577 ~~~~~~lV~ey~~--~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dik~~NIll~~~~~~kL~D  653 (811)
                        ....|||||++  +..+..+....   ........++.+++..+..+ |..   +|+|+||.+.||+++++ .+.|+|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence              24589999998  54554433321   11344566778888866664 676   99999999999999988 999999


Q ss_pred             cCCcccc
Q 003555          654 FSLAKIL  660 (811)
Q Consensus       654 FGla~~~  660 (811)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.51  E-value=5.1e-07  Score=101.80  Aligned_cols=142  Identities=17%  Similarity=0.232  Sum_probs=95.0

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhh----------------------------------------HHHHH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG----------------------------------------ERKFQ  554 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~----------------------------------------~~~~~  554 (811)
                      +.|+.++-|+||+|++++ ++.||||+.++...+.                                        +-++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            468999999999999987 7899999875443211                                        11234


Q ss_pred             HHHHHHhcc----CCCCccceecEEec-ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCC
Q 003555          555 AEMAAVRRT----HHKNLVRLLGFCMQ-TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV  629 (811)
Q Consensus       555 ~E~~~l~~l----~h~niv~l~g~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  629 (811)
                      +|...+.++    ++..-+.+=.++.+ .....|+|||++|-.+.+...-.....+.+.......++.--.-+-  .   
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~--d---  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR--D---  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--c---
Confidence            454444444    23333444455544 4577999999999999888543334455333333322222222222  2   


Q ss_pred             CeeecCCCCCcEEECCCCCeEEEecCCccccCC
Q 003555          630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       630 ~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~  662 (811)
                      ++.|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            899999999999999999999999999887644

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=1e-06  Score=88.84  Aligned_cols=135  Identities=16%  Similarity=0.155  Sum_probs=94.6

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc----------------------hhhHHHHHHHHHHHhccCCC--
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV----------------------EEGERKFQAEMAAVRRTHHK--  566 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----------------------~~~~~~~~~E~~~l~~l~h~--  566 (811)
                      +.++++||.|.-+.||.|...+ +..+|||.-+...                      .......++|.+.|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            4567899999999999999975 5789999532111                      01123467899999999655  


Q ss_pred             CccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC
Q 003555          567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS  646 (811)
Q Consensus       567 niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~  646 (811)
                      .+++.+++    +...+||||+++-.|...--      +....-.|+..|++-+.-+-..   +|||+|+++-||+++++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            66666654    56789999999866654321      1122223344444444333344   99999999999999999


Q ss_pred             CCeEEEecCCccc
Q 003555          647 LTAKISNFSLAKI  659 (811)
Q Consensus       647 ~~~kL~DFGla~~  659 (811)
                      |.+.++||--+..
T Consensus       239 g~~~vIDwPQ~v~  251 (304)
T COG0478         239 GDIVVIDWPQAVP  251 (304)
T ss_pred             CCEEEEeCccccc
Confidence            9999999977654

>PRK09902 hypothetical protein; Provisional

Probab=98.48  E-value=2.8e-06  Score=83.91  Aligned_cols=137  Identities=18%  Similarity=0.137  Sum_probs=104.7

Q ss_pred             cCcccceeEEEEEEcCCCEEEEEEEccCCc------hhhHHHHHHHHHHHhccCCCC--ccceecEEecc-----cceeE
Q 003555          517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV------EEGERKFQAEMAAVRRTHHKN--LVRLLGFCMQT-----SKKLL  583 (811)
Q Consensus       517 LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~-----~~~~l  583 (811)
                      -|+||-+.|++-...  ++.+=+|+-+...      +-+...|.+|+..|.++...+  +++.+ ++...     -..+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            367999999998774  3468889765211      336778999999999995433  44555 33211     14689


Q ss_pred             EEeecCC-CCHHHHhhcC-CCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCC--eEEEecCCccc
Q 003555          584 VYEFMSK-GSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT--AKISNFSLAKI  659 (811)
Q Consensus       584 V~ey~~~-gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~--~kL~DFGla~~  659 (811)
                      |+|-+++ .+|.+++.+. ...++...+..++.+|+..++-||+.   ++.|+|+.+.||+++.++.  ++++||--++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997764 5899998654 23456777889999999999999999   9999999999999986666  99999987764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=1.4e-06  Score=87.89  Aligned_cols=107  Identities=21%  Similarity=0.275  Sum_probs=86.3

Q ss_pred             HHHHHHHHHHHhccCCCC--ccceecEEeccc----ceeEEEeecCCC-CHHHHhhcCCCCCchHHHHHHHHHHHHHHHH
Q 003555          550 ERKFQAEMAAVRRTHHKN--LVRLLGFCMQTS----KKLLVYEFMSKG-SLENLLSNVESGPIWRDRVRIALDVARGITY  622 (811)
Q Consensus       550 ~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~----~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~y  622 (811)
                      .....+|...+.++...+  .++.+++.....    ..+||+|++++. +|.+++..... .+......++.++++.++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            446888988888885444  456677766532    458999999984 89999986333 5556778899999999999


Q ss_pred             HhhccCCCeeecCCCCCcEEECCCC---CeEEEecCCcccc
Q 003555          623 LHEECEVQIIHCNINPRNILLDDSL---TAKISNFSLAKIL  660 (811)
Q Consensus       623 LH~~~~~~ivH~Dik~~NIll~~~~---~~kL~DFGla~~~  660 (811)
                      ||+.   +|+|+|+++.|||++.+.   .+.|+||+.++..
T Consensus       134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   999999999999999877   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.42  E-value=9.2e-08  Score=107.15  Aligned_cols=148  Identities=18%  Similarity=0.247  Sum_probs=102.8

Q ss_pred             HHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCcc--------ccccccCCCccCccccc
Q 003555          613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI--------VTGVKGTRGYMSPEWQN  684 (811)
Q Consensus       613 ~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~  684 (811)
                      +.+++.||.|+|..  .++||++|.|++|.++.++..||+.|+.+..........        ..-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            44566999999987  599999999999999999999999999876543311111        11123456899999999


Q ss_pred             cCCCCcccchHHHHHHHHHHHhCCCC-CCCCCCccchhhHHHHHHHhhhhcccchhcCC--ccccChHHHHHHHHHHHHc
Q 003555          685 SGLITVKSDVYSFGVVVLEIVCCRSN-FEVNVSTADVVLLSTWVYNCFIAKELSKLVGE--DEEVDLRTLETMVRVGLLC  761 (811)
Q Consensus       685 ~~~~t~ksDV~S~Gvll~elltg~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~c  761 (811)
                      +...+.++|+||+|+++|-+..|+++ +.........    .          .....+.  ......+.+.++.+=+..+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~----------~~~~~~~~~~~~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----S----------FSRNLLNAGAFGYSNNLPSELRESLKKL  248 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh----h----------hhhcccccccccccccCcHHHHHHHHHH
Confidence            98899999999999999999955544 3322111100    0          0000111  1122345566777778889


Q ss_pred             ccCCCCCCCCHHHHH
Q 003555          762 IQDEPNLRPSMKNVI  776 (811)
Q Consensus       762 l~~dP~~RPs~~evl  776 (811)
                      +..++..||++.++.
T Consensus       249 l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLL  263 (700)
T ss_pred             hcCCcccCcchhhhh
Confidence            999999999877665

>smart00108 B_lectin Bulb-type mannose-specific lectin

Probab=98.28  E-value=4.5e-06  Score=75.35  Aligned_cols=81  Identities=23%  Similarity=0.399  Sum_probs=57.9

Q ss_pred             EecCceEEEecCC--cceEeeccCCC-CCceeEEEecCCCeEEeeCCCceEEeecCCCccccccCccccCCCeEEecCCC
Q 003555           98 LTMDGLVLQTEES--KHKLIANTTSD-EPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASE  174 (811)
Q Consensus        98 ~~~~G~l~l~~~~--~~~w~~~~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~L~S~~s~  174 (811)
                      ...||++++.+..  ..+|+++.... .....+.|.++|||||++.++.++|+|=   |                     
T Consensus        26 ~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~---t---------------------   81 (114)
T smart00108       26 MQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSN---T---------------------   81 (114)
T ss_pred             CCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEec---c---------------------
Confidence            4478999998765  68899876433 2236789999999999999889999981   1                     


Q ss_pred             CCCCCcceEEE-ecCCceEEeeecCCcceeEe
Q 003555          175 TNSSTGRFCLE-QRDGILVLYPVRDSRQIYWV  205 (811)
Q Consensus       175 ~dps~G~y~l~-~~~~~~~~~~~~~~~~~~~~  205 (811)
                       ....|.|.+. +++|++++|...  .++.|.
T Consensus        82 -~~~~~~~~~~L~ddGnlvl~~~~--~~~~W~  110 (114)
T smart00108       82 -TGANGNYVLVLLDDGNLVIYDSD--GNFLWQ  110 (114)
T ss_pred             -cCCCCceEEEEeCCCCEEEECCC--CCEEeC
Confidence             0134668888 778999887432  234554

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=4.3e-06  Score=93.93  Aligned_cols=143  Identities=17%  Similarity=0.209  Sum_probs=93.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhh-------------------------------------HHHHHHHH
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-------------------------------------ERKFQAEM  557 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-------------------------------------~~~~~~E~  557 (811)
                      +.||..+.|.||+|++++ ++.||||+-++..+..                                     +-+|.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999987 7899999865432211                                     11355555


Q ss_pred             HHHhcc----CCCCc---cceecEEec-ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCC
Q 003555          558 AAVRRT----HHKNL---VRLLGFCMQ-TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV  629 (811)
Q Consensus       558 ~~l~~l----~h~ni---v~l~g~~~~-~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  629 (811)
                      +...+.    .|-++   |.+-.++.+ ...+.|+||||+|..+.+.-.-.+..++...+..-+.+...-+-+-     .
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~-----~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK-----T  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh-----c
Confidence            554443    45551   223333333 3478999999999877666433334454443333333332222222     2


Q ss_pred             CeeecCCCCCcEEEC----CCCCeEEEecCCccccCCC
Q 003555          630 QIIHCNINPRNILLD----DSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       630 ~ivH~Dik~~NIll~----~~~~~kL~DFGla~~~~~~  663 (811)
                      +++|+|=+|.||+++    .++.+.+.|||+.......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            899999999999998    3678999999999876443

>cd00028 B_lectin Bulb-type mannose-specific lectin

Probab=98.16  E-value=9.2e-06  Score=73.57  Aligned_cols=71  Identities=24%  Similarity=0.372  Sum_probs=54.0

Q ss_pred             CceEEEecCC--cceEeeccCC-CCCceeEEEecCCCeEEeeCCCceEEeecCCCccccccCccccCCCeEEecCCCCCC
Q 003555          101 DGLVLQTEES--KHKLIANTTS-DEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNS  177 (811)
Q Consensus       101 ~G~l~l~~~~--~~~w~~~~~~-~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PTDTlLpg~kl~~~~~L~S~~s~~dp  177 (811)
                      +|+|++.+..  ..+|++|... ......+.|.++|||||.+.++.++|||=-                         ..
T Consensus        30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~-------------------------~~   84 (116)
T cd00028          30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNT-------------------------TR   84 (116)
T ss_pred             eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecc-------------------------cC
Confidence            8999987664  6889987653 234567899999999999998999999821                         01


Q ss_pred             CCcceEEE-ecCCceEEeee
Q 003555          178 STGRFCLE-QRDGILVLYPV  196 (811)
Q Consensus       178 s~G~y~l~-~~~~~~~~~~~  196 (811)
                      +.+.+.+. +++|++++|..
T Consensus        85 ~~~~~~~~L~ddGnlvl~~~  104 (116)
T cd00028          85 VNGNYVLVLLDDGNLVLYDS  104 (116)
T ss_pred             CCCceEEEEeCCCCEEEECC
Confidence            24668888 78899998754

The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.12  E-value=3.2e-05  Score=79.01  Aligned_cols=138  Identities=12%  Similarity=0.172  Sum_probs=86.3

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC--ccceecEEecccceeEEEeecCCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN--LVRLLGFCMQTSKKLLVYEFMSKGS  592 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~ey~~~gs  592 (811)
                      +.||+|..+.||+..    +..+++|......  ......+|.++++.+..-+  +++.+++..+.+...+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            578999999999842    3356788876432  3445788999999986544  4678888888888889999999963


Q ss_pred             -HHHHh---------------------hcCC-CCCchHHHH-HHHH----------HHHH-HHHHHhhc-cCCCeeecCC
Q 003555          593 -LENLL---------------------SNVE-SGPIWRDRV-RIAL----------DVAR-GITYLHEE-CEVQIIHCNI  636 (811)
Q Consensus       593 -L~~~l---------------------~~~~-~~~~~~~~~-~i~~----------~ia~-~L~yLH~~-~~~~ivH~Di  636 (811)
                       +.+.+                     +... ......... ++..          .+.. ...+|... ..+.++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             22111                     1100 000111100 0100          0111 12222211 1345789999


Q ss_pred             CCCcEEECCCCCeEEEecCCccc
Q 003555          637 NPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       637 k~~NIll~~~~~~kL~DFGla~~  659 (811)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.06  E-value=4.2e-05  Score=75.90  Aligned_cols=130  Identities=16%  Similarity=0.167  Sum_probs=81.9

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHH---------HHHHHHHhccCCC---CccceecEEec-----
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF---------QAEMAAVRRTHHK---NLVRLLGFCMQ-----  577 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~---------~~E~~~l~~l~h~---niv~l~g~~~~-----  577 (811)
                      +.+-.....-|.+...  +++.+++|.........++.|         .+++..+.+++..   ....++.+...     
T Consensus        37 kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~  114 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY  114 (229)
T ss_pred             EeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence            4444444444544444  457788888765433333332         2344444444332   23332322221     


Q ss_pred             ccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          578 TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       578 ~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      ....+|||||++|..|.++..-     .    -.+...|++++.-||+.   ++.|+|.+|.|+++++++ +++.||+..
T Consensus       115 ~~~~~ll~EYIeG~~l~d~~~i-----~----e~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k  181 (229)
T PF06176_consen  115 TSSYVLLMEYIEGVELNDIEDI-----D----EDLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGK  181 (229)
T ss_pred             eeEEEEEEEEecCeecccchhc-----C----HHHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccc
Confidence            2355799999999888765431     1    13556778889999999   999999999999999655 999999876


Q ss_pred             cc
Q 003555          658 KI  659 (811)
Q Consensus       658 ~~  659 (811)
                      +.
T Consensus       182 ~~  183 (229)
T PF06176_consen  182 RM  183 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.02  E-value=4.8e-05  Score=78.93  Aligned_cols=139  Identities=12%  Similarity=0.080  Sum_probs=86.4

Q ss_pred             hcCcccc-eeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC-CCCccceecEEecccceeEEEeecCCCCH
Q 003555          516 ELGRGCF-GAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEFMSKGSL  593 (811)
Q Consensus       516 ~LG~G~f-g~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ey~~~gsL  593 (811)
                      .|-.|.. ..||+....  +..+.||+.....   ...+.+|+++++.+. +--+++++++....+..++|||+++|.+|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            3455555 789998764  3578888875432   345778888888883 44566788887776678999999999877


Q ss_pred             HHHhh-------------------cCCC-CCc----hHHHHHHHH--------------------HHHHHHHHHhhc---
Q 003555          594 ENLLS-------------------NVES-GPI----WRDRVRIAL--------------------DVARGITYLHEE---  626 (811)
Q Consensus       594 ~~~l~-------------------~~~~-~~~----~~~~~~i~~--------------------~ia~~L~yLH~~---  626 (811)
                      .....                   .... ...    ...++....                    .+...+..|-..   
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            64421                   1100 000    000000000                    011112222111   


Q ss_pred             -cCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          627 -CEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       627 -~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                       ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence             134699999999999999988889999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.01  E-value=1.6e-06  Score=96.17  Aligned_cols=185  Identities=16%  Similarity=0.089  Sum_probs=133.3

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC-ccceecEEecccceeEEEeecC
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN-LVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~ey~~  589 (811)
                      +.+.+.+++|+++.++|.+-......+ .+.+..     .....-++++|.+++||| .+..++-+..+...+++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            345577899999999998765433223 444432     256677899999999999 7777777777778899999998


Q ss_pred             CC-CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccc
Q 003555          590 KG-SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV  668 (811)
Q Consensus       590 ~g-sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~  668 (811)
                      .+ +-..........+...+...+.+.-++++++||+.   .-+|+|    ||+..+ +..|..||+.+..+.+..  ..
T Consensus       318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~  387 (829)
T KOG0576|consen  318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP  387 (829)
T ss_pred             CCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence            76 22111111112222344455677778899999986   568998    777665 688999999987664433  34


Q ss_pred             cccccCCCccCccccccCCCCcccchHHHHHHHHHHHhCCCCC
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF  711 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~elltg~~p~  711 (811)
                      ....+++.++|||......+..+.|+|++|+-.-++--|-.|-
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            4567999999999999999999999999998766666565554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.93  E-value=6.8e-05  Score=76.93  Aligned_cols=141  Identities=21%  Similarity=0.298  Sum_probs=85.8

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC--ccceecEEecc---cceeEEEeecC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN--LVRLLGFCMQT---SKKLLVYEFMS  589 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~---~~~~lV~ey~~  589 (811)
                      +.|+.|..+.||+....+  ..+++|.....  .....+..|+.+++.+....  +++++.++...   ...+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            468899999999999865  48999987543  55677888999988885443  56777655333   24689999999


Q ss_pred             CCCHHH----------------Hh---hcC--C-CCCc-hH--------HHHHH------------HHHHHH-HHHHHhh
Q 003555          590 KGSLEN----------------LL---SNV--E-SGPI-WR--------DRVRI------------ALDVAR-GITYLHE  625 (811)
Q Consensus       590 ~gsL~~----------------~l---~~~--~-~~~~-~~--------~~~~i------------~~~ia~-~L~yLH~  625 (811)
                      +..+..                .+   +..  . .... +.        .....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111  0 0111 00        00000            112222 3344443


Q ss_pred             c----cCCCeeecCCCCCcEEEC-CCCCeEEEecCCccc
Q 003555          626 E----CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKI  659 (811)
Q Consensus       626 ~----~~~~ivH~Dik~~NIll~-~~~~~kL~DFGla~~  659 (811)
                      .    ....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    235799999999999999 666668999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=3.5e-05  Score=76.08  Aligned_cols=102  Identities=23%  Similarity=0.344  Sum_probs=82.8

Q ss_pred             HHHHHHHhccCC-CCccceecEEecccceeEEEeecCCCCHHHH---hhcCCCCCchHHHHHHHHHHHHHHHHHhhccCC
Q 003555          554 QAEMAAVRRTHH-KNLVRLLGFCMQTSKKLLVYEFMSKGSLENL---LSNVESGPIWRDRVRIALDVARGITYLHEECEV  629 (811)
Q Consensus       554 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~ey~~~gsL~~~---l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~  629 (811)
                      ..|..+++.+++ +++++++|+|    ..++|.||...+++...   +.+ -...+|..|++|+.++++.+.+|++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            458888888876 6999999999    45889999987766432   111 12357999999999999999999996544


Q ss_pred             CeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       630 ~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      .+.-+|++++|+-+++++.+|+.|.......
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>smart00473 PAN_AP divergent subfamily of APPLE domains

Probab=97.80  E-value=2.5e-05  Score=64.98  Aligned_cols=69  Identities=19%  Similarity=0.398  Sum_probs=48.2

Q ss_pred             ceeeeeeecccCCCccccccccCChhhHHhhccc-Ccccccceec--cccccccc-ccceecccccCCccceEEe
Q 003555          349 EFYKITSLEISQLGGMAYAKLSVNEKDCSKSCLN-DCYCGAAIYA--NASCSKHK-LPLIFAMKYQNVPATLFIK  419 (811)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~A~~y~--~~~C~~~~-~~l~~~~~~~~~~~~~y~k  419 (811)
                      .|..+.++.+++....  .....++++|++.|++ +|+|.||.|.  ..+|.+|. .++.+.......+.++|.|
T Consensus         5 ~f~~~~~~~l~~~~~~--~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~~   77 (78)
T smart00473        5 CFVRLPNTKLPGFSRI--VISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYEK   77 (78)
T ss_pred             eeEEecCccCCCCcce--eEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEEe
Confidence            4555666655533221  2346799999999999 9999999996  57899999 7777766444445555554

Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.78  E-value=0.00025  Score=71.22  Aligned_cols=136  Identities=21%  Similarity=0.210  Sum_probs=89.0

Q ss_pred             hcCcccceeEEEEEEcCCCEEEEEEEccCCchhh-------------------H-----HHHHHHHHHHhccC--CCCcc
Q 003555          516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-------------------E-----RKFQAEMAAVRRTH--HKNLV  569 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~-------------------~-----~~~~~E~~~l~~l~--h~niv  569 (811)
                      .|+.|.-+.||+|... ++..+|||+.+......                   .     ..-..|+..|.++.  +-.++
T Consensus        55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            4778888999999873 36799999875322110                   0     11335666676663  33444


Q ss_pred             ceecEEecccceeEEEeecCCC-CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCC
Q 003555          570 RLLGFCMQTSKKLLVYEFMSKG-SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLT  648 (811)
Q Consensus       570 ~l~g~~~~~~~~~lV~ey~~~g-sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~  648 (811)
                      +-+++.    .-.|||||+... .-.-.|.+.  .+...+...+..++++.+.-|-..+  ++||+||+.-|||+. ++.
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCe
Confidence            444443    347999998764 111122221  1112245567777888887777632  999999999999999 889


Q ss_pred             eEEEecCCccccC
Q 003555          649 AKISNFSLAKILM  661 (811)
Q Consensus       649 ~kL~DFGla~~~~  661 (811)
                      +.|+|+|-|....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999987543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.64  E-value=0.00056  Score=83.57  Aligned_cols=146  Identities=14%  Similarity=0.274  Sum_probs=92.7

Q ss_pred             hhcCcccceeEEEEEEcCCC--EEEEEEEccCCc-hhhHHHHHHHHHHHhccC-CCCc--cceecEEecc---cceeEEE
Q 003555          515 EELGRGCFGAVYKGSICEGN--KIVAVKRLENPV-EEGERKFQAEMAAVRRTH-HKNL--VRLLGFCMQT---SKKLLVY  585 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~--~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~  585 (811)
                      +.|+.|.+..+|+.....++  ..+++|+..... ......+.+|+++++.+. |.++  ++++.+|.+.   +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            56899999999998875543  467778764322 223457889999999995 6665  7888888764   4678999


Q ss_pred             eecCCCCHHH--------------------H---hhcCCC----------CCch--HHHHHH---------------HHH
Q 003555          586 EFMSKGSLEN--------------------L---LSNVES----------GPIW--RDRVRI---------------ALD  615 (811)
Q Consensus       586 ey~~~gsL~~--------------------~---l~~~~~----------~~~~--~~~~~i---------------~~~  615 (811)
                      ||+++..+.+                    .   |+....          ...+  .+..++               .-.
T Consensus       124 E~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~  203 (822)
T PLN02876        124 EYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPK  203 (822)
T ss_pred             EecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChh
Confidence            9999864321                    1   111100          0000  011111               112


Q ss_pred             HHHHHHHHhhccC--------CCeeecCCCCCcEEECC-C-CCeEEEecCCcccc
Q 003555          616 VARGITYLHEECE--------VQIIHCNINPRNILLDD-S-LTAKISNFSLAKIL  660 (811)
Q Consensus       616 ia~~L~yLH~~~~--------~~ivH~Dik~~NIll~~-~-~~~kL~DFGla~~~  660 (811)
                      +.+.+.+|..+.+        +.++|+|+++.||+++. + ...-|.||.++..-
T Consensus       204 ~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        204 MLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             HHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            3344566755432        35999999999999984 3 34679999988653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.58  E-value=0.00069  Score=66.60  Aligned_cols=133  Identities=26%  Similarity=0.395  Sum_probs=94.6

Q ss_pred             ccccChhHHHHHHhhhhhhcCcccc-eeEEEEEEcCCCEEEEEEEccC-----------Cch----------hhHHHHHH
Q 003555          498 IQSFSTGELERATNGFEEELGRGCF-GAVYKGSICEGNKIVAVKRLEN-----------PVE----------EGERKFQA  555 (811)
Q Consensus       498 ~~~~~~~el~~~~~~~~~~LG~G~f-g~Vy~g~~~~~~~~vAvK~l~~-----------~~~----------~~~~~~~~  555 (811)
                      ++.|+..   .+...|.+.||.|.- |.|||+++  +++.+|+|.++.           ...          .-...|..
T Consensus        29 L~~F~~h---~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~  103 (207)
T PF13095_consen   29 LEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNC  103 (207)
T ss_pred             cCCcCCC---CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHH
Confidence            4456652   267788899999999 99999999  467999999321           001          01125888


Q ss_pred             HHHHHhccC---CCCc--cceecEEecc------------------cceeEEEeecCCCCHHHHhhcCCCCCchHHHHHH
Q 003555          556 EMAAVRRTH---HKNL--VRLLGFCMQT------------------SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI  612 (811)
Q Consensus       556 E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i  612 (811)
                      |.+...+|+   +.++  |+.+||..-.                  ..+.||.||.+...              ....+-
T Consensus       104 ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~~  169 (207)
T PF13095_consen  104 ECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIRD  169 (207)
T ss_pred             HHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchhH
Confidence            988887774   4566  8888887422                  12357777766532              122334


Q ss_pred             HHHHHHHHHHHhhccCCCeeecCCCCCcEEECCCCCeEEEecCCc
Q 003555          613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       613 ~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla  657 (811)
                      +.+|.+-|..+|..   +|+-+|+++.|..     .-||+|||.+
T Consensus       170 ~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  170 IPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            56788888999998   9999999999986     5689999865

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.57  E-value=0.00042  Score=71.46  Aligned_cols=138  Identities=17%  Similarity=0.223  Sum_probs=77.0

Q ss_pred             hhcCcccce-eEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCC---CccceecEEeccc---ceeEEEee
Q 003555          515 EELGRGCFG-AVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK---NLVRLLGFCMQTS---KKLLVYEF  587 (811)
Q Consensus       515 ~~LG~G~fg-~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lV~ey  587 (811)
                      +.|+.|+.. .||+..     ..+++|..+.  ......+.+|++.+..+...   .+.++++.....+   ..++|||+
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457777766 589752     2466776543  22345788999999888532   3445554443322   34889999


Q ss_pred             cCCCCHHHH---------------h---hcCCC-C--C-------------chHHHH--HHH-------HHHHHH-HHHH
Q 003555          588 MSKGSLENL---------------L---SNVES-G--P-------------IWRDRV--RIA-------LDVARG-ITYL  623 (811)
Q Consensus       588 ~~~gsL~~~---------------l---~~~~~-~--~-------------~~~~~~--~i~-------~~ia~~-L~yL  623 (811)
                      ++|.++.+.               +   +.... .  .             .|....  .+.       .+.... +..+
T Consensus        76 i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  155 (235)
T cd05155          76 LEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAA  155 (235)
T ss_pred             ecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHH
Confidence            998766322               1   11100 0  0             011000  000       011111 1111


Q ss_pred             hhc---cCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          624 HEE---CEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       624 H~~---~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ++.   ..+.++|+|+++.||+++++...-|.||+.+..
T Consensus       156 ~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         156 LRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             hcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            111   234589999999999999877678999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.49  E-value=0.00087  Score=63.72  Aligned_cols=127  Identities=20%  Similarity=0.251  Sum_probs=87.0

Q ss_pred             hhhhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCcc-ceecEEecccceeEEEeecCCC
Q 003555          513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV-RLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       513 ~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      ..+.|++|.+|.||+|.+.  +..+|+|+-..+  .....+..|+++|..++-.++. +++.+.    +-++.|||+.+.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            3578999999999999985  458899986533  3456788999999998766654 344443    234559999998


Q ss_pred             CHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCC--CcEEECCCCCeEEEecCCccc
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINP--RNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~--~NIll~~~~~~kL~DFGla~~  659 (811)
                      .|.+.-...    +-+    -+..+++.---|-..   +|-|..|+-  .||++.+ +.+.|+||..|..
T Consensus        98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG----DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc----cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            887766532    112    223344442333333   899999974  4555544 4999999999974

>PRK10593 hypothetical protein; Provisional

Probab=97.48  E-value=0.0011  Score=70.72  Aligned_cols=75  Identities=12%  Similarity=0.041  Sum_probs=55.6

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCC---CCccceecEEecc---cceeEEEeec
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH---KNLVRLLGFCMQT---SKKLLVYEFM  588 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lV~ey~  588 (811)
                      +.||.|..+.||+....++  .+.+|..+.  ......+.+|...|+.+..   -.+++++++|..+   +..+||||++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~--~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG--NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eecCCccceeEEEEEcCCC--CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            5699999999999876443  466676432  1133588999999998853   4688899888653   5689999999


Q ss_pred             CCCCH
Q 003555          589 SKGSL  593 (811)
Q Consensus       589 ~~gsL  593 (811)
                      +++++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.35  E-value=0.0015  Score=67.35  Aligned_cols=140  Identities=20%  Similarity=0.272  Sum_probs=81.0

Q ss_pred             hhcCcccceeEEEEEEcC-CCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCc-cceecEEecccceeEEEeecCCCC
Q 003555          515 EELGRGCFGAVYKGSICE-GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL-VRLLGFCMQTSKKLLVYEFMSKGS  592 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ey~~~gs  592 (811)
                      +.|..|-...+|+....+ .++.|++|+...... ......+|+.++..+...++ +++++...    ..+||||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999987653 246788997654322 22234578888888854444 44444332    248999999876


Q ss_pred             HHHH--------------h---hcCCC----------CCc-hHHHHHHHH----------------------HHHHHHHH
Q 003555          593 LENL--------------L---SNVES----------GPI-WRDRVRIAL----------------------DVARGITY  622 (811)
Q Consensus       593 L~~~--------------l---~~~~~----------~~~-~~~~~~i~~----------------------~ia~~L~y  622 (811)
                      +...              |   +....          ... +..+..+..                      .+.+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            5321              1   11111          111 111111111                      11111122


Q ss_pred             H----hhc-cCCCeeecCCCCCcEEECC-CCCeEEEecCCccc
Q 003555          623 L----HEE-CEVQIIHCNINPRNILLDD-SLTAKISNFSLAKI  659 (811)
Q Consensus       623 L----H~~-~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~  659 (811)
                      |    ... ....++|+|+++.|||+++ ++.+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            2    111 2346999999999999998 57899999998763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.34  E-value=0.0023  Score=63.47  Aligned_cols=132  Identities=17%  Similarity=0.248  Sum_probs=90.5

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc----------------hhhHHHHHHHHHHHhccC------CCCcccee
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV----------------EEGERKFQAEMAAVRRTH------HKNLVRLL  572 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  572 (811)
                      ..||+|+.-.||.--   .+....||+.....                ....++..+|+.-...+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            469999999999632   24456788776443                123455666666555554      88999999


Q ss_pred             cEEecccceeEEEeecCC------CCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC
Q 003555          573 GFCMQTSKKLLVYEFMSK------GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS  646 (811)
Q Consensus       573 g~~~~~~~~~lV~ey~~~------gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~  646 (811)
                      |+...+...-+|+|.+.+      .+|.+++.+.  .++.    .+...+-+-..||-++   .|+.+|++|.||++..+
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence            999999999999998653      2688888643  2332    3333334445666666   89999999999999532


Q ss_pred             --C--CeEEEe-cCCcc
Q 003555          647 --L--TAKISN-FSLAK  658 (811)
Q Consensus       647 --~--~~kL~D-FGla~  658 (811)
                        +  .+.|+| ||-..
T Consensus       155 ~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCCceEEEEEeCCCCcc
Confidence              2  466776 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.26  E-value=0.0017  Score=67.87  Aligned_cols=137  Identities=11%  Similarity=0.050  Sum_probs=79.3

Q ss_pred             hcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCc-cceecEEecccceeEEEeecCCCCHH
Q 003555          516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL-VRLLGFCMQTSKKLLVYEFMSKGSLE  594 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ey~~~gsL~  594 (811)
                      .+..|-...+|+...  +++.+++|..........-...+|..+++.+...++ ++++..+.    ..+|+||+++..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            356677789998873  456788887643322211246788888888865444 44554432    36899999987654


Q ss_pred             HH-----------------hhcCC---CCCchHHH-HHHHH---------HHHHHHHHHhhc-----cCCCeeecCCCCC
Q 003555          595 NL-----------------LSNVE---SGPIWRDR-VRIAL---------DVARGITYLHEE-----CEVQIIHCNINPR  639 (811)
Q Consensus       595 ~~-----------------l~~~~---~~~~~~~~-~~i~~---------~ia~~L~yLH~~-----~~~~ivH~Dik~~  639 (811)
                      ..                 |+...   .......+ .....         .+.+.+..+...     .+..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 11111   01111111 11111         111112222111     1346899999999


Q ss_pred             cEEECCCCCeEEEecCCccc
Q 003555          640 NILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       640 NIll~~~~~~kL~DFGla~~  659 (811)
                      ||++++++ ++|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.16  E-value=0.0025  Score=76.27  Aligned_cols=196  Identities=16%  Similarity=0.176  Sum_probs=135.3

Q ss_pred             HHHHHHHHhccCCCCccceecEEecccce----eEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccC
Q 003555          553 FQAEMAAVRRTHHKNLVRLLGFCMQTSKK----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE  628 (811)
Q Consensus       553 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~  628 (811)
                      ...|+..+.++.|+|++.++.|-.+....    .+..|++...++...+.. ...........+..++.+||+|+|+.  
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~--  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSL--  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence            45577788889999999999988765432    355677888888888775 34455677777888999999999998  


Q ss_pred             CCeeecCCCCC---cEEECCCCCeEEE--ecCCccccCCCCCccccccccCCCccCccccccCCCCc--ccchHHHHHHH
Q 003555          629 VQIIHCNINPR---NILLDDSLTAKIS--NFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV--KSDVYSFGVVV  701 (811)
Q Consensus       629 ~~ivH~Dik~~---NIll~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDV~S~Gvll  701 (811)
                       ...|.-+..+   +.-.+.++...+.  ||+.++.+......  ....-+..+.|||.........  ..|+|.+|.++
T Consensus       306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             5555555554   5555677777777  99988765433321  1223455677888766655444  57999999999


Q ss_pred             HHHHhCCCCCCCCCCccchhhHHHHHHHhhhhcccchhcCCccccChHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 003555          702 LEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML  779 (811)
Q Consensus       702 ~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L  779 (811)
                      ..+..|..+-......                   ..+++..      ....+.+....|+..++++|++..+++.+.
T Consensus       383 ~~~~~~~~i~~~~~~~-------------------~~~l~~~------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVP-------------------VSLLDVL------STSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccch-------------------hhhhccc------cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9999887654322111                   1111110      011456677789999999999999998665

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.14  E-value=0.002  Score=68.95  Aligned_cols=140  Identities=15%  Similarity=0.173  Sum_probs=85.5

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC--ccceecE------EecccceeEEEe
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN--LVRLLGF------CMQTSKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e  586 (811)
                      +.|..|....+|+....+  ..+++|+...   .....+..|+.++..+.+.+  +++++..      ....+..++|++
T Consensus        20 ~~i~~G~~n~~y~v~~~~--~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          20 EGISAGIENTNYFVTTDS--GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             ecccCccccceEEEEeCC--CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            457778778999987633  4688898764   23456777888887775433  4444432      122345689999


Q ss_pred             ecCCCCHHH----H-------h---hcC----CC------CCchHHHH----------HHHHHHHHHHHHHhh----ccC
Q 003555          587 FMSKGSLEN----L-------L---SNV----ES------GPIWRDRV----------RIALDVARGITYLHE----ECE  628 (811)
Q Consensus       587 y~~~gsL~~----~-------l---~~~----~~------~~~~~~~~----------~i~~~ia~~L~yLH~----~~~  628 (811)
                      |++|..+..    .       |   +..    ..      ...|....          .....+..++.++.+    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876432    1       1   110    00      01111110          111223344555553    223


Q ss_pred             CCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          629 VQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       629 ~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                      ..++|+|+.|.||++++++.+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999988889999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.07  E-value=0.012  Score=64.75  Aligned_cols=76  Identities=22%  Similarity=0.236  Sum_probs=54.4

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCc-------hhhHHHHHHHHHHHhccC---CCCccceecEEecccceeEE
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV-------EEGERKFQAEMAAVRRTH---HKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV  584 (811)
                      +.||.|.+..||++...++++.|+||.-....       .-..+.+..|.+.|+.+.   -.++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            57999999999999997655689999753211       123456777888887762   2456777776  33557899


Q ss_pred             EeecCCCC
Q 003555          585 YEFMSKGS  592 (811)
Q Consensus       585 ~ey~~~gs  592 (811)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.90  E-value=0.0044  Score=66.46  Aligned_cols=139  Identities=24%  Similarity=0.313  Sum_probs=83.1

Q ss_pred             hcCcccceeEEEEEEcCC------CEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCc-cceecEEecccceeEEEeec
Q 003555          516 ELGRGCFGAVYKGSICEG------NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL-VRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~------~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ey~  588 (811)
                      .|..|--..+|+....++      ++.+++|+..... .......+|.+++..+...++ +++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            455566668998876542      4678899865433 233466788888888754333 455555532    3589999


Q ss_pred             CCCCHHHH-----------------hhcCCCC---------Cc-hHHHHH--------------------------HHHH
Q 003555          589 SKGSLENL-----------------LSNVESG---------PI-WRDRVR--------------------------IALD  615 (811)
Q Consensus       589 ~~gsL~~~-----------------l~~~~~~---------~~-~~~~~~--------------------------i~~~  615 (811)
                      +|..+...                 |++....         .. +....+                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88765431                 1111110         00 111100                          1112


Q ss_pred             HHHHHHHHhh------ccCCCeeecCCCCCcEEECCC----CCeEEEecCCccc
Q 003555          616 VARGITYLHE------ECEVQIIHCNINPRNILLDDS----LTAKISNFSLAKI  659 (811)
Q Consensus       616 ia~~L~yLH~------~~~~~ivH~Dik~~NIll~~~----~~~kL~DFGla~~  659 (811)
                      +...+..|..      ..+..++|+|+.+.||+++++    +.++|+||..+..
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            2233334432      235679999999999999975    8899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.89  E-value=0.014  Score=63.16  Aligned_cols=140  Identities=11%  Similarity=0.166  Sum_probs=77.3

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC--ccceecE------EecccceeEEEe
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN--LVRLLGF------CMQTSKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e  586 (811)
                      +.|+.|....+|+....+  ..+++|+.+..   ..+....|+..+..|...+  +++.+..      ....+..++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~--g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQ--GEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             chhccccccceEEEEeCC--CcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            456777778999987643  36888987521   2233444555555553222  3333321      122456789999


Q ss_pred             ecCCCCHH-----------HHh---hcCCC----------CC-chHHHHH------------HHH-HHHHHHHHHhh---
Q 003555          587 FMSKGSLE-----------NLL---SNVES----------GP-IWRDRVR------------IAL-DVARGITYLHE---  625 (811)
Q Consensus       587 y~~~gsL~-----------~~l---~~~~~----------~~-~~~~~~~------------i~~-~ia~~L~yLH~---  625 (811)
                      |++|..+.           +.|   +....          .+ .|...+.            ... .+...+..+.+   
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99987431           111   11100          01 1111111            111 11122233321   


Q ss_pred             -ccCCCeeecCCCCCcEEECCCCCeEEEecCCccc
Q 003555          626 -ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       626 -~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~  659 (811)
                       ..+.+++|+|+++.||+++++...-|.||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             1345899999999999999776678999998853

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.39  E-value=0.044  Score=58.88  Aligned_cols=140  Identities=14%  Similarity=0.217  Sum_probs=81.3

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC--ccceecEE------ecccceeEEEe
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN--LVRLLGFC------MQTSKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e  586 (811)
                      +.++.|.-..+|+....  +..+++|+.....  ...+...|++++..|...+  +++++...      ...+..++++|
T Consensus        28 ~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             cccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777899988753  3357788765421  2334556677777764333  34444321      12345689999


Q ss_pred             ecCCCCHH-----------HH---hhcCCCC-----------CchHHHH------------HHHHHHHHHHHHHhh----
Q 003555          587 FMSKGSLE-----------NL---LSNVESG-----------PIWRDRV------------RIALDVARGITYLHE----  625 (811)
Q Consensus       587 y~~~gsL~-----------~~---l~~~~~~-----------~~~~~~~------------~i~~~ia~~L~yLH~----  625 (811)
                      |++|..+.           ..   ++.....           ..|....            .....+.+.+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885431           11   1111000           1121111            011223345555543    


Q ss_pred             ccCCCeeecCCCCCcEEECCCCCeEEEecCCcc
Q 003555          626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       626 ~~~~~ivH~Dik~~NIll~~~~~~kL~DFGla~  658 (811)
                      ..+.+++|+|+++.||++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            234689999999999999998877999999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins

Probab=96.20  E-value=0.0039  Score=51.11  Aligned_cols=32  Identities=22%  Similarity=0.448  Sum_probs=27.4

Q ss_pred             cCChhhHHhhcccCcccccceec--ccccccccc
Q 003555          370 SVNEKDCSKSCLNDCYCGAAIYA--NASCSKHKL  401 (811)
Q Consensus       370 ~~~~~~C~~~Cl~nCsC~A~~y~--~~~C~~~~~  401 (811)
                      ..+.++|++.|+.+|+|.||.|.  ...|+++..
T Consensus        24 ~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~   57 (73)
T cd01100          24 ASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS   57 (73)
T ss_pred             cCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence            56889999999999999999995  467887654

PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions.

>PLN02236 choline kinase

Probab=96.12  E-value=0.035  Score=60.61  Aligned_cols=139  Identities=18%  Similarity=0.215  Sum_probs=81.9

Q ss_pred             hcCcccceeEEEEEEcC----CCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCcc-ceecEEecccceeEEEeecCC
Q 003555          516 ELGRGCFGAVYKGSICE----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV-RLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~----~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~ey~~~  590 (811)
                      .|-.|-.-.+|+.....    .++.|.+|+...... ..-...+|..+++.+...++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            35456667889887543    235788998765432 223347788898888655554 566665333    58999987


Q ss_pred             CCHHHH-----------------hhcCC----CCCc-hHHHHHHHH-----------------HHHHHHHHHhh-----c
Q 003555          591 GSLENL-----------------LSNVE----SGPI-WRDRVRIAL-----------------DVARGITYLHE-----E  626 (811)
Q Consensus       591 gsL~~~-----------------l~~~~----~~~~-~~~~~~i~~-----------------~ia~~L~yLH~-----~  626 (811)
                      .+|...                 +++..    .... +....++..                 .+...+..|.+     .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 11111    0011 222222221                 11122222221     1


Q ss_pred             cCCCeeecCCCCCcEEECC-CCCeEEEecCCccc
Q 003555          627 CEVQIIHCNINPRNILLDD-SLTAKISNFSLAKI  659 (811)
Q Consensus       627 ~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~  659 (811)
                      ....++|+|+++.||++++ ++.++|+||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2347899999999999986 57899999988864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.99  E-value=0.0066  Score=63.14  Aligned_cols=133  Identities=16%  Similarity=0.152  Sum_probs=87.0

Q ss_pred             hhhhhhcCcccceeEEEEEEcCCCEEEEEEEccCCc----------------hhh------HHHHHHHHHHHhccCC--C
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV----------------EEG------ERKFQAEMAAVRRTHH--K  566 (811)
Q Consensus       511 ~~~~~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~----------------~~~------~~~~~~E~~~l~~l~h--~  566 (811)
                      +.+.++||-|.-+-+|.+-..+ +++.++|.-.-..                .+.      .-....|+..|+.|..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4567899999999999999865 4677777421100                000      1124567788888743  2


Q ss_pred             CccceecEEecccceeEEEeecCCCCHHHHhhcCCCCCchHHHHHHHHHHHHHHHHHhhccCCCeeecCCCCCcEEECCC
Q 003555          567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS  646 (811)
Q Consensus       567 niv~l~g~~~~~~~~~lV~ey~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik~~NIll~~~  646 (811)
                      -+++.+++    ++.++|||++.+-.|...-+-..    .+.   +...+..-+.-|..+   ++||+|..-=||+++++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d----~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVED----PPT---LYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeecCC----hHH---HHHHHHHHHHHHHHc---CceecccchheeEEecC
Confidence            34444443    46689999998877765443211    122   222333333344445   99999999999999999


Q ss_pred             CCeEEEecCCcc
Q 003555          647 LTAKISNFSLAK  658 (811)
Q Consensus       647 ~~~kL~DFGla~  658 (811)
                      ..++++||--..
T Consensus       239 ~~i~vIDFPQmv  250 (465)
T KOG2268|consen  239 DKIVVIDFPQMV  250 (465)
T ss_pred             CCEEEeechHhh
Confidence            999999996543

>PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity

Probab=95.93  E-value=0.049  Score=48.91  Aligned_cols=94  Identities=20%  Similarity=0.211  Sum_probs=57.2

Q ss_pred             cCCCeeeeeeEeCCCCeEEEEEeccCCCCeEEEeec-CCCCCCCCCcEEEEecCceEEEecCC-cceEeeccCCCCCcee
Q 003555           49 SPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAF-RDEPPVSSNAKLILTMDGLVLQTEES-KHKLIANTTSDEPASF  126 (811)
Q Consensus        49 S~~g~F~lGFf~~~~~~~lgIw~~~~~~~tvVWvAN-r~~p~~~~~~~l~~~~~G~l~l~~~~-~~~w~~~~~~~~~~~~  126 (811)
                      +.+|.+.|-|-.-|+   |-| |.  ...+++|..+ ....-. ....+.|..+|+|+|.+.. ..+|++..  ....+.
T Consensus        16 ~~s~~~~L~l~~dGn---Lvl-~~--~~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ptdt~   86 (114)
T PF01453_consen   16 SSSGNYTLILQSDGN---LVL-YD--SNGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--YPTDTL   86 (114)
T ss_dssp             ECETTEEEEEETTSE---EEE-EE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--SSS-EE
T ss_pred             cccccccceECCCCe---EEE-Ec--CCCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--CCccEE
Confidence            333666666654322   222 22  2357799994 333222 4688999999999998865 78888832  234455


Q ss_pred             EEEec--CCCeEEeeCCCceEEeecCCC
Q 003555          127 ASILD--SGNFVLCNDRFDFIWESFNFP  152 (811)
Q Consensus       127 a~Lld--sGNlVl~~~~~~~lWQSFd~P  152 (811)
                      +...+  .||++ ......+.|.|=+-|
T Consensus        87 L~~q~l~~~~~~-~~~~~~~sw~s~~dp  113 (114)
T PF01453_consen   87 LPGQKLGDGNVT-GKNDSLTSWSSNTDP  113 (114)
T ss_dssp             EEEET--TSEEE-EESTSSEEEESS---
T ss_pred             EeccCcccCCCc-cccceEEeECCCCCC
Confidence            66666  88888 767788999986655

Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=95.86  E-value=0.067  Score=56.41  Aligned_cols=31  Identities=23%  Similarity=0.575  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCcEEECCCCC-eEEEecCCccc
Q 003555          629 VQIIHCNINPRNILLDDSLT-AKISNFSLAKI  659 (811)
Q Consensus       629 ~~ivH~Dik~~NIll~~~~~-~kL~DFGla~~  659 (811)
                      +.++|+|+++.||++++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997554 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.65  E-value=0.12  Score=54.95  Aligned_cols=135  Identities=15%  Similarity=0.273  Sum_probs=80.8

Q ss_pred             eEEEEEEcCCCEEEEEEEcc-CCchhhHHHHHHHHHHHhccCC--CCccceecEEeccc--ceeEEEeecCCCCH-----
Q 003555          524 AVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHH--KNLVRLLGFCMQTS--KKLLVYEFMSKGSL-----  593 (811)
Q Consensus       524 ~Vy~g~~~~~~~~vAvK~l~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~ey~~~gsL-----  593 (811)
                      .+|.....  ++.++|.+-. ...........+|+.+|+.+.-  --....++.|.++.  ..+.||+|.++..+     
T Consensus        40 ~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          40 DTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             ceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            34444432  5667777221 1233445667888888888743  34556677787766  67999999988322     


Q ss_pred             -------------HHHhhcC---C-------CC---------CchHHHHHH--------HHHHHHHHHHHhhcc-----C
Q 003555          594 -------------ENLLSNV---E-------SG---------PIWRDRVRI--------ALDVARGITYLHEEC-----E  628 (811)
Q Consensus       594 -------------~~~l~~~---~-------~~---------~~~~~~~~i--------~~~ia~~L~yLH~~~-----~  628 (811)
                                   .++|...   .       ..         ..|...++.        +-....-..+|+++.     +
T Consensus       118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~  197 (321)
T COG3173         118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP  197 (321)
T ss_pred             cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence                         1222110   0       00         001111110        112233455665543     3


Q ss_pred             CCeeecCCCCCcEEECCCCCeEEEecCCcccc
Q 003555          629 VQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       629 ~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~  660 (811)
                      +.++|+|+++.||+++.++-+=|.||+++..-
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            46999999999999998888999999999764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.64  E-value=0.059  Score=56.91  Aligned_cols=72  Identities=18%  Similarity=0.303  Sum_probs=47.9

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccC---CCCccceecEEecccceeEEEeecCCC
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH---HKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      +.++.|....+|+..  .+++.+.||.-.   ......|..|++-|+.|.   --.+++.+++....+..+||+||++.+
T Consensus        23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            468889999999987  456789999864   344567888988888883   445778899888777889999998876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.63  E-value=0.0018  Score=79.04  Aligned_cols=158  Identities=10%  Similarity=-0.057  Sum_probs=109.2

Q ss_pred             HHHHHHHhccCCCCccceecEEec--ccceeEEEeecCCCCHHHHhhcCCCC-C--chHHHHHHHHHHHHHHHHHhhcc-
Q 003555          554 QAEMAAVRRTHHKNLVRLLGFCMQ--TSKKLLVYEFMSKGSLENLLSNVESG-P--IWRDRVRIALDVARGITYLHEEC-  627 (811)
Q Consensus       554 ~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ey~~~gsL~~~l~~~~~~-~--~~~~~~~i~~~ia~~L~yLH~~~-  627 (811)
                      ..|...++...|+++.....=...  ..+.+.+++|+..|.+.+.|-+.... .  +.........+...+..-.|... 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            345555566688887665543332  34668899999999999988654322 1  11222222222244444444432 


Q ss_pred             -CCCeeecCCCCCcEEECCCCCeEEEecCCccccCCCCCccccccccCCCccCccccccCCCCcccchHHHHHHHHHHHh
Q 003555          628 -EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC  706 (811)
Q Consensus       628 -~~~ivH~Dik~~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvll~ellt  706 (811)
                       ..-.+|+++|+-|.++..+..+|+.++|+.+.. ...........+++.|++|++...-.++.++|+|..|+.+|+..-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence             224789999999999999999999999999832 222333344567889999998888888989999999999999988


Q ss_pred             CCCCCC
Q 003555          707 CRSNFE  712 (811)
Q Consensus       707 g~~p~~  712 (811)
                      |..+|.
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            777663

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.09  E-value=0.24  Score=53.66  Aligned_cols=82  Identities=22%  Similarity=0.197  Sum_probs=51.1

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccC-------CchhhHHHHHHHHHHHhccC--CC-CccceecEEecccceeEE
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLEN-------PVEEGERKFQAEMAAVRRTH--HK-NLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lV  584 (811)
                      ++||.|...-||++...++++.|+||.-..       ..+-...+..-|...|+...  -| .+++++.+  +.+...+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            368999999999999865557899996432       11223345556667776552  23 34445443  44456799


Q ss_pred             EeecCCC-CHHHHhh
Q 003555          585 YEFMSKG-SLENLLS  598 (811)
Q Consensus       585 ~ey~~~g-sL~~~l~  598 (811)
                      ||+++.. .|.+.|.
T Consensus        79 MEdL~~~~ilR~~Li   93 (370)
T TIGR01767        79 MEDLSHHKIARKGLI   93 (370)
T ss_pred             HhhCccchHHHHHHH
Confidence            9998653 3545543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.08  E-value=0.051  Score=60.08  Aligned_cols=53  Identities=21%  Similarity=0.327  Sum_probs=41.7

Q ss_pred             hhhHHHHHHHHHHHhccCCCCccceecEEeccc-ceeEEEeecCCCCHHHHhhcC
Q 003555          547 EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNV  600 (811)
Q Consensus       547 ~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~ey~~~gsL~~~l~~~  600 (811)
                      ......+......++.+.|+|+..++.+..... +..+|+|++ +.+|++.+...
T Consensus        23 t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   23 TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            344567888899999999999999998877554 467888887 45999988764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.02  E-value=0.1  Score=56.61  Aligned_cols=139  Identities=19%  Similarity=0.318  Sum_probs=80.0

Q ss_pred             hcCcccceeEEEEEEcCC---CEEEEEEEccCCchhhHHHHHHHHHHHhccCCCCc-cceecEEecccceeEEEeecCCC
Q 003555          516 ELGRGCFGAVYKGSICEG---NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL-VRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       516 ~LG~G~fg~Vy~g~~~~~---~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ey~~~g  591 (811)
                      .|..|=.-.+|+....+.   +..|.+|+...... ..-...+|..+++.+...++ +++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            454566677888876432   23788888754433 23345778888888866555 4566665322    589999776


Q ss_pred             CHHH-------H----------hhcCC----CCC-chHHHHHHHH----------------------HHHHHHHHHhh--
Q 003555          592 SLEN-------L----------LSNVE----SGP-IWRDRVRIAL----------------------DVARGITYLHE--  625 (811)
Q Consensus       592 sL~~-------~----------l~~~~----~~~-~~~~~~~i~~----------------------~ia~~L~yLH~--  625 (811)
                      .|..       .          |+...    ..+ .|....++..                      .+.+-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            5521       0          11111    001 1222222111                      11112222221  


Q ss_pred             ---ccCCCeeecCCCCCcEEECC-CCCeEEEecCCccc
Q 003555          626 ---ECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKI  659 (811)
Q Consensus       626 ---~~~~~ivH~Dik~~NIll~~-~~~~kL~DFGla~~  659 (811)
                         ..+...+|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               11235899999999999974 57899999998864

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.91  E-value=0.22  Score=53.70  Aligned_cols=135  Identities=18%  Similarity=0.236  Sum_probs=80.7

Q ss_pred             cceeEEEEEEcCCCEEEEEEEccCCchhhHHHHHHHHHHHhccCCCC------ccceecE----EecccceeEEEeecCC
Q 003555          521 CFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN------LVRLLGF----CMQTSKKLLVYEFMSK  590 (811)
Q Consensus       521 ~fg~Vy~g~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~----~~~~~~~~lV~ey~~~  590 (811)
                      .-..+|+....++.  +++|+.+..  ....++..|+..|..|.-.+      +..+-|-    .......+-|++|++|
T Consensus        37 ~eN~~f~~~~~~g~--~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G  112 (331)
T COG2334          37 EENSNFRVQTEDGR--YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPG  112 (331)
T ss_pred             ccCceEEEEecCCC--eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCC
Confidence            44678888886543  388887654  45566667777777763222      2222221    1122377899999999


Q ss_pred             CCHHH-----Hh----------h----c----CCC---CCchHH---H----------HHHHHHHHHHHHHHhhcc----
Q 003555          591 GSLEN-----LL----------S----N----VES---GPIWRD---R----------VRIALDVARGITYLHEEC----  627 (811)
Q Consensus       591 gsL~~-----~l----------~----~----~~~---~~~~~~---~----------~~i~~~ia~~L~yLH~~~----  627 (811)
                      ..+..     .+          +    +    +..   ...|..   +          .....++...+..+++..    
T Consensus       113 ~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~l  192 (331)
T COG2334         113 RPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHL  192 (331)
T ss_pred             cCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhC
Confidence            87772     11          1    0    011   122320   0          113334445555555442    


Q ss_pred             CCC---eeecCCCCCcEEECCCCC-eEEEecCCccc
Q 003555          628 EVQ---IIHCNINPRNILLDDSLT-AKISNFSLAKI  659 (811)
Q Consensus       628 ~~~---ivH~Dik~~NIll~~~~~-~kL~DFGla~~  659 (811)
                      +..   +||+|+.|.||+++++.. +.+.||+-+..
T Consensus       193 p~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         193 PALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             CcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            223   999999999999998884 99999998763

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.80  E-value=0.16  Score=55.72  Aligned_cols=82  Identities=18%  Similarity=0.187  Sum_probs=51.7

Q ss_pred             hhcCcccceeEEEEEEcCCCEEEEEEEccC------CchhhHHHHHHHHHHHhccC--CC-CccceecEEecccceeEEE
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLEN------PVEEGERKFQAEMAAVRRTH--HK-NLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       515 ~~LG~G~fg~Vy~g~~~~~~~~vAvK~l~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lV~  585 (811)
                      +.||.|.-.-||++.+..+++.|+||.-..      ..+-..++..-|.+.|+...  -| .+++++.+  +.+...+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            578999999999999854456799996432      11233455666777776652  34 35555544  344557888


Q ss_pred             eecCCC-CHHHHhh
Q 003555          586 EFMSKG-SLENLLS  598 (811)
Q Consensus       586 ey~~~g-sL~~~l~  598 (811)
                      |+++.. .|.+.|.
T Consensus       113 EdL~~~~ilR~~Li  126 (409)
T PRK12396        113 EDLSDHTILRTALI  126 (409)
T ss_pred             HhCcccHHHHHHHH
Confidence            888543 3444443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	811
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-36
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-36
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-36
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-33
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-23
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-23
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-23
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-23
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-23
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-23
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-23
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-23
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-23
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-23
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-23
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-23
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-23
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-22
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-15
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-14
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		8e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-09
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		7e-09
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		7e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-07
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-07
3soa_A	444	Full-Length Human Camkii Length = 444		8e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-06
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-05
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-04
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-04
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-04
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  206 bits (524), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 118/298 (39%), Positives = 179/298 (60%), Gaps = 20/298 (6%)
Query: 498 IQSFSTGELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEGERKFQ 554
           ++ FS  EL+ A++ F  +  LGRG FG VYKG + +G  +VAVKRL E   + GE +FQ
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT-LVAVKRLKEERXQGGELQFQ 83
Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN-LLSNVESGPI--WRDRVR 611
            E+  +    H+NL+RL GFCM  +++LLVY +M+ GS+ + L    ES P   W  R R
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
           IAL  ARG+ YLH+ C+ +IIH ++   NILLD+   A + +F LAK++      +   V
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEV-NVSTADVVLLSTWVYNC 730
           +GT G+++PE+ ++G  + K+DV+ +GV++LE++  +  F++  ++  D V+L  WV   
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 731 FIAKELSKLVG-------EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
              K+L  LV        +DEEV     E +++V LLC Q  P  RP M  V+ MLEG
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEV-----EQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (518), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 117/298 (39%), Positives = 178/298 (59%), Gaps = 20/298 (6%)
Query: 498 IQSFSTGELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEGERKFQ 554
           ++ FS  EL+ A++ F  +  LGRG FG VYKG + +G  +VAVKRL E   + GE +FQ
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGX-LVAVKRLKEERTQGGELQFQ 75
Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN-LLSNVESGPI--WRDRVR 611
            E+  +    H+NL+RL GFCM  +++LLVY +M+ GS+ + L    ES P   W  R R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
           IAL  ARG+ YLH+ C+ +IIH ++   NILLD+   A + +F LAK++      +   V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEV-NVSTADVVLLSTWVYNC 730
           +G  G+++PE+ ++G  + K+DV+ +GV++LE++  +  F++  ++  D V+L  WV   
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 731 FIAKELSKLVG-------EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
              K+L  LV        +DEEV     E +++V LLC Q  P  RP M  V+ MLEG
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEV-----EQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  150 bits (380), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 167/310 (53%), Gaps = 15/310 (4%)
Query: 486 INSSLGPSQEFIIQSFSTG--ELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKR 541
           IN +L  S     +S+     +LE ATN F+ +  +G G FG VYKG + +G K VA+KR
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKR 70
Query: 542 LENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE 601
                 +G  +F+ E+  +    H +LV L+GFC + ++ +L+Y++M  G+L+  L   +
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 602 SGPI---WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +   W  R+ I +  ARG+ YLH      IIH ++   NILLD++   KI++F ++K
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 659 ILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
                +QT +   VKGT GY+ PE+   G +T KSDVYSFGVV+ E++C RS   V    
Sbjct: 188 KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLP 246
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGED--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
            ++V L+ W        +L ++V  +  +++   +L       + C+      RPSM +V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 776 ILMLEGTMEI 785
           +  LE  + +
Sbjct: 307 LWKLEYALRL 316

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  150 bits (378), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 103/310 (33%), Positives = 166/310 (53%), Gaps = 15/310 (4%)
Query: 486 INSSLGPSQEFIIQSFSTG--ELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKR 541
           IN +L  S     +S+     +LE ATN F+ +  +G G FG VYKG + +G K VA+KR
Sbjct: 12  INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-VALKR 70
Query: 542 LENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE 601
                 +G  +F+ E+  +    H +LV L+GFC + ++ +L+Y++M  G+L+  L   +
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 602 SGPI---WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +   W  R+ I +  ARG+ YLH      IIH ++   NILLD++   KI++F ++K
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 659 ILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
                 QT +   VKGT GY+ PE+   G +T KSDVYSFGVV+ E++C RS   V    
Sbjct: 188 KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLP 246
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGED--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
            ++V L+ W        +L ++V  +  +++   +L       + C+      RPSM +V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 776 ILMLEGTMEI 785
           +  LE  + +
Sbjct: 307 LWKLEYALRL 316

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  149 bits (376), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 153/297 (51%), Gaps = 22/297 (7%)
Query: 499 QSFSTGELERATNGFEE--------ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---- 546
            SFS  EL+  TN F+E        ++G G FG VYKG +   N  VAVK+L   V    
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 70
Query: 547 EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI- 605
           EE +++F  E+  + +  H+NLV LLGF        LVY +M  GSL + LS ++  P  
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 606 -WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-N 663
            W  R +IA   A GI +LHE      IH +I   NILLD++ TAKIS+F LA+      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
           QT + + + GT  YM+PE    G IT KSD+YSFGVV+LEI+      + +     ++L 
Sbjct: 188 QTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLD 245
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                          +  +  + D  ++E M  V   C+ ++ N RP +K V  +L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  148 bits (374), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 107/297 (36%), Positives = 152/297 (51%), Gaps = 22/297 (7%)
Query: 499 QSFSTGELERATNGFEE--------ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---- 546
            SFS  EL+  TN F+E        ++G G FG VYKG +   N  VAVK+L   V    
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 70
Query: 547 EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI- 605
           EE +++F  E+  + +  H+NLV LLGF        LVY +M  GSL + LS ++  P  
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 606 -WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-N 663
            W  R +IA   A GI +LHE      IH +I   NILLD++ TAKIS+F LA+      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
           QT +   + GT  YM+PE    G IT KSD+YSFGVV+LEI+      + +     ++L 
Sbjct: 188 QTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLD 245
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                          +  +  + D  ++E M  V   C+ ++ N RP +K V  +L+
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  147 bits (370), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 106/297 (35%), Positives = 151/297 (50%), Gaps = 22/297 (7%)
Query: 499 QSFSTGELERATNGFEE--------ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---- 546
            SFS  EL+  TN F+E        ++G G FG VYKG +   N  VAVK+L   V    
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 64
Query: 547 EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI- 605
           EE +++F  E+  + +  H+NLV LLGF        LVY +M  GSL + LS ++  P  
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 606 -WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-N 663
            W  R +IA   A GI +LHE      IH +I   NILLD++ TAKIS+F LA+      
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
           Q  +   + GT  YM+PE    G IT KSD+YSFGVV+LEI+      + +     ++L 
Sbjct: 182 QXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLD 239
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                          +  +  + D  ++E M  V   C+ ++ N RP +K V  +L+
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  139 bits (349), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 103/297 (34%), Positives = 146/297 (49%), Gaps = 22/297 (7%)
Query: 499 QSFSTGELERATNGFEE--------ELGRGCFGAVYKGSICEGNKIVAVKRLENPV---- 546
            SFS  EL+  TN F+E        + G G FG VYKG +   N  VAVK+L   V    
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 61
Query: 547 EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI- 605
           EE +++F  E+    +  H+NLV LLGF        LVY +   GSL + LS ++  P  
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 606 -WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-N 663
            W  R +IA   A GI +LHE      IH +I   NILLD++ TAKIS+F LA+      
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 664 QTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
           Q    + + GT  Y +PE    G IT KSD+YSFGVV+LEI+      + +     ++L 
Sbjct: 179 QXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLD 236
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                          +  +  + D  ++E    V   C+ ++ N RP +K V  +L+
Sbjct: 237 IKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 117/218 (53%), Gaps = 11/218 (5%)
Query: 513 FEEELGRGCFGAVYKGSICE--GNKI-VAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNL 568
           F E +GRG FG VY G++ +  G KI  AVK L    + GE  +F  E   ++   H N+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 569 VRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + LLG C+++    L+V  +M  G L N + N    P  +D +   L VA+G+ YL  + 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK- 151
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQN 684
             + +H ++  RN +LD+  T K+++F LA+ +   +   V   TG K    +M+ E   
Sbjct: 152 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
           +   T KSDV+SFGV++ E++   +    +V+T D+ +
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 29  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 87
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 88  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 147
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 148 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 204
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 205 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 264
Query: 720 VVL 722
           + +
Sbjct: 265 ITV 267

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 5   SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 64  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 123
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 124 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
Query: 720 VVL 722
           + +
Sbjct: 241 ITV 243

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 10  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 68
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 69  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 129 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 186 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 720 VVL 722
           + +
Sbjct: 246 ITV 248

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 2   SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 60
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 61  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 120
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 121 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 177
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 178 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 237
Query: 720 VVL 722
           + +
Sbjct: 238 ITV 240

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 117/218 (53%), Gaps = 11/218 (5%)
Query: 513 FEEELGRGCFGAVYKGSICE--GNKI-VAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNL 568
           F E +GRG FG VY G++ +  G KI  AVK L    + GE  +F  E   ++   H N+
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 569 VRLLGFCMQT-SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + LLG C+++    L+V  +M  G L N + N    P  +D +   L VA+G+ YL  + 
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK- 170
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQN 684
             + +H ++  RN +LD+  T K+++F LA+ +   +   V   TG K    +M+ E   
Sbjct: 171 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
           +   T KSDV+SFGV++ E++   +    +V+T D+ +
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 266

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 117/218 (53%), Gaps = 11/218 (5%)
Query: 513 FEEELGRGCFGAVYKGSICE--GNKI-VAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNL 568
           F E +GRG FG VY G++ +  G KI  AVK L    + GE  +F  E   ++   H N+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 569 VRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + LLG C+++    L+V  +M  G L N + N    P  +D +   L VA+G+ YL  + 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK- 150
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQN 684
             + +H ++  RN +LD+  T K+++F LA+ +   +   V   TG K    +M+ E   
Sbjct: 151 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
           +   T KSDV+SFGV++ E++   +    +V+T D+ +
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 7   SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 66  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 126 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 183 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
Query: 720 VVL 722
           + +
Sbjct: 243 ITV 245

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 9   SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 67
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 68  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 127
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 128 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 184
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 185 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 244
Query: 720 VVL 722
           + +
Sbjct: 245 ITV 247

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/243 (31%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 10  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 68
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 69  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ YL  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 129 NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 186 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 720 VVL 722
           + +
Sbjct: 246 ITV 248

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 126/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 11  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 69
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 70  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 129
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ +L  +   + +H ++  RN +LD+  T K+++F LA+ ++ 
Sbjct: 130 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLD 186
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246
Query: 720 VVL 722
           + +
Sbjct: 247 ITV 249

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 117/218 (53%), Gaps = 11/218 (5%)
Query: 513 FEEELGRGCFGAVYKGSICE--GNKI-VAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNL 568
           F E +GRG FG VY G++ +  G KI  AVK L    + GE  +F  E   ++   H N+
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 569 VRLLGFCMQT-SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + LLG C+++    L+V  +M  G L N + N    P  +D +   L VA+G+ +L  + 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK- 211
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQN 684
             + +H ++  RN +LD+  T K+++F LA+ +   +   V   TG K    +M+ E   
Sbjct: 212 --KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
           +   T KSDV+SFGV++ E++   +    +V+T D+ +
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  105 bits (262), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 10  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 68
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 69  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ +L  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 129 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 720 VVL 722
           + +
Sbjct: 246 ITV 248

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 10  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 68
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 69  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 128
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ +L  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 129 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 245
Query: 720 VVL 722
           + +
Sbjct: 246 ITV 248

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 8   SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 66
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 67  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 126
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ +L  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 127 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 183
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 184 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 243
Query: 720 VVL 722
           + +
Sbjct: 244 ITV 246

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 11  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 69
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 70  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 129
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ +L  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 130 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 186
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 246
Query: 720 VVL 722
           + +
Sbjct: 247 ITV 249

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 125/243 (51%), Gaps = 12/243 (4%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICE--GNKI-VAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ +  G KI  AVK L  
Sbjct: 15  SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 73
Query: 545 PVEEGE-RKFQAEMAAVRRTHHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVES 602
             + GE  +F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 74  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 133
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G+ +L  +   + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 134 NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 190
Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 191 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 250
Query: 720 VVL 722
           + +
Sbjct: 251 ITV 253

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E LG+GCFG   K +  E  +++ +K L    EE +R F  E+  +R   H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +   + E++  G+L  ++ +++S   W  RV  A D+A G+ YLH    + IIH 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMPNQT---GIVTGVKGTRG----------YMSPE 681
           ++N  N L+ ++    +++F LA++++  +T   G+ +  K  R           +M+PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 682 WQNSGLITVKSDVYSFGVVVLEIV 705
             N      K DV+SFG+V+ EI+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 6/202 (2%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +    + LG G FG V+ G      K VAVK L+ P     + F  E   ++   
Sbjct: 9   EIPRESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAFLEEANLMKTLQ 66
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYL 623
           H  LVRL     +     ++ E+M+KGSL + L + E G +   + +  +  +A G+ Y+
Sbjct: 67  HDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 126
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             +     IH ++   N+L+ +SL  KI++F LA+++  N+     G K    + +PE  
Sbjct: 127 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 183
Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KSDV+SFG+++ EIV
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIV 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 6/202 (2%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +    ++LG G FG V+ G      K VAVK L+ P     + F  E   ++   
Sbjct: 8   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLK-PGTMSVQAFLEEANLMKTLQ 65
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYL 623
           H  LVRL     +     ++ EFM+KGSL + L + E G +   + +  +  +A G+ Y+
Sbjct: 66  HDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 125
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             +     IH ++   N+L+ +SL  KI++F LA+++  N+     G K    + +PE  
Sbjct: 126 ERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KS+V+SFG+++ EIV
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIV 204

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 9/213 (4%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER--KFQAEMAAVRRTHHKNLVR 570
            +E++G G FG V++      +  VAVK L       ER  +F  E+A ++R  H N+V 
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL--SNVESGPIWRDRVRIALDVARGITYLHEECE 628
            +G   Q     +V E++S+GSL  LL  S        R R+ +A DVA+G+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             I+H N+   N+L+D   T K+ +F L++ L  +         GT  +M+PE       
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
             KSDVYSFGV++ E+   +  +  N++ A VV
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWG-NLNPAQVV 248

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 62
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 63  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 121
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH N+   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 122 EER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 178
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVT 201

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +E+G G FG V+ G     +K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDK-VAIK----TIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C++ +   LV+EFM  G L + L            + + LDV  G+ YL E C  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 690 VKSDVYSFGVVVLEI 704
            KSDV+SFGV++ E+
Sbjct: 181 SKSDVWSFGVLMWEV 195

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +E+G G FG V+ G     +K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDK-VAIK----TIREGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C++ +   LV+EFM  G L + L            + + LDV  G+ YL E C  
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 690 VKSDVYSFGVVVLEI 704
            KSDV+SFGV++ E+
Sbjct: 183 SKSDVWSFGVLMWEV 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +E+G G FG V+ G     +K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDK-VAIK----TIREGAMSEEDFIEEAEVMMKLSHPKLV 68
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C++ +   LV+EFM  G L + L            + + LDV  G+ YL E C  
Sbjct: 69  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 126
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 690 VKSDVYSFGVVVLEI 704
            KSDV+SFGV++ E+
Sbjct: 186 SKSDVWSFGVLMWEV 200

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 109/213 (51%), Gaps = 9/213 (4%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER--KFQAEMAAVRRTHHKNLVR 570
            +E++G G FG V++      +  VAVK L       ER  +F  E+A ++R  H N+V 
Sbjct: 41  IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL--SNVESGPIWRDRVRIALDVARGITYLHEECE 628
            +G   Q     +V E++S+GSL  LL  S        R R+ +A DVA+G+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             I+H ++   N+L+D   T K+ +F L++ L  +         GT  +M+PE       
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
             KSDVYSFGV++ E+   +  +  N++ A VV
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWG-NLNPAQVV 248

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +E+G G FG V+ G     +K VA+K     ++EG   E  F  E   + +  H  LV
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDK-VAIK----TIKEGSMSEDDFIEEAEVMMKLSHPKLV 85
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C++ +   LV+EFM  G L + L            + + LDV  G+ YL E C  
Sbjct: 86  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 143
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 144 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 690 VKSDVYSFGVVVLEI 704
            KSDV+SFGV++ E+
Sbjct: 203 SKSDVWSFGVLMWEV 217

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 237
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E+G   R    V +A  +A G+ Y
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 295
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
              G  T+KSDV+SFG+++ E+ 
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELT 375

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 237
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E+G   R    V +A  +A G+ Y
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 295
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
              G  T+KSDV+SFG+++ E+ 
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELT 375

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 67
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 68  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 126
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 127 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 183
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 184 NYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 66
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 67  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 68
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 69  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 127
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 128 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 184
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 185 NYGTFTIKSDVWSFGILLTEIVT 207

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLL 572
           EE +GRG FG V K       K VA+K++E+   E ERK F  E+  + R +H N+V+L 
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLY 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA--LDVARGITYLHEECEVQ 630
           G C+      LV E+   GSL N+L   E  P +     ++  L  ++G+ YLH      
Sbjct: 69  GACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 631 IIHCNINPRNILLDDSLTA-KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +IH ++ P N+LL    T  KI +F  A  +   QT + T  KG+  +M+PE       +
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHM-TNNKGSAAWMAPEVFEGSNYS 182
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR 749
            K DV+S+G+++ E++  R  F+     A  ++ +  V+N      +  L    E +  R
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VHNGTRPPLIKNLPKPIESLMTR 240
Query: 750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM 783
                      C   +P+ RPSM+ ++ ++   M
Sbjct: 241 -----------CWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 75
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 76  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 134
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 135 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 191
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 192 NYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 66
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 67  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 182
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 133/274 (48%), Gaps = 28/274 (10%)
Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLL 572
           EE +GRG FG V K       K VA+K++E+   E ERK F  E+  + R +H N+V+L 
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLY 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA--LDVARGITYLHEECEVQ 630
           G C+      LV E+   GSL N+L   E  P +     ++  L  ++G+ YLH      
Sbjct: 68  GACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 631 IIHCNINPRNILLDDSLTA-KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +IH ++ P N+LL    T  KI +F  A  +   QT + T  KG+  +M+PE       +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHM-TNNKGSAAWMAPEVFEGSNYS 181
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR 749
            K DV+S+G+++ E++  R  F+     A  ++ +  V+N      +  L    E +  R
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA--VHNGTRPPLIKNLPKPIESLMTR 239
Query: 750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM 783
                      C   +P+ RPSM+ ++ ++   M
Sbjct: 240 -----------CWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 72
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 73  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 188
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 61
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 62  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 120
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 121 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 177
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 74
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 75  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 133
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 134 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 191 NYGTFTIKSDVWSFGILLTEIVT 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 237
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E+G   R    V +A  +A G+ Y
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 295
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
              G  T+KSDV+SFG+++ E+ 
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELT 375

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 72
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 73  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 131
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 132 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 188
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 66
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 67  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 61
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E+G   R    V +A  +A G+ Y
Sbjct: 62  HEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 119
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 120 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEA 176
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 177 ALYGRFTIKSDVWSFGILLTEL 198

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 72  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 130
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 131 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 187
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 106/203 (52%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 76
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 77  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 135
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  
Sbjct: 136 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 192
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVT 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 64
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E+G   R    V +A  +A G+ Y
Sbjct: 65  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 122
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 123 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 179
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 180 ALYGRFTIKSDVWSFGILLTEL 201

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLR 320
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E+G   R    V +A  +A G+ Y
Sbjct: 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAY 378
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 379 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
              G  T+KSDV+SFG+++ E+ 
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELT 458

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +E+G G FG V+ G     +K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDK-VAIK----TIREGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C++ +   LV EFM  G L + L            + + LDV  G+ YL E C  
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 690 VKSDVYSFGVVVLEI 704
            KSDV+SFGV++ E+
Sbjct: 184 SKSDVWSFGVLMWEV 198

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 60
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L    +      +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 61  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 118
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 119 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 175
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 176 ALYGRFTIKSDVWSFGILLTEL 197

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 62
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L    +      +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 63  HEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 120
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 121 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 177
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 178 ALYGRFTIKSDVWSFGILLTEL 199

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L    +      +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVIEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +E+G G FG V+ G     +K VA+K     + EG   E  F  E   + +  H  LV
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDK-VAIK----TIREGAMSEEDFIEEAEVMMKLSHPKLV 65
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C++ +   LV+EFM  G L + L            + + LDV  G+ YL E    
Sbjct: 66  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---A 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    +
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 690 VKSDVYSFGVVVLEI 704
            KSDV+SFGV++ E+
Sbjct: 183 SKSDVWSFGVLMWEV 197

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L    +      +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVCEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 9/203 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L+ P       F  E   +++  
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLR 238
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKGSL + L   E G   R    V +A  +A G+ Y
Sbjct: 239 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 296
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F L +++  N+     G K    + +PE 
Sbjct: 297 VER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEA 353
Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
              G  T+KSDV+SFG+++ E+ 
Sbjct: 354 ALYGRFTIKSDVWSFGILLTELT 376

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 68
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+M+KGSL + L   E+G   R    V ++  +A G+ Y
Sbjct: 69  HEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKG-ETGKYLRLPQLVDMSAQIASGMAY 126
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 127 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 183
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 184 ALYGRFTIKSDVWSFGILLTEL 205

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 68
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+M+KGSL + L   E+G   R    V ++  +A G+ Y
Sbjct: 69  HEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKG-ETGKYLRLPQLVDMSAQIASGMAY 126
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 127 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEA 183
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 184 ALYGRFTIKSDVWSFGILLTEL 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E++LG G FG V+  +  +  K VAVK ++ P       F AE   ++   
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK-PGSMSVEAFLAEANVMKTLQ 68
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG--PIWRDRVRIALDVARGITY 622
           H  LV+L     +     ++ EFM+KGSL + L + E    P+ +  +  +  +A G+ +
Sbjct: 69  HDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPK-LIDFSAQIAEGMAF 126
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           + +      IH ++   NIL+  SL  KI++F LA+++  N+     G K    + +PE 
Sbjct: 127 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 183
Query: 683 QNSGLITVKSDVYSFGVVVLEIVC 706
            N G  T+KSDV+SFG++++EIV 
Sbjct: 184 INFGSFTIKSDVWSFGILLMEIVT 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L    +      +V E+MSKG L + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYA-VVSEEPIYIVMEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E++LG G FG V+  +  +  K VAVK ++ P       F AE   ++   
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK-PGSMSVEAFLAEANVMKTLQ 241
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG--PIWRDRVRIALDVARGITY 622
           H  LV+L     +     ++ EFM+KGSL + L + E    P+ +  +  +  +A G+ +
Sbjct: 242 HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK-LIDFSAQIAEGMAF 299
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           + +      IH ++   NIL+  SL  KI++F LA+++  N+     G K    + +PE 
Sbjct: 300 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 356
Query: 683 QNSGLITVKSDVYSFGVVVLEIVC 706
            N G  T+KSDV+SFG++++EIV 
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 9/202 (4%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G+   G   VA+K L  P       F  E   +++  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITY 622
           H+ LV+L     +     +V E+MSKG L + L   E G   R    V +A  +A G+ Y
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAY 129
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +     +  +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE 
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 186
Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
              G  T+KSDV+SFG+++ E+
Sbjct: 187 ALYGRFTIKSDVWSFGILLTEL 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 138/296 (46%), Gaps = 48/296 (16%)
Query: 513 FEEELGRGCFGAVYKGSIC-EGNKI-VAVKRL-ENPVEEGERKFQAEMAAV-RRTHHKNL 568
           F++ +G G FG V K  I  +G ++  A+KR+ E   ++  R F  E+  + +  HH N+
Sbjct: 26  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIW------------RDRVRIA 613
           + LLG C       L  E+   G+L + L     +E+ P +            +  +  A
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            DVARG+ YL ++   Q IH N+  RNIL+ ++  AKI++F L++       G    VK 
Sbjct: 146 ADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 195
Query: 674 TRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY 728
           T G +   W      N  + T  SDV+S+GV++ EIV         ++ A++       Y
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 255
Query: 729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
                  L K +  D+EV     + M +    C +++P  RPS   +++ L   +E
Sbjct: 256 ------RLEKPLNCDDEV----YDLMRQ----CWREKPYERPSFAQILVSLNRMLE 297

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 48/296 (16%)
Query: 513 FEEELGRGCFGAVYKGSIC-EGNKI-VAVKRL-ENPVEEGERKFQAEMAAV-RRTHHKNL 568
           F++ +G G FG V K  I  +G ++  A+KR+ E   ++  R F  E+  + +  HH N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIW------------RDRVRIA 613
           + LLG C       L  E+   G+L + L     +E+ P +            +  +  A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            DVARG+ YL ++   Q IH ++  RNIL+ ++  AKI++F L++       G    VK 
Sbjct: 139 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 188
Query: 674 TRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY 728
           T G +   W      N  + T  SDV+S+GV++ EIV         ++ A++       Y
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 248
Query: 729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
                  L K +  D+EV     + M +    C +++P  RPS   +++ L   +E
Sbjct: 249 ------RLEKPLNCDDEV----YDLMRQ----CWREKPYERPSFAQILVSLNRMLE 290

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 48/296 (16%)
Query: 513 FEEELGRGCFGAVYKGSIC-EGNKI-VAVKRL-ENPVEEGERKFQAEMAAV-RRTHHKNL 568
           F++ +G G FG V K  I  +G ++  A+KR+ E   ++  R F  E+  + +  HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSN---VESGPIW------------RDRVRIA 613
           + LLG C       L  E+   G+L + L     +E+ P +            +  +  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            DVARG+ YL ++   Q IH ++  RNIL+ ++  AKI++F L++       G    VK 
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198
Query: 674 TRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY 728
           T G +   W      N  + T  SDV+S+GV++ EIV         ++ A++       Y
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258
Query: 729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
                  L K +  D+EV       ++R    C +++P  RPS   +++ L   +E
Sbjct: 259 ------RLEKPLNCDDEV-----YDLMRQ---CWREKPYERPSFAQILVSLNRMLE 300

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 7/202 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +    + LG G FG V+ G+   GN  VA+K L+ P       F  E   +++  
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGT-WNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLK 62
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           H  LV+L    +      +V E+M+KGSL + L + E   +   + V +A  VA G+ Y+
Sbjct: 63  HDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                +  IH ++   NIL+ + L  KI++F LA+++  N+     G K    + +PE  
Sbjct: 122 ER---MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAA 178
Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
             G  T+KSDV+SFG+++ E+V
Sbjct: 179 LYGRFTIKSDVWSFGILLTELV 200

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE 547
           +S+ PS      ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    
Sbjct: 1   TSMDPSS----PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 56
Query: 548 EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR 607
           E E +F  E A ++   H NLV+LLG C +     ++ EFM+ G+L + L         R
Sbjct: 57  EVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----R 110
Query: 608 DRVR------IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM 661
             V       +A  ++  + YL ++     IH ++  RN L+ ++   K+++F L++++ 
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 167
Query: 662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +      G K    + +PE       ++KSDV++FGV++ EI 
Sbjct: 168 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 19/224 (8%)
Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE 547
           +S+ PS      ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    
Sbjct: 1   TSMDPSS----PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 56
Query: 548 EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR 607
           E E +F  E A ++   H NLV+LLG C +     ++ EFM+ G+L + L         R
Sbjct: 57  EVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----R 110
Query: 608 DRVR------IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM 661
             V       +A  ++  + YL ++     IH ++  RN L+ ++   K+++F L++++ 
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 167
Query: 662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +      G K    + +PE       ++KSDV++FGV++ EI 
Sbjct: 168 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 493 SQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK 552
           ++    QS    E+ER     + +LG G +G VY G   + +  VAVK L+    E E +
Sbjct: 16  TENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-E 74
Query: 553 FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR- 611
           F  E A ++   H NLV+LLG C       +V E+M  G+L + L         R+ V  
Sbjct: 75  FLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECN-----REEVTA 129
Query: 612 -----IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
                +A  ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +   
Sbjct: 130 VVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYT 186
Query: 667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
              G K    + +PE       ++KSDV++FGV++ EI
Sbjct: 187 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           S    E+ER     + +LG G FG VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 115
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 172
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 7/203 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G  G V+ G    G+  VAVK L+      +  F AE   +++  
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMG-YYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQ 66
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L       +  +++  +A  +A G+ ++
Sbjct: 67  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            E      IH ++   NIL+ D+L+ KI++F LA+++   +     G K    + +PE  
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI 182
Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
           N G  T+KSDV+SFG+++ EIV 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 110/221 (49%), Gaps = 20/221 (9%)
Query: 491 GPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE 550
           GPS      ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E
Sbjct: 1   GPSP-----NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE 55
Query: 551 RKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV 610
            +F  E A ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V
Sbjct: 56  -EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEV 109
Query: 611 R------IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
                  +A  ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  + 
Sbjct: 110 NAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166
Query: 665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
                G K    + +PE       ++KSDV++FGV++ EI 
Sbjct: 167 XTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 15/221 (6%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER 551
           P+   +  ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E 
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE- 261
Query: 552 KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR 611
           +F  E A ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V 
Sbjct: 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVS 316
Query: 612 ------IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
                 +A  ++  + YL ++     IH N+  RN L+ ++   K+++F L++++  +  
Sbjct: 317 AVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373
Query: 666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC 706
               G K    + +PE       ++KSDV++FGV++ EI  
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           S    E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 115
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 172
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 117
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
              + +PE       ++KSDV++FGV++ EI
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 122
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF 179
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 15/221 (6%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER 551
           P+   +  ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E 
Sbjct: 242 PTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE- 300
Query: 552 KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR 611
           +F  E A ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V 
Sbjct: 301 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVN 355
Query: 612 ------IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
                 +A  ++  + YL ++     IH N+  RN L+ ++   K+++F L++++  +  
Sbjct: 356 AVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 412
Query: 666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC 706
               G K    + +PE       ++KSDV++FGV++ EI  
Sbjct: 413 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 121
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 119
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 120 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF 176
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 118
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 119 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKF 175
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 117
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
              + +PE       ++KSDV++FGV++ EI
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 12/239 (5%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+E +       +G G FG VYKG    G+  V + ++ +P  E  + F+ E+A +R+T 
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGK-WHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR 90
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
           H N++  +G+ M      +V ++    SL   L   E+       + IA   A+G+ YLH
Sbjct: 91  HVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH 149
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE-- 681
            +    IIH ++   NI L + LT KI +F LA +    + +  V    G+  +M+PE  
Sbjct: 150 AK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206
Query: 682 -WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL 739
             Q++   + +SDVYS+G+V+ E++     +  +++  D ++    V   + + +LSKL
Sbjct: 207 RMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFM--VGRGYASPDLSKL 262

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 136/271 (50%), Gaps = 21/271 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 14  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
              T+ +L +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH
Sbjct: 73  S--TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLIT 689
            ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR 749
            +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V   
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSN 237
Query: 750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
             + M R+   C++ + + RP    ++  +E
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 75
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 130
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 131 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 187
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 188 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 219

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 18  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L   E+    +  + IA   ARG+ YLH +    IIH 
Sbjct: 77  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 132
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L +  T KI +F LA +    + +     + G+  +M+PE    Q+S   + 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V    ++ +LSK       V    
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVGRGSLSPDLSK-------VRSNC 242
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RPS   ++  +E
Sbjct: 243 PKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 122
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 117
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 117
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 117
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 122
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 123 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 179
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 119
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 120 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMA 119
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 120 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 176
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 19  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V    
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSNC 243
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RP    ++  +E
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 14  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V    
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSNC 238
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RP    ++  +E
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 16  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 75  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 130
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V    
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSNC 240
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RP    ++  +E
Sbjct: 241 PKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 41/295 (13%)
Query: 516 ELGRGCFGAVYKGS----ICEGNK-IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           ELG G FG V+       + E +K +VAVK L+   E   + FQ E   +    H+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL-------------SNVESGPIWRDR-VRIALDV 616
             G C +    L+V+E+M  G L   L              +V  GP+   + + +A  V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGT 674
           A G+ YL     +  +H ++  RN L+   L  KI +F +++ +       V G  +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI-A 733
           R +M PE       T +SDV+SFGVV+ EI          +S  + +       +C    
Sbjct: 225 R-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCITQG 276
Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV 788
           +EL +      EV       ++R    C Q EP  R S+K+V   L+   + P V
Sbjct: 277 RELERPRACPPEV-----YAIMRG---CWQREPQQRHSIKDVHARLQALAQAPPV 323

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 19  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 133
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V    
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSNC 243
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RP    ++  +E
Sbjct: 244 PKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           ++   E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 117
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 118 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 133/279 (47%), Gaps = 35/279 (12%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-------RKFQAEMAAVRRTHH 565
           +E+++G+G FG V+KG + +   +VA+K L     EGE       ++FQ E+  +   +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLH 624
            N+V+L G      +  +V EF+  G L + L + ++ PI W  ++R+ LD+A GI Y+ 
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 625 EECEVQIIHCNINPRNILL-----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
            +    I+H ++   NI L     +  + AK+++FSL++         V+G+ G   +M+
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMA 194
Query: 680 PE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
           PE         T K+D YSF +++  I+     F+   S   +  +     N    + L 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFI-----NMIREEGLR 248
Query: 738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
             + ED    LR       V  LC   +P  RP    ++
Sbjct: 249 PTIPEDCPPRLRN------VIELCWSGDPKKRPHFSYIV 281

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 41/295 (13%)
Query: 516 ELGRGCFGAVYKGS----ICEGNK-IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           ELG G FG V+       + E +K +VAVK L+   E   + FQ E   +    H+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL-------------SNVESGPIWRDR-VRIALDV 616
             G C +    L+V+E+M  G L   L              +V  GP+   + + +A  V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGT 674
           A G+ YL     +  +H ++  RN L+   L  KI +F +++ +       V G  +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI-A 733
           R +M PE       T +SDV+SFGVV+ EI          +S  + +       +C    
Sbjct: 196 R-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCITQG 247
Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV 788
           +EL +      EV       ++R    C Q EP  R S+K+V   L+   + P V
Sbjct: 248 RELERPRACPPEV-----YAIMRG---CWQREPQQRHSIKDVHARLQALAQAPPV 294

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 141/310 (45%), Gaps = 47/310 (15%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G+       E    VAVK +       ER +F  E +
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES---------GPIWRDR 609
            ++     ++VRLLG   +    L+V E M+ G L++ L ++            P  ++ 
Sbjct: 74  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+ +   + +H N+  RN ++    T KI +F + + +   +T    
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYR 188
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +M+PE    G+ T  SD++SFGVV+ EI                  L+
Sbjct: 189 --KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LA 230
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ K V +   +D      E +  +  +C Q  PN+RP+   ++ +L+  
Sbjct: 231 EQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290
Query: 783 ME--IPVVPF 790
           +    P V F
Sbjct: 291 LHPSFPEVSF 300

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
           S    E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A 
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR------IA 613
           ++   H NLV+LLG C +     ++ EFM+ G+L + L         R  V       +A
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 115
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             ++  + YL ++     IH ++  RN L+ ++   K+++F L++++  +      G K 
Sbjct: 116 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF 172
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
              + +PE       ++KSDV++FGV++ EI 
Sbjct: 173 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 204

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 135/302 (44%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +         
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX--- 188
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 189 -RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 231
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 232 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 291
Query: 783 ME 784
           ME
Sbjct: 292 ME 293

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 141/310 (45%), Gaps = 47/310 (15%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G+       E    VAVK +       ER +F  E +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES---------GPIWRDR 609
            ++     ++VRLLG   +    L+V E M+ G L++ L ++            P  ++ 
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+ +   + +H N+  RN ++    T KI +F + + +   +T    
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYR 187
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +M+PE    G+ T  SD++SFGVV+ EI                  L+
Sbjct: 188 --KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LA 229
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ K V +   +D      E +  +  +C Q  PN+RP+   ++ +L+  
Sbjct: 230 EQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289
Query: 783 ME--IPVVPF 790
           +    P V F
Sbjct: 290 LHPSFPEVSF 299

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 41/295 (13%)
Query: 516 ELGRGCFGAVYKGS----ICEGNK-IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           ELG G FG V+       + E +K +VAVK L+   E   + FQ E   +    H+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLL-------------SNVESGPIWRDR-VRIALDV 616
             G C +    L+V+E+M  G L   L              +V  GP+   + + +A  V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGT 674
           A G+ YL     +  +H ++  RN L+   L  KI +F +++ +       V G  +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI-A 733
           R +M PE       T +SDV+SFGVV+ EI          +S  + +       +C    
Sbjct: 202 R-WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------DCITQG 253
Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV 788
           +EL +      EV       ++R    C Q EP  R S+K+V   L+   + P V
Sbjct: 254 RELERPRACPPEV-----YAIMRG---CWQREPQQRHSIKDVHARLQALAQAPPV 300

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 42  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V    
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSNC 266
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RP    ++  +E
Sbjct: 267 PKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 136/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +         
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX--- 179
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 180 -RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 222
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + ++ +  +C Q  P +RPS   +I  ++  
Sbjct: 223 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEE 282
Query: 783 ME 784
           ME
Sbjct: 283 ME 284

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 136/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG---------PIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++            P     
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 185
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 186 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 227
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 228 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 287
Query: 783 ME 784
           ME
Sbjct: 288 ME 289

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 41  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 100 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 155
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L + LT KI +F LA +    + +     + G+  +M+PE    Q+    + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       V    
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK-------VRSNC 265
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RP    ++  +E
Sbjct: 266 PKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 136/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG---------PIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++            P     
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 195
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 196 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 237
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 238 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 783 ME 784
           ME
Sbjct: 298 ME 299

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 189
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 190 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 231
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 232 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 291
Query: 783 ME 784
           ME
Sbjct: 292 ME 293

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 139/302 (46%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV----ESGPIW-----RDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++    E+ P+         
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 217
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 218 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 259
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 260 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 319
Query: 783 ME 784
           ME
Sbjct: 320 ME 321

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 186
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 187 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 228
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 229 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 288
Query: 783 ME 784
           ME
Sbjct: 289 ME 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 195
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 196 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 237
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 238 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
Query: 783 ME 784
           ME
Sbjct: 298 ME 299

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 136/271 (50%), Gaps = 21/271 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 30  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
              T+ +L +V ++    SL + L   E+    +  + IA   ARG+ YLH +    IIH
Sbjct: 89  S--TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIH 143
Query: 634 CNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE---WQNSGLIT 689
            ++   NI L +  T KI +F LA +    + +     + G+  +M+PE    Q+S   +
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR 749
            +SDVY+FG+V+ E++  +  +  N++  D ++    V    ++ +LSK       V   
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVGRGSLSPDLSK-------VRSN 253
Query: 750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
             + M R+   C++ + + RPS   ++  +E
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 134/270 (49%), Gaps = 19/270 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 30  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L   E+    +  + IA   ARG+ YLH +    IIH 
Sbjct: 89  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 635 NINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE---WQNSGLITV 690
           ++   NI L +  T KI +F LA +    + +     + G+  +M+PE    Q+S   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           +SDVY+FG+V+ E++  +  +  N++  D ++    V    ++ +LSK       V    
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVGRGSLSPDLSK-------VRSNC 254
Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            + M R+   C++ + + RPS   ++  +E
Sbjct: 255 PKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 139/310 (44%), Gaps = 47/310 (15%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G+       E    VAVK +       ER +F  E +
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES---------GPIWRDR 609
            ++     ++VRLLG   +    L+V E M+ G L++ L ++            P  ++ 
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F + + +         
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX--- 186
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +M+PE    G+ T  SD++SFGVV+ EI                  L+
Sbjct: 187 -RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LA 229
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ K V +   +D      E +  +  +C Q  PN+RP+   ++ +L+  
Sbjct: 230 EQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289
Query: 783 ME--IPVVPF 790
           +    P V F
Sbjct: 290 LHPSFPEVSF 299

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 188
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 189 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 230
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 231 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 290
Query: 783 ME 784
           ME
Sbjct: 291 ME 292

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 182
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 183 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 224
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 225 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 284
Query: 783 ME 784
           ME
Sbjct: 285 ME 286

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 14  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG------VKGTRGYMSPE---WQNS 685
           ++   NI L + LT KI +F LA      +    +G      + G+  +M+PE    Q+ 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
              + +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK------- 233
Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           V     + M R+   C++ + + RP    ++  +E
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-------RKFQAEMAAVRRTHH 565
           +E+++G+G FG V+KG + +   +VA+K L     EGE       ++FQ E+  +   +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLH 624
            N+V+L G      +  +V EF+  G L + L + ++ PI W  ++R+ LD+A GI Y+ 
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 625 EECEVQIIHCNINPRNILL-----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
            +    I+H ++   NI L     +  + AK+++F L++         V+G+ G   +M+
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMA 194
Query: 680 PE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
           PE         T K+D YSF +++  I+     F+   S   +  +     N    + L 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFI-----NMIREEGLR 248
Query: 738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
             + ED    LR       V  LC   +P  RP    ++
Sbjct: 249 PTIPEDCPPRLRN------VIELCWSGDPKKRPHFSYIV 281

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +   +T    
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYR 188
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 189 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 230
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + +  +  +C Q  P +RPS   +I  ++  
Sbjct: 231 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 290
Query: 783 ME 784
           ME
Sbjct: 291 ME 292

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++GRG FG V+ G +   N +VAVK   E    + + KF  E   +++  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL----DVARGITYLHEECEV 629
            C Q     +V E +  G     L    +    R RV+  L    D A G+ YL  +C  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR----GYMSPEWQNS 685
             IH ++  RN L+ +    KIS+F +++       G+     G R     + +PE  N 
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVKWTAPEALNY 289
Query: 686 GLITVKSDVYSFGVVVLE 703
           G  + +SDV+SFG+++ E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++GRG FG V+ G +   N +VAVK   E    + + KF  E   +++  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL----DVARGITYLHEECEV 629
            C Q     +V E +  G     L    +    R RV+  L    D A G+ YL  +C  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKC-- 233
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR----GYMSPEWQNS 685
             IH ++  RN L+ +    KIS+F +++       G+     G R     + +PE  N 
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 686 GLITVKSDVYSFGVVVLE 703
           G  + +SDV+SFG+++ E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K +       ER +F  E +
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L ++          + P     
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN  + +  T KI +F + + +   +T    
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY--ETDYYR 182
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +MSPE    G+ T  SDV+SFGVV+ EI                  L+
Sbjct: 183 --KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----------------LA 224
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ + V E   +D      + ++ +  +C Q  P +RPS   +I  ++  
Sbjct: 225 EQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEE 284
Query: 783 ME 784
           ME
Sbjct: 285 ME 286

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 34  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 93  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 148
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG------VKGTRGYMSPE---WQNS 685
           ++   NI L + LT KI +F LA      +    +G      + G+  +M+PE    Q+ 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 203
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
              + +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       
Sbjct: 204 NPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK------- 253
Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           V     + M R+   C++ + + RP    ++  +E
Sbjct: 254 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 134/275 (48%), Gaps = 29/275 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G G FG VYKG    G+  V +  +  P  +  + F+ E+  +R+T H N++  +G+
Sbjct: 42  QRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             +  +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    IIH 
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHR 156
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG------VKGTRGYMSPE---WQNS 685
           ++   NI L + LT KI +F LA      +    +G      + G+  +M+PE    Q+ 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 211
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
              + +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK       
Sbjct: 212 NPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFM--VGRGYLSPDLSK------- 261
Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           V     + M R+   C++ + + RP    ++  +E
Sbjct: 262 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 141/311 (45%), Gaps = 47/311 (15%)
Query: 504 GELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGER-KFQAEM 557
           GE+ R       ELG+G FG VY+G+       E    VAVK +       ER +F  E 
Sbjct: 11  GEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 70
Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES---------GPIWRD 608
           + ++     ++VRLLG   +    L+V E M+ G L++ L ++            P  ++
Sbjct: 71  SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 130
Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
            +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F + + +   +T   
Sbjct: 131 MIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYY 185
Query: 669 TGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
              KG +G     +M+PE    G+ T  SD++SFGVV+ EI                  L
Sbjct: 186 R--KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------L 227
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
           +   Y     +++ K V +   +D      E +  +  +C Q  P +RP+   ++ +L+ 
Sbjct: 228 AEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287
Query: 782 TME--IPVVPF 790
            +    P V F
Sbjct: 288 DLHPSFPEVSF 298

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 29/285 (10%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVR 561
           EL+R      +ELG G FG V  G   +G   VAVK     ++EG   E +F  E   + 
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKM----IKEGSMSEDEFFQEAQTMM 58
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGIT 621
           +  H  LV+  G C +     +V E++S G L N L +   G      + +  DV  G+ 
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           +L      Q IH ++  RN L+D  L  K+S+F + + ++ +Q     G K    + +PE
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPE 175
Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG 741
             +    + KSDV++FG+++ E+                  L    Y+ +   E+   V 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS----------------LGKMPYDLYTNSEVVLKVS 219
Query: 742 EDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
           +   +    L  +T+ ++   C  + P  RP+ + ++  +E   E
Sbjct: 220 QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 134
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH N+  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 135 ---RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 192 ESKFSVASDVWSFGVVLYEL 211

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 145/323 (44%), Gaps = 50/323 (15%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPV 546
           PS  F+   +   E+ R       ELG+G FG VY+G+       E    VAVK +    
Sbjct: 3   PSSVFVPDEW---EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 547 EEGER-KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES--- 602
              ER +F  E + ++     ++VRLLG   +    L+V E M+ G L++ L ++     
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 603 ------GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
                  P  ++ +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F +
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 657 AKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            + +   +T      KG +G     +M+PE    G+ T  SD++SFGVV+ EI       
Sbjct: 177 TRDIY--ETAYYR--KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----- 227
Query: 712 EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLR 769
                      L+   Y     +++ K V +   +D      E +  +  +C Q  P +R
Sbjct: 228 -----------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 276
Query: 770 PSMKNVILMLEGTME--IPVVPF 790
           P+   ++ +L+  +    P V F
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEVSF 299

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 19/204 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E++LG G FG V+  +  +  K VAVK ++ P       F AE   ++   
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMK-PGSMSVEAFLAEANVMKTLQ 235
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG--PIWRDRVRIALDVARGITY 622
           H  LV+L     +     ++ EFM+KGSL + L + E    P+ +  +  +  +A G+ +
Sbjct: 236 HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPK-LIDFSAQIAEGMAF 293
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           + +      IH ++   NIL+  SL  KI++F LA++          G K    + +PE 
Sbjct: 294 IEQR---NYIHRDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEA 340
Query: 683 QNSGLITVKSDVYSFGVVVLEIVC 706
            N G  T+KSDV+SFG++++EIV 
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVT 364

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 81/323 (25%), Positives = 145/323 (44%), Gaps = 50/323 (15%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPV 546
           PS  F+   +   E+ R       ELG+G FG VY+G+       E    VAVK +    
Sbjct: 3   PSSVFVPDEW---EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 547 EEGER-KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES--- 602
              ER +F  E + ++     ++VRLLG   +    L+V E M+ G L++ L ++     
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 603 ------GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
                  P  ++ +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F +
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 657 AKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            + +   +T      KG +G     +M+PE    G+ T  SD++SFGVV+ EI       
Sbjct: 177 TRDIY--ETDYYR--KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----- 227
Query: 712 EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLR 769
                      L+   Y     +++ K V +   +D      E +  +  +C Q  P +R
Sbjct: 228 -----------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 276
Query: 770 PSMKNVILMLEGTME--IPVVPF 790
           P+   ++ +L+  +    P V F
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEVSF 299

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 143/323 (44%), Gaps = 50/323 (15%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPV 546
           PS  F+   +   E+ R       ELG+G FG VY+G+       E    VAVK +    
Sbjct: 3   PSSVFVPDEW---EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 547 EEGER-KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES--- 602
              ER +F  E + ++     ++VRLLG   +    L+V E M+ G L++ L ++     
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAE 119
Query: 603 ------GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
                  P  ++ +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F +
Sbjct: 120 NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM 176
Query: 657 AKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            + +           KG +G     +M+PE    G+ T  SD++SFGVV+ EI       
Sbjct: 177 TRDIXETDXX----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----- 227
Query: 712 EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLR 769
                      L+   Y     +++ K V +   +D      E +  +  +C Q  P +R
Sbjct: 228 -----------LAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 276
Query: 770 PSMKNVILMLEGTME--IPVVPF 790
           P+   ++ +L+  +    P V F
Sbjct: 277 PTFLEIVNLLKDDLHPSFPEVSF 299

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 143/319 (44%), Gaps = 39/319 (12%)
Query: 482 QKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSI--CEGNK--IV 537
           + L    ++G      +  F+T E+  +    ++ +G G FG VYKG +    G K   V
Sbjct: 18  ENLYFQGAMGSDPNQAVLKFTT-EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV 76
Query: 538 AVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENL 596
           A+K L+    E +R  F  E   + +  H N++RL G   +    +++ E+M  G+L+  
Sbjct: 77  AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 597 LSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
           L   +        V +   +A G+ YL     +  +H ++  RNIL++ +L  K+S+F L
Sbjct: 137 LREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGL 193
Query: 657 AKILM--PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR------ 708
           +++L   P  T   +G K    + +PE  +    T  SDV+SFG+V+ E++         
Sbjct: 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
Query: 709 -SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPN 767
            SN EV  +  D   L T + +C  A                    + ++ + C Q E  
Sbjct: 254 LSNHEVMKAINDGFRLPTPM-DCPSA--------------------IYQLMMQCWQQERA 292
Query: 768 LRPSMKNVILMLEGTMEIP 786
            RP   +++ +L+  +  P
Sbjct: 293 RRPKFADIVSILDKLIRAP 311

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F LA++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 35/279 (12%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-------RKFQAEMAAVRRTHH 565
           +E+++G+G FG V+KG + +   +VA+K L     EGE       ++FQ E+  +   +H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLH 624
            N+V+L G      +  +V EF+  G L + L + ++ PI W  ++R+ LD+A GI Y+ 
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 625 EECEVQIIHCNINPRNILL-----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
            +    I+H ++   NI L     +  + AK+++F  ++         V+G+ G   +M+
Sbjct: 140 NQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMA 194
Query: 680 PE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
           PE         T K+D YSF +++  I+     F+   S   +  +     N    + L 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFI-----NMIREEGLR 248
Query: 738 KLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
             + ED    LR       V  LC   +P  RP    ++
Sbjct: 249 PTIPEDCPPRLRN------VIELCWSGDPKKRPHFSYIV 281

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 222 ESKFSVASDVWSFGVVLYEL 241

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 11/213 (5%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQA 555
           S +  + E     F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ 
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 78
Query: 556 EMAAVRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIA 613
           E+  ++   H N+V+  G C    ++   L+ E++  GSL + L   +        ++  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             + +G+ YL  +   + IH ++  RNIL+++    KI +F L K+L  ++        G
Sbjct: 139 SQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 674 TRG--YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
                + +PE       +V SDV+SFGVV+ E+
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 11/213 (5%)
Query: 500 SFSTGELERATNGFEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQA 555
           S +  + E     F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ 
Sbjct: 19  SHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 78
Query: 556 EMAAVRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIA 613
           E+  ++   H N+V+  G C    ++   L+ E++  GSL + L   +        ++  
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
             + +G+ YL  +   + IH ++  RNIL+++    KI +F L K+L  ++        G
Sbjct: 139 SQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 674 TRG--YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
                + +PE       +V SDV+SFGVV+ E+
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 138/310 (44%), Gaps = 47/310 (15%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGER-KFQAEMA 558
           E+ R       ELG+G FG VY+G+       E    VAVK +       ER +F  E +
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES---------GPIWRDR 609
            ++     ++VRLLG   +    L+V E M+ G L++ L ++            P  ++ 
Sbjct: 70  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+ +   + +H ++  RN ++    T KI +F + + +         
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXX--- 183
Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
             KG +G     +M+PE    G+ T  SD++SFGVV+ EI                  L+
Sbjct: 184 -RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------------LA 226
Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRT--LETMVRVGLLCIQDEPNLRPSMKNVILMLEGT 782
              Y     +++ K V +   +D      E +  +  +C Q  P +RP+   ++ +L+  
Sbjct: 227 EQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 286
Query: 783 ME--IPVVPF 790
           +    P V F
Sbjct: 287 LHPSFPEVSF 296

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 11/207 (5%)
Query: 507 ERATNGFEEELGRGCFGAVYKGSICEG--NKI-VAVKRLENPVEEGE-RKFQAEMAAVRR 562
           ER     +  +G+G FG VY G   +   N+I  A+K L    E  +   F  E   +R 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 563 THHKNLVRLLGFCMQTSK-KLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGIT 621
            +H N++ L+G  +       ++  +M  G L   + + +  P  +D +   L VARG+ 
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR---GYM 678
           YL E+   + +H ++  RN +LD+S T K+++F LA+ ++  +   V   +  R    + 
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIV 705
           + E   +   T KSDV+SFGV++ E++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 191 ESKFSVASDVWSFGVVLYEL 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 138
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 139 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 196 ESKFSVASDVWSFGVVLYEL 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 504 GELERATNGFEE-------ELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERK 552
           G  +R    FEE       +LG+G FG+V    Y        ++VAVK+L++  EE  R 
Sbjct: 1   GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 60
Query: 553 FQAEMAAVRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRV 610
           F+ E+  ++   H N+V+  G C    ++   L+ E++  GSL + L   +        +
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 120
Query: 611 RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG 670
           +    + +G+ YL  +   + IH ++  RNIL+++    KI +F L K+L  ++      
Sbjct: 121 QYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 177
Query: 671 VKGTRG--YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             G     + +PE       +V SDV+SFGVV+ E+
Sbjct: 178 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 140
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 141 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 198 ESKFSVASDVWSFGVVLYEL 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 139
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 140 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 197 ESKFSVASDVWSFGVVLYEL 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 131
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 132 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 189 ESKFSVASDVWSFGVVLYEL 208

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 132
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 133 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 190 ESKFSVASDVWSFGVVLYEL 209

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 191 ESKFSVASDVWSFGVVLYEL 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 137
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 138 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 195 ESKFSVASDVWSFGVVLYEL 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L   +        ++    + +G+ YL  +
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 134 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 191 ESKFSVASDVWSFGVVLYEL 210

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 127/302 (42%), Gaps = 57/302 (18%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVR 570
           LG G FG V K +        G   VAVK L+      E R   +E   +++ +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVES-GPIWR---------------------- 607
           L G C Q    LL+ E+   GSL   L      GP +                       
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  A  +++G+ YL    E++++H ++  RNIL+ +    KIS+F L++ +    +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX- 206
Query: 668 VTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV- 721
              VK ++G +  +W         + T +SDV+SFGV++ EIV    N    +    +  
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
           LL T               G   E      E M R+ L C + EP+ RP   ++   LE 
Sbjct: 264 LLKT---------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
Query: 782 TM 783
            M
Sbjct: 309 MM 310

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F  +LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ EF+  GSL   L   +        ++    + +G+ YL  +
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 137 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 194 ESKFSVASDVWSFGVVLYEL 213

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRLENPVEEGERKFQA---EMAAVRRTHHKNLV 569
           LG G FG V+KG  I EG  I   V +K +E+  + G + FQA    M A+    H ++V
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           RLLG C  +S +L V +++  GSL + +         +  +   + +A+G+ YL E    
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-- 135
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVKGTRGYMSPEWQNSGLI 688
            ++H N+  RN+LL      ++++F +A +L P+   ++ +  K    +M+ E  + G  
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV 720
           T +SDV+S+GV V E++   +     +  A+V
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRLENPVEEGERKFQA---EMAAVRRTHHKNLV 569
           LG G FG V+KG  I EG  I   V +K +E+  + G + FQA    M A+    H ++V
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIED--KSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           RLLG C  +S +L V +++  GSL + +         +  +   + +A+G+ YL E    
Sbjct: 97  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-- 153
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVKGTRGYMSPEWQNSGLI 688
            ++H N+  RN+LL      ++++F +A +L P+   ++ +  K    +M+ E  + G  
Sbjct: 154 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV 720
           T +SDV+S+GV V E++   +     +  A+V
Sbjct: 213 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 244

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 137/299 (45%), Gaps = 41/299 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +     K      VAVK L++     E++   +E+ 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN----VESGPIW------- 606
            +     H+N+V LLG C      L++ E+   G L N L      +E+ P +       
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTL 161
Query: 607 --RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
             RD +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F LA+ +M + 
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 665 TGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
             IV G  +    +M+PE     + TV+SDV+S+G+++ EI      F + ++    +L+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV 272
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           ++  Y         KLV +  ++       + +  +   C   EP  RP+ + +   L+
Sbjct: 273 NSKFY---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 127/302 (42%), Gaps = 57/302 (18%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG V K +        G   VAVK L EN      R   +E   +++ +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVES-GPIWR---------------------- 607
           L G C Q    LL+ E+   GSL   L      GP +                       
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  A  +++G+ YL    E++++H ++  RNIL+ +    KIS+F L++ +    +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 668 VTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV- 721
              VK ++G +  +W         + T +SDV+SFGV++ EIV    N    +    +  
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
           LL T               G   E      E M R+ L C + EP+ RP   ++   LE 
Sbjct: 264 LLKT---------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
Query: 782 TM 783
            M
Sbjct: 309 MM 310

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 137/299 (45%), Gaps = 41/299 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +     K      VAVK L++     E++   +E+ 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN----VESGPIW------- 606
            +     H+N+V LLG C      L++ E+   G L N L      +E+ P +       
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 607 --RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
             RD +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F LA+ +M + 
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 665 TGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL 723
             IV G  +    +M+PE     + TV+SDV+S+G+++ EI      F + ++    +L+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILV 272
Query: 724 STWVYNCFIAKELSKLVGEDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           ++  Y         KLV +  ++       + +  +   C   EP  RP+ + +   L+
Sbjct: 273 NSKFY---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 232
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 114/247 (46%), Gaps = 20/247 (8%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELG------RGCFGAVYKGSICEG--------NKIV 537
           P  +F  +  +  E  RA   F  E+           G+   G +C G        +  V
Sbjct: 21  PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 538 AVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENL 596
           A+K L+    E +R+ F +E + + +  H N++RL G   +    ++V E+M  GSL+  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 597 LSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
           L   +        V +   V  G+ YL    ++  +H ++  RN+L+D +L  K+S+F L
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 657 AKILM--PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
           +++L   P+     TG K    + +PE       +  SDV+SFGVV+ E++        N
Sbjct: 198 SRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 715 VSTADVV 721
           ++  DV+
Sbjct: 258 MTNRDVI 264

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 148
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 249
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 250 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 299

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 134/290 (46%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 158
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 159 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 259
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 260 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVR 570
           LG G FG V K +        G   VAVK L+      E R   +E   +++ +H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVES-GPIW----------------------R 607
           L G C Q    LL+ E+   GSL   L      GP +                       
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  A  +++G+ YL    E+ ++H ++  RNIL+ +    KIS+F L++ +    +  
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX- 206
Query: 668 VTGVKGTRGYMSPEWQN-----SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV- 721
              VK ++G +  +W         + T +SDV+SFGV++ EIV    N    +    +  
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
           LL T               G   E      E M R+ L C + EP+ RP   ++   LE 
Sbjct: 264 LLKT---------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
Query: 782 TM 783
            M
Sbjct: 309 MM 310

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 133/290 (45%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L ++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ---AEMAAVR 561
           E++ A    EE +G G FG VY+ +   G+++       +P E+  +  +    E     
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYR-AFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGIT 621
              H N++ L G C++     LV EF   G L  +LS     P     V  A+ +ARG+ 
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP--DILVNWAVQIARGMN 119
Query: 622 YLHEECEVQIIHCNINPRNILLDDSL--------TAKISNFSLAKILMPNQTGIVTGVKG 673
           YLH+E  V IIH ++   NIL+   +          KI++F LA+    ++T  ++   G
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-G 176
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
              +M+PE   + + +  SDV+S+GV++ E++     F
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 114/247 (46%), Gaps = 20/247 (8%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELG------RGCFGAVYKGSICEG--------NKIV 537
           P  +F  +  +  E  RA   F  E+           G+   G +C G        +  V
Sbjct: 21  PEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPV 80
Query: 538 AVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENL 596
           A+K L+    E +R+ F +E + + +  H N++RL G   +    ++V E+M  GSL+  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 597 LSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
           L   +        V +   V  G+ YL    ++  +H ++  RN+L+D +L  K+S+F L
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 657 AKILM--PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
           +++L   P+     TG K    + +PE       +  SDV+SFGVV+ E++        N
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257
Query: 715 VSTADVV 721
           ++  DV+
Sbjct: 258 MTNRDVI 264

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 513 FEEELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           F ++LG+G FG+V    Y        ++VAVK+L++  EE  R F+ E+  ++   H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G C    ++   L+ E++  GSL + L            ++    + +G+ YL  +
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK 136
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQN 684
              + IH ++  RNIL+++    KI +F L K+L  ++        G     + +PE   
Sbjct: 137 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 685 SGLITVKSDVYSFGVVVLEI 704
               +V SDV+SFGVV+ E+
Sbjct: 194 ESKFSVASDVWSFGVVLYEL 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 119/252 (47%), Gaps = 24/252 (9%)
Query: 490 LGPSQEFIIQSFSTGELERATNGFEEELGRGC------FGAVYKGSICEGNK-------- 535
           + P  +  I  F+  +   A   F +E+   C       GA   G +C G+         
Sbjct: 3   MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI 62
Query: 536 IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLE 594
            VA+K L++   E +R+ F +E + + +  H N++ L G   +++  +++ EFM  GSL+
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 595 NLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF 654
           + L   +        V +   +A G+ YL    ++  +H ++  RNIL++ +L  K+S+F
Sbjct: 123 SFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDF 179
Query: 655 SLAKILM-----PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
            L++ L      P  T  + G    R + +PE       T  SDV+S+G+V+ E++    
Sbjct: 180 GLSRFLEDDTSDPTYTSALGGKIPIR-WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 710 NFEVNVSTADVV 721
               +++  DV+
Sbjct: 239 RPYWDMTNQDVI 250

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 137/295 (46%), Gaps = 37/295 (12%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +     K      VAVK L++     E++   +E+ 
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-------NVESG-PI-WRD 608
            +     H+N+V LLG C      L++ E+   G L N L        + E G P+  RD
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
            +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F LA+ +M +   IV
Sbjct: 154 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 669 TG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV 727
            G  +    +M+PE     + TV+SDV+S+G+++ EI      F + ++    +L+++  
Sbjct: 211 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF 264
Query: 728 YNCFIAKELSKLVGEDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           Y         KLV +  ++       + +  +   C   EP  RP+ + +   L+
Sbjct: 265 Y---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 14/241 (5%)
Query: 501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEM 557
           + + E++     F +ELG G FG V  G    G   VA+K     ++EG   E +F  E 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEA 70
Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
             +    H+ LV+L G C +     ++ E+M+ G L N L  +      +  + +  DV 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130
Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
             + YL  +   Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +
Sbjct: 131 EAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW 187
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAK 734
             PE       + KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A 
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247
Query: 735 E 735
           E
Sbjct: 248 E 248

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E+ R        LG G FG VY+G +           VAVK L E   E+ E  F  E  
Sbjct: 18  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRI 612
            + + +H+N+VR +G  +Q+  + ++ E M+ G L++ L      P         D + +
Sbjct: 78  IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 137
Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVT 669
           A D+A G  YL E      IH +I  RN LL        AKI +F +A+ +         
Sbjct: 138 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 194
Query: 670 GVKGTR-GYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           G       +M PE    G+ T K+D +SFGV++ EI
Sbjct: 195 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G+G FG V  G    GNK VAVK ++N  +   + F AE + + +  H NLV+LLG 
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD-RVRIALDVARGITYLHEECEVQII 632
            ++    L +V E+M+KGSL + L +     +  D  ++ +LDV   + YL        +
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 130
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++  RN+L+ +   AK+S+F L K     Q      VK T    +PE       + KS
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAFSTKS 186
Query: 693 DVYSFGVVVLEI 704
           DV+SFG+++ EI
Sbjct: 187 DVWSFGILLWEI 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 14/241 (5%)
Query: 501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEM 557
           + + E++     F +ELG G FG V  G    G   VA+K     ++EG   E +F  E 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEA 70
Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
             +    H+ LV+L G C +     ++ E+M+ G L N L  +      +  + +  DV 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130
Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
             + YL  +   Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +
Sbjct: 131 EAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAK 734
             PE       + KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A 
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 247
Query: 735 E 735
           E
Sbjct: 248 E 248

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 137/295 (46%), Gaps = 37/295 (12%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +     K      VAVK L++     E++   +E+ 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS-------NVESG-PI-WRD 608
            +     H+N+V LLG C      L++ E+   G L N L        + E G P+  RD
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 161
Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
            +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F LA+ +M +   IV
Sbjct: 162 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 218
Query: 669 TG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV 727
            G  +    +M+PE     + TV+SDV+S+G+++ EI      F + ++    +L+++  
Sbjct: 219 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGILVNSKF 272
Query: 728 YNCFIAKELSKLVGEDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           Y         KLV +  ++       + +  +   C   EP  RP+ + +   L+
Sbjct: 273 Y---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKG-----TRG 676
           E      IH +I  RN LL        AKI +F +A+ +   + G     KG        
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR--KGGCAMLPVK 251
Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           +M PE    G+ T K+D +SFGV++ EI
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 133/290 (45%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 133/290 (45%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 261
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKG-----TRG 676
           E      IH +I  RN LL        AKI +F +A+ +   + G     KG        
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR--KGGCAMLPVK 228
Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           +M PE    G+ T K+D +SFGV++ EI
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 14/241 (5%)
Query: 501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEM 557
           + + E++     F +ELG G FG V  G    G   VA+K     ++EG   E +F  E 
Sbjct: 7   YGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEA 61
Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
             +    H+ LV+L G C +     ++ E+M+ G L N L  +      +  + +  DV 
Sbjct: 62  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 121
Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
             + YL  +   Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +
Sbjct: 122 EAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 178
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAK 734
             PE       + KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A 
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 238
Query: 735 E 735
           E
Sbjct: 239 E 239

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 133/290 (45%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRLENPVEEGERK-FQAEMAAV 560
           EL+      ++ +G G FG V  G +   +K    VA+K L+    E +R+ F  E + +
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E M  GSL++ L   ++       V +   +A G+
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 131
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           SPE       T  SDV+S+G+V+ E++         +S  DV+                K
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----------------K 232
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q + N RP  + ++ +L+  +  P
Sbjct: 233 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 282

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG G FG VY+G +           VAVK L E   E+ E  F  E   + + +H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP------IWRDRVRIALDVARGITYLH 624
            +G  +Q+  + ++ E M+ G L++ L      P         D + +A D+A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 625 EECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR-GYMSP 680
           E      IH +I  RN LL        AKI +F +A+ +         G       +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 681 EWQNSGLITVKSDVYSFGVVVLEI 704
           E    G+ T K+D +SFGV++ EI
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G+G FG V  G    GNK VAVK ++N  +   + F AE + + +  H NLV+LLG 
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD-RVRIALDVARGITYLHEECEVQII 632
            ++    L +V E+M+KGSL + L +     +  D  ++ +LDV   + YL        +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++  RN+L+ +   AK+S+F L K     Q      VK T    +PE       + KS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 367
Query: 693 DVYSFGVVVLEI 704
           DV+SFG+++ EI
Sbjct: 368 DVWSFGILLWEI 379

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V  G    G   VA+K     ++EG   E +F  E   +    H+ LV
Sbjct: 8   FLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C +     ++ E+M+ G L N L  +      +  + +  DV   + YL  +   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +  PE       +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 690 VKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAKE 735
            KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A E
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 134/301 (44%), Gaps = 43/301 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +     K      VAVK L++     E++   +E+ 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------------SNVES 602
            +     H+N+V LLG C      L++ E+   G L N L                N E 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE 161
Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
               RD +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F LA+ +M 
Sbjct: 162 QLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 218
Query: 663 NQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
           +   IV G  +    +M+PE     + TV+SDV+S+G+++ EI      F + ++    +
Sbjct: 219 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLGLNPYPGI 272
Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSMKNVILML 779
           L+++  Y         KLV +  ++       + +  +   C   EP  RP+ + +   L
Sbjct: 273 LVNSKFY---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323
Query: 780 E 780
           +
Sbjct: 324 Q 324

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V  G    G   VA+K     ++EG   E +F  E   +    H+ LV
Sbjct: 12  FLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMNLSHEKLV 66
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C +     ++ E+M+ G L N L  +      +  + +  DV   + YL  +   
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +  PE       +
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 690 VKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAKE 735
            KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A E
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 232

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G+G FG V  G    GNK VAVK ++N  +   + F AE + + +  H NLV+LLG 
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD-RVRIALDVARGITYLHEECEVQII 632
            ++    L +V E+M+KGSL + L +     +  D  ++ +LDV   + YL        +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 139
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++  RN+L+ +   AK+S+F L K     Q      VK T    +PE       + KS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 195
Query: 693 DVYSFGVVVLEI 704
           DV+SFG+++ EI
Sbjct: 196 DVWSFGILLWEI 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V  G    G   VA+K     ++EG   E +F  E   +    H+ LV
Sbjct: 13  FLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C +     ++ E+M+ G L N L  +      +  + +  DV   + YL  +   
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +  PE       +
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 690 VKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAKE 735
            KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A E
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 233

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           + +G+G FG V  G    GNK VAVK ++N  +   + F AE + + +  H NLV+LLG 
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNK-VAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD-RVRIALDVARGITYLHEECEVQII 632
            ++    L +V E+M+KGSL + L +     +  D  ++ +LDV   + YL        +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 124
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++  RN+L+ +   AK+S+F L K     Q      VK T    +PE       + KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 693 DVYSFGVVVLEI 704
           DV+SFG+++ EI
Sbjct: 181 DVWSFGILLWEI 192

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/295 (25%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 505 ELERATNGFEEELGRGCFGAVYKG---SIC-EGNKI-VAVKRLENPVEEGERKFQAEMAA 559
            ++R     + ELG G FG V+     ++C E +KI VAVK L++  +   + F  E   
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--------VESGP----IWR 607
           +    H+++V+  G C++    ++V+E+M  G L   L           E  P       
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
             + IA  +A G+ YL  +     +H ++  RN L+ ++L  KI +F +++ +       
Sbjct: 129 QMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 185
Query: 668 VTG--VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST 725
           V G  +   R +M PE       T +SDV+S GVV+ EI          +S  +V+    
Sbjct: 186 VGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---- 240
Query: 726 WVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
               C       +++           E M    L C Q EP++R ++K +  +L+
Sbjct: 241 ---ECITQ---GRVLQRPRTCPQEVYELM----LGCWQREPHMRKNIKGIHTLLQ 285

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG---ERKFQAEMAAVRRTHHKNLV 569
           F +ELG G FG V  G    G   VA+K     ++EG   E +F  E   +    H+ LV
Sbjct: 13  FLKELGTGQFGVVKYGK-WRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMNLSHEKLV 67
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L G C +     ++ E+M+ G L N L  +      +  + +  DV   + YL  +   
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           Q +H ++  RN L++D    K+S+F L++ ++ ++     G K    +  PE       +
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 690 VKSDVYSFGVVVLEIVCC-RSNFE--VNVSTADVVLLSTWVYNCFIAKE 735
            KSD+++FGV++ EI    +  +E   N  TA+ +     +Y   +A E
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 233

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 114/247 (46%), Gaps = 20/247 (8%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCF------GAVYKGSICEG--------NKIV 537
           P  +  I   +  +  RA + F +EL   C       GA   G +C G        +  V
Sbjct: 15  PGTKTYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAV 74
Query: 538 AVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENL 596
           A+K L+    E +R+ F  E + + +  H N+V L G   +    ++V EFM  G+L+  
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 597 LSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSL 656
           L   +        V +   +A G+ YL    ++  +H ++  RNIL++ +L  K+S+F L
Sbjct: 135 LRKHDGQFTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGL 191
Query: 657 AKILM--PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
           ++++   P      TG K    + +PE       T  SDV+S+G+V+ E++        +
Sbjct: 192 SRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251
Query: 715 VSTADVV 721
           +S  DV+
Sbjct: 252 MSNQDVI 258

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 13/218 (5%)
Query: 513 FEEELGRGCFGAVYKGSI-CEGNK--IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
            EE +G G FG V +G +   G K   VA+K L+    E +R+ F +E + + +  H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G    +   +++ EFM  G+L++ L   +        V +   +A G+ YL    E
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AE 136
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILM-----PNQTGIVTGVKGTRGYMSPEWQ 683
           +  +H ++  RNIL++ +L  K+S+F L++ L      P +T  + G    R + +PE  
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIR-WTAPEAI 195
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
                T  SD +S+G+V+ E++        ++S  DV+
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI 233

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 113/226 (50%), Gaps = 13/226 (5%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAV 560
           E++ +    E+ +G G FG V  G +    K    VA+K L++   E +R+ F +E + +
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 62
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++ L G   +++  +++ EFM  GSL++ L   +        V +   +A G+
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 122
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM-----PNQTGIVTGVKGTR 675
            YL    ++  +H  +  RNIL++ +L  K+S+F L++ L      P  T  + G    R
Sbjct: 123 KYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 179
Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
            + +PE       T  SDV+S+G+V+ E++        +++  DV+
Sbjct: 180 -WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 224

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 27/291 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-CEGNK--IVAVKRLENPVEEGERK-FQAEMAAV 560
           E++ +    EE +G G FG V +G +   G K   VA+K L+    E +R+ F +E + +
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 69
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G    +   +++ EFM  G+L++ L   +        V +   +A G+
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGM 129
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM-----PNQTGIVTGVKGTR 675
            YL    E+  +H ++  RNIL++ +L  K+S+F L++ L      P  T  + G    R
Sbjct: 130 RYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIR 186
Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE 735
            + +PE       T  SD +S+G+V+ E++        ++S  DV+          I ++
Sbjct: 187 -WTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVI--------NAIEQD 237
Query: 736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
                  D    L  L       L C Q + N RP    V+  L+  +  P
Sbjct: 238 YRLPPPPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSALDKMIRNP 282

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 130/295 (44%), Gaps = 36/295 (12%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 20  SKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 79
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN-----VESGPIWRD 608
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +     V    +++D
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 609 RVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  
Sbjct: 140 FLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 663 NQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
           +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V
Sbjct: 197 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGV 250
Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
            +      C   KE +++   D      T   M +  L C   EP+ RP+   ++
Sbjct: 251 KIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELV 298

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 30/209 (14%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLGFCM 576
            RG FG V+K  +   N+ VAVK    P+++ +  + + E+ ++    H+N+++ +G   
Sbjct: 33  ARGRFGCVWKAQLL--NEYVAVKIF--PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEK 88
Query: 577 QTS----KKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITYLHEEC---- 627
           + +       L+  F  KGSL + L +NV S   W +   IA  +ARG+ YLHE+     
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANVVS---WNELCHIAETMARGLAYLHEDIPGLK 145
Query: 628 ---EVQIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-- 681
              +  I H +I  +N+LL ++LTA I++F LA K       G   G  GTR YM+PE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 682 -----WQNSGLITVKSDVYSFGVVVLEIV 705
                +Q    + +  D+Y+ G+V+ E+ 
Sbjct: 206 EGAINFQRDAFLRI--DMYAMGLVLWELA 232

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 27/290 (9%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAV 560
           E+E +    E  +G G FG V  G +    K    VA+K L+    E +R+ F  E + +
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++ L G   ++   ++V E+M  GSL+  L   +        V +   ++ G+
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F L+++L   P       G K    + 
Sbjct: 138 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 194
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           +PE       T  SDV+S+G+V+ E+V         ++  DV+                K
Sbjct: 195 APEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVI----------------K 238
Query: 739 LVGEDEEV--DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
            V E   +   +     + ++ L C Q E N RP    ++ ML+  +  P
Sbjct: 239 AVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIRNP 288

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 25/239 (10%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E+  +   F EELG   FG VYKG +      E  + VA+K L++  E   R+ F+ E  
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 81
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------------SNVESG 603
              R  H N+V LLG   +     +++ + S G L   L                 V+S 
Sbjct: 82  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 141
Query: 604 PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-ILMP 662
               D V +   +A G+ YL       ++H ++  RN+L+ D L  KIS+  L + +   
Sbjct: 142 LEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 198
Query: 663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
           +   ++        +M+PE    G  ++ SD++S+GVV+ E+           S  DVV
Sbjct: 199 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 513 FEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHK 566
           F EELG   FG VYKG +      E  + VA+K L++  E   R+ F+ E     R  H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------------SNVESGPIWRDRVR 611
           N+V LLG   +     +++ + S G L   L                 V+S     D V 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-ILMPNQTGIVTG 670
           +   +A G+ YL       ++H ++  RN+L+ D L  KIS+  L + +   +   ++  
Sbjct: 133 LVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
                 +M+PE    G  ++ SD++S+GVV+ E+           S  DVV
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 133/316 (42%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG GCFG V        +K        VAVK L++   
Sbjct: 8   EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 67
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 68  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 127
Query: 599 ----NVESGP----IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
               ++   P     ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 128 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMK 184
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 185 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 240
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 241 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 281
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 282 CWHAVPSQRPTFKQLV 297

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 108/206 (52%), Gaps = 23/206 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKI---VAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG+V +G++ + +     VAVK  +L+N  +    +F +E A ++   H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 572 LGFCMQTS-----KKLLVYEFMSKGSLEN--LLSNVESGP---IWRDRVRIALDVARGIT 621
           LG C++ S     K +++  FM  G L    L S +E+GP     +  ++  +D+A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIVTGVKGTRGYM 678
           YL        +H ++  RN +L D +T  +++F L+K +      + G +   K    ++
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIA--KMPVKWI 216
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEI 704
           + E     + T KSDV++FGV + EI
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 131/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG GCFG V        +K        VAVK L++   
Sbjct: 13  EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 72
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 73  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 132
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 133 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 189
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 190 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 245
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 246 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 286
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 287 CWHAVPSQRPTFKQLV 302

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 131/300 (43%), Gaps = 38/300 (12%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 22  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 81
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN-----VESGP--IW 606
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +     V   P  ++
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 607 RD------RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
           +D       +  +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 661 MPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
             +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S   
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYP 252
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
            V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++  L
Sbjct: 253 GVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 26/239 (10%)
Query: 505 ELERATNGFEEELGRGCFGAV-----YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
            ++R     + ELG G FG V     Y  S  +   +VAVK L++P     + FQ E   
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--------VESGPI------ 605
           +    H+++V+  G C      ++V+E+M  G L   L          V+  P       
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 606 -WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
                + IA  +A G+ YL  +     +H ++  RN L+  +L  KI +F +++ +    
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 665 TGIVTG--VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
              V G  +   R +M PE       T +SDV+SFGV++ EI          +S  +V+
Sbjct: 188 YYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 131/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG GCFG V        +K        VAVK L++   
Sbjct: 10  EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 69
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 70  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 129
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 130 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 186
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 187 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 242
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 243 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 283
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 284 CWHAVPSQRPTFKQLV 299

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 11  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLVY-EFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 241
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 242 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 778 ML 779
            L
Sbjct: 295 HL 296

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 20  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 197 DIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 250
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 251 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 778 ML 779
            L
Sbjct: 304 HL 305

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 20  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 250
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++
Sbjct: 251 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELV 302

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 11  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 241
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 242 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 778 ML 779
            L
Sbjct: 295 HL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 11  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLVY-EFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 188 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 241
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 242 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 778 ML 779
            L
Sbjct: 295 HL 296

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 11  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 70
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLVY-EFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 71  ELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 188 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 241
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 242 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 294
Query: 778 ML 779
            L
Sbjct: 295 HL 296

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVRL 571
           ++LG G    VY       N  VA+K +  P  E E   ++F+ E+    +  H+N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQ 630
           +    +     LV E++   +L   + +   GP+  D  +     +  GI + H+   ++
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIES--HGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           I+H +I P+NIL+D + T KI +F +AK L          V GT  Y SPE         
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 691 KSDVYSFGVVVLEIVCCRSNF--EVNVSTA 718
            +D+YS G+V+ E++     F  E  VS A
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 20  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 250
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 251 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 778 ML 779
            L
Sbjct: 304 HL 305

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 133/316 (42%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG GCFG V        +K        VAVK L++   
Sbjct: 67  EYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 599 ----NVESGP----IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
               ++   P     ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 243
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 244 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 300 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 340
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 341 CWHAVPSQRPTFKQLV 356

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G+G FG V+KG      K+VA+K ++    E+     Q E+  + +     + +  G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQ 630
             ++ +K  ++ E++  GS  +LL   E GP+  D  +IA    ++ +G+ YLH E +  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSEKK-- 145
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE         
Sbjct: 146 -IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 203
Query: 691 KSDVYSFGVVVLEIV 705
           K+D++S G+  +E+ 
Sbjct: 204 KADIWSLGITAIELA 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 516 ELGRGCFGAVYKGSICEGNKI-------VAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +LG+G FG+V    +C  + +       VAVK+L++   + +R FQ E+  ++  H   +
Sbjct: 17  QLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G      ++   LV E++  G L + L           R R  LD +R + Y  + 
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ----------RHRARLDASRLLLYSSQI 123
Query: 627 CE-------VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--Y 677
           C+        + +H ++  RNIL++     KI++F LAK+L  ++   V    G     +
Sbjct: 124 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 183
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +PE  +  + + +SDV+SFGVV+ E+
Sbjct: 184 YAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 516 ELGRGCFGAVYKGSICEGNKI-------VAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +LG+G FG+V    +C  + +       VAVK+L++   + +R FQ E+  ++  H   +
Sbjct: 30  QLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G      ++   LV E++  G L + L           R R  LD +R + Y  + 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ----------RHRARLDASRLLLYSSQI 136
Query: 627 CE-------VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--Y 677
           C+        + +H ++  RNIL++     KI++F LAK+L  ++   V    G     +
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +PE  +  + + +SDV+SFGVV+ E+
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 516 ELGRGCFGAVYKGSICEGNKI-------VAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +LG+G FG+V    +C  + +       VAVK+L++   + +R FQ E+  ++  H   +
Sbjct: 18  QLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G      ++   LV E++  G L + L           R R  LD +R + Y  + 
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ----------RHRARLDASRLLLYSSQI 124
Query: 627 CE-------VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--Y 677
           C+        + +H ++  RNIL++     KI++F LAK+L  ++   V    G     +
Sbjct: 125 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +PE  +  + + +SDV+SFGVV+ E+
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 136/325 (41%), Gaps = 52/325 (16%)
Query: 482 QKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI 536
           + L     L    E+ +      EL R      + LG G FG V           + N++
Sbjct: 42  ENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRV 101
Query: 537 --VAVKRLENPVEEGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGS 592
             VAVK L++   E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 593 LENLLS---------------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNIN 637
           L   L                N E     +D V  A  VARG+ YL  +   + IH ++ 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 218
Query: 638 PRNILLDDSLTAKISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYS 696
            RN+L+ +    KI++F LA+ I   +     T  +    +M+PE     + T +SDV+S
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 697 FGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----L 751
           FGV++ EI                  L    Y     +EL KL+ E   +D  +     L
Sbjct: 279 FGVLLWEIFT----------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL 322
Query: 752 ETMVRVGLLCIQDEPNLRPSMKNVI 776
             M+R    C    P+ RP+ K ++
Sbjct: 323 YMMMRD---CWHAVPSQRPTFKQLV 344

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 137/308 (44%), Gaps = 50/308 (16%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK-----IVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +     K      VAVK L++     E++   +E+ 
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------------------- 598
            +     H+N+V LLG C      L++ E+   G L N L                    
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 599 -NVESG-PI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
            + E G P+  RD +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F 
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 656 LAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
           LA+ +M +   IV G  +    +M+PE     + TV+SDV+S+G+++ EI      F + 
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI------FSLG 257
Query: 715 VSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL--ETMVRVGLLCIQDEPNLRPSM 772
           ++    +L+++  Y         KLV +  ++       + +  +   C   EP  RP+ 
Sbjct: 258 LNPYPGILVNSKFY---------KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 308
Query: 773 KNVILMLE 780
           + +   L+
Sbjct: 309 QQICSFLQ 316

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 36/295 (12%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 20  SKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS 79
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN-----VESGPIWRD 608
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +     V    +++D
Sbjct: 80  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 609 ------RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
                  +  +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  
Sbjct: 140 FLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK 196
Query: 663 NQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
           +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V
Sbjct: 197 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGV 250
Query: 722 LLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
            +          KE +++   D      T   M +  L C   EP+ RP+   ++
Sbjct: 251 KIDEEFXRRL--KEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELV 298

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G+G FG V+KG      K+VA+K ++    E+     Q E+  + +     + +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQ 630
             ++ +K  ++ E++  GS  +LL   E GP+  D  +IA    ++ +G+ YLH E +  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSEKK-- 125
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE         
Sbjct: 126 -IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 183
Query: 691 KSDVYSFGVVVLEIV 705
           K+D++S G+  +E+ 
Sbjct: 184 KADIWSLGITAIELA 198

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 14  EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL  +   + IH ++  RN+L+ +    K
Sbjct: 134 EFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 191 IADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 247
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 248 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 291
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 292 VPSQRPTFKQLV 303

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 40/299 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 57  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 116
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN---------VESGP 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +         V    
Sbjct: 117 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 234 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 287
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++
Sbjct: 288 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELV 339

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 131/301 (43%), Gaps = 39/301 (12%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 21  SKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 80
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSNVESG--------PI 605
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +  +          +
Sbjct: 81  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDL 140
Query: 606 WRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI 659
           ++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 660 LMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTA 718
           +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S  
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPY 251
Query: 719 DVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM 778
             V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++  
Sbjct: 252 PGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 779 L 779
           L
Sbjct: 305 L 305

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 14  EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL  +   + IH ++  RN+L+ +    K
Sbjct: 134 EYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 247
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 248 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 291
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 292 VPSQRPTFKQLV 303

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 3   EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 62
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 63  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 122
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL      + IH ++  RN+L+ +    K
Sbjct: 123 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 179
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 180 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 236
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 237 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 280
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 281 VPSQRPTFKQLV 292

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 516 ELGRGCFGAVYKGSICEGNKI-------VAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +LG+G FG+V    +C  + +       VAVK+L++   + +R FQ E+  ++  H   +
Sbjct: 14  QLGKGNFGSV---ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 569 VRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           V+  G      +    LV E++  G L + L           R R  LD +R + Y  + 
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ----------RHRARLDASRLLLYSSQI 120
Query: 627 CE-------VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--Y 677
           C+        + +H ++  RNIL++     KI++F LAK+L  ++   V    G     +
Sbjct: 121 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +PE  +  + + +SDV+SFGVV+ E+
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 132/302 (43%), Gaps = 40/302 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGE-RKFQA 555
           S  E  R      + LGRG FG V +      +K      VAVK L+      E R   +
Sbjct: 22  SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 81
Query: 556 EMAA-VRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSN-------VESGP-- 604
           E+   +   HH N+V LLG C +    L+V  EF   G+L   L +        +  P  
Sbjct: 82  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 605 IWRDRVRI------ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           +++D + +      +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 659 ILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            +  +   +  G  +    +M+PE     + T++SDV+SFGV++ EI      F +  S 
Sbjct: 199 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASP 252
Query: 718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
              V +      C   KE +++   D      T   M +  L C   EP+ RP+   ++ 
Sbjct: 253 YPGVKIDEEF--CRRLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 305
Query: 778 ML 779
            L
Sbjct: 306 HL 307

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 7   EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 66
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 67  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 126
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL  +   + IH ++  RN+L+ +    K
Sbjct: 127 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 183
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 184 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 240
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 241 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 284
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 285 VPSQRPTFKQLV 296

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 133/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 14  EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 133
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL  +   + IH ++  RN+L+ +    K
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 190
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 247
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 248 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 291
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 292 VPSQRPTFKQLV 303

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 6   EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 65
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 66  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 125
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL      + IH ++  RN+L+ +    K
Sbjct: 126 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 182
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 183 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 239
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 240 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 283
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 284 VPSQRPTFKQLV 295

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 52/312 (16%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVE 547
           E+ +      EL R      + LG G FG V           + N++  VAVK L++   
Sbjct: 14  EYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 73
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 74  EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGL 133
Query: 599 --------NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                   N E     +D V  A  VARG+ YL      + IH ++  RN+L+ +    K
Sbjct: 134 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMK 190
Query: 651 ISNFSLAK-ILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS 709
           I++F LA+ I   +     T  +    +M+PE     + T +SDV+SFGV++ EI     
Sbjct: 191 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 247
Query: 710 NFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQD 764
                        L    Y     +EL KL+ E   +D  +     L  M+R    C   
Sbjct: 248 -------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHA 291
Query: 765 EPNLRPSMKNVI 776
            P+ RP+ K ++
Sbjct: 292 VPSQRPTFKQLV 303

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 31/226 (13%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAV 560
           S+G + R +    E   RG FG V+K  +   N  VAVK    P+++ +  + + E+ + 
Sbjct: 8   SSGLVPRGSLQLLEIKARGRFGCVWKAQLM--NDFVAVKIF--PLQDKQSWQSEREIFST 63
Query: 561 RRTHHKNLVRLLGFCMQTS----KKLLVYEFMSKGSLENLLS-NVESGPIWRDRVRIALD 615
               H+NL++ +    + S    +  L+  F  KGSL + L  N+ +   W +   +A  
Sbjct: 64  PGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIIT---WNELCHVAET 120
Query: 616 VARGITYLHEEC--------EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ-TG 666
           ++RG++YLHE+         +  I H +   +N+LL   LTA +++F LA    P +  G
Sbjct: 121 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 180
Query: 667 IVTGVKGTRGYMSPE-------WQNSGLITVKSDVYSFGVVVLEIV 705
              G  GTR YM+PE       +Q    + +  D+Y+ G+V+ E+V
Sbjct: 181 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRI--DMYAMGLVLWELV 224

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 35/231 (15%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V   +    +K      VAVK L+   +  ER+   +E+ 
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN-----VESGPIWRDRVRI 612
            + +   H+N+V LLG C  +    L++E+   G L N L +      E    + ++ R+
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 613 -----------------ALDVARGITYLH-EECEVQIIHCNINPRNILLDDSLTAKISNF 654
                            A  VA+G+ +L  + C    +H ++  RN+L+      KI +F
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDF 216
Query: 655 SLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
            LA+ +M +   +V G  +    +M+PE    G+ T+KSDV+S+G+++ EI
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKI--VAVKRLENPVEEGE-RKFQAE 556
           EL R      + LG G FG V           + N++  VAVK L++   E +     +E
Sbjct: 9   ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 557 MAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS---------------NV 600
           M  ++    HKN++ LLG C Q     ++ E+ SKG+L   L                N 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 601 ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-I 659
           E     +D V  A  VARG+ YL  +   + IH ++  RN+L+ +    KI++F LA+ I
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
              +     T  +    +M+PE     + T +SDV+SFGV++ EI               
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT------------- 232
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRT-----LETMVRVGLLCIQDEPNLRPSMKN 774
              L    Y     +EL KL+ E   +D  +     L  M+R    C    P+ RP+ K 
Sbjct: 233 ---LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD---CWHAVPSQRPTFKQ 286
Query: 775 VI 776
           ++
Sbjct: 287 LV 288

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 84/316 (26%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRL-ENPV 546
           E+ +      E  R      + LG G FG V        +K        VAVK L ++  
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 547 EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           EE      +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G+G FG V+KG      K+VA+K ++    E+     Q E+  + +     + +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQ 630
             ++ +K  ++ E++  GS  +LL   E GP+  D  +IA    ++ +G+ YLH E +  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSEKK-- 140
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   N+LL +    K+++F +A  L   Q      V GT  +M+PE         
Sbjct: 141 -IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDS 198
Query: 691 KSDVYSFGVVVLEIV 705
           K+D++S G+  +E+ 
Sbjct: 199 KADIWSLGITAIELA 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 13/195 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E +G+G FG V+KG      ++VA+K ++    E+     Q E+  + +     + +  G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQ 630
             ++ SK  ++ E++  GS  +LL    +GP   D  +IA    ++ +G+ YLH E +  
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLL---RAGPF--DEFQIATMLKEILKGLDYLHSEKK-- 141
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE         
Sbjct: 142 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 199
Query: 691 KSDVYSFGVVVLEIV 705
           K+D++S G+  +E+ 
Sbjct: 200 KADIWSLGITAIELA 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHK 566
           R    F + LG G F  V         K+VA+K +     EG E   + E+A + +  H 
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHE 625
           N+V L           L+ + +S G L + +  VE G    RD  R+   V   + YLH 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH- 133
Query: 626 ECEVQIIHCNINPRNIL---LDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
             ++ I+H ++ P N+L   LD+     IS+F L+K  M +   +++   GT GY++PE 
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVAPEV 189
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                 +   D +S GV+   ++C    F
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G+G FG V+KG      K+VA+K ++    E+     Q E+  + +     + +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQ 630
             ++ +K  ++ E++  GS  +LL   E GP+  D  +IA    ++ +G+ YLH E +  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSEKK-- 125
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   N+LL +    K+++F +A  L   Q      V GT  +M+PE         
Sbjct: 126 -IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDS 183
Query: 691 KSDVYSFGVVVLEIV 705
           K+D++S G+  +E+ 
Sbjct: 184 KADIWSLGITAIELA 198

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHK 566
           R    F + LG G F  V         K+VA+K +     EG E   + E+A + +  H 
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHE 625
           N+V L           L+ + +S G L + +  VE G    RD  R+   V   + YLH 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH- 133
Query: 626 ECEVQIIHCNINPRNIL---LDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
             ++ I+H ++ P N+L   LD+     IS+F L+K  M +   +++   GT GY++PE 
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVAPEV 189
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                 +   D +S GV+   ++C    F
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHK 566
           R    F + LG G F  V         K+VA+K +     EG E   + E+A + +  H 
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHP 76
Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHE 625
           N+V L           L+ + +S G L + +  VE G    RD  R+   V   + YLH 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH- 133
Query: 626 ECEVQIIHCNINPRNIL---LDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
             ++ I+H ++ P N+L   LD+     IS+F L+K  M +   +++   GT GY++PE 
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVAPEV 189
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                 +   D +S GV+   ++C    F
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 12/209 (5%)
Query: 508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHK 566
           R    F + LG G F  V         K+VA+K +     EG E   + E+A + +  H 
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 76
Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHE 625
           N+V L           L+ + +S G L + +  VE G    RD  R+   V   + YLH 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH- 133
Query: 626 ECEVQIIHCNINPRNIL---LDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
             ++ I+H ++ P N+L   LD+     IS+F L+K  M +   +++   GT GY++PE 
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVAPEV 189
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                 +   D +S GV+   ++C    F
Sbjct: 190 LAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 97/193 (50%), Gaps = 9/193 (4%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           + +G+G FG VYKG      ++VA+K ++    E+     Q E+  + +     + R  G
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
             ++++K  ++ E++  GS  +LL   + GP+    +   L ++ +G+ YLH E +   I
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK---I 138
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I   N+LL +    K+++F +A  L   Q      V GT  +M+PE         K+
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDFKA 197
Query: 693 DVYSFGVVVLEIV 705
           D++S G+  +E+ 
Sbjct: 198 DIWSLGITAIELA 210

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 56/314 (17%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 599 ----NVESGP----IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
               ++   P     ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTR---GYMSPEWQNSGLITVKSDVYSFGVVVLEIVCC 707
           I++F LA+ +  N           R    +M+PE     + T +SDV+SFGV++ EI   
Sbjct: 198 IADFGLARDI--NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT- 254
Query: 708 RSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLLCI 762
                          L    Y     +EL KL+ E   +D        L  M+R    C 
Sbjct: 255 ---------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD---CW 296
Query: 763 QDEPNLRPSMKNVI 776
              P+ RP+ K ++
Sbjct: 297 HAVPSQRPTFKQLV 310

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAV 560
           E++ +    E+ +G G FG V  G +    K    VA+K L+    + +R+ F +E + +
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++ L G   +    +++ E+M  GSL+  L   +        V +   +  G+
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 144
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F ++++L   P       G K    + 
Sbjct: 145 KYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 201
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY------NCFI 732
           +PE       T  SDV+S+G+V+ E++        ++S  DV+      Y      +C I
Sbjct: 202 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 261
Query: 733 AKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
           A  L +L+                  L C Q E + RP    ++ ML+  +  P
Sbjct: 262 A--LHQLM------------------LDCWQKERSDRPKFGQIVNMLDKLIRNP 295

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 130/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN------ 599
           E +     +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 600 ---------VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
                     E    ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMR 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAV 560
           E++ +    E+ +G G FG V  G +    K    VA+K L+    + +R+ F +E + +
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++ L G   +    +++ E+M  GSL+  L   +        V +   +  G+
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 123
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F ++++L   P       G K    + 
Sbjct: 124 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 180
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY------NCFI 732
           +PE       T  SDV+S+G+V+ E++        ++S  DV+      Y      +C I
Sbjct: 181 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 240
Query: 733 AKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
           A  L +L+                  L C Q E + RP    ++ ML+  +  P
Sbjct: 241 A--LHQLM------------------LDCWQKERSDRPKFGQIVNMLDKLIRNP 274

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAV 560
           E++ +    E+ +G G FG V  G +    K    VA+K L+    + +R+ F +E + +
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++ L G   +    +++ E+M  GSL+  L   +        V +   +  G+
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGM 129
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM--PNQTGIVTGVKGTRGYM 678
            YL    ++  +H ++  RNIL++ +L  K+S+F ++++L   P       G K    + 
Sbjct: 130 KYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT 186
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY------NCFI 732
           +PE       T  SDV+S+G+V+ E++        ++S  DV+      Y      +C I
Sbjct: 187 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 246
Query: 733 AKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
           A  L +L+                  L C Q E + RP    ++ ML+  +  P
Sbjct: 247 A--LHQLM------------------LDCWQKERSDRPKFGQIVNMLDKLIRNP 280

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 38/281 (13%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG- 573
           E +G G FG V+K       K   +KR++   E+ ER    E+ A+ +  H N+V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72
Query: 574 -----FCMQTSKK----------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALD--- 615
                +  +TS K           +  EF  KG+LE  +       +  D+V +AL+   
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL--DKV-LALELFE 129
Query: 616 -VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT 674
            + +G+ Y+H +   ++I+ ++ P NI L D+   KI +F L   L  +  G     KGT
Sbjct: 130 QITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--GKRXRSKGT 184
Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIV-CCRSNFEVNVSTADVVLLSTWVYNCFIA 733
             YMSPE  +S     + D+Y+ G+++ E++  C + FE +    D  L    + + F  
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD--LRDGIISDIFDK 242
Query: 734 KE---LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS 771
           KE   L KL+ +  E    T E +  + +     E N R +
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  + EG  +   VA+K L E    +   +F  E   +    H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+  + +L V + M  G L   +   +     +  +   + +A+G+ YL E    ++
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LA++L  ++      G K    +M+ E  +    T 
Sbjct: 139 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV + E++
Sbjct: 199 QSDVWSYGVTIWELM 213

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+  +G +   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 136
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANT 215

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 133
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI+NF  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 190
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 191 LWSLGVLCYEFLVGKPPFEANT 212

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++  + SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGM 140
Query: 599 ----NVESGP----IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
               ++   P     ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 20/230 (8%)
Query: 489 SLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVE 547
           ++G  +++ ++ F  G            LG+G FG VY     +   I+A+K L +  +E
Sbjct: 2   AMGSKRQWALEDFEIGR----------PLGKGKFGNVYLAREKQSKFILALKVLFKAQLE 51
Query: 548 EG--ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI 605
           +   E + + E+       H N++RL G+    ++  L+ E+   G++   L  +     
Sbjct: 52  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 111
Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
            R    I  ++A  ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+  
Sbjct: 112 QRTATYIT-ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSR 166
Query: 666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
              T + GT  Y+ PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 167 R--TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LGRG FG V+   +    K+ A K+L     +  + +Q  M   +   + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNV-ESGPIWRDRVRI--ALDVARGITYLHEECEV 629
           +  +T   L LV   M+ G +   + NV E  P +++   I     +  G+ +LH+    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P N+LLDD    +IS+  LA  L   QT    G  GT G+M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
              D ++ GV + E++  R  F   
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LGRG FG V+   +    K+ A K+L     +  + +Q  M   +   + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNV-ESGPIWRDRVRI--ALDVARGITYLHEECEV 629
           +  +T   L LV   M+ G +   + NV E  P +++   I     +  G+ +LH+    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P N+LLDD    +IS+  LA  L   QT    G  GT G+M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
              D ++ GV + E++  R  F   
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LGRG FG V+   +    K+ A K+L     +  + +Q  M   +   + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNV-ESGPIWRDRVRI--ALDVARGITYLHEECEV 629
           +  +T   L LV   M+ G +   + NV E  P +++   I     +  G+ +LH+    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P N+LLDD    +IS+  LA  L   QT    G  GT G+M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
              D ++ GV + E++  R  F   
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
           E++G G +G VYK    +G +IVA+KR+    E+      A  E++ ++  HH N+V L+
Sbjct: 27  EKVGEGTYGVVYKAKDSQG-RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
                     LV+EFM K  L+ +L   ++G +   +++I L  + RG+ + H+    +I
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLIT 689
           +H ++ P+N+L++     K+++F LA+   +P ++   T    T  Y +P+    S   +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYS 198
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G +  E++  +  F
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLF 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
           E++G G +G VYK    +G +IVA+KR+    E+      A  E++ ++  HH N+V L+
Sbjct: 27  EKVGEGTYGVVYKAKDSQG-RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
                     LV+EFM K  L+ +L   ++G +   +++I L  + RG+ + H+    +I
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHCHQH---RI 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLIT 689
           +H ++ P+N+L++     K+++F LA+   +P ++   T    T  Y +P+    S   +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYS 198
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G +  E++  +  F
Sbjct: 199 TSVDIWSIGCIFAEMITGKPLF 220

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 134
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI+NF  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANT 213

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  + EG  +   VA+K L E    +   +F  E   +    H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+  + +L V + M  G L   +   +     +  +   + +A+G+ YL E    ++
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RL 161
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LA++L  ++      G K    +M+ E  +    T 
Sbjct: 162 VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTH 221
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV + E++
Sbjct: 222 QSDVWSYGVTIWELM 236

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLLG 573
           LGRG FG V+   +    K+ A K+L     +  + +Q  M   +   + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-A 251
Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNV-ESGPIWRDRVRI--ALDVARGITYLHEECEV 629
           +  +T   L LV   M+ G +   + NV E  P +++   I     +  G+ +LH+    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P N+LLDD    +IS+  LA  L   QT    G  GT G+M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEYD 367
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
              D ++ GV + E++  R  F   
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+  +G +   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 136
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+       + GT  Y+ PE     +   K D
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX--LXGTLDYLPPEMIEGRMHDEKVD 193
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANT 215

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 12/217 (5%)
Query: 504 GELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMA 558
           G+ + A   FE    LG+G FG VY     +   I+A+K L +  +E+   E + + E+ 
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
                 H N++RL G+    ++  L+ E+   G++   L  +      R    I  ++A 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
            ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+     T + GT  Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TXLCGTLDYL 173
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
            PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R    +  ++G G FG V++         E   +VAVK L E    + +  FQ E A
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW---------RDR 609
            +    + N+V+LLG C       L++E+M+ G L   L ++    +          R R
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 610 VR--------------IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
           V               IA  VA G+ YL E    + +H ++  RN L+ +++  KI++F 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 219
Query: 656 LAKILMPNQTGIVTGVKGTR-GYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           L++ +         G       +M PE       T +SDV+++GVV+ EI
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/316 (25%), Positives = 131/316 (41%), Gaps = 60/316 (18%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK-------IVAVKRLENPVE 547
           E+ +      E  R      + LG G FG V        +K        VAVK L++   
Sbjct: 21  EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 80
Query: 548 EGE-RKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS------- 598
           E +     +EM  ++    HKN++ LLG C Q     ++  + SKG+L   L        
Sbjct: 81  EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGM 140
Query: 599 ----NVESGP----IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
               ++   P     ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   K
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 197
Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           I++F LA+ +      I    K T G     +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 198 IADFGLARDI----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
Query: 706 CCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD-----LRTLETMVRVGLL 760
                            L    Y     +EL KL+ E   +D        L  M+R    
Sbjct: 254 T----------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD--- 294
Query: 761 CIQDEPNLRPSMKNVI 776
           C    P+ RP+ K ++
Sbjct: 295 CWHAVPSQRPTFKQLV 310

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 16/279 (5%)
Query: 516 ELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           +LG G FG V    Y  +     ++VAVK L+       R  +Q E+  +R  +H+++V+
Sbjct: 16  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 75
Query: 571 LLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
             G C    +K   LV E++  GSL + L     G      +  A  +  G+ YLH +  
Sbjct: 76  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG--LAQLLLFAQQICEGMAYLHAQ-- 131
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQNSG 686
              IH  +  RN+LLD+    KI +F LAK +            G     + +PE     
Sbjct: 132 -HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 687 LITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                SDV+SFGV + E++  C SN   +    +++  +          EL +  GE   
Sbjct: 191 KFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLER-GERLP 249
Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
              R    +  +   C + E + RP+ +N++ +L+   E
Sbjct: 250 RPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 16/279 (5%)
Query: 516 ELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           +LG G FG V    Y  +     ++VAVK L+       R  +Q E+  +R  +H+++V+
Sbjct: 15  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVK 74
Query: 571 LLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
             G C    +K   LV E++  GSL + L     G      +  A  +  G+ YLH +  
Sbjct: 75  YKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVG--LAQLLLFAQQICEGMAYLHAQ-- 130
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQNSG 686
              IH  +  RN+LLD+    KI +F LAK +            G     + +PE     
Sbjct: 131 -HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 687 LITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                SDV+SFGV + E++  C SN   +    +++  +          EL +  GE   
Sbjct: 190 KFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLER-GERLP 248
Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
              R    +  +   C + E + RP+ +N++ +L+   E
Sbjct: 249 RPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 22/282 (7%)
Query: 516 ELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           +LG G FG V    Y  +     ++VAVK L+       R  ++ E+  +R  +H+++++
Sbjct: 21  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 571 LLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
             G C    +K   LV E++  GSL + L     G      +  A  +  G+ YLH +  
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG--LAQLLLFAQQICEGMAYLHAQ-- 136
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQNSG 686
              IH N+  RN+LLD+    KI +F LAK +            G     + +PE     
Sbjct: 137 -HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 687 LITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                SDV+SFGV + E++  C S+        +++ ++           L++L+   E 
Sbjct: 196 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLTELLERGER 252
Query: 746 VDLRTLETMVRVGLL---CIQDEPNLRPSMKNVILMLEGTME 784
           +  R  +    V  L   C + E + RP+ +N+I +L+   E
Sbjct: 253 LP-RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 22/282 (7%)
Query: 516 ELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           +LG G FG V    Y  +     ++VAVK L+       R  ++ E+  +R  +H+++++
Sbjct: 21  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 571 LLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
             G C    +K   LV E++  GSL + L     G      +  A  +  G+ YLH +  
Sbjct: 81  YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG--LAQLLLFAQQICEGMAYLHSQ-- 136
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQNSG 686
              IH N+  RN+LLD+    KI +F LAK +            G     + +PE     
Sbjct: 137 -HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 687 LITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                SDV+SFGV + E++  C S+        +++ ++           L++L+   E 
Sbjct: 196 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ---GQMTVLRLTELLERGER 252
Query: 746 VDLRTLETMVRVGLL---CIQDEPNLRPSMKNVILMLEGTME 784
           +  R  +    V  L   C + E + RP+ +N+I +L+   E
Sbjct: 253 LP-RPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHE 293

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 13/219 (5%)
Query: 494 QEFIIQSFSTGELERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER 551
           + F+ Q    GEL+   + FE+  ELG G  G V+K S      ++A K +   ++   R
Sbjct: 53  EAFLTQKQKVGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 110
Query: 552 -KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV 610
            +   E+  +   +   +V   G      +  +  E M  GSL+ +L   ++G I    +
Sbjct: 111 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQIL 168
Query: 611 -RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
            ++++ V +G+TYL E+   +I+H ++ P NIL++     K+ +F ++  L+     +  
Sbjct: 169 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMAN 223
Query: 670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
              GTR YMSPE       +V+SD++S G+ ++E+   R
Sbjct: 224 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 132
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANT 211

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I +G  +   VA+K L EN   +  ++   E   +       + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   LV + M  G L + +         +D +   + +A+G++YL +   V++
Sbjct: 85  LGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRL 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LA++L  ++T     G K    +M+ E       T 
Sbjct: 141 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTH 200
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 201 QSDVWSYGVTVWELM 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 504 GELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMA 558
           G  + A   FE    LG+G FG VY     +   I+A+K L +  +E+   E + + E+ 
Sbjct: 1   GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
                 H N++RL G+    ++  L+ E+   G++   L  +      R    I  ++A 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
            ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+     T + GT  Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYL 173
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
            PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 131
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANT 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 84  LGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 139
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 199
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 200 QSDVWSYGVTVWELM 214

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 136
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANT 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 131
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANT 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 504 GELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMA 558
           G  + A   FE    LG+G FG VY     +   I+A+K L +  +E+   E + + E+ 
Sbjct: 1   GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
                 H N++RL G+    ++  L+ E+   G++   L  +      R    I  ++A 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
            ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+     T + GT  Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TELCGTLDYL 173
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
            PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 134
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANT 213

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 85  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 201 QSDVWSYGVTVWELM 215

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 130
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 131 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 187
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 188 LWSLGVLCYEFLVGKPPFEANT 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 136
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANT 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 87  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 142
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 202
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 203 QSDVWSYGVTVWELM 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 86  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 141
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 202 QSDVWSYGVTVWELM 216

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 30/241 (12%)
Query: 486 INSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSIC----EGNKI---VA 538
           I S   P+ E     F    L+R       +LG G FG V    +C    EG+     VA
Sbjct: 3   IVSEKKPATEVDPTHFEKRFLKRI-----RDLGEGHFGKV---ELCRYDPEGDNTGEQVA 54
Query: 539 VKRLENPVEEGER--KFQAEMAAVRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLE 594
           VK L+ P   G      + E+  +R  +H+N+V+  G C +       L+ EF+  GSL+
Sbjct: 55  VKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 595 NLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF 654
             L   ++    + +++ A+ + +G+ YL      Q +H ++  RN+L++     KI +F
Sbjct: 114 EYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 170
Query: 655 SLAKILMPNQTGIVTGVKGTRG----YMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRS 709
            L K +  ++      VK  R     + +PE        + SDV+SFGV + E++  C S
Sbjct: 171 GLTKAIETDKEXXT--VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS 228
Query: 710 N 710
           +
Sbjct: 229 D 229

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 83  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 199 QSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 84  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 139
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 140 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 199
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 200 QSDVWSYGVTVWELM 214

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 494 QEFIIQSFSTGELERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER 551
           + F+ Q    GEL+   + FE+  ELG G  G V+K S      ++A K +   ++   R
Sbjct: 10  EAFLTQKQKVGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 67
Query: 552 -KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV 610
            +   E+  +   +   +V   G      +  +  E M  GSL+ +L   ++G I    +
Sbjct: 68  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQIL 125
Query: 611 -RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
            ++++ V +G+TYL E+   +I+H ++ P NIL++     K+ +F ++  L+ +   +  
Sbjct: 126 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 180
Query: 670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
              GTR YMSPE       +V+SD++S G+ ++E+   R
Sbjct: 181 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 83  LGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 199 QSDVWSYGVTVWELM 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 199 QSDVWSYGVTVWELM 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 77  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 132
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 193 QSDVWSYGVTVWELM 207

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 516 ELGRGCFGAVYKGSIC----EGNKI---VAVKRLENPVEEGER--KFQAEMAAVRRTHHK 566
           +LG G FG V    +C    EG+     VAVK L+ P   G      + E+  +R  +H+
Sbjct: 16  DLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHE 71
Query: 567 NLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
           N+V+  G C +       L+ EF+  GSL+  L   ++    + +++ A+ + +G+ YL 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG----YMSP 680
                Q +H ++  RN+L++     KI +F L K +  ++      VK  R     + +P
Sbjct: 132 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXT--VKDDRDSPVFWYAP 186
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVC-CRSN 710
           E        + SDV+SFGV + E++  C S+
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLTYCDSD 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 108 LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 163
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 164 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 223
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 224 QSDVWSYGVTVWELM 238

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 89  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 144
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 145 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 204
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 205 QSDVWSYGVTVWELM 219

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 134
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANT 213

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 85  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 201 QSDVWSYGVTVWELM 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 86  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 141
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 202 QSDVWSYGVTVWELM 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 13/219 (5%)
Query: 494 QEFIIQSFSTGELERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER 551
           + F+ Q    GEL+   + FE+  ELG G  G V+K S      ++A K +   ++   R
Sbjct: 18  EAFLTQKQKVGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 552 -KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV 610
            +   E+  +   +   +V   G      +  +  E M  GSL+ +L   ++G I    +
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQIL 133
Query: 611 -RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
            ++++ V +G+TYL E+   +I+H ++ P NIL++     K+ +F ++  L+     +  
Sbjct: 134 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMAN 188
Query: 670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
              GTR YMSPE       +V+SD++S G+ ++E+   R
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 86  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 141
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 202 QSDVWSYGVTVWELM 216

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 491 GPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG 549
           G  +++ ++ F  G            LG+G FG VY     +   I+A+K L +  +E+ 
Sbjct: 1   GKKRQWALEDFEIGR----------PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA 50
Query: 550 --ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR 607
             E + + E+       H N++RL G+    ++  L+ E+   G++   L  +      R
Sbjct: 51  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 110
Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
               I  ++A  ++Y H +   ++IH +I P N+LL  +   KI++F  +       +  
Sbjct: 111 TATYIT-ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSR 163
Query: 668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
            T + GT  Y+ PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 164 RTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 86  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 141
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 142 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 201
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 202 QSDVWSYGVTVWELM 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 93  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 148
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 149 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 208
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 209 QSDVWSYGVTVWELM 223

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLLG 573
           E +G G +G VYKG   +  ++ A+K ++   +E E + + E+  +++ +HH+N+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 88
Query: 574 FCMQTSKK------LLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
             ++ +         LV EF   GS+ +L+ N +   +  + +  I  ++ RG+++LH+ 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----- 681
              ++IH +I  +N+LL ++   K+ +F ++  L     G      GT  +M+PE     
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 682 WQNSGLITVKSDVYSFGVVVLEIV 705
                    KSD++S G+  +E+ 
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMA 228

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 90  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 145
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 205
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 206 QSDVWSYGVTVWELM 220

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 157
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P  +   T + GT  Y+ PE     +   K D
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRTTLCGTLDYLPPEMIEGRMHDEKVD 214
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 215 LWSLGVLCYEFLVGKPPFEANT 236

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLL 572
           E+G G FGAVY       +++VA+K++    ++   K+Q  +  VR   +  H N ++  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEV 629
           G  ++     LV E+   GS  +LL  V   P+    V IA       +G+ YLH     
Sbjct: 121 GCYLREHTAWLVMEY-CLGSASDLL-EVHKKPL--QEVEIAAVTHGALQGLAYLHSH--- 173
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSG 686
            +IH ++   NILL +    K+ +F  A I+ P    +     GT  +M+PE     + G
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 228
Query: 687 LITVKSDVYSFGVVVLEIVCCRSN-FEVNVSTA 718
               K DV+S G+  +E+   +   F +N  +A
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 148
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 205
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 206 LWSLGVLCYEFLVGKPPFEANT 227

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKG-SICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 199 QSDVWSYGVTVWELM 213

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 12/219 (5%)
Query: 502 STGELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAE 556
           + G  + A   FE    LG+G FG VY     +   I+A+K L +  +E+   E + + E
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 557 MAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDV 616
           +       H N++RL G+    ++  L+ E+   G++   L  +      R    I  ++
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-EL 120
Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
           A  ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+       + GT  
Sbjct: 121 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--AALCGTLD 174
Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
           Y+ PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 51/292 (17%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG- 573
           E +G G FG V+K       K   ++R++   E+ ER    E+ A+ +  H N+V   G 
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 73
Query: 574 -------------------FCMQTSKK---------LLVYEFMSKGSLENLLSNVESGPI 605
                              +  + SK           +  EF  KG+LE  +       +
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 133
Query: 606 WRDRVRIALD----VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM 661
             D+V +AL+    + +G+ Y+H +   ++IH ++ P NI L D+   KI +F L   L 
Sbjct: 134 --DKV-LALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV-CCRSNFEVNVSTADV 720
            +  G  T  KGT  YMSPE  +S     + D+Y+ G+++ E++  C + FE +    D 
Sbjct: 188 ND--GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD- 244
Query: 721 VLLSTWVYNCFIAKE---LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLR 769
            L    + + F  KE   L KL+ +  E    T E +  + +     E N R
Sbjct: 245 -LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 295

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 128
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE     +   K D
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEMIEGRMHDEKVD 185
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 186 LWSLGVLCYEFLVGKPPFEANT 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 131
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+       + GT  Y+ PE     +   K D
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--AALCGTLDYLPPEMIEGRMHDEKVD 188
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANT 210

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           + E   NG    LG+G +G VY G        +A+K +        +    E+A  +   
Sbjct: 4   DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 63
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGIT 621
           HKN+V+ LG   +     +  E +  GSL  LL + + GP+  +   I      +  G+ 
Sbjct: 64  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLK 122
Query: 622 YLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGI---VTGVKGTRGY 677
           YLH+    QI+H +I   N+L++  S   KIS+F  +K L     GI        GT  Y
Sbjct: 123 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL----AGINPCTETFTGTLQY 175
Query: 678 MSPEWQNSGL--ITVKSDVYSFGVVVLEIVCCRSNF 711
           M+PE  + G       +D++S G  ++E+   +  F
Sbjct: 176 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           + E   NG    LG+G +G VY G        +A+K +        +    E+A  +   
Sbjct: 18  DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 77
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGIT 621
           HKN+V+ LG   +     +  E +  GSL  LL + + GP+  +   I      +  G+ 
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLK 136
Query: 622 YLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGI---VTGVKGTRGY 677
           YLH+    QI+H +I   N+L++  S   KIS+F  +K L     GI        GT  Y
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL----AGINPCTETFTGTLQY 189
Query: 678 MSPEWQNSGL--ITVKSDVYSFGVVVLEIVCCRSNF 711
           M+PE  + G       +D++S G  ++E+   +  F
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 21/198 (10%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---RTHHKNLVRLL 572
           E+G G FGAVY       +++VA+K++    ++   K+Q  +  VR   +  H N ++  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEV 629
           G  ++     LV E+   GS  +LL  V   P+    V IA       +G+ YLH     
Sbjct: 82  GCYLREHTAWLVMEY-CLGSASDLLE-VHKKPL--QEVEIAAVTHGALQGLAYLHSH--- 134
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSG 686
            +IH ++   NILL +    K+ +F  A I+ P    +     GT  +M+PE     + G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 189
Query: 687 LITVKSDVYSFGVVVLEI 704
               K DV+S G+  +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A G+ YL +    ++
Sbjct: 80  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR---RL 135
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 136 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 195
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 196 QSDVWSYGVTVWELM 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 12/217 (5%)
Query: 504 GELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMA 558
           G+ + A   FE    LG+G FG VY     +   I+A+K L +  +E+   E + + E+ 
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
                 H N++RL G+    ++  L+ E+   G++   L  +      R    I  ++A 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELAN 119
Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
            ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+       + GT  Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX--LCGTLDYL 173
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
            PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 508 RATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
           R T  F E LG G F  V+        K+ A+K ++      +   + E+A +++  H+N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP-IWRDRVRIALDVARGITYLHEE 626
           +V L      T+   LV + +S G L + +  +E G    +D   +   V   + YLHE 
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 627 CEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
               I+H ++ P N+L    +++    I++F L+K+    Q GI++   GT GY++PE  
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVL 179
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                +   D +S GV+   ++C    F
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 490 LGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEE 548
           LG  +++ ++ F  G            LG+G FG VY     +   I+A+K L +  +E+
Sbjct: 3   LGSKRQWTLEDFDIGR----------PLGKGKFGNVYLARERQSKFILALKVLFKTQLEK 52
Query: 549 G--ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW 606
              E + + E+       H N++RL G+    ++  L+ E+   G++   L  +      
Sbjct: 53  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 607 RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
           R    I  ++A  ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+   
Sbjct: 113 RTATYIT-ELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRR 167
Query: 667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
             T + GT  Y+ PE     +   K D++S GV+  E +     FE + 
Sbjct: 168 --TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 491 GP--SQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVE 547
           GP  S+++ ++ F  G            LG+G FG VY     +   I+A+K L +  +E
Sbjct: 1   GPLGSRQWALEDFEIGR----------PLGKGKFGNVYLAREKQSKFILALKVLFKAQLE 50
Query: 548 EG--ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI 605
           +   E + + E+       H N++RL G+    ++  L+ E+   G++   L  +     
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
            R    I  ++A  ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+  
Sbjct: 111 QRTATYIT-ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSR 165
Query: 666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
                + GT  Y+ PE     +   K D++S GV+  E +  +  FE N 
Sbjct: 166 R--DDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY         I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +   +++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---KVIH 131
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+       + GT  Y+ PE     +   K D
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--AALCGTLDYLPPEMIEGRMHDEKVD 188
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 189 LWSLGVLCYEFLVGKPPFEANT 210

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 136
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+     T + GT  Y+ PE         K D
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGTLDYLPPEXIEGRXHDEKVD 193
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 194 LWSLGVLCYEFLVGKPPFEANT 215

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 133
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+       + GT  Y+ PE     +   K D
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX--LCGTLDYLPPEMIEGRMHDEKVD 190
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 191 LWSLGVLCYEFLVGKPPFEANT 212

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 132
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+       + GT  Y+ PE     +   K D
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--DTLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANT 211

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 134
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P+       + GT  Y+ PE     +   K D
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXX--LCGTLDYLPPEMIEGRMHDEKVD 191
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 192 LWSLGVLCYEFLVGKPPFEANT 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHH-KNLVRLLG 573
           E+GRG +G+V K       +I+AVKR+ + V+E E+K    ++  V R+     +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHEEC 627
              +     +  E MS  S +     V S  +  D +      +I L   + + +L E  
Sbjct: 89  ALFREGDCWICMELMST-SFDKFYKYVYS--VLDDVIPEEILGKITLATVKALNHLKE-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
            ++IIH +I P NILLD S   K+ +F ++  L+ +     T   G R YM+PE  +   
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSA 201
Query: 688 ----ITVKSDVYSFGVVVLEIVCCR 708
                 V+SDV+S G+ + E+   R
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 16/279 (5%)
Query: 516 ELGRGCFGAV----YKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           +LG G FG V    Y  +     ++VAVK L+       R  ++ E+  +R  +H+++++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 571 LLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
             G C         LV E++  GSL + L     G      +  A  +  G+ YLH +  
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG--LAQLLLFAQQICEGMAYLHAQ-- 153
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--YMSPEWQNSG 686
              IH ++  RN+LLD+    KI +F LAK +            G     + +PE     
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 687 LITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                SDV+SFGV + E++  C S+        +++ ++          EL +  GE   
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER-GERLP 271
Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
              +    +  +   C + E + RP+ +N+I +L+   E
Sbjct: 272 RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L +  +E+   E + + E+       H N++RL G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           +    ++  L+ E+   G++   L  +      R    I  ++A  ++Y H +   ++IH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT-ELANALSYCHSK---RVIH 157
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            +I P N+LL  +   KI++F  + +  P  +     + GT  Y+ PE     +   K D
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWS-VHAP--SSRRDDLCGTLDYLPPEMIEGRMHDEKVD 214
Query: 694 VYSFGVVVLEIVCCRSNFEVNV 715
           ++S GV+  E +  +  FE N 
Sbjct: 215 LWSLGVLCYEFLVGKPPFEANT 236

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 87  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 142
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F  AK+L   +      G K    +M+ E     + T 
Sbjct: 143 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 202
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 203 QSDVWSYGVTVWELM 217

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 85  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F  AK+L   +      G K    +M+ E     + T 
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 201 QSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 85  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F  AK+L   +      G K    +M+ E     + T 
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 201 QSDVWSYGVTVWELM 215

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           L  G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 90  LGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 145
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 205
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 206 QSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           L  G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 199 QSDVWSYGVTVWELM 213

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKG-SICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 85  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F  AK+L   +      G K    +M+ E     + T 
Sbjct: 141 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 200
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 201 QSDVWSYGVTVWELM 215

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 494 QEFIIQSFSTGELERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER 551
           + F+ Q    GEL+   + FE   ELG G  G V K        I+A K +   ++   R
Sbjct: 1   EAFLTQKAKVGELK--DDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIR 58
Query: 552 -KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV 610
            +   E+  +   +   +V   G      +  +  E M  GSL+ +L   +  P   + +
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP---EEI 115
Query: 611 --RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
             ++++ V RG+ YL E+   QI+H ++ P NIL++     K+ +F ++  L+     + 
Sbjct: 116 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMA 170
Query: 669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
               GTR YM+PE       +V+SD++S G+ ++E+   R
Sbjct: 171 NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E+LG G +G+VYK    E  +IVA+K++  PVE   ++   E++ +++    ++V+  G 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALD-VARGITYLHEECEVQIIH 633
             + +   +V E+   GS+ +++  + +  +  D +   L    +G+ YLH    ++ IH
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDII-RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIH 148
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
            +I   NILL+    AK+++F +A  L  +       V GT  +M+PE  Q  G   V +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAPEVIQEIGYNCV-A 206
Query: 693 DVYSFGVVVLEIVCCRSNF 711
           D++S G+  +E+   +  +
Sbjct: 207 DIWSLGITAIEMAEGKPPY 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 57/303 (18%)
Query: 508 RATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           R  + FEE   LG+G FG V K      ++  A+K++ +  EE      +E+  +   +H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61
Query: 566 -------------KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS----NVESGPIWRD 608
                        +N V+ +    + S   +  E+   G+L +L+     N +    WR 
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR- 120
Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-------IL- 660
              +   +   ++Y+H +    IIH ++ P NI +D+S   KI +F LAK       IL 
Sbjct: 121 ---LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 661 -----MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
                +P  +  +T   GT  Y++ E    +G    K D+YS G++  E++         
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227
Query: 715 VSTADVVLLSTWVYNCFIAKELSKLVGE-DEEVDLRTLETMVRVGLLCIQDEPNLRPSMK 773
                    ST +    I K+L  +  E   + D   ++   ++  L I  +PN RP  +
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
Query: 774 NVI 776
            ++
Sbjct: 280 TLL 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQAEMAAVRRTHHKNLVRL 571
           F+E LG G F  V         K+ AVK +     +G E   + E+A +R+  H+N+V L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHEECEVQ 630
                  +   LV + +S G L + +  VE G    +D   +   V   + YLH    + 
Sbjct: 86  EDIYESPNHLYLVMQLVSGGELFDRI--VEKGFYTEKDASTLIRQVLDAVYYLH---RMG 140
Query: 631 IIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
           I+H ++ P N+L    D+     IS+F L+K  M  +  +++   GT GY++PE      
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSK--MEGKGDVMSTACGTPGYVAPEVLAQKP 198
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D +S GV+   ++C    F
Sbjct: 199 YSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 124/306 (40%), Gaps = 50/306 (16%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV-----------------------VLL 723
             +  SD + FGV + E+        + ++ + +                       V++
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 253
Query: 724 STWVYN-----CFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM 778
             W +       F+A  L   + E +  D+R L+       L IQ        M +VI +
Sbjct: 254 QCWAHKPEDRPTFVA--LRDFLLEAQPTDMRALQDFEEPDKLHIQ--------MNDVITV 303
Query: 779 LEGTME 784
           +EG  E
Sbjct: 304 IEGRAE 309

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 83  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 138
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F  AK+L   +      G K    +M+ E     + T 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 199 QSDVWSYGVTVWELM 213

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 506 LERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRR 562
           +E   + FE+  ELG G  G V+K S      ++A K +   ++   R +   E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGIT 621
            +   +V   G      +  +  E M  GSL+ +L   ++G I    + ++++ V +G+T
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           YL E+   +I+H ++ P NIL++     K+ +F ++  L+     +     GTR YMSPE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 173
Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                  +V+SD++S G+ ++E+   R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           L  G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 90  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 145
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 205
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 206 QSDVWSYGVTVWELM 220

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+K L E    +  ++   E   +    + ++ RL
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 90  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 145
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F  AK+L   +      G K    +M+ E     + T 
Sbjct: 146 VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 205
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 206 QSDVWSYGVTVWELM 220

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 506 LERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRR 562
           +E   + FE+  ELG G  G V+K S      ++A K +   ++   R +   E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGIT 621
            +   +V   G      +  +  E M  GSL+ +L   ++G I    + ++++ V +G+T
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           YL E+   +I+H ++ P NIL++     K+ +F ++  L+     +     GTR YMSPE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 173
Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                  +V+SD++S G+ ++E+   R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 506 LERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRR 562
           +E   + FE+  ELG G  G V+K S      ++A K +   ++   R +   E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGIT 621
            +   +V   G      +  +  E M  GSL+ +L   ++G I    + ++++ V +G+T
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           YL E+   +I+H ++ P NIL++     K+ +F ++  L+     +     GTR YMSPE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 173
Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                  +V+SD++S G+ ++E+   R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 506 LERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRR 562
           +E   + FE+  ELG G  G V+K S      ++A K +   ++   R +   E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGIT 621
            +   +V   G      +  +  E M  GSL+ +L   ++G I    + ++++ V +G+T
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           YL E+   +I+H ++ P NIL++     K+ +F ++  L+     +     GTR YMSPE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 173
Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                  +V+SD++S G+ ++E+   R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF--QAEMAAVRRTHHKNLVR-L 571
           E +GRG +GAVYKGS+ E    V V    N      + F  +  +  V    H N+ R +
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFI 73
Query: 572 LGFCMQTS----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           +G    T+    + LLV E+   GSL   LS   S   W    R+A  V RG+ YLH E 
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD--WVSSCRLAHSVTRGLAYLHTEL 131
Query: 628 ------EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ--------TGIVTGVKG 673
                 +  I H ++N RN+L+ +  T  IS+F L+  L  N+           ++ V G
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV-G 190
Query: 674 TRGYMSPEWQNSGLITVKS--------DVYSFGVVVLEI 704
           T  YM+PE    G + ++         D+Y+ G++  EI
Sbjct: 191 TIRYMAPEVL-EGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 11/207 (5%)
Query: 506 LERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRR 562
           +E   + FE+  ELG G  G V+K S      ++A K +   ++   R +   E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGIT 621
            +   +V   G      +  +  E M  GSL+ +L   ++G I    + ++++ V +G+T
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLT 118
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           YL E+   +I+H ++ P NIL++     K+ +F ++  L+     +     GTR YMSPE
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPE 173
Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                  +V+SD++S G+ ++E+   R
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 23/252 (9%)
Query: 498 IQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQ 554
           I+ F  G L          LG+G F  VY+         VA+K ++          ++ Q
Sbjct: 10  IEDFKVGNL----------LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ 59
Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL 614
            E+    +  H +++ L  +   ++   LV E    G +   L N    P   +  R  +
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFM 118
Query: 615 -DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVK 672
             +  G+ YLH      I+H ++   N+LL  ++  KI++F LA ++ MP++      + 
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173
Query: 673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV--STADVVLLSTWVYNC 730
           GT  Y+SPE        ++SDV+S G +   ++  R  F+ +   +T + V+L+ +    
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 731 FIAKELSKLVGE 742
           F++ E   L+ +
Sbjct: 234 FLSIEAKDLIHQ 245

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 7/199 (3%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           EELG G FG V++ +        A K +  P E  +   + E+  +    H  LV L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
               ++ +++YEFMS G L   +++  +     + V     V +G+ ++HE      +H 
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHL 279
Query: 635 NINPRNILL--DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           ++ P NI+     S   K+ +F L   L P Q+  VT   GT  + +PE      +   +
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 337
Query: 693 DVYSFGVVVLEIVCCRSNF 711
           D++S GV+   ++   S F
Sbjct: 338 DMWSVGVLSYILLSGLSPF 356

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ELGRG +G V K       +I+AVKR+   V  +E +R       ++R       V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRV--RIALDVARGITYLHEECEVQ 630
              +     +  E M   SL+     V + G    + +  +IA+ + + + +LH   ++ 
Sbjct: 74  ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLS 130
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL--- 687
           +IH ++ P N+L++     K+ +F ++  L+ +    +    G + YM+PE  N  L   
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERINPELNQK 188
Query: 688 -ITVKSDVYSFGVVVLEIVCCRSNFE 712
             +VKSD++S G+ ++E+   R  ++
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 516 ELGRGCFGAVYKGSICEGNKI--VAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVRLL 572
           ELG G FG+V +G      K   VA+K L+   E+ +  +   E   + +  +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 573 GFCMQTSKKLLVYEFMSKGSLEN-LLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           G C Q    +LV E    G L   L+   E  P+  +   +   V+ G+ YL E+     
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV-SNVAELLHQVSMGMKYLEEK---NF 457
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG--TRGYMSPEWQNSGLIT 689
           +H N+  RN+LL +   AKIS+F L+K L  + +       G     + +PE  N    +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 690 VKSDVYSFGVVVLEIV 705
            +SDV+S+GV + E +
Sbjct: 518 SRSDVWSYGVTMWEAL 533

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 517 LGRGCFGAVYKGS-ICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG VYKG  I EG K+   VA+  L E    +  ++   E   +    + ++ RL
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           LG C+ TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +    ++
Sbjct: 117 LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 172
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQNSGLITV 690
           +H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     + T 
Sbjct: 173 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 232
Query: 691 KSDVYSFGVVVLEIV 705
           +SDV+S+GV V E++
Sbjct: 233 QSDVWSYGVTVWELM 247

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 687 LITVKSDVYSFGVVVLEI 704
             +  SD + FGV + E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 7/199 (3%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           EELG G FG V++ +        A K +  P E  +   + E+  +    H  LV L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
               ++ +++YEFMS G L   +++  +     + V     V +G+ ++HE      +H 
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHL 173
Query: 635 NINPRNILL--DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           ++ P NI+     S   K+ +F L   L P Q+  VT   GT  + +PE      +   +
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 231
Query: 693 DVYSFGVVVLEIVCCRSNF 711
           D++S GV+   ++   S F
Sbjct: 232 DMWSVGVLSYILLSGLSPF 250

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 140
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 687 LITVKSDVYSFGVVVLEI 704
             +  SD + FGV + E+
Sbjct: 200 TFSHASDTWMFGVTLWEM 217

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ELGRG +G V K       +I+AVKR+   V  +E +R       ++R       V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRV--RIALDVARGITYLHEECEVQ 630
              +     +  E M   SL+     V + G    + +  +IA+ + + + +LH   ++ 
Sbjct: 118 ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLS 174
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL--- 687
           +IH ++ P N+L++     K+ +F ++  L+ +    +    G + YM+PE  N  L   
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA--GCKPYMAPERINPELNQK 232
Query: 688 -ITVKSDVYSFGVVVLEIVCCRSNFE 712
             +VKSD++S G+ ++E+   R  ++
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFPYD 258

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 39/280 (13%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F  +L     G ++KG     + +V V ++ +      R F  E   +R   H N++ +L
Sbjct: 14  FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 573 GFCM--QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEV 629
           G C         L+  +M  GSL N+L    +  + + + V+ ALD+ARG+ +LH   E 
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLI 688
            I    +N R++++D+ +TA+I   S+A +    Q+    G      +++PE  Q     
Sbjct: 133 LIPRHALNSRSVMIDEDMTARI---SMADVKFSFQS---PGRMYAPAWVAPEALQKKPED 186
Query: 689 TVK--SDVYSFGVVVLEIVCCR------SNFEVNVSTADVVLLSTWVYNCFIAKELSKLV 740
           T +  +D++SF V++ E+V         SN E+ +  A   L  T      I+  +SKL+
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT--IPPGISPHVSKLM 244
Query: 741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                              +C+ ++P  RP    ++ +LE
Sbjct: 245 K------------------ICMNEDPAKRPKFDMIVPILE 266

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 140
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 687 LITVKSDVYSFGVVVLEI 704
             +  SD + FGV + E+
Sbjct: 200 TFSHASDTWMFGVTLWEM 217

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 20/229 (8%)
Query: 490 LGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEE 548
           LG  +++ ++ F  G            LG+G FG VY     +   I+A+K L +  +E+
Sbjct: 3   LGSKRQWTLEDFDIGR----------PLGKGKFGNVYLARERQSKFILALKVLFKTQLEK 52
Query: 549 G--ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW 606
              E + + E+       H N++RL G+    ++  L+ E+   G++   L  +      
Sbjct: 53  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQ 112
Query: 607 RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
           R    I  ++A  ++Y H +   ++IH +I P N+LL  +   KI++F  + +  P+   
Sbjct: 113 RTATYIT-ELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRR 167
Query: 667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNV 715
               + GT  Y+ PE     +   K D++S GV+  E +     FE + 
Sbjct: 168 --DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 687 LITVKSDVYSFGVVVLEI 704
             +  SD + FGV + E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 687 LITVKSDVYSFGVVVLEI 704
             +  SD + FGV + E+
Sbjct: 194 TFSHASDTWMFGVTLWEM 211

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 10/192 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKF-QAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V K    +  +IVA+K+ LE+  ++  +K    E+  +++  H+NLV LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
           C +  +  LV+EF+    L++ L    +G  ++   +    +  GI + H      IIH 
Sbjct: 93  CKKKKRWYLVFEFVDHTILDD-LELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHR 148
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS- 692
           +I P NIL+  S   K+ +F  A+ L  P +  +      TR Y +PE     +   K+ 
Sbjct: 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAV 206
Query: 693 DVYSFGVVVLEI 704
           DV++ G +V E+
Sbjct: 207 DVWAIGCLVTEM 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 515 EELGRGCFGAVYKG--SICEGNKI-VAVKRLENPV---EEGERKFQAEMAAVRRTHHKNL 568
           E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ A+    H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           +RL G  +    K +V E    GSL + L   +   +     R A+ VA G+ YL  +  
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK-- 130
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSG 686
            + IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   + 
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 687 LITVKSDVYSFGVVVLEI 704
             +  SD + FGV + E+
Sbjct: 190 TFSHASDTWMFGVTLWEM 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 9/219 (4%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           EELG G FG V++       ++   K +  P    +   + E++ + + HH  L+ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
                + +L+ EF+S G L + ++  +      + +        G+ ++HE     I+H 
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHL 173
Query: 635 NINPRNILLD--DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           +I P NI+ +   + + KI +F LA  L P++  IV     T  + +PE  +   +   +
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYT 231
Query: 693 DVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYN 729
           D+++ GV+   ++   S F  E ++ T   V    W ++
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 508 RATNGFE--EELGRGCFGAVYKG-SICEGNKIVAVKRLENPVEEGERKFQ----AEMAAV 560
           RA   +E   E+G G +G V+K   +  G + VA+KR+   V+ GE         E+A +
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 65
Query: 561 RRTH---HKNLVRLLGFCM-----QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR- 611
           R      H N+VRL   C      + +K  LV+E + +  L   L  V    +  + ++ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
           +   + RG+ +LH     +++H ++ P+NIL+  S   K+++F LA+I        +T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSV 179
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             T  Y +PE           D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 508 RATNGFE--EELGRGCFGAVYKG-SICEGNKIVAVKRLENPVEEGERKFQ----AEMAAV 560
           RA   +E   E+G G +G V+K   +  G + VA+KR+   V+ GE         E+A +
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 65
Query: 561 RRTH---HKNLVRLLGFCM-----QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR- 611
           R      H N+VRL   C      + +K  LV+E + +  L   L  V    +  + ++ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
           +   + RG+ +LH     +++H ++ P+NIL+  S   K+++F LA+I        +T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSV 179
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             T  Y +PE           D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 508 RATNGFE--EELGRGCFGAVYKG-SICEGNKIVAVKRLENPVEEGERKFQ----AEMAAV 560
           RA   +E   E+G G +G V+K   +  G + VA+KR+   V+ GE         E+A +
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 65
Query: 561 RRTH---HKNLVRLLGFCM-----QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR- 611
           R      H N+VRL   C      + +K  LV+E + +  L   L  V    +  + ++ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
           +   + RG+ +LH     +++H ++ P+NIL+  S   K+++F LA+I        +T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSV 179
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             T  Y +PE           D++S G +  E+
Sbjct: 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 501 FSTGELERATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEM 557
            + GEL+   + FE+  ELG G  G V+K S      ++A K +   ++   R +   E+
Sbjct: 1   MALGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 58
Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDV 616
             +   +   +V   G      +  +  E M  GSL+ +L   ++G I    + ++++ V
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAV 116
Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
            +G+TYL E+   +I+H ++ P NIL++     K+ +F ++  L+     +     GTR 
Sbjct: 117 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRS 171
Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR 708
           YMSPE       +V+SD++S G+ ++E+   R
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L+      ER+   +E+ 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI------------ 605
            +    +H N+V LLG C      L++ E+   G L N L       I            
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 606 -----WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
                  D +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 661 MPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
             +   +V G  +    +M+PE   + + T +SDV+S+G+ + E+      F +  S   
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYP 249
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
            + + +  Y   I +    L  E    +      M  +   C   +P  RP+ K ++ ++
Sbjct: 250 GMPVDSKFYK-MIKEGFRMLSPEHAPAE------MYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 780 E 780
           E
Sbjct: 303 E 303

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 516 ELGRGCFGAVYKGSICEGNKI--VAVKRLENPVEEGE-RKFQAEMAAVRRTHHKNLVRLL 572
           ELG G FG+V +G      K   VA+K L+   E+ +  +   E   + +  +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 573 GFCMQTSKKLLVYEFMSKGSLEN-LLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           G C Q    +LV E    G L   L+   E  P+  +   +   V+ G+ YL E+     
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV-SNVAELLHQVSMGMKYLEEK---NF 131
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT--RGYMSPEWQNSGLIT 689
           +H ++  RN+LL +   AKIS+F L+K L  + +       G     + +PE  N    +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 690 VKSDVYSFGVVVLE 703
            +SDV+S+GV + E
Sbjct: 192 SRSDVWSYGVTMWE 205

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 509 ATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ----AEMAAVRR 562
           AT+ +E   E+G G +G VYK         VA+K +  P   GE         E+A +RR
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRR 59
Query: 563 TH---HKNLVRLLGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IA 613
                H N+VRL+  C  +      K  LV+E + +  L   L       +  + ++ + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
               RG+ +LH  C   I+H ++ P NIL+    T K+++F LA+I   +    +  V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVV 173
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           T  Y +PE           D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA++++    +  +     E+  +R
Sbjct: 15  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 73
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 129
Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH NI   NILL    + K+++F     + P Q+   T V GT  +M+
Sbjct: 130 LEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 185
Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E++
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L+      ER+   +E+ 
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI------------ 605
            +    +H N+V LLG C      L++ E+   G L N L       I            
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 606 -----WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
                  D +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 661 MPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
             +   +V G  +    +M+PE   + + T +SDV+S+G+ + E+      F +  S   
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYP 272
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
            + + +  Y   I +    L  E    +      M  +   C   +P  RP+ K ++ ++
Sbjct: 273 GMPVDSKFYK-MIKEGFRMLSPEHAPAE------MYDIMKTCWDADPLKRPTFKQIVQLI 325
Query: 780 E 780
           E
Sbjct: 326 E 326

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L+      ER+   +E+ 
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI------------ 605
            +    +H N+V LLG C      L++ E+   G L N L       I            
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 606 -----WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
                  D +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 661 MPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
             +   +V G  +    +M+PE   + + T +SDV+S+G+ + E+      F +  S   
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYP 272
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
            + + +  Y   I +    L  E    +      M  +   C   +P  RP+ K ++ ++
Sbjct: 273 GMPVDSKFYK-MIKEGFRMLSPEHAPAE------MYDIMKTCWDADPLKRPTFKQIVQLI 325
Query: 780 E 780
           E
Sbjct: 326 E 326

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 509 ATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ----AEMAAVRR 562
           AT+ +E   E+G G +G VYK         VA+K +  P   GE         E+A +RR
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRR 59
Query: 563 TH---HKNLVRLLGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IA 613
                H N+VRL+  C  +      K  LV+E + +  L   L       +  + ++ + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
               RG+ +LH  C   I+H ++ P NIL+    T K+++F LA+I   +    +  V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVVV 173
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           T  Y +PE           D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E ELGRG    VY+       K  A+K L+  V++  +  + E+  + R  H N+++L  
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKE 115
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQII 632
                ++  LV E ++ G L + +  VE G    RD       +   + YLHE     I+
Sbjct: 116 IFETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLHENG---IV 170
Query: 633 HCNINPRNILL-----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
           H ++ P N+L      D  L  KI++F L+KI+      ++  V GT GY +PE      
Sbjct: 171 HRDLKPENLLYATPAPDAPL--KIADFGLSKIV--EHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 688 ITVKSDVYSFGVVVLEIVC 706
              + D++S G++   ++C
Sbjct: 227 YGPEVDMWSVGIITYILLC 245

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 126/301 (41%), Gaps = 41/301 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L+      ER+   +E+ 
Sbjct: 37  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI------------ 605
            +    +H N+V LLG C      L++ E+   G L N L       I            
Sbjct: 97  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 606 -----WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
                  D +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 661 MPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
             +   +V G  +    +M+PE   + + T +SDV+S+G+ + E+      F +  S   
Sbjct: 214 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYP 267
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
            + + +  Y   + KE  +++  +          M  +   C   +P  RP+ K ++ ++
Sbjct: 268 GMPVDSKFYK--MIKEGFRMLSPEH-----APAEMYDIMKTCWDADPLKRPTFKQIVQLI 320
Query: 780 E 780
           E
Sbjct: 321 E 321

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 41/301 (13%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L+      ER+   +E+ 
Sbjct: 35  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 559 AVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI------------ 605
            +    +H N+V LLG C      L++ E+   G L N L       I            
Sbjct: 95  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 606 -----WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
                  D +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 661 MPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
             +   +V G  +    +M+PE   + + T +SDV+S+G+ + E+      F +  S   
Sbjct: 212 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL------FSLGSSPYP 265
Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
            + + +  Y   I +    L  E    +      M  +   C   +P  RP+ K ++ ++
Sbjct: 266 GMPVDSKFYK-MIKEGFRMLSPEHAPAE------MYDIMKTCWDADPLKRPTFKQIVQLI 318
Query: 780 E 780
           E
Sbjct: 319 E 319

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 8/193 (4%)
Query: 517 LGRGCFGAVYKGSIC--EGNKI-VAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLL 572
           LG G FG VY+G     +G KI VAVK  +     + + KF +E   ++   H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G  ++     ++ E    G L + L   ++       V  +L + + + YL     +  +
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCV 135
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I  RNIL+      K+ +F L++ +        +  +    +MSPE  N    T  S
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTAS 195
Query: 693 DVYSFGVVVLEIV 705
           DV+ F V + EI+
Sbjct: 196 DVWMFAVCMWEIL 208

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 8/193 (4%)
Query: 517 LGRGCFGAVYKGSIC--EGNKI-VAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLL 572
           LG G FG VY+G     +G KI VAVK  +     + + KF +E   ++   H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G  ++     ++ E    G L + L   ++       V  +L + + + YL     +  +
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCV 131
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I  RNIL+      K+ +F L++ +        +  +    +MSPE  N    T  S
Sbjct: 132 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTAS 191
Query: 693 DVYSFGVVVLEIV 705
           DV+ F V + EI+
Sbjct: 192 DVWMFAVCMWEIL 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR----RTHHKNLVRLL 572
           LG+G FG V    + E   + AVK L+  V   +   +  M   R      +H  L +L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 573 GFCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
             C QT  +L  V EF++ G L  +    +S      R R  A ++   + +LH++    
Sbjct: 91  C-CFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDK---G 144
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYMSPEWQNS 685
           II+ ++   N+LLD     K+++F + K       GI  GV      GT  Y++PE    
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTTATFCGTPDYIAPEILQE 198
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTA-------DVVLLSTWVY 728
            L     D ++ GV++ E++C  + FE             D V+  TW++
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 509 ATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ----AEMAAVRR 562
           AT+ +E   E+G G +G VYK         VA+K +  P   GE         E+A +RR
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRR 59
Query: 563 TH---HKNLVRLLGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IA 613
                H N+VRL+  C  +      K  LV+E + +  L   L       +  + ++ + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
               RG+ +LH  C   I+H ++ P NIL+    T K+++F LA+I   +    +  V  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVV 173
Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           T  Y +PE           D++S G +  E+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 8/193 (4%)
Query: 517 LGRGCFGAVYKGSIC--EGNKI-VAVKRLENPVE-EGERKFQAEMAAVRRTHHKNLVRLL 572
           LG G FG VY+G     +G KI VAVK  +     + + KF +E   ++   H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G  ++     ++ E    G L + L   ++       V  +L + + + YL     +  +
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCV 147
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I  RNIL+      K+ +F L++ +        +  +    +MSPE  N    T  S
Sbjct: 148 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTAS 207
Query: 693 DVYSFGVVVLEIV 705
           DV+ F V + EI+
Sbjct: 208 DVWMFAVCMWEIL 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 126/303 (41%), Gaps = 57/303 (18%)
Query: 508 RATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           R  + FEE   LG+G FG V K      ++  A+K++ +  EE      +E+  +   +H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNH 61
Query: 566 -------------KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS----NVESGPIWRD 608
                        +N V+ +    + S   +  E+    +L +L+     N +    WR 
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR- 120
Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-------IL- 660
              +   +   ++Y+H +    IIH ++ P NI +D+S   KI +F LAK       IL 
Sbjct: 121 ---LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 661 -----MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
                +P  +  +T   GT  Y++ E    +G    K D+YS G++  E++         
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227
Query: 715 VSTADVVLLSTWVYNCFIAKELSKLVGE-DEEVDLRTLETMVRVGLLCIQDEPNLRPSMK 773
                    ST +    I K+L  +  E   + D   ++   ++  L I  +PN RP  +
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
Query: 774 NVI 776
            ++
Sbjct: 280 TLL 282

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 9/216 (4%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E LG G FG V+K         +A K ++    + + + + E++ + +  H NL++L   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
               +  +LV E++  G L + + +        D +     +  GI ++H   ++ I+H 
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHL 211
Query: 635 NINPRNILL--DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           ++ P NIL    D+   KI +F LA+   P +   V    GT  +++PE  N   ++  +
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNYDFVSFPT 269
Query: 693 DVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTW 726
           D++S GV+   ++   S F  + +  T + +L   W
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA++++    +  +     E+  +R
Sbjct: 14  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 128
Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+   T V GT  +M+
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMA 184
Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 25/222 (11%)
Query: 491 GPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEE 548
           GP + ++ +   T E        ++ELG G FG V KG   + +  K VAVK L+N   +
Sbjct: 1   GPKEVYLDRKLLTLE--------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 52
Query: 549 GERKFQ--AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESG 603
              K +  AE   +++  +  +VR++G C +    +LV E    G L   L    +V+  
Sbjct: 53  PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK 111
Query: 604 PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN 663
            I    + +   V+ G+ YL E      +H ++  RN+LL     AKIS+F L+K L  +
Sbjct: 112 NI----IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 164
Query: 664 QTGIVTGVKGTR--GYMSPEWQNSGLITVKSDVYSFGVVVLE 703
           +        G     + +PE  N    + KSDV+SFGV++ E
Sbjct: 165 ENXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERK-FQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G   K       KI+  K L+   + E E++   +E+  +R   H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 575 CMQTSKKLL--VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ-- 630
            +  +   L  V E+   G L ++++       + D     L V   +T   +EC  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQLTLALKECHRRSD 132
Query: 631 ----IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
               ++H ++ P N+ LD     K+ +F LA+IL  + T       GT  YMSPE  N  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
               KSD++S G ++ E+      F
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 509 ATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA-----EMAAVR 561
           AT+ +E   E+G G +G VYK         VA+K +  P   G           E+A +R
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 562 RTH---HKNLVRLLGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-I 612
           R     H N+VRL+  C  +      K  LV+E + +  L   L       +  + ++ +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK 672
                RG+ +LH  C   I+H ++ P NIL+    T K+++F LA+I   +    +T V 
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVV 180
Query: 673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
            T  Y +PE           D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+S    + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 72  DVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 125
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 25/222 (11%)
Query: 491 GPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEE 548
           GP + ++ +   T E        ++ELG G FG V KG   + +  K VAVK L+N   +
Sbjct: 1   GPKEVYLDRKLLTLE--------DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 52
Query: 549 GERKFQ--AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESG 603
              K +  AE   +++  +  +VR++G C +    +LV E    G L   L    +V+  
Sbjct: 53  PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDK 111
Query: 604 PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN 663
            I    + +   V+ G+ YL E      +H ++  RN+LL     AKIS+F L+K L  +
Sbjct: 112 NI----IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 164
Query: 664 QTGIVTGVKGTR--GYMSPEWQNSGLITVKSDVYSFGVVVLE 703
           +        G     + +PE  N    + KSDV+SFGV++ E
Sbjct: 165 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+S    + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 71  DVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE-RKFQAEMAAVRRTHHKNLVRLLG 573
           +G+G FG V      +  K+ A+K +     VE  E R    E+  ++   H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 574 FCMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
                    +V + +  G L  +L  NV       + V++ + ++   + YL  +   +I
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQ---RI 136
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW---QNSGLI 688
           IH ++ P NILLD+     I++F++A +L P +T I T + GT+ YM+PE    +     
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT-MAGTKPYMAPEMFSSRKGAGY 194
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW 726
           +   D +S GV   E++  R  + +  ST+   ++ T+
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 34/284 (11%)
Query: 517 LGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRL 571
           LG+G FG+V +  + + +     VAVK L+  +       +F  E A ++   H ++ +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 572 LGFCMQTSKK------LLVYEFMSKGSLENLL--SNVESGPI---WRDRVRIALDVARGI 620
           +G  +++  K      +++  FM  G L   L  S +   P     +  VR  +D+A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMS 679
            YL        IH ++  RN +L + +T  +++F L+ KI   +        K    +++
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL 739
            E     L TV SDV++FGV + EI+         +  A+       +YN  I     K 
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYLIGGNRLKQ 260
Query: 740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM 783
             E        +E +  +   C   +P  RPS   + + LE  +
Sbjct: 261 PPE-------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGXKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERK-FQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G   K       KI+  K L+   + E E++   +E+  +R   H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 575 CMQTSKKLL--VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ-- 630
            +  +   L  V E+   G L ++++       + D     L V   +T   +EC  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQLTLALKECHRRSD 132
Query: 631 ----IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
               ++H ++ P N+ LD     K+ +F LA+IL  + T       GT  YMSPE  N  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
               KSD++S G ++ E+      F
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 76  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 129
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGXKY 187
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLV-- 569
            +E LG G FG V +    +  + VA+K+    +    R ++  E+  +++ +H N+V  
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 570 RLLGFCMQ----TSKKLLVYEFMSKGSLENLLSNVES------GPIWRDRVRIALDVARG 619
           R +   +Q        LL  E+   G L   L+  E+      GPI   R  ++ D++  
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---RTLLS-DISSA 134
Query: 620 ITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
           + YLHE    +IIH ++ P NI+L      L  KI +   AK L  +Q  + T   GT  
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQ 189
Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           Y++PE       TV  D +SFG +  E +
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECI 218

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+++ H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLSFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLV-- 569
            +E LG G FG V +    +  + VA+K+    +    R ++  E+  +++ +H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 570 RLLGFCMQ----TSKKLLVYEFMSKGSLENLLSNVES------GPIWRDRVRIAL-DVAR 618
           R +   +Q        LL  E+   G L   L+  E+      GPI     R  L D++ 
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-----RTLLSDISS 132
Query: 619 GITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTR 675
            + YLHE    +IIH ++ P NI+L      L  KI +   AK L  +Q  + T   GT 
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTL 187
Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            Y++PE       TV  D +SFG +  E +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECI 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE----NPVEEG-ERKFQAEMAAVRRTHHKNLVRL 571
           LG G F  VYK      N+IVA+K+++    +  ++G  R    E+  ++   H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQ 630
           L      S   LV++FM    LE ++ +  S  +    ++   L   +G+ YLH+     
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW--- 132
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPEWQ-NSGLI 688
           I+H ++ P N+LLD++   K+++F LAK    PN+      V  TR Y +PE    + + 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARMY 190
Query: 689 TVKSDVYSFGVVVLEIV 705
            V  D+++ G ++ E++
Sbjct: 191 GVGVDMWAVGCILAELL 207

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 122/273 (44%), Gaps = 32/273 (11%)
Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA----EMAAVRRTHHKNLV 569
           E+++GRG F  VY+ +       VA+K+++   +  + K +A    E+  +++ +H N++
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNHPNVI 95
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSN-------VESGPIWRDRVRIALDVARGITY 622
           +     ++ ++  +V E    G L  ++ +       +    +W+  V++       + +
Sbjct: 96  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SALEH 151
Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           +H     +++H +I P N+ +  +   K+ +  L +    ++T     + GT  YMSPE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPER 207
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
            +      KSD++S G ++ E+   +S F  +    ++  L   +  C    +   L  +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLYSLCKKIEQC----DYPPLPSD 261
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
               +LR L  M      CI  +P  RP +  V
Sbjct: 262 HYSEELRQLVNM------CINPDPEKRPDVTYV 288

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 123/282 (43%), Gaps = 38/282 (13%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E +G+G FG VY G    G   + +  +E   E+  + F+ E+ A R+T H+N+V  +G 
Sbjct: 39  ELIGKGRFGQVYHGR-WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRD---RVRIALDVARGITYLHEECEVQI 631
           CM +   L +   + KG    L S V    I  D     +IA ++ +G+ YLH +    I
Sbjct: 98  CM-SPPHLAIITSLCKG--RTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGY-----------MS 679
           +H ++  +N+  D+     I++F L  I    Q G     ++   G+           +S
Sbjct: 152 LHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 680 PEWQNSGL-ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK 738
           P+ +   L  +  SDV++ G +  E+      F+   + A +     W     +   LS+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-----WQMGTGMKPNLSQ 265
Query: 739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            +G  +E+          + L C   E   RP+   ++ MLE
Sbjct: 266 -IGMGKEIS--------DILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 57/303 (18%)
Query: 508 RATNGFEE--ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           R  + FEE   LG+G FG V K      ++  A+K++ +  EE      +E+  +   +H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNH 61
Query: 566 KNLVRLLGFCMQ----------TSKKLLVY---EFMSKGSLENLLS----NVESGPIWRD 608
           + +VR     ++            KK  ++   E+    +L +L+     N +    WR 
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR- 120
Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK-------IL- 660
              +   +   ++Y+H +    IIH N+ P NI +D+S   KI +F LAK       IL 
Sbjct: 121 ---LFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 661 -----MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN 714
                +P  +  +T   GT  Y++ E    +G    K D YS G++  E +         
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYP------- 227
Query: 715 VSTADVVLLSTWVYNCFIAKELSKLVGE-DEEVDLRTLETMVRVGLLCIQDEPNLRPSMK 773
                    ST      I K+L  +  E   + D    +   ++  L I  +PN RP  +
Sbjct: 228 --------FSTGXERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGAR 279
Query: 774 NVI 776
            ++
Sbjct: 280 TLL 282

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 126
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 184 YYKFSSKSDVWSFGVLMWE 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 179
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 179
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 76  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 129
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 187
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALF 211

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 70  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 181
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 70  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 124
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 125 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 181
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 182 YYKFSSKSDVWSFGVLMWE 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 179
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 29/215 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLGFC 575
           LGRG FG V++      +   A+KR+  P  E  R K   E+ A+ +  H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 576 MQ---------TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-----IALDVARGIT 621
           ++         +S K+ +Y  M     ENL   +       +R R     I L +A  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIV--------TG 670
           +LH +    ++H ++ P NI        K+ +F L   +  +   QT +         TG
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             GT+ YMSPE  +    + K D++S G+++ E++
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+S    + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 70  DVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 90  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 144
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 145 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 201
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 202 YYKFSSKSDVWSFGVLMWE 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+S    + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 72  DVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 125
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 126 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 70  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 179
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 72  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 125
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 71  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 146
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 92  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 146
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 70  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 71  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 73  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 126
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 184
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 82  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 136
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 194 YYKFSSKSDVWSFGVLMWE 212

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 72  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 125
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 102/204 (50%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 73  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 126
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 127 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 184
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALF 208

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-RKFQAEMAAVRRTHH-KNLVRLLG 573
           E+G G  G V+K    +   ++AVK++     + E ++   ++  V ++H    +V+  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEECEVQI 631
             +  +   +  E M  G+    L     GPI  +R+  ++ + + + + YL E+  V  
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKRMQGPI-PERILGKMTVAIVKALYYLKEKHGV-- 146
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT-- 689
           IH ++ P NILLD+    K+ +F ++  L+ ++    +   G   YM+PE  +    T  
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKP 204
Query: 690 ---VKSDVYSFGVVVLEIVC-------CRSNFEV 713
              +++DV+S G+ ++E+         C+++FEV
Sbjct: 205 DYDIRADVWSLGISLVELATGQFPYKNCKTDFEV 238

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 71  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 124
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALF 206

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA++++    +  +     E+  +R
Sbjct: 14  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 128
Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+     V GT  +M+
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMA 184
Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA++++    +  +     E+  +R
Sbjct: 14  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 128
Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+     V GT  +M+
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMA 184
Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMI 210

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 70  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 123
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALF 205

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 502 STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR 561
           S G+ ++    FE+ +G+G  G VY        + VA++++    +  +     E+  +R
Sbjct: 15  SVGDPKKKYTRFEK-IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 73
Query: 562 RTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARG 619
              + N+V  L   +   +  +V E+++ GSL ++++   ++ G I      +  +  + 
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI----AAVCRECLQA 129
Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           + +LH     Q+IH +I   NILL    + K+++F     + P Q+     V GT  +M+
Sbjct: 130 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMA 185
Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE         K D++S G++ +E++
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMI 211

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK +VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDVVY--------LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +     + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 72  DVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 125
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERK-FQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G   K       KI+  K L+   + E E++   +E+  +R   H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 575 CMQTSKKLL--VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ-- 630
            +  +   L  V E+   G L ++++       + D     L V   +T   +EC  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQLTLALKECHRRSD 132
Query: 631 ----IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
               ++H ++ P N+ LD     K+ +F LA+IL  ++      V GT  YMSPE  N  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRM 191
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
               KSD++S G ++ E+      F
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 488
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 489 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 546 YYKFSSKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 514 EEELGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQ--AEMAAVRRTHHKNLV 569
           ++ELG G FG V KG   + +  K VAVK L+N   +   K +  AE   +++  +  +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLS---NVESGPIWRDRVRIALDVARGITYLHEE 626
           R++G C +    +LV E    G L   L    +V+   I    + +   V+ G+ YL E 
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI----IELVHQVSMGMKYLEES 489
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--GYMSPEWQN 684
                +H ++  RN+LL     AKIS+F L+K L  ++        G     + +PE  N
Sbjct: 490 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 546
Query: 685 SGLITVKSDVYSFGVVVLE 703
               + KSDV+SFGV++ E
Sbjct: 547 YYKFSSKSDVWSFGVLMWE 565

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPVEEGERKFQAEMAA--VRRTHHKNLVRL 571
           LG+G FG V+   K S  +  ++ A+K L+    +   + + +M    +   +H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
             +  QT  KL L+ +F+  G L   LS  +      + V+  L ++A  + +LH    +
Sbjct: 92  -HYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---L 145
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P NILLD+    K+++F L+K  + ++    +   GT  YM+PE  N    T
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHT 204
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
             +D +SFGV++ E++     F+
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           FC Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 159
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 160 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 219
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 220 SDLWALGCIIYQLVAGLPPF 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V +G+     E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDEVY--------LNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPVEEGERKFQAEMAA--VRRTHHKNLVRL 571
           LG+G FG V+   K S  +  ++ A+K L+    +   + + +M    +   +H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
             +  QT  KL L+ +F+  G L   LS  +      + V+  L ++A  + +LH    +
Sbjct: 93  -HYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---L 146
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P NILLD+    K+++F L+K  + ++    +   GT  YM+PE  N    T
Sbjct: 147 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHT 205
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
             +D +SFGV++ E++     F+
Sbjct: 206 QSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPVEEGERKFQAEMAA--VRRTHHKNLVRL 571
           LG+G FG V+   K S  +  ++ A+K L+    +   + + +M    +   +H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
             +  QT  KL L+ +F+  G L   LS  +      + V+  L ++A  + +LH    +
Sbjct: 92  -HYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHS---L 145
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P NILLD+    K+++F L+K  + ++    +   GT  YM+PE  N    T
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRGHT 204
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
             +D +SFGV++ E++     F+
Sbjct: 205 QSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 514 EEELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +EELG+G F  V    +K +  E   KI+  K+L        +K + E    R+  H N+
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNI 67
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           VRL     + S   LV++ ++ G L E++++         D       +   I Y H   
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQILESIAYCHSN- 124
Query: 628 EVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
              I+H N+ P N+LL         K+++F LA  +  N +    G  GT GY+SPE   
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 685 SGLITVKSDVYSFGVVV 701
               +   D+++ GV++
Sbjct: 181 KDPYSKPVDIWACGVIL 197

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIV-AVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
            E  +GRG +G V K ++ +G +I  A K++     E   +F+ E+  ++   H N++RL
Sbjct: 13  LENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITYLHEECEV 629
                  +   LV E  + G    L   V    ++R  D  RI  DV   + Y H   ++
Sbjct: 72  YETFEDNTDIYLVMELCTGG---ELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 630 QIIHCNINPRNIL-LDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
            + H ++ P N L L DS  +  K+ +F LA    P +  + T V GT  Y+SP+    G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQVLE-G 182
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
           L   + D +S GV++  ++C    F
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIV-AVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
            E  +GRG +G V K ++ +G +I  A K++     E   +F+ E+  ++   H N++RL
Sbjct: 30  LENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 88
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR--DRVRIALDVARGITYLHEECEV 629
                  +   LV E  + G    L   V    ++R  D  RI  DV   + Y H   ++
Sbjct: 89  YETFEDNTDIYLVMELCTGG---ELFERVVHKRVFRESDAARIMKDVLSAVAYCH---KL 142
Query: 630 QIIHCNINPRNIL-LDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
            + H ++ P N L L DS  +  K+ +F LA    P +  + T V GT  Y+SP+    G
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYVSPQVLE-G 199
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
           L   + D +S GV++  ++C    F
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    +AVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 574 -FCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEE 626
            F   TS +      LV   M    L N+   V+   +  D V+  +  + RG+ Y+H  
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMG-ADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS- 172
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----W 682
               IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W
Sbjct: 173 --ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNW 226
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            +  +     D++S G ++ E++  R+ F
Sbjct: 227 MHYNMTV---DIWSVGCIMAELLTGRTLF 252

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+   RL+   E        E++ ++  +H N+V+LL
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 69  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 122
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 180
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALF 204

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+   RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+EF+ +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 179
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 514 EEELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +EELG+G F  V    +K +  E   KI+  K+L        +K + E    R+  H N+
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNI 67
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           VRL     + S   LV++ ++ G L E++++         D       +   I Y H   
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQILESIAYCHSN- 124
Query: 628 EVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
              I+H N+ P N+LL         K+++F LA  +  N +    G  GT GY+SPE   
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 685 SGLITVKSDVYSFGVVV 701
               +   D+++ GV++
Sbjct: 181 KDPYSKPVDIWACGVIL 197

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
              ++ + +   ++ +  +E +L   ++S  +  D +   L  + RG+ Y+H      ++
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS---ANVL 166
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+L++ +   KI +F LA+I  P  + TG +T    TR Y +PE   NS   T
Sbjct: 167 HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIF 248

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 514 EEELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +EELG+G F  V    +K +  E   KI+  K+L        +K + E    R+  H N+
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNI 66
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           VRL     + S   LV++ ++ G L E++++         D       +   I Y H   
Sbjct: 67  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQILESIAYCHSN- 123
Query: 628 EVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
              I+H N+ P N+LL         K+++F LA  +  N +    G  GT GY+SPE   
Sbjct: 124 --GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 685 SGLITVKSDVYSFGVVV 701
               +   D+++ GV++
Sbjct: 180 KDPYSKPVDIWACGVIL 196

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 96  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 199
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 118 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 221
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 85  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 137 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 188
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 92  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 144 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 195
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 103 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 155 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 206
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 96  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 199
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 88  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 140 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 191
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 112 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 164 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 215
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E   + A K +E   EE    +  E+  +    H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
               K  ++ EF   G+++ ++  ++ G        +   +   + +LH +   +IIH +
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 134
Query: 636 INPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNSG 686
           +   N+L+      ++++F ++    K L    + I     GT  +M+P     E     
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDT 189
Query: 687 LITVKSDVYSFGVVVLEI 704
               K+D++S G+ ++E+
Sbjct: 190 PYDYKADIWSLGITLIEM 207

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 93/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   +     K VAVK+++   ++       E+  +R  HH N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V R ++YLH +    +IH +
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNE--EQIATVCLSVLRALSYLHNQG---VIHRD 166
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV----GTPYWMAPEVISRLPYGTEV 222
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E++
Sbjct: 223 DIWSLGIMVIEMI 235

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 89  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 141 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 192
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E + + A K ++   EE    +  E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHC 634
              +   ++ EF + G+++ ++  +E  P+   ++++        + YLH+    +IIH 
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 635 NINPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNS 685
           ++   NIL       K+++F ++    + +    + I     GT  +M+P     E    
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKD 214
Query: 686 GLITVKSDVYSFGVVVLEI 704
                K+DV+S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 89/198 (44%), Gaps = 17/198 (8%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E   + A K +E   EE    +  E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
               K  ++ EF   G+++ ++  ++ G        +   +   + +LH +   +IIH +
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 142
Query: 636 INPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNSG 686
           +   N+L+      ++++F ++    K L    + I     GT  +M+P     E     
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDT 197
Query: 687 LITVKSDVYSFGVVVLEI 704
               K+D++S G+ ++E+
Sbjct: 198 PYDYKADIWSLGITLIEM 215

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 122 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 174 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 225
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ELGRG +G V K       +I AVKR+   V  +E +R       + R       V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRV--RIALDVARGITYLHEECEVQ 630
              +     +  E +   SL+     V + G    + +  +IA+ + + + +LH   ++ 
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLS 157
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL--- 687
           +IH ++ P N+L++     K  +F ++  L+ +    +    G + Y +PE  N  L   
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA--GCKPYXAPERINPELNQK 215
Query: 688 -ITVKSDVYSFGVVVLEIVCCRSNFE 712
             +VKSD++S G+  +E+   R  ++
Sbjct: 216 GYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 118 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 221
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 126/282 (44%), Gaps = 23/282 (8%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA---EMAAVRRTHHKNLVRLLG 573
           LG G FG V+        +  A+K L+  +    ++ +    E   +    H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
                 +  ++ +++  G L +LL   +  P    +   A +V   + YLH +    II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLHSK---DIIY 129
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NILLD +   KI++F  AK  +P+ T  +    GT  Y++PE  ++       D
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAK-YVPDVTYXLC---GTPDYIAPEVVSTKPYNKSID 185
Query: 694 VYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL 751
            +SFG+++ E++   + F     + T + +L +   +  F  +++  L+       L T 
Sbjct: 186 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR-----LITR 240
Query: 752 ETMVRVGLL--CIQDEPNLRPSMKNVIL--MLEGTMEIPVVP 789
           +   R+G L    +D  N  P  K V+   +L   +E P  P
Sbjct: 241 DLSQRLGNLQNGTEDVKN-HPWFKEVVWEKLLSRNIETPYEP 281

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 120 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 172 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 223
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 163 SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 215 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 266
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 97  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 149 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 200
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E + + A K ++   EE    +  E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHC 634
              +   ++ EF + G+++ ++  +E  P+   ++++        + YLH+    +IIH 
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 635 NINPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNS 685
           ++   NIL       K+++F ++    + +    + I     GT  +M+P     E    
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-----GTPYWMAPEVVMCETSKD 214
Query: 686 GLITVKSDVYSFGVVVLEI 704
                K+DV+S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V + +R    E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 19/197 (9%)
Query: 514 EEELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL 568
           +EELG+G F  V    +K +  E   KI+  K+L        +K + E    R+  H N+
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNI 90
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           VRL     + S   LV++ ++ G L E++++         D       +   I Y H   
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQILESIAYCHSNG 148
Query: 628 EVQIIHCNINPRNILLDDSLTA---KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
              I+H N+ P N+LL         K+++F LA  +  N +    G  GT GY+SPE   
Sbjct: 149 ---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 685 SGLITVKSDVYSFGVVV 701
               +   D+++ GV++
Sbjct: 204 KDPYSKPVDIWACGVIL 220

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 23/237 (9%)
Query: 482 QKLRINSSLGP---SQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVA 538
           QK+  NSS  P   ++ F I  F  G            LG+G FG VY     + + IVA
Sbjct: 3   QKVMENSSGTPDILTRHFTIDDFEIGR----------PLGKGKFGNVYLAREKKSHFIVA 52
Query: 539 VKRL-ENPVE-EG-ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN 595
           +K L ++ +E EG E + + E+      HH N++RL  +     +  L+ E+  +G L  
Sbjct: 53  LKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYK 112
Query: 596 LLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
            L    +    R    I  ++A  + Y H +   ++IH +I P N+LL      KI++F 
Sbjct: 113 ELQKSCTFDEQRT-ATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG 168
Query: 656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            + +  P+       + GT  Y+ PE     +   K D++  GV+  E++     FE
Sbjct: 169 WS-VHAPSLRR--KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V +G+     E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENPVEEGERKFQAEMAA--VRRTHHKNLVRL 571
           LG+G FG V+   K +  +   + A+K L+    +   + + +M    +   +H  +V+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
             +  QT  KL L+ +F+  G L   LS  +      + V+  L ++A G+ +LH    +
Sbjct: 96  -HYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELALGLDHLHS---L 149
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P NILLD+    K+++F L+K  + ++    +   GT  YM+PE  N    +
Sbjct: 150 GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC-GTVEYMAPEVVNRQGHS 208
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
             +D +S+GV++ E++     F+
Sbjct: 209 HSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 41/216 (18%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG VY+  +C+  ++VA+K+    V +G+     E+  +R+  H N+VRL  F  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 577 QT-SKKLLVYEFMSKGSLENLLSNVESGPIWR-----DRVRIALDVA----------RGI 620
            +  KK  VY         NL+ +     ++R      R +  L V           R +
Sbjct: 84  SSGEKKDEVYL--------NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 621 TYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRG 676
            Y+H      I H +I P+N+LLD D+   K+ +F  AK L+   PN + I      +R 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-----SRY 187
Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE    +   T   DV+S G V+ E++  +  F
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G   S       VA+K  +N   +  R KF  E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 66  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAP 181
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/294 (22%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTH 564
           + R     +E +G G    V         + VA+KR+     +    +   E+ A+ + H
Sbjct: 7   INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 66
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV------ESGPIWRDRVRIAL-DVA 617
           H N+V      +   +  LV + +S GS+ +++ ++      +SG +    +   L +V 
Sbjct: 67  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK----- 672
            G+ YLH+  +   IH ++   NILL +  + +I++F ++  L     G +T  K     
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATG--GDITRNKVRKTF 181
Query: 673 -GTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL-------- 722
            GT  +M+PE  +       K+D++SFG+  +E+    + +        ++L        
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 241
Query: 723 LSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           L T V +    KE+ K  G       ++   M+    LC+Q +P  RP+   ++
Sbjct: 242 LETGVQD----KEMLKKYG-------KSFRKMIS---LCLQKDPEKRPTAAELL 281

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ELG G FG VYK    E + + A K ++   EE    +  E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHC 634
              +   ++ EF + G+++ ++  +E  P+   ++++        + YLH+    +IIH 
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 635 NINPRNILLDDSLTAKISNFSLA----KILMPNQTGIVTGVKGTRGYMSP-----EWQNS 685
           ++   NIL       K+++F ++    + +      I     GT  +M+P     E    
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-----GTPYWMAPEVVMCETSKD 214
Query: 686 GLITVKSDVYSFGVVVLEI 704
                K+DV+S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRL 571
           ++LG+G +G V+K       ++VAVK++ +  +   + +R F+  M     + H+N+V L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 572 LGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L      + +   LV+++M       + +N+   P+ +  V   L   + I YLH     
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILE-PVHKQYVVYQL--IKVIKYLHSGG-- 129
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILM--------------------PNQTGIVT 669
            ++H ++ P NILL+     K+++F L++  +                     +   I+T
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 670 GVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
               TR Y +PE    S   T   D++S G ++ EI+C +  F
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +      + RG+ Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 146
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIF 228

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/294 (22%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTH 564
           + R     +E +G G    V         + VA+KR+     +    +   E+ A+ + H
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV------ESGPIWRDRVRIAL-DVA 617
           H N+V      +   +  LV + +S GS+ +++ ++      +SG +    +   L +V 
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK----- 672
            G+ YLH+  +   IH ++   NILL +  + +I++F ++  L     G +T  K     
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATG--GDITRNKVRKTF 186
Query: 673 -GTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL-------- 722
            GT  +M+PE  +       K+D++SFG+  +E+    + +        ++L        
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 723 LSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           L T V +    KE+ K  G       ++   M+    LC+Q +P  RP+   ++
Sbjct: 247 LETGVQD----KEMLKKYG-------KSFRKMIS---LCLQKDPEKRPTAAELL 286

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCAKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 195 HYNQTV---DIWSVGCIMAELLTGRTLF 219

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 10/211 (4%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK-RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G G +G VYK     G      K RLE   E        E++ ++   H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
                 + +LV+E + +  L+ LL   E G          L +  GI Y H+    +++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 634 CNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVK 691
            ++ P+N+L++     KI++F LA+   +P +    T    T  Y +P+    S   +  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
            D++S G +  E+V     F   VS AD ++
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFP-GVSEADQLM 211

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+E + +   + + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 72  DVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 125
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T     V  T  Y +PE       
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALF 207

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G   S       VA+K  +N   +  R KF  E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 66  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 124
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 10/211 (4%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK-RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G G +G VYK     G      K RLE   E        E++ ++   H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
                 + +LV+E + +  L+ LL   E G          L +  GI Y H+    +++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 634 CNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVK 691
            ++ P+N+L++     KI++F LA+   +P +    T    T  Y +P+    S   +  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYSTT 181
Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
            D++S G +  E+V     F   VS AD ++
Sbjct: 182 IDIWSVGCIFAEMVNGAPLFP-GVSEADQLM 211

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRL 571
           E LG G FG V   +  +  + VA+K +   +    +   + + E++ ++   H ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQ 630
                  +  ++V E+ + G L + +  VE   +  D   R    +   I Y H     +
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYI--VEKKRMTEDEGRRFFQQIICAIEYCHRH---K 128
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT- 689
           I+H ++ P N+LLDD+L  KI++F L+ I+       +    G+  Y +PE  N  L   
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
            + DV+S G+V+  ++  R  F+
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G           VA+K  +N   +  R KF  E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 66  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 124
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 10/211 (4%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK-RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           E++G G +G VYK     G      K RLE   E        E++ ++   H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
                 + +LV+E + +  L+ LL   E G          L +  GI Y H+    +++H
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 634 CNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVK 691
            ++ P+N+L++     KI++F LA+   +P +    T    T  Y +P+    S   +  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
            D++S G +  E+V     F   VS AD ++
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFP-GVSEADQLM 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEV 629
           L +  +T   L LV   M+ G L+  + ++        R V  A ++  G+  LH E   
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--- 305
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +I++ ++ P NILLDD    +IS+  LA  +   QT  + G  GT GYM+PE   +   T
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYT 363
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
              D ++ G ++ E++  +S F+
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 146
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIF 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 150
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIF 232

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G           VA+K  +N   +  R KF  E   +
Sbjct: 34  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 94  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 152
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 153 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 209
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 210 ESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEV 629
           L +  +T   L LV   M+ G L+  + ++        R V  A ++  G+  LH E   
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--- 305
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +I++ ++ P NILLDD    +IS+  LA  +   QT  + G  GT GYM+PE   +   T
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYT 363
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
              D ++ G ++ E++  +S F+
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQ 386

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG--ERKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 150
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIF 232

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G   S       VA+K  +N   +  R KF  E   +
Sbjct: 6   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 66  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 124
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 125 AYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 181
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 182 ESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           E LG G    V+       ++ VAVK L   +        +F+ E       +H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 572 --LGFCMQTSKKL--LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEE 626
              G     +  L  +V E++   +L +++     GP+   R + +  D  + + + H+ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN 135
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQN 684
               IIH ++ P NIL+  +   K+ +F +A+ +    N       V GT  Y+SPE   
Sbjct: 136 G---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
              +  +SDVYS G V+ E++     F
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 146
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 99  FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE       +  
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKS 214
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 215 SDLWALGCIIYQLVAGLPPF 234

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ-AEMAAVRRTHHKNLVRLLG 573
           E+LG G +  VYKG        VA+K ++   EEG       E++ ++   H+N+VRL  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITYLHE 625
                +K  LV+EFM      +L   ++S  +      + L++ +        G+ + HE
Sbjct: 71  VIHTENKLTLVFEFMDN----DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQ 683
               +I+H ++ P+N+L++     K+ +F LA+   +P  T     V  T  Y +P+   
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPDVLM 181
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            S   +   D++S G ++ E++  +  F
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGKPLF 209

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G           VA+K  +N   +  R KF  E   +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 71  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 130 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 186
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESG---PIWRDRVRIALDVARGITYLHEECEV 629
                 +K  LV+E + +     + ++  +G   P+ +  +     + +G+ + H     
Sbjct: 68  DVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL---FQLLQGLAFCHSH--- 121
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
           +++H ++ P+N+L++     K+++F LA+   +P +T   T    T  Y +PE       
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKY 179
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
            +   D++S G +  E+V  R+ F
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALF 203

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G           VA+K  +N   +  R KF  E   +
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 63  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKXQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           LG G  G V+     + +K VA+K++     +  +    E+  +RR  H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 577 QTSKKL---------LVYEFMSKGSLENLLSNV-ESGPIWRDRVRIAL-DVARGITYLHE 625
            +  +L         L   ++ +  +E  L+NV E GP+  +  R+ +  + RG+ Y+H 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH- 137
Query: 626 ECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPN--QTGIVTGVKGTRGYMSPEW 682
                ++H ++ P N+ ++ + L  KI +F LA+I+ P+    G ++    T+ Y SP  
Sbjct: 138 --SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195
Query: 683 QNSGLITVKS-DVYSFGVVVLEIVCCRSNF 711
             S     K+ D+++ G +  E++  ++ F
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 151
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 211
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 152
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 153 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 212
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 213 KSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 143
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 144 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 203
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 204 KSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 150
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIF 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 91
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 209 KSIDIWSVGCILAEMLSNRPIF 230

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG G FG V         + VA+K +   V    + + + + E++ +R   H ++++L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHEEC 627
                 + ++V E+      + +        + RD++      R    +   + Y H   
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYI--------VQRDKMSEQEARRFFQQIISAVEYCHRH- 126
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +I+H ++ P N+LLD+ L  KI++F L+ I+       +    G+  Y +PE  +  L
Sbjct: 127 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 182
Query: 688 IT-VKSDVYSFGVVVLEIVCCRSNFE 712
               + DV+S GV++  ++C R  F+
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 97
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 215 KSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 146
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 146
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIF 228

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG G FG V         + VA+K +   V    + + + + E++ +R   H ++++L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHEEC 627
                 + ++V E+      + +        + RD++      R    +   + Y H   
Sbjct: 72  VIKSKDEIIMVIEYAGNELFDYI--------VQRDKMSEQEARRFFQQIISAVEYCHRH- 122
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +I+H ++ P N+LLD+ L  KI++F L+ I+       +    G+  Y +PE  +  L
Sbjct: 123 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 688 IT-VKSDVYSFGVVVLEIVCCRSNFE 712
               + DV+S GV++  ++C R  F+
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 151
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 152 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 211
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 212 SDLWALGCIIYQLVAGLPPF 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ-NSG 686
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE   N+ 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNAM 198
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
                 D++S G ++ E++  R+ F
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 152
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKS 212
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 213 SDLWALGCIIYQLVAGLPPF 232

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G           VA+K  +N   +  R KF  E   +
Sbjct: 8   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 68  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 126
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 127 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 183
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 184 ESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 144
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIF 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 149 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 204 HYNQTV---DIWSVGCIMAELLTGRTLF 228

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 153
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 154 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 208
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 209 HYNQTV---DIWSVGCIMAELLTGRTLF 233

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG G FG V         + VA+K +   V    + + + + E++ +R   H ++++L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHEEC 627
                 + ++V E+      + +        + RD++      R    +   + Y H   
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYI--------VQRDKMSEQEARRFFQQIISAVEYCHRH- 132
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +I+H ++ P N+LLD+ L  KI++F L+ I+       +    G+  Y +PE  +  L
Sbjct: 133 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 188
Query: 688 IT-VKSDVYSFGVVVLEIVCCRSNFE 712
               + DV+S GV++  ++C R  F+
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG G FG V         + VA+K +   V    + + + + E++ +R   H ++++L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV------RIALDVARGITYLHEEC 627
                 + ++V E+      + +        + RD++      R    +   + Y H   
Sbjct: 81  VIKSKDEIIMVIEYAGNELFDYI--------VQRDKMSEQEARRFFQQIISAVEYCHRH- 131
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
             +I+H ++ P N+LLD+ L  KI++F L+ I+       +    G+  Y +PE  +  L
Sbjct: 132 --KIVHRDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 688 IT-VKSDVYSFGVVVLEIVCCRSNFE 712
               + DV+S GV++  ++C R  F+
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 144
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 145 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 204
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 205 KSIDIWSVGCILAEMLSNRPIF 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 166
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIF 248

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 94/205 (45%), Gaps = 8/205 (3%)
Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGER-KFQAEMAAV 560
           E++R        +G G FG V++G           VA+K  +N   +  R KF  E   +
Sbjct: 9   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 69  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 127
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+P
Sbjct: 128 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 184
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  N    T  SDV+ FGV + EI+
Sbjct: 185 ESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 195 HYNQTV---DIWSVGCIMAELLTGRTLF 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 205 HYNQTV---DIWSVGCIMAELLTGRTLF 229

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W 
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNWM 205
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 206 HYNQTV---DIWSVGCIMAELLTGRTLF 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKS 214
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 215 SDLWALGCIIYQLVAGLPPF 234

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 155
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 215
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 216 SDLWALGCIIYQLVAGLPPF 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKXQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 162
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 163 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 218 HYNQTV---DIWSVGCIMAELLTGRTLF 242

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W 
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNWM 205
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 206 HYNQTV---DIWSVGCIMAELLTGRTLF 230

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 149 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 204 HYNQTV---DIWSVGCIMAELLTGRTLF 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 95
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 151
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 152 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 211
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 212 SDLWALGCIIYQLVAGLPPF 231

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W 
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV----ATRWYRAPEIMLNWM 205
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 206 HYNQTV---DIWSVGCIMAELLTGRTLF 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 219 HYNQTV---DIWSVGCIMAELLTGRTLF 243

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           E LG G    V+       ++ VAVK L   +        +F+ E       +H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 572 --LGFCMQTSKKL--LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEE 626
              G     +  L  +V E++   +L +++     GP+   R + +  D  + + + H+ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN 135
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQN 684
               IIH ++ P NI++  +   K+ +F +A+ +    N       V GT  Y+SPE   
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
              +  +SDVYS G V+ E++     F
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           E LG G    V+       ++ VAVK L   +        +F+ E       +H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 572 --LGFCMQTSKKL--LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEE 626
              G     +  L  +V E++   +L +++     GP+   R + +  D  + + + H+ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQN 135
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQN 684
               IIH ++ P NI++  +   K+ +F +A+ +    N       V GT  Y+SPE   
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
              +  +SDVYS G V+ E++     F
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 583 LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQIIHCNINPRNI 641
           +V E++   +L +++     GP+   R + +  D  + + + H+     IIH ++ P NI
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 642 LLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGV 699
           ++  +   K+ +F +A+ +    N       V GT  Y+SPE      +  +SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 700 VVLEIVCCRSNF 711
           V+ E++     F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 215 SDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 101
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 157
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 158 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 217
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 218 SDLWALGCIIYQLVAGLPPF 237

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 583 LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQIIHCNINPRNI 641
           +V E++   +L +++     GP+   R + +  D  + + + H+     IIH ++ P NI
Sbjct: 93  IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 642 LLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGV 699
           ++  +   K+ +F +A+ +    N       V GT  Y+SPE      +  +SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 700 VVLEIVCCRSNF 711
           V+ E++     F
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 155 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 210 HYNQTV---DIWSVGCIMAELLTGRTLF 234

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +GRG FG V         K+ A+K L     ++  +  F  E   +    +   V  L +
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD----RVRIALDVARGITYLHEECEV 629
             Q  + L +V E+M  G L NL+SN +    W       V +ALD    + +       
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------- 194
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNS- 685
             IH ++ P N+LLD S   K+++F     +  N+ G+V   T V GT  Y+SPE   S 
Sbjct: 195 --IHRDVKPDNMLLDKSGHLKLADF--GTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 249
Query: 686 ---GLITVKSDVYSFGVVVLEIVCCRSNF 711
              G    + D +S GV + E++   + F
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 99
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 155
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 215
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 216 SDLWALGCIIYQLVAGLPPF 235

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 80
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 81  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 136
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 137 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 196
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 197 SDLWALGCIIYQLVAGLPPF 216

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVVLEIVC 706
           DV+S G+V+  ++ 
Sbjct: 190 DVWSCGIVLTAMLA 203

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +GRG FG V         K+ A+K L     ++  +  F  E   +    +   V  L +
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD----RVRIALDVARGITYLHEECEV 629
             Q  + L +V E+M  G L NL+SN +    W       V +ALD    + +       
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------- 194
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNS- 685
             IH ++ P N+LLD S   K+++F     +  N+ G+V   T V GT  Y+SPE   S 
Sbjct: 195 --IHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAV-GTPDYISPEVLKSQ 249
Query: 686 ---GLITVKSDVYSFGVVVLEIVCCRSNF 711
              G    + D +S GV + E++   + F
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 111/282 (39%), Gaps = 35/282 (12%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F  +L     G ++KG     + +V V ++ +      R F  E   +R   H N++ +L
Sbjct: 14  FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 573 GFCM--QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEV 629
           G C         L+  +   GSL N+L    +  + + + V+ ALD ARG  +LH   E 
Sbjct: 74  GACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH-TLEP 132
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
            I    +N R++ +D+  TA+IS   +      P +      V        PE  N    
Sbjct: 133 LIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRR-- 190
Query: 689 TVKSDVYSFGVVVLEIVCCR------SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
              +D +SF V++ E+V         SN E+    A   L  T      I+  +SKL   
Sbjct: 191 --SADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPT--IPPGISPHVSKLXK- 245
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
                            +C  ++P  RP    ++ +LE   +
Sbjct: 246 -----------------ICXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 215 SDLWALGCIIYQLVAGLPPF 234

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 149 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 204 HYNQTV---DIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 142
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 143 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 197
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 198 HYNQTV---DIWSVGCIMAELLTGRTLF 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 205
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 206 HYNQTV---DIWSVGCIMAELLTGRTLF 230

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 152
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 212
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 213 SDLWALGCIIYQLVAGLPPF 232

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 152
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 212
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 213 SDLWALGCIIYQLVAGLPPF 232

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 583 LVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEECEVQIIHCNINPRNI 641
           +V E++   +L +++     GP+   R + +  D  + + + H+     IIH ++ P NI
Sbjct: 110 IVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 642 LLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGV 699
           ++  +   K+ +F +A+ +    N       V GT  Y+SPE      +  +SDVYS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 700 VVLEIVCCRSNF 711
           V+ E++     F
Sbjct: 225 VLYEVLTGEPPF 236

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 189 DVWSCGIVL 197

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 71
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 127
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 188 DVWSCGIVL 196

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 146 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 201 HYNQTV---DIWSVGCIMAELLTGRTLF 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 195 HYNQTV---DIWSVGCIMAELLTGRTLF 219

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA++++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 150
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIF 232

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 9/194 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 693 DVYSFGVVVLEIVC 706
           DV+S G+V+  ++ 
Sbjct: 189 DVWSCGIVLTAMLA 202

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 211 HYNQTV---DIWSVGCIMAELLTGRTLF 235

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 215 SDLWALGCIIYQLVAGLPPF 234

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 140
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 141 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 196 HYNQTV---DIWSVGCIMAELLTGRTLF 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +GRG FG V         K+ A+K L     ++  +  F  E   +    +   V  L +
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD----RVRIALDVARGITYLHEECEV 629
             Q  + L +V E+M  G L NL+SN +    W       V +ALD    + +       
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF------- 189
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNS- 685
             IH ++ P N+LLD S   K+++F     +  N+ G+V   T V GT  Y+SPE   S 
Sbjct: 190 --IHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAV-GTPDYISPEVLKSQ 244
Query: 686 ---GLITVKSDVYSFGVVVLEIVCCRSNF 711
              G    + D +S GV + E++   + F
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 146 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 201 HYNQTV---DIWSVGCIMAELLTGRTLF 225

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+   +  +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 141
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 142 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 196
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 197 HYNQTV---DIWSVGCIMAELLTGRTLF 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 149 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 204 HYNQTV---DIWSVGCIMAELLTGRTLF 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 75
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 76  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 131
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 132 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 191
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 192 SDLWALGCIIYQLVAGLPPF 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 74
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 75  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 130
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 190
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 191 SDLWALGCIIYQLVAGLPPF 210

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 98
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 154
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 215 SDLWALGCIIYQLVAGLPPF 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 73
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 74  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 129
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 130 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 189
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 190 SDLWALGCIIYQLVAGLPPF 209

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 146 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 201 HYNQTV---DIWSVGCIMAELLTGRTLF 225

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPAFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHS--- 131
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 188
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 76
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 77  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 132
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 133 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 192
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 193 SDLWALGCIIYQLVAGLPPF 212

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 140
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 141 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 196 HYNQTV---DIWSVGCIMAELLTGRTLF 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 8/214 (3%)
Query: 496 FIIQSFSTGELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRLENPVEEGER- 551
           + + S    E++R        +G G FG V++G   S       VA+K  +N   +  R 
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 552 KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR 611
           KF  E   +R+  H ++V+L+G   + +   ++ E  + G L + L   +        + 
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL 495
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
            A  ++  + YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           K    +M+PE  N    T  SDV+ FGV + EI+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 205 HYNQTV---DIWSVGCIMAELLTGRTLF 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 155 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 210 HYNQTV---DIWSVGCIMAELLTGRTLF 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 205 HYNQTV---DIWSVGCIMAELLTGRTLF 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 211 HYNQTV---DIWSVGCIMAELLTGRTLF 235

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   ++   +  D +   L  + RG+ Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---ANVL 150
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS   T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIF 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 211 HYNQTV---DIWSVGCIMAELLTGRTLF 235

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 575 ----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
                ++  K + +   +    L  LL   ++  +  D +   L  + RG+ Y+H     
Sbjct: 110 IRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKYIHS---A 163
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSG 686
            ++H ++ P N+LL+ +   KI +F LA++  P  + TG +T    TR Y +PE   NS 
Sbjct: 164 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNF 711
             T   D++S G ++ E++  R  F
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 162
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 163 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 218 HYNQTV---DIWSVGCIMAELLTGRTLF 242

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHS--- 131
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 188
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 150 -ADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 205 HYNQTV---DIWSVGCIMAELLTGRTLF 229

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 146 -ADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 201 HYNQTV---DIWSVGCIMAELLTGRTLF 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 219 HYNQTV---DIWSVGCIMAELLTGRTLF 243

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 8/214 (3%)
Query: 496 FIIQSFSTGELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRLENPVEEGER- 551
           + + S    E++R        +G G FG V++G   S       VA+K  +N   +  R 
Sbjct: 377 YTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE 436
Query: 552 KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR 611
           KF  E   +R+  H ++V+L+G   + +   ++ E  + G L + L   +        + 
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL 495
Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
            A  ++  + YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +  
Sbjct: 496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           K    +M+PE  N    T  SDV+ FGV + EI+
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+S  +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKSQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F L +    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    +TG   TR Y +PE    W 
Sbjct: 167 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 221
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 222 HYNQTV---DIWSVGCIMAELLTGRTLF 246

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESL-TEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G V+K    E ++IVA+K  RL++  E        E+  ++   HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
                  K  LV+EF  +  L+    +  +G +  + V+  L  + +G+ + H      +
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAK 658
           +H ++ P+N+L++ +   K++NF LA+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLQALSVLHAQG---VIHRD 141
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEV 197
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 198 DIWSLGIMVIEMV 210

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+       G V     TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+       G V     TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLQALSVLHAQG---VIHRD 145
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEV 201
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 202 DIWSLGIMVIEMV 214

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+       G V     TR Y +PE    W 
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWM 194
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 195 HYNQTV---DIWSVGCIMAELLTGRTLF 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI  F LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 24/237 (10%)
Query: 487 NSSLG--PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-E 543
           N++L   P ++F I  F  G            LG+G FG VY     +   I+A+K L +
Sbjct: 1   NTALAEMPKRKFTIDDFDIGR----------PLGKGKFGNVYLAREKQNKFIMALKVLFK 50
Query: 544 NPVE-EG-ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVE 601
           + +E EG E + + E+       H N++R+  +     +  L+ EF  +G L   L   +
Sbjct: 51  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--K 108
Query: 602 SGPIWRDRVRIALD-VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
            G     R    ++ +A  + Y HE    ++IH +I P N+L+      KI++F  + + 
Sbjct: 109 HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-VH 164
Query: 661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
            P+       + GT  Y+ PE         K D++  GV+  E +     F+    T
Sbjct: 165 APSLRR--RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 219

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLQALSVLHAQG---VIHRD 150
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 151 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 207 DIWSLGIMVIEMV 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 616 VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKG 673
           + RG+ Y+H      ++H ++ P N+LL+ +   KI +F LA++  P  + TG +T    
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 674 TRGYMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           TR Y +PE   NS   T   D++S G ++ E++  R  F
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI ++ LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V K       +    K +  +R ++      R+  + E++ ++   H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E ++ G L + L+  ES     +       +  G+ YLH    
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHS--- 132
Query: 629 VQIIHCNINPRNILLDDSLTAK----ISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQ 683
           +QI H ++ P NI+L D    K    I +F LA KI   N+      + GT  +++PE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV 189
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLQALSVLHAQG---VIHRD 152
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 153 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEV 208
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 209 DIWSLGIMVIEMV 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 616 VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKG 673
           + RG+ Y+H      ++H ++ P N+LL+ +   KI +F LA++  P  + TG +T    
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 674 TRGYMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           TR Y +PE   NS   T   D++S G ++ E++  R  F
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 150
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +     TR Y +PE   NS   T
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 210
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G G +G V           VA+K++ +P E     ++   E+  + R  H+N++ +   
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 575 CMQTSKKLLVYEFMSKGSLE-NLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
               + + +   ++ +  +E +L   +++  +  D +   L  + RG+ Y+H      ++
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 151
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQ-NSGLIT 689
           H ++ P N+LL+ +   KI +F LA++  P  + TG +     TR Y +PE   NS   T
Sbjct: 152 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYT 211
Query: 690 VKSDVYSFGVVVLEIVCCRSNF 711
              D++S G ++ E++  R  F
Sbjct: 212 KSIDIWSVGCILAEMLSNRPIF 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 9/189 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG G +G V         + VAVK   ++  V+  E   + E+      +H+N+V+  G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINAMLNHENVVKFYGH 73
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
             + + + L  E+ S G L + +   + G    D  R    +  G+ YLH    + I H 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKS 692
           +I P N+LLD+    KIS+F LA +    N+  ++  + GT  Y++PE  +         
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 693 DVYSFGVVV 701
           DV+S G+V+
Sbjct: 190 DVWSCGIVL 198

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 23/227 (10%)
Query: 469 SSLLAYKQRVNQYQKLRINS----SLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGA 524
           ++LLA  +++N  Q     +    S+GP  E  +  ++  +        ++ +GRG    
Sbjct: 52  ANLLAEAKKLNDAQPKGTENLYFQSMGPEDE--LPDWAAAKEFYQKYDPKDVIGRGVSSV 109
Query: 525 VYKGSICEGNKIVAVKRLENPVEE--GERKFQAEMAAVRRTH-------HKNLVRLLGFC 575
           V +          AVK +E   E    E+  +   A  R TH       H +++ L+   
Sbjct: 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQIIHC 634
             +S   LV++ M KG L + L+  E   +     R I   +   +++LH      I+H 
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLT--EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHR 224
Query: 635 NINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           ++ P NILLDD++  ++S+F  +  L P +   +  + GT GY++PE
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPE 269

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-V 671
           +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  +   +  G  
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF 731
           +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V +      C 
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEF--CR 305
Query: 732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
             KE +++   D      T   M +  L C   EP+ RP+   ++  L
Sbjct: 306 RLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    + G   TR Y +PE    W 
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGXVATRWYRAPEIMLNWM 218
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 219 HYNQTV---DIWSVGCIMAELLTGRTLF 243

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 88/200 (44%), Gaps = 10/200 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F           ++  A+K LE  + ++E +  +   E   + R  H   V+L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 574 FCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGKG---II 152
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P ++        GT  Y+SPE          
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 212
Query: 692 SDVYSFGVVVLEIVCCRSNF 711
           SD+++ G ++ ++V     F
Sbjct: 213 SDLWALGCIIYQLVAGLPPF 232

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-V 671
           +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  +   +  G  
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF 731
           +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V +      C 
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEF--CR 307
Query: 732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
             KE +++   D      T   M +  L C   EP+ RP+   ++  L
Sbjct: 308 RLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 26/209 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN--PVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +GRG FG V         K+ A+K L     ++  +  F  E   +    +   V  L  
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 142
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD----RVRIALDVARGITYLHEECEV 629
             Q  K L +V E+M  G L NL+SN +    W       V +ALD    +         
Sbjct: 143 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG-------- 194
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSPEWQNS- 685
            +IH ++ P N+LLD     K+++F     +  ++TG+V   T V GT  Y+SPE   S 
Sbjct: 195 -LIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVHCDTAV-GTPDYISPEVLKSQ 250
Query: 686 ---GLITVKSDVYSFGVVVLEIVCCRSNF 711
              G    + D +S GV + E++   + F
Sbjct: 251 GGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-V 671
           +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  +   +  G  
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF 731
           +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V +      C 
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEF--CR 314
Query: 732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
             KE +++   D      T   M +  L C   EP+ RP+   ++  L
Sbjct: 315 RLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-V 671
           +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  +   +  G  
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF 731
           +    +M+PE     + T++SDV+SFGV++ EI      F +  S    V +      C 
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGVKIDEEF--CR 312
Query: 732 IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
             KE +++   D      T   M +  L C   EP+ RP+   ++  L
Sbjct: 313 RLKEGTRMRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 105/232 (45%), Gaps = 22/232 (9%)
Query: 491 GPSQEFIIQSF--STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE 548
           GP   F  Q    +  E+ +   G    +G G +G+V         + VAVK+L  P + 
Sbjct: 9   GPRAGFYRQELNKTVWEVPQRLQGLRP-VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQS 67
Query: 549 --GERKFQAEMAAVRRTHHKNLVRLLG-FCMQTSKKLLVYEFMSKGSLENLLSN-VESGP 604
               R+   E+  ++   H+N++ LL  F   TS +     ++    +   L+N V+S  
Sbjct: 68  LIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA 127
Query: 605 IWRDRVR-IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN 663
           +  + V+ +   + RG+ Y+H      IIH ++ P N+ +++    +I +F LA+     
Sbjct: 128 LSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE 184
Query: 664 QTGIVTGVKGTRGYMSPE----WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            TG V     TR Y +PE    W +        D++S G ++ E++  ++ F
Sbjct: 185 MTGYV----ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLQGKALF 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 21/200 (10%)
Query: 513 FEEELGRGCFGAVY-----KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
           F+ +LG G FG V+        +    K +   R + P+E+     +AE+  ++   H N
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ----IEAEIEVLKSLDHPN 81
Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDR--VRIALDVARGITYLH 624
           ++++           +V E    G L E ++S    G    +     +   +   + Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 625 EECEVQIIHCNINPRNILLDDSLTA---KISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
            +    ++H ++ P NIL  D+      KI +F LA++   ++    T   GT  YM+PE
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE 196
Query: 682 WQNSGLITVKSDVYSFGVVV 701
                 +T K D++S GVV+
Sbjct: 197 VFKRD-VTFKCDIWSAGVVM 215

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 535 KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLE 594
           KIV +KR  +  E      + E+   +  +H+N+V+  G   + + + L  E+ S G L 
Sbjct: 37  KIVDMKRAVDCPE----NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 595 NLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF 654
           + +   + G    D  R    +  G+ YLH    + I H +I P N+LLD+    KIS+F
Sbjct: 93  DRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDF 148
Query: 655 SLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVV 701
            LA +    N+  ++  + GT  Y++PE  +         DV+S G+V+
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 197

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 22/224 (9%)
Query: 502 STGELERATNGFE--EELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERK-F 553
           ST   E   + +E  EELG G F  V     KG+  E   K +  +RL +      R+  
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 554 QAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA 613
           + E+  +R   H N++ L       +  +L+ E +S G L + L+  ES  +  D     
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQF 120
Query: 614 L-DVARGITYLHEECEVQIIHCNINPRNILLDDSLTA----KISNFSLA-KILMPNQTGI 667
           L  +  G+ YLH +   +I H ++ P NI+L D        K+ +F +A KI   N+   
Sbjct: 121 LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 174
Query: 668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
              + GT  +++PE  N   + +++D++S GV+   ++   S F
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           + LG G FG V  G        VAVK L            K + E+  ++   H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQ 630
                  S   +V E++S G L + +   ++G +  ++  R+   +  G+ Y H      
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLFQQILSGVDYCHRH---M 136
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT- 689
           ++H ++ P N+LLD  + AKI++F L+ ++   +   +    G+  Y +PE  +  L   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRXSCGSPNYAAPEVISGRLYAG 194
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
            + D++S GV++  ++C    F+
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFD 217

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLQALSVLHAQG---VIHRD 195
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEV 251
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 252 DIWSLGIMVIEMV 264

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +F LA+    +    + G   TR Y +PE    W 
Sbjct: 167 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGYVATRWYRAPEIMLNWM 221
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 222 HYNQTV---DIWSVGCIMAELLTGRTLF 246

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G V+K    E ++IVA+K  RL++  E        E+  ++   HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
                  K  LV+EF  +  L+    +  +G +  + V+  L  + +G+ + H      +
Sbjct: 68  DVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NV 122
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAK 658
           +H ++ P+N+L++ +   K+++F LA+
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRLLG 573
           ++LG G +  VYKG     + +VA+K +    EEG       E++ ++   H N+V L  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
                    LV+E++ K  L+  L +     I    V++ L  + RG+ Y H +   +++
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVL 122
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++ P+N+L+++    K+++F LA+   +P +T     V  T  Y  P+    S   + 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYST 180
Query: 691 KSDVYSFGVVVLEIVCCRSNF 711
           + D++  G +  E+   R  F
Sbjct: 181 QIDMWGVGCIFYEMATGRPLF 201

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN-----PVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G    V++G   +   + A+K   N     PV+   R+F+     +++ +HKN+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV----LKKLNHKNIVKL 72
Query: 572 LGFCMQTS--KKLLVYEFMSKGSLENLL---SNVESGPIWRDRVRIALDVARGITYLHEE 626
                +T+   K+L+ EF   GSL  +L   SN    P   + + +  DV  G+ +L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIVLRDVVGGMNHLREN 131
Query: 627 CEVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
               I+H NI P NI+     D     K+++F  A+ L  ++  +   + GT  Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLYGTEEYLHPD 185

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 515 EELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V     KG+  E   K +  +RL +      R+  + E+  +R   H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
           + L       +  +L+ E +S G L + L+  ES  +  D     L  +  G+ YLH + 
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSK- 148
Query: 628 EVQIIHCNINPRNILLDDSLTA----KISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEW 682
             +I H ++ P NI+L D        K+ +F +A KI   N+      + GT  +++PE 
Sbjct: 149 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 203
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            N   + +++D++S GV+   ++   S F
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 94/193 (48%), Gaps = 12/193 (6%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V   ++    K+VAVK+++   ++       E+  +R   H+N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCN 635
           +   +  +V EF+  G+L +++++            + L V + ++ LH +    +IH +
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLQALSVLHAQG---VIHRD 272
Query: 636 INPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +      + 
Sbjct: 273 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV----GTPYWMAPELISRLPYGPEV 328
Query: 693 DVYSFGVVVLEIV 705
           D++S G++V+E+V
Sbjct: 329 DIWSLGIMVIEMV 341

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 515 EELGRGCFGAV----YKGSICE-GNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
           EELG G F  V     KG+  E   K +  +RL +      R+  + E+  +R   H N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
           + L       +  +L+ E +S G L + L+  ES  +  D     L  +  G+ YLH + 
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSK- 127
Query: 628 EVQIIHCNINPRNILLDDSLTA----KISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEW 682
             +I H ++ P NI+L D        K+ +F +A KI   N+      + GT  +++PE 
Sbjct: 128 --RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEI 182
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            N   + +++D++S GV+   ++   S F
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLEN-----PVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G    V++G   +   + A+K   N     PV+   R+F+     +++ +HKN+V+L
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV----LKKLNHKNIVKL 72
Query: 572 LGFCMQTS--KKLLVYEFMSKGSLENLL---SNVESGPIWRDRVRIALDVARGITYLHEE 626
                +T+   K+L+ EF   GSL  +L   SN    P   + + +  DV  G+ +L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIVLRDVVGGMNHLREN 131
Query: 627 CEVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
               I+H NI P NI+     D     K+++F  A+ L  ++  +   + GT  Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPD 185

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVRL 571
           + +G G +GAV           VA+K+L  P +     +R ++ E+  ++   H+N++ L
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89
Query: 572 LGFCMQT------SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLH 624
           L            +   LV  FM    L  L+ + + G    DR++ +   + +G+ Y+H
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLG---EDRIQFLVYQMLKGLRYIH 145
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--- 681
                 IIH ++ P N+ +++    KI +F LA+       G V     TR Y +PE   
Sbjct: 146 A---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV----TRWYRAPEVIL 198
Query: 682 -WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            W      T   D++S G ++ E++  ++ F+
Sbjct: 199 NWMR---YTQTVDIWSVGCIMAEMITGKTLFK 227

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/274 (22%), Positives = 119/274 (43%), Gaps = 37/274 (13%)
Query: 517 LGRGCFGA-VYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGF 574
           LG G  G  VY+G     N+ VAVKR+   + E       E+  +R +  H N++R   F
Sbjct: 32  LGHGAEGTIVYRGMF--DNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRY--F 84
Query: 575 CMQTSKKLLVYEF-MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
           C +  ++       +   +L+  +   +   +  + + +      G+ +LH    + I+H
Sbjct: 85  CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVH 141
Query: 634 CNINPRNILL-----DDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPEWQNSG 686
            ++ P NIL+        + A IS+F L K L   +      +GV GT G+++PE  +  
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 687 L---ITVKSDVYSFGVVVLEIVCCRSN-FEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
                T   D++S G V   ++   S+ F  ++     +LL     +C   ++   ++  
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIAR 261
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           +       +E M+ +       +P  RPS K+V+
Sbjct: 262 E------LIEKMIAM-------DPQKRPSAKHVL 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 517 LGRGCFGAVYK--GSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG+G FG V K    I +    V V    +   +       E+  +++  H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 575 CMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
              +S   +V E  + G L + ++          D  RI   V  GITY+H+     I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHKH---NIVH 144
Query: 634 CNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            ++ P NILL   +     KI +F L+     N    +    GT  Y++PE    G    
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLR-GTYDE 201
Query: 691 KSDVYSFGVVV 701
           K DV+S GV++
Sbjct: 202 KCDVWSAGVIL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 83/191 (43%), Gaps = 14/191 (7%)
Query: 517 LGRGCFGAVYK--GSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG+G FG V K    I +    V V    +   +       E+  +++  H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 575 CMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
              +S   +V E  + G L + ++          D  RI   V  GITY+H+     I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHKH---NIVH 144
Query: 634 CNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            ++ P NILL   +     KI +F L+     N    +    GT  Y++PE    G    
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLR-GTYDE 201
Query: 691 KSDVYSFGVVV 701
           K DV+S GV++
Sbjct: 202 KCDVWSAGVIL 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 517 LGRGCFGAVYK----GSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           LG G +G V +     ++C     +  K+    +  GE   + E+  +RR  HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 573 G--FCMQTSKKLLVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHEECEV 629
              +  +  K  +V E+   G  E L S  E   P+ +        +  G+ YLH +   
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC-QLIDGLEYLHSQ--- 128
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMP-NQTGIVTGVKGTRGYMSPEWQNSGLI 688
            I+H +I P N+LL    T KIS   +A+ L P          +G+  +  PE  N GL 
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN-GLD 187
Query: 689 T---VKSDVYSFGVVVLEIVCCRSNFE 712
           T    K D++S GV +  I      FE
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKI-------VAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           F E LG+G F  ++KG   E           V +K L+         F    + + +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES--GPIWRDRVRIALDVARGITYL 623
           K+LV   G C+   + +LV EF+  GSL+  L   ++    +W  ++ +A  +A  + +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL 129
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG---VKGTRGYMSP 680
            E     +IH N+  +NILL      K  N    K+  P  +  V     ++    ++ P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 681 E-WQNSGLITVKSDVYSFGVVVLEI 704
           E  +N   + + +D +SFG  + EI
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HKNLVRLL 572
           ++ LG G F    K    + N+  AVK +   +E   +K   E+ A++    H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 573 GFCMQTSKKLLVYEFMSKGSL------ENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
                     LV E ++ G L      +   S  E+  I R  V         ++++H+ 
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-------AVSHMHD- 124
Query: 627 CEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             V ++H ++ P N+L    +D+L  KI +F  A++  P+   + T    T  Y +PE  
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           N        D++S GV++  ++  +  F+
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 517 LGRGCFGAVYK--GSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           LG+G FG V K    I +    V V    +   +       E+  +++  H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
              +S   +V E  + G L + +   +      D  RI   V  GITY+H+     I+H 
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHDAARIIKQVFSGITYMHKH---NIVHR 145
Query: 635 NINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ P NILL   +     KI +F L+     N T +   + GT  Y++PE    G    K
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVLR-GTYDEK 202
Query: 692 SDVYSFGVVV 701
            DV+S GV++
Sbjct: 203 CDVWSAGVIL 212

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 38/292 (13%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKI-------VAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           F E LG+G F  ++KG   E           V +K L+         F    + + +  H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES--GPIWRDRVRIALDVARGITYL 623
           K+LV   G C    + +LV EF+  GSL+  L   ++    +W  ++ +A  +A  + +L
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL 129
Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG---VKGTRGYMSP 680
            E     +IH N+  +NILL      K  N    K+  P  +  V     ++    ++ P
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPP 186
Query: 681 E-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL 739
           E  +N   + + +D +SFG  + EI    S  +  +S  D                  KL
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEIC---SGGDKPLSALD---------------SQRKL 228
Query: 740 VGEDEEVDLRTLETMVRVGLL--CIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
              ++   L   +      L+  C+  EP+ RPS + +I  L       +VP
Sbjct: 229 QFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V         + VA+K+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 574 FCMQTSKKLLVYEF-MSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
                S     Y+F +    ++  L  +       ++++ +   + +G+ Y+H      +
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGV 165
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQNSGL 687
           +H ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W +   
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQ 221
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFE 712
                D++S G ++ E++  ++ F+
Sbjct: 222 TV---DIWSVGCIMAEMLTGKTLFK 243

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 103/216 (47%), Gaps = 18/216 (8%)
Query: 515 EELGRGCFG-AVYKGSICEGNKIVA----VKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           +++G G FG A+   S  +G + V     + R+ +   E  R+   E+A +    H N+V
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR---EVAVLANMKHPNIV 86
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIA--LDVARGITYLHEEC 627
           +      +     +V ++   G L   + N + G ++++   +   + +   + ++H+  
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSG 686
             +I+H +I  +NI L    T ++ +F +A++L  N T  +     GT  Y+SPE   + 
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENK 200
Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
               KSD+++ G V+ E+   +  FE   S  ++VL
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVL 235

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE---GERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V         + VA+K+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 574 FCMQTSKKLLVYEF-MSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
                S     Y+F +    ++  L  +       ++++ +   + +G+ Y+H      +
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGV 147
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQNSGL 687
           +H ++ P N+ +++    KI +F LA+      TG V     TR Y +PE    W +   
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQ 203
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFE 712
                D++S G ++ E++  ++ F+
Sbjct: 204 TV---DIWSVGCIMAEMLTGKTLFK 225

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 21/224 (9%)
Query: 493 SQEFIIQSFSTGELERATNG----FEEELGRGCFGAVYKGSICEGNKIVAVKRLEN-PVE 547
            Q+  I+   T  +  + +G    F+ E+GRG F  VYKG   E    VA   L++  + 
Sbjct: 6   QQQDDIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT 65
Query: 548 EGER-KFQAEMAAVRRTHHKNLVRLLGFCMQTSKK----LLVYEFMSKGSLENLLS--NV 600
           + ER +F+ E   ++   H N+VR       T K     +LV E  + G+L+  L    V
Sbjct: 66  KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV 125
Query: 601 ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKI 659
               + R   R    + +G+ +LH      IIH ++   NI +     + KI +  LA +
Sbjct: 126 XKIKVLRSWCR---QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLE 703
               +      V GT  + +PE           DVY+FG   LE
Sbjct: 182 ---KRASFAKAVIGTPEFXAPEXYEEKY-DESVDVYAFGXCXLE 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +  LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 93/194 (47%), Gaps = 14/194 (7%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           ++G G  G V         + VAVK ++   ++       E+  +R   H N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 576 MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALD-VARGITYLHEECEVQIIHC 634
           +   +  ++ EF+  G+L +++S V    +  +++    + V + + YLH +    +IH 
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQG---VIHR 165
Query: 635 NINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           +I   +ILL      K+S+F     +   +P +  +V    GT  +M+PE  +  L   +
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV----GTPYWMAPEVISRSLYATE 221
Query: 692 SDVYSFGVVVLEIV 705
            D++S G++V+E+V
Sbjct: 222 VDIWSLGIMVIEMV 235

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 18/196 (9%)
Query: 515 EELGRGCFGAVYKG-SICEGN----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E++G+G F  V +   +C G+    KI+  K+L        +K + E    R   H N+V
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSA---RDHQKLEREARICRLLKHSNIV 66
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           RL     +     LV++ ++ G L E++++         D       +   + + H   +
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA--DASHCIQQILEAVLHCH---Q 121
Query: 629 VQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           + ++H ++ P N+LL         K+++F LA  +  +Q     G  GT GY+SPE    
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF-GFAGTPGYLSPEVLRK 180
Query: 686 GLITVKSDVYSFGVVV 701
                  D+++ GV++
Sbjct: 181 EAYGKPVDIWACGVIL 196

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 20/205 (9%)
Query: 508 RATNGFE--EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERKFQAEMAAV 560
           R T+ ++  EELG+G F  V +      +     KI+  K+L        +K + E    
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLS---ARDHQKLEREARIC 84
Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARG 619
           R   H N+VRL     +     LV++ ++ G L E++++         D       +   
Sbjct: 85  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA--DASHCIHQILES 142
Query: 620 ITYLHEECEVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
           + ++H+     I+H ++ P N+LL         K+++F LA I +  +     G  GT G
Sbjct: 143 VNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPG 198
Query: 677 YMSPEWQNSGLITVKSDVYSFGVVV 701
           Y+SPE           D+++ GV++
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +  LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 515 EELGRGCFGAVYKG-SICEGN----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           EELG+G F  V +   +  G     KI+  K+L        +K + E    R   H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA---RDHQKLEREARICRLLKHPNIV 84
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           RL     +     L+++ ++ G L E++++         D       +   + + H   +
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA--DASHCIQQILEAVLHCH---Q 139
Query: 629 VQIIHCNINPRNILLDDSL---TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           + ++H ++ P N+LL   L     K+++F LA I +  +     G  GT GY+SPE    
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 686 GLITVKSDVYSFGVVV 701
                  D+++ GV++
Sbjct: 199 DPYGKPVDLWACGVIL 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 515 EELGRGCFGAVYKG-SICEGNK----IVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           EELG+G F  V +   +  G +    I+  K+L        +K + E    R   H N+V
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA---RDHQKLEREARICRLLKHPNIV 73
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           RL     +     L+++ ++ G L E++++         D       +   + + H   +
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA--DASHCIQQILEAVLHCH---Q 128
Query: 629 VQIIHCNINPRNILLDDSL---TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           + ++H N+ P N+LL   L     K+++F LA I +  +     G  GT GY+SPE    
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 686 GLITVKSDVYSFGVVV 701
                  D+++ GV++
Sbjct: 188 DPYGKPVDLWACGVIL 203

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 85/158 (53%), Gaps = 14/158 (8%)
Query: 550 ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL--VYEFMSKGSLENLLSNVESGPIWR 607
           E+ +Q E+A +++  H N+V+L+      ++  L  V+E +++G +  + +     P+  
Sbjct: 81  EQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSE 136
Query: 608 DRVRIAL-DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
           D+ R    D+ +GI YLH +   +IIH +I P N+L+ +    KI++F ++         
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDA 192
Query: 667 IVTGVKGTRGYMSPE--WQNSGLITVKS-DVYSFGVVV 701
           +++   GT  +M+PE   +   + + K+ DV++ GV +
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRL 571
           E +G G +G V         + VA+K++ N    V   +R  + E+  ++   H N++ +
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAI 118
Query: 572 LGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHE 625
                 T      K + V   + +  L  ++ +  S P+  + VR  L  + RG+ Y+H 
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEW 682
               Q+IH ++ P N+L++++   KI +F +A+ L          +T    TR Y +PE 
Sbjct: 177 ---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 683 QNS-GLITVKSDVYSFGVVVLEIVCCRSNF 711
             S    T   D++S G +  E++  R  F
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 4/98 (4%)
Query: 608 DRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           D +  +  VARG+ +L      + IH ++  RNILL ++   KI +F LA+ +  N   +
Sbjct: 200 DLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYV 256
Query: 668 VTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
             G  +    +M+PE     + + KSDV+S+GV++ EI
Sbjct: 257 RKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 20/251 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR----RTHHKNLVRLL 572
           LG+G FG V+     + N+  A+K L+  V   +   +  M   R       H  L  + 
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM- 84
Query: 573 GFC-MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
            FC  QT + L  V E+++ G L   + +     + R     A ++  G+ +LH +    
Sbjct: 85  -FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAAEIILGLQFLHSKG--- 139
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK--GTRGYMSPEWQNSGLI 688
           I++ ++   NILLD     KI++F + K    N  G     +  GT  Y++PE       
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
               D +SFGV++ E++  +S F  +    + +  S  + N F  + L K   +D  V L
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWLEK-EAKDLLVKL 253
Query: 749 RTLETMVRVGL 759
              E   R+G+
Sbjct: 254 FVREPEKRLGV 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/249 (25%), Positives = 108/249 (43%), Gaps = 16/249 (6%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR----RTHHKNLVRLL 572
           LG+G FG V+     + N+  A+K L+  V   +   +  M   R       H  L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM- 83
Query: 573 GFC-MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
            FC  QT + L  V E+++ G L   + +     + R     A ++  G+ +LH +    
Sbjct: 84  -FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF-YAAEIILGLQFLHSKG--- 138
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           I++ ++   NILLD     KI++F + K  M           GT  Y++PE         
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAPEILLGQKYNH 197
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
             D +SFGV++ E++  +S F  +    + +  S  + N F  + L K   +D  V L  
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHSIRMDNPFYPRWLEK-EAKDLLVKLFV 254
Query: 751 LETMVRVGL 759
            E   R+G+
Sbjct: 255 REPEKRLGV 263

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G +G+V      +    VAVK+L  P +     +R ++ E+  ++   H+N++ LL 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 574 F-----CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
                  ++    + +   +    L N+   V+   +  D V+  +  + RG+ Y+H   
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQ 683
              IIH ++ P N+ +++    KI +  LA+    +    +TG   TR Y +PE    W 
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +        D++S G ++ E++  R+ F
Sbjct: 199 HYNQTV---DIWSVGCIMAELLTGRTLF 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 22/232 (9%)
Query: 491 GPSQEFIIQSF--STGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE 548
           GP   F  Q    +  E+ +   G    +G G +G+V         + VAVK+L  P + 
Sbjct: 9   GPRAGFYRQELNKTVWEVPQRLQGLRP-VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQS 67
Query: 549 --GERKFQAEMAAVRRTHHKNLVRLLG-FCMQTSKKLLVYEFMSKGSLENLLSN-VESGP 604
               R+   E+  ++   H+N++ LL  F   TS +     ++    +   L+N V+   
Sbjct: 68  LIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA 127
Query: 605 IWRDRVR-IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN 663
           +  + V+ +   + RG+ Y+H      IIH ++ P N+ +++    +I +F LA+     
Sbjct: 128 LSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE 184
Query: 664 QTGIVTGVKGTRGYMSPE----WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            TG V     TR Y +PE    W +        D++S G ++ E++  ++ F
Sbjct: 185 MTGYV----ATRWYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLQGKALF 229

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRL 571
           E +G G +G V         + VA+K++ N    V   +R  + E+  ++   H N++ +
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAI 119
Query: 572 LGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHE 625
                 T      K + V   + +  L  ++ +  S P+  + VR  L  + RG+ Y+H 
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEW 682
               Q+IH ++ P N+L++++   KI +F +A+ L          +T    TR Y +PE 
Sbjct: 178 ---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 683 QNS-GLITVKSDVYSFGVVVLEIVCCRSNF 711
             S    T   D++S G +  E++  R  F
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQLF 264

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEE--GERKFQAEMAAVRRTHHKNLVRLLG- 573
           +G G +G+V         + VAVK+L  P +     R+   E+  ++   H+N++ LL  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSN-VESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
           F   TS +     ++    +   L+N V+   +  + V+ +   + RG+ Y+H      I
Sbjct: 88  FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS---AGI 144
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQNSGL 687
           IH ++ P N+ +++    +I +F LA+      TG V     TR Y +PE    W +   
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV----ATRWYRAPEIMLNWMHYNQ 200
Query: 688 ITVKSDVYSFGVVVLEIVCCRSNF 711
                D++S G ++ E++  ++ F
Sbjct: 201 TV---DIWSVGCIMAELLQGKALF 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAE--MAAVRRTHHKNLVRL 571
           +GRG FG VY     +  K+ A+K L+     +++GE     E  M ++  T     +  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           + +   T  KL  + + M+ G L   LS  + G      +R  A ++  G+ ++H     
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-- 311
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G+  
Sbjct: 312 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 367
Query: 690 VKS-DVYSFGVVVLEIVCCRSNF 711
             S D +S G ++ +++   S F
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSPF 390

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +++G G FG        + N++VAVK +E   E+ +   + E+   R   H N+VR    
Sbjct: 25  KDIGAGNFGVARLMRDKQANELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
            +  +   +V E+ S G L   + N  +G    D  R     +  G++Y H    +Q+ H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYAH---AMQVAH 138
Query: 634 CNINPRNILLDDSLTA--KISNF--SLAKILMPNQTGIVTGVKGTRGYMSPE----WQNS 685
            ++   N LLD S     KI++F  S A +L       V    GT  Y++PE     +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV----GTPAYIAPEVLLKKEYD 194
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFE 712
           G +   +DV+S GV +  ++     FE
Sbjct: 195 GKV---ADVWSCGVTLYVMLVGAYPFE 218

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 508 RATNGF------EEELGRGCFGAVYKGSICEGNKIVAVKRLE---------NPVEEGERK 552
            +T+GF      +E LGRG    V +       K  AVK ++           V+E    
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 553 FQAEMAAVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDR 609
              E+  +R+ + H N+++L       +   LV++ M KG L + L+     S    R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +R  L+V   I  LH+   + I+H ++ P NILLDD +  K+++F  +  L P +   + 
Sbjct: 130 MRALLEV---ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LR 181
Query: 670 GVKGTRGYMSPEW------QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            V GT  Y++PE        N      + D++S GV++  ++     F
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAE--MAAVRRTHHKNLVRL 571
           +GRG FG VY     +  K+ A+K L+     +++GE     E  M ++  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           + +   T  KL  + + M+ G L   LS  + G      +R  A ++  G+ ++H     
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G+  
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 368
Query: 690 VKS-DVYSFGVVVLEIVCCRSNF 711
             S D +S G ++ +++   S F
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAE--MAAVRRTHHKNLVRL 571
           +GRG FG VY     +  K+ A+K L+     +++GE     E  M ++  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           + +   T  KL  + + M+ G L   LS  + G      +R  A ++  G+ ++H     
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G+  
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 368
Query: 690 VKS-DVYSFGVVVLEIVCCRSNF 711
             S D +S G ++ +++   S F
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAE--MAAVRRTHHKNLVRL 571
           +GRG FG VY     +  K+ A+K L+     +++GE     E  M ++  T     +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
           + +   T  KL  + + M+ G L   LS  + G      +R  A ++  G+ ++H     
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRFYAAEIILGLEHMHNRF-- 312
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G+  
Sbjct: 313 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAY 368
Query: 690 VKS-DVYSFGVVVLEIVCCRSNF 711
             S D +S G ++ +++   S F
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 98/230 (42%), Gaps = 22/230 (9%)
Query: 492 PSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVE-EG 549
           P ++F I  F               LG+G FG VY     +   I+A+K L ++ +E EG
Sbjct: 7   PKRKFTIDDFDIVR----------PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG 56
Query: 550 -ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRD 608
            E + + E+       H N++R+  +     +  L+ EF  +G L   L   + G     
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQ 114
Query: 609 RVRIALD-VARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           R    ++ +A  + Y HE    ++IH +I P N+L+      KI++F  + +  P+    
Sbjct: 115 RSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRR- 169
Query: 668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVST 717
              + GT  Y+ PE         K D++  GV+  E +     F+    T
Sbjct: 170 -RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 21/195 (10%)
Query: 517 LGRGCFGAVY------KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG+G FG V        G  C   K+++ ++++   ++       E+  +++  H N+++
Sbjct: 34  LGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDK--ESLLREVQLLKQLDHPNIMK 90
Query: 571 LLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  F        LV E  + G L + ++S      +  D  RI   V  GITY+H+    
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLSGITYMHKN--- 145
Query: 630 QIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
           +I+H ++ P N+LL+        +I +F L+     ++   +    GT  Y++PE  + G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH-G 202
Query: 687 LITVKSDVYSFGVVV 701
               K DV+S GV++
Sbjct: 203 TYDEKCDVWSTGVIL 217

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 21/195 (10%)
Query: 517 LGRGCFGAVY------KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG+G FG V        G  C   K+++ ++++   ++       E+  +++  H N+++
Sbjct: 40  LGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDK--ESLLREVQLLKQLDHPNIMK 96
Query: 571 LLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  F        LV E  + G L + ++S      +  D  RI   V  GITY+H+    
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLSGITYMHKN--- 151
Query: 630 QIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
           +I+H ++ P N+LL+        +I +F L+     ++   +    GT  Y++PE  + G
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH-G 208
Query: 687 LITVKSDVYSFGVVV 701
               K DV+S GV++
Sbjct: 209 TYDEKCDVWSTGVIL 223

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHKNL 568
           EELG G F  V K          A K ++       R+       + E++ +R+  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E +S G L + L+  ES     +       +  G+ YLH +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTA----KISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQ 683
            +I H ++ P NI+L D        K+ +F LA  +   + G+    + GT  +++PE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIV 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 23/215 (10%)
Query: 504 GELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT 563
           G+ E       E LG G +  V      +  K  AVK +E        +   E+  + + 
Sbjct: 8   GKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQC 67
Query: 564 H-HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--VRIALDVARGI 620
             +KN++ L+ F    ++  LV+E +  GS   +L++++    + +R   R+  DVA  +
Sbjct: 68  QGNKNILELIEFFEDDTRFYLVFEKLQGGS---ILAHIQKQKHFNEREASRVVRDVAAAL 124
Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLT---AKISNFSLAKIL------MPNQTGIVTGV 671
            +LH +    I H ++ P NIL +        KI +F L   +       P  T  +T  
Sbjct: 125 DFLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTP 181
Query: 672 KGTRGYMSPE-----WQNSGLITVKSDVYSFGVVV 701
            G+  YM+PE        +     + D++S GVV+
Sbjct: 182 CGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 508 RATNGF------EEELGRGCFGAVYKGSICEGNKIVAVKRLE---------NPVEEGERK 552
            +T+GF      +E LGRG    V +       K  AVK ++           V+E    
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 553 FQAEMAAVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDR 609
              E+  +R+ + H N+++L       +   LV++ M KG L + L+     S    R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +R  L+V   I  LH+   + I+H ++ P NILLDD +  K+++F  +  L P +   + 
Sbjct: 130 MRALLEV---ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LR 181
Query: 670 GVKGTRGYMSPEW------QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            V GT  Y++PE        N      + D++S GV++  ++     F
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHKNL 568
           EELG G F  V K          A K ++       R+       + E++ +R+  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E +S G L + L+  ES     +       +  G+ YLH +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTA----KISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQ 683
            +I H ++ P NI+L D        K+ +F LA  +   + G+    + GT  +++PE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIV 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHKNL 568
           EELG G F  V K          A K ++       R+       + E++ +R+  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E +S G L + L+  ES     +       +  G+ YLH +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTA----KISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQ 683
            +I H ++ P NI+L D        K+ +F LA  +   + G+    + GT  +++PE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIV 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 21/195 (10%)
Query: 517 LGRGCFGAVY------KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG+G FG V        G  C   K+++ ++++   ++       E+  +++  H N+++
Sbjct: 57  LGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDK--ESLLREVQLLKQLDHPNIMK 113
Query: 571 LLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  F        LV E  + G L + ++S      +  D  RI   V  GITY+H+    
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLSGITYMHKN--- 168
Query: 630 QIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
           +I+H ++ P N+LL+        +I +F L+     ++   +    GT  Y++PE  + G
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH-G 225
Query: 687 LITVKSDVYSFGVVV 701
               K DV+S GV++
Sbjct: 226 TYDEKCDVWSTGVIL 240

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHKNL 568
           EELG G F  V K          A K ++       R+       + E++ +R+  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E +S G L + L+  ES     +       +  G+ YLH +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTA----KISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQ 683
            +I H ++ P NI+L D        K+ +F LA  +   + G+    + GT  +++PE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIV 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHKNL 568
           EELG G F  V K          A K ++       R+       + E++ +R+  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E +S G L + L+  ES     +       +  G+ YLH +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTA----KISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQ 683
            +I H ++ P NI+L D        K+ +F LA  +   + G+    + GT  +++PE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIV 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 21/195 (10%)
Query: 517 LGRGCFGAVY------KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG+G FG V        G  C   K+++ ++++   ++       E+  +++  H N+++
Sbjct: 58  LGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDK--ESLLREVQLLKQLDHPNIMK 114
Query: 571 LLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  F        LV E  + G L + ++S      +  D  RI   V  GITY+H+    
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLSGITYMHKN--- 169
Query: 630 QIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
           +I+H ++ P N+LL+        +I +F L+     ++   +    GT  Y++PE  + G
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH-G 226
Query: 687 LITVKSDVYSFGVVV 701
               K DV+S GV++
Sbjct: 227 TYDEKCDVWSTGVIL 241

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           + LG G FG V  G        VAVK L            K + E+  ++   H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLL---SNVESGPIWRDRVRIALDVARGITYLHEECE 628
                  +   +V E++S G L + +     VE      +  R+   +   + Y H    
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSAVDYCHRH-- 130
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             ++H ++ P N+LLD  + AKI++F L+ ++   +   +    G+  Y +PE  +  L 
Sbjct: 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRDSCGSPNYAAPEVISGRLY 187
Query: 689 T-VKSDVYSFGVVVLEIVCCRSNFE 712
              + D++S GV++  ++C    F+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           + LG G FG V  G        VAVK L            K + E+  ++   H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLL---SNVESGPIWRDRVRIALDVARGITYLHEECE 628
                  +   +V E++S G L + +     VE      +  R+   +   + Y H    
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSAVDYCHRH-- 130
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             ++H ++ P N+LLD  + AKI++F L+ ++   +   +    G+  Y +PE  +  L 
Sbjct: 131 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLY 187
Query: 689 T-VKSDVYSFGVVVLEIVCCRSNFE 712
              + D++S GV++  ++C    F+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHKNL 568
           EELG G F  V K          A K ++       R+       + E++ +R+  H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L       +  +L+ E +S G L + L+  ES     +       +  G+ YLH +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS-EEEATSFIKQILDGVNYLHTK-- 134
Query: 629 VQIIHCNINPRNILLDDSLTA----KISNFSLAKILMPNQTGI-VTGVKGTRGYMSPEWQ 683
            +I H ++ P NI+L D        K+ +F LA  +   + G+    + GT  +++PE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIV 190
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           N   + +++D++S GV+   ++   S F
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 517 LGRGCFGAVYKG--SICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRL 571
           +G G  G V     +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 572 LG-FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEV 629
           L  F  Q S +     ++    ++  LS V    +  +R+   L  +  GI +LH     
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG-- 146
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            IIH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE        
Sbjct: 147 -IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYK 203
Query: 690 VKSDVYSFGVVVLEIV 705
              D++S GV++ E++
Sbjct: 204 ENVDIWSVGVIMGEMI 219

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +ELGRG F  V +       +  A K L+       R+ Q   A +   H   ++ L   
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKK-----RRRGQDCRAEI--LHEIAVLELAKS 87
Query: 575 CMQ----------TSKKLLVYEFMSKGSLENL-LSNVESGPIWRDRVRIALDVARGITYL 623
           C +          TS+ +L+ E+ + G + +L L  +       D +R+   +  G+ YL
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 624 HEECEVQIIHCNINPRNILLDDSL---TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
           H+     I+H ++ P+NILL         KI +F +++ +       +  + GT  Y++P
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAP 202
Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           E  N   IT  +D+++ G++   ++   S F
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 21/208 (10%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH------KNLVR 570
           +GRG FG V    +   +K+ A+K L     + E   +AE A  R             + 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESG-PIWRDRVRIALDVARGITYLHEECE 628
            L +  Q    L LV ++   G L  LLS  E   P    R  +A ++   I  +H+   
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQ--- 193
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS--- 685
           +  +H +I P NIL+D +   ++++F     LM + T   +   GT  Y+SPE   +   
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 686 --GLITVKSDVYSFGVVVLEIVCCRSNF 711
             G    + D +S GV + E++   + F
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENP-------------VEEGERKFQAEMAAVRR 562
           +LG G +G V       G+   A+K ++               +E+   +   E++ ++ 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGIT 621
             H N+++L           LV EF   G L E +++  +      D   I   +  GI 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC--DAANIMKQILSGIC 160
Query: 622 YLHEECEVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
           YLH+     I+H +I P NILL++    L  KI +F L+     +    +    GT  Y+
Sbjct: 161 YLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYI 215
Query: 679 SPEWQNSGLITVKSDVYSFGVVVLEIVC 706
           +PE         K DV+S GV++  ++C
Sbjct: 216 APEVLKKKY-NEKCDVWSCGVIMYILLC 242

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLE---------NPVEEGERKFQAEMAAVRR-T 563
           +E LGRG    V +       K  AVK ++           V+E       E+  +R+ +
Sbjct: 9   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 68
Query: 564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN--VESGPIWRDRVRIALDVARGIT 621
            H N+++L       +   LV++ M KG L + L+     S    R  +R  L+V   I 
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV---IC 125
Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
            LH+   + I+H ++ P NILLDD +  K+++F  +  L P +   +  V GT  Y++PE
Sbjct: 126 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPE 180
Query: 682 W------QNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                   N      + D++S GV++  ++     F
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +++G G FG        + N++VAVK +E   E+ +   + E+   R   H N+VR    
Sbjct: 24  KDIGSGNFGVARLMRDKQSNELVAVKYIERG-EKIDENVKREIINHRSLRHPNIVRFKEV 82
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
            +  +   +V E+ S G L   + N  +G    D  R     +  G++Y H    +Q+ H
Sbjct: 83  ILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCH---AMQVCH 137
Query: 634 CNINPRNILLDDSLTA--KISNFSLAK--ILMPNQTGIVTGVKGTRGYMSPE----WQNS 685
            ++   N LLD S     KI +F  +K  +L       V    GT  Y++PE     +  
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLKKEYD 193
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFE 712
           G +   +DV+S GV +  ++     FE
Sbjct: 194 GKV---ADVWSCGVTLYVMLVGAYPFE 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G    G + VAVK + +  EE     +AE+       H+N   +L
Sbjct: 46  LQESIGKGRFGEVWRGK-WRGEE-VAVK-IFSSREERSWFREAEIYQTVMLRHEN---IL 99
Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGIT 621
           GF    +K         LV ++   GSL + L+     VE        +++AL  A G+ 
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG------MIKLALSTASGLA 153
Query: 622 YLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---- 672
           +LH E      +  I H ++  +NIL+  + T  I++  LA +   + T  +        
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 212
Query: 673 GTRGYMSPEWQNSGLIT------VKSDVYSFGVVVLEIV 705
           GT+ YM+PE  +  +         ++D+Y+ G+V  EI 
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 84/193 (43%), Gaps = 8/193 (4%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKFQ-AEMAAVRRTHHKNLVRLLG 573
           ++G G +G V+K    +  +IVA+K+ LE+  +   +K    E+  +++  H NLV LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIH 633
              +  +  LV+E+     L  L    + G        I     + + + H+      IH
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIH 125
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ-NSGLITVKS 692
            ++ P NIL+      K+ +F  A++L    +        TR Y SPE            
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 693 DVYSFGVVVLEIV 705
           DV++ G V  E++
Sbjct: 185 DVWAIGCVFAELL 197

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G    G + VAVK + +  EE     +AE+       H+N   +L
Sbjct: 33  LQESIGKGRFGEVWRGK-WRGEE-VAVK-IFSSREERSWFREAEIYQTVMLRHEN---IL 86
Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGIT 621
           GF    +K         LV ++   GSL + L+     VE        +++AL  A G+ 
Sbjct: 87  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG------MIKLALSTASGLA 140
Query: 622 YLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---- 672
           +LH E      +  I H ++  +NIL+  + T  I++  LA +   + T  +        
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 199
Query: 673 GTRGYMSPEWQNSGLIT------VKSDVYSFGVVVLEIV 705
           GT+ YM+PE  +  +         ++D+Y+ G+V  EI 
Sbjct: 200 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G    G + VAVK + +  EE     +AE+       H+N   +L
Sbjct: 8   LQESIGKGRFGEVWRGK-WRGEE-VAVK-IFSSREERSWFREAEIYQTVMLRHEN---IL 61
Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGIT 621
           GF    +K         LV ++   GSL + L+     VE        +++AL  A G+ 
Sbjct: 62  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG------MIKLALSTASGLA 115
Query: 622 YLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---- 672
           +LH E      +  I H ++  +NIL+  + T  I++  LA +   + T  +        
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 174
Query: 673 GTRGYMSPEWQNSGLIT------VKSDVYSFGVVVLEIV 705
           GT+ YM+PE  +  +         ++D+Y+ G+V  EI 
Sbjct: 175 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +++G G FG        + N++VAVK +E   E+ +   + E+   R   H N+VR    
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
            +  +   +V E+ S G L   + N  +G    D  R     +  G++Y H    +Q+ H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCH---AMQVCH 138
Query: 634 CNINPRNILLDDSLTAKIS----NFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQNS 685
            ++   N LLD S   ++      +S + +L       V    GT  Y++PE     +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV----GTPAYIAPEVLLKKEYD 194
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFE 712
           G +   +DV+S GV +  ++     FE
Sbjct: 195 GKV---ADVWSCGVTLYVMLVGAYPFE 218

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +++G G FG        + N++VAVK +E   E+ +   + E+   R   H N+VR    
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKYIER-GEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
            +  +   +V E+ S G L   + N  +G    D  R     +  G++Y H    +Q+ H
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCH---AMQVCH 138
Query: 634 CNINPRNILLDDSLTAKIS----NFSLAKILMPNQTGIVTGVKGTRGYMSPE----WQNS 685
            ++   N LLD S   ++      +S + +L       V    GT  Y++PE     +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLKKEYD 194
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFE 712
           G +   +DV+S GV +  ++     FE
Sbjct: 195 GKV---ADVWSCGVTLYVMLVGAYPFE 218

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G    G + VAVK + +  EE     +AE+       H+N   +L
Sbjct: 10  LQESIGKGRFGEVWRGK-WRGEE-VAVK-IFSSREERSWFREAEIYQTVMLRHEN---IL 63
Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGIT 621
           GF    +K         LV ++   GSL + L+     VE        +++AL  A G+ 
Sbjct: 64  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG------MIKLALSTASGLA 117
Query: 622 YLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---- 672
           +LH E      +  I H ++  +NIL+  + T  I++  LA +   + T  +        
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 176
Query: 673 GTRGYMSPEWQNSGLIT------VKSDVYSFGVVVLEIV 705
           GT+ YM+PE  +  +         ++D+Y+ G+V  EI 
Sbjct: 177 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  LS V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---II 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S GV++ E++
Sbjct: 207 DIWSVGVIMGEMI 219

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 515 EELGRGCFGAVYK-GSICEGN----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           EELG+G F  V +   I  G     KI+  K+L        +K + E    R   H N+V
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLS---ARDHQKLEREARICRLLKHPNIV 66
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHE--- 625
           RL     +     LV++ ++ G L E++++        R+    A D +  I  + E   
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGELFEDIVA--------REYYSEA-DASHCIQQILESVN 117
Query: 626 ECEVQ-IIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
            C +  I+H ++ P N+LL         K+++F LA  +  +Q     G  GT GY+SPE
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF-GFAGTPGYLSPE 176
Query: 682 WQNSGLITVKSDVYSFGVVV 701
                      D+++ GV++
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/236 (22%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F ++LG G F  V            A+KR+    ++   + Q E    R  +H N++RL+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 573 GFCMQ----TSKKLLVYEFMSKGSLENLLSNV--------ESGPIWRDRVRIALDVARGI 620
            +C++      +  L+  F  +G+L N +  +        E   +W     + L + RG+
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGICRGL 147
Query: 621 TYLHEECEVQIIHCNINPRNILLDDS---LTAKISNFSLAKILMPNQTGIVT-----GVK 672
             +H +      H ++ P NILL D    +   + + + A I +      +T       +
Sbjct: 148 EAIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 673 GTRGYMSPEW---QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLST 725
            T  Y +PE    Q+  +I  ++DV+S G V+  ++     +++     D V L+ 
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G    G + VAVK + +  EE     +AE+       H+N   +L
Sbjct: 13  LQESIGKGRFGEVWRGK-WRGEE-VAVK-IFSSREERSWFREAEIYQTVMLRHEN---IL 66
Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGIT 621
           GF    +K         LV ++   GSL + L+     VE        +++AL  A G+ 
Sbjct: 67  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG------MIKLALSTASGLA 120
Query: 622 YLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---- 672
           +LH E      +  I H ++  +NIL+  + T  I++  LA +   + T  +        
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 179
Query: 673 GTRGYMSPEWQNSGLIT------VKSDVYSFGVVVLEIV 705
           GT+ YM+PE  +  +         ++D+Y+ G+V  EI 
Sbjct: 180 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G    G + VAVK + +  EE     +AE+       H+N   +L
Sbjct: 7   LQESIGKGRFGEVWRGK-WRGEE-VAVK-IFSSREERSWFREAEIYQTVMLRHEN---IL 60
Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSN----VESGPIWRDRVRIALDVARGIT 621
           GF    +K         LV ++   GSL + L+     VE        +++AL  A G+ 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG------MIKLALSTASGLA 114
Query: 622 YLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---- 672
           +LH E      +  I H ++  +NIL+  + T  I++  LA +   + T  +        
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRV 173
Query: 673 GTRGYMSPEWQNSGLIT------VKSDVYSFGVVVLEI 704
           GT+ YM+PE  +  +         ++D+Y+ G+V  EI
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 26/200 (13%)
Query: 515 EELGRGCFGAVYK-GSICEGN----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           EELG+G F  V +   I  G     KI+  K+L        +K + E    R   H N+V
Sbjct: 10  EELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA---RDHQKLEREARICRLLKHPNIV 66
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHE--- 625
           RL     +     LV++ ++ G L E++++        R+    A D +  I  + E   
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGELFEDIVA--------REYYSEA-DASHCIQQILESVN 117
Query: 626 ECEVQ-IIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
            C +  I+H ++ P N+LL         K+++F LA  +  +Q     G  GT GY+SPE
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF-GFAGTPGYLSPE 176
Query: 682 WQNSGLITVKSDVYSFGVVV 701
                      D+++ GV++
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER---KFQAEMAAVRRTHHKNLVRL 571
           +++G G FG        + N++VAVK     +E GE+     + E+   R   H N+VR 
Sbjct: 25  KDIGSGNFGVARLMRDKQSNELVAVKY----IERGEKIAANVKREIINHRSLRHPNIVRF 80
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
               +  +   +V E+ S G L   + N  +G    D  R     +  G++Y H    +Q
Sbjct: 81  KEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCH---AMQ 135
Query: 631 IIHCNINPRNILLDDSLTA--KISNFSLAK--ILMPNQTGIVTGVKGTRGYMSPE----W 682
           + H ++   N LLD S     KI +F  +K  +L       V    GT  Y++PE     
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLKK 191
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           +  G +   +DV+S GV +  ++     FE
Sbjct: 192 EYDGKV---ADVWSCGVTLYVMLVGAYPFE 218

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F +++G G FG           ++VAVK +E      E   Q E+   R   H N+VR  
Sbjct: 24  FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFK 82
Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
              +  +   ++ E+ S G L   + N  +G    D  R     +  G++Y H    +QI
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCH---SMQI 137
Query: 632 IHCNINPRNILLDDSLTA--KISNFSLAK--ILMPNQTGIVTGVKGTRGYMSPE----WQ 683
            H ++   N LLD S     KI +F  +K  +L       V    GT  Y++PE     +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLRQE 193
Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
             G I   +DV+S GV +  ++     FE
Sbjct: 194 YDGKI---ADVWSCGVTLYVMLVGAYPFE 219

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 517 LGRGCFGAVY------KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           LG+G FG V        G  C   K+++ ++++   ++       E+  +++  H N+ +
Sbjct: 34  LGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDK--ESLLREVQLLKQLDHPNIXK 90
Query: 571 LLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  F        LV E  + G L + ++S      +  D  RI   V  GITY H+    
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLSGITYXHKN--- 145
Query: 630 QIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
           +I+H ++ P N+LL+        +I +F L+     ++        GT  Y++PE  + G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--XKDKIGTAYYIAPEVLH-G 202
Query: 687 LITVKSDVYSFGVVV 701
               K DV+S GV++
Sbjct: 203 TYDEKCDVWSTGVIL 217

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 82/196 (41%), Gaps = 16/196 (8%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG G +G V+K    E  ++ AVKR  +P    ++  RK     +  +   H   VRL  
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 574 FCMQTSKKLLVYEFMS---KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
              +     L  E      +   E   +++    +W   +R   D    + +LH +    
Sbjct: 125 AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVW-GYLR---DTLLALAHLHSQG--- 177
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           ++H ++ P NI L      K+ +F L   L     G V   +G   YM+PE    G    
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ--EGDPRYMAPELLQ-GSYGT 234
Query: 691 KSDVYSFGVVVLEIVC 706
            +DV+S G+ +LE+ C
Sbjct: 235 AADVFSLGLTILEVAC 250

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 28/209 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG V++  + E ++ VA+K+    V + +R    E+  +R   H N+V L  F  
Sbjct: 48  IGNGSFGVVFQAKLVESDE-VAIKK----VLQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 577 QTSKKL------LVYEFMSKG---SLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
               K       LV E++ +    +  +     ++ P+   ++ +   + R + Y+H   
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM-YQLLRSLAYIH--- 158
Query: 628 EVQIIHCNINPRNILLD-DSLTAKISNFSLAKILM---PNQTGIVTGVKGTRGYMSPEWQ 683
            + I H +I P+N+LLD  S   K+ +F  AKIL+   PN + I      +R Y +PE  
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC-----SRYYRAPELI 213
Query: 684 -NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
             +   T   D++S G V+ E++  +  F
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E +G+G +G V++G +  G   VAVK   +  E+   + + E+       H N++  +  
Sbjct: 14  ECVGKGRYGEVWRG-LWHGES-VAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIAS 70
Query: 575 CM----QTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC--- 627
            M     +++  L+  +   GSL + L      P     +R+A+  A G+ +LH E    
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP--HLALRLAVSAACGLAHLHVEIFGT 128
Query: 628 --EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---GTRGYMSPEW 682
             +  I H +   RN+L+  +L   I++  LA +       +  G     GT+ YM+PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 683 QNSGLIT------VKSDVYSFGVVVLEI 704
            +  + T        +D+++FG+V+ EI
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
            +G   A Y  +I E N  VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 30  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 86
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      IIH
Sbjct: 87  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIH 143
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           D
Sbjct: 144 RDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVD 201
Query: 694 VYSFGVVVLEIVCCRSNF 711
           ++S G ++ E+VC +  F
Sbjct: 202 LWSVGCIMGEMVCHKILF 219

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E M    +++L   + E G +  +  R     V   + + H  
Sbjct: 76  IRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 132
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 133 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 187
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
            +G   A Y  +I E N  VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 41  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 97
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      IIH
Sbjct: 98  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIH 154
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           D
Sbjct: 155 RDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVD 212
Query: 694 VYSFGVVVLEIVCCRSNF 711
           ++S G ++ E+VC +  F
Sbjct: 213 LWSVGCIMGEMVCHKILF 230

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +       KIV    L  P +    K   E++  R   H+++V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 80
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEV 629
            GF        +V E   + SL  L    +  + P  R  +R    +  G  YLH     
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN--- 134
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           ++IH ++   N+ L++ L  KI +F LA K+    +   V  + GT  Y++PE  +    
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVN 714
           + + DV+S G ++  ++  +  FE +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLN 90
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHSAG---I 147
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +       KIV    L  P +    K   E++  R   H+++V  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 104
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEV 629
            GF        +V E   + SL  L    +  + P  R  +R    +  G  YLH     
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN--- 158
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           ++IH ++   N+ L++ L  KI +F LA K+    +   V  + GT  Y++PE  +    
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 216
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVN 714
           + + DV+S G ++  ++  +  FE +
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRLENP--VEEGE--RKFQAEMAAVRRTHHKNLV 569
           LG G +G V+   K S  +  K+ A+K L+    V++ +     + E   +        +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
             L +  QT  KL L+ ++++ G L   LS  E        V+I + ++   + +LH+  
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK-- 177
Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
            + II+ +I   NILLD +    +++F L+K  + ++T       GT  YM+P+    G 
Sbjct: 178 -LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 236
Query: 688 ITVKS--DVYSFGVVVLEIVCCRSNFEVN 714
                  D +S GV++ E++   S F V+
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVD 265

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           +++G+G +G V+ G    G K VAVK      EE     + E+       H+N+   LGF
Sbjct: 43  KQIGKGRYGEVWMGK-WRGEK-VAVKVFFT-TEEASWFRETEIYQTVLMRHENI---LGF 96
Query: 575 CMQTSKK-------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
                K         L+ ++   GSL + L +       +  +++A     G+ +LH E 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA--KSMLKLAYSSVSGLCHLHTEI 154
Query: 628 -----EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP--NQTGIVTGVK-GTRGYMS 679
                +  I H ++  +NIL+  + T  I++  LA   +   N+  I    + GT+ YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 680 PEWQNSGL------ITVKSDVYSFGVVVLEI 704
           PE  +  L        + +D+YSFG+++ E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +       KIV    L  P +    K   E++  R   H+++V  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 106
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEV 629
            GF        +V E   + SL  L    +  + P  R  +R    +  G  YLH     
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN--- 160
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           ++IH ++   N+ L++ L  KI +F LA K+    +   V  + GT  Y++PE  +    
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218
Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVN 714
           + + DV+S G ++  ++  +  FE +
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 495 EFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQ 554
           +F+ Q+   GEL          L  G F  VY+       +  A+KRL +  EE  R   
Sbjct: 17  DFVGQTVELGELRLRVRRV---LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73
Query: 555 AEMAAVRR-THHKNLVRLLGFCMQTS----------KKLLVYEFMSKGSLENLLSNVES- 602
            E+  +++ + H N+V+   FC   S           + L+   + KG L   L  +ES 
Sbjct: 74  QEVCFMKKLSGHPNIVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR 130
Query: 603 GPIWRDRV-RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
           GP+  D V +I     R + ++H + +  IIH ++   N+LL +  T K+ +F  A
Sbjct: 131 GPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 17/200 (8%)
Query: 515 EELGRGCFGAVYKGSICEGN-----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E +G+G F  V +    E       KIV V +  +         + E +      H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRV--RIALDVARGITYLHEE 626
            LL          +V+EFM    L   ++   ++G ++ + V       +   + Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 627 CEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVK-GTRGYMSPEW 682
               IIH ++ P N+LL   ++S   K+ +F +A  L   ++G+V G + GT  +M+PE 
Sbjct: 150 ---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFMAPEV 204
Query: 683 QNSGLITVKSDVYSFGVVVL 702
                     DV+  GV++ 
Sbjct: 205 VKREPYGKPVDVWGCGVILF 224

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           +G G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+M  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     K+++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +       KIV    L  P +    K   E++  R   H+++V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEV 629
            GF        +V E   + SL  L    +  + P  R  +R    +  G  YLH     
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN--- 136
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           ++IH ++   N+ L++ L  KI +F LA  +  +     T + GT  Y++PE  +    +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
            + DV+S G ++  ++  +  FE +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           +G G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+M  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     K+++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +       KIV    L  P +    K   E++  R   H+++V  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 86
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEV 629
            GF        +V E   + SL  L    +  + P  R  +R    +  G  YLH     
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN--- 140
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           ++IH ++   N+ L++ L  KI +F LA  +  +     T + GT  Y++PE  +    +
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
            + DV+S G ++  ++  +  FE +
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLAGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 517 LGRGCFGAVYKGSICE-----GNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +       KIV    L  P +    K   E++  R   H+++V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 82
Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEV 629
            GF        +V E   + SL  L    +  + P  R  +R    +  G  YLH     
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR---QIVLGCQYLHRN--- 136
Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           ++IH ++   N+ L++ L  KI +F LA  +  +     T + GT  Y++PE  +    +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN 714
            + DV+S G ++  ++  +  FE +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLXGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE----NPVEEGERKFQAEMAAVRRTHHKNL 568
            ++ +G+G F  V         + VAVK ++    NP     +K   E+  ++  +H N+
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPT--SLQKLFREVRIMKILNHPNI 76
Query: 569 VRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEE 626
           V+L    ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++
Sbjct: 77  VKLFE-VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQK 133
Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQN 684
               I+H ++   N+LLD  +  KI++F  + +  + N+        G+  Y +PE +Q 
Sbjct: 134 Y---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC---GSPPYAAPELFQG 187
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                 + DV+S GV++  +V     F+
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  LS V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG---II 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E++
Sbjct: 207 DIWSVGCIMGEMI 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGI 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 141 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 199 VDIWSVGCIMGEMV 212

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLN 90
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 147
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLN 90
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 147
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE----NPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           +G+G F  V         + VA+K ++    NP     +K   E+  ++  +H N+V+L 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT--SLQKLFREVRIMKILNHPNIVKLF 80
Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
              ++T K L L+ E+ S G + + L  V  G +     R     +   + Y H++   +
Sbjct: 81  E-VIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQK---R 134
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLIT 689
           I+H ++   N+LLD  +  KI++F  +        G +    G   Y +PE +Q      
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
            + DV+S GV++  +V     F+
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 90
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGI 147
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 206 VDIWSVGCIMGEMV 219

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  LS V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E++
Sbjct: 207 DIWSVGCIMGEMI 219

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 87
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 145
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D+    ++++F  AK +     G    + GT  Y++PE   
Sbjct: 146 S---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 198
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 133
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 134 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 188
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLGF 574
           LG G +G V   +     +IVA+K++E P ++     +   E+  ++   H+N++ +   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--VRIALDVARGITYLHEECEVQII 632
               S +     ++ +  ++  L  V S  +  D           R +  LH      +I
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVI 134
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKIL----------MPNQTGIVTGVKGTRGYMSPEW 682
           H ++ P N+L++ +   K+ +F LA+I+             Q+G+V  V  TR Y +PE 
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV-ATRWYRAPEV 193
Query: 683 Q-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
              S   +   DV+S G ++ E+   R  F
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 95
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 153
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 154 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 206
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 11/218 (5%)
Query: 493 SQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEG 549
           SQ+  +   S    + +   F + +G+G FG V            AVK L+      ++ 
Sbjct: 22  SQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE 81
Query: 550 ERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD 608
           E+   +E   + +      +  L F  QT+ KL  V ++++ G L   L           
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEP 139
Query: 609 RVRI-ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
           R R  A ++A  + YLH    + I++ ++ P NILLD      +++F L K  + + +  
Sbjct: 140 RARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196
Query: 668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            T   GT  Y++PE  +        D +  G V+ E++
Sbjct: 197 STFC-GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE----NPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           +G+G F  V         + VA+K ++    NP     +K   E+  ++  +H N+V+L 
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPT--SLQKLFREVRIMKILNHPNIVKLF 77
Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
              ++T K L L+ E+ S G + + L  V  G +     R     +   + Y H++   +
Sbjct: 78  E-VIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSAVQYCHQK---R 131
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLIT 689
           I+H ++   N+LLD  +  KI++F  +        G +    G+  Y +PE +Q      
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
            + DV+S GV++  +V     F+
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 9/193 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG- 573
           +G G  G V        ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 186
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E+V
Sbjct: 245 DIWSVGCIMGEMV 257

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
               ++H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 128
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 129 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 128
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 129 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 183
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++     TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIVCCRSNF 711
           D++S G ++ E+VC +  F
Sbjct: 207 DIWSVGCIMGEMVCHKILF 225

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 121
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 179
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 232
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKAFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 175
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 176 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 230
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 121
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 179
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPEIIL 232
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 161
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 162 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 216
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 133
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 134 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 188
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 161
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 162 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 216
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 132
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 133 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 187
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFAEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 160
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 161 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 215
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  LS V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E++
Sbjct: 207 DIWSVGCIMGEMI 219

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 75  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 131
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 132 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 186
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 133
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 134 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 188
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 148
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 149 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 203
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 147
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 148 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 202
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 161
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 162 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 216
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 160
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 161 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 215
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 99  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 155
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 156 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 210
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 11/174 (6%)
Query: 537 VAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG-FCMQTSKKLLVYEFMSKGS 592
           VAVK+L  P +     +R ++ E+  ++  +HKN++ LL  F  Q + +     ++    
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 593 LENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI 651
           ++  L  V    +  +R+   L  +  GI +LH      IIH ++ P NI++    T KI
Sbjct: 111 MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI 167
Query: 652 SNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +F LA+    N   ++T    TR Y +PE           D++S G ++ E+V
Sbjct: 168 LDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 160
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 161 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 215
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 161
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 162 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 216
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K +E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+   G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+++D     K+++F LAK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 147
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 148 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 202
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 14/193 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  LS V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E++
Sbjct: 207 DIWSVGCIMGEMI 219

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 160
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 161 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 215
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 93
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 151
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 204
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 148
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 149 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 203
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 148
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 149 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 203
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G F  V         K VAVK ++         +K   E+  ++  +H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE- 80
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
            ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++    I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 633 HCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++   N+LLD  +  KI++F  + +    N+        G+  Y +PE +Q       
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYDGP 192
Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + DV+S GV++  +V     F+
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 175
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 176 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 230
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G F  V         K VAVK ++         +K   E+  ++  +H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE- 80
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
            ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++    I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 633 HCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++   N+LLD  +  KI++F  + +    N+        G+  Y +PE +Q       
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYDGP 192
Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + DV+S GV++  +V     F+
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 46/290 (15%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF------QAEMAAVRRT----HHK 566
           LG+G FG V+ G        VA+K +      G            E+A + +      H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVRIAL-DVARGITYLH 624
            ++RLL +       +LV E       ++L   + E GP+     R     V   I + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLE--RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156
Query: 625 EECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW- 682
                 ++H +I   NIL+D     AK+ +F    +L        T   GTR Y  PEW 
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPEWI 210
Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
                  + + V+S G+++ ++VC    FE +      +L +   +   ++ +   L+  
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----ILEAELHFPAHVSPDCCALIRR 266
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPI 792
                             C+  +P+ RPS++ +  +L+  M+ P    P+
Sbjct: 267 ------------------CLAPKPSSRPSLEEI--LLDPWMQTPAEDVPL 296

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 9/193 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG- 573
           +G G  G V        ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 130 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 186
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E+V
Sbjct: 245 DIWSVGCIMGEMV 257

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 124 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 180
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 181 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 235
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG 573
           +LG G +G VYK      N+ VA+KR+    EE      A  E++ ++   H+N++ L  
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEECEVQI 631
                 +  L++E+       +L   ++  P    RV       +  G+ + H     + 
Sbjct: 101 VIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RC 153
Query: 632 IHCNINPRNILL---DDSLTA--KISNFSLAK 658
           +H ++ P+N+LL   D S T   KI +F LA+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGE----RKFQAEMAAVRR--THHKNL 568
           LG G FG+VY G     N  VA+K +E     + GE     +   E+  +++  +    +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARGITYLHEE 626
           +RLL +  +    +L+ E      +++L   + E G +  +  R     V   + + H  
Sbjct: 111 IRLLDWFERPDSFVLILE--RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH-N 167
Query: 627 CEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
           C V  +H +I   NIL+D +    K+ +F    +L   +  + T   GTR Y  PEW   
Sbjct: 168 CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRY 222
Query: 686 GLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +S  V+S G+++ ++VC    FE
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFXEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ++G+G FG V+K    +  + VA+K+  +EN  E        E+  ++   H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 574 FCMQTSKK--------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
            C   +           LV++F  +  L  LLSNV       +  R+   +  G+ Y+H 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 143
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
               +I+H ++   N+L+      K+++F LA+
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK------NLVR 570
           +GRG FG V    +    +I A+K L N  E  +R   AE A  R             + 
Sbjct: 98  IGRGAFGEVAVVKMKNTERIYAMKIL-NKWEMLKR---AETACFREERDVLVNGDCQWIT 153
Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECE 628
            L +  Q    L LV ++   G L  LLS  E   +  D  R  + ++   I  +H+   
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGGDLLTLLSKFED-KLPEDMARFYIGEMVLAIDSIHQ--- 209
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGTRGYMSPEWQNS- 685
           +  +H +I P N+LLD +   ++++F     L  N  G V      GT  Y+SPE   + 
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADF--GSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 686 ----GLITVKSDVYSFGVVVLEIVCCRSNF 711
               G    + D +S GV + E++   + F
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-----------RKFQAEMAAVRRTHH 565
           +  G +GAV  G   EG   VA+KR+ N V +G            ++   E+  +   HH
Sbjct: 30  ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITY--- 622
            N++ L    +   +  +   ++    +   L+ V    I   R+ I+    +   Y   
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV----IHDQRIVISPQHIQYFMYHIL 144
Query: 623 --LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK--ILMPNQTGIVTGVKGTRGYM 678
             LH   E  ++H +++P NILL D+    I +F+LA+      N+T  VT     R Y 
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYR 200
Query: 679 SPE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +PE   Q  G  T   D++S G V+ E+   ++ F
Sbjct: 201 APELVMQFKGF-TKLVDMWSAGCVMAEMFNRKALF 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 91
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 148
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 207 VDIWSVGCIMGEMV 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ++G+G FG V+K    +  + VA+K+  +EN  E        E+  ++   H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 574 FCMQTSKK--------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
            C   +           LV++F  +  L  LLSNV       +  R+   +  G+ Y+H 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 143
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
               +I+H ++   N+L+      K+++F LA+
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ++G+G FG V+K    +  + VA+K+  +EN  E        E+  ++   H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 574 FCMQTSKK--------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
            C   +           LV++F  +  L  LLSNV       +  R+   +  G+ Y+H 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 143
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
               +I+H ++   N+L+      K+++F LA+
Sbjct: 144 N---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 84
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 85  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 141
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 200 VDIWSVGCIMGEMV 213

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/287 (21%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           +G G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     K+++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 14/153 (9%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
           ++G+G FG V+K    +  + VA+K+  +EN  E        E+  ++   H+N+V L+ 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 574 FCMQTSKK--------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
            C   +           LV++F  +  L  LLSNV       +  R+   +  G+ Y+H 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
               +I+H ++   N+L+      K+++F LA+
Sbjct: 143 N---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G F  V         K VAVK ++         +K   E+  ++  +H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE- 80
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
            ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++    I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 633 HCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++   N+LLD  +  KI++F  + +    N+   +    G   Y +PE +Q       
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAPELFQGKKYDGP 192
Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + DV+S GV++  +V     F+
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLGF 574
           LG G +G V   +     +IVA+K++E P ++     +   E+  ++   H+N++ +   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--VRIALDVARGITYLHEECEVQII 632
               S +     ++ +  ++  L  V S  +  D           R +  LH      +I
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVI 134
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKIL----------MPNQTGIVTGVKGTRGYMSPEW 682
           H ++ P N+L++ +   K+ +F LA+I+             Q+G+   V  TR Y +PE 
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV-ATRWYRAPEV 193
Query: 683 Q-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
              S   +   DV+S G ++ E+   R  F
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 140
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 199 VDIWSVGCIMGEMV 212

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
            +G   A Y  +I E N  VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      IIH
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIH 149
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NI++    T KI +F LA+      + ++     TR Y +PE           D
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYRAPEVILGMGYKENVD 207
Query: 694 VYSFGVVVLEIVCCRSNF 711
           ++S G ++ E+VC +  F
Sbjct: 208 LWSVGCIMGEMVCHKILF 225

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE-----------RKFQAEMAAVRRTHH 565
           +  G +GAV  G   EG   VA+KR+ N V +G            ++   E+  +   HH
Sbjct: 30  ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITY--- 622
            N++ L    +   +  +   ++    +   L+ V    I   R+ I+    +   Y   
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV----IHDQRIVISPQHIQYFMYHIL 144
Query: 623 --LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK--ILMPNQTGIVTGVKGTRGYM 678
             LH   E  ++H +++P NILL D+    I +F+LA+      N+T  VT     R Y 
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYR 200
Query: 679 SPE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           +PE   Q  G  T   D++S G V+ E+   ++ F
Sbjct: 201 APELVMQFKGF-TKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 9/193 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG- 573
           +G G  G V        ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 91  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 147
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 148 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 205
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E+V
Sbjct: 206 DIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 9/193 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG- 573
           +G G  G V        ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E+V
Sbjct: 207 DIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 9/193 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG- 573
           +G G  G V        ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E+V
Sbjct: 207 DIWSVGCIMGEMV 219

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 93
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 151
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 204
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 9/193 (4%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG- 573
           +G G  G V        ++ VA+K+L  P +      +A  E+  ++  +HKN++ LL  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 142
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 143 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 200
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E+V
Sbjct: 201 DIWSVGCIMGEMV 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 25/210 (11%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHK------NLVR 570
           +GRG FG V    +    +I A+K L N  E  +R   AE A  R             + 
Sbjct: 82  IGRGAFGEVAVVKMKNTERIYAMKIL-NKWEMLKR---AETACFREERDVLVNGDCQWIT 137
Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECE 628
            L +  Q    L LV ++   G L  LLS  E   +  D  R  + ++   I  +H+   
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGGDLLTLLSKFED-KLPEDMARFYIGEMVLAIDSIHQ--- 193
Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG--VKGTRGYMSPEWQNS- 685
           +  +H +I P N+LLD +   ++++F     L  N  G V      GT  Y+SPE   + 
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADF--GSCLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 686 ----GLITVKSDVYSFGVVVLEIVCCRSNF 711
               G    + D +S GV + E++   + F
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 86
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 144
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIIL 197
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 11/194 (5%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG 573
           +G G  G V        ++ VA+K+L  P +     +R ++ E+  ++  +HKN++ LL 
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 91
Query: 574 -FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQI 631
            F  Q + +     ++    ++  L  V    +  +R+   L  +  GI +LH      I
Sbjct: 92  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGI 148
Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE          
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 692 SDVYSFGVVVLEIV 705
            D++S G ++ E+V
Sbjct: 207 VDIWSVGCIMGEMV 220

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 37/211 (17%)
Query: 517 LGRGCFGAVYKGSICE-GNKIVAVKRLENPVEEGERKF-----------------QAEMA 558
           L +G F  +    +CE  NK  A+K+ E  + E +R F                 + E+ 
Sbjct: 39  LNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSL---ENLLSNVESG-----PIWRDRV 610
            +    ++  +   G      +  ++YE+M   S+   +     ++       PI   + 
Sbjct: 96  IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 611 RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG 670
            I   V    +Y+H E    I H ++ P NIL+D +   K+S+F  ++ ++  +   + G
Sbjct: 156 -IIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK---IKG 209
Query: 671 VKGTRGYMSPEW--QNSGLITVKSDVYSFGV 699
            +GT  +M PE+    S     K D++S G+
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 20/210 (9%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLGF 574
           LG G +G V   +     +IVA+K++E P ++     +   E+  ++   H+N++ +   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR--VRIALDVARGITYLHEECEVQII 632
               S +     ++ +  ++  L  V S  +  D           R +  LH      +I
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS---NVI 134
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKIL----------MPNQTGIVTGVKGTRGYMSPEW 682
           H ++ P N+L++ +   K+ +F LA+I+             Q+G+   V  TR Y +PE 
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV-ATRWYRAPEV 193
Query: 683 Q-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
              S   +   DV+S G ++ E+   R  F
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAELFLRRPIF 223

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 121
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 179
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 232
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G F  V         K VAVK ++         +K   E+  ++  +H N+V+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE- 73
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
            ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++    I+
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFRQIVSAVQYCHQKF---IV 128
Query: 633 HCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++   N+LLD  +  KI++F  + +    N+        G+  Y +PE +Q       
Sbjct: 129 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYDGP 185
Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + DV+S GV++  +V     F+
Sbjct: 186 EVDVWSLGVILYTLVSGSLPFD 207

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G F  V         K VAV+ ++         +K   E+  ++  +H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE- 80
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
            ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++    I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 633 HCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++   N+LLD  +  KI++F  + +    N+        G+  Y +PE +Q       
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQGKKYDGP 192
Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + DV+S GV++  +V     F+
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 29/207 (14%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K +E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+   G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+++D     ++++F LAK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNF 711
           S       D ++ GV++ E+      F
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNE-KRIQQA-------VNF 101
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+   G + + L  +  G       R  A  +     YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 159
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     K+++F  AK +     G    + GT  Y++PE   
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----KGRTWXLCGTPEYLAPEIIL 212
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 272
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 273 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 317

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ ++      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G F   Y+ +  +  ++ A K +   +      + K   E+A  +   + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQI 631
           F        +V E   + SL  L    +  + P  R  +R  +   +G+ YLH     ++
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---RV 147
Query: 632 IHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           IH ++   N+ L+D +  KI +F LA KI    +      + GT  Y++PE       + 
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KDLCGTPNYIAPEVLCKKGHSF 205
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVN 714
           + D++S G ++  ++  +  FE +
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETS 229

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 14/193 (7%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG- 573
            +G   A Y  +I E N  VA+K+L  P +     +R ++ E+  ++  +HKN++ LL  
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV 91
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
           F  Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      II
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGII 148
Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           
Sbjct: 149 HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 693 DVYSFGVVVLEIV 705
           D++S G ++ E++
Sbjct: 207 DIWSVGCIMGEMI 219

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G F   Y+ +  +  ++ A K +   +      + K   E+A  +   + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQI 631
           F        +V E   + SL  L    +  + P  R  +R  +   +G+ YLH     ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---RV 163
Query: 632 IHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           IH ++   N+ L+D +  KI +F LA KI    +      + GT  Y++PE       + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KDLCGTPNYIAPEVLCKKGHSF 221
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVN 714
           + D++S G ++  ++  +  FE +
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 11/174 (6%)
Query: 537 VAVKRLENPVE---EGERKFQAEMAAVRRTHHKNLVRLLG-FCMQTSKKLLVYEFMSKGS 592
           VAVK+L  P +     +R ++ E+  ++  +HKN++ LL  F  Q + +     ++    
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 108
Query: 593 LENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI 651
           ++  L  V    +  +R+   L  +  GI +LH      IIH ++ P NI++    T KI
Sbjct: 109 MDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKI 165
Query: 652 SNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +F LA+    N   ++T    TR Y +PE           D++S G ++ E+V
Sbjct: 166 LDFGLARTASTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 517 LGRGCFGAVYKG--SICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
           +G G  G V     +I E N  VA+K+L  P +      +A  E+  ++  +HKN++ LL
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 573 G-FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQ 630
             F  Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AG 147
Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           IIH ++ P NI++    T KI +F LA+      + ++T    TR Y +PE         
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKE 205
Query: 691 KSDVYSFGVVVLEIV 705
             D++S G ++ E++
Sbjct: 206 NVDIWSVGCIMGEMI 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G F   Y+ +  +  ++ A K +   +      + K   E+A  +   + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQI 631
           F        +V E   + SL  L    +  + P  R  +R  +   +G+ YLH     ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---RV 163
Query: 632 IHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           IH ++   N+ L+D +  KI +F LA KI    +      + GT  Y++PE       + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KXLCGTPNYIAPEVLCKKGHSF 221
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVN 714
           + D++S G ++  ++  +  FE +
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G F   Y+ +  +  ++ A K +   +      + K   E+A  +   + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVE--SGPIWRDRVRIALDVARGITYLHEECEVQI 631
           F        +V E   + SL  L    +  + P  R  +R  +   +G+ YLH     ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---RV 163
Query: 632 IHCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           IH ++   N+ L+D +  KI +F LA KI    +      + GT  Y++PE       + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KTLCGTPNYIAPEVLCKKGHSF 221
Query: 691 KSDVYSFGVVVLEIVCCRSNFEVN 714
           + D++S G ++  ++  +  FE +
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLLGF 574
           +G+G F  V         K VAV+ ++         +K   E+  ++  +H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE- 80
Query: 575 CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQII 632
            ++T K L LV E+ S G + + L  V  G +     R     +   + Y H++    I+
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFRQIVSAVQYCHQKF---IV 135
Query: 633 HCNINPRNILLDDSLTAKISNFSLA-KILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           H ++   N+LLD  +  KI++F  + +    N+   +    G+  Y +PE +Q       
Sbjct: 136 HRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGP 192
Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + DV+S GV++  +V     F+
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFD 214

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 12/192 (6%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
            +G   A Y  +I E N  VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      IIH
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIH 149
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           D
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 694 VYSFGVVVLEIV 705
           ++S G ++ E++
Sbjct: 208 IWSVGCIMGEMI 219

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           +   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           +   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKDGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 12/192 (6%)
Query: 518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLLG-F 574
            +G   A Y  +I E N  VA+K+L  P +      +A  E+  ++  +HKN++ LL  F
Sbjct: 36  AQGIVCAAY-DAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92
Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEECEVQIIH 633
             Q S +     ++    ++  L  V    +  +R+   L  +  GI +LH      IIH
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIH 149
Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSD 693
            ++ P NI++    T KI +F LA+      + ++T    TR Y +PE           D
Sbjct: 150 RDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRYYRAPEVILGMGYKENVD 207
Query: 694 VYSFGVVVLEIV 705
           ++S G ++ E++
Sbjct: 208 IWSVGCIMGEMI 219

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           +   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E++  G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++PE   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 101/234 (43%), Gaps = 24/234 (10%)
Query: 515 EELGRGCFGAVYK-----GSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E+LGRG FG V++            K V VK  +  +       + E++ +    H+N++
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNIARHRNIL 64
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
            L        + ++++EF+S   +   ++        R+ V     V   + +LH     
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 630 QIIHCNINPRNILLDD--SLTAKISNFSLAKILMP--NQTGIVTGVKGTRGYMSPEWQNS 685
            I H +I P NI+     S T KI  F  A+ L P  N   + T  +    Y +PE    
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE----YYAPEVHQH 177
Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELS 737
            +++  +D++S G +V  ++   + F  E N    + ++ + + ++    KE+S
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 514 EEELGRGCFGAV-YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E+ LG G  G V ++GS     + VAVKR+   ++  +              H N++R  
Sbjct: 20  EKILGYGSSGTVVFQGSF--QGRPVAVKRML--IDFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 573 GFCMQTSKKLLVYEFM-----------SKG-SLENLLSNVESGPIWRDRVRIALDVARGI 620
            +C +T+ + L                SK  S ENL    E  PI      +   +A G+
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-----SLLRQIASGV 128
Query: 621 TYLHEECEVQIIHCNINPRNILLDDS-------------LTAKISNFSLAKILMPNQTGI 667
            +LH    ++IIH ++ P+NIL+  S             L   IS+F L K L   Q+  
Sbjct: 129 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 668 VTGVK---GTRGYMSPE-------WQNSGLITVKSDVYSFGVVVLEIV 705
            T +    GT G+ +PE        Q    +T   D++S G V   I+
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/287 (20%), Positives = 119/287 (41%), Gaps = 33/287 (11%)
Query: 517 LGRGCFGAV-----------YKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           LG G FG V           Y   I +  K+V +K++E+ + E +R  QA        + 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRILQA-------VNF 100
Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLH 624
             LV+L       S   +V E+++ G + + L  +  G       R  A  +     YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH 158
Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
               + +I+ ++ P N+L+D     ++++F  AK +     G    + GT  Y++P    
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPAIIL 211
Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGE 742
           S       D ++ GV++ E+      F  +  +   + ++     +    + +L  L+  
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271
Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVP 789
             +VDL      ++ G+  I++      +  + I + +  +E P +P
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF--ATTDWIAIYQRKVEAPFIP 316

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 516 ELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL-----VR 570
           ++G G FG V      +  K  AVK + N +++  R  + E   +++  + ++     V+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
             G  M      L++E +     E +  N  +G    D     +++ + + YL +   + 
Sbjct: 101 YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MS 157
Query: 631 IIHCNINPRNILLDDSLTAK-------ISNFSLAKILMPNQTGIVT-------------- 669
           + H ++ P NILLDD    K       +++    +I     TGI                
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217
Query: 670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
            +  TR Y +PE   +    V SD++SFG V+ E+
Sbjct: 218 SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 19/167 (11%)
Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR----- 609
           A    +RR    +    +G    +S K+ +Y  M     ENL   +       DR     
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166
Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK----------I 659
           + I + +A  + +LH +    ++H ++ P NI        K+ +F L            +
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 660 LMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           L P        G  GT+ YMSPE  +    + K D++S G+++ E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 515 EELGRGCFGAVYKGSICEGN-----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E +G+G F  V +    E       KIV V +  +         + E +      H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRV--RIALDVARGITYLHEE 626
            LL          +V+EFM    L   ++   ++G ++ + V       +   + Y H+ 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 627 CEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVK-GTRGYMSPEW 682
               IIH ++ P  +LL   ++S   K+  F +A  L   ++G+V G + GT  +M+PE 
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEV 204
Query: 683 QNSGLITVKSDVYSFGVVVL 702
                     DV+  GV++ 
Sbjct: 205 VKREPYGKPVDVWGCGVILF 224

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 515 EELGRGCFGAVYKGSICEGN-----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLV 569
           E +G+G F  V +    E       KIV V +  +         + E +      H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 570 RLLGFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIWRDRV--RIALDVARGITYLHEE 626
            LL          +V+EFM    L   ++   ++G ++ + V       +   + Y H+ 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 151
Query: 627 CEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVK-GTRGYMSPEW 682
               IIH ++ P  +LL   ++S   K+  F +A  L   ++G+V G + GT  +M+PE 
Sbjct: 152 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEV 206
Query: 683 QNSGLITVKSDVYSFGVVVL 702
                     DV+  GV++ 
Sbjct: 207 VKREPYGKPVDVWGCGVILF 226

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	811
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-108
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-94
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-69
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-58
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-55
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-54
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-38
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-36
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-34
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-33
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-26
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-26
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-25
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-24
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-19
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-19
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-18
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-17
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-16
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-15
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-14
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-13
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-13
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-13
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-13
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-12
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-12
3m7h_A	276	Putidacin L1; monocot mannose-binding lectin, bact	2e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-09
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	2e-09
1dlp_A	236	Lectin scafet precursor; two-domain lectin, beta p	4e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-09
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-09
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	1e-06
3a0c_A	110	Mannose/sialic acid-binding lectin; beta-prism II,	8e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-06
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	2e-06
2dpf_A	115	Curculin; sweet taste, taste modifying, plant prot	2e-04
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	5e-06
1b2p_A	119	Protein (lectin); mannose-binding lectin, monocot,	7e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-06
3r0e_B	110	Lectin; carbohydrate binding, carbohydrate, sugar	1e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-05
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	8e-05
1xd5_A	112	Gastrodianin-1, antifungal protein GAFP-1; monocot	2e-04
3mez_B	113	Mannose-specific lectin 3 chain 2; heterotetramer,	1e-04
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	2e-04
1kj1_A	109	Lectin I, lecgna 1; BULB lectin, mannose, plant pr	3e-04
3dzw_A	109	Agglutinin; lectin, mannobiose, mannose-alpha1, 3-	4e-04
3r0e_A	109	Lectin; carbohydrate binding, carbohydrate, sugar	4e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (856), Expect = e-108
 Identities = 113/295 (38%), Positives = 175/295 (59%), Gaps = 14/295 (4%)

Query: 498 IQSFSTGELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG-ERKFQ 554
           ++ FS  EL+ A++ F  +  LGRG FG VYKG + +G  +VAVKRL+    +G E +FQ
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERTQGGELQFQ 75

Query: 555 AEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI---WRDRVR 611
            E+  +    H+NL+RL GFCM  +++LLVY +M+ GS+ + L           W  R R
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGV 671
           IAL  ARG+ YLH+ C+ +IIH ++   NILLD+   A + +F LAK++    T + T V
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN-VSTADVVLLSTWVYNC 730
           +GT G+++PE+ ++G  + K+DV+ +GV++LE++  +  F++  ++  D V+L  WV   
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 731 FIAKELSKLVGED----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG 781
              K+L  LV  D           +E +++V LLC Q  P  RP M  V+ MLEG
Sbjct: 256 LKEKKLEALV--DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  303 bits (778), Expect = 9e-97
 Identities = 100/308 (32%), Positives = 159/308 (51%), Gaps = 17/308 (5%)

Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEE--LGRGCFGAVYKGSICEGNKIVAVKRLENP 545
            S      F        +LE ATN F+ +  +G G FG VYKG + +G   VA+KR    
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPE 74

Query: 546 VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI 605
             +G  +F+ E+  +    H +LV L+GFC + ++ +L+Y++M  G+L+  L   +   +
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM 134

Query: 606 ---WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI-LM 661
              W  R+ I +  ARG+ YLH      IIH ++   NILLD++   KI++F ++K    
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191

Query: 662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV 721
            +QT + T VKGT GY+ PE+   G +T KSDVYSFGVV+ E++C RS    ++    V 
Sbjct: 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251

Query: 722 LLSTWVYNCFIAKELSKLVGED----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
           L   W        +L ++V  D    +++   +L       + C+      RPSM +V+ 
Sbjct: 252 LA-EWAVESHNNGQLEQIV--DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308

Query: 778 MLEGTMEI 785
            LE  + +
Sbjct: 309 KLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  296 bits (761), Expect = 2e-94
 Identities = 110/303 (36%), Positives = 154/303 (50%), Gaps = 32/303 (10%)

Query: 499 QSFSTGELERATNGFEEE--------LGRGCFGAVYKGSICEGNKIVAVKRLENPVE--- 547
            SFS  EL+  TN F+E         +G G FG VYKG +   N  VAVK+L   V+   
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 70

Query: 548 -EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI- 605
            E +++F  E+  + +  H+NLV LLGF        LVY +M  GSL + LS ++  P  
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 606 -WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP-- 662
            W  R +IA   A GI +LHE      IH +I   NILLD++ TAKIS+F LA+      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKF 186

Query: 663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
            QT + + + GT  YM+PE    G IT KSD+YSFGVV+LEI+       V+      +L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA--VDEHREPQLL 243

Query: 723 LSTWVYNCFI-AKELSKLVGED---EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM 778
           L           K +   +  D    + D  ++E M  V   C+ ++ N RP +K V  +
Sbjct: 244 L-DIKEEIEDEEKTIEDYI--DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300

Query: 779 LEG 781
           L+ 
Sbjct: 301 LQE 303

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  229 bits (587), Expect = 4e-69
 Identities = 69/308 (22%), Positives = 126/308 (40%), Gaps = 35/308 (11%)

Query: 501 FSTGELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMA 558
             T  L   +   +  E   RG FG V+K  +   N+ VAVK      ++   + + E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF-PIQDKQSWQNEYEVY 70

Query: 559 AVRRTHHKNLVRLLGFCMQTSK----KLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIA 613
           ++    H+N+++ +G   + +       L+  F  KGSL + L       + W +   IA
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIA 127

Query: 614 LDVARGITYLHEECEVQ-------IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
             +ARG+ YLHE+           I H +I  +N+LL ++LTA I++F LA      ++ 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 667 IVT-GVKGTRGYMSPE-----WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADV 720
             T G  GTR YM+PE             ++ D+Y+ G+V+ E+    +  +  V    +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYM 246

Query: 721 VLLSTWVYNCFIAKELSKLVGE--------DEEVDLRTLETMVRVGLLCIQDEPNLRPSM 772
           +     +      +++ ++V          D       +  +      C   +   R S 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 773 KNVILMLE 780
             V   + 
Sbjct: 307 GCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  200 bits (511), Expect = 2e-58
 Identities = 82/294 (27%), Positives = 131/294 (44%), Gaps = 35/294 (11%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
            +E++G G FG V++         VAVK L  ++   E   +F  E+A ++R  H N+V 
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI--WRDRVRIALDVARGITYLHEECE 628
            +G   Q     +V E++S+GSL  LL    +      R R+ +A DVA+G+ YLH    
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             I+H N+   N+L+D   T K+ +F L+++   +         GT  +M+PE       
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPS 216

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
             KSDVYSFGV++ E+   +  +  N++ A VV                  VG       
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWG-NLNPAQVVA----------------AVGFK---CK 256

Query: 749 R------TLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNF 796
           R          +  +   C  +EP  RPS   ++ +L   +    VP P  S+ 
Sbjct: 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR-PLIKSAVPPPNRSDL 309

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  197 bits (503), Expect = 5e-57
 Identities = 75/340 (22%), Positives = 129/340 (37%), Gaps = 46/340 (13%)

Query: 501 FSTGELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAE-- 556
            +  E     +  +  E +GRG +GAVYKGS+    + VAVK          + F  E  
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFS---FANRQNFINEKN 57

Query: 557 MAAVRRTHHKNLVRLLGFCMQTS-----KKLLVYEFMSKGSLENLLSNVESGPIWRDRVR 611
           +  V    H N+ R +    + +     + LLV E+   GSL   LS       W    R
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCR 115

Query: 612 IALDVARGITYLHEE------CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN-- 663
           +A  V RG+ YLH E       +  I H ++N RN+L+ +  T  IS+F L+  L  N  
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 664 -----QTGIVTGVKGTRGYMSPE-------WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
                +        GT  YM+PE        ++      + D+Y+ G++  EI    ++ 
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 712 EVNVSTADVVL-LSTWVYNCFIAKELSKLVGEDEE---------VDLRTLETMVRVGLLC 761
               S  +  +   T V N    +++  LV  +++          +   + ++      C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 762 IQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSSNSQ 801
              +   R + +     +   M I      +      +  
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHH 335

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (488), Expect = 3e-55
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 26/271 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            EE +GRG FG V K       K VA+K++E+  E   + F  E+  + R +H N+V+L 
Sbjct: 12  VEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLY 67

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI--WRDRVRIALDVARGITYLHEECEVQ 630
           G C+      LV E+   GSL N+L   E  P       +   L  ++G+ YLH      
Sbjct: 68  GACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 631 IIHCNINPRNILLDDSLT-AKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           +IH ++ P N+LL    T  KI +F  A     +    +T  KG+  +M+PE       +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYS 181

Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR 749
            K DV+S+G+++ E++  R  F+  +          +     +       + ++    + 
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFD-EIGG------PAFRIMWAVHNGTRPPLIKNLPKPIE 234

Query: 750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           +L  M R    C   +P+ RPSM+ ++ ++ 
Sbjct: 235 SL--MTR----CWSKDPSQRPSMEEIVKIMT 259

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  190 bits (485), Expect = 8e-55
 Identities = 73/309 (23%), Positives = 128/309 (41%), Gaps = 31/309 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             E LG+GCFG   K +  E  +++ +K L    EE +R F  E+  +R   H N+++ +
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G   +  +   + E++  G+L  ++ +++S   W  RV  A D+A G+ YLH      II
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQT-------------GIVTGVKGTRGYMS 679
           H ++N  N L+ ++    +++F LA++++  +T                  V G   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFE-VNVSTADVVLLSTWVYNCFIAKELSK 738
           PE  N      K DV+SFG+V+ EI+   +        T D  L         +   L +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------VRGFLDR 242

Query: 739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNFSS 798
               +       +   VR    C   +P  RPS   +   LE          P+      
Sbjct: 243 YCPPNCPPSFFPI--TVR----CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296

Query: 799 NSQTLSSAF 807
             +     +
Sbjct: 297 LDRGFWETY 305

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  188 bits (479), Expect = 3e-54
 Identities = 74/314 (23%), Positives = 129/314 (41%), Gaps = 53/314 (16%)

Query: 487 NSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV 546
            S    S+   +      E+E     +E+++G+G FG V+KG + +   +VA+K L    
Sbjct: 5   GSEFPKSRLPTLAD---NEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56

Query: 547 EEGE-------RKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSN 599
            EGE       ++FQ E+  +   +H N+V+L G         +V EF+  G L + L +
Sbjct: 57  SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD 114

Query: 600 VESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-----LTAKISNF 654
                 W  ++R+ LD+A GI Y+       I+H ++   NI L        + AK+++F
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 655 SLAKILMPNQTGIVTGVKGTRGYMSPE--WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            L++         V+G+ G   +M+PE         T K+D YSF +++  I+     F+
Sbjct: 174 GLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

Query: 713 VNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR------TLETMVRVGLLCIQDEP 766
              S   +  ++                       LR          +  V  LC   +P
Sbjct: 230 -EYSYGKIKFINMIREE-----------------GLRPTIPEDCPPRLRNVIELCWSGDP 271

Query: 767 NLRPSMKNVILMLE 780
             RP    ++  L 
Sbjct: 272 KKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (473), Expect = 1e-53
 Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 43/282 (15%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           F  +L     G ++KG        + VK L   +      R F  E   +R   H N++ 
Sbjct: 14  FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 571 LLGFCMQTSKKLL--VYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEEC 627
           +LG C          +  +M  GSL N+L    +  +     V+ ALD+ARG+ +LH   
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-L 130

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQN 684
           E  I    +N R++++D+ +TA+IS   +             G      +++PE    + 
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKP 184

Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE 744
                  +D++SF V++ E+V     F  ++S  ++ +         +A E         
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMK--------VALE--------- 226

Query: 745 EVDLR------TLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
              LR          + ++  +C+ ++P  RP    ++ +LE
Sbjct: 227 --GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  184 bits (470), Expect = 6e-53
 Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 23/274 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
             + +G G FG VYKG    G+  VAVK L    P  +  + F+ E+  +R+T H N++ 
Sbjct: 28  VGQRIGSGSFGTVYKG-KWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
            +G+     +  +V ++    SL + L   E+    +  + IA   ARG+ YLH +    
Sbjct: 85  FMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---S 140

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGIVTGVKGTRGYMSPE---WQNSG 686
           IIH ++   NI L +  T KI +F LA      + +     + G+  +M+PE    Q+S 
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV 746
             + +SDVY+FG+V+ E++  +  +  N++  D ++    +            V  +   
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII---EMVGRGSLSPDLSKVRSNCPK 256

Query: 747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            ++ L  M      C++ + + RPS   ++  +E
Sbjct: 257 RMKRL--MAE----CLKKKRDERPSFPRILAEIE 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  182 bits (464), Expect = 3e-52
 Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 33/280 (11%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL----ENPVEEGERKFQAEMAAVRRTHHKNL 568
            EE +G G FG VY+         VAVK      +  + +     + E        H N+
Sbjct: 11  LEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           + L G C++     LV EF   G L  +LS           V  A+ +ARG+ YLH+E  
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP--PDILVNWAVQIARGMNYLHDEAI 126

Query: 629 VQIIHCNINPRNILLDDSL--------TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
           V IIH ++   NIL+   +          KI++F LA+              G   +M+P
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMAP 183

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV 740
           E   + + +  SDV+S+GV++ E++     F   +    V      V       +L+  +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAY---GVAM----NKLALPI 235

Query: 741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                     L  M      C   +P+ RPS  N++  L 
Sbjct: 236 PSTCPEPFAKL--MED----CWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (463), Expect = 1e-51
 Identities = 58/286 (20%), Positives = 116/286 (40%), Gaps = 42/286 (14%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
             E +G+G FG VY G    G   VA++ +  E   E+  + F+ E+ A R+T H+N+V 
Sbjct: 37  IGELIGKGRFGQVYHG-RWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
            +G CM      ++       +L +++ + +         +IA ++ +G+ YLH +    
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---G 150

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKI----LMPNQTGIVTGVKGTRGYMSPE----- 681
           I+H ++  +N+  D+     I++F L  I        +   +    G   +++PE     
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 682 ----WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS 737
                ++    +  SDV++ G +  E+      F+       ++    W           
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAII----WQ---------- 254

Query: 738 KLVGED---EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
             +G         +   + +  + L C   E   RP+   ++ MLE
Sbjct: 255 --MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  171 bits (435), Expect = 2e-47
 Identities = 58/324 (17%), Positives = 123/324 (37%), Gaps = 48/324 (14%)

Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE 547
           S  G     ++Q     +++       +++G+G +G V+ G      + VAVK      E
Sbjct: 21  SGSGSGLPLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKWR--GEKVAVKVF-FTTE 72

Query: 548 EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK----LLVYEFMSKGSLENLLSNVESG 603
           E     + E+       H+N++  +   ++ +       L+ ++   GSL + L +    
Sbjct: 73  EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---T 129

Query: 604 PI-WRDRVRIALDVARGITYLHEE-----CEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
            +  +  +++A     G+ +LH E      +  I H ++  +NIL+  + T  I++  LA
Sbjct: 130 TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

Query: 658 KILMPN---QTGIVTGVKGTRGYMSPE------WQNSGLITVKSDVYSFGVVVLEIVCCR 708
              + +            GT+ YM PE       +N     + +D+YSFG+++ E+    
Sbjct: 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249

Query: 709 SNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED------------EEVDLRTLETMVR 756
            +  +       +     V +    +++ ++V               +E   +  + M  
Sbjct: 250 VSGGIVEEYQ--LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307

Query: 757 VGLLCIQDEPNLRPSMKNVILMLE 780
               C    P  R +   V   L 
Sbjct: 308 ----CWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  169 bits (430), Expect = 2e-47
 Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 33/294 (11%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             E +G+G +G V++GS     + VAVK   +  +E     + E+       H+N++  +
Sbjct: 12  LLECVGKGRYGEVWRGSWQ--GENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 573 GFCMQTSKK----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
              M +        L+  +   GSL + L            +RI L +A G+ +LH E  
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 629 VQ-----IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVKGTRGYMSP 680
                  I H ++  +NIL+  +    I++  LA +   +   +        GT+ YM+P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 681 E------WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK 734
           E        +      + D+++FG+V+ E+     +  +             V N    +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK--PPFYDVVPNDPSFE 244

Query: 735 ELSKLVGEDEE-----VDLRTLETMVRVGLL---CIQDEPNLRPSMKNVILMLE 780
           ++ K+V  D++         +  T+  +  L   C    P+ R +   +   L 
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (422), Expect = 8e-46
 Identities = 64/298 (21%), Positives = 114/298 (38%), Gaps = 41/298 (13%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G      + VAVK   +  EE     +AE+       H+N++  +
Sbjct: 46  LQESIGKGRFGEVWRGKWR--GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 573 GFCMQTSKK----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
               + +       LV ++   GSL + L+           +++AL  A G+ +LH E  
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIV 160

Query: 629 VQ-----IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI---VTGVKGTRGYMSP 680
                  I H ++  +NIL+  + T  I++  LA         I        GT+ YM+P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 681 E-WQNSGLITV-----KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK 734
           E   +S  +       ++D+Y+ G+V  EI    S   ++      +     V +    +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ--LPYYDLVPSDPSVE 278

Query: 735 ELSKLVGED------------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           E+ K+V E              E      + M      C       R +   +   L 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  154 bits (392), Expect = 3e-41
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 11/206 (5%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRRT 563
            L        E++GRG FG V+ G +   N +VAVK   E    + + KF  E   +++ 
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169

Query: 564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYL 623
            H N+VRL+G C Q     +V E +  G     L    +    +  +++  D A G+ YL
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY----MS 679
             +     IH ++  RN L+ +    KIS+F +++       G+     G R       +
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGLRQVPVKWTA 283

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE  N G  + +SDV+SFG+++ E  
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETF 309

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  154 bits (392), Expect = 2e-40
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 5/202 (2%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ER     + +LG G +G VY+G   + +  VAVK L         +F  E A ++   
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIK 274

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           H NLV+LLG C +     ++ EFM+ G+L + L       +     + +A  ++  + YL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            ++     IH N+  RN L+ ++   K+++F L++++  +      G K    + +PE  
Sbjct: 335 EKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
                ++KSDV++FGV++ EI 
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIA 413

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  150 bits (381), Expect = 3e-39
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G    G   VA+K L  P       F  E   +++  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMG-TWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 237

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITYL 623
           H+ LV+L     +     +V E+MSKGSL + L             V +A  +A G+ Y+
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                   +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE  
Sbjct: 297 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 353

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
             G  T+KSDV+SFG+++ E+ 
Sbjct: 354 LYGRFTIKSDVWSFGILLTELT 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  149 bits (378), Expect = 2e-38
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E +LG+GCFG V+ G    G   VA+K L  P       F  E   +++  
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMG-TWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLR 320

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITYL 623
           H+ LV+L     +     +V E+MSKGSL + L             V +A  +A G+ Y+
Sbjct: 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                   +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE  
Sbjct: 380 ERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 436

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
             G  T+KSDV+SFG+++ E+ 
Sbjct: 437 LYGRFTIKSDVWSFGILLTELT 458

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (362), Expect = 3e-38
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 20/220 (9%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E++     F +ELG G FG V  G    G   VA+K +       E +F  E   +    
Sbjct: 20  EIDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLS 77

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
           H+ LV+L G C +     ++ E+M+ G L N L  +      +  + +  DV   + YL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRGYMSP 680
            +   Q +H ++  RN L++D    K+S+F L++ ++ ++     G    V+    +  P
Sbjct: 138 SK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPP 190

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVCC-------RSNFEV 713
           E       + KSD+++FGV++ EI           +N E 
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (363), Expect = 3e-38
 Identities = 58/206 (28%), Positives = 106/206 (51%), Gaps = 13/206 (6%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ER     + +LG G +G VY+G   + +  VAVK L+    E E +F  E A ++   
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           H NLV+LLG C +     ++ EFM+ G+L + L       +     + +A  ++  + YL
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRGYMS 679
            ++     IH ++  RN L+ ++   K+++F L++++  +      G    +K    + +
Sbjct: 128 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTA 180

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE       ++KSDV++FGV++ EI 
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIA 206

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  142 bits (360), Expect = 4e-38
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 13/205 (6%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           EL+R      +ELG G FG V  G   +G   VAVK ++      E +F  E   + +  
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLG-KWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLS 61

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
           H  LV+  G C +     +V E++S G L N L +   G      + +  DV  G+ +L 
Sbjct: 62  HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRGYMSP 680
                Q IH ++  RN L+D  L  K+S+F + + ++ +Q     G    VK    + +P
Sbjct: 122 SH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WSAP 174

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIV 705
           E  +    + KSDV++FG+++ E+ 
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVF 199

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  147 bits (372), Expect = 5e-38
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 7/202 (3%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R +   E++LG G FG V+       +  VAVK +  P       F AE   ++   
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMA-TYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQ 241

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITYL 623
           H  LV+L     +     ++ EFM+KGSL + L S+  S       +  +  +A G+ ++
Sbjct: 242 HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
            +      IH ++   NIL+  SL  KI++F LA+++  N+     G K    + +PE  
Sbjct: 301 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 357

Query: 684 NSGLITVKSDVYSFGVVVLEIV 705
           N G  T+KSDV+SFG++++EIV
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIV 379

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (356), Expect = 1e-37
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 20/220 (9%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
            ++ +   F +E+G G FG V+ G        VA+K +       E  F  E   + +  
Sbjct: 4   VIDPSELTFVQEIGSGQFGLVHLG-YWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 61

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
           H  LV+L G C++ +   LV EFM  G L + L            + + LDV  G+ YL 
Sbjct: 62  HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 121

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRGYMSP 680
           E     +IH ++  RN L+ ++   K+S+F + + ++ +Q    TG    VK    + SP
Sbjct: 122 EA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WASP 174

Query: 681 EWQNSGLITVKSDVYSFGVVVLEIVCC-------RSNFEV 713
           E  +    + KSDV+SFGV++ E+          RSN EV
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  141 bits (358), Expect = 2e-37
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 11/208 (5%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRL-ENPVEEGERKFQAEMAAV 560
           E+E +    E+ +G G  G V  G      + +  VA+K L     E   R F +E + +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   +    ++V E+M  GSL+  L   +        V +   V  G+
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT---RGY 677
            YL +      +H ++  RN+L+D +L  K+S+F L+++L  +     T   G    R +
Sbjct: 165 RYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR-W 220

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +PE       +  SDV+SFGVV+ E++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  145 bits (367), Expect = 2e-37
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
            L        + +G+G FG V  G    GNK VAVK ++N      + F AE + + +  
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLG-DYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLR 244

Query: 565 HKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITY 622
           H NLV+LLG  ++    L +V E+M+KGSL + L S   S       ++ +LDV   + Y
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           L        +H ++  RN+L+ +   AK+S+F L K     Q      VK    + +PE 
Sbjct: 305 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEA 357

Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
                 + KSDV+SFG+++ EI 
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIY 380

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  140 bits (355), Expect = 4e-37
 Identities = 64/295 (21%), Positives = 118/295 (40%), Gaps = 32/295 (10%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG----SICEGNKIVAVKRL-ENPVEEGERKFQAEMAA 559
             E+       +LG G FG V             + VAVK L            + E+  
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76

Query: 560 VRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
           +R  +H+N+V+  G C +       L+ EF+  GSL+  L   ++    + +++ A+ + 
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT--- 674
           +G+ YL      Q +H ++  RN+L++     KI +F L K +  ++             
Sbjct: 137 KGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193

Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIV-CCRSNFEVNVSTADVVLLSTWVYNCFIA 733
             + +PE        + SDV+SFGV + E++  C S+       A  + +    +     
Sbjct: 194 F-WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS---PMALFLKMIGPTHGQMTV 249

Query: 734 KELSKLVGEDEE--------VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
             L   + E +          ++  L  M      C + +P+ R S +N+I   E
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQL--M----RKCWEFQPSNRTSFQNLIEGFE 298

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  140 bits (356), Expect = 6e-37
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 12/209 (5%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG----SICEGNKIVAVKRL-ENPVEEGERKFQAEMAA 559
           E+  +    ++ +G G FG VYKG    S  +    VA+K L     E+    F  E   
Sbjct: 40  EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 99

Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARG 619
           + +  H N++RL G   +    +++ E+M  G+L+  L   +        V +   +A G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR---G 676
           + YL        +H ++  RNIL++ +L  K+S+F L+++L  +     T   G +    
Sbjct: 160 MKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT-TSGGKIPIR 215

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           + +PE  +    T  SDV+SFG+V+ E++
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVM 244

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (355), Expect = 8e-37
 Identities = 69/314 (21%), Positives = 132/314 (42%), Gaps = 38/314 (12%)

Query: 490 LGPSQEFIIQSFSTG---ELERATNGFEEELGRGCFGAVYKG---SICEGNKI-VAVKRL 542
           +G       Q ++       E     +  +LG+G FG+V       + +     VAVK+L
Sbjct: 1   MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60

Query: 543 ENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNV 600
           ++   + +R FQ E+  ++  H   +V+  G      ++   LV E++  G L + L   
Sbjct: 61  QHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120

Query: 601 ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
            +       +  +  + +G+ YL      + +H ++  RNIL++     KI++F LAK+L
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177

Query: 661 MPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV-CCRSNFEVN 714
             ++      V    G     + +PE  +  + + +SDV+SFGVV+ E+   C  +    
Sbjct: 178 PLDKDYY---VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS-- 232

Query: 715 VSTADVVLLSTWVYNCFIAKELSKLVGEDEE--------VDLRTLETMVRVGLLCIQDEP 766
             +A+ + +     +      L +L+ E +          ++  L  M     LC    P
Sbjct: 233 -PSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHEL--M----KLCWAPSP 285

Query: 767 NLRPSMKNVILMLE 780
             RPS   +   L+
Sbjct: 286 QDRPSFSALGPQLD 299

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  138 bits (350), Expect = 1e-36
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 15/206 (7%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           E+ R T    E LG G FG V+ G    G+  VAVK L          F AE   +++  
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMG-YYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQ 66

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITYL 623
           H+ LVRL     Q     ++ E+M  GSL + L +           + +A  +A G+ ++
Sbjct: 67  HQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRGYMS 679
            E      IH ++   NIL+ D+L+ KI++F LA+++  N+     G    +K    + +
Sbjct: 126 EER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTA 178

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIV 705
           PE  N G  T+KSDV+SFG+++ EIV
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIV 204

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (351), Expect = 1e-36
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 11/209 (5%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAV 560
                   F E +GRG FG VY G++ + +      AVK L          +F  E   +
Sbjct: 21  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80

Query: 561 RRTHHKNLVRLLGFCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARG 619
           +   H N++ LLG C+++    L V  +M  G L N + N    P  +D +   L VA+G
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 140

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR---G 676
           + YL  +   + +H ++  RN +LD+  T K+++F LA+ +   +   V    G +    
Sbjct: 141 MKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           +M+ E   +   T KSDV+SFGV++ E++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELM 226

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (350), Expect = 2e-36
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 507 ERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRR 562
           ER     +  +G+G FG VY G      +     A+K L      +    F  E   +R 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78

Query: 563 THHKNLVRLLGFCMQTS-KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGIT 621
            +H N++ L+G  +       ++  +M  G L   + + +  P  +D +   L VARG+ 
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG----- 676
           YL E+   + +H ++  RN +LD+S T K+++F LA+ +        +  +         
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVK 193

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           + + E   +   T KSDV+SFGV++ E++
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELL 222

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  138 bits (349), Expect = 2e-36
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKI-VAVKRLENPVEEGERKFQAEMAAV 560
           + E     F ++LG+G FG+V       + +     VAVK+L++  EE  R F+ E+  +
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 561 RRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
           +   H N+V+  G C    ++   L+ E++  GSL + L   +        ++    + +
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG------VK 672
           G+ YL  +   + IH ++  RNIL+++    KI +F L K+L  ++            + 
Sbjct: 126 GMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
               + +PE       +V SDV+SFGVV+ E+ 
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (351), Expect = 2e-36
 Identities = 67/295 (22%), Positives = 128/295 (43%), Gaps = 32/295 (10%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKI-VAVKRLENPVEEGERKFQAEMAAV 560
           + E     F ++LG+G FG+V       + +     VAVK+L++  EE  R F+ E+  +
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 561 RRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
           +   H N+V+  G C    ++   L+ E++  GSL + L   +        ++    + +
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG-- 676
           G+ YL  +   + IH ++  RNIL+++    KI +F L K+L  ++           G  
Sbjct: 157 GMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY---KVKEPGES 210

Query: 677 ---YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA 733
              + +PE       +V SDV+SFGVV+ E+         +     + ++        I 
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 734 KELSKLVGEDEE--------VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
             L +L+  +           ++  +  M      C  +  N RPS +++ L ++
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMI--M----TECWNNNVNQRPSFRDLALRVD 318

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (350), Expect = 3e-36
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKI-VAVKRL-ENPVEEGERKFQAEMAA 559
             +       + LG G FG V+KG      E  KI V +K + +    +  +     M A
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARG 619
           +    H ++VRLLG C   S   LV +++  GSL + +         +  +   + +A+G
Sbjct: 69  IGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-----VKGT 674
           + YL E     ++H N+  RN+LL      ++++F +A +L P+   ++       +K  
Sbjct: 128 MYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK-- 182

Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             +M+ E  + G  T +SDV+S+GV V E++
Sbjct: 183 --WMALESIHFGKYTHQSDVWSYGVTVWELM 211

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (352), Expect = 4e-36
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 22/226 (9%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAV 560
                   F E +GRG FG VY G++ + +      AVK L          +F  E   +
Sbjct: 85  GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144

Query: 561 RRTHHKNLVRLLGFCMQTSKKLL-VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARG 619
           +   H N++ LLG C+++    L V  +M  G L N + N    P  +D +   L VA+G
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 204

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG--- 676
           + +L      + +H ++  RN +LD+  T K+++F LA+ +   +   V     T     
Sbjct: 205 MKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLP 259

Query: 677 --YMSPEWQNSGLITVKSDVYSFGVVVLEIV-------CCRSNFEV 713
             +M+ E   +   T KSDV+SFGV++ E++          + F++
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 305

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  136 bits (346), Expect = 4e-36
 Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
            L        + +G+G FG V  G        VAVK ++N      + F AE + + +  
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLR 72

Query: 565 HKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLL-SNVESGPIWRDRVRIALDVARGITY 622
           H NLV+LLG  ++    L +V E+M+KGSL + L S   S       ++ +LDV   + Y
Sbjct: 73  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           L        +H ++  RN+L+ +   AK+S+F L K     Q      VK    + +PE 
Sbjct: 133 LEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEA 185

Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
                 + KSDV+SFG+++ EI 
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIY 208

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  138 bits (349), Expect = 5e-36
 Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 34/236 (14%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG-----SICEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E+ R       ELG+G FG VY+G        E    VA+K + E        +F  E +
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------SNVESGPIWRDR 609
            ++  +  ++VRLLG   Q    L++ E M++G L++ L         + V + P     
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +++A ++A G+ YL+     + +H ++  RN ++ +  T KI +F + + +         
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----Y 193

Query: 670 GVKGTRGY-----MSPEWQNSGLITVKSDVYSFGVVVLEIV-------CCRSNFEV 713
             KG +G      MSPE    G+ T  SDV+SFGVV+ EI           SN +V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  136 bits (346), Expect = 9e-36
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 36/230 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L  +          +E+ 
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 559 AVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-----------------SNV 600
            +    +H N+V LLG C      L++ E+   G L N L                  + 
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 601 ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
           E      D +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 661 MPNQTGIVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             +   +V G     VK    +M+PE   + + T +SDV+S+G+ + E+ 
Sbjct: 196 KNDSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWELF 241

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (343), Expect = 1e-35
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRL-ENPVEEGERKFQAEMAAV 560
           E++R        +G G FG V++G           VA+K       +    KF  E   +
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 71  RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRG 676
            YL  +   + +H +I  RN+L+  +   K+ +F L++ +  +     +     +K    
Sbjct: 130 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---- 182

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           +M+PE  N    T  SDV+ FGV + EI+
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEIL 211

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  136 bits (345), Expect = 1e-35
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 513 FEEELGRGCFGAVYKG---SICEGNKI-VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKN 567
             + LG G FG VYKG      E  KI VA+K L E    +  ++   E   +    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + RLLG C+  S   L+ + M  G L + +   +     +  +   + +A+G+ YL +  
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-----VKGTRGYMSPEW 682
              ++H ++  RN+L+      KI++F LAK+L   +           +K    +M+ E 
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALES 190

Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
               + T +SDV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  136 bits (345), Expect = 2e-35
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 32/226 (14%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R    F + LG G FG V + +       +    VAVK L      + +    +E+ 
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101

Query: 559 AVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-------------SNVESGP 604
            +     H+N+V LLG C      L++ E+   G L N L             +   S  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 605 IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
             RD +  +  VA+G+ +L  +     IH ++  RN+LL +   AKI +F LA+ +M + 
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

Query: 665 TGIVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             IV G     VK    +M+PE     + TV+SDV+S+G+++ EI 
Sbjct: 219 NYIVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (343), Expect = 2e-35
 Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 38/297 (12%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKI-VAVKRL-ENPVEEGERKFQAEMAA 559
              +       +LG G FG V         +G    VAVK L  +   +    ++ E+  
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86

Query: 560 VRRTHHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
           +R  +H+++++  G C         LV E++  GSL + L            +  A  + 
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQIC 144

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG- 676
            G+ YLH +     IH ++  RN+LLD+    KI +F LAK +               G 
Sbjct: 145 EGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR---VREDGD 198

Query: 677 ----YMSPEWQNSGLITVKSDVYSFGVVVLEIV-CCRSNFEVNVSTADVVLLSTWVYNCF 731
               + +PE          SDV+SFGV + E++  C S+        +++ ++       
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQM 255

Query: 732 IAKELSKLVGEDEE--------VDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
               L++L+   E          ++  L  M      C + E + RP+ +N+I +L+
Sbjct: 256 TVLRLTELLERGERLPRPDKCPAEVYHL--M----KNCWETEASFRPTFENLIPILK 306

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (342), Expect = 3e-35
 Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 34/236 (14%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNKI---VAVKRL--ENPVEEGERKFQAEMAA 559
            ++R      + LG G FG+V +G++ + +     VAVK +  +N  +    +F +E A 
Sbjct: 30  VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89

Query: 560 VRRTHHKNLVRLLGFCMQT-----SKKLLVYEFMSKGSLENLL-----SNVESGPIWRDR 609
           ++   H N++RLLG C++       K +++  FM  G L   L              +  
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           ++  +D+A G+ YL        +H ++  RN +L D +T  +++F L+K +         
Sbjct: 150 LKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY--- 203

Query: 670 GVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV-------CCRSNFEV 713
             +G        +++ E     + T KSDV++FGV + EI            N E+
Sbjct: 204 -RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (346), Expect = 3e-35
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 11/208 (5%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG---SICEGNKIVAVKRL-ENPVEEGERKFQAEMAAV 560
           EL+      ++ +G G FG V  G      +    VA+K L     E+  R F  E + +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            +  H N++RL G   ++   ++V E+M  GSL++ L   ++       V +   +A G+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT---RGY 677
            YL +      +H ++  RNIL++ +L  K+S+F L ++L  +     T   G    R +
Sbjct: 161 KYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR-W 216

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            SPE       T  SDV+S+G+V+ E++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  135 bits (343), Expect = 3e-35
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E+ R        LG G FG VY+G +           VAVK L E   E+ E  F  E  
Sbjct: 26  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL------SNVESGPIWRDRVRI 612
            + + +H+N+VR +G  +Q+  + ++ E M+ G L++ L       +  S     D + +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVT 669
           A D+A G  YL E      IH +I  RN LL        AKI +F +A+ +         
Sbjct: 146 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----Y 198

Query: 670 GVKGTRGY-----MSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             KG         M PE    G+ T K+D +SFGV++ EI 
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (341), Expect = 5e-35
 Identities = 57/254 (22%), Positives = 105/254 (41%), Gaps = 36/254 (14%)

Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRL-E 543
            SLG S E + +      +          LG+G FG+V +  + + +     VAVK L  
Sbjct: 3   DSLGISDE-LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61

Query: 544 NPVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQ------TSKKLLVYEFMSKGSLENL 596
           + +   + + F  E A ++   H ++ +L+G  ++          +++  FM  G L   
Sbjct: 62  DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121

Query: 597 L-----SNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI 651
           L              +  VR  +D+A G+ YL        IH ++  RN +L + +T  +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178

Query: 652 SNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV- 705
           ++F L++ +           +G        +++ E     L TV SDV++FGV + EI+ 
Sbjct: 179 ADFGLSRKIYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

Query: 706 ------CCRSNFEV 713
                     N E+
Sbjct: 235 RGQTPYAGIENAEI 248

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  133 bits (338), Expect = 6e-35
 Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 39/241 (16%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG-----SICEGNKIVAVKRLENPVEEGERKFQAEMAA 559
            ++R     + ELG G FG V+       S  +   +VAVK L++P     + FQ E   
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------------SNVESGP 604
           +    H+++V+  G C      ++V+E+M  G L   L                  +   
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 605 IWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
                + IA  +A G+ YL  +     +H ++  RN L+  +L  KI +F +++ +    
Sbjct: 131 GLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187

Query: 665 TGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV-------CCRSNFE 712
                   G        +M PE       T +SDV+SFGV++ EI           SN E
Sbjct: 188 ----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243

Query: 713 V 713
           V
Sbjct: 244 V 244

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  133 bits (338), Expect = 1e-34
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 35/229 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R      + LGRG FG V +            + VAVK L E       R   +E+ 
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82

Query: 559 AVRR-THHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLL---------------SNVE 601
            +    HH N+V LLG C +    L+V  EF   G+L   L                  +
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 602 SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM 661
                   +  +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 199

Query: 662 PNQTGIVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +   +  G     +K    +M+PE     + T++SDV+SFGV++ EI 
Sbjct: 200 KDPDYVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  133 bits (338), Expect = 1e-34
 Identities = 67/250 (26%), Positives = 109/250 (43%), Gaps = 36/250 (14%)

Query: 485 RINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKG-------SICEGNKIV 537
             +  L    E+ +      E  R      + LG G FG V             +    V
Sbjct: 11  SQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70

Query: 538 AVKRL-ENPVEEGERKFQAEMAAVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN 595
           AVK L ++  E+      +EM  ++    HKN++ LLG C Q     ++ E+ SKG+L  
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130

Query: 596 LL--------------SNVESGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRN 640
            L              + V    + ++D V     +ARG+ YL  +   + IH ++  RN
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187

Query: 641 ILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVY 695
           +L+ ++   KI++F LA+ +  N        K T G     +M+PE     + T +SDV+
Sbjct: 188 VLVTENNVMKIADFGLARDI--NNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVW 243

Query: 696 SFGVVVLEIV 705
           SFGV++ EI 
Sbjct: 244 SFGVLMWEIF 253

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  133 bits (338), Expect = 1e-34
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 34/225 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSICEGNK--IVAVKRL-ENPVEEGERKFQAEMAAVR 561
            L+     F++ +G G FG V K  I +       A+KR+ E   ++  R F  E+  + 
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80

Query: 562 R-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVESGPI- 605
           +  HH N++ LLG C       L  E+   G+L + L              +N  +  + 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
            +  +  A DVARG+ YL ++   Q IH ++  RNIL+ ++  AKI++F L++       
Sbjct: 141 SQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------- 190

Query: 666 GIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           G    VK T G     +M+ E  N  + T  SDV+S+GV++ EIV
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (338), Expect = 1e-34
 Identities = 62/240 (25%), Positives = 95/240 (39%), Gaps = 38/240 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERKFQAEMAA 559
            ++R     + ELG G FG V+          +   +VAVK L+   E   + FQ E   
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 560 VRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVESGPI 605
           +    H+++VR  G C +    L+V+E+M  G L   L                      
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
               + +A  VA G+ YL     +  +H ++  RN L+   L  KI +F +++ +     
Sbjct: 157 LGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD- 212

Query: 666 GIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV-------CCRSNFEV 713
                  G R      +M PE       T +SDV+SFGVV+ EI           SN E 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (337), Expect = 2e-34
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 41/235 (17%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R      + LG G FG V K +        G   VAVK L EN      R   +E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------------- 597
            +++ +H ++++L G C Q    LL+ E+   GSL   L                     
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 598 -SNVESGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
             + +   +   D +  A  +++G+ YL E   ++++H ++  RNIL+ +    KIS+F 
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 656 LAKILMPNQTGIVTGVKGTRG-----YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           L++ +    +     VK ++G     +M+ E     + T +SDV+SFGV++ EIV
Sbjct: 196 LSRDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  132 bits (335), Expect = 2e-34
 Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 40/242 (16%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG-----SICEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E+  +   F EELG   FG VYKG     +  E  + VA+K L +        +F+ E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL---------------SNVESG 603
              R  H N+V LLG   +     +++ + S G L   L                 V+S 
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 604 PIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN 663
               D V +   +A G+ YL       ++H ++  RN+L+ D L  KIS+  L + +   
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181

Query: 664 QTGIVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV-------CCRSNF 711
               + G     ++    +M+PE    G  ++ SD++S+GVV+ E+        C  SN 
Sbjct: 182 DYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237

Query: 712 EV 713
           +V
Sbjct: 238 DV 239

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  132 bits (334), Expect = 2e-34
 Identities = 49/232 (21%), Positives = 93/232 (40%), Gaps = 31/232 (13%)

Query: 505 ELERATNGFEEELGRGCFGAVYKG-------SICEGNKIVAVKRLENPVEEGERKFQAEM 557
           ++      F E LG+G F  ++KG               V +K L+         F    
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63

Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
           + + +  HK+LV   G C+   + +LV EF+  GSL+  L   ++      ++ +A  +A
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 618 RGITYLHEECEVQIIHCNINPRNILLD--------DSLTAKISNFSLAKILMPNQTGIVT 669
             + +L E     +IH N+  +NILL         +    K+S+  ++  ++P       
Sbjct: 124 AAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 670 GVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCC-------RSNFEV 713
            +     ++ PE  +N   + + +D +SFG  + EI            +   
Sbjct: 181 -IP----WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  132 bits (334), Expect = 2e-34
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 16/209 (7%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGS--ICEGNKI-VAVKRL-ENPVEEGERKFQAEMAAV 560
            + R        LG G FG VY+G     +G KI VAVK   ++   + + KF +E   +
Sbjct: 8   GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           +   H ++V+L+G   +     ++ E    G L + L   ++       V  +L + + +
Sbjct: 68  KNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG----VKGTRG 676
            YL        +H +I  RNIL+      K+ +F L++ +        +     +K    
Sbjct: 127 AYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK---- 179

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           +MSPE  N    T  SDV+ F V + EI+
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEIL 208

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  133 bits (338), Expect = 2e-34
 Identities = 67/273 (24%), Positives = 115/273 (42%), Gaps = 48/273 (17%)

Query: 474 YKQRV---NQYQKLRINSSLGPSQEFI----IQSFSTGELERATNGFEEELGRGCFGAVY 526
           YK++    +Q Q +++  S      ++     +     E  R    F + LG G FG V 
Sbjct: 3   YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVM 62

Query: 527 KGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRR-THHKNLVRLLGFCMQTS 579
             +         +  VAVK L E           +E+  + +   H+N+V LLG C  + 
Sbjct: 63  NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122

Query: 580 KKLLVYEFMSKGSLENLL----------------------SNVESGPIWRDRVRIALDVA 617
              L++E+   G L N L                          +   + D +  A  VA
Sbjct: 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 182

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-----VK 672
           +G+ +L  +     +H ++  RN+L+      KI +F LA+ +M +   +V G     VK
Sbjct: 183 KGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK 239

Query: 673 GTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
               +M+PE    G+ T+KSDV+S+G+++ EI 
Sbjct: 240 ----WMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (339), Expect = 2e-34
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 27/221 (12%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E+ R        LG G FG VY+G +           VAVK L E   E+ E  F  E  
Sbjct: 67  EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL------SNVESGPIWRDRVRI 612
            + + +H+N+VR +G  +Q+  + ++ E M+ G L++ L       +  S     D + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVT 669
           A D+A G  YL E      IH +I  RN LL        AKI +F +A+ +         
Sbjct: 187 ARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----Y 239

Query: 670 GVKGTRGY-----MSPEWQNSGLITVKSDVYSFGVVVLEIV 705
             KG         M PE    G+ T K+D +SFGV++ EI 
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  134 bits (338), Expect = 3e-34
 Identities = 72/279 (25%), Positives = 110/279 (39%), Gaps = 39/279 (13%)

Query: 459 ITFLCFLIAISSLLAYKQRVNQ---YQKLRINSSLGPSQEFIIQSFSTGELERATNGFEE 515
            T   +   +     +          + L     L    E+ +      EL R      +
Sbjct: 16  TTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK 75

Query: 516 ELGRGCFGAVYKG-------SICEGNKIVAVKRL-ENPVEEGERKFQAEMAAVRR-THHK 566
            LG G FG V                  VAVK L  +  E+      +EM  ++    HK
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLL-----------SNVESGPIW----RDRVR 611
           N++ LLG C Q     ++ E+ SKG+L   L            N    P      +D V 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG- 670
            A  VARG+ YL  +   + IH ++  RN+L+ +    KI++F LA+ +        T  
Sbjct: 196 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252

Query: 671 ----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
               VK    +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 253 GRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  133 bits (336), Expect = 6e-34
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 36/230 (15%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-------CEGNKIVAVKRL-ENPVEEGERKFQAE 556
           E  R      + LG GCFG V             +    VAVK L ++  E+      +E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 557 MAAVRR-THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVE 601
           M  ++    HKN++ LLG C Q     ++ E+ SKG+L   L              + V 
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 602 SGPI-WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
              + ++D V     +ARG+ YL  +   + IH ++  RN+L+ ++   KI++F LA+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 661 MPNQTGIVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
                   T      VK    +M+PE     + T +SDV+SFGV++ EI 
Sbjct: 254 NNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (333), Expect = 6e-34
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 18/203 (8%)

Query: 513 FEEELGRGCFGAVYKG---SICEGNKI-VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKN 567
             + LG G FG VYKG      E  KI VA+K L E    +  ++   E   +    + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + RLLG C+  S   L+ + M  G L + +   +     +  +   + +A+G+ YL +  
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-----VKGTRGYMSPEW 682
              ++H ++  RN+L+      KI++F LAK+L   +           +K    +M+ E 
Sbjct: 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK----WMALES 190

Query: 683 QNSGLITVKSDVYSFGVVVLEIV 705
               + T +SDV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (329), Expect = 8e-34
 Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 11/198 (5%)

Query: 514 EEELGRGCFGAVYKGSICEGNKI--VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           + ELG G FG+V +G      K   VA+K L +   +    +   E   + +  +  +VR
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
           L+G C Q    +LV E    G L   L          +   +   V+ G+ YL    E  
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT---RGYMSPEWQNSGL 687
            +H ++  RN+LL +   AKIS+F L+K L  + +       G    + + +PE  N   
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-WYAPECINFRK 189

Query: 688 ITVKSDVYSFGVVVLEIV 705
            + +SDV+S+GV + E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  131 bits (331), Expect = 2e-33
 Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 48/250 (19%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRL-ENPVEEGERKFQAEMA 558
           E  R    +  ++G G FG V++         E   +VAVK L E    + +  FQ E A
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------------- 597
            +    + N+V+LLG C       L++E+M+ G L   L                     
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 598 --SNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
             S         +++ IA  VA G+ YL    E + +H ++  RN L+ +++  KI++F 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 656 LAKILMPNQTGIVTGVKGTRGY-----MSPEWQNSGLITVKSDVYSFGVVVLEIV----- 705
           L++ +                      M PE       T +SDV+++GVV+ EI      
Sbjct: 220 LSRNIYSAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275

Query: 706 --CCRSNFEV 713
                ++ EV
Sbjct: 276 PYYGMAHEEV 285

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  129 bits (326), Expect = 2e-33
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 14/210 (6%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGS--ICEGNKI-VAVKRLENPV---EEGERKFQAEMA 558
            +        E+LG G FG V +G      G  + VAVK L+  V    E    F  E+ 
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 559 AVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR 618
           A+    H+NL+RL G  +      +V E    GSL + L   +   +     R A+ VA 
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTR--- 675
           G+ YL  +   + IH ++  RN+LL      KI +F L + L  N        +  +   
Sbjct: 133 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVMQEHRKVPF 188

Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            + +PE   +   +  SD + FGV + E+ 
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMF 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  127 bits (321), Expect = 1e-32
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 514 EEELGRGCFGAVYKGSICEGNKI--VAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLV 569
           ++ELG G FG V KG       +  VAVK L  E      + +  AE   +++  +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           R++G C      +LV E    G L   L         ++ + +   V+ G+ YL E    
Sbjct: 82  RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYLEES--- 136

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT---RGYMSPEWQNSG 686
             +H ++  RN+LL     AKIS+F L+K L  ++        G    + + +PE  N  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK-WYAPECINYY 195

Query: 687 LITVKSDVYSFGVVVLEIV 705
             + KSDV+SFGV++ E  
Sbjct: 196 KFSSKSDVWSFGVLMWEAF 214

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (334), Expect = 3e-32
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 18/210 (8%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGS--ICEGNKI-VAVKRL-ENPVEEGERKFQAEMAAV 560
           E++R        +G G FG V++G     E   + VA+K       +    KF  E   +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
           R+  H ++V+L+G   + +   ++ E  + G L + L   +        +  A  ++  +
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG---- 676
            YL      + +H +I  RN+L+  +   K+ +F L++ +  +        K ++G    
Sbjct: 505 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPI 556

Query: 677 -YMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
            +M+PE  N    T  SDV+ FGV + EI+
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (329), Expect = 8e-32
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 11/198 (5%)

Query: 514 EEELGRGCFGAVYKGSICEGNKI--VAVKRL-ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           + ELG G FG+V +G      K   VA+K L +   +    +   E   + +  +  +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
           L+G C Q    +LV E    G L   L          +   +   V+ G+ YL E+    
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT---RGYMSPEWQNSGL 687
            +H N+  RN+LL +   AKIS+F L+K L  + +       G    + + +PE  N   
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-WYAPECINFRK 515

Query: 688 ITVKSDVYSFGVVVLEIV 705
            + +SDV+S+GV + E +
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 3e-30
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 11/222 (4%)

Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE 547
           S     +          + E   NG    LG+G +G VY G        +A+K +     
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 548 EGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWR 607
              +    E+A  +   HKN+V+ LG   +     +  E +  GSL  LL + + GP+  
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKD 119

Query: 608 DRVRIAL---DVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMPN 663
           +   I      +  G+ YLH+    QI+H +I   N+L++      KIS+F  +K L   
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176

Query: 664 QTGIVTGVKGTRGYMSPE--WQNSGLITVKSDVYSFGVVVLE 703
                T   GT  YM+PE   +        +D++S G  ++E
Sbjct: 177 NPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  117 bits (296), Expect = 2e-29
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 15/201 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           F+ E+GRG F  VYKG   E    VA    +     +   ++F+ E   ++   H N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 571 LLGFCMQTSKK----LLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHE 625
                  T K     +LV E M+ G+L+  L       +    +R     + +G+ +LH 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLH- 146

Query: 626 ECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
                IIH ++   NI +     + KI +  LA +   +       V GT  +M+PE   
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYE 203

Query: 685 SGLITVKSDVYSFGVVVLEIV 705
                   DVY+FG+ +LE+ 
Sbjct: 204 EKY-DESVDVYAFGMCMLEMA 223

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  116 bits (293), Expect = 9e-29
 Identities = 54/272 (19%), Positives = 118/272 (43%), Gaps = 32/272 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKF-QAEMAAVRRTHHKNLVRL 571
           +++GRG F  VY+ +       VA+K  ++ + ++   R     E+  +++ +H N+++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP-------IWRDRVRIALDVARGITYLH 624
               ++ ++  +V E    G L  ++ + +          +W    +  + +   + ++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMH 153

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQ 683
                +++H +I P N+ +  +   K+ +  L +    ++T     + GT  YMSPE   
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIH 209

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED 743
            +G    KSD++S G ++ E+   +S F  +    ++  L   +  C      S    E+
Sbjct: 210 ENG-YNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLYSLCKKIEQCDYPPLPSDHYSEE 266

Query: 744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNV 775
                  L  +V    +CI  +P  RP +  V
Sbjct: 267 -------LRQLVN---MCINPDPEKRPDVTYV 288

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (296), Expect = 2e-28
 Identities = 44/206 (21%), Positives = 85/206 (41%), Gaps = 21/206 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRL 571
            ++ LG G  G +    + +  + VAVKR+         +   E+  +R    H N++R 
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDN-RDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRY 83

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
                +  +   +  E  +  +L+  +   +   +  + + +      G+ +LH      
Sbjct: 84  FCTE-KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---N 138

Query: 631 IIHCNINPRNILL-----DDSLTAKISNFSLAKILMPNQ--TGIVTGVKGTRGYMSPE-- 681
           I+H ++ P NIL+        + A IS+F L K L   +      +GV GT G+++PE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 682 -WQNSGLITVKSDVYSFGVVVLEIVC 706
                   T   D++S G V   ++ 
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVIS 224

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (290), Expect = 3e-28
 Identities = 51/198 (25%), Positives = 79/198 (39%), Gaps = 22/198 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             +GRG FG V++    +     AVK  RLE    E       E+ A        +V L 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
           G   +     +  E +  GSL  L+   + G +  DR          G+ YLH     +I
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYYLGQALEGLEYLHTR---RI 171

Query: 632 IHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTG----VKGTRGYMSPE-WQNS 685
           +H ++   N+LL  D   A + +F  A  L P+  G        + GT  +M+PE     
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 686 GLITVKSDVYSFGVVVLE 703
                K D++S   ++L 
Sbjct: 232 P-CDAKVDIWSSCCMMLH 248

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (291), Expect = 3e-28
 Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 9/214 (4%)

Query: 493 SQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK 552
            + F+ Q    GEL+        ELG G  G V+K S      ++A K +   ++   R 
Sbjct: 17  LEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN 76

Query: 553 F-QAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV- 610
               E+  +   +   +V   G      +  +  E M  GSL+ +L   ++G I    + 
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILG 134

Query: 611 RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG 670
           ++++ V +G+TYL E+   +I+H ++ P NIL++     K+ +F ++  L+ +     + 
Sbjct: 135 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SF 190

Query: 671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEI 704
           V GTR YMSPE       +V+SD++S G+ ++E+
Sbjct: 191 V-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  111 bits (279), Expect = 3e-27
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 52/291 (17%)

Query: 507 ERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH 564
           +R    F+  E +G G FG V+K       K   +KR    V+    K + E+ A+ +  
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLD 62

Query: 565 HKNLVRLLGF-------------CMQTSKKLLVY---EFMSKGSLENLLSNVESGPIWRD 608
           H N+V   G                  SK   ++   EF  KG+LE  +       + + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 609 RV-RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI 667
               +   + +G+ Y+H +   ++I+ ++ P NI L D+   KI +F L   L     G 
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGK 177

Query: 668 VTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLST 725
            T  KGT  YMSPE   +      + D+Y+ G+++ E++  C + FE +        L  
Sbjct: 178 RTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS---KFFTDLRD 233

Query: 726 WVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
            + +    K+   L+                     +  +P  RP+   ++
Sbjct: 234 GIISDIFDKKEKTLLQ------------------KLLSKKPEDRPNTSEIL 266

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  112 bits (283), Expect = 3e-27
 Identities = 41/202 (20%), Positives = 87/202 (43%), Gaps = 9/202 (4%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           +++G G FG        E  +   +K   +     +   + + E+A +    H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
               +     +V ++   G L   ++  +      D++    + +   + ++H+    +I
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           +H +I  +NI L    T ++ +F +A++L            GT  Y+SPE  +N      
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP-YNN 204

Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           KSD+++ G V+ E+   +  FE
Sbjct: 205 KSDIWALGCVLYELCTLKHAFE 226

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (276), Expect = 1e-26
 Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 20/202 (9%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRT-HHKNLVRLL 572
            ELGRG +G V K       +I+AVKR+   V   E+K    ++    RT      V   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNV--ESGPIWRDRV-RIALDVARGITYLHEECEV 629
           G   +     +  E M   SL+     V  +   I  D + +IA+ + + + +LH   ++
Sbjct: 73  GALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KL 129

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPE----W 682
            +IH ++ P N+L++     K+ +F ++  L   +           G + YM+PE     
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYMAPERINPE 184

Query: 683 QNSGLITVKSDVYSFGVVVLEI 704
            N    +VKSD++S G+ ++E+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (276), Expect = 1e-26
 Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 16/198 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRR-THHKNLVRL 571
             LG G +G V+K    E  ++ AVKR  +P    +   +  AE+ +  +   H   VRL
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
                +    L L  E     SL+          +   +V     D    + +LH +   
Sbjct: 123 EQ-AWEEGGILYLQTEL-CGPSLQQHCEA-WGASLPEAQVWGYLRDTLLALAHLHSQ--- 176

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLI 688
            ++H ++ P NI L      K+ +F L   L     G     +G   YM+PE  Q S   
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQEGDPRYMAPELLQGS--Y 232

Query: 689 TVKSDVYSFGVVVLEIVC 706
              +DV+S G+ +LE+ C
Sbjct: 233 GTAADVFSLGLTILEVAC 250

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 35/229 (15%)

Query: 508 RATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH 565
           R  + FE    LG+G FG V K      ++  A+K++    EE      +E+  +   +H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNH 61

Query: 566 KNLVRLLGF------------CMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRV-R 611
           + +VR                 ++    L +  E+   G+L +L+ + E+    RD   R
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWR 120

Query: 612 IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL----------- 660
           +   +   ++Y+H +    IIH ++ P NI +D+S   KI +F LAK +           
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 661 --MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVC 706
             +P  +  +T   GT  Y++ E    +G    K D+YS G++  E++ 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  107 bits (269), Expect = 1e-25
 Identities = 46/211 (21%), Positives = 92/211 (43%), Gaps = 25/211 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNL--VR 570
           +++G G    V++  + E  +I A+K   LE    +    ++ E+A + +    +   +R
Sbjct: 34  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  +   T + + +V E      L + L   +S   W  +     ++   +  +H+    
Sbjct: 93  LYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH--- 146

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVKGTRGYMSPE------- 681
            I+H ++ P N L+ D    K+ +F +A  + P+ T +V     GT  YM PE       
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 682 ----WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                ++   I+ KSDV+S G ++  +   +
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (269), Expect = 2e-25
 Identities = 47/211 (22%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVR--RTHHKNLVR 570
           +++G G    V++  + E  +I A+K   LE    +    ++ E+A +   + H   ++R
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           L  +   T + + +V E      L + L   +S   W  +     ++   +  +H+    
Sbjct: 74  LYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH--- 127

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV-TGVKGTRGYMSPE------- 681
            I+H ++ P N L+ D    K+ +F +A  + P+ T +V     GT  YM PE       
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 682 ----WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                ++   I+ KSDV+S G ++  +   +
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  107 bits (270), Expect = 3e-25
 Identities = 49/254 (19%), Positives = 104/254 (40%), Gaps = 28/254 (11%)

Query: 475 KQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNG---FEEELGRGCFGAVYKGSIC 531
           +    ++++  ++S    + +    S S  E            +++G G    V++  + 
Sbjct: 19  ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LN 77

Query: 532 EGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNL--VRLLGFCMQTSKKL-LVYE 586
           E  +I A+K   LE    +    ++ E+A + +    +   +RL  +   T + + +V E
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVME 136

Query: 587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS 646
                 L + L   +S   W  +     ++   +  +H+     I+H ++ P N L+ D 
Sbjct: 137 C-GNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 191

Query: 647 LTAKISNFSLAKILMPNQTGIV-TGVKGTRGYMSPE-----------WQNSGLITVKSDV 694
              K+ +F +A  + P+ T +V     G   YM PE            ++   I+ KSDV
Sbjct: 192 -MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 695 YSFGVVVLEIVCCR 708
           +S G ++  +   +
Sbjct: 251 WSLGCILYYMTYGK 264

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (264), Expect = 3e-25
 Identities = 44/224 (19%), Positives = 84/224 (37%), Gaps = 42/224 (18%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRR-THHKNLVRL 571
           E++G G FG+V+K        I A+KR + P+     E+    E+ A      H ++VR 
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGP-------IWRDRVRIALDVARGITYLH 624
                +    L+  E+ + GSL + +S             +      + L V RG+ Y+H
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK----DLLLQVGRGLRYIH 132

Query: 625 EECEVQIIHCNINPRNILLD-------------------DSLTAKISNFSLAKILMPNQT 665
                 ++H +I P NI +                    + +  KI +      +   Q 
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 666 GIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCR 708
                 +G   +++ E  Q +     K+D+++  + V+      
Sbjct: 190 -----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  105 bits (265), Expect = 3e-25
 Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 33/228 (14%)

Query: 508 RATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTH 564
           R    FE  + LGRG FG V++      +   A+KR+     E    K   E+ A+ +  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 565 HKNLVRLLGF---------CMQTSKKLLVY---EFMSKGSLENLLSNVESGPIWRDRV-- 610
           H  +VR                +S K+ +Y   +   K +L++ ++   +       V  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 611 RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL---------- 660
            I L +A  + +LH +    ++H ++ P NI        K+ +F L   +          
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 661 -MPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVC 706
                    TG  GT+ YMSPE    +   + K D++S G+++ E++ 
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  105 bits (263), Expect = 4e-25
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 12/208 (5%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             +G G +G   K       KI+  K     +  E  ++   +E+  +R   H N+VR  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 573 G-FCMQTSKKL-LVYEFMSKGSLENLLSNV--ESGPIWRDRV-RIALDVARGITYLHEEC 627
                +T+  L +V E+   G L ++++    E   +  + V R+   +   +   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 628 EV--QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQN 684
           +    ++H ++ P N+ LD     K+ +F LA+IL  + +   T V GT  YMSPE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190

Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                 KSD++S G ++ E+      F 
Sbjct: 191 MSY-NEKSDIWSLGCLLYELCALMPPFT 217

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (265), Expect = 4e-25
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 39/234 (16%)

Query: 489 SLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE 548
            + P Q +    F+  +L+        E+GRG +G+V K       +I+AVKR+ + V+E
Sbjct: 10  KISPEQHW---DFTAEDLKD-----LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 549 GERK-FQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES---G 603
            E+K    ++  V R+     +V+  G   +     +  E MS  S +     V S    
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDD 120

Query: 604 PIWRDRV-RIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNF-------- 654
            I  + + +I L   + + +L E   ++IIH +I P NILLD S   K+ +F        
Sbjct: 121 VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178

Query: 655 SLAKILMPNQTGIVTGVKGTRGYMSPE----WQNSGLITVKSDVYSFGVVVLEI 704
           S+AK          T   G R YM+PE      +     V+SDV+S G+ + E+
Sbjct: 179 SIAK----------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  104 bits (262), Expect = 7e-25
 Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE---RKFQAEMAAVRRTHHKNLVR 570
            ++LG G    VY       N  VA+K +  P  E E   ++F+ E+    +  H+N+V 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEV 629
           ++    +     LV E++   +L   +     GP+     +     +  GI + H+    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDTAINFTNQILDGIKHAHDM--- 130

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIVTGVKGTRGYMSPEWQNSG 686
           +I+H +I P+NIL+D + T KI +F +AK L      QT  V G   T  Y SPE     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG---TVQYFSPEQAKGE 187

Query: 687 LITVKSDVYSFGVVVLEIV 705
                +D+YS G+V+ E++
Sbjct: 188 ATDECTDIYSIGIVLYEML 206

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (273), Expect = 1e-24
 Identities = 37/207 (17%), Positives = 81/207 (39%), Gaps = 22/207 (10%)

Query: 514 EEELGRGCFGAVYKGS-ICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRL 571
           +  +  G  G +Y         + V +K L +  +   +    AE   +    H ++V++
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 572 LGFCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHE 625
             F   T +       +V E++   SL+          +   + +   L++   ++YLH 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSYLHS 200

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
              + +++ ++ P NI+L +    K+ +      +  N  G + G   T G+ +PE    
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYLYG---TPGFQAPE-IVR 250

Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFE 712
              TV +D+Y+ G  +  +        
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRN 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  104 bits (261), Expect = 1e-24
 Identities = 55/291 (18%), Positives = 111/291 (38%), Gaps = 44/291 (15%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F ++LG G F  V            A+KR+    ++   + Q E    R  +H N++RL+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 573 GFCMQTSKK----LLVYEFMSKGSLENLLSN--VESGPIWRDRV-RIALDVARGITYLHE 625
            +C++         L+  F  +G+L N +     +   +  D++  + L + RG+  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK--------GTRGY 677
           +      H ++ P NILL D     + +         +  G    +          T  Y
Sbjct: 153 K---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 678 MSPE-WQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLL-----STWVYN 729
            +PE +      +I  ++DV+S G V+  ++     +++     D V L      +   +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269

Query: 730 CFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
              +  L +L+                     +  +P+ RP +  ++  LE
Sbjct: 270 PRHSSALWQLLNS------------------MMTVDPHQRPHIPLLLSQLE 302

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (262), Expect = 2e-24
 Identities = 35/217 (16%), Positives = 72/217 (33%), Gaps = 28/217 (12%)

Query: 513 FEEELGRGCFGAVYKGSICEGN-----KIVAVKRLENPVEEGERKFQAEMAAVRRTHHKN 567
               LG G F  VY+ +  + N     +   +K  +             M  ++ +    
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLL---SNVESGPIWRDRVR-IALDVARGITYL 623
            ++     +  +  +LV E  S G+L N +    N     + +  V   A+ +   I  +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 624 HEECEVQIIHCNINPRNILLDDSLTA-----------KISNFSLA---KILMPNQTGIVT 669
           H   + +IIH +I P N +L +                + +   +   K+         T
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI--FT 243

Query: 670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC 706
               T G+   E  ++     + D +     V  ++ 
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (262), Expect = 5e-24
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 40/225 (17%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRL 571
            E+ LG G  G V      +G + VAVKR+     +       E+  +  +  H N++R 
Sbjct: 19  SEKILGYGSSGTVVFQGSFQG-RPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRY 74

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLL------SNVESGPIWRDRVRIALDVARGITYLH 624
                 T + L +  E  +  +L++L+                + + +   +A G+ +LH
Sbjct: 75  YCSE-TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 625 EECEVQIIHCNINPRNILLD-------------DSLTAKISNFSLAKILMPNQTGIVTGV 671
                +IIH ++ P+NIL+              ++L   IS+F L K L   Q+   T +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 672 K---GTRGYMSPE-------WQNSGLITVKSDVYSFGVVVLEIVC 706
               GT G+ +PE        Q    +T   D++S G V   I+ 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  103 bits (258), Expect = 6e-24
 Identities = 32/274 (11%), Positives = 70/274 (25%), Gaps = 47/274 (17%)

Query: 476 QRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK 535
           +      +    +    + E  + S  +    +      E L  G    V+     E  +
Sbjct: 31  KEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLK--LVEPLRVGDRSVVFLVRDVERLE 88

Query: 536 IVAVKRL---ENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC----------------- 575
             A+K              +      A  R   ++                         
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 576 ---------MQTSKKLLVYEFMSKGSLENLLSNVESGPIWR------DRVRIALDVARGI 620
                       +  LL+    S   LE L S ++   ++R          +   + R  
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
             L  +    ++H +  P N+ +       + + S          G  +       Y   
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK--VGTRGPASS--VPVTYAPR 260

Query: 681 EW--QNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           E+   ++   T   + +  G+ +  + C    F 
Sbjct: 261 EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  102 bits (256), Expect = 1e-23
 Identities = 41/205 (20%), Positives = 77/205 (37%), Gaps = 20/205 (9%)

Query: 515 EELGRGC--FGAVYKGSICEGNKIVAVKR--LENPVEEGERKFQAEMAAVRRTHHKNLVR 570
             +G+G      V         + V V+R  LE    E     Q E+   +  +H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEEC 627
                +  ++  +V  FM+ GS ++L+       +  + + IA     V + + Y+H   
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDYIHHM- 147

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT------GIVTGVKGTRGYMSPE 681
               +H ++   +IL+       +S       ++ +                   ++SPE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 682 --WQNSGLITVKSDVYSFGVVVLEI 704
              QN      KSD+YS G+   E+
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACEL 230

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (252), Expect = 2e-23
 Identities = 46/194 (23%), Positives = 95/194 (48%), Gaps = 12/194 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK--FQAEMAAVRRTHHKNLVRLL 572
           E++G+G  G VY        + VA++++   +++  +K     E+  +R   + N+V  L
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
              +   +  +V E+++ GSL ++   V    +   ++  +  +  + + +LH     Q+
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH +I   NILL    + K+++F     + P Q+   T V GT  +M+PE         K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196

Query: 692 SDVYSFGVVVLEIV 705
            D++S G++ +E++
Sbjct: 197 VDIWSLGIMAIEMI 210

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  100 bits (250), Expect = 3e-23
 Identities = 57/247 (23%), Positives = 106/247 (42%), Gaps = 29/247 (11%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRL-----ENPVEEGERKFQAEMAAVRRTHHKNL 568
            E LG G    V+       ++ VAVK L      +P      +F+ E       +H  +
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP--SFYLRFRREAQNAAALNHPAI 74

Query: 569 VRLL--GFCMQTSKKL--LVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYL 623
           V +   G     +  L  +V E++   +L +++     GP+  +  + +  D  + + + 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNFS 132

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI-VTG-VKGTRGYMSPE 681
           H+     IIH ++ P NI++  +   K+ +F +A+ +  +   +  T  V GT  Y+SPE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCRSNF--EVNVSTA------DVVLLSTWVYNCFIA 733
                 +  +SDVYS G V+ E++     F  +  VS A      D +  S       ++
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG--LS 247

Query: 734 KELSKLV 740
            +L  +V
Sbjct: 248 ADLDAVV 254

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (251), Expect = 3e-23
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 27/224 (12%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLL 572
              L  G F  VY+       +  A+KRL +  EE  R    E+  +++ + H N+V+  
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 573 GFCM-------QTSKKLLVYEFMSKGSLENLLSNVES-GPIWRDRV-RIALDVARGITYL 623
                          + L+   + KG L   L  +ES GP+  D V +I     R + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK----------- 672
           H   +  IIH ++   N+LL +  T K+ +F  A  +        +  +           
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 673 GTRGYMSPE----WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            T  Y +PE    + N   I  K D+++ G ++  +   +  FE
Sbjct: 212 TTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFE 254

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (250), Expect = 4e-23
 Identities = 45/194 (23%), Positives = 91/194 (46%), Gaps = 12/194 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK--FQAEMAAVRRTHHKNLVRLL 572
            ++G G  G V         + VAVK +   + + +R+     E+  +R   H N+V + 
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMY 108

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
              +   +  ++ EF+  G+L ++   V    +  +++  +   V + + YLH +    +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH +I   +ILL      K+S+F     +  +     + V GT  +M+PE  +  L   +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATE 221

Query: 692 SDVYSFGVVVLEIV 705
            D++S G++V+E+V
Sbjct: 222 VDIWSLGIMVIEMV 235

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.4 bits (248), Expect = 7e-23
 Identities = 45/198 (22%), Positives = 89/198 (44%), Gaps = 14/198 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTH-HKNLVRLL 572
            E+G G  G V+K    +   ++AVK++     + E K    ++  V ++H    +V+  
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIALDVARGITYLHEECEVQI 631
           G  +  +   +  E M   +    L     GPI    + ++ + + + + YL E  +  +
Sbjct: 91  GTFITNTDVFIAMELMGTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGV 146

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-----WQNSG 686
           IH ++ P NILLD+    K+ +F ++  L+           G   YM+PE          
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAAYMAPERIDPPDPTKP 204

Query: 687 LITVKSDVYSFGVVVLEI 704
              +++DV+S G+ ++E+
Sbjct: 205 DYDIRADVWSLGISLVEL 222

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 48/211 (22%), Positives = 83/211 (39%), Gaps = 22/211 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRL 571
             + LG+G    V++G   +   + A+K   N            E   +++ +HKN+V+L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 572 LGF--CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEEC 627
                   T  K+L+ EF   GSL  +L    +     +     +  DV  G+ +L E  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131

Query: 628 EVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-- 681
              I+H NI P NI+     D     K+++F  A+ L  ++      + GT  Y+ P+  
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMY 187

Query: 682 ------WQNSGLITVKSDVYSFGVVVLEIVC 706
                   +        D++S GV       
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 17/196 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF---QAEMAAVRRTHHKNLVRL 571
           E++G+G FG V+KG      K+VA+K +   +EE E +    Q E+  + +     + + 
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECE 628
            G  ++ +K  ++ E++  GS  +LL   E GP+  D  +IA    ++ +G+ YLH E  
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSE-- 138

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
            + IH +I   N+LL +    K+++F +A  L   Q    T V GT  +M+PE       
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 196

Query: 689 TVKSDVYSFGVVVLEI 704
             K+D++S G+  +E+
Sbjct: 197 DSKADIWSLGITAIEL 212

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 97.2 bits (242), Expect = 1e-21
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 22/211 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRL 571
             + LG+G    V++G   +   + A+K   N            E   +++ +HKN+V+L
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 572 LGF--CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITYLHEEC 627
                   T  K+L+ EF   GSL  +L    +     +     +  DV  G+ +L E  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131

Query: 628 EVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-- 681
              I+H NI P NI+     D     K+++F  A+ L  ++   V+ + GT  Y+ P+  
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS-LYGTEEYLHPDMY 187

Query: 682 ------WQNSGLITVKSDVYSFGVVVLEIVC 706
                   +        D++S GV       
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF---QAEMAAVRRTHHKNLVRL 571
           E +G G    V         + VA+KR+   +E+ +        E+ A+ + HH N+V  
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRV----RIAL---DVARGITYLH 624
               +   +  LV + +S GS+ +++ ++ +    +  V     IA    +V  G+ YLH
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK----GTRGYMSP 680
           +      IH ++   NILL +  + +I++F ++  L          V+    GT  +M+P
Sbjct: 139 KN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 681 E--WQNSGLITVKSDVYSFGVVVLEI 704
           E   Q  G    K+D++SFG+  +E+
Sbjct: 196 EVMEQVRGY-DFKADIWSFGITAIEL 220

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 97.4 bits (242), Expect = 4e-21
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 19/207 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGER-KFQAEMAAVRRTHHKNLVRL 571
            +E LG G FG V +    +  + VA+K+    +    R ++  E+  +++ +H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 572 LGFCMQTSKKL-------LVYEFMSKGSLENLLSNVESGPIWRDRV--RIALDVARGITY 622
                   +KL       L  E+   G L   L+  E+    ++     +  D++  + Y
Sbjct: 78  RE-VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 623 LHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           LHE    +IIH ++ P NI+L      L  KI +   AK L   +  + T   GT  Y++
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLA 191

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIVC 706
           PE       TV  D +SFG +  E + 
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECIT 218

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.0 bits (234), Expect = 4e-21
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 12/193 (6%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
            E+LG G +G+VYK    E  +IVA+K++  PVE   ++   E++ +++    ++V+  G
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYG 91

Query: 574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECEVQ 630
              + +   +V E+   GS+ +++  + +  +      IA       +G+ YLH     +
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDII-RLRNKTL--TEDEIATILQSTLKGLEYLHFM---R 145

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            IH +I   NILL+    AK+++F +A  L        T + GT  +M+PE         
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204

Query: 691 KSDVYSFGVVVLE 703
            +D++S G+  +E
Sbjct: 205 VADIWSLGITAIE 217

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 19/201 (9%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRL-----ENPVEEGERKFQAEMAAVRRTHHKNL 568
              +GRG  G VY+       +IVA+K +      +P      + Q E     R    ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP--VFRTRMQREARTAGRLQEPHV 96

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-VRIALDVARGITYLHEEC 627
           V +  F     +  +    ++   L  +L     GP+   R V I   +   +   H   
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAMLR--RQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---QTGIVTGVKGTRGYMSPEWQN 684
                H ++ P NIL+     A + +F +A         Q G   G   T  YM+PE  +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG---TLYYMAPERFS 208

Query: 685 SGLITVKSDVYSFGVVVLEIV 705
               T ++D+Y+   V+ E +
Sbjct: 209 ESHATYRADIYALTCVLYECL 229

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.4 bits (234), Expect = 1e-20
 Identities = 39/272 (14%), Positives = 79/272 (29%), Gaps = 47/272 (17%)

Query: 476 QRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK 535
              +    L   S     Q F ++S           G    LG+    A  + +  E  +
Sbjct: 47  YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG--TVLGQEDPYAYLEATDQETGE 104

Query: 536 IVAVKRL---ENPVEEGERKFQAEMAAVRRTHH----------------KNLVRLLGFC- 575
              V      E P     ++ + E+  +R                     +LV+      
Sbjct: 105 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164

Query: 576 ----------MQTSKKLLVYEFMSKGSLENLLSNV-----ESGPI-WRDRVRIALDVARG 619
                     M    +  +Y  M   +L+     +         +    R+++ L V R 
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           +  LH      ++H  + P +I+LD      ++ F        +    +          +
Sbjct: 224 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTA 280

Query: 680 PEW-----QNSGLITVKSDVYSFGVVVLEIVC 706
                    +  L+T   D ++ G+ +  I C
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 43/195 (22%), Positives = 90/195 (46%), Gaps = 11/195 (5%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
            ELG G FG VYK    E   + A K +E   EE    +  E+  +    H  +V+LLG 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQIIH 633
                K  ++ EF   G+++ ++  ++   +   +++ +   +   + +LH +   +IIH
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140

Query: 634 CNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-----WQNSGLI 688
            ++   N+L+      ++++F ++   +       + + GT  +M+PE            
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199

Query: 689 TVKSDVYSFGVVVLE 703
             K+D++S G+ ++E
Sbjct: 200 DYKADIWSLGITLIE 214

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 92.8 bits (230), Expect = 3e-20
 Identities = 46/289 (15%), Positives = 92/289 (31%), Gaps = 59/289 (20%)

Query: 466 IAISSLLAYKQRVNQYQKLRINSSLGPS-QEFIIQSFSTGELERATNGFEEELGRGCFGA 524
           I  +++    + +       +++SL  + Q F ++S           G    LG+    A
Sbjct: 31  IPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRG--TVLGQEDPYA 88

Query: 525 VYKGSICEGNKIVAVK---RLENPVEEGERKFQAEMAAVRR------------------- 562
             + +  E  +   V      E P     ++ + E+  +R                    
Sbjct: 89  YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148

Query: 563 ------THHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNVESGPI------WRD 608
                    K ++R+              +Y  M   +L+     + S            
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHA 207

Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
           R+++ L V R +  LH      ++H  + P +I+LD      ++ F         + G  
Sbjct: 208 RLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGAR 259

Query: 669 TGVKGTRGYMSPEW-----------QNSGLITVKSDVYSFGVVVLEIVC 706
                +RG+  PE                L+T   D ++ G+V+  I C
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 24/206 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRT-HHKNLVRLL 572
           E +G G +G VYKG   +  ++ A+K +   V   E +  + E+  +++  HH+N+    
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 573 G-----FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYL 623
           G            +L LV EF   GS+ +L+ N +   +      IA    ++ RG+++L
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL--KEEWIAYICREILRGLSHL 145

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-- 681
           H+    ++IH +I  +N+LL ++   K+ +F ++  L        T + GT  +M+PE  
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 201

Query: 682 ---WQNSGLITVKSDVYSFGVVVLEI 704
                       KSD++S G+  +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEM 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 45/194 (23%), Positives = 86/194 (44%), Gaps = 15/194 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             EELG G FG V++       ++   K +  P    +   + E++ + + HH  L+ L 
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114

Query: 573 GFCMQTSKKL-LVYEFMSKGSL-ENLLSNVESGPIW--RDRVRIALDVARGITYLHEECE 628
               +   ++ L+ EF+S G L + +             + +        G+ ++HE   
Sbjct: 115 DAF-EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHEH-- 168

Query: 629 VQIIHCNINPRNILL--DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
             I+H +I P NI+     + + KI +F LA  L P++  IV     T  + +PE  +  
Sbjct: 169 -SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDRE 225

Query: 687 LITVKSDVYSFGVV 700
            +   +D+++ GV+
Sbjct: 226 PVGFYTDMWAIGVL 239

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 21/199 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF---QAEMAAVRRTHHKNLVRL 571
            E+G G FGAVY       +++VA+K++    ++   K+     E+  +++  H N ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL---DVARGITYLHEECE 628
            G  ++     LV E+   GS  +LL  V   P+    V IA       +G+ YLH    
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLL-EVHKKPL--QEVEIAAVTHGALQGLAYLHSH-- 173

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNS 685
             +IH ++   NILL +    K+ +F  A I+ P  + +     GT  +M+PE     + 
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDE 227

Query: 686 GLITVKSDVYSFGVVVLEI 704
           G    K DV+S G+  +E+
Sbjct: 228 GQYDGKVDVWSLGITCIEL 246

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 44/197 (22%), Positives = 83/197 (42%), Gaps = 16/197 (8%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +  ++ A K      L  P      K   E++  R   H+++V  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP--HQREKMSMEISIHRSLAHQHVVGF 106

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
            G   + +  + +V E   + SL  L        +     R     +  G  YLH     
Sbjct: 107 HG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRN--- 160

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           ++IH ++   N+ L++ L  KI +F LA  +  +       + GT  Y++PE  +    +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219

Query: 690 VKSDVYSFGVVVLEIVC 706
            + DV+S G ++  ++ 
Sbjct: 220 FEVDVWSIGCIMYTLLV 236

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 88.6 bits (220), Expect = 4e-19
 Identities = 48/260 (18%), Positives = 97/260 (37%), Gaps = 45/260 (17%)

Query: 474 YKQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEG 533
            K  ++ Y  L   +     ++  I  +               L +G F  +      + 
Sbjct: 6   MKDILSNYSNLIYLNKYVKEKDKYINDYRIIR----------TLNQGKFNKIILCE--KD 53

Query: 534 NKIVAVKRLE-----------------NPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           NK  A+K+ E                   ++     F+ E+  +    ++  +   G  +
Sbjct: 54  NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-I 112

Query: 577 QTSKKL-LVYEFMSKGSL------ENLLSNVESGPIWRDRVR-IALDVARGITYLHEECE 628
               ++ ++YE+M   S+        +L    +  I    ++ I   V    +Y+H E  
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--WQNSG 686
             I H ++ P NIL+D +   K+S+F  ++  M +    + G +GT  +M PE     S 
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDFGESEY-MVD--KKIKGSRGTYEFMPPEFFSNESS 227

Query: 687 LITVKSDVYSFGVVVLEIVC 706
               K D++S G+ +  +  
Sbjct: 228 YNGAKVDIWSLGICLYVMFY 247

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 14/195 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEG-ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L      + G E + + E+       H N++RL G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
           +    + ++ L+ E+   G++   L   +       R      ++A  ++Y H +   ++
Sbjct: 77  Y-FHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYCHSK---RV 130

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH +I P N+LL  +   KI++F  +     ++    T + GT  Y+ PE     +   K
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDYLPPEMIEGRMHDEK 187

Query: 692 SDVYSFGVVVLEIVC 706
            D++S GV+  E + 
Sbjct: 188 VDLWSLGVLCYEFLV 202

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 14/194 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F E LG G F  V+        K+ A+K ++      +   + E+A +++  H+N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECEVQ 630
               +++    LV + +S G L + +  +E G    +D   +   V   + YLHE     
Sbjct: 73  DI-YESTTHYYLVMQLVSGGELFDRI--LERGVYTEKDASLVIQQVLSAVKYLHEN---G 126

Query: 631 IIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
           I+H ++ P N+L    +++    I++F L+K+      GI++   GT GY++PE      
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPEVLAQKP 183

Query: 688 ITVKSDVYSFGVVV 701
            +   D +S GV+ 
Sbjct: 184 YSKAVDCWSIGVIT 197

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 16/203 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F   ++ S  +  ++ A K      L  P      K   E++  R   H+++V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP--HQREKMSMEISIHRSLAHQHVVGF 80

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
            G   + +  + +V E   + SL  L        +     R     +  G  YLH     
Sbjct: 81  HG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVLGCQYLHRN--- 134

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           ++IH ++   N+ L++ L  KI +F LA  +  +       + GT  Y++PE  +    +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193

Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
            + DV+S G ++  ++  +  FE
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE 216

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 89.5 bits (222), Expect = 1e-18
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 25/198 (12%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             EELG G FG V++ +        A K +  P E  +   + E+  +    H  LV L 
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 573 GFCMQTSKKLLVYEFMSKGSL-------ENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
                 ++ +++YEFMS G L        N +S  E      + V     V +G+ ++HE
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS--E-----DEAVEYMRQVCKGLCHMHE 273

Query: 626 ECEVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
                 +H ++ P NI+      + L  K+ +F L   L P Q+  V    GT  + +PE
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQS--VKVTTGTAEFAAPE 326

Query: 682 WQNSGLITVKSDVYSFGV 699
                 +   +D++S GV
Sbjct: 327 VAEGKPVGYYTDMWSVGV 344

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 86.9 bits (216), Expect = 1e-18
 Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 34/207 (16%)

Query: 513 FEEELGRGCFGAVYKGSICE----GN----KIVAVKRLENPVEEGER-KFQAEMAAVRRT 563
             EELG G F  V K   C     G     K +  ++         R + + E++ +R+ 
Sbjct: 16  IGEELGSGQFAIVKK---CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSL------ENLLSNVESGPIWRDRVRIALDVA 617
            H N++ L       +  +L+ E +S G L      +  LS  E      +       + 
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--E-----EEATSFIKQIL 125

Query: 618 RGITYLHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            G+ YLH +   +I H ++ P NI+L          K+ +F LA  +          + G
Sbjct: 126 DGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFG 180

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVV 700
           T  +++PE  N   + +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 85.7 bits (213), Expect = 2e-18
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 12/194 (6%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEG-ERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG VY     +   I+A+K L      +EG E + + E+       H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           +     K++ L+ EF  +G L   L         R       ++A  + Y HE    ++I
Sbjct: 82  Y-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHER---KVI 136

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H +I P N+L+      KI++F  +           T + GT  Y+ PE         K 
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRT-MCGTLDYLPPEMIEGKTHDEKV 193

Query: 693 DVYSFGVVVLEIVC 706
           D++  GV+  E + 
Sbjct: 194 DLWCAGVLCYEFLV 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 37/223 (16%)

Query: 498 IQSFSTGELERATNGFEEELGRGCFGAVYKGSICE----GN----KIVAVKRLENPVEEG 549
           +++F   ++E   +   EELG G F  V K   C     G     K +  ++        
Sbjct: 2   METFKQQKVEDFYD-IGEELGSGQFAIVKK---CREKSTGLEYAAKFIKKRQSRASRRGV 57

Query: 550 ER-KFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL-LVYEFMSKGSL------ENLLSNVE 601
            R + + E++ +R+  H N++ L     +    + L+ E +S G L      +  LS  E
Sbjct: 58  CREEIEREVSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLS--E 114

Query: 602 SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLA 657
                 +       +  G+ YLH +   +I H ++ P NI+L          K+ +F LA
Sbjct: 115 -----EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

Query: 658 KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVV 700
             +          + GT  +++PE  N   + +++D++S GV+
Sbjct: 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 32/209 (15%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK---------RLENPVEEGERKFQAEMAAVRR- 562
            +E LGRG    V +       K  AVK              V+E       E+  +R+ 
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 563 THHKNLVRLLGFCMQTSKKL-LVYEFMSKGSL-ENLLSNV---ESGPIWRDRVRIALDVA 617
           + H N+++L     +T+    LV++ M KG L + L   V   E     ++  +I   + 
Sbjct: 81  SGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSE-----KETRKIMRALL 134

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
             I  LH+     I+H ++ P NILLDD +  K+++F  +  L P +   +  V GT  Y
Sbjct: 135 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSY 189

Query: 678 MSPE------WQNSGLITVKSDVYSFGVV 700
           ++PE        N      + D++S GV+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 21/202 (10%), Positives = 56/202 (27%), Gaps = 37/202 (18%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVR 570
               G       ++      ++ VA+  ++      ++  ++  +    + R     + R
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
           +L      +  L+V E++  GSL+ +    ++ P     +R    +A      H      
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAHRA---G 149

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           +     +P  + +       +                          M            
Sbjct: 150 VALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDA-------NP 181

Query: 691 KSDVYSFGVVVLEIVCCRSNFE 712
           + D+   G  +  ++  R    
Sbjct: 182 QDDIRGIGASLYALLVNRWPLP 203

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 87.4 bits (217), Expect = 4e-18
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 27/212 (12%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL-------------ENPVEEGERKFQAEMAA 559
              +LG G +G V       G+   A+K +                +E+   +   E++ 
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 560 VRRTHHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVA 617
           ++   H N+++L     +  K   LV EF   G L   +  +        D   I   + 
Sbjct: 100 LKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAANIMKQIL 156

Query: 618 RGITYLHEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGT 674
            GI YLH+     I+H +I P NILL   +  L  KI +F L+     +    +    GT
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLGT 211

Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC 706
             Y++PE         K DV+S GV++  ++C
Sbjct: 212 AYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC 242

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 86.3 bits (214), Expect = 6e-18
 Identities = 47/238 (19%), Positives = 92/238 (38%), Gaps = 29/238 (12%)

Query: 485 RINSSLGPSQEFIIQSFSTGELERATNGFE------EELGRGCFGAVYKGSICEGNKIVA 538
            I  SL  ++ F+    +  +               + LG G  G V      +  K VA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164

Query: 539 VKRL--------ENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK 590
           ++ +             +     + E+  +++ +H  ++++  F        +V E M  
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEG 223

Query: 591 GSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL---DDS 646
           G L + +  V +  +           +   + YLHE     IIH ++ P N+LL   ++ 
Sbjct: 224 GELFDKV--VGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 278

Query: 647 LTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSGLITVKSDVYSFGVVV 701
              KI++F  +KIL      ++  + GT  Y++PE      +       D +S GV++
Sbjct: 279 CLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 28/204 (13%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGER-KFQAEMAAVRRTHHK 566
             EELG G F  V K       K  A K     RL +      R + + E+  +R   H 
Sbjct: 9   MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSL------ENLLSNVESGPIWRDRVRIALDVARGI 620
           N++ L       +  +L+ E +S G L      +  L+  E      +  +    +  G+
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT--E-----DEATQFLKQILDGV 121

Query: 621 TYLHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
            YLH +   +I H ++ P NI+L      +   K+ +F +A  +          + GT  
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPE 176

Query: 677 YMSPEWQNSGLITVKSDVYSFGVV 700
           +++PE  N   + +++D++S GV+
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVI 200

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 86.7 bits (215), Expect = 6e-18
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 17/202 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAEMAAVRRTHHKNLV 569
            +  LG+G FG V         +  AVK +       +  +     E+  +++  H N++
Sbjct: 30  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEEC 627
           +L  F  +      LV E  + G L + +  +        D  RI   V  GITY+H+  
Sbjct: 90  KLYEFF-EDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITYMHKN- 145

Query: 628 EVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQN 684
             +I+H ++ P N+LL         +I +F L+     ++   +    GT  Y++PE  +
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLH 201

Query: 685 SGLITVKSDVYSFGVVVLEIVC 706
            G    K DV+S GV++  ++ 
Sbjct: 202 -GTYDEKCDVWSTGVILYILLS 222

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 42/192 (21%), Positives = 79/192 (41%), Gaps = 14/192 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             E+LGRG FG V++       K    K ++    +     + E++ +    H+N++ L 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLH 67

Query: 573 GFCMQTSKKLLVYEFMSKGSL-ENLLSNVESGPIW--RDRVRIALDVARGITYLHEECEV 629
                  + ++++EF+S   + E +     S      R+ V     V   + +LH     
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSH--- 121

Query: 630 QIIHCNINPRNILLDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
            I H +I P NI+     ++  KI  F  A+ L P        +     Y +PE     +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDV 179

Query: 688 ITVKSDVYSFGV 699
           ++  +D++S G 
Sbjct: 180 VSTATDMWSLGT 191

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 83.7 bits (208), Expect = 7e-18
 Identities = 49/197 (24%), Positives = 82/197 (41%), Gaps = 15/197 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G F  VY+         VA+K      +        ++ Q E+    +  H +++ L
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA--GMVQRVQNEVKIHCQLKHPSILEL 76

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEV 629
                + S  + LV E    G +   L N    P   +  R     +  G+ YLH     
Sbjct: 77  YN-YFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH--- 131

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            I+H ++   N+LL  ++  KI++F LA  L        T + GT  Y+SPE        
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHG 190

Query: 690 VKSDVYSFGVVVLEIVC 706
           ++SDV+S G +   ++ 
Sbjct: 191 LESDVWSLGCMFYTLLI 207

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 86.3 bits (214), Expect = 9e-18
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 16/201 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVR 570
             ++LG G +G V        +   A+K +   +       K   E+A ++   H N+++
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L  F  +  +   LV E    G L + +  +        D   I   V  G+TYLH+   
Sbjct: 101 LYDFF-EDKRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH-- 155

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             I+H ++ P N+LL   +     KI +F L+ +    +   +    GT  Y++PE    
Sbjct: 156 -NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPEVLR- 211

Query: 686 GLITVKSDVYSFGVVVLEIVC 706
                K DV+S GV++  ++ 
Sbjct: 212 KKYDEKCDVWSIGVILFILLA 232

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 47/195 (24%), Positives = 77/195 (39%), Gaps = 18/195 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            E  +GRG +G V            A K++     E   +F+ E+  ++   H N++RL 
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECEVQ 630
               + +  + LV E  + G L   +  V        D  RI  DV   + Y H+     
Sbjct: 73  ETF-EDNTDIYLVMELCTGGELFERV--VHKRVFRESDAARIMKDVLSAVAYCHKL---N 126

Query: 631 IIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--WQNS 685
           + H ++ P N L          K+ +F LA    P +   +    GT  Y+SP+      
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLEGLY 184

Query: 686 GLITVKSDVYSFGVV 700
           G    + D +S GV+
Sbjct: 185 GP---ECDEWSAGVM 196

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 30/205 (14%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGER-KFQAEMAAVRRTHHK 566
             EELG G F  V K          A K     R ++      R   + E++ ++   H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 567 NLVRLLGFCMQTSKKL-LVYEFMSKGSL------ENLLSNVESGPIWRDRVRIALDVARG 619
           N++ L     +    + L+ E ++ G L      +  L+  E      +       +  G
Sbjct: 75  NVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLT--E-----EEATEFLKQILNG 126

Query: 620 ITYLHEECEVQIIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTR 675
           + YLH     QI H ++ P NI+L          KI +F LA  +          + GT 
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTP 181

Query: 676 GYMSPEWQNSGLITVKSDVYSFGVV 700
            +++PE  N   + +++D++S GV+
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVI 206

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.3 bits (211), Expect = 3e-17
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 18/204 (8%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAE---MAAVRRTHHKNLVR 570
           +GRG FG VY     +  K+ A+K L+      ++GE     E   ++ V       +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECE 628
           +  +   T  KL  + + M+ G L   LS    G      +R  A ++  G+ ++H    
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR-- 311

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G+ 
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKGVA 367

Query: 689 TVKS-DVYSFGVVVLEIVCCRSNF 711
              S D +S G ++ +++   S F
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPF 391

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 45/240 (18%), Positives = 84/240 (35%), Gaps = 56/240 (23%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKN 567
            +  +G+G +G V      +   I A+K     ++     +   + + E+  +++ HH N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 568 LVRLLGFCMQTSKKL-LVYEFMSKGSL-------------ENLLSNVESGPIW------- 606
           + RL     +  + + LV E    G L             +  +  V++           
Sbjct: 90  IARLYEVY-EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 607 -------------------RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL--DD 645
                              +    I   +   + YLH +    I H +I P N L   + 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205

Query: 646 SLTAKISNFSLAKILMPNQTGIVTGVK---GTRGYMSPE--WQNSGLITVKSDVYSFGVV 700
           S   K+ +F L+K       G   G+    GT  +++PE     +     K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 83.2 bits (206), Expect = 3e-17
 Identities = 45/193 (23%), Positives = 89/193 (46%), Gaps = 13/193 (6%)

Query: 512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
              E LG G FG V+K         +A K ++    + + + + E++ + +  H NL++L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW--RDRVRIALDVARGITYLHEECE 628
                ++   + LV E++  G L + +  ++        D +     +  GI ++H+   
Sbjct: 152 YDAF-ESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMHQM-- 206

Query: 629 VQIIHCNINPRNILLDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
             I+H ++ P NIL  +      KI +F LA+   P +   +    GT  +++PE  N  
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYD 263

Query: 687 LITVKSDVYSFGV 699
            ++  +D++S GV
Sbjct: 264 FVSFPTDMWSVGV 276

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 17/200 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKN 567
             E +G+G F  V +    E  +  AVK     +  +         + E +      H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 568 LVRLLGFCMQTSKKL-LVYEFMSKGSL-ENLLSNVESGPIW--RDRVRIALDVARGITYL 623
           +V LL     +   L +V+EFM    L   ++   ++G ++           +   + Y 
Sbjct: 88  IVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 624 HEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
           H+     IIH ++ P  +LL   ++S   K+  F +A  L  +   +  G  GT  +M+P
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAP 202

Query: 681 EWQNSGLITVKSDVYSFGVV 700
           E           DV+  GV+
Sbjct: 203 EVVKREPYGKPVDVWGCGVI 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 15/193 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            E ELGRG    VY+       K  A+K L+      ++  + E+  + R  H N+++L 
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECEVQ 630
               +T  ++ LV E ++ G L + +  VE G    RD       +   + YLHE     
Sbjct: 115 EIF-ETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLHEN---G 168

Query: 631 IIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL 687
           I+H ++ P N+L          KI++F L+KI+      ++  V GT GY +PE      
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCA 226

Query: 688 ITVKSDVYSFGVV 700
              + D++S G++
Sbjct: 227 YGPEVDMWSVGII 239

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 44/198 (22%), Positives = 83/198 (41%), Gaps = 19/198 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           F+ +LG G FG V+            +K +  +  +    + +AE+  ++   H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85

Query: 572 LGFCMQTSKKL-LVYEFMSKGSL-ENLLSNVESGPIW--RDRVRIALDVARGITYLHEEC 627
                +    + +V E    G L E ++S    G          +   +   + Y H + 
Sbjct: 86  FEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143

Query: 628 EVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--W 682
              ++H ++ P NIL          KI +F LA++   ++    T   GT  YM+PE   
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALYMAPEVFK 199

Query: 683 QNSGLITVKSDVYSFGVV 700
           ++      K D++S GVV
Sbjct: 200 RDVTF---KCDIWSAGVV 214

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.9 bits (203), Expect = 6e-17
 Identities = 42/195 (21%), Positives = 88/195 (45%), Gaps = 14/195 (7%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRR-THHKNLVR 570
            +ELGRG F  V +       +  A K  +     ++   +   E+A +        ++ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L     + + ++ L+ E+ + G + +L     +  +   D +R+   +  G+ YLH+   
Sbjct: 94  LHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN-- 150

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             I+H ++ P+NILL         KI +F +++ +       +  + GT  Y++PE  N 
Sbjct: 151 -NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNY 207

Query: 686 GLITVKSDVYSFGVV 700
             IT  +D+++ G++
Sbjct: 208 DPITTATDMWNIGII 222

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.1 bits (203), Expect = 8e-17
 Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--------ENPVEEGERKFQAEMAAVRR-T 563
            ++ +GRG    V +          AVK +           +EE     + E   +R+  
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSL-ENLLSNV---ESGPIWRDRVRIALDVAR 618
            H +++ L+    ++S  + LV++ M KG L + L   V   E     ++   I   +  
Sbjct: 158 GHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSE-----KETRSIMRSLLE 211

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
            +++LH      I+H ++ P NILLDD++  ++S+F  +  L P +   +  + GT GY+
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYL 266

Query: 679 SPE------WQNSGLITVKSDVYSFGVV 700
           +PE       +       + D+++ GV+
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVI 294

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.5 bits (204), Expect = 2e-16
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 11/201 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LG+G FG V    +    K+ A K+LE       +GE     E   + + + + +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  +T   L LV   M+ G L+  + ++        R    A ++  G+  LH E   +I
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RI 307

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           ++ ++ P NILLDD    +IS+  LA  +   QT  + G  GT GYM+PE   +   T  
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFS 365

Query: 692 SDVYSFGVVVLEIVCCRSNFE 712
            D ++ G ++ E++  +S F+
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQ 386

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 81.7 bits (202), Expect = 2e-16
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 16/201 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVR 570
               LG+G FG V K       +  AVK +   +   +       E+  +++  H N+++
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L     + S    +V E  + G L + +  ++       D  RI   V  GITY+H+   
Sbjct: 86  LFEIL-EDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKH-- 140

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             I+H ++ P NILL   +     KI +F L+     N    +    GT  Y++PE    
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLR- 196

Query: 686 GLITVKSDVYSFGVVVLEIVC 706
           G    K DV+S GV++  ++ 
Sbjct: 197 GTYDEKCDVWSAGVILYILLS 217

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 20/197 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVR 570
               LG+G FG V K       +  AVK +   +   +       E+  +++  H N+++
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L     + S    +V E  + G L + +  ++       D  RI   V  GITY+H+   
Sbjct: 86  LFEIL-EDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMHKH-- 140

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--WQ 683
             I+H ++ P NILL   +     KI +F L+     N    +    GT  Y++PE    
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG 197

Query: 684 NSGLITVKSDVYSFGVV 700
                  K DV+S GV+
Sbjct: 198 TYDE---KCDVWSAGVI 211

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 44/203 (21%), Positives = 82/203 (40%), Gaps = 23/203 (11%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--------ENPVEEGERKFQAEMAAVRRTH 564
             + LG G  G V      +  K VA+K +             +     + E+  +++ +
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYL 623
           H  ++++  F        +V E M  G L + +  V +  +           +   + YL
Sbjct: 74  HPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLAVQYL 130

Query: 624 HEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
           HE     IIH ++ P N+LL   ++    KI++F  +KIL      ++  + GT  Y++P
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAP 185

Query: 681 E---WQNSGLITVKSDVYSFGVV 700
           E      +       D +S GV+
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVI 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 49/195 (25%), Positives = 78/195 (40%), Gaps = 15/195 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVR 570
            +EELG+G F  V +          A K +          +K + E    R+  H N+VR
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L     Q      LV++ ++ G L   +  V        D       +   I Y H    
Sbjct: 70  LHDSI-QEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSN-- 124

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             I+H N+ P N+LL         K+++F LA  +  ++     G  GT GY+SPE    
Sbjct: 125 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKK 181

Query: 686 GLITVKSDVYSFGVV 700
              +   D+++ GV+
Sbjct: 182 DPYSKPVDIWACGVI 196

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 80.0 bits (198), Expect = 6e-16
 Identities = 43/195 (22%), Positives = 73/195 (37%), Gaps = 14/195 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVR 570
             EELG+G F  V +       +  A   +          +K + E    R   H N+VR
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L            L+++ ++ G L   +  V        D       +   + + H+   
Sbjct: 75  LHDSI-SEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCIQQILEAVLHCHQM-- 129

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             ++H N+ P N+LL         K+++F LA  +   Q        GT GY+SPE    
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRK 187

Query: 686 GLITVKSDVYSFGVV 700
                  D+++ GV+
Sbjct: 188 DPYGKPVDLWACGVI 202

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 49/195 (25%), Positives = 78/195 (40%), Gaps = 15/195 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE--NPVEEGERKFQAEMAAVRRTHHKNLVR 570
            +EELG+G F  V +          A K +          +K + E    R+  H N+VR
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECE 628
           L     Q      LV++ ++ G L   +  V        D       +   I Y H    
Sbjct: 93  LHDSI-QEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESIAYCHSN-- 147

Query: 629 VQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             I+H N+ P N+LL         K+++F LA  +  ++     G  GT GY+SPE    
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKK 204

Query: 686 GLITVKSDVYSFGVV 700
              +   D+++ GV+
Sbjct: 205 DPYSKPVDIWACGVI 219

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 32/153 (20%), Positives = 63/153 (41%), Gaps = 27/153 (17%)

Query: 574 FCMQTSKKLLVY---EFMSKGSLENLLSN------VESGPIWRDRVRIALDVARGITYLH 624
               +S K+ +Y   +   K +L++ ++        E G        I + +A  + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH----IFIQIAEAVEFLH 181

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-----------MPNQTGIVTGVKG 673
            +    ++H ++ P NI        K+ +F L   +                   TG  G
Sbjct: 182 SK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC 706
           T+ YMSPE  +    + K D++S G+++ E++ 
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 40/213 (18%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE----NPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           LG G +G V +    E     AVK L+      +  GE   + E+  +RR  HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 573 G-FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITY 622
                +  +K+ +V E+   G  E +L +V          R  +  A         G+ Y
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE-MLDSVPEK-------RFPVCQAHGYFCQLIDGLEY 124

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSP 680
           LH +    I+H +I P N+LL    T KIS   +A+ L P        T   G+  +  P
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPP 180

Query: 681 EWQNSGLIT-------VKSDVYSFGVVVLEIVC 706
           E     +          K D++S GV +  I  
Sbjct: 181 E-----IANGLDTFSGFKVDIWSAGVTLYNITT 208

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 20/154 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-----RKFQAEMAAVRRTHHKN 567
           E+LG G +  VYKG        VA+K  +L++  EEG      R    E++ ++   H+N
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIR----EISLMKELKHEN 64

Query: 568 LVRLLGFCMQTSKKLLVYEFMS---KGSLENLLSNVESGPIWRDRVR-IALDVARGITYL 623
           +VRL       +K  LV+EFM    K  +++         +  + V+     + +G+ + 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 624 HEECEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
           HE    +I+H ++ P+N+L++     K+ +F LA
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 78.7 bits (194), Expect = 3e-15
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 12/203 (5%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLG 573
           LGRG FG V+   +    K+ A K+L        +G +    E   + + H + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVES--GPIWRDRVRI-ALDVARGITYLHEECEV 629
           +  +T   L LV   M+ G +   + NV+         R       +  G+ +LH+    
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--- 308

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P N+LLDD    +IS+  LA  L   QT       GT G+M+PE        
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYD 367

Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
              D ++ GV + E++  R  F 
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFR 390

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 35/175 (20%), Positives = 70/175 (40%), Gaps = 16/175 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRL 571
            +E++G G +    +      N   AVK ++    +       E+  + R   H N++ L
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITL 81

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIW-RDRVRIALDVARGITYLHEECEVQ 630
                      +V E M  G L + +  +       R+   +   + + + YLH +    
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLHAQ---G 136

Query: 631 IIHCNINPRNILL----DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           ++H ++ P NIL      +  + +I +F  AK L      ++T    T  +++PE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 46/202 (22%), Positives = 83/202 (41%), Gaps = 34/202 (16%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLL 572
           ++ LG G F    K    + N+  AVK +   +E   +K   E+ A++    H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 573 GFCMQTSKKLLVYEFMSKGSL-----------ENLLSNVESGPIWRDRVRIALDVARGIT 621
                     LV E ++ G L           E             +   I   +   ++
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSE------------TEASYIMRKLVSAVS 120

Query: 622 YLHEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYM 678
           ++H+     ++H ++ P N+L    +D+L  KI +F  A++  P+   + T    T  Y 
Sbjct: 121 HMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYA 176

Query: 679 SPEWQNSGLITVKSDVYSFGVV 700
           +PE  N        D++S GV+
Sbjct: 177 APELLNQNGYDESCDLWSLGVI 198

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.7 bits (186), Expect = 8e-15
 Identities = 31/104 (29%), Positives = 54/104 (51%), Gaps = 12/104 (11%)

Query: 607 RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG 666
              +  +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  +   
Sbjct: 193 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249

Query: 667 IVTG-----VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIV 705
           +  G     +K    +M+PE     + T++SDV+SFGV++ EI 
Sbjct: 250 VRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 41/168 (24%), Positives = 62/168 (36%), Gaps = 16/168 (9%)

Query: 505 ELERATNGFEEELGRGCFGAVYKGSI-----CEGNKIVAVKRLENPVEEGERK-FQAEMA 558
           E  R      + LGRG FG V +            + VAVK L+      E +   +E+ 
Sbjct: 18  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77

Query: 559 -AVRRTHHKNLVRLLGFCMQTSKKLLV-YEFMSKGSLENLLSNVESGPIWRDRVRIALDV 616
             +   HH N+V LLG C +    L+V  EF   G+L   L           R       
Sbjct: 78  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYK 129

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ 664
            +G  +   +  V  I  ++  R   +  S ++  S F   K L   +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVR 570
             + +G+G F  V         + VA+K ++         +K   E+  ++  +H N+V+
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 571 LLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GIT 621
           L    ++T K L L+ E+ S G + + L  V  G       R+    AR         + 
Sbjct: 79  LFE-VIETEKTLYLIMEYASGGEVFDYL--VAHG-------RMKEKEARSKFRQIVSAVQ 128

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           Y H++    I+H ++   N+LLD  +  KI++F  +         +     G   Y +PE
Sbjct: 129 YCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFC-GAPPYAAPE 183

Query: 682 -WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            +Q       + DV+S GV++  +V     F+
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 75.3 bits (186), Expect = 9e-15
 Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 19/152 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-----RKFQAEMAAVRRTHHKN 567
           ++LG G +  VYKG     + +VA+K  RLE+  EEG      R    E++ ++   H N
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR----EVSLLKDLKHAN 61

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
           +V L           LV+E++ K  L+  L +     I    V+     + RG+ Y H +
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ 119

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +++H ++ P+N+L+++    K+++F LA+
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLAR 148

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 75.0 bits (185), Expect = 9e-15
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 20/200 (10%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKF-QAEMAAVRRTHHKNLVRLLG 573
           LG G F  V        ++  A+K LE    ++E +  +   E   + R  H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           F  Q  +KL     +   G L   +  + S      R   A ++   + YLH +    II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-EIVSALEYLHGK---GII 152

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVK 691
           H ++ P NILL++ +  +I++F  AK+L P           GT  Y+SPE     L+T K
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-----LLTEK 207

Query: 692 -----SDVYSFGVVVLEIVC 706
                SD+++ G ++ ++V 
Sbjct: 208 SACKSSDLWALGCIIYQLVA 227

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 21/191 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQA-EMAAVRRTHHKNLVRL 571
            ++G G +G V+K    +  +IVA+K        +   +K    E+  +++  H NLV L
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNL 67

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
           L    +  +  LV+E+    ++ + L   + G        I     + + + H+      
Sbjct: 68  LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NC 123

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           IH ++ P NIL+      K+ +F  A++L          V     TR Y SPE      +
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA----TRWYRSPE------L 173

Query: 689 TVKSDVYSFGV 699
            V    Y   V
Sbjct: 174 LVGDTQYGPPV 184

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 21/191 (10%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA--EMAAVRRTHHKNLVRLL 572
             +G G +G V K    +  +IVA+K+     ++   K  A  E+  +++  H+NLV LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEECEVQI 631
             C +  +  LV+EF+   ++ + L       +    V+     +  GI + H      I
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH---NI 145

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKIL---MPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
           IH +I P NIL+  S   K+ +F  A+ L          V     TR Y +PE      +
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA----TRWYRAPE------L 195

Query: 689 TVKSDVYSFGV 699
            V    Y   V
Sbjct: 196 LVGDVKYGKAV 206

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 74.1 bits (183), Expect = 2e-14
 Identities = 38/152 (25%), Positives = 77/152 (50%), Gaps = 17/152 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-----RKFQAEMAAVRRTHHKN 567
           E++G G +G VYK       ++VA+K  RL+    EG      R    E++ ++  +H N
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIR----EISLLKELNHPN 63

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
           +V+LL      +K  LV+EF+ +  L+  +       I    ++     + +G+ + H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +++H ++ P+N+L++     K+++F LA+
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 15/200 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERK-FQAEMAAVRRTHHKNLVRLLG 573
           +GRG FG V    +   +K+ A+K L     ++  E   F+ E   +     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  Q    L LV ++   G L  LLS  E   +  +  R    ++   I  +H+   +  
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ---LHY 196

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-----WQNSG 686
           +H +I P NIL+D +   ++++F     LM + T   +   GT  Y+SPE         G
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256

Query: 687 LITVKSDVYSFGVVVLEIVC 706
               + D +S GV + E++ 
Sbjct: 257 RYGPECDWWSLGVCMYEMLY 276

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 48/219 (21%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
            + +G G FG V++  + E ++ VA+K++        R    E+  +R   H N+V L  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKA 99

Query: 574 FCMQTSKKL------LVYEFMSKGSLENLLSNVESGPIWRDRVRIALD--------VARG 619
           F      K       LV E++     E +          + +  + +         + R 
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVP----ETVYRASRH--YAKLKQTMPMLLIKLYMYQLLRS 153

Query: 620 ITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTG---IVTGVKGTR 675
           + Y+H    + I H +I P+N+LLD  S   K+ +F  AKIL+  +     I      +R
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-----SR 205

Query: 676 GYMSPEWQNSGLI------TVKSDVYSFGVVVLEIVCCR 708
            Y +PE     LI      T   D++S G V+ E++  +
Sbjct: 206 YYRAPE-----LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.7 bits (184), Expect = 3e-14
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 45/218 (20%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
            + +G G FG VY+  +C+  ++VA+K++        R    E+  +R+  H N+VRL  
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRY 114

Query: 574 FCMQTSKKL------LVYEFMSKGSLENLLSNVESGPIWRDRVRIALD--------VARG 619
           F   + +K       LV +++     E +          R +  + +         + R 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP----ETVYRVARH--YSRAKQTLPVIYVKLYMYQLFRS 168

Query: 620 ITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQ--TGIVTGVKGTRG 676
           + Y+H      I H +I P+N+LLD D+   K+ +F  AK L+  +     +     +R 
Sbjct: 169 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC----SRY 221

Query: 677 YMSPEWQNSGLI------TVKSDVYSFGVVVLEIVCCR 708
           Y +PE     LI      T   DV+S G V+ E++  +
Sbjct: 222 YRAPE-----LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 72.2 bits (178), Expect = 5e-14
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 27/203 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           LG G +G V         + VAVK ++     +     + E+   +  +H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73

Query: 576 MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITYLHEE 626
            +      L  E+ S G L + +            + +    A+        G+ YLH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPE-WQ 683
               I H +I P N+LLD+    KIS+F LA +   N    +      GT  Y++PE  +
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
                    DV+S G+V+  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 41/216 (18%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKR-LENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E   G+G FG V  G        VA+K+ +++P     R+ Q  M  +   HH N+V+L 
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQLQ 85

Query: 573 GFCMQTSKK-------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL------DVARG 619
            +     ++        +V E++     + L     +    +      L       + R 
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141

Query: 620 ITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTG---IVTGVKGTR 675
           I  LH    V + H +I P N+L++    T K+ +F  AK L P++     I      +R
Sbjct: 142 IGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC-----SR 195

Query: 676 GYMSPEWQNSGLI------TVKSDVYSFGVVVLEIV 705
            Y +PE     LI      T   D++S G +  E++
Sbjct: 196 YYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMM 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 73.2 bits (180), Expect = 8e-14
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 39/213 (18%)

Query: 517 LGRGCFGAVY----KGSICEGNKIVAVKRL--ENPVEEGERK-FQAEMAAVRRTHHKNLV 569
           +GRG F  V     K +     ++ A+K +   + ++ GE   F+ E   +     + + 
Sbjct: 69  IGRGAFSEVAVVKMKQT----GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GI 620
           +L  F  Q    L LV E+   G L  LLS            RI  ++AR         I
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAI 175

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSP 680
             +H    +  +H +I P NILLD     ++++F     L  + T       GT  Y+SP
Sbjct: 176 DSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

Query: 681 E-------WQNSGLITVKSDVYSFGVVVLEIVC 706
           E          +G    + D ++ GV   E+  
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 41/213 (19%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLL 572
           E+ LG G    V        ++  AVK +E        +   E+  + +   H+N++ L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 573 GFCMQTSKKLLVYEFMSKGSL-----------ENLLSNVESGPIWRDRVRIALDVARGIT 621
            F  +  +  LV+E M  GS+           E             +   +  DVA  + 
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE------------LEASVVVQDVASALD 125

Query: 622 YLHEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVK------ 672
           +LH +    I H ++ P NIL    +     KI +F L   +  N               
Sbjct: 126 FLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 673 GTRGYMSPEWQNSGLITVKS-----DVYSFGVV 700
           G+  YM+PE   +            D++S GV+
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.8 bits (177), Expect = 1e-13
 Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 18/152 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-----RKFQAEMAAVRRTHHKN 567
           E++G G +G V+K    E ++IVA+K  RL++  +EG      R    E+  ++   HKN
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALR----EICLLKELKHKN 62

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
           +VRL        K  LV+EF  +  L+    +  +G +  + V+     + +G+ + H  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
               ++H ++ P+N+L++ +   K++NF LA+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLAR 149

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 39/218 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK-------------------RLENPVEEGERKFQA 555
           +E+G+G +G V        N   A+K                   R   P   G  + + 
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 556 EMAAVRR-------THHKNLVRLLG-FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIW 606
            +  V +         H N+V+L+          L +V+E +++G +   +      P+ 
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLS 135

Query: 607 RDRVR-IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
            D+ R    D+ +GI YLH +   +IIH +I P N+L+ +    KI++F ++     +  
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192

Query: 666 GIVTGVKGTRGYMSPE---WQNSGLITVKSDVYSFGVV 700
            +   V GT  +M+PE              DV++ GV 
Sbjct: 193 LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 49/203 (24%), Positives = 83/203 (40%), Gaps = 27/203 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRLLGFC 575
           LG G +G V         + VAVK ++     +     + E+   +  +H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73

Query: 576 MQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITYLHEE 626
            +      L  E+ S G L + +            + +    A+        G+ YLH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLMAGVVYLHGI 124

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPE-WQ 683
               I H +I P N+LLD+    KIS+F LA +   N    +      GT  Y++PE  +
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 684 NSGLITVKSDVYSFGVVVLEIVC 706
                    DV+S G+V+  ++ 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 26/170 (15%)

Query: 508 RATNGFE--EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVR-- 561
            AT+ +E   E+G G +G VYK         VA+K  R+ N    G       ++ VR  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGL--PISTVREV 62

Query: 562 -------RTHHKNLVRLL----GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDR 609
                     H N+VRL+            K+ LV+E + +  L   L       +  + 
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 121

Query: 610 VR-IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
           ++ +     RG+ +LH      I+H ++ P NIL+    T K+++F LA+
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 38/215 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------H 564
             +G G +G+V         + VA+K+L  P       FQ+E+ A +R            
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFA-KRAYRELLLLKHMQ 81

Query: 565 HKNLVRLLG-FCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVA 617
           H+N++ LL  F   +S +      LV  FM     +  L  +       ++++ +   + 
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQML 136

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
           +G+ Y+H      ++H ++ P N+ +++    KI +F LA+      TG V     TR Y
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWY 189

Query: 678 MSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            +PE   +        D++S G ++ E++  ++ F
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 49/241 (20%), Positives = 88/241 (36%), Gaps = 40/241 (16%)

Query: 475 KQRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGN 534
                Q+ +  + S L   +  II  +             + LG G  G V +       
Sbjct: 37  PPPPQQFPQFHVKSGLQIKKNAIIDDYKV---------TSQVLGLGINGKVLQIFNKRTQ 87

Query: 535 KIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLLGFC----MQTSKKLLVYEFMS 589
           +  A+K L++       K + E+    R +   ++VR++             L+V E + 
Sbjct: 88  EKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142

Query: 590 KGSLENLLSN-VESGPIW---RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL-- 643
            G    L S   + G      R+   I   +   I YLH      I H ++ P N+L   
Sbjct: 143 GGE---LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTS 196

Query: 644 -DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE---WQNSGLITVKSDVYSFGV 699
              +   K+++F  AK    + +  +T    T  Y++PE    +         D++S GV
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDK---SCDMWSLGV 251

Query: 700 V 700
           +
Sbjct: 252 I 252

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 21/166 (12%)

Query: 505 ELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-------RKF 553
           +++     +E  + LG G F  VYK      N+IVA+K  +L +  E  +       R  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-- 61

Query: 554 QAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-I 612
             E+  ++   H N++ LL      S   LV++FM    LE ++ +  S  +    ++  
Sbjct: 62  --EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAY 117

Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
            L   +G+ YLH+     I+H ++ P N+LLD++   K+++F LAK
Sbjct: 118 MLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 49/243 (20%), Positives = 93/243 (38%), Gaps = 39/243 (16%)

Query: 487 NSSLGPSQEFIIQSFSTGELERATNG---FEEELGRGCFGAVYKGSICEGNKIVAVKRL- 542
            S + P  +      + G+ +            LG G FG+VY G     N  VA+K + 
Sbjct: 18  GSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE 77

Query: 543 -----ENPVEEGERKFQAEMAAVRRTHHK--NLVRLLGFCMQTSKKL-LVYEFMS-KGSL 593
                +        +   E+  +++       ++RLL +  +      L+ E       L
Sbjct: 78  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDL 136

Query: 594 ENLLSNVESGPIWRDRVRIALDVAR--------GITYLHEECEVQIIHCNINPRNILLD- 644
            + +   E G        +  ++AR         + + H      ++H +I   NIL+D 
Sbjct: 137 FDFI--TERG-------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184

Query: 645 DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW-QNSGLITVKSDVYSFGVVVLE 703
           +    K+ +F    +L   +  + T   GTR Y  PEW +        + V+S G+++ +
Sbjct: 185 NRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241

Query: 704 IVC 706
           +VC
Sbjct: 242 MVC 244

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 35/212 (16%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------HHK 566
           +G G  G V         + VA+K+L  P       FQ +  A +R           +HK
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHA-KRAYRELVLMKCVNHK 84

Query: 567 NLVRLLG-FCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARG 619
           N++ LL  F  Q S +      +V E M     +  L  V    +  +R+   L  +  G
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQMLCG 139

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           I +LH      IIH ++ P NI++    T KI +F LA+    +   ++T    TR Y +
Sbjct: 140 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRA 194

Query: 680 PEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           PE           D++S G ++ E++     F
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 43/198 (21%), Positives = 76/198 (38%), Gaps = 24/198 (12%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRLL 572
           ++ LG G  G V +       +  A+K L +       K + E+    + +   ++V +L
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88

Query: 573 GFC----MQTSKKLLVYEFMSKGSLENLLSNVESGPIW---RDRVRIALDVARGITYLHE 625
                        L++ E M  G L + +   E G      R+   I  D+   I +LH 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLHS 146

Query: 626 ECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
                I H ++ P N+L    +     K+++F  AK    N    +     T  Y++PE 
Sbjct: 147 H---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEV 200

Query: 683 QNSGLITVKSDVYSFGVV 700
                     D++S GV+
Sbjct: 201 LGPEKYDKSCDMWSLGVI 218

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 69.1 bits (170), Expect = 7e-13
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 19/152 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-----RKFQAEMAAVRRTHHKN 567
           E++G G +G VYK       +  A+K  RLE   +EG      R    E++ ++   H N
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEKE-DEGIPSTTIR----EISILKELKHSN 61

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
           +V+L        + +LV+E + +  L+ LL     G +     +   L +  GI Y H+ 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +++H ++ P+N+L++     KI++F LA+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLAR 148

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 69.1 bits (170), Expect = 7e-13
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 19/152 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-----RKFQAEMAAVRRTHHKN 567
           E++G G +G VYK       +IVA+K  RL+   +EG      R    E++ ++  HH N
Sbjct: 27  EKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAE-DEGIPSTAIR----EISLLKELHHPN 80

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLHEE 626
           +V L+          LV+EFM K  L+ +L       +   +++     + RG+ + H+ 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
              +I+H ++ P+N+L++     K+++F LA+
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLAR 167

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 28/159 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGE-------RKFQAEMAAVRRTHH 565
            +LG G +G VYK      N+ VA+K  RLE+   E E       R    E++ ++   H
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH---EEEGVPGTAIR----EVSLLKELQH 92

Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVARGITYLH 624
           +N++ L        +  L++E+     L+  +    +  +    ++     +  G+ + H
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCH 149

Query: 625 EECEVQIIHCNINPRNILLDDSLTA-----KISNFSLAK 658
                + +H ++ P+N+LL  S  +     KI +F LA+
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 30/171 (17%)

Query: 508 RATNGFE--EELGRGCFGAVYKG-SICEGNKIVAVK--RLENPVEEGERKFQAEMAAVR- 561
           RA   +E   E+G G +G V+K   +  G + VA+K  R++   EEG       ++ +R 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEG-----MPLSTIRE 61

Query: 562 --------RTHHKNLVRLL----GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRD 608
                      H N+VRL             KL LV+E + +  L   L  V    +  +
Sbjct: 62  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120

Query: 609 RVR-IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK 658
            ++ +   + RG+ +LH      ++H ++ P+NIL+  S   K+++F LA+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 49/215 (22%), Positives = 79/215 (36%), Gaps = 38/215 (17%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRL------ENPVEEGERKFQAE---MAAVRRT- 563
              LG+G FG V+ G        VA+K +                   E   +  V    
Sbjct: 36  GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGS-LENLLSNVESGPIWRDRVRIALDVAR--- 618
            H  ++RLL +  +T +   LV E       L + +   E G        +    +R   
Sbjct: 96  GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI--TEKG-------PLGEGPSRCFF 145

Query: 619 -----GITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVK 672
                 I + H      ++H +I   NIL+D     AK+ +F    +L        T   
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD 199

Query: 673 GTRGYMSPEW-QNSGLITVKSDVYSFGVVVLEIVC 706
           GTR Y  PEW        + + V+S G+++ ++VC
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 517 LGRGCFGAVY----KGSICEGNKIVAVKRL--ENPVEEGE-RKFQAEMAAVRRTHHKNLV 569
           LG+G FG V     K +     +  A+K L  E  V + E      E   ++ + H  L 
Sbjct: 156 LGKGTFGKVILVKEKAT----GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
            L  +  QT  +L  V E+ + G L   LS        R R   A ++   + YLH E  
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE-- 267

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             +++ ++   N++LD     KI++F L K  + +   + T   GT  Y++PE       
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 326

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFE 712
               D +  GVV+ E++C R  F 
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFY 350

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 16/199 (8%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERK-FQAEMAAVRRTHHKNLVRLLG 573
           +GRG FG V         K+ A+K L     ++  +   F  E   +   +   +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  Q  + L +V E+M  G L NL+SN     +     R    +V   +  +H    +  
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS---MGF 189

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITV 690
           IH ++ P N+LLD S   K+++F     +            GT  Y+SPE  ++ G    
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249

Query: 691 --KS-DVYSFGVVVLEIVC 706
             +  D +S GV + E++ 
Sbjct: 250 YGRECDWWSVGVFLYEMLV 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 47/205 (22%), Positives = 89/205 (43%), Gaps = 32/205 (15%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG V  G        VAVK     ++ +   +   K + E+  ++   H ++++L
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITY 622
               + T     +V E++S G L + +   + G       R+    AR         + Y
Sbjct: 77  YQ-VISTPTDFFMVMEYVSGGELFDYI--CKHG-------RVEEMEARRLFQQILSAVDY 126

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE- 681
            H      ++H ++ P N+LLD  + AKI++F L+ ++       +    G+  Y +PE 
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEV 181

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVC 706
                    + D++S GV++  ++C
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLC 206

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 16/209 (7%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGE-RKFQAEMAAVRRTHHKNLVRLLG 573
           +G+G FG V      +  K+ A+K +  +  VE  E R    E+  ++   H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 574 FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEVQI 631
           +  Q  + + +V + +  G L   L          + V++   ++   + YL  +   +I
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMALDYLQNQ---RI 136

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE--WQNSGLIT 689
           IH ++ P NILLD+     I++F++A +L       +T + GT+ YM+PE      G   
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 690 VKS-DVYSFGVVVLEIVCCRSNFEVNVST 717
             + D +S GV   E++  R  + +  ST
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSST 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 35/235 (14%)

Query: 492 PSQEFIIQSFSTGELERATN-GFEEELGRGCFGAVYKGSICEGNKIVAVKRLE------- 543
           P +   ++  +  E E +        LG G FG V+     E NK V VK ++       
Sbjct: 6   PPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED 65

Query: 544 -NPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL-LVYEFMSKGS-LENLLSNV 600
               +    K   E+A + R  H N++++L    +      LV E    G  L   +   
Sbjct: 66  CWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDR- 123

Query: 601 ESGPIWRDRVRIALDVAR--------GITYLHEECEVQIIHCNINPRNILLDDSLTAKIS 652
                     R+   +A          + YL  +    IIH +I   NI++ +  T K+ 
Sbjct: 124 --------HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172

Query: 653 NFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLITVKSDVYSFGVVVLEIVC 706
           +F  A  L   +    T   GT  Y +PE    +     + +++S GV +  +V 
Sbjct: 173 DFGSAAYLERGKL-FYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 35/214 (16%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------H 564
           + +G G  G V        ++ VA+K+L  P       FQ +  A +R           +
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHA-KRAYRELVLMKCVN 119

Query: 565 HKNLVRLLG-FCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVA 617
           HKN++ LL  F  Q + +      LV E M     +  L  V    +  +R+   L  + 
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQML 174

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
            GI +LH      IIH ++ P NI++    T KI +F LA+    +   ++T    TR Y
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 229

Query: 678 MSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            +PE           D++S G ++ E+V  +  F
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 28/208 (13%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCM 576
           +G G FG           ++VAVK +E      +   Q E+   R   H N+VR     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKE-VI 85

Query: 577 QTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITYLHEEC 627
            T   L ++ E+ S G L   +    +G       R + D AR        G++Y H   
Sbjct: 86  LTPTHLAIIMEYASGGELYERI--CNAG-------RFSEDEARFFFQQLLSGVSYCHSM- 135

Query: 628 EVQIIHCNINPRNILLDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQN 684
             QI H ++   N LLD S     KI +F  +K  + +     + V GT  Y++PE    
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV-GTPAYIAPEVLLR 191

Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                  +DV+S GV +  ++     FE
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFE 219

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 43/218 (19%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------H 564
           + +G G +GAV           VA+K+L  P       FQ+E+ A +R            
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFA-KRAYRELRLLKHMR 82

Query: 565 HKNLVRLLG-FCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVA 617
           H+N++ LL  F    +        LV  FM    L  L+       +  DR++ +   + 
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQML 138

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGY 677
           +G+ Y+H      IIH ++ P N+ +++    KI +F LA+      TG V     TR Y
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----TRWY 191

Query: 678 MSPE----WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
            +PE    W      T   D++S G ++ E++  ++ F
Sbjct: 192 RAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLF 226

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 39/216 (18%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------H 564
             +G G +G+V      +    VAVK+L  P       FQ+ + A +RT           
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHA-KRTYRELRLLKHMK 86

Query: 565 HKNLVRLLG-FCMQTSKKL-----LVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDV 616
           H+N++ LL  F    S +      LV   M        L+N+ +   +  D V+ +   +
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQI 141

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRG 676
            RG+ Y+H      IIH ++ P N+ +++    KI +F LA+      TG V     TR 
Sbjct: 142 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRW 194

Query: 677 YMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE   N        D++S G ++ E++  R+ F
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276

 Score = 64.7 bits (156), Expect = 2e-11
 Identities = 29/248 (11%), Positives = 58/248 (23%), Gaps = 33/248 (13%)

Query: 32  ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGT----GFSVGTWLVTSPNITVIWTAFRDE 87
           +    +LS         SP+  F+     +G           W+             R++
Sbjct: 17  LPAYQTLSAGQ---YLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPLRNK 73

Query: 88  PPVSSNAKLILTMDGLVLQTEESKHKLIANTTS-----DEPASFASILDSGNFVLCNDRF 142
                         G  L     +   + + ++         +   + D GN VL +   
Sbjct: 74  K----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLA 129

Query: 143 DFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQI 202
            +            +    L  GS+L         ++      Q DG LV Y        
Sbjct: 130 LWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVF--QGDGNLVAYGPNG---- 183

Query: 203 YWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSN--ETVIYRATLDF 260
                  W +                        +    +  +  S+          L  
Sbjct: 184 ----AATWNAG-----TQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQA 234

Query: 261 DGILRLYS 268
           +G + +  
Sbjct: 235 NGSIAILD 242

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 49/211 (23%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG V  G        VAVK     ++ +   +   K + E+  ++   H ++++L
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS--LDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITY 622
               + T   + +V E++S G L + +   ++G       R+    +R        G+ Y
Sbjct: 82  YQV-ISTPSDIFMVMEYVSGGELFDYI--CKNG-------RLDEKESRRLFQQILSGVDY 131

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE- 681
            H      ++H ++ P N+LLD  + AKI++F L+ ++   +  + T   G+  Y +PE 
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTSC-GSPNYAAPEV 186

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                    + D++S GV++  ++C    F+
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 40/172 (23%), Positives = 75/172 (43%), Gaps = 36/172 (20%)

Query: 508 RATNGFE--EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQA--EMAAVR 561
              + +E   ++G+G FG V+K    +  + VA+K   +EN  +EG     A  E+  ++
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFP-ITALREIKILQ 71

Query: 562 RTHHKNLVRLLGFCMQTSKKL--------LVYEFMS---KGSLEN-----LLSNVESGPI 605
              H+N+V L+  C   +           LV++F      G L N      LS ++    
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--- 128

Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
                 +   +  G+ Y+H     +I+H ++   N+L+      K+++F LA
Sbjct: 129 ------VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.2 bits (157), Expect = 5e-11
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 40/215 (18%)

Query: 517 LGRGCFGAV----YKGSICEGNKIVAVKRL--ENPVEEGERKF-QAEMAAVRRTHHKNLV 569
           LG+G FG V     K +     +  A+K L  E  + + E      E   ++ T H  L 
Sbjct: 13  LGKGTFGKVILVREKAT----GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 570 RLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEEC 627
            L  +  QT  +L  V E+ + G L   LS         +R R    ++   + YLH   
Sbjct: 69  ALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE--ERARFYGAEIVSALEYLHSR- 124

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYMSPEW 682
              +++ +I   N++LD     KI++F L K       GI  G       GT  Y++PE 
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPE- 175

Query: 683 QNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
               ++         D +  GVV+ E++C R  F 
Sbjct: 176 ----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 65.6 bits (159), Expect = 5e-11
 Identities = 90/640 (14%), Positives = 179/640 (27%), Gaps = 209/640 (32%)

Query: 104 VLQTEESKHKLIANTTSDEPAS---FASILDSGN-----FV--LCNDRFDFIWESF---- 149
           +L  EE  H  I  +      +   F ++L         FV  +    + F+        
Sbjct: 45  ILSKEEIDH--IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 150 ---NFPTHTIVGGQS-LVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWV 205
              +  T   +  +  L N +++F+   + N S  +  L+ R  +L L P +       V
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFA---KYNVSRLQPYLKLRQALLELRPAK------NV 153

Query: 206 SKLYWASDRVHGMVNLTPGGILQAG-SADATQILARSSYSVKSSNETVIY--------RA 256
                    + G+      G   +G +  A  +    SY V+   +  I+          
Sbjct: 154 L--------IDGV-----LG---SGKTWVALDVC--LSYKVQCKMDFKIFWLNLKNCNSP 195

Query: 257 TLDFDGILRLYSHHFTSD--------SNYRADIEW-------------Y-----VLQNQC 290
               + + +L  +    +        SN +  I               Y     VL N  
Sbjct: 196 ETVLEMLQKLL-YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254

Query: 291 LVKGFCGFNSFC--------SNPTNS----STKGECFCFRGFNFINPEM-----KFLGCY 333
             K +  FN  C           T+     +T               E+     K+L C 
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC- 313

Query: 334 RNFTDEEGCKRKMPAEFYKITSLEISQLGGMA---------YAKLSVNEKDCS-KSCLN- 382
               D       +P E        +S +             +  ++ ++     +S LN 
Sbjct: 314 -RPQD-------LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365

Query: 383 -------DCYCGAAIYANASCSKHKLPLIFAMKYQNVPA-TLFIKWSSGQ-------ANL 427
                    +           S      +F     ++P   L + W            N 
Sbjct: 366 LEPAEYRKMF--------DRLS------VF-PPSAHIPTILLSLIWFDVIKSDVMVVVNK 410

Query: 428 STNLSALPIVSKKHGDNKKKLVSVLAACLGSITFLCFLIAISSLLA-YKQRVNQYQKLRI 486
               S +    +K    K+  +S+      SI      + + +  A ++  V+ Y   + 
Sbjct: 411 LHKYSLV----EK--QPKESTISIP-----SIYLE-LKVKLENEYALHRSIVDHYNIPKT 458

Query: 487 --NSSLGPSQE------FIIQSFSTGELERATNGFEEELGRGCFGAVY------KGSIC- 531
             +  L P          I       E       F           V+      +  I  
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM---------VFLDFRFLEQKIRH 509

Query: 532 EGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKG 591
           +     A   + N +++  + ++  +      + + +  +L F  +  + L+  ++    
Sbjct: 510 DSTAWNASGSILNTLQQ-LKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKY---- 564

Query: 592 SLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
                           D +RIAL       +  EE   Q+
Sbjct: 565 ---------------TDLLRIALMAEDEAIF--EEAHKQV 587

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.8 bits (156), Expect = 6e-11
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 32/215 (14%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRL--------ENPVE--EGERKFQAEMAAVRRT 563
           LG G +G V+   K S  +  K+ A+K L            E    ER+    +  +R  
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV---LEHIR-- 116

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
               LV L  +  QT  KL L+ ++++ G L   LS  E        V+I   ++   + 
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTE--HEVQIYVGEIVLALE 173

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           +LH+     II+ +I   NILLD +    +++F L+K  + ++T       GT  YM+P+
Sbjct: 174 HLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230

Query: 682 ---WQNSGLITVKS-DVYSFGVVVLEIVCCRSNFE 712
                +SG    K+ D +S GV++ E++   S F 
Sbjct: 231 IVRGGDSG--HDKAVDWWSLGVLMYELLTGASPFT 263

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 31/187 (16%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRT--------- 563
             +  G +GAV    +      VA+KR+ N V +G             +R          
Sbjct: 28  RFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRLLNH 85

Query: 564 -HHKNLVRLLGFCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDV 616
            HH N++ L    +   +       LV E M    L  ++ + +   I    ++     +
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD-QRIVISPQHIQYFMYHI 143

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ--TGIVTGVKGT 674
             G+  LHE     ++H +++P NILL D+    I +F+LA+    +   T  VT     
Sbjct: 144 LLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT----H 196

Query: 675 RGYMSPE 681
           R Y +PE
Sbjct: 197 RWYRAPE 203

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 39/214 (18%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK-----RLENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG G FG V   +  +  + VA+K      L+    +   + + E++ ++   H ++++L
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKK--SDMHMRVEREISYLKLLRHPHIIKL 74

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVAR--------GITY 622
               + T   + +V E+   G L + +  VE         R+  D  R         I Y
Sbjct: 75  YDV-ITTPTDIVMVIEYAG-GELFDYI--VEKK-------RMTEDEGRRFFQQIICAIEY 123

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK---GTRGYMS 679
            H      I+H ++ P N+LLDD+L  KI++F L+ I+          +K   G+  Y +
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-----LKTSCGSPNYAA 175

Query: 680 PE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           PE          + DV+S G+V+  ++  R  F+
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 37/204 (18%)

Query: 504 GELERATNGFE---EELGRGCFGAVYKGSICEG--NKIVAVKRLENPVEEG-ERKFQAEM 557
            E ER  + FE    ++GRG +G VYK    +G  +K  A+K++E     G       E+
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREI 69

Query: 558 AAVRRTHHKNLVRLLG-FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIALD 615
           A +R   H N++ L   F     +K+ L++++     L +++    +    +  V++   
Sbjct: 70  ALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRG 128

Query: 616 VA--------RGITYLHEECEVQIIHCNINPRNILLDDSLTA----KISNFSLAKIL--- 660
           +          GI YLH      ++H ++ P NIL+          KI++   A++    
Sbjct: 129 MVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

Query: 661 ---MPNQTGIVTGVKGTRGYMSPE 681
              + +   +V     T  Y +PE
Sbjct: 186 LKPLADLDPVVV----TFWYRAPE 205

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 61.4 bits (150), Expect = 3e-10
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVRL 571
           LG+G FG V+   K S  +  ++ A+K L           + + E   +   +H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 572 LGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHEECEV 629
             +  QT  KL L+ +F+  G L   LS         + V+    ++A  + +LH     
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE--EDVKFYLAELALALDHLHSL--- 145

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P NILLD+    K+++F L+K  + ++    +   GT  YM+PE     ++ 
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPE-----VVN 199

Query: 690 VKS-----DVYSFGVVVLEIVCCRSNFE 712
            +      D +SFGV++ E++     F+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 51/221 (23%)

Query: 517 LGRGCFGAVY----KGSICEGNKIVAVKRL-------ENPVE--EGERKFQAEMAAVRRT 563
           LG+G FG V     K +      + AVK L       ++ VE    E++  +        
Sbjct: 31  LGKGSFGKVMLARVKET----GDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-----R 81

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
           +H  L +L   C QT  +L  V EF++ G L   +    S      R R  A ++   + 
Sbjct: 82  NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEIISALM 138

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRG 676
           +LH++    II+ ++   N+LLD     K+++F + K       GI  GV      GT  
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTTATFCGTPD 189

Query: 677 YMSPEWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
           Y++PE     ++         D ++ GV++ E++C  + FE
Sbjct: 190 YIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 54/232 (23%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLEN-----PVEEGERKF-----QAEMAAVRRTH 564
            +LG G F  V+       N  VA+K +          E E K       A+        
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 565 HKNLVRLLGF-----------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-I 612
             ++++LL              M       V+E + + +L  L+   E   I    V+ I
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVM-------VFEVLGE-NLLALIKKYEHRGIPLIYVKQI 136

Query: 613 ALDVARGITYLHEECEVQIIHCNINPRNILLDDS------LTAKISNFSLAKILMPNQTG 666
           +  +  G+ Y+H  C   IIH +I P N+L++        +  KI++   A     + T 
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194

Query: 667 IVTGVKGTRGYMSPE------WQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            +     TR Y SPE      W         +D++S   ++ E++     FE
Sbjct: 195 SIQ----TREYRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFE 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 60.7 bits (148), Expect = 7e-10
 Identities = 48/224 (21%), Positives = 100/224 (44%), Gaps = 43/224 (19%)

Query: 517 LGRGCFGAVY----KGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-----THHKN 567
           +GRG +  V     K +    ++I A+K ++  +   + +    +   +      ++H  
Sbjct: 17  IGRGSYAKVLLVRLKKT----DRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPF 71

Query: 568 LVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGITYLHE 625
           LV L   C QT  +L  V E+++ G L   +       +  +  R  + +++  + YLHE
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHE 128

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRGYMSP 680
                II+ ++   N+LLD     K++++ + K       G+  G       GT  Y++P
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTTSTFCGTPNYIAP 179

Query: 681 EWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFEVNVSTAD 719
           E     ++  +      D ++ GV++ E++  RS F++  S+ +
Sbjct: 180 E-----ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 60.4 bits (147), Expect = 8e-10
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 36/186 (19%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------H 564
             +G G +G V           VA+K++          F+ +    +RT           
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYC-QRTLREIKILLRFR 83

Query: 565 HKNLVRLLGFCMQTSKKL-----LVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVA 617
           H+N++ +       + +      +V + M     E  L  + ++  +  D +      + 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL 138

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ--TGIVTGVKGTR 675
           RG+ Y+H      ++H ++ P N+LL+ +   KI +F LA++  P+   TG +T    TR
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 676 GYMSPE 681
            Y +PE
Sbjct: 196 WYRAPE 201

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 48/228 (21%), Positives = 101/228 (44%), Gaps = 51/228 (22%)

Query: 517 LGRGCFGAVY----KGSICEGNKIVAVKRL-------ENPVE--EGERKFQAEMAAVRRT 563
           +GRG +  V     K +    ++I A++ +       +  ++  + E+    +      +
Sbjct: 60  IGRGSYAKVLLVRLKKT----DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-----S 110

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
           +H  LV L   C QT  +L  V E+++ G L   +       +  +  R  + +++  + 
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALN 167

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRG 676
           YLHE     II+ ++   N+LLD     K++++ + K       G+  G       GT  
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTTSTFCGTPN 218

Query: 677 YMSPEWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFEVNVSTAD 719
           Y++PE     ++  +      D ++ GV++ E++  RS F++  S+ +
Sbjct: 219 YIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 51/221 (23%)

Query: 517 LGRGCFGAV----YKGSICEGNKIVAVKRL-------ENPVE--EGERKFQAEMAAVRRT 563
           LG+G FG V    +K +    N+  A+K L       ++ VE    E++  +        
Sbjct: 25  LGKGSFGKVFLAEFKKT----NQFFAIKALKKDVVLMDDDVECTMVEKRVLS-----LAW 75

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
            H  L  +     QT + L  V E+++ G L   +           R    A ++  G+ 
Sbjct: 76  EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQ 132

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRG 676
           +LH +    I++ ++   NILLD     KI++F + K        ++   K     GT  
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNTFCGTPD 183

Query: 677 YMSPEWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
           Y++PE     ++  +      D +SFGV++ E++  +S F 
Sbjct: 184 YIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 37/206 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           + LG G  G V+     + +K VA+K++   +P    +   + E+  +RR  H N+V++ 
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ-SVKHALR-EIKIIRRLDHDNIVKVF 74

Query: 573 GFCMQTSKKL--------------LVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDV 616
                +  +L              +V E+M     E  L+NV E GP+  +  R     +
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQL 129

Query: 617 ARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQ--TGIVTGVKG 673
            RG+ Y+H      ++H ++ P N+ ++ + L  KI +F LA+I+ P+    G ++    
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGV 699
           T+ Y SP       + +  + Y+  +
Sbjct: 187 TKWYRSPR------LLLSPNNYTKAI 206

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 38/188 (20%), Positives = 68/188 (36%), Gaps = 30/188 (15%)

Query: 484 LRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLE 543
             + S L   +  II  +             + LG G  G V +       +  A+K L+
Sbjct: 2   PHVKSGLQIKKNAIIDDYKV---------TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ 52

Query: 544 NPVEEGERKFQAEMAAVRR-THHKNLVRLLGFC----MQTSKKLLVYEFMSKGSLENLLS 598
           +       K + E+    R +   ++VR++             L+V E +  G L + + 
Sbjct: 53  D-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI- 106

Query: 599 NVESGPIW---RDRVRIALDVARGITYLHEECEVQIIHCNINPRNILL---DDSLTAKIS 652
             + G      R+   I   +   I YLH      I H ++ P N+L      +   K++
Sbjct: 107 -QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162

Query: 653 NFSLAKIL 660
           +F  AK  
Sbjct: 163 DFGFAKET 170

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 51/221 (23%)

Query: 517 LGRGCFGAV----YKGSICEGNKIVAVKRL-------ENPVE--EGERKFQAEMAAVRRT 563
           LG+G FG V     KG+    +++ AVK L       ++ VE    E++  A        
Sbjct: 349 LGKGSFGKVMLSERKGT----DELYAVKILKKDVVIQDDDVECTMVEKRVLA-----LPG 399

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
               L +L   C QT  +L  V E+++ G L   +  V             A ++A G+ 
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK--EPHAVFYAAEIAIGLF 456

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRG 676
           +L  +    II+ ++   N++LD     KI++F + K        I  GV      GT  
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTTKTFCGTPD 507

Query: 677 YMSPEWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
           Y++PE     +I  +      D ++FGV++ E++  ++ FE
Sbjct: 508 YIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 57.6 bits (138), Expect = 2e-09
 Identities = 27/206 (13%), Positives = 58/206 (28%), Gaps = 20/206 (9%)

Query: 71  LVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASI 129
           LV   +   +W +       ++  + +L  DG LV+ T ++  +  + T          +
Sbjct: 38  LVLFDSDVRVWAS---NTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVL 94

Query: 130 LDSGNFVLCND-----RFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCL 184
                  +                        +   +  N +   +  +  +     + L
Sbjct: 95  QPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRL 154

Query: 185 E-QRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSY 243
             + D  LVL+   D     W +              L P G +   +     +     +
Sbjct: 155 SMETDCNLVLF---DRDDRVWSTNTAGKGTGCR--AVLQPNGRMDVLTNQNIAV-----W 204

Query: 244 SVKSSNETVIYRATLDFDGILRLYSH 269
           +  +S     Y   L  D  L +Y  
Sbjct: 205 TSGNSRSAGRYVFVLQPDRNLAIYGG 230

>1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236

 Score = 41.8 bits (97), Expect = 4e-04
 Identities = 19/127 (14%), Positives = 34/127 (26%), Gaps = 26/127 (20%)

Query: 69  TWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFAS 128
               T  N     T    +    S  +L +  D  ++  +        NT        A 
Sbjct: 127 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 186

Query: 129 ILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QR 187
           +  +G   +  ++   +W                          S  + S GR+    Q 
Sbjct: 187 LQPNGRMDVLTNQNIAVW-------------------------TSGNSRSAGRYVFVLQP 221

Query: 188 DGILVLY 194
           D  L +Y
Sbjct: 222 DRNLAIY 228

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 43/243 (17%), Positives = 86/243 (35%), Gaps = 69/243 (28%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQA-EMAAVRRTHHKNLVRLL 572
            + LG G FG V +    E  K  A+K++       + +++  E+  ++   H N+++L+
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLV 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALD----------------- 615
            +   T  +            +    N       +  +                      
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 616 -----------------------VARGITYLHEECEVQIIHCNINPRNILLD-DSLTAKI 651
                                  + R + ++H    + I H +I P+N+L++    T K+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183

Query: 652 SNFSLAKILMPNQTG---IVTGVKGTRGYMSPEWQNSGLI------TVKSDVYSFGVVVL 702
            +F  AK L+P++     I      +R Y +PE     L+      T   D++S G V  
Sbjct: 184 CDFGSAKKLIPSEPSVAYIC-----SRFYRAPE-----LMLGATEYTPSIDLWSIGCVFG 233

Query: 703 EIV 705
           E++
Sbjct: 234 ELI 236

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 51/221 (23%)

Query: 517 LGRGCFGAV----YKGSICEGNKIVAVKRL-------ENPVE--EGERKFQAEMAAVRRT 563
           LG+G FG V     KG+    +++ AVK L       ++ VE    E++  A        
Sbjct: 28  LGKGSFGKVMLSERKGT----DELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----- 78

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
               L +L   C QT  +L  V E+++ G L   +  V             A ++A G+ 
Sbjct: 79  KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE--PHAVFYAAEIAIGLF 135

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRG 676
           +L  +    II+ ++   N++LD     KI++F + K        I  GV      GT  
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTTKTFCGTPD 186

Query: 677 YMSPEWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
           Y++PE     +I  +      D ++FGV++ E++  ++ FE
Sbjct: 187 YIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 57.9 bits (141), Expect = 4e-09
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 38/216 (17%)

Query: 517 LGRGCFGAVY---KGSICEGNKIVAVKRL--------ENPVE--EGERKFQAEMAAVRRT 563
           LG+G +G V+   K +     KI A+K L               + ER     +  V+  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNI---LEEVK-- 79

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
            H  +V L+ +  QT  KL L+ E++S G L   L          D       +++  + 
Sbjct: 80  -HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFME--DTACFYLAEISMALG 135

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE 681
           +LH++    II+ ++ P NI+L+     K+++F L K  + + T   T   GT  YM+PE
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPE 191

Query: 682 WQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
                ++         D +S G ++ +++     F 
Sbjct: 192 -----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 40/190 (21%), Positives = 79/190 (41%), Gaps = 31/190 (16%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------- 563
           ++LG+G +G V+K       ++VAVK++ +        FQ    A +RT           
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDA-QRTFREIMILTELS 66

Query: 564 HHKNLVRLLGFCMQTSKK--LLVYEFMSKGSLENLLSNV-ESGPIWRDRVR-IALDVARG 619
            H+N+V LL      + +   LV+++M     E  L  V  +  +     + +   + + 
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKV 121

Query: 620 ITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMS 679
           I YLH      ++H ++ P NILL+     K+++F L++  +  +               
Sbjct: 122 IKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 680 PEWQNSGLIT 689
               +  ++T
Sbjct: 179 NFDDDQPILT 188

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 53/221 (23%), Positives = 82/221 (37%), Gaps = 51/221 (23%)

Query: 517 LGRGCFGAVY----KGSICEGNKIVAVKRL-------ENPVE--EGERKFQAEMAAVRRT 563
           +G+G FG V     K          AVK L       +   +    ER    +       
Sbjct: 46  IGKGSFGKVLLARHKAE----EVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-----NV 96

Query: 564 HHKNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRI-ALDVARGIT 621
            H  LV L  F  QT+ KL  V ++++ G L   L           R R  A ++A  + 
Sbjct: 97  KHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLE--PRARFYAAEIASALG 153

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVK-----GTRG 676
           YLH      I++ ++ P NILLD      +++F L K        I          GT  
Sbjct: 154 YLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTTSTFCGTPE 204

Query: 677 YMSPEWQNSGLITVKS-----DVYSFGVVVLEIVCCRSNFE 712
           Y++PE     ++  +      D +  G V+ E++     F 
Sbjct: 205 YLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 40/192 (20%), Positives = 75/192 (39%), Gaps = 41/192 (21%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT----------H 564
             LG G +G V   +     +IVA+K++          F   + A  RT           
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFA-LRTLREIKILKHFK 67

Query: 565 HKNLVRLLGFCMQTSKKL-----LVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVAR 618
           H+N++ +       S +      ++ E M    L  ++S   +  +  D ++       R
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFIYQTLR 123

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN---------QTGIVT 669
            +  LH      +IH ++ P N+L++ +   K+ +F LA+I+  +         Q   + 
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 670 GVKGTRGYMSPE 681
               TR Y +PE
Sbjct: 181 EFVATRWYRAPE 192

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 37/200 (18%), Positives = 68/200 (34%), Gaps = 47/200 (23%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---------RTHH 565
             +GRG +G VY        K VA+K++          F+  +   R         R   
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKS 84

Query: 566 KNLVRLLGFCMQTSKKL-----LVYEFM---------SKGSLENLLSNVESGPIWRDRVR 611
             ++RL    +           +V E           +   L              + ++
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTE------------EHIK 132

Query: 612 -IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ-TGIVT 669
            I  ++  G  ++H   E  IIH ++ P N LL+   + K+ +F LA+ +   + T IV 
Sbjct: 133 TILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 670 GVKGTRGYMSPEWQNSGLIT 689
            ++               +T
Sbjct: 190 DLEENEEPGPHNKNLKKQLT 209

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 44/215 (20%), Positives = 86/215 (40%), Gaps = 50/215 (23%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---------RTHH 565
           + +G+G FG V K    + ++ VA+K + N     +R  +     +R         + + 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 566 KNLVRLLGF-------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVA 617
            N++ +L         CM        +E +S  +L  L+   +        VR  A  + 
Sbjct: 159 MNVIHMLENFTFRNHICM-------TFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTR 675
           + +  LH+    +IIHC++ P NILL     +  K+ +F  +          +     +R
Sbjct: 211 QCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ----SR 263

Query: 676 GYMSPE------WQNSGLITVKSDVYSFGVVVLEI 704
            Y +PE      +       +  D++S G ++ E+
Sbjct: 264 FYRAPEVILGARY------GMPIDMWSLGCILAEL 292

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 28/167 (16%), Positives = 62/167 (37%), Gaps = 46/167 (27%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---------RTHH 565
             +G G +G V +       ++VA+K++          F+  +   R         R +H
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIAILNRLNH 111

Query: 566 KNLVRLLGFCMQTSKKL-----LVYEFM---------SKGSLENLLSNVESGPIWRDRVR 611
            ++V++L   +    +      +V E           +   L                ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTE------------LHIK 159

Query: 612 -IALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA 657
            +  ++  G+ Y+H      I+H ++ P N L++   + K+ +F LA
Sbjct: 160 TLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 41/205 (20%), Positives = 83/205 (40%), Gaps = 35/205 (17%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEG----ERKFQAEMAAVRRTHHKNLVR 570
            +LGRG +  V++      N+ V VK L  PV++     E K    +         N++ 
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKIL-KPVKKKKIKREIKILENL-----RGGPNIIT 95

Query: 571 LLG-FCMQTSKKL-LVYEFMSKGSLENLLSNVESGPIWRDRVRIAL-DVARGITYLHEEC 627
           L        S+   LV+E ++    + L   +         +R  + ++ + + Y H   
Sbjct: 96  LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD-----YDIRFYMYEILKALDYCHSM- 149

Query: 628 EVQIIHCNINPRNILLDDSLTA-KISNFSLAKILMPNQ--TGIVTGVKGTRGYMSPE--- 681
              I+H ++ P N+++D      ++ ++ LA+   P Q     V     +R +  PE   
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----SRYFKGPELLV 203

Query: 682 -WQNSGLITVKSDVYSFGVVVLEIV 705
            +Q         D++S G ++  ++
Sbjct: 204 DYQM---YDYSLDMWSLGCMLASMI 225

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 48/214 (22%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVR---------RTHH 565
             +G+G FG V K       + VA+K ++N     +         VR             
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 566 KNLVRLLGF-------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVA 617
             +V L          C+       V+E +S  +L +LL N     +  +  R  A  + 
Sbjct: 116 YYIVHLKRHFMFRNHLCL-------VFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTA--KISNFSLAKILMPNQTGIVTGVKGTR 675
             + +L    E+ IIHC++ P NILL +   +  KI +F  +  L       +     +R
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ----SR 222

Query: 676 GYMSPE------WQNSGLITVKSDVYSFGVVVLE 703
            Y SPE      +       +  D++S G +++E
Sbjct: 223 FYRSPEVLLGMPY------DLAIDMWSLGCILVE 250

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 54/264 (20%), Positives = 84/264 (31%), Gaps = 82/264 (31%)

Query: 517 LGRGCFGAVYKGSICEGNKIVAVK---RLENPVEEG--ERKFQAEMAAVRRTH--HKNLV 569
           LG G F  V+     +G K VA+K     E+  E    E +    +          + +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 570 RLLG-F----------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVA 617
           +LL  F          CM       V+E +    L   +       +    V+ I   V 
Sbjct: 105 QLLDDFKISGVNGTHICM-------VFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 618 RGITYLHEECEVQIIHCNINPRNILL---------------------------------- 643
           +G+ YLH +C  +IIH +I P NILL                                  
Sbjct: 157 QGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 644 ---------------DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
                           + L  KI++   A  +  + T  +     TR Y S E       
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGY 270

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFE 712
              +D++S   +  E+      FE
Sbjct: 271 NTPADIWSTACMAFELATGDYLFE 294

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 49/233 (21%), Positives = 87/233 (37%), Gaps = 66/233 (28%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKF--QA--EMAAVRR-----THH 565
            ++G G FG V      +  K  AVK + N      +K+   A  E   +++      ++
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINN 95

Query: 566 KNLVRLLGF-------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IALDVA 617
            N+V+  G        C+       ++E +   SL  +++         + ++   +++ 
Sbjct: 96  NNIVKYHGKFMYYDHMCL-------IFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV---TGVK-- 672
           + + YL +   + + H ++ P NILLDD    K                     TG+K  
Sbjct: 148 KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 673 --G--------------TRGYMSPE------WQNSGLITVKSDVYSFGVVVLE 703
             G              TR Y +PE      W       V SD++SFG V+ E
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 47.1 bits (112), Expect = 1e-06
 Identities = 23/127 (18%), Positives = 42/127 (33%), Gaps = 39/127 (30%)

Query: 89  PVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWE 147
            V  + +LI+  D   VL  +  K    +NT         ++ ++GN V+ +     IW 
Sbjct: 17  EVGPSYRLIMQGDCNFVL-YDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIW- 74

Query: 148 SFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVS 206
                                    ++TN     + L  Q+D  +V+Y            
Sbjct: 75  ------------------------QTKTNGKEDHYVLVLQQDRNVVIY-----------G 99

Query: 207 KLYWASD 213
            + WA+ 
Sbjct: 100 PVVWATG 106

>3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110

 Score = 39.0 bits (91), Expect = 8e-04
 Identities = 23/116 (19%), Positives = 35/116 (30%), Gaps = 19/116 (16%)

Query: 154 HTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWAS 212
           +++    SL  G  L             + L  Q D   VLY   DS +  W S      
Sbjct: 2   NSLSSPNSLFTGHSL--------EVGPSYRLIMQGDCNFVLY---DSGKPVWASNTG--G 48

Query: 213 DRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYS 268
                 + L   G L         I     +  K++ +   Y   L  D  + +Y 
Sbjct: 49  LGSGCRLTLHNNGNLVIYDQSNRVI-----WQTKTNGKEDHYVLVLQQDRNVVIYG 99

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 50.3 bits (119), Expect = 1e-06
 Identities = 25/202 (12%), Positives = 48/202 (23%), Gaps = 53/202 (26%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQA---------------EM 557
           E++G G FG V++      +  VA+K   +E P        +                 +
Sbjct: 26  EKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83

Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKL------------------------------LVYEF 587
           +       +  + L                                         +V EF
Sbjct: 84  SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143

Query: 588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL 647
              G    L               I   +   +         +  H +++  N+LL  + 
Sbjct: 144 EFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTS 199

Query: 648 TAKISNFSLAKILMPNQTGIVT 669
             K+      K       G+  
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQV 221

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 47/231 (20%), Positives = 75/231 (32%), Gaps = 66/231 (28%)

Query: 515 EELGRGCFGAVYKGSIC----EGNKIVAVKRLENPVEEGERKFQAEMAAVR--------- 561
             LG G FG V +   C     G   VA+K + N      +  +A    +          
Sbjct: 25  GNLGEGTFGKVVE---CLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKD 77

Query: 562 RTHHKNLVRLLGF-------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IA 613
           + +    V +  +       C+        +E + K +    L      P     VR +A
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCI-------AFELLGK-NTFEFLKENNFQPYPLPHVRHMA 129

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGI----- 667
             +   + +LHE    Q+ H ++ P NIL  +S    + N   +        T I     
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186

Query: 668 ---------VTGVKGTRGYMSPE------WQNSGLITVKSDVYSFGVVVLE 703
                     T +  TR Y  PE      W          DV+S G ++ E
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFE 231

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 46.8 bits (111), Expect = 2e-06
 Identities = 20/117 (17%), Positives = 34/117 (29%), Gaps = 20/117 (17%)

Query: 154 HTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWAS 212
           + ++ GQ+L     L +         G + L  Q    LV Y    + +  W S      
Sbjct: 3   NVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVKY---QNGRQIWASNTDRRG 50

Query: 213 DRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSH 269
                 + L   G L     +   +   + +          Y   L  DG   +Y  
Sbjct: 51  SGCR--LTLLSDGNLVIYDHNNNDVWGSACWGDNGK-----YALVLQKDGRFVIYGP 100

>2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115

 Score = 41.0 bits (96), Expect = 2e-04
 Identities = 20/124 (16%), Positives = 36/124 (29%), Gaps = 33/124 (26%)

Query: 86  DEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDF 144
           D    +    L +     LV   +  +    +NT         ++L  GN V+ +   + 
Sbjct: 14  DHSLQAGAYTLTIQNKCNLVK-YQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNND 72

Query: 145 IWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIY 203
           +W                          S      G++ L  Q+DG  V+Y       + 
Sbjct: 73  VW-------------------------GSACWGDNGKYALVLQKDGRFVIY-----GPVL 102

Query: 204 WVSK 207
           W   
Sbjct: 103 WSLG 106

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 45.3 bits (107), Expect = 5e-06
 Identities = 21/147 (14%), Positives = 37/147 (25%), Gaps = 39/147 (26%)

Query: 69  TWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFA 127
                +    +  T   +    +   + I+  D  LVL  + +      NT        A
Sbjct: 7   KQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL-YDNNNPIWATNTGGLGNGCRA 65

Query: 128 SILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-Q 186
            +   G  V+  +    +W                          S      G + L  Q
Sbjct: 66  VLQPDGVLVVITNENVTVW-------------------------QSPVAGKAGHYVLVLQ 100

Query: 187 RDGILVLYPVRDSRQIYWVSKLYWASD 213
            D  +V+Y               WA+ 
Sbjct: 101 PDRNVVIY-----------GDALWATQ 116

>1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119

 Score = 39.1 bits (91), Expect = 7e-04
 Identities = 20/113 (17%), Positives = 35/113 (30%), Gaps = 13/113 (11%)

Query: 159 GQSLVNGSKLFSSAS--ETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWASDRV 215
            Q   N  ++  +    E    T  +    Q D  LVLY   D+    W +         
Sbjct: 7   KQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVLY---DNNNPIWATNTG--GLGN 61

Query: 216 HGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYS 268
                L P G+L   + +   +     +    + +   Y   L  D  + +Y 
Sbjct: 62  GCRAVLQPDGVLVVITNENVTV-----WQSPVAGKAGHYVLVLQPDRNVVIYG 109

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 38/189 (20%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVK----RLENPVEEGERKFQAEMAAVRRTHHKNL 568
               +G G FG +++G+    N+ VA+K    R + P    E +    +A         +
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC-----TGI 68

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-------VRIALDVARGIT 621
             +  F  +    +LV + +   SLE+LL           R          A  +   + 
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGP-SLEDLLD-------LCGRKFSVKTVAMAAKQMLARVQ 120

Query: 622 YLHEECEVQIIHCNINPRNILLDDSLTAK-----ISNFSLAKILMPNQTGI------VTG 670
            +HE+    +++ +I P N L+    +       + +F + K      T           
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177

Query: 671 VKGTRGYMS 679
           + GT  YMS
Sbjct: 178 LSGTARYMS 186

>3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 25/112 (22%), Positives = 41/112 (36%), Gaps = 29/112 (25%)

Query: 85  RDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFD 143
            D    + N +L++  D  LVL     K+   +NT  +    F  +   G  ++ +D F 
Sbjct: 17  GDGRLTAKNHQLVMQGDCNLVLY--GGKYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFK 74

Query: 144 FIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLY 194
            IW                         +S ++S  G + L  Q DG  V+Y
Sbjct: 75  TIW-------------------------SSRSSSKQGEYVLILQDDGFGVIY 101

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 39/186 (20%), Positives = 68/186 (36%), Gaps = 36/186 (19%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVK----RLENPVEEGERKFQAEMAAVRRTHHKNLV 569
             ++G G FG +Y G+     + VA+K    + ++P    E K    M          + 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIP 68

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-------VRIALDVARGITY 622
            +     +    ++V E +   SLE+L +       +  R       + +A  +   I Y
Sbjct: 69  TIRWCGAEGDYNVMVMELLGP-SLEDLFN-------FCSRKFSLKTVLLLADQMISRIEY 120

Query: 623 LHEECEVQIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGIV------TGVKG 673
           +H +     IH ++ P N L+          I +F LAK     +T           + G
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177

Query: 674 TRGYMS 679
           T  Y S
Sbjct: 178 TARYAS 183

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 46/231 (19%), Positives = 85/231 (36%), Gaps = 66/231 (28%)

Query: 515 EELGRGCFGAVYKGSIC----EGNKIVAVKRLENPVEEGERKFQAEMAAVR--------- 561
           + LG G FG V +   C     G + VAVK ++N     +R  +A  + ++         
Sbjct: 20  DTLGEGAFGKVVE---CIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTD 72

Query: 562 RTHHKNLVRLLGF-------CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVR-IA 613
                  V++L +       C+       V+E +   S  + +      P   D +R +A
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICI-------VFELLGL-STYDFIKENGFLPFRLDHIRKMA 124

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL-MPNQTGI----- 667
             + + + +LH     ++ H ++ P NIL   S   +  N  + +         I     
Sbjct: 125 YQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181

Query: 668 ---------VTGVKGTRGYMSPE------WQNSGLITVKSDVYSFGVVVLE 703
                     + +  TR Y +PE      W      +   DV+S G +++E
Sbjct: 182 GSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 40/188 (21%), Positives = 73/188 (38%), Gaps = 38/188 (20%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVK----RLENPVEEGERKFQAEMAAVRRTHHKNLV 569
            +++G G FG +  G     N+ VA+K    +   P    E +F  ++ +        + 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG-----DGIP 68

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDR-------VRIALDVARGITY 622
           ++  F        +V E +   SLE+L           DR       + IA+ +   + Y
Sbjct: 69  QVYYFGPCGKYNAMVLELLGP-SLEDLFD-------LCDRTFSLKTVLMIAIQLISRMEY 120

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAK-----ISNFSLAKILMPNQTGI------VTGV 671
           +H +    +I+ ++ P N L+            I +F+LAK  +  +T           +
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 672 KGTRGYMS 679
            GT  YMS
Sbjct: 178 TGTARYMS 185

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 37/179 (20%), Positives = 71/179 (39%), Gaps = 22/179 (12%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVK----RLENPVEEGERKFQAEMAAVRRTHHKNLV 569
             ++G G FG +Y G+  + N+ VA+K    + ++P    E K    +          + 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-----TGIP 66

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
            +  F ++    +LV + +   SLE+L +        +  + +A  +   + ++H +   
Sbjct: 67  NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123

Query: 630 QIIHCNINPRNILL---DDSLTAKISNFSLAKILMPNQTGI------VTGVKGTRGYMS 679
             +H +I P N L+     +    I +F LAK      T           + GT  Y S
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 41.8 bits (98), Expect = 8e-05
 Identities = 19/117 (16%), Positives = 39/117 (33%), Gaps = 14/117 (11%)

Query: 32  ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVS 91
           ++ G  L         +   G + F    +         LV   N   +W +       +
Sbjct: 4   LNSGHQLDTGG-----SLAEGGYLFIIQNDCN-------LVLYDNNRAVWASGT--NGKA 49

Query: 92  SNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWES 148
           S   L +  DG ++    S+    +NT       +  +    N V+ ++  + IW +
Sbjct: 50  SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106

>1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 22/119 (18%), Positives = 39/119 (32%), Gaps = 21/119 (17%)

Query: 153 THTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWA 211
           +  +  G  L  G  L           G +    Q D  LVLY   D+ +  W S     
Sbjct: 1   SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLY---DNNRAVWASGTNGK 48

Query: 212 SDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHH 270
           +      + +   G L   S        R+ ++  ++ +   Y   L  D  + +Y + 
Sbjct: 49  ASGCV--LKMQNDGNLVIYSGS------RAIWASNTNRQNGNYYLILQRDRNVVIYDNS 99

>3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113

 Score = 41.4 bits (97), Expect = 1e-04
 Identities = 19/114 (16%), Positives = 39/114 (34%), Gaps = 28/114 (24%)

Query: 84  FRDEPPVSSNAKLILTMDG-LVL-QTEESKHKLIANTTSDEPASFASILDSGNFVLCNDR 141
           + +    + +  L++  D  LVL +  ++     + T+      F  +  SG   + +DR
Sbjct: 16  YDNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR 75

Query: 142 FDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLY 194
            + ++                          S T    G + L  Q +G  V+Y
Sbjct: 76  LNTVF-------------------------VSNTVGQEGDYVLILQINGQAVVY 104

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 40.6 bits (95), Expect = 2e-04
 Identities = 24/116 (20%), Positives = 36/116 (31%), Gaps = 17/116 (14%)

Query: 154 HTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASD 213
           + +  G+ L  G  L       +     F + Q D  LVLY   D     W S       
Sbjct: 2   NLLTNGEGLYAGQSL-------DVEPYHFIM-QEDCNLVLY---DHSTSVWASNTGILGK 50

Query: 214 RVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSH 269
           +    V L   G      A+   +     ++  S      Y   L  DG + +Y  
Sbjct: 51  KGCKAV-LQSDGNFVVYDAEGRSL-----WASHSVRGNGNYVLVLQEDGNVVIYGS 100

>1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109

 Score = 40.2 bits (94), Expect = 3e-04
 Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 5/80 (6%)

Query: 71  LVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASI 129
           LV   + T +W +           K +L  DG  V+   E +    +++          +
Sbjct: 31  LVLYDHSTSVWASNTG-ILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVL 89

Query: 130 LDSGNFVLCNDRFDFIWESF 149
            + GN V+       IW + 
Sbjct: 90  QEDGNVVIYGSD---IWSTG 106

>3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109

 Score = 39.9 bits (93), Expect = 4e-04
 Identities = 25/125 (20%), Positives = 38/125 (30%), Gaps = 39/125 (31%)

Query: 91  SSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESF 149
           +     I+  D  LVL  +  K     NT   +     S+   GN V+ + R + IW   
Sbjct: 18  NGRYVFIMQEDCNLVLY-DVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIW--- 73

Query: 150 NFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKL 208
                                 AS T    G +    Q+D  +V+Y              
Sbjct: 74  ----------------------ASNTGGENGNYVCVLQKDRNVVIY-----------GTA 100

Query: 209 YWASD 213
            WA+ 
Sbjct: 101 RWATG 105

>3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109

 Score = 39.8 bits (93), Expect = 4e-04
 Identities = 32/124 (25%), Positives = 45/124 (36%), Gaps = 18/124 (14%)

Query: 157 VGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWASDRV 215
           +G   L++G  L +     N   G F L  Q D  LVLY         W S         
Sbjct: 1   LGTNYLLSGQTLDTEGHLKN---GDFDLVMQDDCNLVLYNGN------WQSNTANNGRDC 51

Query: 216 HGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHH-FTSD 274
              + LT  G L   + D + +    + SVK +     Y A +  DG L ++    F  D
Sbjct: 52  K--LTLTDYGELVIKNGDGSTVWKSGAQSVKGN-----YAAVVHPDGRLVVFGPSVFKID 104

Query: 275 SNYR 278
              R
Sbjct: 105 PWVR 108

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 30/194 (15%), Positives = 70/194 (36%), Gaps = 32/194 (16%)

Query: 514 EEELGRGCFGAVYKGS--------ICEGNKIVAVK------RLENPVEEGERKFQAEMAA 559
           +    R   G +Y+ +             +  ++K      RL N     +R  +     
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 560 VRRTHHKNLV----RLLGFCMQTSK-KLLVYEFMSKGSLENLLSNVESGPIWRDRV-RIA 613
             +  +   +      +GF +   K + LV   + + SL++ L       +    V ++A
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVA 165

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI--SNFSLAKILMPNQTGI---- 667
             +   + +LH   E + +H N+   NI +D    +++  + +  A    P+   +    
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 668 --VTGVKGTRGYMS 679
              +  +G   ++S
Sbjct: 223 GSRSPHEGDLEFIS 236

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 34/193 (17%), Positives = 69/193 (35%), Gaps = 33/193 (17%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVA-----VKRLENPVEEGERKF------QAEMAAVRR 562
            +++G G FG +Y        +  A     V+  EN     E KF      +  +     
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 563 THHKNLV---RLLGFCMQTSKK----LLVYEFMSKGSLENLLSNVESGPIWRDRV-RIAL 614
               + +      G  +   K      +V E +    L+ +    ++G   +  V ++ +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISG--QNGTFKKSTVLQLGI 158

Query: 615 DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKI--SNFSLAKILMPNQTGI----- 667
            +   + Y+HE    + +H +I   N+LL      ++  +++ L+    PN         
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215

Query: 668 -VTGVKGTRGYMS 679
              G  GT  + S
Sbjct: 216 PRKGHNGTIEFTS 228

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	811
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-61
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-52
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-48
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	7e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-34
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	2e-09
d1kj1a_	109	b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium	4e-05
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	2e-09
d1dlpa1	115	b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p	0.001
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	5e-09
d1dlpa2	120	b.78.1.1 (A:116-235) Fetuin-binding protein Scafet	5e-07
d1b2pa_	119	b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill	8e-08
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	5e-06
d1xd5a_	112	b.78.1.1 (A:) Gastrodianin (antifungal protein) {G	9e-06
d1jpca_	108	b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan	2e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 4e-61
 Identities = 71/274 (25%), Positives = 133/274 (48%), Gaps = 23/274 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
             + +G G FG VYKG     +  VAVK L    P  +  + F+ E+  +R+T H N++ 
Sbjct: 12  VGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
            +G+     +  +V ++    SL + L  +E+       + IA   A+G+ YLH +    
Sbjct: 69  FMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--- 124

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ-TGIVTGVKGTRGYMSPEW---QNSG 686
           IIH ++   NI L + LT KI +F LA +      +     + G+  +M+PE    Q+  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV 746
             + +SDVY+FG+V+ E++  +  +  N++  D ++    V   +++ +LSK+       
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIF--MVGRGYLSPDLSKVRSN---- 237

Query: 747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                + M R+   C++ + + RP    ++  +E
Sbjct: 238 ---CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 3e-60
 Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 21/269 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             E LG G FG V+ G    G+  VAVK L          F AE   +++  H+ LVRL 
Sbjct: 17  LVERLGAGQFGEVWMG-YYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQI 631
               Q     ++ E+M  GSL + L       +     + +A  +A G+ ++ E      
Sbjct: 75  AVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---Y 130

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++   NIL+ D+L+ KI++F LA+++  N+     G K    + +PE  N G  T+K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL 751
           SDV+SFG+++ EIV         ++  +V+      Y                       
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP-------------- 236

Query: 752 ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           E + ++  LC ++ P  RP+   +  +LE
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 5e-58
 Identities = 71/272 (26%), Positives = 121/272 (44%), Gaps = 19/272 (6%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F +E+G G FG V+ G        VA+K +       E  F  E   + +  H  LV+L 
Sbjct: 9   FVQEIGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G C++ +   LV+EFM  G L + L            + + LDV  G+ YL E C   +I
Sbjct: 67  GVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++  RN L+ ++   K+S+F + + ++ +Q    TG K    + SPE  +    + KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 693 DVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLE 752
           DV+SFGV++ E+         N S ++VV   +  +  +  +  S               
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS--------------T 229

Query: 753 TMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
            + ++   C ++ P  RP+   ++  L    E
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-56
 Identities = 59/268 (22%), Positives = 110/268 (41%), Gaps = 19/268 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           F +ELG G FG V  G    G   VA+K +       E +F  E   +    H+ LV+L 
Sbjct: 8   FLKELGTGQFGVVKYG-KWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
           G C +     ++ E+M+ G L N L  +      +  + +  DV   + YL  +     +
Sbjct: 66  GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FL 122

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++  RN L++D    K+S+F L++ ++ ++     G K    +  PE       + KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 693 DVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLE 752
           D+++FGV++ EI           + ++           +     S              E
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS--------------E 228

Query: 753 TMVRVGLLCIQDEPNLRPSMKNVILMLE 780
            +  +   C  ++ + RP+ K ++  + 
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 2e-56
 Identities = 70/308 (22%), Positives = 132/308 (42%), Gaps = 36/308 (11%)

Query: 498 IQSFSTGELERATNGFEEE-----------LGRGCFGAVYKGSICEGNK---IVAVKRLE 543
           I  F+  +   A   F +E           +G G FG V  G +    K    VA+K L+
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 544 NPVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVES 602
           +   E +R+ F +E + + +  H N++ L G   +++  +++ EFM  GSL++ L   + 
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
                  V +   +A G+ YL +      +H ++  RNIL++ +L  K+S+F L++ L  
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 663 NQTGI----VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTA 718
           + +        G K    + +PE       T  SDV+S+G+V+ E++        +++  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 719 DVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM 778
           DV+      Y      +                  + ++ L C Q + N RP    ++  
Sbjct: 241 DVINAIEQDYRLPPPMDCP--------------SALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 779 LEGTMEIP 786
           L+  +  P
Sbjct: 287 LDKMIRNP 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 2e-56
 Identities = 77/305 (25%), Positives = 133/305 (43%), Gaps = 26/305 (8%)

Query: 488 SSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNK---IVAVKRLEN 544
           S+L P     +Q    G      + F E +GRG FG VY G++ + +      AVK L  
Sbjct: 7   SALNPELVQAVQHVVIGPSSLIVH-FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65

Query: 545 PVEEGERK-FQAEMAAVRRTHHKNLVRLLGFCMQTSKK-LLVYEFMSKGSLENLLSNVES 602
             + GE   F  E   ++   H N++ LLG C+++    L+V  +M  G L N + N   
Sbjct: 66  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 125

Query: 603 GPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP 662
            P  +D +   L VA+G   +      + +H ++  RN +LD+  T K+++F LA+ +  
Sbjct: 126 NPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182

Query: 663 NQTGIV---TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD 719
            +   V   TG K    +M+ E   +   T KSDV+SFGV++ E++   +    +V+T D
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242

Query: 720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILML 779
           + +           +                 + +  V L C   +  +RPS   ++  +
Sbjct: 243 ITVYLLQGRRLLQPEYCP--------------DPLYEVMLKCWHPKAEMRPSFSELVSRI 288

Query: 780 EGTME 784
                
Sbjct: 289 SAIFS 293

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 9e-56
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 21/269 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            E +LG+GCFG V+ G    G   VA+K L  P       F  E   +++  H+ LV+L 
Sbjct: 21  LEVKLGQGCFGEVWMG-TWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 78

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQI 631
               +     +V E+MSKGSL + L       +     V +A  +A G+ Y+        
Sbjct: 79  AVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 134

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           +H ++   NIL+ ++L  K+++F LA+++  N+     G K    + +PE    G  T+K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL 751
           SDV+SFG+++ E+          +   +V+                   G          
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------GYRMPCPPECP 240

Query: 752 ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           E++  +   C + EP  RP+ + +   LE
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 6e-55
 Identities = 66/269 (24%), Positives = 119/269 (44%), Gaps = 19/269 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            + +LG G +G VY+G   + +  VAVK L+    E E  F  E A ++   H NLV+LL
Sbjct: 21  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLL 79

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQI 631
           G C +     ++ EFM+ G+L + L       +     + +A  ++  + YL ++     
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 136

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVK 691
           IH ++  RN L+ ++   K+++F L++++  +      G K    + +PE       ++K
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 692 SDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTL 751
           SDV++FGV++ EI     +    +  + V  L    Y     +                 
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCP-------------- 242

Query: 752 ETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           E +  +   C Q  P+ RPS   +    E
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-54
 Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 27/270 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             + +G+G FG V  G        VAVK ++N  +   + F AE + + +  H NLV+LL
Sbjct: 11  LLQTIGKGEFGDVMLGD--YRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLL 66

Query: 573 GFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQ 630
           G  ++    L +V E+M+KGSL + L +     +     ++ +LDV   + YL       
Sbjct: 67  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--- 123

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
            +H ++  RN+L+ +   AK+S+F L K     Q       K    + +PE       + 
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179

Query: 691 KSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRT 750
           KSDV+SFG+++ EI          +   DVV          + K      G   +     
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR--------VEK------GYKMDAPDGC 225

Query: 751 LETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
              +  V   C   +  +RPS   +   LE
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-53
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 9/210 (4%)

Query: 506 LERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRR 562
           +E   + FE   ELG G  G V+K S      ++A K +   ++   R     E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 563 THHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITY 622
            +   +V   G      +  +  E M  GSL+ +L      P  +   ++++ V +G+TY
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP-EQILGKVSIAVIKGLTY 119

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           L E+   +I+H ++ P NIL++     K+ +F ++  L+ +         GTR YMSPE 
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPER 174

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                 +V+SD++S G+ ++E+   R    
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 4e-53
 Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 23/272 (8%)

Query: 514 EEELGRGCFGAVYKGSICEGNK--IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVR 570
           + ELG G FG+V +G      K   VA+K L+   E+ + +    E   + +  +  +VR
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 571 LLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ 630
           L+G C Q    +LV E    G L   L          +   +   V+ G+ YL E+    
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 129

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPEWQNSGLI 688
            +H ++  RN+LL +   AKIS+F L+K L  + +     +  K    + +PE  N    
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
           + +SDV+S+GV + E +         +   +V+             E             
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP----------- 238

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                +  +   C   +   RP    V   + 
Sbjct: 239 ---PELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 7e-52
 Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 29/292 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            +E +G+G FG V++G      + VAVK   +  EE     +AE+       H+N++  +
Sbjct: 7   LQESIGKGRFGEVWRGK--WRGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFI 63

Query: 573 GFCMQTSKKL----LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
               + +       LV ++   GSL + L+           +++AL  A G+ +LH E  
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 629 VQ-----IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI---VTGVKGTRGYMSP 680
                  I H ++  +NIL+  + T  I++  LA         I        GT+ YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 681 EW------QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCF--- 731
           E               ++D+Y+ G+V  EI    S   ++                    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 732 ---IAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
              + ++  +    +       L  M ++   C       R +   +   L 
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 9e-52
 Identities = 69/291 (23%), Positives = 130/291 (44%), Gaps = 24/291 (8%)

Query: 503 TGELERATNGFEEELGRGCFGAVYKGSICEGN----KIVAVKRLENPVEEGERK-FQAEM 557
           T E+  +    ++ +G G FG VYKG +   +      VA+K L+    E +R  F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 558 AAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
             + +  H N++RL G   +    +++ E+M  G+L+  L   +        V +   +A
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTR 675
            G+ YL        +H ++  RNIL++ +L  K+S+F L+++L  +     T  G K   
Sbjct: 121 AGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177

Query: 676 GYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKE 735
            + +PE  +    T  SDV+SFG+V+ E++         +S  +V+            K 
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------------KA 225

Query: 736 LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP 786
           ++   G      +     + ++ + C Q E   RP   +++ +L+  +  P
Sbjct: 226 IND--GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 5e-51
 Identities = 70/275 (25%), Positives = 111/275 (40%), Gaps = 29/275 (10%)

Query: 514 EEELGRGCFGAVYKGSICEG--NKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLV 569
           ++ELG G FG V KG        K VAVK L+N   +     +  AE   +++  +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           R++G C      +LV E    G L   L         ++ + +   V+ G+ YL E    
Sbjct: 72  RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVK-DKNIIELVHQVSMGMKYLEESN-- 127

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT--GVKGTRGYMSPEWQNSGL 687
             +H ++  RN+LL     AKIS+F L+K L  ++         K    + +PE  N   
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD 747
            + KSDV+SFGV++ E                        Y      E++ ++ + E + 
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYG----------------QKPYRGMKGSEVTAMLEKGERMG 230

Query: 748 L--RTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                   M  +  LC   +   RP    V L L 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-51
 Identities = 61/271 (22%), Positives = 108/271 (39%), Gaps = 26/271 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
           F+ E+GRG F  VYKG   E    VA   L      +   ++F+ E   ++   H N+VR
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 571 LLGFCMQTSKK----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
                  T K     +LV E M+ G+L+  L   +     +        + +G+ +LH  
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMK-IKVLRSWCRQILKGLQFLHTR 131

Query: 627 CEVQIIHCNINPRNILLDD-SLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
               IIH ++   NI +   + + KI +  LA +   +       V GT  +M+PE    
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPE-MYE 186

Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                  DVY+FG+ +LE+      +       +   +   V +        K+   +  
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKVAIPE-- 241

Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                   +  +   CI+   + R S+K+++
Sbjct: 242 --------VKEIIEGCIRQNKDERYSIKDLL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 49/312 (15%)

Query: 505 ELERATNGFE--EELGRGCFGAVYKG-----SICEGNKIVAVKRL-ENPVEEGERKFQAE 556
            LE   N  E   ++G G FG V++         E   +VAVK L E    + +  FQ E
Sbjct: 7   SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66

Query: 557 MAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI----------- 605
            A +    + N+V+LLG C       L++E+M+ G L   L ++    +           
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 606 ------------WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN 653
                         +++ IA  VA G+ YL E      +H ++  RN L+ +++  KI++
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIAD 183

Query: 654 FSLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
           F L++ +         G       +M PE       T +SDV+++GVV+ EI        
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 713 VNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSM 772
             ++  +V+         ++        G            +  +  LC    P  RPS 
Sbjct: 244 YGMAHEEVIY--------YVRD------GNILACPENCPLELYNLMRLCWSKLPADRPSF 289

Query: 773 KNVILMLEGTME 784
            ++  +L+   E
Sbjct: 290 CSIHRILQRMCE 301

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 4e-50
 Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 40/314 (12%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKI--VAVKRL-ENPVEEGERKFQAEMAAVRR-THHKNL 568
           F++ +G G FG V K  I +       A+KR+ E   ++  R F  E+  + +  HH N+
Sbjct: 14  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLL--------------SNVESGPI-WRDRVRIA 613
           + LLG C       L  E+   G+L + L              +N  +  +  +  +  A
Sbjct: 74  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133

Query: 614 LDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKG 673
            DVARG+ YL ++   Q IH ++  RNIL+ ++  AKI++F L++          T  + 
Sbjct: 134 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRL 188

Query: 674 TRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA 733
              +M+ E  N  + T  SDV+S+GV++ EIV         ++ A++             
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------------ 236

Query: 734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI--PVVPFP 791
           ++L +  G   E  L   + +  +   C +++P  RPS   +++ L   +E     V   
Sbjct: 237 EKLPQ--GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294

Query: 792 ILSNFSSNSQTLSS 805
           +   F+      S+
Sbjct: 295 LYEKFTYAGIDCSA 308

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-50
 Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 41/297 (13%)

Query: 513 FEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGERK-FQAEMAAVRR-THH 565
           F + LG G FG V + +       +    VAVK L+      ER+   +E+  +    +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-----------------WRD 608
            N+V LLG C      L++ E+   G L N L       I                   D
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
            +  +  VA+G+ +L  +     IH ++  RNILL      KI +F LA+ +  +   +V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 669 TG-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV 727
            G  +    +M+PE   + + T +SDV+S+G+ + E+    S+    +            
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK---- 259

Query: 728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
               I +    L  E    ++        +   C   +P  RP+ K ++ ++E  + 
Sbjct: 260 ---MIKEGFRMLSPEHAPAEMY------DIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 7e-50
 Identities = 57/276 (20%), Positives = 107/276 (38%), Gaps = 22/276 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNL 568
               +G G FG V++G           VA+K  +N   +  R+ F  E   +R+  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
           V+L+G   + +   ++ E  + G L + L   +        +  A  ++  + YL  +  
Sbjct: 71  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
              +H +I  RN+L+  +   K+ +F L++ +  +     +  K    +M+PE  N    
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
           T  SDV+ FGV + EI+         V   DV+          +                
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP----------- 235

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
               T+  +   C   +P+ RP    +   L   +E
Sbjct: 236 ---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (443), Expect = 2e-49
 Identities = 56/269 (20%), Positives = 108/269 (40%), Gaps = 31/269 (11%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK---FQAEMAAVRRTHHKNLVRL 571
            E+G G FGAVY       +++VA+K++    ++   K      E+  +++  H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQ 630
            G  ++     LV E+    + +  L  V   P+   +   +     +G+ YLH      
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW---QNSGL 687
           +IH ++   NILL +    K+ +F  A I+ P  +       GT  +M+PE     + G 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQ 190

Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD 747
              K DV+S G+  +E+   +       + + +  ++        +   S          
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS---------- 240

Query: 748 LRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
               E        C+Q  P  RP+ + ++
Sbjct: 241 ----EYFRNFVDSCLQKIPQDRPTSEVLL 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 8e-49
 Identities = 53/269 (19%), Positives = 105/269 (39%), Gaps = 22/269 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
              ELG G FG VYK    E + + A K ++   EE    +  E+  +    H N+V+LL
Sbjct: 16  IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                 +   ++ EF + G+++ ++  +E          +       + YLH+    +II
Sbjct: 76  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KII 132

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW-----QNSGL 687
           H ++   NIL       K+++F ++               GT  +M+PE           
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSKDRP 191

Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD 747
              K+DV+S G+ ++E+          ++   V+L         IAK     + +     
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLK--------IAKSEPPTLAQPSRWS 242

Query: 748 LRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
               + + +    C++   + R +   ++
Sbjct: 243 SNFKDFLKK----CLEKNVDARWTTSQLL 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-48
 Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 29/275 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVR 570
               +G G +G   K       KI+  K L   +  E  ++   +E+  +R   H N+VR
Sbjct: 8   VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 571 LLGFCMQTSKKLL--VYEFMSKGSLENLLSNV--ESGPI-WRDRVRIALDVARGITYLHE 625
                +  +   L  V E+   G L ++++    E   +     +R+   +   +   H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 626 --ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
             +    ++H ++ P N+ LD     K+ +F LA+IL  + +       GT  YMSPE  
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQM 186

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV--G 741
           N      KSD++S G ++ E+      F                   F  KEL+  +  G
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFT-----------------AFSQKELAGKIREG 229

Query: 742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           +   +  R  + +  +    +  +   RPS++ ++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-48
 Identities = 57/266 (21%), Positives = 111/266 (41%), Gaps = 20/266 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLE-NPVEEGERKFQAEMAAVRRTHHKNLVRL 571
             + LG G +G V         + VAVK ++     +     + E+   +  +H+N+V+ 
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQI 631
            G   + + + L  E+ S G L + +   + G    D  R    +  G+ YLH      I
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124

Query: 632 IHCNINPRNILLDDSLTAKISNFSLAKILMPN-QTGIVTGVKGTRGYMSPEW-QNSGLIT 689
            H +I P N+LLD+    KIS+F LA +   N +  ++  + GT  Y++PE  +      
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR 749
              DV+S G+V+  ++     ++    +      S W           K+  +   + L 
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKTYLNPWKKI--DSAPLAL- 239

Query: 750 TLETMVRVGLLCIQDEPNLRPSMKNV 775
               + +     + + P+ R ++ ++
Sbjct: 240 ----LHK----ILVENPSARITIPDI 257

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 6e-48
 Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 46/298 (15%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKI-----VAVKRLENPVEEGERK-FQAEMAAVRR-THH 565
           F + LG G FG V   +    +K      VAVK L+   +  ER+   +E+  + +   H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-------------------- 605
           +N+V LLG C  +    L++E+   G L N L +                          
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 606 --WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN 663
             + D +  A  VA+G+ +L  +     +H ++  RN+L+      KI +F LA+ +M +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 664 QTGIV-TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL 722
              +V    +    +M+PE    G+ T+KSDV+S+G+++ EI     N    +       
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277

Query: 723 LSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                    + +      G   +      E +  +   C   +   RPS  N+   L 
Sbjct: 278 K--------LIQN-----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-47
 Identities = 71/276 (25%), Positives = 110/276 (39%), Gaps = 25/276 (9%)

Query: 513 FEEELGRGCFGAVYKGSICEGNK---IVAVKRLENPV---EEGERKFQAEMAAVRRTHHK 566
             E+LG G FG V +G     +     VAVK L+  V    E    F  E+ A+    H+
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           NL+RL G    T    +V E    GSL + L   +   +     R A+ VA G+ YL  +
Sbjct: 72  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPEWQN 684
                IH ++  RN+LL      KI +F L + L  N    V     K    + +PE   
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 685 SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE 744
           +   +  SD + FGV + E+        + ++ + ++          I KE     GE  
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK--------IDKE-----GERL 234

Query: 745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
                  + +  V + C   +P  RP+   +   L 
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-47
 Identities = 69/312 (22%), Positives = 125/312 (40%), Gaps = 33/312 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNK----IVAVKRL-ENPVEEGERKFQAEMAAVRRTHHKN 567
             + LG G FG VYKG      +     VA+K L E    +  ++   E   +    + +
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72

Query: 568 LVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
           + RLLG C  TS   L+ + M  G L + +   +     +  +   + +A+G+ YL +  
Sbjct: 73  VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT-GVKGTRGYMSPEWQNSG 686
             +++H ++  RN+L+      KI++F LAK+L   +      G K    +M+ E     
Sbjct: 131 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV--GEDE 744
           + T +SDV+S+GV V E++   S                  Y+   A E+S ++  GE  
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISSILEKGERL 232

Query: 745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNF-----SSN 799
                    +  + + C   + + RP  + +I+        P     I  +      S  
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292

Query: 800 SQTLSSAFTNTD 811
                 A  + +
Sbjct: 293 DSNFYRALMDEE 304

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 3e-47
 Identities = 57/269 (21%), Positives = 110/269 (40%), Gaps = 30/269 (11%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLV 569
               LG+G FG VY     +   I+A+K L          E + + E+       H N++
Sbjct: 10  IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           RL G+    ++  L+ E+   G++   L  +      +       ++A  ++Y H +   
Sbjct: 70  RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATYITELANALSYCHSK--- 125

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
           ++IH +I P N+LL  +   KI++F  +     ++    T + GT  Y+ PE     +  
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPEMIEGRMHD 182

Query: 690 VKSDVYSFGVVVLEIVCCRSNFEVN--VSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD 747
            K D++S GV+  E +  +  FE N    T   +    + +  F+ +    L+       
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI------- 235

Query: 748 LRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                         ++  P+ RP ++ V+
Sbjct: 236 -----------SRLLKHNPSQRPMLREVL 253

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-47
 Identities = 53/262 (20%), Positives = 114/262 (43%), Gaps = 19/262 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGF 574
           E++G+G  G VY        + VA++++    +  +     E+  +R   + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 575 CMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHC 634
            +   +  +V E+++ GSL +++   E+         +  +  + + +LH     Q+IH 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 635 NINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDV 694
           +I   NILL    + K+++F     + P Q+   + + GT  +M+PE         K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 695 YSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETM 754
           +S G++ +E++     +  N +    + L        IA   +  +   E++     + +
Sbjct: 200 WSLGIMAIEMIEGEPPYL-NENPLRALYL--------IATNGTPELQNPEKLSAIFRDFL 250

Query: 755 VRVGLLCIQDEPNLRPSMKNVI 776
            R    C+  +   R S K ++
Sbjct: 251 NR----CLDMDVEKRGSAKELL 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 4e-46
 Identities = 73/305 (23%), Positives = 129/305 (42%), Gaps = 37/305 (12%)

Query: 513 FEEELGRGCFGAVYKG-----SICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHK 566
              ELG+G FG VY+G        E    VA+K +       ER  F  E + ++  +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESG---------PIWRDRVRIALDVA 617
           ++VRLLG   Q    L++ E M++G L++ L ++            P     +++A ++A
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 618 RGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRG 676
            G+ YL+     + +H ++  RN ++ +  T KI +F + + +         G       
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 677 YMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL 736
           +MSPE    G+ T  SDV+SFGVV+ EI          +S   V+          + +  
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF--------VME-- 250

Query: 737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNF 796
               G   +      + +  +  +C Q  P +RPS   +I  ++  ME    P     +F
Sbjct: 251 ----GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME----PGFREVSF 302

Query: 797 SSNSQ 801
             + +
Sbjct: 303 YYSEE 307

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 4e-45
 Identities = 75/300 (25%), Positives = 123/300 (41%), Gaps = 46/300 (15%)

Query: 513 FEEELGRGCFGAVYKGSICEGNK-------IVAVKRL-ENPVEEGERKFQAEMAAVRR-T 563
             + LG G FG V        +K        VAVK L  +  E+      +EM  ++   
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 564 HHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI---------------WRD 608
            HKN++ LLG C Q     ++ E+ SKG+L   L       +                +D
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 609 RVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV 668
            V  A  VARG+ YL  +   + IH ++  RN+L+ +    KI++F LA+ +        
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 669 T-GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV 727
           T   +    +M+PE     + T +SDV+SFGV++ EI     +                 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---------------- 237

Query: 728 YNCFIAKELSKLVGEDEEVDL--RTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI 785
           Y     +EL KL+ E   +D        +  +   C    P+ RP+ K ++  L+  + +
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-44
 Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 40/296 (13%)

Query: 513 FEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPVEEGERK-FQAEMAAVRRT-HH 565
             + LGRG FG V +            + VAVK L+      E +   +E+  +    HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 566 KNLVRLLGFCMQTSKKL-LVYEFMSKGSLENLLSNVESGPI---------------WRDR 609
            N+V LLG C +    L ++ EF   G+L   L +  +  +                   
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 610 VRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT 669
           +  +  VA+G+ +L      + IH ++  RNILL +    KI +F LA+ +  +   +  
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 670 G-VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY 728
           G  +    +M+PE     + T++SDV+SFGV++ EI    ++    V   +         
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------- 246

Query: 729 NCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
            C   KE     G        T   M +  L C   EP+ RP+   ++  L   ++
Sbjct: 247 -CRRLKE-----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (409), Expect = 2e-44
 Identities = 61/268 (22%), Positives = 111/268 (41%), Gaps = 23/268 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             EELG G FG V++ +        A K +  P E  +   + E+  +    H  LV L 
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                 ++ +++YEFMS G L   +++  +     + V     V +G+ ++HE      +
Sbjct: 90  DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146

Query: 633 HCNINPRNILL--DDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           H ++ P NI+     S   K+ +F L   L P Q+  VT   GT  + +PE      +  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 204

Query: 691 KSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
            +D++S GV+   ++   S F  E +  T   V    W  +      +S+        D 
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE--------DG 256

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           +    + +     +  +PN R ++   +
Sbjct: 257 KDF--IRK----LLLADPNTRMTIHQAL 278

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (405), Expect = 7e-44
 Identities = 57/268 (21%), Positives = 113/268 (42%), Gaps = 23/268 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             EELG G FG V++       ++   K +  P    +   + E++ + + HH  L+ L 
Sbjct: 33  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                  + +L+ EF+S G L + ++  +      + +        G+ ++HE     I+
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149

Query: 633 HCNINPRNILLD--DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           H +I P NI+ +   + + KI +F LA  L P++   V     T  + +PE  +   +  
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGF 207

Query: 691 KSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
            +D+++ GV+   ++   S F  E ++ T   V    W ++      +S      E  D 
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS-----PEAKDF 262

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                +       +Q EP  R ++ + +
Sbjct: 263 -----IKN----LLQKEPRKRLTVHDAL 281

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 61/268 (22%), Positives = 108/268 (40%), Gaps = 22/268 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAVRRTHHKNLVRL 571
           F + LG G F  V         K+VA+K +     EG+    + E+A + +  H N+V L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 572 LGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECEVQ 630
                      L+ + +S G L + +  VE G    RD  R+   V   + YLH+   V 
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 130

Query: 631 IIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
                 N     LD+     IS+F L+K+  P     ++   GT GY++PE       + 
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQKPYSK 188

Query: 691 KSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
             D +S GV+   ++C    F  E +    + +L + + ++     ++S     D   D 
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS-----DSAKDF 243

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                +       ++ +P  R + +  +
Sbjct: 244 -----IRH----LMEKDPEKRFTCEQAL 262

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 3e-41
 Identities = 48/204 (23%), Positives = 78/204 (38%), Gaps = 8/204 (3%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLV 569
           F + LG G F  V        ++  A+K LE      E        E   + R  H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           +L        K      +   G L   +  + S            ++   + YLH +   
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCTRFYTAEIVSALEYLHGKG-- 128

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG-VKGTRGYMSPEWQNSGLI 688
            IIH ++ P NILL++ +  +I++F  AK+L P           GT  Y+SPE       
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFE 712
              SD+++ G ++ ++V     F 
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFR 211

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 7e-41
 Identities = 54/267 (20%), Positives = 107/267 (40%), Gaps = 24/267 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             E+LGRG FG V++       K    K ++    + +   + E++ +    H+N++ L 
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLH 67

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                  + ++++EF+S   +   ++        R+ V     V   + +LH      I 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124

Query: 633 HCNINPRNILLD--DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITV 690
           H +I P NI+     S T KI  F  A+ L P        +     Y +PE     +++ 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVST 182

Query: 691 KSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
            +D++S G +V  ++   + F  E N    + ++ + + ++    KE+S      E +D 
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS-----IEAMDF 237

Query: 749 RTLETMVRVGLLCIQDEPNLRPSMKNV 775
                + R     +  E   R +    
Sbjct: 238 -----VDR----LLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 53/270 (19%), Positives = 104/270 (38%), Gaps = 29/270 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLV 569
             E LG G    V+       ++ VAVK L   +        +F+ E       +H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 570 RLLGFCMQTSKKL----LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE 625
            +       +       +V E++   +L +++         +  + +  D  + + + H+
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT-PKRAIEVIADACQALNFSHQ 129

Query: 626 ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIV--TGVKGTRGYMSPEWQ 683
                IIH ++ P NI++  +   K+ +F +A+ +  +   +     V GT  Y+SPE  
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAKELSKLVG 741
               +  +SDVYS G V+ E++     F  +  VS A   +    +      + LS    
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA--- 243

Query: 742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPS 771
                DL  +  +++     +   P  R  
Sbjct: 244 -----DLDAV--VLK----ALAKNPENRYQ 262

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 2e-38
 Identities = 54/271 (19%), Positives = 98/271 (36%), Gaps = 29/271 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRT-HHKNL 568
             + LG+G FG V+     + N+  A+K L+  V   ++       E   +     H  L
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 569 VRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECE 628
             +            V E+++ G L   + +             A ++  G+ +LH +  
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAAEIILGLQFLHSKG- 123

Query: 629 VQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLI 688
             I++ ++   NILLD     KI++F + K  M           GT  Y++PE       
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKY 180

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEV--NVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV 746
               D +SFGV++ E++  +S F           + +    Y  ++ KE   L+      
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL------ 234

Query: 747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL 777
                       +     EP  R  ++  I 
Sbjct: 235 ------------VKLFVREPEKRLGVRGDIR 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (363), Expect = 3e-38
 Identities = 60/314 (19%), Positives = 109/314 (34%), Gaps = 45/314 (14%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLEN---PVEEGERKFQAE---MAAVRRTHHK 566
               +GRG FG VY     +  K+ A+K L+     +++GE     E   ++ V      
Sbjct: 8   VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
            +V +        K   + + M+ G L   LS         D    A ++  G+ ++H  
Sbjct: 68  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR 126

Query: 627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSG 686
               +++ ++ P NILLD+    +IS+  LA      +        GT GYM+PE    G
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180

Query: 687 L-ITVKSDVYSFGVVVLEIVCCRSNFEV-NVSTADVVLLSTWVYNCFIAKELSKLVGEDE 744
           +     +D +S G ++ +++   S F          +   T      +    S       
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP------ 234

Query: 745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI----------------LMLEGTMEIPVV 788
             +LR+L          +Q + N R                       ++       P++
Sbjct: 235 --ELRSLLEG------LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286

Query: 789 PFPILSNFSSNSQT 802
           P     N +     
Sbjct: 287 PPRGEVNAADAFDI 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 7e-38
 Identities = 43/277 (15%), Positives = 86/277 (31%), Gaps = 22/277 (7%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
              ++G G FG +Y G+     + VA+K     V+    +   E    +       +  +
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
            +C       ++   +   SLE+L +        +  + +A  +   I Y+H +     I
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 125

Query: 633 HCNINPRNIL---LDDSLTAKISNFSLAKILMPNQTGIV------TGVKGTRGYMSPEWQ 683
           H ++ P N L           I +F LAK     +T           + GT  Y S    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED 743
                + + D+ S G V++        ++           +      +      K+    
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK--------AATKRQKYERISEKKMSTPI 237

Query: 744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLE 780
           E +              C     + +P    +  +  
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (354), Expect = 7e-38
 Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 38/282 (13%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL---------ENPVEEGERKFQAEMAAVRRT 563
            +E LGRG    V +       K  AVK +            V+E       E+  +R+ 
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 564 H-HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITY 622
             H N+++L       +   LV++ M KG L + L+   +    ++  +I   +   I  
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EKETRKIMRALLEVICA 125

Query: 623 LHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
           LH+     I+H ++ P NILLDD +  K+++F  +  L P +   +  V GT  Y++PE 
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEI 180

Query: 683 ------QNSGLITVKSDVYSFGVVVLEIVCCRSNF--EVNVSTADVVLLSTWVYNCFIAK 734
                  N      + D++S GV++  ++     F     +    +++   + +      
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 735 ELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           + S          ++ L +        +  +P  R + +  +
Sbjct: 241 DYSD--------TVKDLVSR------FLVVQPQKRYTAEEAL 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 5e-37
 Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 29/293 (9%)

Query: 508 RATNGFE--EELGRGCFGAVYKG-SICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRR 562
           RA   +E   E+G G +G V+K   +  G + VA+KR+  +   E        E+A +R 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 563 ---THHKNLVRLLGFCMQTSKK-----LLVYEFMSKGSLENLLSNVESGPIWRDRVRIAL 614
                H N+VRL   C  +         LV+E + +     L    E G        +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 615 DVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGT 674
            + RG+ +LH      ++H ++ P+NIL+  S   K+++F LA+I        +T V  T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 178

Query: 675 RGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVN---------VSTADVVLLST 725
             Y +PE           D++S G +  E+   +  F  +         +    +     
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 726 WVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLL--CIQDEPNLRPSMKNVI 776
           W  +  + ++              T    +   LL  C+   P  R S  + +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 5e-37
 Identities = 49/274 (17%), Positives = 95/274 (34%), Gaps = 38/274 (13%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRL------ENPVEEGERKFQAEMAAVRR--TH 564
               LG G FG+VY G     N  VA+K +      +        +   E+  +++  + 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 565 HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
              ++RLL +  +    +L+ E                             V   + +  
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC- 126

Query: 625 EECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW- 682
                 ++H +I   NIL+D +    K+ +F    +L        T   GTR Y  PEW 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
           +        + V+S G+++ ++VC    FE      + ++     +   ++ E   L+  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDEEIIRGQVFFRQRVSSECQHLI-- 235

Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
                             C+   P+ RP+ + + 
Sbjct: 236 ----------------RWCLALRPSDRPTFEEIQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 6e-37
 Identities = 55/309 (17%), Positives = 110/309 (35%), Gaps = 30/309 (9%)

Query: 514 EEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLG 573
            + LG G  G V +       +  A+K L++   +  R+ +      R +   ++VR++ 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHW---RASQCPHIVRIVD 72

Query: 574 FCMQTSKK----LLVYEFMSKGSLENLLSNVESGPI-WRDRVRIALDVARGITYLHEECE 628
                       L+V E +  G L + + +        R+   I   +   I YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130

Query: 629 VQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNS 685
             I H ++ P N+L      +   K+++F  AK    + +  +T    T  Y++PE    
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGP 187

Query: 686 GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE 745
                  D++S GV++  ++C    F  N      + +S  +       +      E  E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSN----HGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNV-----ILMLEGTMEIPVVPFPILSNFSSNS 800
           V       +       ++ EP  R ++        I+      + P+    +L       
Sbjct: 244 VSEEVKMLIRN----LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 299

Query: 801 QTLSSAFTN 809
           + +    T+
Sbjct: 300 EDVKEEMTS 308

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  136 bits (343), Expect = 5e-36
 Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 11/203 (5%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLV 569
               LG G FG V+        +  A+K L+  +    +       E   +    H  ++
Sbjct: 8   ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
           R+ G      +  ++ +++  G L +LL   +  P    +   A +V      L      
Sbjct: 68  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAEVCL---ALEYLHSK 123

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            II+ ++ P NILLD +   KI++F  AK +      +     GT  Y++PE  ++    
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYN 179

Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
              D +SFG+++ E++   + F 
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFY 202

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-36
 Identities = 56/281 (19%), Positives = 104/281 (37%), Gaps = 25/281 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL-----ENPVEEGERKFQAEMAAVRRTHHKNLV 569
           + LG G F  VYK      N+IVA+K++         +   R    E+  ++   H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
            LL      S   LV++FM       +  N              L   +G+ YLH+    
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGLI 688
            I+H ++ P N+LLD++   K+++F LAK            V  TR Y +PE    + + 
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMY 178

Query: 689 TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDL 748
            V  D+++ G ++ E++        + S  D +            ++   +    + V  
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGD-SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 749 RTLETMVRVGLL-------------CIQDEPNLRPSMKNVI 776
           ++   +    +                   P  R +    +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-36
 Identities = 56/277 (20%), Positives = 109/277 (39%), Gaps = 18/277 (6%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       ++VA+K  RL+   E        E++ ++  +H N+V+LL
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                 +K  LV+EF+ +   + + ++  +G            + +G+ + H      ++
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VL 124

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P+N+L++     K+++F LA+            V                 +   
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 693 DVYSFGVVVLEIVCCRSNFE------------VNVSTADVVLLSTWVYNCFIAKELSKLV 740
           D++S G +  E+V  R+ F               + T D V+               K  
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 741 GEDEEVDLRTLETMVRVGLL-CIQDEPNLRPSMKNVI 776
            +D    +  L+   R  L   +  +PN R S K  +
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  132 bits (332), Expect = 8e-35
 Identities = 41/283 (14%), Positives = 90/283 (31%), Gaps = 24/283 (8%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
               +G G FG +++G+    N+ VA+K    P      + + E    +       +  +
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
            +  Q     ++   +   SLE+LL         +     A  +   +  +HE+    ++
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123

Query: 633 HCNINPRNILLDDSLT-----AKISNFSLAKILMPNQTGIV------TGVKGTRGYMSPE 681
           + +I P N L+    +       + +F + K      T           + GT  YMS  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 682 WQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG 741
                  + + D+ + G V +  +     ++  +  A        +     +  L +L  
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQ-GLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME 784
                     E   +          +  P    +  +    +E
Sbjct: 243 G-------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 51/274 (18%), Positives = 106/274 (38%), Gaps = 28/274 (10%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK------FQAEMAAVRRTHHK 566
             EELG G F  V K          A K ++    +  R+       + E++ ++   H 
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73

Query: 567 NLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEE 626
           N++ L       +  +L+ E ++ G L + L+  +      +       +  G   ++  
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNG---VYYL 129

Query: 627 CEVQIIHCNINPRNILLDD----SLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW 682
             +QI H ++ P NI+L D        KI +F LA  +          + GT  +++PE 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEI 187

Query: 683 QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE 742
            N   + +++D++S GV+   ++   S F  +     +  +S   Y      E       
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------EFEDEYFS 241

Query: 743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVI 776
           +     +    + R     +  +P  R ++++ +
Sbjct: 242 NTSALAKDF--IRR----LLVKDPKKRMTIQDSL 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-34
 Identities = 44/216 (20%), Positives = 92/216 (42%), Gaps = 11/216 (5%)

Query: 504 GELERATNGFE--EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERK-FQAEMAAV 560
           G++      +     +G G +G V           VA+K++     +   +    E+  +
Sbjct: 1   GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 561 RRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNV-ESGPI-WRDRVRIALDVAR 618
            R  H+N++ +       + + +   ++    +   L  + ++  +           + R
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 619 GITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT--GIVTGVKGTRG 676
           G+ Y+H      ++H ++ P N+LL+ +   KI +F LA++  P+    G +T    TR 
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 677 YMSPE-WQNSGLITVKSDVYSFGVVVLEIVCCRSNF 711
           Y +PE   NS   T   D++S G ++ E++  R  F
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  129 bits (324), Expect = 7e-34
 Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 22/278 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G VYK       +  A+K  RLE   E        E++ ++   H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                  + +LV+E +    L+ LL   E G          L +  GI Y H+     ++
Sbjct: 67  DVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P+N+L++     KI++F LA+            +             S   +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 693 DVYSFGVVVLEIVCCRSNFEVNVSTADV------VLLSTWVYNCFIAKELSKLVGEDEEV 746
           D++S G +  E+V     F   VS AD       +L +    N     EL K        
Sbjct: 183 DIWSVGCIFAEMVNGTPLFP-GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 747 DLRTLETMVR------VGLL--CIQDEPNLRPSMKNVI 776
           +    E+ ++      + LL   ++ +PN R + K  +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-33
 Identities = 59/315 (18%), Positives = 118/315 (37%), Gaps = 37/315 (11%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
             + +G G FG VY+  +C+  ++VA+K++       +R    E+  +R+  H N+VRL 
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLR 79

Query: 573 GFCMQTSKK------LLVYEFMSKGSLENLLSNVESGPI--WRDRVRIALDVARGITYLH 624
            F   + +K       LV +++ +           +               + R + Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 625 EECEVQIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQ 683
                 I H +I P+N+LLD D+   K+ +F  AK L+  +   V+ +            
Sbjct: 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRYYRAPELIF 195

Query: 684 NSGLITVKSDVYSFGVVVLEIVCCRSNF----EVNVSTADVVLLSTWVYNCFIAKELSKL 739
            +   T   DV+S G V+ E++  +  F     V+     + +L T           +  
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 740 VGEDEEVDLRTLETMVRVGL---------LCIQDEPNLRPSMKNVIL------MLEGTME 784
             +  ++       + R              ++  P  R +            + +  ++
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315

Query: 785 IP-VVPFPILSNFSS 798
           +P     P L NF++
Sbjct: 316 LPNGRDTPALFNFTT 330

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 8e-32
 Identities = 47/277 (16%), Positives = 96/277 (34%), Gaps = 20/277 (7%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVK--RLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
           E++G G +G V+K    E ++IVA+K  RL++  E        E+  ++   HKN+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 573 GFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQII 632
                  K  LV+EF  +        +                + +G+ + H      ++
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123

Query: 633 HCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKS 692
           H ++ P+N+L++ +   K++NF LA+            V             + L +   
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 693 DVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLE 752
           D++S G +  E+              D +     +      ++   +    +        
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243

Query: 753 TMVRVGLL--------------CIQDEPNLRPSMKNV 775
               +  +               ++  P  R S +  
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 9e-32
 Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 18/212 (8%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRL--ENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
            ++G+G FG V+K    +  + VA+K++  EN  E        E+  ++   H+N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 573 GFCMQTSKK--------LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLH 624
             C   +           LV++F        LLSNV       +  R+   +  G   L+
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNG---LY 131

Query: 625 EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG---IVTGVKGTRGYMSPE 681
                +I+H ++   N+L+      K+++F LA+     +       T    T  Y  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 682 W-QNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
                       D++  G ++ E+       +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 9e-32
 Identities = 47/203 (23%), Positives = 78/203 (38%), Gaps = 8/203 (3%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLV 569
           + + LG+G FG V         +  A+K L   V   ++       E   ++ T H  L 
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68

Query: 570 RLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
            L        +   V E+ + G L   LS        R R     ++      L      
Sbjct: 69  ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR-FYGAEIVSA---LEYLHSR 124

Query: 630 QIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLIT 689
            +++ +I   N++LD     KI++F L K  + +   + T   GT  Y++PE        
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 183

Query: 690 VKSDVYSFGVVVLEIVCCRSNFE 712
              D +  GVV+ E++C R  F 
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFY 206

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 2e-30
 Identities = 46/237 (19%), Positives = 91/237 (38%), Gaps = 14/237 (5%)

Query: 482 QKLRINSSLGPSQEFIIQSFSTGELERAT-NGFE--EELGRGCFGAVYKGSICEGNKIVA 538
           ++  +   L  ++E  ++ + T     A  + F+  + LG G FG V      E     A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70

Query: 539 VKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSKGSLEN 595
           +K L+       +       E   ++  +   LV+L       S   +V E+++ G + +
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 596 LLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFS 655
            L  +            A  +     YLH      +I+ ++ P N+L+D     ++++F 
Sbjct: 131 HLRRIGRFS-EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 656 LAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
            AK +          + GT   ++PE   S       D ++ GV++ E+      F 
Sbjct: 187 FAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-29
 Identities = 63/341 (18%), Positives = 123/341 (36%), Gaps = 50/341 (14%)

Query: 501 FSTGELERATNGFE------EELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERK 552
           F   E+ +            + +G G +GAV           VA+K+L  P   E   ++
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 553 FQAEMAAVRRTHHKNLVRLLGFCMQTSKK------LLVYEFMSKGSLENLLSNVESGPI- 605
              E+  ++   H+N++ LL                LV  FM     + +    +   + 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM----KHEKLG 119

Query: 606 WRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT 665
                 +   + +G+ Y+H      IIH ++ P N+ +++    KI +F LA+      T
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176

Query: 666 GIVTGVKGTRGYMSPEW-QNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLS 724
           G V     TR Y +PE   N    T   D++S G ++ E++  ++ F+ +    D +   
Sbjct: 177 GYV----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS-DHLDQLKEI 231

Query: 725 TWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLL----------------CIQDEPNL 768
             V     A+ + +L  ++ +  ++ L  + +                     +  +   
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291

Query: 769 RPSMKNV-----ILMLEGTMEIPVVPFPILSNFSSNSQTLS 804
           R +            L  T + P V      +F    +TL 
Sbjct: 292 RVTAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLD 331

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (296), Expect = 1e-29
 Identities = 44/290 (15%), Positives = 102/290 (35%), Gaps = 39/290 (13%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRR-THHKNLVRL 571
              +LGRG +  V++      N+ V VK L+      ++K + E+  +       N++ L
Sbjct: 39  LVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITL 95

Query: 572 LGFCMQTSKKL--LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEV 629
                    +   LV+E ++    + L   +       D      ++ + + Y H     
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRFYMYEILKALDYCHSMG-- 149

Query: 630 QIIHCNINPRNILLD-DSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPE-WQNSGL 687
            I+H ++ P N+++D +    ++ ++ LA+   P Q         +R +  PE   +  +
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQM 206

Query: 688 ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV------------YNCFIAKE 735
                D++S G ++  ++  +  F       D ++    V            YN  +   
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 736 LSKLVGEDEEVDLRTLETMVRVGLL----------CIQDEPNLRPSMKNV 775
            + ++G                 L+           ++ +   R + +  
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 7e-29
 Identities = 54/247 (21%), Positives = 99/247 (40%), Gaps = 24/247 (9%)

Query: 476 QRVNQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEG-- 533
           Q +    +LR  +  G +++  I++F             + LG G +G V+      G  
Sbjct: 1   QLLTVKHELRTANLTGHAEKVGIENFE----------LLKVLGTGAYGKVFLVRKISGHD 50

Query: 534 -NKIVAVKRLENPV----EEGERKFQAEMAAVRR-THHKNLVRLLGFCMQTSKKLLVYEF 587
             K+ A+K L+        +     + E   +        LV L       +K  L+ ++
Sbjct: 51  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110

Query: 588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL 647
           ++ G L   LS  E          + + V   +  L    ++ II+ +I   NILLD + 
Sbjct: 111 INGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166

Query: 648 TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGL--ITVKSDVYSFGVVVLEIV 705
              +++F L+K  + ++T       GT  YM+P+    G        D +S GV++ E++
Sbjct: 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226

Query: 706 CCRSNFE 712
              S F 
Sbjct: 227 TGASPFT 233

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-28
 Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 31/241 (12%)

Query: 479 NQYQKLRINSSLGPSQEFIIQSFSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVA 538
           NQ+  + +  S      F +       L+R      + +G G  G V        ++ VA
Sbjct: 1   NQFYSVEVGDS-----TFTV-------LKRYQ--NLKPIGSGAQGIVCAAYDAVLDRNVA 46

Query: 539 VKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK------LLVYEFMSK 590
           +K+L  P   +   ++   E+  ++  +HKN++ LL                LV E M  
Sbjct: 47  IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106

Query: 591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK 650
              + +   ++          +   +  GI +LH      IIH ++ P NI++    T K
Sbjct: 107 NLCQVIQMELD----HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 159

Query: 651 ISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSN 710
           I +F LA+    +    +T    TR Y +PE           D++S G ++ E+V  +  
Sbjct: 160 ILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

Query: 711 F 711
           F
Sbjct: 218 F 218

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-25
 Identities = 55/283 (19%), Positives = 109/283 (38%), Gaps = 34/283 (12%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGE--RKFQAEMAAVRRTHHKNLVRLL 572
             +G G +G+V      +    VAVK+L  P +     ++   E+  ++   H+N++ LL
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 573 GFC-----MQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC 627
                   ++    + +   +    L N++              +   + RG+ Y+H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD 141

Query: 628 EVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEW-QNSG 686
              IIH ++ P N+ +++    KI +F LA+      TG V     TR Y +PE   N  
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWM 194

Query: 687 LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV 746
                 D++S G ++ E++  R+ F       D + L   +     A+ L K+  E    
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGT-DHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 747 DLRTLETMVRVGLL----------------CIQDEPNLRPSMK 773
            +++L  M ++                    +  + + R +  
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (251), Expect = 1e-23
 Identities = 44/221 (19%), Positives = 81/221 (36%), Gaps = 28/221 (12%)

Query: 513 FEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL 572
              +LG G F  V+       N  VA+K +    +      + E+  ++R +  +  +  
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 573 GFCMQTSKKLLVY---------------EFMSKGSLENLLSNVESGPIWRDRVRIALDVA 617
                   KLL +               E + +  L  +      G       +I+  + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 618 RGITYLHEECEVQIIHCNINPRNILLD------DSLTAKISNFSLAKILMPNQTGIVTGV 671
            G+ Y+H  C   IIH +I P N+L++      + +  KI++   A     +     T  
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY----TNS 189

Query: 672 KGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFE 712
             TR Y SPE          +D++S   ++ E++     FE
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 1e-15
 Identities = 20/160 (12%), Positives = 47/160 (29%), Gaps = 27/160 (16%)

Query: 515 EELGRGCFGAVYKGSICEGNKIVAVKRLE----------NPVEEGERKFQAEMAAVRRTH 564
           + +G G   AV+     E      VK  +             + G+  F        R  
Sbjct: 6   KLMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 565 HKNLVRLLGFCMQT----SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGI 620
            + L +L G  +          ++ E +                   +   +   +   +
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEV 116

Query: 621 TYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL 660
              +      I+H +++  N+L+ +     I +F  +  +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 53.8 bits (129), Expect = 2e-09
 Identities = 18/118 (15%), Positives = 36/118 (30%), Gaps = 17/118 (14%)

Query: 35  GSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNA 94
           G  L         +     + F   ++         LV   + T +W +           
Sbjct: 7   GEGLYAGQ-----SLDVEPYHFIMQEDCN-------LVLYDHSTSVWASNTGIL-GKKGC 53

Query: 95  KLILTMDG-LVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNF 151
           K +L  DG  V+   E +    +++          + + GN V+       IW +  +
Sbjct: 54  KAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWSTGTY 108

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

 Score = 41.5 bits (97), Expect = 4e-05
 Identities = 25/118 (21%), Positives = 36/118 (30%), Gaps = 13/118 (11%)

Query: 162 LVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVN 220
           L NG  L++  S        +    Q D  LVLY   D     W S       +      
Sbjct: 4   LTNGEGLYAGQS---LDVEPYHFIMQEDCNLVLY---DHSTSVWASNTGILGKK-GCKAV 56

Query: 221 LTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYR 278
           L   G      A+   +     ++  S      Y   L  DG + +Y     S   Y+
Sbjct: 57  LQSDGNFVVYDAEGRSL-----WASHSVRGNGNYVLVLQEDGNVVIYGSDIWSTGTYK 109

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 53.8 bits (129), Expect = 2e-09
 Identities = 22/127 (17%), Positives = 38/127 (29%), Gaps = 29/127 (22%)

Query: 70  WLVTSPNITVIWTAFRDEPPVSSNAKLILTMDG-LVLQTEESKHKLIANTTSDEPASFAS 128
               S   +   T    +    S+ +  +  D  LVL   +S  ++ A+ T+      A 
Sbjct: 4   LFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLF--DSDVRVWASNTAGATGCRAV 61

Query: 129 ILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QR 187
           +   G  V+   +    W S                          T  S G + L  Q 
Sbjct: 62  LQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQP 96

Query: 188 DGILVLY 194
           D  + +Y
Sbjct: 97  DRTVTIY 103

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 37.2 bits (86), Expect = 0.001
 Identities = 27/115 (23%), Positives = 37/115 (32%), Gaps = 25/115 (21%)

Query: 155 TIVGGQSLVNGSKLFSSASETNSSTGRFCLEQRDGILVLYPVRDSRQIYWVSKLYWASDR 214
           T+   QSL   S              RF + Q D  LVL+   DS    W S    A+  
Sbjct: 16  TLHAAQSLELSS-------------FRFTM-QSDCNLVLF---DSDVRVWASNTAGATG- 57

Query: 215 VHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSH 269
                 L   G+L   +A  T       +S  +      Y   L  D  + +Y  
Sbjct: 58  --CRAVLQSDGLLVILTAQNTIR-----WSSGTKGSIGNYVLVLQPDRTVTIYGP 105

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 52.6 bits (126), Expect = 5e-09
 Identities = 19/127 (14%), Positives = 34/127 (26%), Gaps = 26/127 (20%)

Query: 69  TWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFAS 128
               T  N     T    +    S  +L +  D  ++  +        NT        A 
Sbjct: 12  ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71

Query: 129 ILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QR 187
           +  +G   +  ++   +W S                           + S GR+    Q 
Sbjct: 72  LQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQP 106

Query: 188 DGILVLY 194
           D  L +Y
Sbjct: 107 DRNLAIY 113

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 46.8 bits (111), Expect = 5e-07
 Identities = 24/143 (16%), Positives = 41/143 (28%), Gaps = 30/143 (20%)

Query: 127 ASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLEQ 186
             + ++GN +L      +  +  +    T+   QSL                  R  + +
Sbjct: 3   VVVANNGNSIL------YSTQGNDNHPQTLHATQSLQLSP-------------YRLSM-E 42

Query: 187 RDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVK 246
            D  LVL+   D     W +              L P G +     +    +  S  S  
Sbjct: 43  TDCNLVLF---DRDDRVWSTNTAGKGTGCR--AVLQPNGRM-DVLTNQNIAVWTSGNSRS 96

Query: 247 SSNETVIYRATLDFDGILRLYSH 269
           +      Y   L  D  L +Y  
Sbjct: 97  AGR----YVFVLQPDRNLAIYGG 115

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

 Score = 49.2 bits (117), Expect = 8e-08
 Identities = 22/136 (16%), Positives = 39/136 (28%), Gaps = 22/136 (16%)

Query: 144 FIWESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQI 202
           F  +  +     +   +SL           E    T  +    Q D  LVLY   D+   
Sbjct: 5   FSKQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLY---DNNNP 50

Query: 203 YWVSKLYWASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDG 262
            W +              L P G+L   + +   +     +    + +   Y   L  D 
Sbjct: 51  IWATNTG--GLGNGCRAVLQPDGVLVVITNENVTV-----WQSPVAGKAGHYVLVLQPDR 103

Query: 263 ILRLYSHHFTSDSNYR 278
            + +Y     +    R
Sbjct: 104 NVVIYGDALWATQTVR 119

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 44.0 bits (103), Expect = 5e-06
 Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 9/100 (9%)

Query: 51  SGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEES 110
            G + F    +         LV   N   +W +  +    +S   L +  DG ++    S
Sbjct: 18  EGGYLFIIQNDCN-------LVLYDNNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSGS 68

Query: 111 KHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFN 150
           +    +NT       +  +    N V+ ++  + IW +  
Sbjct: 69  RAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHT 108

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

 Score = 43.2 bits (101), Expect = 9e-06
 Identities = 21/118 (17%), Positives = 39/118 (33%), Gaps = 21/118 (17%)

Query: 153 THTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWA 211
           +  +  G  L  G  L           G +    Q D  LVLY   D+ +  W S     
Sbjct: 1   SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLY---DNNRAVWASGTNGK 48

Query: 212 SDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSH 269
           +      + +   G L           +R+ ++  ++ +   Y   L  D  + +Y +
Sbjct: 49  ASGCV--LKMQNDGNLVI------YSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDN 98

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

 Score = 42.3 bits (99), Expect = 2e-05
 Identities = 20/106 (18%), Positives = 30/106 (28%), Gaps = 16/106 (15%)

Query: 51  SGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILT-MDGLVLQTEE 109
            G F F   ++         LV       IW         S +  L +     LV+    
Sbjct: 18  YGSFVFIMQEDCN-------LVLYDVDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68

Query: 110 SKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHT 155
           +K    +NT          +    N V+        W +    THT
Sbjct: 69  NKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATG---THT 108

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	811
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	99.79
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	99.71
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	99.68
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	99.66
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	99.49
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	99.32
d1dlpa1	115	Fetuin-binding protein Scafet precursor {Bluebell	98.89
d1b2pa_	119	Lectin (agglutinin) {Bluebell (Scilla campanulata)	98.88
d1jpca_	108	Lectin (agglutinin) {Snowdrop (Galanthus nivalis)	98.81
d1dlpa2	120	Fetuin-binding protein Scafet precursor {Bluebell	98.8
d1kj1a_	109	Lectin (agglutinin) {Garlic (Allium sativum) [TaxI	98.73
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.68
d1xd5a_	112	Gastrodianin (antifungal protein) {Gastrodia elata	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.18
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.37
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.57
d1emoa2	39	Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}	82.68

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=371.51  Aligned_cols=267  Identities=24%  Similarity=0.385  Sum_probs=217.3

Q ss_pred             CCHHHHHHHHHH-----------HHHHCCCCCCEEEEEEEECCCCE---EEEEEECCCC-CHHHHHHHHHHHHHHHCCCC
Q ss_conf             695689999722-----------32211856624399999848978---9999974697-62309999999999862587
Q 003555          501 FSTGELERATNG-----------FEEELGRGCFGAVYKGSICEGNK---IVAVKRLENP-VEEGERKFQAEMAAVRRTHH  565 (811)
Q Consensus       501 ~~~~el~~~~~~-----------~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h  565 (811)
                      +++.++.+++.+           +.+.||+|+||+||+|.+..+++   .||||++... .....+.|.+|+.++++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf             88798999996046220800427856980278829999999579978899999997844598999999999999985799


Q ss_pred             CCCCCEECEEECCCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC
Q ss_conf             89530310796056214899506989988874148999845789999999999999876216887462388889688879
Q 003555          566 KNLVRLLGFCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD  645 (811)
Q Consensus       566 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~  645 (811)
                      ||||+++|++.+.+..++||||+++|+|.+++......+++.+++.++.||++||.|||++   +|+||||||+|||++.
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~  163 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS  163 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECC
T ss_conf             8886189999628877999972279853002104567999999999999999988988527---9835761504489889


Q ss_pred             CCCEEEEECCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCH
Q ss_conf             9976997057752258898761----003445788668101136888863314889999999890-99788888775220
Q 003555          646 SLTAKISNFSLAKILMPNQTGI----VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADV  720 (811)
Q Consensus       646 ~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~  720 (811)
                      ++.+||+|||+++.........    .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+  
T Consensus       164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--  241 (299)
T d1jpaa_         164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--  241 (299)
T ss_dssp             TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred             CCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--
T ss_conf             991998884431575677776536502566688300387888369978612144535789999867999999999999--


Q ss_pred             HHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf             34778898753101100001786312768999999999882569999999989999994315699
Q 003555          721 VLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       721 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                        +...    ...       +.+...+...+..+.+++.+||+.+|.+||||.+|++.|+.+++.
T Consensus       242 --~~~~----i~~-------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         242 --VINA----IEQ-------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --HHHH----HHT-------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HHHH----HHC-------CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             --9999----973-------788999742269999999997587976892999999999998418

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=372.52  Aligned_cols=267  Identities=25%  Similarity=0.372  Sum_probs=221.9

Q ss_pred             CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCC
Q ss_conf             69568999972232211856624399999848978999997469762309999999999862587895303107960562
Q 003555          501 FSTGELERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSK  580 (811)
Q Consensus       501 ~~~~el~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~  580 (811)
                      +...|+....+.+.++||+|+||+||+|++..+++.||||+++.. ....++|.+|+.++++++||||++++|++.+.+.
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCE
T ss_conf             765174579939865982088808999999999969999997776-1039999999999986799988267752745785


Q ss_pred             EEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             14899506989988874148-99984578999999999999987621688746238888968887999769970577522
Q 003555          581 KLLVYEFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       581 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~  659 (811)
                      .++||||+++|+|.+++... ...+++..+..|+.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             47876314676067775303554157999999999999978889878---930576045768998999289832445465


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHH
Q ss_conf             58898761003445788668101136888863314889999999890997888887752203477889875310110000
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      .............|+..|+|||.+.+..++.++||||||+++|||++++.|+..........   ..+    ..      
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~---~~i----~~------  231 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELL----EK------  231 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH----HT------
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH----HC------
T ss_conf             37887221035566546669278727999810430217899999986799887742599999---998----55------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf             1786312768999999999882569999999989999994315699
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                       +.....+...++++.+|+.+||+.||++|||+.++++.|+.+.+-
T Consensus       232 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         232 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -CCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             -888888743309999999997577976893999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.07  Aligned_cols=256  Identities=27%  Similarity=0.392  Sum_probs=213.1

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECC
Q ss_conf             72232211856624399999848978999997469762309999999999862587895303107960562148995069
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~  589 (811)
                      .+.+.++||+|+||+||+|.+.+ ++.||||+++.. ....++|.+|+.++++++||||++++|+|.+.+..++||||++
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HCEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             95888898208882999999889-999999998788-6768999999999996689975653524315993379998369


Q ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             89988874148999845789999999999999876216887462388889688879997699705775225889876100
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  669 (811)
                      +|+|.+++......+++..++.|+.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++...........
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEEC
T ss_conf             9918997520134788999999999999987765316---4310443153266668877686553210023688733504


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCCHH
Q ss_conf             34457886681011368888633148899999998909978888877522034778898753101100001786312768
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...||..|+|||.+.+..++.++||||||+++|||+|++.|+..........   ..+    ..+       .+...+..
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~---~~i----~~~-------~~~~~p~~  226 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDI----STG-------FRLYKPRL  226 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH---HHH----HHT-------CCCCCCTT
T ss_pred             CEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HHC-------CCCCCCCC
T ss_conf             3001766678578607999840332105999999987898887789999999---999----806-------88899543


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             99999999988256999999998999999431569
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       750 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      .++++.+++.+||+.||++||||+++++.|+++.+
T Consensus       227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             67999999999765797689199999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.67  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=210.3

Q ss_pred             HHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEE
Q ss_conf             999722322118566243999998489789999974697--623099999999998625878953031079605621489
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV  584 (811)
                      ....+.+.++||+|+||+||+|++.   ..||||+++..  .....+.|.+|+.++++++||||++++|++.+ ...++|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEE
T ss_conf             5451899889830788589999999---989999997346998999999999999984799878645679715-589999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             95069899888741489998457899999999999998762168874623888896888799976997057752258898
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  664 (811)
                      |||+++|+|.+++......+++.+++.|+.||++||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf             965899888999852357899999999999999998887509---99516147899798189978875002213335567


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHC
Q ss_conf             7-61003445788668101136---8888633148899999998909978888877522034778898753101100001
Q 003555          665 T-GIVTGVKGTRGYMSPEWQNS---GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       665 ~-~~~~~~~gt~~y~aPE~~~~---~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      . .......||+.|||||++.+   ..++.++|||||||++|||+||+.||..........   ..+..    +...   
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~---~~~~~----~~~~---  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---FMVGR----GYLS---  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---HHHHH----TSCC---
T ss_pred             CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHC----CCCC---
T ss_conf             7631256655743179999950568999953151635999999997889989989699999---99965----8889---


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             78631276899999999988256999999998999999431569
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      ..........++.+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus       229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             86000365554999999999758897689299999999999997

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.38  Aligned_cols=257  Identities=29%  Similarity=0.431  Sum_probs=210.4

Q ss_pred             HHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEE
Q ss_conf             99997223221185662439999984897899999746976230999999999986258789530310796056214899
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +....+.+.++||+|+||+||+|.++ ++..||||+++.. ....+.|.+|+.++++++|||||+++|++.+ +..++||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             CCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
T ss_conf             38899388679810798289999999-9999999998647-6888999999999986799988578731045-9769999


Q ss_pred             EECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             5069899888741489-998457899999999999998762168874623888896888799976997057752258898
Q 003555          586 EFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       586 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  664 (811)
                      ||+++|+|.+++.... ..+++.++++|+.||++||.|||++   +|+||||||+|||+++++.+||+|||+++......
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf             957898288887514789887889999999999999999748---95467564225156202440423410147735886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCC
Q ss_conf             76100344578866810113688886331488999999989099788888775220347788987531011000017863
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      ........|++.|+|||.+....++.++||||||+++|||+|++.|+.......+..   .    ....+       .+.
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~---~----~i~~~-------~~~  229 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---Q----NLERG-------YRM  229 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H----HHHTT-------CCC
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHHC-------CCC
T ss_conf             442035677444458289837999824564525799999996898888888999999---9----99706-------888


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             12768999999999882569999999989999994315
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       745 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..+...++++.+|+.+||+.+|++||||++|+++|+..
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             89655719999999997588976893999999986113

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.62  Aligned_cols=249  Identities=18%  Similarity=0.288  Sum_probs=209.5

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECC
Q ss_conf             72232211856624399999848978999997469762309999999999862587895303107960562148995069
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~  589 (811)
                      +|.+.++||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
T ss_conf             53887898128582999999989998999999843017279999999999986799988058577988999899997037


Q ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             89988874148999845789999999999999876216887462388889688879997699705775225889876100
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  669 (811)
                      +|+|.+++..  ..+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus       101 gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~  174 (293)
T d1yhwa1         101 GGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRS  174 (293)
T ss_dssp             TCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBC
T ss_pred             CCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-CCCC
T ss_conf             9808988641--5999999999999999999999987---97226776888688789968642515641321366-6444


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCCHH
Q ss_conf             34457886681011368888633148899999998909978888877522034778898753101100001786312768
Q 003555          670 GVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.........   ...     ....     ......+..
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~-----~~~~-----~~~~~~~~~  241 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL---YLI-----ATNG-----TPELQNPEK  241 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH-----HHHC-----SCCCSSGGG
T ss_pred             CCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHH---HHH-----HHCC-----CCCCCCCCC
T ss_conf             444477736826644799880120313729999980488998997999999---999-----8579-----998888553


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9999999998825699999999899999
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       750 ~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      .+..+.+++.+||+.||.+|||+.|+++
T Consensus       242 ~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7999999999986699668909999964

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.46  Aligned_cols=261  Identities=24%  Similarity=0.396  Sum_probs=214.9

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECCCC----EEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEE
Q ss_conf             97223221185662439999984897----89999974697-62309999999999862587895303107960562148
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGN----KIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      ..+.+.+.||+|+||+||+|.+..++    ..||||++... .......|.+|+.++.+++|||||+++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             99506989988874148999845789999999999999876216887462388889688879997699705775225889
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  663 (811)
                      |+||+.+++|.+++......+++.+++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCC
T ss_conf             9972135740222102345420899999999999854121212---3425765644278889984998455103003578


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCC
Q ss_conf             87--6100344578866810113688886331488999999989099788888775220347788987531011000017
Q 003555          664 QT--GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       664 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..  .......||..|+|||.+.+..++.++||||||+++|||++++.|+..........   .    ....+       
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~---~----~i~~~-------  229 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---K----AINDG-------  229 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H----HHHTT-------
T ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHCC-------
T ss_conf             765267426777734348888704999973556344898999996798865568999999---9----98635-------


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf             863127689999999998825699999999899999943156999
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIP  786 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~  786 (811)
                      .+...+...+..+.+|+.+||+.+|++||+|.+|+++|+.+++.|
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf             789985045799999999977679768939999999999986695

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=356.11  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=212.3

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECC
Q ss_conf             72232211856624399999848978999997469762309999999999862587895303107960562148995069
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~  589 (811)
                      .|.+.+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             75898898407681999999889998999999845243169999999999986799799929999998999999998579


Q ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             8998887414899984578999999999999987621688746238888968887--99976997057752258898761
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD--DSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      +|+|.+++......+++.++..++.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+++......  .
T Consensus       107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~  181 (350)
T d1koaa2         107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S  181 (350)
T ss_dssp             SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--C
T ss_pred             CCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC--C
T ss_conf             9889999976237899999999999999999999756---9760001546736416889869995452104425654--3


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCC
Q ss_conf             00344578866810113688886331488999999989099788888775220347788987531011000017863127
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   +..     ......    .......
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~-----i~~~~~----~~~~~~~  249 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRN-----VKSCDW----NMDDSAF  249 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-----HHHTCC----CSCCGGG
T ss_pred             CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHH-----HHHCCC----CCCCCCC
T ss_conf             2000686242188997589987267655465999999859899899799999---999-----984788----9894223


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             6899999999988256999999998999999
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...++.+.+|+.+||+.||++|||+.|+++.
T Consensus       250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             5899999999999756896679089998629

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.14  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=212.0

Q ss_pred             HHHHHHHHHHHHCCCCCCEEEEEEEECCCC-----EEEEEEECCCCC-HHHHHHHHHHHHHHHCC-CCCCCCCEECEEEC
Q ss_conf             899997223221185662439999984897-----899999746976-23099999999998625-87895303107960
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICEGN-----KIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQ  577 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  577 (811)
                      |+....+.+.++||+|+||+||+|++...+     ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             57789939701983078819999998578855420499999966335878999999999999971589968687788862


Q ss_pred             CCCEEEEEEECCCCCHHHHHHCCCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf             5621489950698998887414899----------------------984578999999999999987621688746238
Q 003555          578 TSKKLLVYEFMSKGSLENLLSNVES----------------------GPIWRDRVRIALDVARGITYLHEECEVQIIHCN  635 (811)
Q Consensus       578 ~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D  635 (811)
                      .+..++||||+++|+|.++|...+.                      .+++..++.++.||+.||+|||++   +|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECC
T ss_conf             99589999727999599999862577751022100001222001257789999999999999999999739---905052


Q ss_pred             CCCCCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCC
Q ss_conf             8889688879997699705775225889876-1003445788668101136888863314889999999890-9978888
Q 003555          636 INPRNILLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEV  713 (811)
Q Consensus       636 ikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~  713 (811)
                      |||+|||++.++.+||+|||+++........ ......||+.|||||.+.+..++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCC
T ss_conf             70321443459828985142222045778615623435787657838872799996330300039999998389999999


Q ss_pred             CCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             87752203477889875310110000178631276899999999988256999999998999999431
Q 003555          714 NVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEG  781 (811)
Q Consensus       714 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  781 (811)
                      ........   ..+    ..+       .+...+...++++.+|+.+||+.+|++|||++||+++|..
T Consensus       270 ~~~~~~~~---~~~----~~~-------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         270 IPVDANFY---KLI----QNG-------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCCSHHHH---HHH----HTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHHH---HHH----HCC-------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             89899999---998----569-------9899887678999999999758896689399999999748

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.35  Aligned_cols=250  Identities=20%  Similarity=0.276  Sum_probs=209.0

Q ss_pred             HHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECCC
Q ss_conf             22322118566243999998489789999974697623099999999998625878953031079605621489950698
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~  590 (811)
                      |++.++||+|+||+||+|++..+++.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCCC
T ss_conf             59847993077819999999999939999998728999999999999999867999988498898009958999962799


Q ss_pred             CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf             99888741489998457899999999999998762168874623888896888799976997057752258898761003
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  670 (811)
                      |+|.+++.+....+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus        94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~  169 (288)
T d2jfla1          94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDS  169 (288)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTC
T ss_pred             CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-CCCCCC
T ss_conf             818899986289999999999999999999999988---9887140700314878999899716123035778-641001


Q ss_pred             CCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCC
Q ss_conf             4457886681011-----36888863314889999999890997888887752203477889875310110000178631
Q 003555          671 VKGTRGYMSPEWQ-----NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       671 ~~gt~~y~aPE~~-----~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      ..||+.|+|||++     ....++.++|||||||++|||++|+.||......+..   ...     ....     .+...
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~---~~i-----~~~~-----~~~~~  236 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL---LKI-----AKSE-----PPTLA  236 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHH-----HHSC-----CCCCS
T ss_pred             CCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHH-----HCCC-----CCCCC
T ss_conf             0256264799998320257888880665787899999982088999998999999---999-----7079-----98777


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             27689999999998825699999999899999
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      .+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             65669999999999976699668919999962

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.50  Aligned_cols=266  Identities=26%  Similarity=0.395  Sum_probs=217.6

Q ss_pred             HHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEE
Q ss_conf             99997223221185662439999984897899999746976230999999999986258789530310796056214899
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      +....+++.++||+|+||+||+|+++++ ..||||+++.. ....+.|.+|+.++++++|+|||+++|++.+ +..++||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             CCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEE
T ss_conf             4779979846993079809999999999-99999998804-4888999999999986666788689999823-9759999


Q ss_pred             EECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             506989988874148-9998457899999999999998762168874623888896888799976997057752258898
Q 003555          586 EFMSKGSLENLLSNV-ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       586 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  664 (811)
                      ||+++|+|.+++... ...+++.+++.|+.||+.||+|||++   +|+|+||||+|||++.++.+||+|||+++......
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf             944799435420000355305999999999999999987541---14335312307999899929984425554256887


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCC
Q ss_conf             76100344578866810113688886331488999999989099788888775220347788987531011000017863
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                      ........|++.|+|||.+....++.++||||||+++|||++|+.|+.......+..   ..+    ..+       ...
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~---~~i----~~~-------~~~  233 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQV----ERG-------YRM  233 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHH----HTT-------CCC
T ss_pred             CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HHC-------CCC
T ss_conf             335245455665458089837998917741323589999986899999888899999---999----826-------899


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Q ss_conf             12768999999999882569999999989999994315699999988
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFP  791 (811)
Q Consensus       745 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~p  791 (811)
                      ..+...++++.+++.+||+.||++||+|++|+++|+.......|+.+
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~  280 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  280 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCCCCCC
T ss_conf             99832379999999997566975891999999987666238999999

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=353.49  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=212.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECC
Q ss_conf             72232211856624399999848978999997469762309999999999862587895303107960562148995069
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~  589 (811)
                      .|++.++||+|+||+||+|++..+++.||||++..........+.+|+.++++++||||+++++++.+....++||||++
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  109 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  109 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf             35998999317782999999989997999999887264679999999999986799798919999998999999998289


Q ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             8998887414899984578999999999999987621688746238888968887--99976997057752258898761
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD--DSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      +|+|.+++......+++.++..|+.||+.||.|||++   +|+||||||+|||++  .++.+||+|||+++.......  
T Consensus       110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--  184 (352)
T d1koba_         110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--  184 (352)
T ss_dssp             CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred             CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCC--
T ss_conf             9808888986389989999999999999999999977---92651314455311346788489952563034378872--


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCC
Q ss_conf             00344578866810113688886331488999999989099788888775220347788987531011000017863127
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....|++.|+|||++.+..++.++||||+||++|||++|+.||......+.   + .    ......    ........
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~-~----~i~~~~----~~~~~~~~  252 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---L-Q----NVKRCD----WEFDEDAF  252 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H-H----HHHHCC----CCCCSSTT
T ss_pred             EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH---H-H----HHHHCC----CCCCCCCC
T ss_conf             0100476453489997479989763338989999999968899899799999---9-9----998478----89893002


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             6899999999988256999999998999999
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       748 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             4799999999999756996689189999609

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.84  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=207.3

Q ss_pred             HHHH-HCCCCCCEEEEEEEECC--CCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEE
Q ss_conf             2322-11856624399999848--97899999746976-23099999999998625878953031079605621489950
Q 003555          512 GFEE-ELGRGCFGAVYKGSICE--GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       512 ~~~~-~LG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~  587 (811)
                      .+.+ +||+|+||+||+|.+..  .+..||||+++... ....+.|.+|+.++++++|||||+++|++.. +..++||||
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~   89 (285)
T d1u59a_          11 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM   89 (285)
T ss_dssp             EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred             EECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEE
T ss_conf             8878487306080999999960897689999998820397899999999999986799888068656036-807999980


Q ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-
Q ss_conf             6989988874148999845789999999999999876216887462388889688879997699705775225889876-
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG-  666 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-  666 (811)
                      +++|+|.+++...+..+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus        90 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          90 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             CTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCCC
T ss_conf             789968997521256999999999999999987899868---81057676466045468854203313421155434321


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCC
Q ss_conf             -1003445788668101136888863314889999999890-99788888775220347788987531011000017863
Q 003555          667 -IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       667 -~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                       ......||+.|+|||.+....++.++||||||+++|||+| |+.||......+ .   ..    ....+       .++
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-~---~~----~i~~~-------~~~  231 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-V---MA----FIEQG-------KRM  231 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-H---HH----HHHTT-------CCC
T ss_pred             CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH-H---HH----HHHCC-------CCC
T ss_conf             135621137433586887279999541232201789999938999999979999-9---99----99818-------999


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             12768999999999882569999999989999994315
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       745 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ..+...+.++.+|+.+||+.+|++||+|.+|++.|+..
T Consensus       232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99976789999999997577976890999999999999

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.03  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=208.3

Q ss_pred             HHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEE
Q ss_conf             9997223221185662439999984897899999746976-230999999999986258789530310796056214899
Q 003555          507 ERATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       507 ~~~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      ....|.+.++||+|+||+||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++.+..+.++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             75688897897127780999999989996999999875409789999999999998679999994999999899999999


Q ss_pred             EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             5069899888741489998457899999999999998762-168874623888896888799976997057752258898
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       586 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  664 (811)
                      ||+++|+|.+++.+ ...+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        84 Ey~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             ECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             ECCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf             76799868998742-499999999999999999999999859---99714457799468789989995487762567886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHH-----------
Q ss_conf             761003445788668101136888863314889999999890997888887752203477889875310-----------
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA-----------  733 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~-----------  733 (811)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||......................           
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf             ---21113771411946875899894888998999999999888998998878999999887517754577421233322


Q ss_pred             ---------------CCCCHHCCCCC--CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ---------------11000017863--127689999999998825699999999899999
Q 003555          734 ---------------KELSKLVGEDE--EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 ---------------~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                                     ...........  ......+.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             1111222354134778876650268766764448999999999986899467908999960

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.97  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=206.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEEC
Q ss_conf             7223221185662439999984897899999746976-230999999999986258789530310796056214899506
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~  588 (811)
                      .|.+.++||+|+||+||+|++..+++.||||++.... .+..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf             60899897217480999999999997999999845664127999999999998579988846965404674367988645


Q ss_pred             CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC-CC
Q ss_conf             98998887414899984578999999999999987621688746238888968887999769970577522588987-61
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-GI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~  667 (811)
                      ++|+|.+++.. ...+++.++..++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus        86 ~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          86 SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             TTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCCCC
T ss_conf             89808999753-79999999999999999999999975---983575468997887899879832314224046886531


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCC
Q ss_conf             003445788668101136888-8633148899999998909978888877522034778898753101100001786312
Q 003555          668 VTGVKGTRGYMSPEWQNSGLI-TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~-t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||..........  ...     ....      .....
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~~-----~~~~------~~~~~  228 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDW-----KEKK------TYLNP  228 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HHH-----HTTC------TTSTT
T ss_pred             CCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH--HHH-----HCCC------CCCCC
T ss_conf             1132557474287286189999971016173799999982997888898599999--998-----6388------87886


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             7689999999998825699999999899999
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      ....+.++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4469999999999976799668909999961

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.69  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=213.5

Q ss_pred             HHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECCC
Q ss_conf             22322118566243999998489789999974697623099999999998625878953031079605621489950698
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       511 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~  590 (811)
                      +.+.++||+|+||+||+|+++ ++..||||+++.. ....++|.+|+.++++++||||++++|++.+.+..++|+||+++
T Consensus         6 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             CEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCC
T ss_conf             799689820788399999988-9989999998747-57789999999999966898601588998507816999970489


Q ss_pred             CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf             99888741489998457899999999999998762168874623888896888799976997057752258898761003
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVTG  670 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  670 (811)
                      |+|..++......+.+..+.+++.|+++||.|||+.   +|+|+||||+|||++.++.+||+|||+++............
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEECC
T ss_conf             938886410246776899999999999999987546---84346654135887699847988614420235787225246


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCCHH
Q ss_conf             445788668101136888863314889999999890-9978888877522034778898753101100001786312768
Q 003555          671 VKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVDLR  749 (811)
Q Consensus       671 ~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  749 (811)
                      ..||..|+|||.+.+..++.++||||||+++|||+| |+.||......+ .       .......       .+...+..
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~-------~~~i~~~-------~~~~~p~~  225 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-T-------AEHIAQG-------LRLYRPHL  225 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-H-------HHHHHTT-------CCCCCCTT
T ss_pred             CCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH-H-------HHHHHHC-------CCCCCCCC
T ss_conf             5788775780786379988521033643246739755999988999999-9-------9999807-------97899654


Q ss_pred             HHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             999999999882569999999989999994315
Q 003555          750 TLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       750 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      .++++.+++.+||+.||++|||++++++.|.++
T Consensus       226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             659999999997668976893999999874188

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.69  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=207.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEE
Q ss_conf             722322118566243999998489789999974697---62309999999999862587895303107960562148995
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .|.+.+.||+|+||+||+|++..+++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf             76998898517785899999989994999999816885676899999999999985688888859999998999899985


Q ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             06989988874148999845789999999999999876216887462388889688879997699705775225889876
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  666 (811)
                      |+++|+|.+++.. ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        87 y~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          87 YAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             CCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred             ECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC--
T ss_conf             0479858988750-48999999999999999999999988---94652202344146689987115556335448885--


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCC
Q ss_conf             10034457886681011368888633148899999998909978888877522034778898753101100001786312
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                       .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.   +             ..+.......
T Consensus       161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~-------------~~i~~~~~~~  223 (263)
T d2j4za1         161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y-------------KRISRVEFTF  223 (263)
T ss_dssp             -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H-------------HHHHTTCCCC
T ss_pred             -CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H-------------HHHHCCCCCC
T ss_conf             -2355788763499997589989314404675999998329999888999999---9-------------9997189999


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             7689999999998825699999999899999
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      +...++++.+++.+||+.||.+|||+.|+++
T Consensus       224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             8668999999999976479768909999971

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.39  Aligned_cols=248  Identities=28%  Similarity=0.367  Sum_probs=203.5

Q ss_pred             HHCCCCCCEEEEEEEECC--CCEEEEEEECCCCC--HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECCC
Q ss_conf             211856624399999848--97899999746976--23099999999998625878953031079605621489950698
Q 003555          515 EELGRGCFGAVYKGSICE--GNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMSK  590 (811)
Q Consensus       515 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~  590 (811)
                      ++||+|+||+||+|.+..  .++.||||+++...  ....+.|.+|+.++++++||||++++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC--CC
Q ss_conf             9988874148999845789999999999999876216887462388889688879997699705775225889876--10
Q 003555          591 GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG--IV  668 (811)
Q Consensus       591 gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~  668 (811)
                      |+|.+++.. ...+++.+++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........  ..
T Consensus        92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf             968999752-25789999999999999997668747---95567776113102356751234134533134323443224


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCC
Q ss_conf             03445788668101136888863314889999999890-99788888775220347788987531011000017863127
Q 003555          669 TGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       669 ~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+    +..    ....+       .+...+
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~----~i~~~-------~~~~~p  232 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTA----MLEKG-------ERMGCP  232 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHH----HHHTT-------CCCCCC
T ss_pred             CCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH----HHH----HHHCC-------CCCCCC
T ss_conf             456778420391665379998434430340313289658999999989999----999----99828-------999998


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             68999999999882569999999989999994315
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       748 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ...+.++.+|+.+||+.||++|||+++|+++|+..
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             65679999999997588976890989999985288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.44  Aligned_cols=259  Identities=27%  Similarity=0.469  Sum_probs=212.3

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCC---EEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECC-CCEEEE
Q ss_conf             7223221185662439999984897---89999974697-623099999999998625878953031079605-621489
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGN---KIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT-SKKLLV  584 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lV  584 (811)
                      +.+|.++||+|+||+||+|++..++   ..||||+++.. .....++|.+|+.++++++||||++++|++.+. ...++|
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             EECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             55266698136880999999977998799999999884369789999999999998678999867867898069943899


Q ss_pred             EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             95069899888741489998457899999999999998762168874623888896888799976997057752258898
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  664 (811)
                      |||+++|+|.+++........+..+++++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             987406741442101345404899999999988765200336---76257766875767799988991065232255665


Q ss_pred             CC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCC
Q ss_conf             76---100344578866810113688886331488999999989099788888775220347788987531011000017
Q 003555          665 TG---IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       665 ~~---~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..   ......||..|+|||.+....++.++||||||+++|||++++.||.......+..   ..+    ..+       
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~---~~i----~~g-------  250 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYL----LQG-------  250 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH---HHH----HTT-------
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HCC-------
T ss_conf             553100256555645567688743799974574661999999997899998889999999---999----808-------


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf             86312768999999999882569999999989999994315699
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                      .+...+...++.+.+++.+||+.||++||+|.||++.|+.+..-
T Consensus       251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             98899644759999999997688976893999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.19  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=208.3

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEE
Q ss_conf             97223221185662439999984897899999746976-23099999999998625878953031079605621489950
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~  587 (811)
                      ..|.+.+.||+|+||+||+|++..+++.||||++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             66699889940658399999999999899999981577312899999999999867998999198999989988898852


Q ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCCC
Q ss_conf             698998887414899984578999999999999987621688746238888968887---99976997057752258898
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~~~~~  664 (811)
                      +++|+|.+++.. ...+++.+...++.||+.||.|||+.   +|+||||||+|||+.   +++.+||+|||+++......
T Consensus        89 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          89 VSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             CCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             CCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCC
T ss_conf             689848886530-36788789999999999998752413---05568704630011046888249983154358725897


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCC
Q ss_conf             76100344578866810113688886331488999999989099788888775220347788987531011000017863
Q 003555          665 TGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDE  744 (811)
Q Consensus       665 ~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  744 (811)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+    +...    .....    .....
T Consensus       165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~----i~~~~----~~~~~  230 (307)
T d1a06a_         165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQ----ILKAE----YEFDS  230 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHH----HHTTC----CCCCT
T ss_pred             --EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH----HHCCC----CCCCC
T ss_conf             --0440032842259188737999807873451599999985979999989999----9999----86168----77787


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             1276899999999988256999999998999999
Q 003555          745 EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       745 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ......++++.+++.+||+.||.+|||+.|+++.
T Consensus       231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             6666789999999999760897579189998629

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.82  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=198.8

Q ss_pred             HHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCCCCCEECEEEC----CCCEEEE
Q ss_conf             22322118566243999998489789999974697--62309999999999862587895303107960----5621489
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQ----TSKKLLV  584 (811)
Q Consensus       511 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~lV  584 (811)
                      ++|.++||+|+||+||+|++..++..||+|++...  .....+.+.+|++++++++||||+++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEEECCCCCCCC
Q ss_conf             9506989988874148999845789999999999999876216887--46238888968887-99976997057752258
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQ--IIHCNINPRNILLD-DSLTAKISNFSLAKILM  661 (811)
Q Consensus       585 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~  661 (811)
                      |||+++|+|.+++.+ ...+++..+..++.||+.||+|||++   +  |+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EECCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf             957898948999751-35546999999999999999999978---99799687674351166799988980057654236


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCC
Q ss_conf             89876100344578866810113688886331488999999989099788888775220347788987531011000017
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVG  741 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  741 (811)
                      ..   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.........   ..    ....+.      
T Consensus       167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~----~i~~~~------  229 (270)
T d1t4ha_         167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YR----RVTSGV------  229 (270)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HH----HHTTTC------
T ss_pred             CC---CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHCCC------
T ss_conf             87---6677553813008988478-9998671100799999998788999876559999---99----997389------


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             863127689999999998825699999999899999
Q 003555          742 EDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       742 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      .....+...++++.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             986567557899999999976379758929999967

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.62  Aligned_cols=248  Identities=20%  Similarity=0.272  Sum_probs=208.3

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEE
Q ss_conf             722322118566243999998489789999974697---62309999999999862587895303107960562148995
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .|.+.+.||+|+||+||+|++..+++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf             77898898508790999999989997999999865775577789999999999987688886179999998998899997


Q ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC-
Q ss_conf             0698998887414899984578999999999999987621688746238888968887999769970577522588987-
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT-  665 (811)
Q Consensus       587 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-  665 (811)
                      |+++|+|.+++.. ...+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.+..... 
T Consensus        89 y~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          89 YAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC
T ss_conf             0489877776531-59999999999999999999762165---0884767741236688853886032102422567764


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCC
Q ss_conf             61003445788668101136888863314889999999890997888887752203477889875310110000178631
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+   .+             ..+......
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~-------------~~i~~~~~~  228 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF-------------QKIIKLEYD  228 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-------------HHHHTTCCC
T ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHH---HH-------------HHHHCCCCC
T ss_conf             33355567755258440026898966623045699999803889989959999---99-------------999718999


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             27689999999998825699999999899999
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      .+...++++.+|+.+||+.||.+|||++|++.
T Consensus       229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             98547999999999985579768919789737

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=349.51  Aligned_cols=246  Identities=22%  Similarity=0.310  Sum_probs=202.9

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC---HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEE
Q ss_conf             97223221185662439999984897899999746976---230999999999986258789530310796056214899
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      ..|...++||+|+||+||+|++..+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             50698998887414899984578999999999999987621688746238888968887999769970577522588987
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  665 (811)
                      ||+++|+|..++.. ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......  
T Consensus        95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (309)
T ss_dssp             ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             EECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC--
T ss_conf             80699945789973-79999999999999999999999868---9766678842179879997898443653346778--


Q ss_pred             CCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCC
Q ss_conf             61003445788668101136---888863314889999999890997888887752203477889875310110000178
Q 003555          666 GIVTGVKGTRGYMSPEWQNS---GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~---~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                         ....||+.|+|||++.+   ..++.++|||||||++|||++|+.||......+..   ..     .......     
T Consensus       169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~---~~-----i~~~~~~-----  232 (309)
T d1u5ra_         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YH-----IAQNESP-----  232 (309)
T ss_dssp             ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HH-----HHHSCCC-----
T ss_pred             ---CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HH-----HHHCCCC-----
T ss_conf             ---7313476636889983467888672145455899999998788999997999999---99-----9828999-----


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             63127689999999998825699999999899999
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       743 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                       ...+...++.+.+++.+||+.||.+|||+.|+++
T Consensus       233 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 -ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             -8887888999999999977379657918999971

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.83  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=206.0

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECC--CCEEEEE
Q ss_conf             722322118566243999998489789999974697--623099999999998625878953031079605--6214899
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--SKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--~~~~lV~  585 (811)
                      .|.+.+.||+|+||+||+|++..+++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+.  ...++||
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm   84 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   84 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             37996798308891999999999997999999874657979999999999999977899982489999917899899999


Q ss_pred             EECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             506989988874148---999845789999999999999876216--887462388889688879997699705775225
Q 003555          586 EFMSKGSLENLLSNV---ESGPIWRDRVRIALDVARGITYLHEEC--EVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       586 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~  660 (811)
                      ||+++|+|.+++...   ...+++..+..++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~  164 (269)
T d2java1          85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL  164 (269)
T ss_dssp             ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred             ECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEEC
T ss_conf             56899938999985154578999999999999999999999971677887885867654257478885798001000322


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHC
Q ss_conf             88987610034457886681011368888633148899999998909978888877522034778898753101100001
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+    +    .........    
T Consensus       165 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~----~----~~~i~~~~~----  231 (269)
T d2java1         165 NHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----L----AGKIREGKF----  231 (269)
T ss_dssp             ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----H----HHHHHHTCC----
T ss_pred             CCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH----H----HHHHHCCCC----
T ss_conf             4577-75566778823279999839999938988752789999801889989989999----9----999971899----


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             7863127689999999998825699999999899999
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                         ...+...++++.+++.+||+.||.+|||+.|+++
T Consensus       232 ---~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 ---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ---8897435999999999976799557918999972

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.51  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=209.8

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECC-----CCEEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEE
Q ss_conf             972232211856624399999848-----97899999746976-230999999999986258789530310796056214
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKL  582 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~  582 (811)
                      ..+.+.++||+|+||+||+|+.+.     +++.||||+++... .+..++|.+|+.++++++|+||+++++++.+....+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEE
T ss_conf             89388679820788399999988876577882999999882108579999999999999668997655246660598038


Q ss_pred             EEEEECCCCCHHHHHHCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCC
Q ss_conf             8995069899888741489-----------------------99845789999999999999876216887462388889
Q 003555          583 LVYEFMSKGSLENLLSNVE-----------------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPR  639 (811)
Q Consensus       583 lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~  639 (811)
                      +|+||+++|+|.+++....                       ..+++.+++.|+.|++.||+|||+.   +++||||||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~  169 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR  169 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEECCC
T ss_conf             9998158992999998527554210000111001210346788989999999999999985541357---8685488401


Q ss_pred             CEEECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCC
Q ss_conf             68887999769970577522588987-61003445788668101136888863314889999999890997-88888775
Q 003555          640 NILLDDSLTAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS-NFEVNVST  717 (811)
Q Consensus       640 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~-p~~~~~~~  717 (811)
                      |||++.++.+||+|||+++....... .......|++.|+|||.+....++.++||||||+++|||+++.. ||......
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             CEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCHH
T ss_conf             16898999289833144211367764111577776767679899726889805630252362999980689999998999


Q ss_pred             CCHHHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             2203477889875310110000178631276899999999988256999999998999999431569
Q 003555          718 ADVVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       718 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                       +..       .....+..       ...+...+.++.+|+.+||+.+|.+||||.||+++|+.+.+
T Consensus       250 -e~~-------~~v~~~~~-------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         250 -EVI-------YYVRDGNI-------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             -HHH-------HHHHTTCC-------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -HHH-------HHHHCCCC-------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             -999-------99973997-------88873252999999999748896579399999999998429

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.96  Aligned_cols=254  Identities=23%  Similarity=0.369  Sum_probs=209.5

Q ss_pred             HHHHHHCCCCCCEEEEEEEECCCCE----EEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEE
Q ss_conf             2232211856624399999848978----9999974697-6230999999999986258789530310796056214899
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNK----IVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       511 ~~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      |++.++||+|+||+||+|.+..+++    .||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEEE
T ss_conf             9783198208992999999958998898999999965134979999999999999867998881589999619-836999


Q ss_pred             EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             50698998887414899984578999999999999987621688746238888968887999769970577522588987
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  665 (811)
                      |++.+|+|.+++......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCCC
T ss_conf             84268740101113345799999999999999999999876---950476212031167998758602552223354445


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCC
Q ss_conf             6-1003445788668101136888863314889999999890-9978888877522034778898753101100001786
Q 003555          666 G-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGED  743 (811)
Q Consensus       666 ~-~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  743 (811)
                      . ......||..|+|||.+.+..++.++||||||+++|||+| |+.||......+ .   ...+    ..       ..+
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~---~~~i----~~-------~~~  231 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-I---SSIL----EK-------GER  231 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-H---HHHH----HH-------TCC
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-H---HHHH----HC-------CCC
T ss_conf             3223651058644670887469998356544079999999977999999999899-9---9999----75-------998


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             3127689999999998825699999999899999943156
Q 003555          744 EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       744 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      ...+...+..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             9998556899999999847899346919999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.30  Aligned_cols=247  Identities=21%  Similarity=0.258  Sum_probs=207.4

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEE
Q ss_conf             722322118566243999998489789999974697---62309999999999862587895303107960562148995
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .|.+.+.||+|+||.||+|+...+++.||+|+++..   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEE
T ss_conf             42898898317684999999989998999999815654497999999999999986799988778764035642111000


Q ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             06989988874148999845789999999999999876216887462388889688879997699705775225889876
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  666 (811)
                      |+++|+|.+++.. ...+++.....++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        86 y~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~  160 (337)
T d1o6la_          86 YANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A  160 (337)
T ss_dssp             CCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred             CCCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC-C
T ss_conf             3579860555532-56775999999999996521134315---96224647778476589988882056520035678-6


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCC
Q ss_conf             10034457886681011368888633148899999998909978888877522034778898753101100001786312
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+    +    ..        .+.......
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~----~~--------~i~~~~~~~  224 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----L----FE--------LILMEEIRF  224 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----H----HH--------HHHHCCCCC
T ss_pred             CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH----H----HH--------HHHCCCCCC
T ss_conf             2055100889966665048988833310223067889987899999969999----9----99--------985289989


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             7689999999998825699999999-----899999
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  777 (811)
                      +...+.++.+|+.+||+.||.+||+     +.++++
T Consensus       225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             866899999999866638934422565234999972

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.75  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=214.0

Q ss_pred             HHHHHHHHHHHCCCCCCEEEEEEEECCCC---EEEEEEECCCCC-HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCE
Q ss_conf             99997223221185662439999984897---899999746976-23099999999998625878953031079605621
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGN---KIVAVKRLENPV-EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~  581 (811)
                      +....+.+.+.||+|+||.||+|++...+   ..||||.++... ....+.+.+|+.++++++||||++++|++. .+..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEE
T ss_conf             688996987799307882999999936996449999999365668799999999999998689999856988995-3747


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             48995069899888741489998457899999999999998762168874623888896888799976997057752258
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~  661 (811)
                      ++||||+++|+|.+++......+++.+++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf             999984069807765422478999999999999998775230226---74414102655320678967876503421336


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHC
Q ss_conf             898761003445788668101136888863314889999999890-9978888877522034778898753101100001
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ...........||+.|+|||.+....++.++||||||+++|||++ |..||......+-.    .    ....+      
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~----~----~i~~~------  225 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----G----RIENG------  225 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----H----HHHTT------
T ss_pred             CCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH----H----HHHCC------
T ss_conf             776233054005831032667516998874524442478999982699998889999999----9----99818------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             7863127689999999998825699999999899999943156
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                       .....+...++.+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       226 -~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         226 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             -999898777999999999976879768929999999999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.69  Aligned_cols=275  Identities=27%  Similarity=0.403  Sum_probs=215.5

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCE--EEEEEECCCC-CHHHHHHHHHHHHHHHCC-CCCCCCCEECEEECCCCEEEEE
Q ss_conf             72232211856624399999848978--9999974697-623099999999998625-8789530310796056214899
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNK--IVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      .+.+.++||+|+||+||+|++..++.  .||||++... ..+..+.|.+|+.++.++ +||||++++|++.+.+..++|+
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~   90 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   90 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
T ss_conf             96887798207882899999989996999999997823385799999999999986228998836788884187369999


Q ss_pred             EECCCCCHHHHHHCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf             506989988874148---------------99984578999999999999987621688746238888968887999769
Q 003555          586 EFMSKGSLENLLSNV---------------ESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAK  650 (811)
Q Consensus       586 e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k  650 (811)
                      ||+++|+|.++|...               ...+++.++.+++.||+.||.|||+.   +++||||||+|||++.++.+|
T Consensus        91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~k  167 (309)
T d1fvra_          91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  167 (309)
T ss_dssp             CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCEE
T ss_conf             80289869999864035555512310123457899999999999999998766308---954555052048986887638


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHHHH
Q ss_conf             97057752258898761003445788668101136888863314889999999890997-88888775220347788987
Q 003555          651 ISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRS-NFEVNVSTADVVLLSTWVYN  729 (811)
Q Consensus       651 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~-p~~~~~~~~~~~~l~~~~~~  729 (811)
                      |+|||+++......  ......||..|+|||.+....++.++||||||+++|||++|.. ||... ...+.       ..
T Consensus       168 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~-------~~  237 (309)
T d1fvra_         168 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAEL-------YE  237 (309)
T ss_dssp             ECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHH-------HH
T ss_pred             ECCCCCCCCCCCCC--CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC-CHHHH-------HH
T ss_conf             74344322444223--4553013775555387526999962215313889999983689999999-99999-------99


Q ss_pred             HHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCC--CCCCCCCCCCCCCCCC
Q ss_conf             53101100001786312768999999999882569999999989999994315699999--9887755688986558
Q 003555          730 CFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVV--PFPILSNFSSNSQTLS  804 (811)
Q Consensus       730 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~--~~p~~~~~~~~~~~~~  804 (811)
                      ....+       .+...+...++++.+|+.+||+.||++||||.+|++.|+.+.+-...  ..+..+.++..+...+
T Consensus       238 ~i~~~-------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~~~~~~e~~~~~~~~~~  307 (309)
T d1fvra_         238 KLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS  307 (309)
T ss_dssp             HGGGT-------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCCCCCCGG
T ss_pred             HHHHC-------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCCCCCCCHHHCCCCCCCCCC
T ss_conf             99826-------88888766789999999997678966894999999999999861867789750010445688877

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.17  Aligned_cols=250  Identities=21%  Similarity=0.285  Sum_probs=206.3

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC------HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEE
Q ss_conf             7223221185662439999984897899999746976------2309999999999862587895303107960562148
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV------EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .|.+.++||+|+||+||+|++..+++.||||+++...      ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             77982798117895999999999998999999875663213406899999999999986799899938899997998999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEECCCCCC
Q ss_conf             9950698998887414899984578999999999999987621688746238888968887999----769970577522
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL----TAKISNFSLAKI  659 (811)
Q Consensus       584 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfGla~~  659 (811)
                      ||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++    .+||+|||++..
T Consensus        91 v~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          91 ILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEECCCCCCCCCHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf             9986778643100103-56421557899999999998766625---4221133301279825898666469643344210


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHH
Q ss_conf             58898761003445788668101136888863314889999999890997888887752203477889875310110000
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      .....  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+..    .    ......    
T Consensus       167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~----~i~~~~----  232 (293)
T d1jksa_         167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL----A----NVSAVN----  232 (293)
T ss_dssp             CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----H----HHHTTC----
T ss_pred             CCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH----H----HHHHCC----
T ss_conf             57776--312247777430999981899997665221409999997088998899999999----9----998168----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             17863127689999999998825699999999899999
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      ...........+..+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             88870104788999999999986389668919999961

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=338.26  Aligned_cols=248  Identities=21%  Similarity=0.241  Sum_probs=200.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC---HHHHHHHHH---HHHHHHCCCCCCCCCEECEEECCCCEEE
Q ss_conf             7223221185662439999984897899999746976---230999999---9999862587895303107960562148
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQA---EMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .|.+.+.||+|+||.||+|++..+++.||||++....   ......+.+   ++.+++.++||||+++++++.+.+..++
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEE
T ss_conf             68510188428890999999999997999999845875426679999999999999850899858899999998998899


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             99506989988874148999845789999999999999876216887462388889688879997699705775225889
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  663 (811)
                      ||||+++|+|.+++.. ...+.+..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 vmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEECCCC
T ss_conf             9991489838999873-25532789999999999999999977---9622044422167858896798220102333788


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCC
Q ss_conf             876100344578866810113-6888863314889999999890997888887752203477889875310110000178
Q 003555          664 QTGIVTGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGE  742 (811)
Q Consensus       664 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  742 (811)
                      .   .....||+.|+|||++. +..++.++|||||||++|||++|+.||.......... +            .......
T Consensus       161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~------------~~~~~~~  224 (364)
T d1omwa3         161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-I------------DRMTLTM  224 (364)
T ss_dssp             C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-H------------HHHSSSC
T ss_pred             C---CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHH-H------------HHHCCCC
T ss_conf             6---4331134554216876038999844104677899999985999888899899999-9------------9860468


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             63127689999999998825699999999-----899999
Q 003555          743 DEEVDLRTLETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       743 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  777 (811)
                      ....+...+.++.+++.+||+.||.+||+     ++++++
T Consensus       225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             8878877899999999998566988808874357999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=340.89  Aligned_cols=244  Identities=21%  Similarity=0.260  Sum_probs=205.7

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEE
Q ss_conf             722322118566243999998489789999974697---62309999999999862587895303107960562148995
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .|++.++||+|+||+||+|+++.+++.||||+++..   .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEE
T ss_conf             70888897207680899999989997999999845775488999999999999986369675330356852880056765


Q ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             06989988874148999845789999999999999876216887462388889688879997699705775225889876
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  666 (811)
                      |+++|+|..++.. .....+.....++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus        85 ~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---  157 (316)
T d1fota_          85 YIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  157 (316)
T ss_dssp             CCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             ECCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECCC---
T ss_conf             0378632234322-22111007999999998765541247---6770556810503868998898317521671245---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCC
Q ss_conf             10034457886681011368888633148899999998909978888877522034778898753101100001786312
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                       .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+.                ...+.......
T Consensus       158 -~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----------------~~~i~~~~~~~  220 (316)
T d1fota_         158 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----------------YEKILNAELRF  220 (316)
T ss_dssp             -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHCCCCC
T ss_pred             -CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH----------------HHHHHCCCCCC
T ss_conf             -6434576343599998389998043046533368999759899999699999----------------99997089889


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             768999999999882569999999-----9899999
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  777 (811)
                      +...+.++.+++.+||+.||.+|+     +++++++
T Consensus       221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             977899999999999544997666431021999981

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.40  Aligned_cols=262  Identities=26%  Similarity=0.386  Sum_probs=207.9

Q ss_pred             HHHHHHHHHHHCCCCCCEEEEEEEECC-----CCEEEEEEECCCC-CHHHHHHHHHHHHHHHCC-CCCCCCCEECEEECC
Q ss_conf             999972232211856624399999848-----9789999974697-623099999999998625-878953031079605
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENP-VEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQT  578 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~  578 (811)
                      +....|.+.++||+|+||.||+|.+..     .++.||||+++.. .....+.+..|...+.++ +|+||+.+++++.+.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf             16799798449841678399999986777555783999999860017178999999999988614998499741154047


Q ss_pred             C-CEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf             6-2148995069899888741489---------------99845789999999999999876216887462388889688
Q 003555          579 S-KKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNIL  642 (811)
Q Consensus       579 ~-~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl  642 (811)
                      + ..++||||+++|+|.+++....               ..+++.++..++.||+.||.|||++   +|+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEE
T ss_conf             9757999984589929999985366666532220233214689999999999999999988737---9717867731065


Q ss_pred             ECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCCCH
Q ss_conf             879997699705775225889876-100344578866810113688886331488999999989099-788888775220
Q 003555          643 LDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR-SNFEVNVSTADV  720 (811)
Q Consensus       643 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~-~p~~~~~~~~~~  720 (811)
                      ++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+++. .||.........
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf             77998289845752001135665222475166721020368646889966322136789999986889999899989999


Q ss_pred             HHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             3477889875310110000178631276899999999988256999999998999999431569
Q 003555          721 VLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       721 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      .       .....+       .....+...+.++.+++.+||+.||++|||+.|++++|+.+++
T Consensus       247 ~-------~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 C-------RRLKEG-------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             H-------HHHHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-------HHHHCC-------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             9-------999638-------9888886578999999999767796679199999999979986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=337.23  Aligned_cols=244  Identities=18%  Similarity=0.178  Sum_probs=205.8

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEE
Q ss_conf             722322118566243999998489789999974697---62309999999999862587895303107960562148995
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e  586 (811)
                      .|.+.++||+|+||.||+|+++.+++.||||++...   .....+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf             70898896117680899999989998999999826774588999999999999997487727403444432222232222


Q ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             06989988874148999845789999999999999876216887462388889688879997699705775225889876
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTG  666 (811)
Q Consensus       587 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~  666 (811)
                      |+.+|+|..++.. ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       122 ~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             CCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             CCCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC---
T ss_conf             3346622666751-58989999999999999989999859---9861767999936077897886101033322566---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCC
Q ss_conf             10034457886681011368888633148899999998909978888877522034778898753101100001786312
Q 003555          667 IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       667 ~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                       .....||+.|||||++.+..++.++|||||||++|||++|+.||.......   .+             ..+.......
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~-------------~~i~~~~~~~  257 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY-------------EKIVSGKVRF  257 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-------------HHHHHCCCCC
T ss_pred             -CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHH---HH-------------HHHHCCCCCC
T ss_conf             -643367635678899717998853311450078999975889989959999---99-------------9986179889


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             768999999999882569999999-----9899999
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRP-----SMKNVIL  777 (811)
Q Consensus       747 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~  777 (811)
                      +...+.++.+++.+||+.||.+|+     +++++++
T Consensus       258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             766899999999998340998606553454999971

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.16  Aligned_cols=250  Identities=20%  Similarity=0.260  Sum_probs=207.1

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECC
Q ss_conf             72232211856624399999848978999997469762309999999999862587895303107960562148995069
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~  589 (811)
                      +|.+.++||+|+||+||+|.+..+++.||+|.++... .....+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~   84 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
T ss_conf             0588789831778399999998999699999975786-659999999999985799798909899988998899995389


Q ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCCCCCC
Q ss_conf             89988874148999845789999999999999876216887462388889688879--9976997057752258898761
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD--SLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      +|+|.+++......+++.++..++.||+.||.|||+.   +|+||||||+|||++.  ...+||+|||+++......  .
T Consensus        85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~  159 (321)
T d1tkia_          85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N  159 (321)
T ss_dssp             CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred             CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC--C
T ss_conf             9808899875389999999999999999999999876---9975135544434437885189976441110034677--5


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCCC
Q ss_conf             00344578866810113688886331488999999989099788888775220347788987531011000017863127
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEVD  747 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  747 (811)
                      .....+++.|+|||...+..++.++||||+||++|||++|+.||......+..        .......    ........
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~--------~~i~~~~----~~~~~~~~  227 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII--------ENIMNAE----YTFDEEAF  227 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------HHHHHTC----CCCCHHHH
T ss_pred             CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHH--------HHHHHCC----CCCCHHHC
T ss_conf             32122332223402104877784011302799999998289999998999999--------9998389----99880223


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             689999999998825699999999899999
Q 003555          748 LRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       748 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      ...+.++.+++.+||+.||.+|||+.|+++
T Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         228 KEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             678999999999986699668909999963

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.26  Aligned_cols=262  Identities=26%  Similarity=0.433  Sum_probs=210.9

Q ss_pred             HHHHHHHHHHHHCCCCCCEEEEEEEECC-----CCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECC
Q ss_conf             8999972232211856624399999848-----9789999974697-623099999999998625878953031079605
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSICE-----GNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT  578 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~  578 (811)
                      |+....+.+.++||+|+||+||+|.+..     .+..||||+++.. .......|.+|+.++++++|+||++++|++...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC
T ss_conf             42689918835982078818999998786447789689999987012868999999999999976999884125478428


Q ss_pred             CCEEEEEEECCCCCHHHHHHCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             62148995069899888741489---------998457899999999999998762168874623888896888799976
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVE---------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTA  649 (811)
Q Consensus       579 ~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~  649 (811)
                      ...++|+||+++|+|.+++...+         ..+++..+.+++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred             CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEE
T ss_conf             810677760489988999875033211344468879999999999999999987647---96543286775403599649


Q ss_pred             EEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCCCHHHHHHHH
Q ss_conf             99705775225889876-100344578866810113688886331488999999989099-7888887752203477889
Q 003555          650 KISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCR-SNFEVNVSTADVVLLSTWV  727 (811)
Q Consensus       650 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~-~p~~~~~~~~~~~~l~~~~  727 (811)
                      ||+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||+|++ .|+... ...+..      
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~~~------  245 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQVL------  245 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHHH------
T ss_pred             EEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-CHHHHH------
T ss_conf             9942454202357763031340231632378888736998833344437899999996899999998-999999------


Q ss_pred             HHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             875310110000178631276899999999988256999999998999999431569
Q 003555          728 YNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                       .....+.       ....+...+..+.+++.+||+.+|.+||||.+|+++|++.++
T Consensus       246 -~~i~~~~-------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 -RFVMEGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -HHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHHCC-------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             -9998088-------888863353999999999757796589399999999787617

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.27  Aligned_cols=270  Identities=22%  Similarity=0.265  Sum_probs=202.1

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCC----CEEEEE
Q ss_conf             7223221185662439999984897899999746976230999999999986258789530310796056----214899
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS----KKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lV~  585 (811)
                      ++.+.++||+|+||+||+|++  .++.||||+++.. ......+..|+..+.+++||||++++|+|.+..    ..++||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             899988982078819999999--9989999998720-0467999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             506989988874148999845789999999999999876216-----887462388889688879997699705775225
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEEC-----EVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       586 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~  660 (811)
                      ||+++|+|.++|.+  ..++|.++++++.|++.||.|||+..     ..+|+|+||||+|||++.++.+||+|||+++..
T Consensus        81 Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          81 DYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ECCCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
T ss_conf             64669898999865--8999899999999999999998876652046898661531731357868877688763866234


Q ss_pred             CCCCCC---CCCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH-------HH
Q ss_conf             889876---100344578866810113688------88633148899999998909978888877522034-------77
Q 003555          661 MPNQTG---IVTGVKGTRGYMSPEWQNSGL------ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVL-------LS  724 (811)
Q Consensus       661 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~-------l~  724 (811)
                      ......   ......||+.|+|||++.+..      ++.++||||||++||||+||..|+...........       ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf             67776200135525035476782210565454677767501220159999999628998876631124101225564309


Q ss_pred             HHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf             8898753101100001786312768999999999882569999999989999994315699
Q 003555          725 TWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEI  785 (811)
Q Consensus       725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~  785 (811)
                      .........+....-+. ......+....+.+++.+||+.||++|||+.||++.|+.+.+-
T Consensus       239 ~~~~~~~~~~~~~p~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCC-GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             99999875024688877-6557768999999999997606985895999999999988886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.90  Aligned_cols=263  Identities=24%  Similarity=0.384  Sum_probs=212.2

Q ss_pred             HHHHHHHHHHHHCCCCCCEEEEEEEEC-----CCCEEEEEEECCCCC-HHHHHHHHHHHHHHHCC-CCCCCCCEECEEEC
Q ss_conf             899997223221185662439999984-----897899999746976-23099999999998625-87895303107960
Q 003555          505 ELERATNGFEEELGRGCFGAVYKGSIC-----EGNKIVAVKRLENPV-EEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQ  577 (811)
Q Consensus       505 el~~~~~~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~  577 (811)
                      |+....+.+.++||+|+||.||+|++.     ..++.||||+++... ......+.+|+.++.++ +||||++++|++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf             37789969854982068829999998066447788699999987424877999999999998762699988789989831


Q ss_pred             CCCEEEEEEECCCCCHHHHHHCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf             562148995069899888741489-----------------998457899999999999998762168874623888896
Q 003555          578 TSKKLLVYEFMSKGSLENLLSNVE-----------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRN  640 (811)
Q Consensus       578 ~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~N  640 (811)
                      ....++||||+++|+|.+++....                 ..+++..+..++.||+.||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCC
T ss_conf             997899997379987999998535665444445332223345889999999999999999988757---92666241021


Q ss_pred             EEECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             8887999769970577522588987-610034457886681011368888633148899999998909978888877522
Q 003555          641 ILLDDSLTAKISNFSLAKILMPNQT-GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTAD  719 (811)
Q Consensus       641 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~  719 (811)
                      |+++.++.+||+|||+++....... .......||+.|+|||.+....++.++||||||+++|||+|++.|+........
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf             00002575210234010233678861586201359687677886179999740010258999999858998877899899


Q ss_pred             HHHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             0347788987531011000017863127689999999998825699999999899999943156
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      .  +...+     ....      +...+...+..+.+|+.+||+.||++||||.+++++|++.+
T Consensus       256 ~--~~~~i-----~~~~------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         256 K--FYKMI-----KEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             H--HHHHH-----HHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHHH-----HCCC------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             9--99998-----6689------88985436599999999975779657929999999998765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.47  Aligned_cols=261  Identities=26%  Similarity=0.375  Sum_probs=212.0

Q ss_pred             HHHHHHHHHHHCCCCCCEEEEEEEECCCC-------EEEEEEECCCCCH-HHHHHHHHHHHHHHCC-CCCCCCCEECEEE
Q ss_conf             99997223221185662439999984897-------8999997469762-3099999999998625-8789530310796
Q 003555          506 LERATNGFEEELGRGCFGAVYKGSICEGN-------KIVAVKRLENPVE-EGERKFQAEMAAVRRT-HHKNLVRLLGFCM  576 (811)
Q Consensus       506 l~~~~~~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~g~~~  576 (811)
                      +....+.+.++||+|+||.||+|+....+       ..||||+++.... ....++.+|+..+.++ +||||++++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf             25899697009851678289999985787555667549999998811286889999999999998139996973465220


Q ss_pred             CCCCEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf             0562148995069899888741489---------------9984578999999999999987621688746238888968
Q 003555          577 QTSKKLLVYEFMSKGSLENLLSNVE---------------SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNI  641 (811)
Q Consensus       577 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI  641 (811)
                      ++...++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||+.   +|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCE
T ss_conf             18868999973699909999986067764322233457434679999999999999999876637---978630221022


Q ss_pred             EECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf             8879997699705775225889876-1003445788668101136888863314889999999890-9978888877522
Q 003555          642 LLDDSLTAKISNFSLAKILMPNQTG-IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTAD  719 (811)
Q Consensus       642 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~  719 (811)
                      |++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-~  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-E  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-H
T ss_pred             EECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH-H
T ss_conf             454789767622111011355555431466788846632667517988825554775888887401798989999999-9


Q ss_pred             HHHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             03477889875310110000178631276899999999988256999999998999999431569
Q 003555          720 VVLLSTWVYNCFIAKELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       720 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                             +......+       .....+...+.++.+|+.+||+.||.+|||+.||+++|+.++.
T Consensus       246 -------~~~~i~~~-------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 -------LFKLLKEG-------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -------HHHHHHTT-------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHHHHHCC-------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -------99999728-------8889874352999999999766797679399999999988860

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=333.19  Aligned_cols=251  Identities=20%  Similarity=0.219  Sum_probs=199.0

Q ss_pred             HHHHH-HHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCC-CCCCCCCEECEEEC----CCCEEE
Q ss_conf             72232-2118566243999998489789999974697623099999999998625-87895303107960----562148
Q 003555          510 TNGFE-EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRT-HHKNLVRLLGFCMQ----TSKKLL  583 (811)
Q Consensus       510 ~~~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~~~~l  583 (811)
                      .|.+. +.||+|+||+||+|++..+++.||||+++.     ...+.+|+.++.++ +||||+++++++.+    ....++
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEE
T ss_conf             879810796545486999999889998999999897-----477999999999866999978298999503468978999


Q ss_pred             EEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCCC
Q ss_conf             995069899888741489-99845789999999999999876216887462388889688879---99769970577522
Q 003555          584 VYEFMSKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD---SLTAKISNFSLAKI  659 (811)
Q Consensus       584 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla~~  659 (811)
                      ||||+++|+|.+++.... ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.   .+.+||+|||+++.
T Consensus        87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf             99778998499999862787757999999999999999999976---986444100220113555566311354551233


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHH
Q ss_conf             58898761003445788668101136888863314889999999890997888887752203477889875310110000
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      ......  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+        ........
T Consensus       164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--------~~~i~~~~  233 (335)
T d2ozaa1         164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQ  233 (335)
T ss_dssp             CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------CCCSCS
T ss_pred             CCCCCC--CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHH--------HHHHHCCC
T ss_conf             368886--43226775637927774898888888876451677886588998898877889999--------99985388


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             178631276899999999988256999999998999999
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ...........++++.+|+.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             888985434699999999999756996579099999709

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.38  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=207.3

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCC---CEEEEEEECCCC---CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEE
Q ss_conf             722322118566243999998489---789999974697---62309999999999862587895303107960562148
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEG---NKIVAVKRLENP---VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~l  583 (811)
                      .+++.+.||+|+||+||+|++...   ...||||++...   ..+..+.|.+|+.++++++||||++++|++.+ ...++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHHE
T ss_conf             91997898038883999999988999079999999983555798999999999999986899998789877740-10011


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             99506989988874148999845789999999999999876216887462388889688879997699705775225889
Q 003555          584 VYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPN  663 (811)
Q Consensus       584 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~  663 (811)
                      |+||+++|+|.+++......+++..++.++.||+.||.|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             EEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCC
T ss_conf             4654238612544421268999999999999999999875217---8752056688815655654332561155530358


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHC
Q ss_conf             876--1003445788668101136888863314889999999890-9978888877522034778898753101100001
Q 003555          664 QTG--IVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       664 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+..    ..    ....      
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----~~----i~~~------  230 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HK----IDKE------  230 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HH----HHTS------
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HH----HHHC------
T ss_conf             875265476325731079999837999942156614899999996899999996999999----99----9847------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             786312768999999999882569999999989999994315
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGT  782 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~  782 (811)
                      ......+...+..+.+++.+||+.||++||||.+|++.|+++
T Consensus       231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             999998544539999999997688966792999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=333.98  Aligned_cols=257  Identities=20%  Similarity=0.272  Sum_probs=209.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC---HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCC----CEE
Q ss_conf             7223221185662439999984897899999746976---230999999999986258789530310796056----214
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV---EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS----KKL  582 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~  582 (811)
                      +|.+.+.||+|+||+||+|++..+++.||||+++...   .+....+.+|+.+++.++||||+++++++....    ..+
T Consensus         8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~   87 (277)
T d1o6ya_           8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   87 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             EEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEE
T ss_conf             06986899608992999999999998999999855664698999999999999985699988731143543268876699


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             89950698998887414899984578999999999999987621688746238888968887999769970577522588
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~  662 (811)
                      +||||+++++|.+++.. ...+++.++..++.||+.||.|||+.   +|+||||||+|||++.++..+|+|||.+.....
T Consensus        88 lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          88 IVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEECCCCCEEHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf             99977889871011203-58999999999999999999999857---952763467556657543201003444322123


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHC
Q ss_conf             987--610034457886681011368888633148899999998909978888877522034778898753101100001
Q 003555          663 NQT--GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLV  740 (811)
Q Consensus       663 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  740 (811)
                      ...  .......||+.|+|||.+.+..++.++||||||+++|||+||+.||......+.   +    .......     .
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~----~~~~~~~-----~  231 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---A----YQHVRED-----P  231 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H----HHHHHCC-----C
T ss_pred             CCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH---H----HHHHHCC-----C
T ss_conf             54433334642576243699998399999663202652899999769799899699999---9----9998469-----9


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHCC
Q ss_conf             786312768999999999882569999999-989999994315
Q 003555          741 GEDEEVDLRTLETMVRVGLLCIQDEPNLRP-SMKNVILMLEGT  782 (811)
Q Consensus       741 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~  782 (811)
                      ..........++++.+++.+||+.||.+|| ++++++..|..+
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf             9971003478999999999986679767773999999999997

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.89  Aligned_cols=247  Identities=20%  Similarity=0.275  Sum_probs=203.4

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC---CHHHHHHHHHHHHHHH-CCCCCCCCCEECEEECCCCEEEEE
Q ss_conf             722322118566243999998489789999974697---6230999999999986-258789530310796056214899
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP---VEEGERKFQAEMAAVR-RTHHKNLVRLLGFCMQTSKKLLVY  585 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~~~~~~lV~  585 (811)
                      .|.+.++||+|+||+||+|++..+++.||||+++..   .....+.+..|..++. .++||||+++++++.+++..++||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             71886589408782899999999998999999805553384899999999999998479996878988970498316777


Q ss_pred             EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             50698998887414899984578999999999999987621688746238888968887999769970577522588987
Q 003555          586 EFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       586 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~  665 (811)
                      ||+++|+|.+++.. ...+++.++..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 Ey~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          83 EYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             ECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             EECCCCCHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCC-
T ss_conf             50379808998640-47899999999999999999999868---93403476540444489963015553023235665-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCC
Q ss_conf             61003445788668101136888863314889999999890997888887752203477889875310110000178631
Q 003555          666 GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEE  745 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  745 (811)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+    +    ...        +......
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~----~~~--------i~~~~~~  221 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----L----FHS--------IRMDNPF  221 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H----HHH--------HHHCCCC
T ss_pred             CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----H----HHH--------HHCCCCC
T ss_conf             33454578777689999827998832320112278989873889999989999----9----999--------9718998


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             2768999999999882569999999989-9999
Q 003555          746 VDLRTLETMVRVGLLCIQDEPNLRPSMK-NVIL  777 (811)
Q Consensus       746 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~  777 (811)
                      .+...+.++.+|+.+||+.||.+||++. ++++
T Consensus       222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             975679999999999654489878388999980

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.86  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=204.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECC-CCEEEEEEEC
Q ss_conf             722322118566243999998489789999974697623099999999998625878953031079605-6214899506
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT-SKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~  588 (811)
                      .+.+.++||+|+||.||+|.++  +..||||+++..  ...+.+.+|+.++++++||||++++|+|.+. +..++|+||+
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf             9488579820798089999999--909999998857--779999999999986789898549878872389289999636


Q ss_pred             CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             9899888741489-998457899999999999998762168874623888896888799976997057752258898761
Q 003555          589 SKGSLENLLSNVE-SGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       589 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      ++|+|.++|.... ..+++..+++|+.||+.||.|||+.   +++|+||||+|||++.++.+||+|||+++.....    
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----  156 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  156 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC----
T ss_conf             999899998745788889999999999998523211337---6553666567601468997763245600344787----


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHCCCCCCC
Q ss_conf             003445788668101136888863314889999999890-9978888877522034778898753101100001786312
Q 003555          668 VTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVC-CRSNFEVNVSTADVVLLSTWVYNCFIAKELSKLVGEDEEV  746 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  746 (811)
                      .....++..|+|||.+.+..++.++||||||+++|||+| |+.|+......+ .   ...+    ..       ..+++.
T Consensus       157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-~---~~~i----~~-------~~~~~~  221 (262)
T d1byga_         157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-V---VPRV----EK-------GYKMDA  221 (262)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-H---HHHH----TT-------TCCCCC
T ss_pred             CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-H---HHHH----HC-------CCCCCC
T ss_conf             7655666467781787279888588777579999999978999999999999-9---9999----80-------899999


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             7689999999998825699999999899999943156
Q 003555          747 DLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTM  783 (811)
Q Consensus       747 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~  783 (811)
                      +...+.++.+++.+||+.||.+||||.+++++|+.+.
T Consensus       222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             7657999999999975669768939999999999998

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=329.94  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=204.8

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCH---------HHHHHHHHHHHHHHCCC-CCCCCCEECEEECCC
Q ss_conf             72232211856624399999848978999997469762---------30999999999986258-789530310796056
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE---------EGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTS  579 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~  579 (811)
                      .|.+.+.||+|+||+||+|++..+++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+.+
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCC
T ss_conf             38885288417684999999999998999999962446411478889999999999999998507997479976214676


Q ss_pred             CEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             21489950698998887414899984578999999999999987621688746238888968887999769970577522
Q 003555          580 KKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       580 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~  659 (811)
                      ..++||||+++|+|.+++.. +..+++.++..++.||+.||+|||++   +|+|+||||+|||++.++.+||+|||+++.
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CEEEEEECCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf             05999976898668999986-59999999999999999999999875---994323462548986899838712403167


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             5889876100344578866810113------6888863314889999999890997888887752203477889875310
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQN------SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIA  733 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~  733 (811)
                      ......  .....||+.|+|||++.      ...++.++||||+|+++|||++|+.||........        ......
T Consensus       160 ~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--------~~~i~~  229 (277)
T d1phka_         160 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--------LRMIMS  229 (277)
T ss_dssp             CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHH
T ss_pred             CCCCCC--EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH--------HHHHHH
T ss_conf             268872--1345246788898886053445678899233185656023103228889889999999--------999981


Q ss_pred             CCCCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             11000017863127689999999998825699999999899999
Q 003555          734 KELSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       734 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      +...    .........++++.+++.+||+.+|++||++.|+++
T Consensus       230 ~~~~----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         230 GNYQ----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TCCC----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCC----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             8988----898543468999999999976589668919999973

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=330.33  Aligned_cols=258  Identities=21%  Similarity=0.248  Sum_probs=199.0

Q ss_pred             HHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHH-----HHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEECC
Q ss_conf             2118566243999998489789999974697623-----09999999999862587895303107960562148995069
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPVEE-----GERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEFMS  589 (811)
Q Consensus       515 ~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~  589 (811)
                      +.||+|+||+||+|++..+++.||||+++.....     ..+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             EEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHHC
T ss_conf             38512728299999999999699999984202124567999999999999986799998689854225874022045534


Q ss_pred             CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf             89988874148999845789999999999999876216887462388889688879997699705775225889876100
Q 003555          590 KGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGIVT  669 (811)
Q Consensus       590 ~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  669 (811)
                      ++++..++.. ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        84 ~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~  158 (299)
T d1ua2a_          84 TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT  158 (299)
T ss_dssp             EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred             CHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-CCC
T ss_conf             5077655412-66778999999999999999886316---355035776258853778411465761000578755-433


Q ss_pred             CCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHH--------C
Q ss_conf             3445788668101136-888863314889999999890997888887752203477889875310110000--------1
Q 003555          670 GVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL--------V  740 (811)
Q Consensus       670 ~~~gt~~y~aPE~~~~-~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--------~  740 (811)
                      ...||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+....+.... ...........        .
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~-~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL-GTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTTTSSSTTSSTTCCCC
T ss_pred             CEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHC-CCCCHHHCCCHHCCCHHHHH
T ss_conf             02047333639997267788805643630428999985969999999999999999851-89972545210002134430


Q ss_pred             CCCC-----CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             7863-----1276899999999988256999999998999999
Q 003555          741 GEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       741 ~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ....     ......++.+.+|+.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             3478988678565689999999999763894569089999679

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.49  Aligned_cols=262  Identities=20%  Similarity=0.252  Sum_probs=202.6

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC--HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEE
Q ss_conf             7223221185662439999984897899999746976--23099999999998625878953031079605621489950
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~  587 (811)
                      .|.+.++||+|+||+||+|++..+++.||||+++...  ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf             97765177237680999999999997999999802225758999999999999867998388744533224320378862


Q ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             69899888741489998457899999999999998762168874623888896888799976997057752258898761
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      +.++.+..........+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||.++...... ..
T Consensus        83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~  158 (298)
T d1gz8a_          83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT  158 (298)
T ss_dssp             CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred             CCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC-CC
T ss_conf             377445554420256888899999999999999986528---89921357114011346762103578613436886-41


Q ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHH--HC---CCCHHCC
Q ss_conf             00344578866810113688-886331488999999989099788888775220347788987531--01---1000017
Q 003555          668 VTGVKGTRGYMSPEWQNSGL-ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFI--AK---ELSKLVG  741 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~-~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~--~~---~~~~~~~  741 (811)
                      .....|++.|+|||.+.... .+.++||||+||++|+|++|+.||......+..   .........  ..   ......+
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL---FRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHH---HHHHHHCCCCCHHHCCCCCCCCC
T ss_conf             001036521541122136657774221033331342796687998988999999---99998328983331444222421


Q ss_pred             CC-----------CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             86-----------31276899999999988256999999998999999
Q 003555          742 ED-----------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       742 ~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..           .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             243454322220444166789999999999763995579189999678

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=320.27  Aligned_cols=264  Identities=23%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECC-CCEEEEEEECCCCC--HHHHHHHHHHHHHHHCC---CCCCCCCEECEEEC-----
Q ss_conf             972232211856624399999848-97899999746976--23099999999998625---87895303107960-----
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICE-GNKIVAVKRLENPV--EEGERKFQAEMAAVRRT---HHKNLVRLLGFCMQ-----  577 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~-----  577 (811)
                      ..|.+.++||+|+||+||+|++.. +++.||||+++...  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf             89798889921558699999998889989999998023245167999999999999874258988023663221466666


Q ss_pred             CCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf             56214899506989988874148999845789999999999999876216887462388889688879997699705775
Q 003555          578 TSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLA  657 (811)
Q Consensus       578 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla  657 (811)
                      ....++++|+++++.+..........+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~  163 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  163 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECCHHHH
T ss_conf             7469999974058714444430378999899999999999999999758---8983579862789858997542100010


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf             22588987610034457886681011368888633148899999998909978888877522034778898753101100
Q 003555          658 KILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELS  737 (811)
Q Consensus       658 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  737 (811)
                      +....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+......... .........
T Consensus       164 ~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~  240 (305)
T d1blxa_         164 RIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGEEDWP  240 (305)
T ss_dssp             CCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCGGGSC
T ss_pred             HHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH-CCCCHHCCC
T ss_conf             11002--345777654851148310017988811100032899999987879989989899999999840-799611053


Q ss_pred             -------HH-----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -------00-----178631276899999999988256999999998999999
Q 003555          738 -------KL-----VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       738 -------~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                             ..     ...........++.+.+|+.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             21111033302234564544044589999999999874896679189999669

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=312.36  Aligned_cols=268  Identities=21%  Similarity=0.261  Sum_probs=204.1

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCC------CE
Q ss_conf             722322118566243999998489789999974697--6230999999999986258789530310796056------21
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS------KK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~------~~  581 (811)
                      +|.+.++||+|+||+||+|.+..+++.||||+++..  .....+.+.+|+.+|++++||||+++++++...+      +.
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~   98 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF   98 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEE
T ss_conf             18998898017781999999999998999999852225969999999999999866898754799986357655554159


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             48995069899888741489998457899999999999998762168874623888896888799976997057752258
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~  661 (811)
                      ++||||+ +.+|..++..  ..+++..+..++.||+.||.|||++   +|+|+||||+|||++.++.+||+|||+++...
T Consensus        99 ~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          99 YLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             EEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEECC-CCCHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCCEECCC
T ss_conf             9998405-5218999874--0226999999999999999998737---87645668511112100122113431022068


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH-------HHHHHHH
Q ss_conf             898761003445788668101136-88886331488999999989099788888775220347788-------9875310
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTW-------VYNCFIA  733 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~-------~~~~~~~  733 (811)
                      ..    .+...|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...............       .......
T Consensus       173 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         173 SE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             SS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             CC----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCC
T ss_conf             76----31024553335889981787899650103003899999978699888976899999985037884888865300


Q ss_pred             -------CCCCHHCCCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHCCCCCCC
Q ss_conf             -------1100001786-31276899999999988256999999998999999--431569999
Q 003555          734 -------KELSKLVGED-EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM--LEGTMEIPV  787 (811)
Q Consensus       734 -------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~~~~~  787 (811)
                             .......... ..........+.+|+.+||+.||.+|||+.|+++.  ++.+.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~  312 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED  312 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred             HHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf             0344331157866655667755689999999999977299557929999963962375877664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=326.18  Aligned_cols=239  Identities=21%  Similarity=0.335  Sum_probs=196.4

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCH------HHHHHHHHHHHHHHCCC--CCCCCCEECEEECCCCE
Q ss_conf             72232211856624399999848978999997469762------30999999999986258--78953031079605621
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE------EGERKFQAEMAAVRRTH--HKNLVRLLGFCMQTSKK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~------~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~  581 (811)
                      +|.+.+.||+|+||+||+|++..+++.||||++.....      .....+.+|+.++++++  ||||+++++++.+.+..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             EEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEE
T ss_conf             37996798408783999999999997999999856884433455679999999999997435898812799998309968


Q ss_pred             EEEEEECCC-CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEECCCCCC
Q ss_conf             489950698-9988874148999845789999999999999876216887462388889688879-99769970577522
Q 003555          582 LLVYEFMSK-GSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-SLTAKISNFSLAKI  659 (811)
Q Consensus       582 ~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~  659 (811)
                      ++|+||+.+ +++.+++.. ...+++.++..++.||+.||.|||+.   +|+||||||+|||++. ++.+||+|||+++.
T Consensus        85 ~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf             9999833686228999861-58999999999999999999999877---9755667611147744788489775465353


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCH
Q ss_conf             58898761003445788668101136888-86331488999999989099788888775220347788987531011000
Q 003555          660 LMPNQTGIVTGVKGTRGYMSPEWQNSGLI-TVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSK  738 (811)
Q Consensus       660 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  738 (811)
                      ....   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....                      
T Consensus       161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----------------------  215 (273)
T d1xwsa_         161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------------------  215 (273)
T ss_dssp             CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------------------
T ss_pred             CCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH----------------------
T ss_conf             2444---556656587747999984899788653325540345367568899887367----------------------


Q ss_pred             HCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             017863127689999999998825699999999899999
Q 003555          739 LVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       739 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      +.......+...+.++.+++.+||+.||++|||++|+++
T Consensus       216 i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             761544778779999999999976089758939999853

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=312.78  Aligned_cols=263  Identities=19%  Similarity=0.258  Sum_probs=199.9

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCC----CEEEE
Q ss_conf             722322118566243999998489789999974697-6230999999999986258789530310796056----21489
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP-VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTS----KKLLV  584 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~lV  584 (811)
                      +|.+.++||+|+||+||+|++..+++.||||++... .....+.+++|+.+|.+++|||++++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf             85997899406480999999999994999999803109589999999999999768989885888995056455414999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             95069899888741489998457899999999999998762168874623888896888799976997057752258898
Q 003555          585 YEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQ  664 (811)
Q Consensus       585 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~  664 (811)
                      ++++.+|+|.+++..  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          89 VTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEECCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf             996259865664405--8999999999999999999999978---98677787643788799977875457056504777


Q ss_pred             C--CCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHC-------
Q ss_conf             7--610034457886681011-368888633148899999998909978888877522034778898753101-------
Q 003555          665 T--GIVTGVKGTRGYMSPEWQ-NSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK-------  734 (811)
Q Consensus       665 ~--~~~~~~~gt~~y~aPE~~-~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~-------  734 (811)
                      .  .......|++.|+|||.+ ....++.++||||+|+++|||++|+.||......+.... ...........       
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-ILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCSCCHHHHHTCCC
T ss_pred             CCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_conf             6410101102652000387860478887410100467013377669799788888999998-765206997566423433


Q ss_pred             ----C-CCHHCCCC----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ----1-00001786----31276899999999988256999999998999999
Q 003555          735 ----E-LSKLVGED----EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 ----~-~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                          . ........    .......+.++.+++.+||+.||.+|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             22220244677557787778378999999999999764895679089998619

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=313.54  Aligned_cols=259  Identities=20%  Similarity=0.238  Sum_probs=200.5

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC--HHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEE
Q ss_conf             7223221185662439999984897899999746976--23099999999998625878953031079605621489950
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~  587 (811)
                      +|.+.++||+|+||+||+|+++ +++.||||++....  ....+.+.+|+.++++++||||+++++.+...+..++++|+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             9634318722778189999968-999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             69899888741489998457899999999999998762168874623888896888799976997057752258898761
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      +.++.+..+... ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||.+........ .
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~  156 (286)
T d1ob3a_          82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K  156 (286)
T ss_dssp             CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EHHHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC-C
T ss_conf             004567899860-47751445689999999999986057---488267877505686899787323664301146765-4


Q ss_pred             CCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH--HHHHCC---CCHH--
Q ss_conf             003445788668101136-88886331488999999989099788888775220347788987--531011---0000--
Q 003555          668 VTGVKGTRGYMSPEWQNS-GLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN--CFIAKE---LSKL--  739 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~-~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~--~~~~~~---~~~~--  739 (811)
                      .....+++.|+|||.+.. ..++.++||||+|+++|||++|+.||......+..   ......  ......   ....  
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHH---HHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             101024311013788717888884100211175899997797998988989999---99998638997110421233322


Q ss_pred             ----CCC-----CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----178-----63127689999999998825699999999899999
Q 003555          740 ----VGE-----DEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       740 ----~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                          ...     ........+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             14333335676466651258999999999986689668909999856

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=312.15  Aligned_cols=261  Identities=16%  Similarity=0.170  Sum_probs=203.7

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEE-CEEECCCCEEEEEEEC
Q ss_conf             722322118566243999998489789999974697623099999999998625878953031-0796056214899506
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLL-GFCMQTSKKLLVYEFM  588 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~-g~~~~~~~~~lV~e~~  588 (811)
                      +|.+.++||+|+||+||+|++..+++.||||.+....  ...++..|+++++.++|++++..+ .+..+....++|+||+
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC
T ss_conf             8999689850788099999998899899999972100--58889999999997038996017999995198778999873


Q ss_pred             CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCCCC
Q ss_conf             98998887414899984578999999999999987621688746238888968887---999769970577522588987
Q 003555          589 SKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLD---DSLTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       589 ~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~~~~~~  665 (811)
                      . ++|...+......+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++.......
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             C-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCC
T ss_conf             8-713332443068876899999999999999999979---944266787660643357776156504675134255445


Q ss_pred             ------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHH
Q ss_conf             ------61003445788668101136888863314889999999890997888887752203477889875310110000
Q 003555          666 ------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       666 ------~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                            .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................        ...
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~--------~~~  233 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--------KKM  233 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH--------HHH
T ss_pred             CCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHC--------CCC
T ss_conf             541000135776787353299999189989832188617789999849876655305779999998523--------567


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf             178631276899999999988256999999998999999431569
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTME  784 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~  784 (811)
                      ..+........+.++.+++..|++.+|++||+++++.+.|+....
T Consensus       234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             898357534788999999999843995579199999999999999

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=310.09  Aligned_cols=274  Identities=15%  Similarity=0.151  Sum_probs=213.3

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCC-CCCCCEECEEECCCCEEEEEEE
Q ss_conf             972232211856624399999848978999997469762309999999999862587-8953031079605621489950
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHH-KNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~  587 (811)
                      .+|.+.++||+|+||+||+|++..+++.||||.+....  ....+.+|++.+..++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf             80699799841788299999998899799999975025--8299999999999964899987799996018811799996


Q ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCCCCC
Q ss_conf             6989988874148999845789999999999999876216887462388889688879-----99769970577522588
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDD-----SLTAKISNFSLAKILMP  662 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGla~~~~~  662 (811)
                      + +++|.+++......++...+..++.|++.||.|||+.   +|+||||||+|||++.     ++.+||+|||+++....
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             C-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCC
T ss_conf             4-8887999975203110689999999999999999977---96626677131523475434479568723660577146


Q ss_pred             CCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf             987------61003445788668101136888863314889999999890997888887752203477889875310110
Q 003555          663 NQT------GIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL  736 (811)
Q Consensus       663 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  736 (811)
                      ...      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||............. .+.........
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~-~i~~~~~~~~~  237 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-RIGEKKQSTPL  237 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH-HHHHHHHHSCH
T ss_pred             CCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HHHHCCCCCCH
T ss_conf             76654111024676277510267989648888869998983199999986987678853021999999-99705679995


Q ss_pred             CHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf             000178631276899999999988256999999998999999431569999998877556
Q 003555          737 SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILMLEGTMEIPVVPFPILSNF  796 (811)
Q Consensus       737 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~p~~~~~  796 (811)
                             .+.....++++.+++..|++.+|.+||+++.+.+.|+++.+.........+.|
T Consensus       238 -------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw  290 (293)
T d1csna_         238 -------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  290 (293)
T ss_dssp             -------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             -------HHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             -------89657998999999999843993008599999999999999759999999898

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=312.81  Aligned_cols=260  Identities=21%  Similarity=0.279  Sum_probs=193.5

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCCCCEECEEECC------CCEEE
Q ss_conf             722322118566243999998489789999974697623099999999998625878953031079605------62148
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SKKLL  583 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~l  583 (811)
                      +|...++||+|+||+||+|++..+++.||||++....    ..+.+|+.++++++|+||+++++++...      .+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             7675169821768399999999999799999988160----689999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf             995069899888741--4899984578999999999999987621688746238888968887999-7699705775225
Q 003555          584 VYEFMSKGSLENLLS--NVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSL-TAKISNFSLAKIL  660 (811)
Q Consensus       584 V~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~  660 (811)
                      ||||++++.+..+..  .....+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             984168860788886310368999999999999999999999866---87645788603787358971167336605440


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH-------HHHHH
Q ss_conf             889876100344578866810113-6888863314889999999890997888887752203477889-------87531
Q 003555          661 MPNQTGIVTGVKGTRGYMSPEWQN-SGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV-------YNCFI  732 (811)
Q Consensus       661 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~-------~~~~~  732 (811)
                      .....  .....|+..|+|||.+. ...++.++||||+||++|||++|+.||......+.........       .....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             CCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf             47765--3200255555682776404688821000246527785502879989879999999999974898177654306


Q ss_pred             HC----CCCHHCCCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             01----100001786--31276899999999988256999999998999999
Q 003555          733 AK----ELSKLVGED--EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       733 ~~----~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ..    .........  .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             2101103554456744443156899999999999765895579299999669

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=309.17  Aligned_cols=265  Identities=18%  Similarity=0.222  Sum_probs=198.6

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECC--------
Q ss_conf             9722322118566243999998489789999974697--623099999999998625878953031079605--------
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT--------  578 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~--------  578 (811)
                      .+|.+.++||+|+||+||+|++..+++.||||++...  .......+.+|+.++++++|+|++++++++...        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf             79889999722748299999998999799999984222463789999999999998359996606765402465444457


Q ss_pred             CCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             62148995069899888741489998457899999999999998762168874623888896888799976997057752
Q 003555          579 SKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAK  658 (811)
Q Consensus       579 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~  658 (811)
                      ...++|+|++.++.+..+.. .........+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEECCCCCCCCHHHH-CCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf             63899985357874101222-034433089999999999999885229---98856767222036689968763135002


Q ss_pred             CCCCCCC---CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf             2588987---610034457886681011368-888633148899999998909978888877522034778898753101
Q 003555          659 ILMPNQT---GIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAK  734 (811)
Q Consensus       659 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~  734 (811)
                      .......   .......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||................ ......
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~  244 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSITPE  244 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTT
T ss_pred             ECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHC-CCCCHH
T ss_conf             2355444321135660249787428997079998917870067864661744879989989999999999841-899825


Q ss_pred             CCCH--------H---CCCCCC-C-----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             1000--------0---178631-2-----76899999999988256999999998999999
Q 003555          735 ELSK--------L---VGEDEE-V-----DLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       735 ~~~~--------~---~~~~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      ....        .   ...... .     .......+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             5344320344433201334455503340444599899999999873896589099999749

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.81  Aligned_cols=252  Identities=20%  Similarity=0.244  Sum_probs=204.4

Q ss_pred             HHHHHHHCCCCCCEEEEEEEEC---CCCEEEEEEECCCCC----HHHHHHHHHHHHHHHCCCC-CCCCCEECEEECCCCE
Q ss_conf             7223221185662439999984---897899999746976----2309999999999862587-8953031079605621
Q 003555          510 TNGFEEELGRGCFGAVYKGSIC---EGNKIVAVKRLENPV----EEGERKFQAEMAAVRRTHH-KNLVRLLGFCMQTSKK  581 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~  581 (811)
                      .|.+.++||+|+||+||+|+..   .+++.||||.++...    ....+.+.+|+.++.+++| +||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCE
T ss_conf             25999898328783999999876588794899999836772101689999999999998646798399962000248730


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             48995069899888741489998457899999999999998762168874623888896888799976997057752258
Q 003555          582 LLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILM  661 (811)
Q Consensus       582 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~  661 (811)
                      ++++||+.+|+|.+++... ..........++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|||+++.+.
T Consensus       105 ~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf             0123123411799998730-4543788888899999999885149---98965477320124699988874132022203


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHH
Q ss_conf             8987610034457886681011368--88863314889999999890997888887752203477889875310110000
Q 003555          662 PNQTGIVTGVKGTRGYMSPEWQNSG--LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKELSKL  739 (811)
Q Consensus       662 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  739 (811)
                      ...........|++.|+|||.+.+.  .++.++||||+||+||||++|+.||...........+.            ...
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~------------~~~  248 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------------RRI  248 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH------------HHH
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------------HHC
T ss_conf             44443221222333331068760577688713251777799999976899988887777999999------------833


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             17863127689999999998825699999999-----899999
Q 003555          740 VGEDEEVDLRTLETMVRVGLLCIQDEPNLRPS-----MKNVIL  777 (811)
Q Consensus       740 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~  777 (811)
                      .......+...+.++.+++.+||+.||.+||+     ++|+++
T Consensus       249 ~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             5689988654799999999997445898819997450999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=304.22  Aligned_cols=256  Identities=16%  Similarity=0.262  Sum_probs=197.8

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCC-CCCCCCEECEEECC--CCEEEEEE
Q ss_conf             7223221185662439999984897899999746976230999999999986258-78953031079605--62148995
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQT--SKKLLVYE  586 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e  586 (811)
                      .|.+.++||+|+||+||+|++..+++.||||+++..   ..+.+.+|+.++..++ |+||+++++++...  ...++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf             718978983174819999998899979999998889---99999999999985157998767999998168771268886


Q ss_pred             ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEECCCCCCCCCCCC
Q ss_conf             069899888741489998457899999999999998762168874623888896888799-9769970577522588987
Q 003555          587 FMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDS-LTAKISNFSLAKILMPNQT  665 (811)
Q Consensus       587 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~~  665 (811)
                      |+++++|..+.    ..+++.++..++.||+.||.|||++   +|+||||||+|||++.+ ..+||+|||+++.......
T Consensus       113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~  185 (328)
T d3bqca1         113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE  185 (328)
T ss_dssp             CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred             ECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCCC
T ss_conf             31798589974----6899999999999999999887643---3443456441237748998366415654266468874


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH------HHH------
Q ss_conf             610034457886681011368-8886331488999999989099788888775220347788987------531------
Q 003555          666 GIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYN------CFI------  732 (811)
Q Consensus       666 ~~~~~~~gt~~y~aPE~~~~~-~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~------~~~------  732 (811)
                        .....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||..................      ...      
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCC
T ss_conf             --443224864247610268888884523233545558760488999887601899999999878841555554225444


Q ss_pred             HCCCCHHCCCC----------CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             01100001786----------3127689999999998825699999999899999
Q 003555          733 AKELSKLVGED----------EEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL  777 (811)
Q Consensus       733 ~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  777 (811)
                      ...........          .......+.++.+|+.+||+.||++|||++|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7430000033343311211552112448999999999986699568908999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=305.11  Aligned_cols=264  Identities=19%  Similarity=0.198  Sum_probs=204.8

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHCCCCCCCCCEECEEECCCCEEEEEEE
Q ss_conf             722322118566243999998489789999974697--623099999999998625878953031079605621489950
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENP--VEEGERKFQAEMAAVRRTHHKNLVRLLGFCMQTSKKLLVYEF  587 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~  587 (811)
                      +|++.++||+|+||+||+|++..+++.||||+++..  .......+.+|+.+++.++|+||+++++++.+....++|+|+
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf             97862697128681999999999996999999803217868999999999999856757888213544444311588630


Q ss_pred             CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             69899888741489998457899999999999998762168874623888896888799976997057752258898761
Q 003555          588 MSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMPNQTGI  667 (811)
Q Consensus       588 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~  667 (811)
                      +.+++|..++.. .....+..+..++.|++.||+|||++   +|+|+||||+|||++.++.+||+|||.++....... .
T Consensus        83 ~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~  157 (292)
T d1unla_          83 CDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C  157 (292)
T ss_dssp             CSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred             CCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC-C
T ss_conf             233222112123-56540367899999999998774339---986001467612113378266520460110468875-1


Q ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC----------
Q ss_conf             00344578866810113688-8863314889999999890997888887752203477889875310110----------
Q 003555          668 VTGVKGTRGYMSPEWQNSGL-ITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVYNCFIAKEL----------  736 (811)
Q Consensus       668 ~~~~~gt~~y~aPE~~~~~~-~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~----------  736 (811)
                      .....++..|+|||.+.... ++.++||||+||++|||++|+.||.......+.................          
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCC
T ss_conf             00103443101466750698888044402654188998518999988999999999998611899735513443222113


Q ss_pred             ----CHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             ----000178631276899999999988256999999998999999
Q 003555          737 ----SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       737 ----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                          .................+.+|+.+||+.||.+|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             3444544310433065689999999999864996689099999649

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=303.28  Aligned_cols=259  Identities=21%  Similarity=0.230  Sum_probs=199.6

Q ss_pred             HHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC--HHHHHHHHHHHHHHHCCCCCCCCCEECEEECC------CCEE
Q ss_conf             223221185662439999984897899999746976--23099999999998625878953031079605------6214
Q 003555          511 NGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT------SKKL  582 (811)
Q Consensus       511 ~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~~~  582 (811)
                      |++.++||+|+||+||+|.+..+++.||||++....  ......+.+|+.++++++||||+++++++...      ...+
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEE
T ss_conf             59988962175859999999999989999998823369799999999999998648987648998970256434576269


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             89950698998887414899984578999999999999987621688746238888968887999769970577522588
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~  662 (811)
                      +|+||+.++.+ ..+.   ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+|++|||+++....
T Consensus        99 iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          99 LVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEECCCHHHH-HHHH---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHHHCCCC
T ss_conf             99841446778-7650---3899999999999999999886522---112456776321136544313201023211466


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH---------------
Q ss_conf             98761003445788668101136888863314889999999890997888887752203477889---------------
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWV---------------  727 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~---------------  727 (811)
                      ..  ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||................               
T Consensus       172 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             CC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHH
T ss_conf             65--5332214655558133147777877433356625789865989988897788999999720589879998765667


Q ss_pred             HHHHHHC------CC-----CHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             8753101------10-----000178631276899999999988256999999998999999
Q 003555          728 YNCFIAK------EL-----SKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKNVILM  778 (811)
Q Consensus       728 ~~~~~~~------~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  778 (811)
                      .......      ..     ..............+..+.+|+.+||+.||++|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             77764175435666421264333543210133379999999999876994579089999669

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=302.11  Aligned_cols=266  Identities=18%  Similarity=0.247  Sum_probs=200.8

Q ss_pred             HHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCC--HHHHHHHHHHHHHHHCCCCCCCCCEECEEECC-----CCEE
Q ss_conf             7223221185662439999984897899999746976--23099999999998625878953031079605-----6214
Q 003555          510 TNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPV--EEGERKFQAEMAAVRRTHHKNLVRLLGFCMQT-----SKKL  582 (811)
Q Consensus       510 ~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~~~  582 (811)
                      +|...++||+|+||+||+|++..+++.||||+++...  ....+.+.+|+.++++++|+|++++++++...     ...+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEE
T ss_conf             71888898317883999999999997999999882002868999999999999866898742599999634645668649


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             89950698998887414899984578999999999999987621688746238888968887999769970577522588
Q 003555          583 LVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISNFSLAKILMP  662 (811)
Q Consensus       583 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~  662 (811)
                      ++++++.+|+|.+++..  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++.....
T Consensus        99 ~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEEECCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCC
T ss_conf             99996258862320022--4530999999999999999999738---876516677633455432200132100012575


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH-------HHHHHC
Q ss_conf             987610034457886681011368-888633148899999998909978888877522034778898-------753101
Q 003555          663 NQTGIVTGVKGTRGYMSPEWQNSG-LITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVVLLSTWVY-------NCFIAK  734 (811)
Q Consensus       663 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~~l~~~~~-------~~~~~~  734 (811)
                          ......|++.|+|||...+. .++.++||||+|+++|+|++|+.||.................       ......
T Consensus       174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  249 (348)
T d2gfsa1         174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  249 (348)
T ss_dssp             ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred             ----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCH
T ss_conf             ----4444345435558355337756785512432058999997688997889889999999973079975773200102


Q ss_pred             ---CCCHHCCCCC-----CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHCCCC
Q ss_conf             ---1000017863-----127689999999998825699999999899999--9431569
Q 003555          735 ---ELSKLVGEDE-----EVDLRTLETMVRVGLLCIQDEPNLRPSMKNVIL--MLEGTME  784 (811)
Q Consensus       735 ---~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~  784 (811)
                         ..........     ......+..+.+|+.+||+.||.+|||+.|+++  .+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf             445444303557875556626789999999999977588345938999855995487999

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-42  Score=278.24  Aligned_cols=279  Identities=20%  Similarity=0.234  Sum_probs=198.3

Q ss_pred             HHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCC-----------CCCCCCEECEEEC
Q ss_conf             97223221185662439999984897899999746976230999999999986258-----------7895303107960
Q 003555          509 ATNGFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-----------HKNLVRLLGFCMQ  577 (811)
Q Consensus       509 ~~~~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~~~~  577 (811)
                      .+|.+.++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             8579989975077818999999999979999998343-133689999999999840145555542276764789987631


Q ss_pred             C--CCEEEEEEECCCCC-HHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC-----
Q ss_conf             5--62148995069899-88874-1489998457899999999999998762-1688746238888968887999-----
Q 003555          578 T--SKKLLVYEFMSKGS-LENLL-SNVESGPIWRDRVRIALDVARGITYLHE-ECEVQIIHCNINPRNILLDDSL-----  647 (811)
Q Consensus       578 ~--~~~~lV~e~~~~gs-L~~~l-~~~~~~~~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~-----  647 (811)
                      .  ...+++++++..+. ..... ........+..+..++.||+.||.|||+ .   +|+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCCCC
T ss_conf             256520234320003542000001223467868999999999999988876405---86465677057056305765644


Q ss_pred             -CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHH---HH
Q ss_conf             -76997057752258898761003445788668101136888863314889999999890997888887752203---47
Q 003555          648 -TAKISNFSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVVLEIVCCRSNFEVNVSTADVV---LL  723 (811)
Q Consensus       648 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll~elltg~~p~~~~~~~~~~~---~l  723 (811)
                       .+|++|||.+......    .....|++.|+|||.+....++.++||||+|++++||++|+.||..........   .+
T Consensus       169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             CEEEEEECCCCCCCCCC----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf             30567531442123445----42236652105713214667776432012378999998788998987554321026899


Q ss_pred             HHHH--HHH-----HHH----------CC------------CCHHCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf             7889--875-----310----------11------------000017863127689999999998825699999999899
Q 003555          724 STWV--YNC-----FIA----------KE------------LSKLVGEDEEVDLRTLETMVRVGLLCIQDEPNLRPSMKN  774 (811)
Q Consensus       724 ~~~~--~~~-----~~~----------~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  774 (811)
                      ...+  ...     ...          ..            .................++.+|+.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             99999837998788624532200013201220243235776444210001567435899999999987799457908999


Q ss_pred             HHHH--HHCC---CCCCCCCCCCCCC
Q ss_conf             9999--4315---6999999887755
Q 003555          775 VILM--LEGT---MEIPVVPFPILSN  795 (811)
Q Consensus       775 vl~~--L~~~---~~~~~~~~p~~~~  795 (811)
                      +++.  +++.   .+...|+.+....
T Consensus       325 ~L~Hp~f~~~~~~~~~~~p~~~~~~~  350 (362)
T d1q8ya_         325 LVNHPWLKDTLGMEEIRVPDRELYGS  350 (362)
T ss_dssp             HHTCGGGTTCTTCTTCCCTTSCTTCB
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             96693407898744477998666788

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1.7e-22  Score=153.91  Aligned_cols=169  Identities=12%  Similarity=0.066  Sum_probs=118.2

Q ss_pred             HHHHHCCCCCCEEEEEEEECCCCEEEEEEECCCCCH------------------HHHHHHHHHHHHHHCCCCCCCCCEEC
Q ss_conf             232211856624399999848978999997469762------------------30999999999986258789530310
Q 003555          512 GFEEELGRGCFGAVYKGSICEGNKIVAVKRLENPVE------------------EGERKFQAEMAAVRRTHHKNLVRLLG  573 (811)
Q Consensus       512 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~g  573 (811)
                      .+.++||+|+||+||+|.+.+ ++.||||+++....                  ........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             HHCCEEEECCCEEEEEEECCC-CCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf             227780248565999999799-9999999986044346665565630008889999997789999999816999144998


Q ss_pred             EEECCCCEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf             79605621489950698998887414899984578999999999999987621688746238888968887999769970
Q 003555          574 FCMQTSKKLLVYEFMSKGSLENLLSNVESGPIWRDRVRIALDVARGITYLHEECEVQIIHCNINPRNILLDDSLTAKISN  653 (811)
Q Consensus       574 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D  653 (811)
                      +.    ..+++||++++..+..        +.......++.|++.++.|||+.   +|+|+||||+|||++++ .++|+|
T Consensus        82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             EC----CCEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEEE
T ss_conf             62----8889999504565420--------01578999999999999998268---88983689036114289-899987


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             577522588987610034457886681011368888633148899999
Q 003555          654 FSLAKILMPNQTGIVTGVKGTRGYMSPEWQNSGLITVKSDVYSFGVVV  701 (811)
Q Consensus       654 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~~DV~SlGvll  701 (811)
                      ||+|...........-.  .... ...++ ....+..++|+||..--+
T Consensus       146 FG~a~~~~~~~~~~~l~--rd~~-~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWREILE--RDVR-NIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHHHHH--HHHH-HHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CCCCCCCCCCCCHHHHH--HHHH-HHHHH-HCCCCCCCCCHHHHHHHH
T ss_conf             78843089987099998--7799-99999-757899844689999987

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=99.79  E-value=5e-19  Score=132.45  Aligned_cols=112  Identities=15%  Similarity=0.238  Sum_probs=92.8

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEEC
Q ss_conf             65636999657899999212699914665673899819999800489982999605999998998489996170189841
Q 003555           29 SKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTE  108 (811)
Q Consensus        29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lGFf~~~~~~~lgiw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~  108 (811)
                      +|+|.+||.|.+++.+   +  +|.|+|.|+..++   |.++.    ..++||.||++.|..  .+.+.|+.+|+|+|.+
T Consensus         1 tDtL~~gq~L~~g~~l---~--~g~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~   66 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSL---A--EGGYLFIIQNDCN---LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYS   66 (112)
T ss_dssp             CCEEETTEEECTTCEE---E--ETTEEEEECTTSC---EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEE
T ss_pred             CCEECCCCEECCCCEE---E--ECCEEEEECCCCC---EEEEC----CCCEEEECCCCCCCC--CCEEEEECCCCEEEEE
T ss_conf             9890699995599999---8--7879999817998---89873----983899846734788--8579996153499993


Q ss_pred             CCCCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECCCCCC
Q ss_conf             8962376224899871369980688768961799648700388865
Q 003555          109 ESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTH  154 (811)
Q Consensus       109 ~~~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~PTD  154 (811)
                      .++.+|+++++......+|+|+|+|||||++.++.++|||+.+|++
T Consensus        67 ~~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n  112 (112)
T d1xd5a_          67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN  112 (112)
T ss_dssp             TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred             CCCEEEEEEECCCCCCEEEEECCCCCEEEECCCCCEEECCCCCCCC
T ss_conf             4874999830368872599996789999998999679618885698

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.71  E-value=2.4e-17  Score=122.05  Aligned_cols=101  Identities=20%  Similarity=0.197  Sum_probs=87.8

Q ss_pred             EEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEECCCCCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEE
Q ss_conf             98004899829996059999989984899961701898418962376224899871369980688768961799648700
Q 003555           69 TWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWES  148 (811)
Q Consensus        69 iw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQS  148 (811)
                      |||.++++++++|++|++.|+.....+|.+..||+|+|.+.+..+|++++........|.|+|+|||||++.++.++|||
T Consensus        12 il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S   91 (120)
T d1dlpa2          12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTS   91 (120)
T ss_dssp             ECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEEEC
T ss_pred             EEECCCCCCCCCCEECCCCEEECCCEEEEECCCCCEEEECCCCEEEEECCCCCCCCEEEEEECCEEEEEECCCCCEEEEE
T ss_conf             99828988885628839972174887999968983899649968999752247774799990776499992999889981


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEE-ECCCCEEEE
Q ss_conf             3888651115750037976973488889998206988-528964885
Q 003555          149 FNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLY  194 (811)
Q Consensus       149 Fd~PTDTlLpgq~l~~~~~L~S~~s~~d~s~G~~~l~-~~~~~~~~~  194 (811)
                      |.                         +.+.|.|.+. +.+|++++|
T Consensus        92 ~t-------------------------~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          92 GN-------------------------SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             CC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred             CC-------------------------CCCCCCEEEEECCCCCEEEE
T ss_conf             99-------------------------99998489998889869996

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=99.68  E-value=1.9e-16  Score=116.43  Aligned_cols=107  Identities=13%  Similarity=0.231  Sum_probs=83.6

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEEC
Q ss_conf             65636999657899999212699914665673899819999800489982999605999998998489996170189841
Q 003555           29 SKPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTE  108 (811)
Q Consensus        29 ~~~~~~g~~l~~~~~~~~~~S~~g~F~lGFf~~~~~~~lgiw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~  108 (811)
                      .+.|.+|+.|.+++.+   .  +|.|.|+|...++   |.++.    ..++||+||++.|... .+.|.|+.+|+|+|.+
T Consensus         1 ~~~L~~g~~L~~g~~l---~--~g~~~l~~q~dgn---Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~   67 (109)
T d1kj1a_           1 RNLLTNGEGLYAGQSL---D--VEPYHFIMQEDCN---LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYD   67 (109)
T ss_dssp             CCEEETTCEEETTCEE---E--ETTEEEEECTTSC---EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEEC
T ss_pred             CCCCCCCCEEECCCEE---E--ECCEEEEECCCCE---EEEEE----CCEEEEEECCCCCCCE-EEEEEECCCCEEEEEE
T ss_conf             9892599988289989---8--3788999448986---99986----9989998378998751-0799993796099990


Q ss_pred             CC-CCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECCC
Q ss_conf             89-62376224899871369980688768961799648700388
Q 003555          109 ES-KHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNF  151 (811)
Q Consensus       109 ~~-~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~  151 (811)
                      .+ ..+|+++++.+.....|+|+|+|||||++.   .+|||+-|
T Consensus        68 ~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~  108 (109)
T d1kj1a_          68 AEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY  108 (109)
T ss_dssp             SSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred             CCCCEEEEEEEECCCCCEEEEEECCCCEEEECC---CEECCCCC
T ss_conf             898679997308899977999947975999799---87217985

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=99.66  E-value=3.1e-16  Score=115.13  Aligned_cols=105  Identities=18%  Similarity=0.172  Sum_probs=82.4

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEECC
Q ss_conf             56369996578999992126999146656738998199998004899829996059999989984899961701898418
Q 003555           30 KPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEE  109 (811)
Q Consensus        30 ~~~~~g~~l~~~~~~~~~~S~~g~F~lGFf~~~~~~~lgiw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~  109 (811)
                      ++|.+|++|.+++.+     .+|.|.|.|+..++   |.|+.    ..++||.||++.|  +..+.+.+..+|+|++.+.
T Consensus         2 ~~L~~g~~L~~G~~l-----~ng~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~   67 (108)
T d1jpca_           2 NILYSGETLSTGEFL-----NYGSFVFIMQEDCN---LVLYD----VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP   67 (108)
T ss_dssp             CEEETTEEECTTCEE-----EETTEEEEECTTSC---EEEEE----TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred             CCCCCCCEECCCCEE-----ECCCEEEEECCCCE---EEEEE----CCCEEEEECCCCC--CCCCEEEEECCCEEEEECC
T ss_conf             995699772699989-----72888999878980---99970----9902157078899--8754799812603999779


Q ss_pred             C-CCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECCC
Q ss_conf             9-62376224899871369980688768961799648700388
Q 003555          110 S-KHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNF  151 (811)
Q Consensus       110 ~-~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~  151 (811)
                      + ..+|++++.......+|+|+|+|||||++.   .+||||+|
T Consensus        68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~  107 (108)
T d1jpca_          68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH  107 (108)
T ss_dssp             TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred             CCCCEEECCCCCCCCCEEEEECCCCCEEEECC---CCCCCCCC
T ss_conf             85512770455888767999968889999699---84568888

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.49  E-value=1e-14  Score=105.71  Aligned_cols=101  Identities=17%  Similarity=0.175  Sum_probs=86.7

Q ss_pred             EEEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEECCCCCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEE
Q ss_conf             99800489982999605999998998489996170189841896237622489987136998068876896179964870
Q 003555           68 GTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWE  147 (811)
Q Consensus        68 giw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQ  147 (811)
                      .|||.-.++.+..|..+.+.++.+...+|.+..||+|+|.+++..+|++++ .+..+..+.|+|+|||||++.++.++||
T Consensus         2 ~~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t-~~~~~~~l~l~~dGNLvl~d~~~~~vWs   80 (115)
T d1dlpa1           2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNT-AGATGCRAVLQSDGLLVILTAQNTIRWS   80 (115)
T ss_dssp             CCCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCC-CSCSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred             CEEEECCCCCCCCCEECCCCCEECCCEEEEECCCCEEEEECCCEEEEECCC-CCCCCEEEEEECCCCEEEECCCCCEEEE
T ss_conf             677864789988212469981775988999979983999819906897116-8997568999446789999058978998


Q ss_pred             ECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEE-ECCCCEEEE
Q ss_conf             03888651115750037976973488889998206988-528964885
Q 003555          148 SFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLY  194 (811)
Q Consensus       148 SFd~PTDTlLpgq~l~~~~~L~S~~s~~d~s~G~~~l~-~~~~~~~~~  194 (811)
                      |+-                         +.+.|.|.+. +.+|++++|
T Consensus        81 S~t-------------------------~~~~g~y~l~Lq~DGNlvlY  103 (115)
T d1dlpa1          81 SGT-------------------------KGSIGNYVLVLQPDRTVTIY  103 (115)
T ss_dssp             CCC-------------------------CCCSSCCEEEECSSSCEEEE
T ss_pred             CCC-------------------------CCCCCCEEEEECCCCCEEEE
T ss_conf             188-------------------------89999789999899869996

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=99.32  E-value=7.1e-12  Score=88.08  Aligned_cols=103  Identities=13%  Similarity=0.196  Sum_probs=76.2

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEECC
Q ss_conf             56369996578999992126999146656738998199998004899829996059999989984899961701898418
Q 003555           30 KPISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEE  109 (811)
Q Consensus        30 ~~~~~g~~l~~~~~~~~~~S~~g~F~lGFf~~~~~~~lgiw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~  109 (811)
                      ++|.++|+|       ...+..|.|.|.|...++ +-  + |.   ..++||.||+..+.  ....|.|..+|+|+|.+.
T Consensus        15 ~~l~~~q~l-------~~~~~~~~y~l~mQ~DGN-LV--L-y~---~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~   78 (119)
T d1b2pa_          15 QILHATESL-------EILFGTHVYRFIMQTDCN-LV--L-YD---NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITN   78 (119)
T ss_dssp             CEEETTCEE-------EEEETTEEEEEEECTTSC-EE--E-EE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred             CEEECCCEE-------EEECCCCEEEEEECCCCC-EE--E-EE---CCEEEEEECCCCCC--CCEEEEEEECCCEEEECC
T ss_conf             888289758-------870478538999889982-99--9-97---99679994678877--416999983777999899


Q ss_pred             C-CCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECCC
Q ss_conf             9-62376224899871369980688768961799648700388
Q 003555          110 S-KHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNF  151 (811)
Q Consensus       110 ~-~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~  151 (811)
                      + ..+|++++.......+|+|+|+|||||++   ..+|||-.+
T Consensus        79 ~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T~  118 (119)
T d1b2pa_          79 ENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQTV  118 (119)
T ss_dssp             TCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCCC
T ss_pred             CCCEEEECCCCCCCCCEEEEECCCCCEEEEC---CCEECCCCC
T ss_conf             9857997887699886599996998899979---988416974

>d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.89  E-value=4.1e-09  Score=70.93  Aligned_cols=101  Identities=12%  Similarity=0.181  Sum_probs=69.8

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEECCCCCCEEEEEECCCCCCCCCCCEEEEECCCEEEEECCC-
Q ss_conf             3699965789999921269991466567389981999980048998299960599999899848999617018984189-
Q 003555           32 ISLGSSLSPSSEPSSWTSPSGLFQFGFYKEGTGFSVGTWLVTSPNITVIWTAFRDEPPVSSNAKLILTMDGLVLQTEES-  110 (811)
Q Consensus        32 ~~~g~~l~~~~~~~~~~S~~g~F~lGFf~~~~~~~lgiw~~~~~~~t~vW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~-  110 (811)
                      .+..++|.+++.   +  .+|.|.|.|...++   |.++.    ...+||.+|...   ...+++.+..+|+|++.+.. 
T Consensus        11 ~~~~~tl~~~~~---l--~~g~~~l~~q~DGN---LvL~~----~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~   75 (115)
T d1dlpa1          11 GSHPQTLHAAQS---L--ELSSFRFTMQSDCN---LVLFD----SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQN   75 (115)
T ss_dssp             SCSCSCCCTTCE---E--CSTTEEEEECTTSC---EEEEE----SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTT
T ss_pred             CCCCCEECCCCC---E--ECCCEEEEECCCCE---EEEEC----CCEEEEECCCCC---CCCEEEEEECCCCEEEECCCC
T ss_conf             988212469981---7--75988999979983---99981----990689711689---975689994467899990589


Q ss_pred             CCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECC
Q ss_conf             6237622489987136998068876896179964870038
Q 003555          111 KHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFN  150 (811)
Q Consensus       111 ~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd  150 (811)
                      ..+|++.+......-+++|+++|||||++   ..+|+|-.
T Consensus        76 ~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt  112 (115)
T d1dlpa1          76 TIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGT  112 (115)
T ss_dssp             CCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred             CEEEECCCCCCCCCEEEEECCCCCEEEEC---CCEECCCC
T ss_conf             78998188899997899998998699968---97643889

>d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.88  E-value=1.2e-08  Score=68.17  Aligned_cols=76  Identities=20%  Similarity=0.281  Sum_probs=58.7

Q ss_pred             CEEEEECCCEEEEECCCCCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf             48999617018984189623762248998713699806887689617996487003888651115750037976973488
Q 003555           94 AKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSAS  173 (811)
Q Consensus        94 ~~l~~~~~g~l~l~~~~~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~L~S~~s  173 (811)
                      -.|.+..||+|+|.+.+..+|++++........+.|.++|||||.+.++.++|+|.-                       
T Consensus        32 y~l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t-----------------------   88 (119)
T d1b2pa_          32 YRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV-----------------------   88 (119)
T ss_dssp             EEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred             EEEEECCCCCEEEEECCEEEEEECCCCCCCCEEEEEEECCCEEEECCCCCEEEECCC-----------------------
T ss_conf             899988998299997996799946788774169999837779998999857997887-----------------------


Q ss_pred             CCCCCCCCEEEE-ECCCCEEEE
Q ss_conf             889998206988-528964885
Q 003555          174 ETNSSTGRFCLE-QRDGILVLY  194 (811)
Q Consensus       174 ~~d~s~G~~~l~-~~~~~~~~~  194 (811)
                        .-+.|.|.+. +++|++++|
T Consensus        89 --~~~~~~~~l~Lq~DGNlvlY  108 (119)
T d1b2pa_          89 --AGKAGHYVLVLQPDRNVVIY  108 (119)
T ss_dssp             --CCCSSCEEEEECTTSCEEEE
T ss_pred             --CCCCCCEEEEECCCCCEEEE
T ss_conf             --69988659999699889997

>d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Snowdrop (Galanthus nivalis) [TaxId: 4670]

Probab=98.81  E-value=1.7e-08  Score=67.18  Aligned_cols=77  Identities=26%  Similarity=0.349  Sum_probs=60.4

Q ss_pred             CCEEEEECCCEEEEECCCCCEEEECCCCCCCCEEEEEECCCCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf             84899961701898418962376224899871369980688768961799648700388865111575003797697348
Q 003555           93 NAKLILTMDGLVLQTEESKHKLIANTTSDEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSSA  172 (811)
Q Consensus        93 ~~~l~~~~~g~l~l~~~~~~vw~~~~~~~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~L~S~~  172 (811)
                      .-+|.+..||+|+|.+.+..||++++........+.|.++|||||.+.++.++|+|=                       
T Consensus        20 ~~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~-----------------------   76 (108)
T d1jpca_          20 SFVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASN-----------------------   76 (108)
T ss_dssp             TEEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC-----------------------
T ss_pred             CEEEEECCCCEEEEEECCCEEEEECCCCCCCCCEEEEECCCEEEEECCCCCCEEECC-----------------------
T ss_conf             889998789809997099021570788998754799812603999779855127704-----------------------


Q ss_pred             CCCCCCCCCEEEE-ECCCCEEEE
Q ss_conf             8889998206988-528964885
Q 003555          173 SETNSSTGRFCLE-QRDGILVLY  194 (811)
Q Consensus       173 s~~d~s~G~~~l~-~~~~~~~~~  194 (811)
                        ...+.+.|.+. +++|++++|
T Consensus        77 --t~~~~~~~~l~L~ddGNlVly   97 (108)
T d1jpca_          77 --TGGQNGNYVCILQKDRNVVIY   97 (108)
T ss_dssp             --CCCSCSCEEEEECTTSCEEEE
T ss_pred             --CCCCCCCEEEEECCCCCEEEE
T ss_conf             --558887679999688899996

>d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Fetuin-binding protein Scafet precursor
species: Bluebell (Scilla campanulata) [TaxId: 81759]

Probab=98.80  E-value=7.4e-09  Score=69.37  Aligned_cols=110  Identities=21%  Similarity=0.287  Sum_probs=63.9

Q ss_pred             CCEEEEECCCCEEE--EECCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEE-ECCCCEEEEEECCCCCEEEEEEEE
Q ss_conf             87689617996487--003888651115750037976973488889998206988-528964885313896215741133
Q 003555          133 GNFVLCNDRFDFIW--ESFNFPTHTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLY  209 (811)
Q Consensus       133 GNlVl~~~~~~~lW--QSFd~PTDTlLpgq~l~~~~~L~S~~s~~d~s~G~~~l~-~~~~~~~~~~~~~~~~~y~~~~~y  209 (811)
                      ||+|++++.+.++|  +++|.|+++|.++|.|.               .|.|+|. +.+|++++|.   ...++|.+.. 
T Consensus         1 g~~v~~~~~n~il~~~~~~~~~~~~l~~~q~l~---------------~g~y~L~~q~DGNLvL~~---~~~~vW~s~t-   61 (120)
T d1dlpa2           1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQ---------------LSPYRLSMETDCNLVLFD---RDDRVWSTNT-   61 (120)
T ss_dssp             SCCCCSSCCCEECCCC--CCCCCCEECSSCCCB---------------CSSCEEEEETTTEEEEEB---TTBCCSCCCC-
T ss_pred             CCEEEEECCCEEEECCCCCCCCCCEECCCCEEE---------------CCCEEEEECCCCCEEEEC---CCCEEEEECC-
T ss_conf             968787289869982898888562883997217---------------488799996898389964---9968999752-


Q ss_pred             ECCCCCCCEEEECCCCEEEEEECCCCEEEEEEEEEEEECCCCEEEEEEEEECCCEEEE
Q ss_conf             1267533124304786034410374105775321234068536999999306948999
Q 003555          210 WASDRVHGMVNLTPGGILQAGSADATQILARSSYSVKSSNETVIYRATLDFDGILRLY  267 (811)
Q Consensus       210 w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~dG~l~~y  267 (811)
                       .+......+.++.+|.+.....+....-..  .+   ....-.++++|+.||+|++|
T Consensus        62 -~~~~~~~~~~l~~~GnLvl~d~~~~~lW~S--~t---~~~~~~~~l~Lq~DGnlvlY  113 (120)
T d1dlpa2          62 -AGKGTGCRAVLQPNGRMDVLTNQNIAVWTS--GN---SRSAGRYVFVLQPDRNLAIY  113 (120)
T ss_dssp             -CSSCSSCEEEEETTTEEEEEETTTEEEEEC--CC---CCSSSCCEEEECSSSCEEEE
T ss_pred             -CCCCCCEEEEEECCEEEEEECCCCCEEEEE--CC---CCCCCCEEEEECCCCCEEEE
T ss_conf             -247774799990776499992999889981--99---99998489998889869996

>d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Lectin (agglutinin)
species: Garlic (Allium sativum) [TaxId: 4682]

Probab=98.73  E-value=6.8e-08  Score=63.40  Aligned_cols=77  Identities=25%  Similarity=0.386  Sum_probs=60.1

Q ss_pred             CCEEEEECCCEEEEECCCCCEEEECCCC-CCCCEEEEEECCCCEEEEECCCCEEEEECCCCCCCCCCCCCCCCCCEEEEC
Q ss_conf             8489996170189841896237622489-987136998068876896179964870038886511157500379769734
Q 003555           93 NAKLILTMDGLVLQTEESKHKLIANTTS-DEPASFASILDSGNFVLCNDRFDFIWESFNFPTHTIVGGQSLVNGSKLFSS  171 (811)
Q Consensus        93 ~~~l~~~~~g~l~l~~~~~~vw~~~~~~-~~~~~~a~Lld~GNlVl~~~~~~~lWQSFd~PTDTlLpgq~l~~~~~L~S~  171 (811)
                      .-.|.+..||+|++...+..||++++.. +.....+.|.++|||||++.++.++|+|-                      
T Consensus        20 ~~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~----------------------   77 (109)
T d1kj1a_          20 PYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH----------------------   77 (109)
T ss_dssp             TEEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC----------------------
T ss_pred             CEEEEECCCCEEEEEECCEEEEEECCCCCCCEEEEEEECCCCEEEEEECCCCEEEEEE----------------------
T ss_conf             8899944898699986998999837899875107999937960999908986799973----------------------


Q ss_pred             CCCCCCCCCCEEEE-ECCCCEEEE
Q ss_conf             88889998206988-528964885
Q 003555          172 ASETNSSTGRFCLE-QRDGILVLY  194 (811)
Q Consensus       172 ~s~~d~s~G~~~l~-~~~~~~~~~  194 (811)
                         +..+.|.|.+. +++|++++|
T Consensus        78 ---t~~~~~~~~l~L~ddGNlvly   98 (109)
T d1kj1a_          78 ---SVRGNGNYVLVLQEDGNVVIY   98 (109)
T ss_dssp             ---CCCCSSCCEEEECTTSCEEEE
T ss_pred             ---EECCCCCEEEEEECCCCEEEE
T ss_conf             ---088999779999479759997

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.68  E-value=1.3e-07  Score=61.74  Aligned_cols=134  Identities=13%  Similarity=0.057  Sum_probs=91.6

Q ss_pred             CCCCCEEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCC-CCCCCCEECEEECCCCEEEEEEECCCCCHHHH
Q ss_conf             85662439999984897899999746976230999999999986258-78953031079605621489950698998887
Q 003555          518 GRGCFGAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH-HKNLVRLLGFCMQTSKKLLVYEFMSKGSLENL  596 (811)
Q Consensus       518 G~G~~g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~  596 (811)
                      +.+..+.||+...  ++..+.+|+...........+.+|...+..+. +-.+.+++.+..+.+..++||+++++.++.+.
T Consensus        23 ~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          23 EGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred             CCCCCCCEEEEEE--CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCC
T ss_conf             8998771899990--89869999848876532556999999999876069987289997508964999986043343543


Q ss_pred             HHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------------
Q ss_conf             4148999845789999999999999876216-------------------------------------------------
Q 003555          597 LSNVESGPIWRDRVRIALDVARGITYLHEEC-------------------------------------------------  627 (811)
Q Consensus       597 l~~~~~~~~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------------------  627 (811)
                      ....      .....++.++++.+..||+..                                                 
T Consensus       101 ~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         101 YEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             TTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             CCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
T ss_conf             3440------2699999989999999855684214357644656555778998776555543033232005799999999


Q ss_pred             -------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             -------88746238888968887999769970577522
Q 003555          628 -------EVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       628 -------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~  659 (811)
                             ...++|+|+.+.||+++++...-|.||+.+..
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             844986781789860047642364996599960231441

>d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]}

class: All beta proteins
fold: beta-Prism II
superfamily: alpha-D-mannose-specific plant lectins
family: alpha-D-mannose-specific plant lectins
domain: Gastrodianin (antifungal protein)
species: Gastrodia elata [TaxId: 91201]

Probab=98.65  E-value=1.4e-07  Score=61.51  Aligned_cols=110  Identities=23%  Similarity=0.325  Sum_probs=67.7

Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCCCCCCCEEEE-ECCCCEEEEEECCCCCEEEEEEEEECCCCCCCEEEECCCCEEEEEE
Q ss_conf             651115750037976973488889998206988-5289648853138962157411331267533124304786034410
Q 003555          153 THTIVGGQSLVNGSKLFSSASETNSSTGRFCLE-QRDGILVLYPVRDSRQIYWVSKLYWASDRVHGMVNLTPGGILQAGS  231 (811)
Q Consensus       153 TDTlLpgq~l~~~~~L~S~~s~~d~s~G~~~l~-~~~~~~~~~~~~~~~~~y~~~~~yw~~~~~~~~~~~~~~~~~~~~~  231 (811)
                      ||||+|||.|..|..|++         |.|.|. +.+|++++|.   ...++|.+..  ........+.++.+|.+....
T Consensus         1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~---~~~~vW~s~~--~~~~~~~~l~l~~dGnLvl~~   66 (112)
T d1xd5a_           1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYD---NNRAVWASGT--NGKASGCVLKMQNDGNLVIYS   66 (112)
T ss_dssp             CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE---TTEEEEECCC--TTSCSSEEEEECTTSCEEEEE
T ss_pred             CCEECCCCEECCCCEEEE---------CCEEEEECCCCCEEEEC---CCCEEEECCC--CCCCCCCEEEEECCCCEEEEE
T ss_conf             989069999559999987---------87999981799889873---9838998467--347888579996153499993


Q ss_pred             CCCCEEEEEEEEEEEECCCCEEEEEEEEECCCEEEEEEECCCCCCCCEEEEEEEECCCC
Q ss_conf             37410577532123406853699999930694899995136899961239984504566
Q 003555          232 ADATQILARSSYSVKSSNETVIYRATLDFDGILRLYSHHFTSDSNYRADIEWYVLQNQC  290 (811)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~dG~l~~y~w~~~~~~~~~w~~~~~~p~~~C  290 (811)
                      .... ...     ..........+++|..||+|++|.-   .     ....|+...+.|
T Consensus        67 ~~~~-~w~-----s~t~~~~~~~~l~L~ddGNlvly~~---~-----~~~~W~S~t~~~  111 (112)
T d1xd5a_          67 GSRA-IWA-----SNTNRQNGNYYLILQRDRNVVIYDN---S-----NNAIWATHTNVG  111 (112)
T ss_dssp             TTEE-EEE-----CCCCCSCCCCEEEECTTSCEEEECT---T-----SCEEEECCCCCC
T ss_pred             CCCE-EEE-----EEECCCCCCEEEEECCCCCEEEECC---C-----CCEEECCCCCCC
T ss_conf             4874-999-----8303688725999967899999989---9-----967961888569

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.22  E-value=8.4e-06  Score=50.40  Aligned_cols=132  Identities=14%  Similarity=0.137  Sum_probs=80.3

Q ss_pred             HHCCCCCC-EEEEEEEECCCCEEEEEEECCCCCHHHHHHHHHHHHHHHCCC--CCCCCCEECEEECCCCEEEEEEECCCC
Q ss_conf             21185662-439999984897899999746976230999999999986258--789530310796056214899506989
Q 003555          515 EELGRGCF-GAVYKGSICEGNKIVAVKRLENPVEEGERKFQAEMAAVRRTH--HKNLVRLLGFCMQTSKKLLVYEFMSKG  591 (811)
Q Consensus       515 ~~LG~G~~-g~Vy~~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~g  591 (811)
                      +.+..|.. ..||+..... +..+.+|......   ...+..|+..++.+.  ...+.+++.++.+.+..++|++++++.
T Consensus        16 ~~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             EECSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EECCCCCCCCEEEEEEECC-CCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECC
T ss_conf             8767865477589999389-8789999589667---76899999999999865999886132224566159998744135


Q ss_pred             CHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf             988874148999845789999999999999876-----------------------------------------------
Q 003555          592 SLENLLSNVESGPIWRDRVRIALDVARGITYLH-----------------------------------------------  624 (811)
Q Consensus       592 sL~~~l~~~~~~~~~~~~~~i~~~ia~~L~yLH-----------------------------------------------  624 (811)
                      ++.+....         ...++.++++.|.-||                                               
T Consensus        92 ~~~~~~~~---------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          92 DLLSSHLA---------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             ETTTSCCC---------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             CCCCCCCC---------HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf             54322126---------899999999999987368854488755412468899999987541101134011213799999


Q ss_pred             ----HCC----CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             ----216----88746238888968887999769970577522
Q 003555          625 ----EEC----EVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       625 ----~~~----~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~  659 (811)
                          ...    .+.++|+|+.+.||+++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             9998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.18  E-value=1.2e-05  Score=49.45  Aligned_cols=141  Identities=18%  Similarity=0.155  Sum_probs=80.2

Q ss_pred             HHCCCCCCEEEEEEEECCCCEEEEEEECCCCC-------HHHHHHHHHHHHHHHCCC-C--CCCCCEECEEECCCCEEEE
Q ss_conf             21185662439999984897899999746976-------230999999999986258-7--8953031079605621489
Q 003555          515 EELGRGCFGAVYKGSICEGNKIVAVKRLENPV-------EEGERKFQAEMAAVRRTH-H--KNLVRLLGFCMQTSKKLLV  584 (811)
Q Consensus       515 ~~LG~G~~g~Vy~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~g~~~~~~~~~lV  584 (811)
                      +.||.|....||+....++++.+.||.-....       .....+...|...+..+. +  ..+++++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf             9807985276899995799848999617713034677788877899999999998650579885528998--59887798


Q ss_pred             EEECCCCCH-HHHHHCCCCCCCHHHHHHHHH-------------------------------------------------
Q ss_conf             950698998-887414899984578999999-------------------------------------------------
Q 003555          585 YEFMSKGSL-ENLLSNVESGPIWRDRVRIAL-------------------------------------------------  614 (811)
Q Consensus       585 ~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~-------------------------------------------------  614 (811)
                      ||++++..+ ...+.........  ...+..                                                 
T Consensus       110 mE~L~~~~~~~~~l~~~~~~~~~--a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~  187 (392)
T d2pula1         110 MEDLSHLKIARKGLIEGENYPHL--SQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDT  187 (392)
T ss_dssp             ECCCTTSEEHHHHHHHTCCCTTH--HHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTT
T ss_pred             EECCCCCCCCHHHHCCCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
T ss_conf             71357765302220154212899--9999999999998735033442111012334465788877776401047889887


Q ss_pred             ------------------HHHHHHHHHH---HCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             ------------------9999999876---216887462388889688879997699705775225
Q 003555          615 ------------------DVARGITYLH---EECEVQIIHCNINPRNILLDDSLTAKISNFSLAKIL  660 (811)
Q Consensus       615 ------------------~ia~~L~yLH---~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~  660 (811)
                                        .+......|.   ...+..++|+|+.+.|||++++ .++|+||..+...
T Consensus       188 ~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G  253 (392)
T d2pula1         188 NDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  253 (392)
T ss_dssp             CCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEEE
T ss_pred             HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCCC
T ss_conf             41065455778765520789999999874323688600335776784667599-3089522652228

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.37  E-value=0.0009  Score=37.84  Aligned_cols=31  Identities=23%  Similarity=0.267  Sum_probs=25.1

Q ss_pred             CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             688746238888968887999769970577522
Q 003555          627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       627 ~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~  659 (811)
                      .+.+++|+|+.+.|||++++  ..+.||+-+..
T Consensus       190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             87120247888042878389--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.27  E-value=0.00072  Score=38.42  Aligned_cols=73  Identities=16%  Similarity=0.181  Sum_probs=43.7

Q ss_pred             HHCCCCCCEEEEEEEECCC-------CEEEEEEECCCCCHHHHHHHHHHHHHHHCCCCCCC-CCEECEEECCCCEEEEEE
Q ss_conf             2118566243999998489-------78999997469762309999999999862587895-303107960562148995
Q 003555          515 EELGRGCFGAVYKGSICEG-------NKIVAVKRLENPVEEGERKFQAEMAAVRRTHHKNL-VRLLGFCMQTSKKLLVYE  586 (811)
Q Consensus       515 ~~LG~G~~g~Vy~~~~~~~-------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e  586 (811)
                      ++|+.|-.-.+|+......       .+.|.+++.. . ........+|..+++.+.-.++ +++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf             991785334348999688775445789817999659-9-61165899999999999757999808998189----56999


Q ss_pred             ECCCCCH
Q ss_conf             0698998
Q 003555          587 FMSKGSL  593 (811)
Q Consensus       587 ~~~~gsL  593 (811)
                      |+++.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EECCCCC
T ss_conf             7345548

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.57  E-value=0.015  Score=30.17  Aligned_cols=33  Identities=15%  Similarity=0.230  Sum_probs=28.7

Q ss_pred             CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             688746238888968887999769970577522
Q 003555          627 CEVQIIHCNINPRNILLDDSLTAKISNFSLAKI  659 (811)
Q Consensus       627 ~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~  659 (811)
                      .+.+++|+|+.+.||+++.+...-|.||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             545033378636564020454126742221236

>d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Small proteins
fold: Knottins (small inhibitors, toxins, lectins)
superfamily: EGF/Laminin
family: EGF-type module
domain: Fibrillin-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.68  E-value=0.29  Score=22.25  Aligned_cols=33  Identities=36%  Similarity=0.636  Sum_probs=26.4

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             5667877888998667999999973010589996369
Q 003555          288 NQCLVKGFCGFNSFCSNPTNSSTKGECFCFRGFNFIN  324 (811)
Q Consensus       288 ~~Cd~~g~CG~~g~C~~~~~~~~~~~C~C~~Gf~~~~  324 (811)
                      |+|.+-..|| +|-|++-   .....|.|-+||+|..
T Consensus         2 dECsignpCG-nGTCtNv---iGgFec~C~~GFepgp   34 (39)
T d1emoa2           2 DECSVGNPCG-NGTCKNV---IGGFECTCEEGFEPGP   34 (39)
T ss_dssp             CGGGTTCSSS-SSCEEEC---SSSEEECCSSSSCCCS
T ss_pred             CCCCCCCCCC-CCEEEEC---CCCEEEEECCCCCCCC
T ss_conf             7331078457-8625403---4526875037767876